001-001-00-9	hydrogen	215-605-7	1333-74-0	Flam. Gas 1Press. Gas	H220	GHS02GHS04Dgr	H220	EUH001		U	CLP00
001-002-00-4	aluminium lithium hydride	240-877-9	16853-85-3	Water-react. 1Skin Corr. 1A	H260H314	GHS02GHS05Dgr	H260H314				CLP00/ATP01
001-003-00-X	sodium hydride	231-587-3	7646-69-7	Water-react. 1	H260	GHS02Dgr	H260				CLP00
001-004-00-5	calcium hydride	232-189-2	7789-78-8	Water-react. 1	H260	GHS02Dgr	H260				CLP00
003-001-00-4	lithium	231-102-5	7439-93-2	Water-react. 1Skin Corr. 1B	H260H314	GHS02GHS05Dgr	H260H314	EUH014			CLP00
003-002-00-X	n-hexyllithium	404-950-0	21369-64-2	Pyr. Sol. 1Water-react. 1Skin Corr. 1A	H250H260H314	GHS02GHS05Dgr	H260H250H314	EUH014			CLP00
003-003-00-5	(2-methylpropyl)lithium; isobutyllithium	440-620-2	920-36-5	Pyr. Liq. 1Water-react. 1STOT SE 3Skin Corr. 1AAquatic Acute 1Aquatic Chronic 1	H250H260H336H314H400H410	GHS02GHS05GHS07GHS09Dgr	H260H250H314H336H410	EUH014			ATP01
004-001-00-7	beryllium	231-150-7	7440-41-7	Carc. 1BAcute Tox. 2 *Acute Tox. 3 *STOT SE 3STOT RE 1Skin Irrit. 2Eye Irrit. 2Skin Sens. 1	H350iH330H301H335H372 **H315H319H317	GHS06GHS08Dgr	H350iH330H301H372 **H319H335H315H317				CLP00
004-002-00-2	"beryllium compounds with the exception of aluminium beryllium silicates, and with those specified elsewhere in this Annex"			Carc. 1BAcute Tox. 2 *Acute Tox. 3 *STOT SE 3STOT RE 1Skin Irrit. 2Eye Irrit. 2Skin Sens. 1Aquatic Chronic 2	H350iH330H301H335H372 **H315H319H317H411	GHS06GHS08GHS09Dgr	H350iH330H301H372 **H319H335H315H317H411			A	CLP00
004-003-00-8	beryllium oxide	215-133-1	1304-56-9	Carc. 1BAcute Tox. 2 *Acute Tox. 3 *STOT SE 3STOT RE 1Skin Irrit. 2Eye Irrit. 2Skin Sens. 1	H350iH330H301H335H372 **H315H319H317	GHS06GHS08Dgr	H350iH330H301H372 **H319H335H315H317				CLP00
005-001-00-X	boron trifluoride	231-569-5	7637-07-2	Press. GasAcute Tox. 2 *Skin Corr. 1A	H330H314	GHS04GHS06GHS05Dgr	H330H314	EUH014		U	CLP00
005-002-00-5	boron trichloride	233-658-4	10294-34-5	Press. GasAcute Tox. 2 *Acute Tox. 2 *Skin Corr. 1B	H330H300H314	GHS04GHS06GHS05Dgr	H330H300H314	EUH014		U	CLP00
005-003-00-0	boron tribromide	233-657-9	10294-33-4	Acute Tox. 2 *Acute Tox. 2 *Skin Corr. 1A	H330H300H314	GHS06GHS05Dgr	H330H300H314	EUH014			CLP00
005-004-00-6	trialkylboranes			Pyr. Sol. 1Skin Corr. 1B	H250H314	GHS02GHS05Dgr	H250H314			A	CLP00
005-004-01-3	"trialkylboranes, liquid"			Pyr. Liq. 1Skin Corr. 1B	H250H314	GHS02GHS05Dgr	H250H314			A	CLP00
005-005-00-1	trimethyl borate	204-468-9	121-43-7	Flam. Liq. 3Acute Tox. 4 *	H226H312	GHS02GHS07Wng	H226H312				CLP00
005-006-00-7	dibutyltin hydrogen borate	401-040-5	75113-37-0	Muta. 2Repr. 1BAcute Tox. 4 *Acute Tox. 4 *STOT RE 1Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H341H360FDH312H302H372 **H318H317H400H410	GHS05GHS08GHS07GHS09Dgr	H302H312H318H317H341H360FDH372 **H410				CLP00/ATP01corr
005-007-00-2	boric acid [1]boric acid [2]	233-139-2 [1]234-343-4 [2]	10043-35-3 [1]11113-50-1 [2]	Repr. 1B	H360FD	GHS08Dgr	H360FD		"Repr. 1B; H360FD: C = 5,5 %"		ATP01/ATP01corr
005-008-00-8	diboron trioxide; boric oxide	215-125-8	1303-86-2	Repr. 1B	H360FD	GHS08Dgr	H360FD		"Repr. 1B; H360FD: C ? 3,1 %"		ATP01
005-009-00-3	tetrabutylammonium butyltriphenylborate	418-080-4	120307-06-4	Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410				CLP00
005-010-00-9	"N,N-dimethylanilinium tetrakis(pentafluorophenyl)borate"	422-050-6	118612-00-3	Carc. 2Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1	H351H302H315H318	GHS08GHS05GHS07Dgr	H351H302H315H318				CLP00
005-011-00-4	"disodium tetraborate, anhydrous; boric acid, disodium salt [1]tetraboron disodium heptaoxide, hydrate [2]orthoboric acid, sodium salt  [3]"	215-540-4 [1]235-541-3 [2]237-560-2 [3]	1330-43-4 [1]12267-73-1 [2]13840-56-7 [3]	Repr. 1B	H360FD	GHS08Dgr	H360FD		"Repr. 1B; H360FD: C ? 4,5 %"		ATP01
005-011-01-1	disodium tetraborate decahydrate; borax decahydrate	215-540-4	1303-96-4	Repr. 1B	H360FD	GHS08Dgr	H360FD		"Repr. 1B; H360FD: C ? 8,5 %"		ATP01
005-011-02-9	disodium tetraborate pentahydrate; borax pentahydrate	215-540-4	12179-04-3	Repr. 1B	H360FD	GHS08Dgr	H360FD		"Repr. 1B; H360FD: C ? 6,5 %"		ATP01
005-012-00-X	"diethyl{}{4-[1,5,5-tris(4-diethylaminophenyl)penta-2,4-dienylidene]cyclohexa-2,5-dienylidene}}ammonium butyltriphenylborate"	418-070-1	141714-54-7	Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410				CLP00
005-013-00-5	diethylmethoxyborane	425-380-9	7397-46-8	Pyr. Liq. 1Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Skin Corr. 1BSkin Sens. 1Aquatic Chronic 4	H250H332H312H302H373 **H314H317H413	GHS02GHS05GHS08GHS07Dgr	H250H332H312H302H373 **H314H317H413				ATP01
005-014-00-0	4-formylphenylboronic acid	438-670-5	87199-17-5	Skin Sens. 1	H317	GHS07Wng	H317				ATP01
005-015-00-6	"1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate)"	414-380-4	140681-55-6	Acute Tox. 4 *Eye Dam. 1Skin Sens. 1Aquatic Chronic 3	H302H318H317H412	GHS05GHS07Dgr	H302H318H317H412				ATP01
005-016-00-1	tetrabutylammonium butyl tris-(4-tert-butylphenyl)borate	431-370-5	-	Aquatic Chronic 4	H413	-	H413				ATP01
005-017-00-7	"sodium perborate; [containing = 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 µm] [1]sodium peroxometaborate; sodium peroxoborate; [containing = 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 µm] [2]"	239-172-9 [1]231-556-4 [2]	15120-21-5 [1]7632-04-4 [2]	Ox. Sol. 2Repr. 1BAcute Tox. 4 *STOT SE 3Eye Dam. 1	H272H360DfH302H335H318	GHS03GHS05GHS08GHS07Dgr	H272H302H318H360DfH335		"Repr. 1B; H360Df: C = 9 %Repr. 1B; H360D: 6,5 % = C < 9 %Eye Dam. 1; H318: C = 22 %Eye Irrit. 2; H319: 14 % = C < 22 %"		ATP01/ATP01corr
005-017-01-4	"sodium perborate; [containing = 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 µm] [1]sodium peroxometaborate; sodium peroxoborate; [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 µm] [2]"	239-172-9 [1]231-556-4 [2]	15120-21-5 [1]7632-04-4 [2]	Ox. Sol. 2Repr. 1BAcute Tox. 3 *Acute Tox. 4 *STOT SE 3Eye Dam. 1	H272H360DfH331H302H335H318	GHS03GHS06GHS05GHS08Dgr	H272H302H331H318H360DfH335		"Repr. 1B; H360Df: C = 9 %Repr. 1B; H360D: 6,5 % = C < 9 %Eye Dam. 1; H318: C = 22 %Eye Irrit. 2; H319: 14 % = C < 22 %"		ATP01/ATP01corr
005-018-00-2	"perboric acid (H3BO2(O2)), monosodium salt trihydrate; [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 µm] [1]perboric acid, sodium salt, tetrahydrate; [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 µm] [2]perboric acid (HBO(O2)), sodium salt, tetrahydrate sodium peroxoborate hexahydrate; [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 µm] [3]"	239-172-9 [1]234-390-0 [2]231-556-4 [3]	13517-20-9 [1]37244-98-7 [2]10486-00-7 [3]	Repr. 1BSTOT SE 3Eye Dam. 1	H360DfH335H318	GHS05GHS08GHS07Dgr	H318H360DfH335		Repr. 1B; H360Df: C = 14 %Repr. 1B; H360D: 10 % = C < 14 %Eye Dam. 1; H318: C = 36 %Eye Irrit. 2; H319: 22 % = C < 36 %		ATP01/ATP01corr
005-018-01-X	"perboric acid (H3BO2(O2)), monosodium salt, trihydrate [1]perboric acid, sodium salt, tetrahydrate [2]perboric acid (HBO(O2)), sodium salt, tetrahydrate [3]"	239-172-9 [1]234-390-0 [2]231-556-4 [3]	13517-20-9 [1]37244-98-7 [2]10486-00-7 [3]	Repr. 1BAcute Tox. 4 *STOT SE 3Eye Dam. 1	H360DfH332H335H318	GHS05GHS08GHS07Dgr	H360DfH332H335H318		Repr. 1B; H360 Df: C ? 14 %Repr. 1B; H360D: 10 % ? C < 14 %Eye Dam. 1; H318: C ? 36 %Eye Irrit. 2; H319: 22 % ? C < 36 %		ATP01
005-019-00-8	"perboric acid, sodium salt; [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 µm] [1]perboric acid, sodium salt, monohydrate; [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 µm] [2]perboric acid (HBO(O2)), sodium salt, monohydrate; sodium peroxoborate; [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 µm] [3]"	234-390-0 [1]234-390-0 [2]231-556-4 [3]	11138-47-9 [1]12040-72-1 [2]10332-33-9 [3]	Ox. Sol. 3Repr. 1BAcute Tox. 4 *STOT SE 3Eye Dam. 1	H272H360DfH302H335H318	GHS03GHS05GHS08GHS07Dgr	H272H302H318H360DfH335		"Repr. 1B; H360Df: C = 9 %Repr. 1B; H360D: 6,5 % = C < 9 %Eye Dam. 1; H318: C = 22 %Eye Irrit. 2; H319: 14 % = C < 22 %"		ATP01/ATP01corr
005-019-01-5	"perboric acid, sodium salt [1]perboric acid, sodium salt, monohydrate; [containing = 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 µm] [2]perboric acid (HBO(O2)), sodium salt, monohydrate; sodium peroxoborate; [containing = 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 µm] [3]"	234-390-0 [1]234-390-0 [2]231-556-4 [3]	11138-47-9 [1]12040-72-1 [2]10332-33-9 [3]	Ox. Sol. 3Repr. 1BAcute Tox. 3 *Acute Tox. 4 *STOT SE 3Eye Dam. 1	H272H360DfH331H302H335H318	GHS03GHS06GHS05GHS08Dgr	H272H302H331H318H360DfH335		"Repr. 1B; H360Df: C = 9 %Repr. 1B; H360D: 6,5 % = C < 9 %Eye Dam. 1; H318: C = 22 %Eye Irrit. 2; H319: 14 % = C < 22 %"		ATP01/ATP01corr
006-001-00-2	carbon monoxide	211-128-3	630-08-0	Flam. Gas 1Press. GasRepr. 1AAcute Tox. 3 *STOT RE 1	H220H360D ***H331H372 **	GHS02GHS04GHS06GHS08Dgr	H220H360D ***H331H372 **			U	CLP00
006-002-00-8	phosgene; carbonyl chloride	200-870-3	75-44-5	Press. GasAcute Tox. 2 *Skin Corr. 1B	H330H314	GHS04GHS06GHS05Dgr	H330H314			U	CLP00
006-003-00-3	carbon disulphide	200-843-6	75-15-0	Flam. Liq. 2Repr. 2STOT RE 1Skin Irrit. 2Eye Irrit. 2	H225H361fdH372 **H315H319	GHS02GHS08GHS07Dgr	H225H361fdH372 **H319H315		"Repr. 2; H361fd: C ? 1 %STOT RE 1; H372: C ? 1 %STOT RE 2; H373: 0,2 % ?C < 1 %"		CLP00
006-004-00-9	calcium carbide	200-848-3	75-20-7	Water-react. 1	H260	GHS02Dgr	H260			T	CLP00
006-005-00-4	thiram (ISO); tetramethylthiuram disulphide	205-286-2	137-26-8	Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Skin Irrit. 2Eye Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H332H302H373 **H315H319H317H400H410	GHS08GHS07GHS09Wng	H332H302H373 **H319H315H317H410		M=10		CLP00
006-006-00-X	hydrogen cyanide; hydrocyanic acid	200-821-6	74-90-8	Flam. Liq. 1Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1	H224H330H400H410	GHS02GHS06GHS09Dgr	H224H330H410				CLP00
006-006-01-7	hydrogen cyanide ...%; hydrocyanic acid ...%	200-821-6	74-90-8	Acute Tox. 1Acute Tox. 2 *Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1	H310H330H300H400H410	GHS06GHS09Dgr	H330H310H300H410			B	CLP00
006-007-00-5	"salts of hydrogen cyanide with the exception of complex cyanides such as ferrocyanides, ferricyanides and mercuric oxycyanide and those specified elsewhere in this Annex"	-	-	Acute Tox. 1Acute Tox. 2 *Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1	H310H330H300H400H410	GHS06GHS09Dgr	H330H310H300H410	EUH032		A	CLP00/ATP01
006-008-00-0	antu (ISO); 1-(1-naphthyl)-2-thiourea	201-706-3	86-88-4	Carc. 2Acute Tox. 2 *	H351H300	GHS06GHS08Dgr	H300H351				CLP00
006-009-00-6	1-isopropyl-3-methylpyrazol-5-yl dimethylcarbamate; Isolan	204-318-2	119-38-0	Acute Tox. 1Acute Tox. 2 *	H310H300	GHS06Dgr	H310H300				CLP00
006-010-00-1	"5,5-dimethyl-3-oxocyclohex-1-enyl dimethylcarbamate 5,5-dimethyldihydroresorcinol dimethylcarbamate; Dimetan"	204-525-8	122-15-6	Acute Tox. 3 *	H301	GHS06Dgr	H301				CLP00
006-011-00-7	carbaryl (ISO); 1-naphthyl methylcarbamate	200-555-0	63-25-2	Carc. 2Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1	H351H332H302H400	GHS08GHS07GHS09Wng	H351H332H302H400		M=100		CLP00/ATP01
006-012-00-2	ziram (ISO); zinc bis dimethyldithiocarbamate	205-288-3	137-30-4	Acute Tox. 2 *Acute Tox. 4 *STOT SE 3STOT RE 2 *Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H330H302H335H373 **H318H317H400H410	GHS06GHS08GHS05GHS09Dgr	H330H302H373 **H335H318H317H410		M=100		CLP00
006-013-00-8	metam-sodium (ISO); sodium methyldithiocarbamate	205-293-0	137-42-8	Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H314H317H400H410	GHS05GHS07GHS09Dgr	H302H314H317H410	EUH031			CLP00
006-014-00-3	"nabam (ISO); disodium ethylenebis(N,N'-dithiocarbamate)"	205-547-0	142-59-6	Acute Tox. 4 *STOT SE 3Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H335H317H400H410	GHS07GHS09Wng	H302H335H317H410				CLP00
006-015-00-9	"diuron (ISO); 3-(3,4-dichlorophenyl)-1,1-dimethylurea"	206-354-4	330-54-1	Carc. 2Acute Tox. 4 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H351H302H373 **H400H410	GHS08GHS07GHS09Wng	H302H351H373 **H410		M=10		CLP00/ATP01corr
006-016-00-4	propoxur (ISO); 2-isopropyloxyphenyl N-methylcarbamate; 2-isopropoxyphenyl methylcarbamate	204-043-8	114-26-1	Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H301H400H410	GHS06GHS09Dgr	H301H410				CLP00
006-017-00-X	aldicarb (ISO); 2-methyl-2-(methylthio)propanal-O-(N-methylcarbamoyl)oxime	204-123-2	116-06-3	Acute Tox. 2 *Acute Tox. 2 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H330H300H311H400H410	GHS06GHS09Dgr	H330H300H311H410				CLP00
006-018-00-5	aminocarb (ISO); 4-dimethylamino-3-tolyl methylcarbamate	217-990-7	2032-59-9	Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H311H301H400H410	GHS06GHS09Dgr	H311H301H410				CLP00
006-019-00-0	"di-allate (ISO); S-(2,3-dichloroallyl)-N,N-diisopropylthiocarbamate"	218-961-1	2303-16-4	Carc. 2Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H351H302H400H410	GHS08GHS07GHS09Wng	H351H302H410				CLP00
006-020-00-6	barban (ISO); 4-chlorbut-2-ynyl N-(3-chlorophenyl)carbamate	202-930-4	101-27-9	Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H317H400H410	GHS07GHS09Wng	H302H317H410				CLP00
006-021-00-1	"linuron (ISO); 3-(3,4-dichlorophenyl)-1-methoxy-1-methylurea"	206-356-5	330-55-2	Carc. 2Repr. 1BAcute Tox. 4 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H351H360DfH302H373 **H400H410	GHS08GHS07GHS09Dgr	H360DfH351H302H373 **H410				CLP00
006-022-00-7	"decarbofuran (ISO); 2,3-dihydro-2-methylbenzofuran-7-yl methylcarbamate"		1563-67-3	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *	H331H311H301	GHS06Dgr	H331H311H301				CLP00
006-023-00-2	"mercaptodimethur (ISO); methiocarb (ISO); 3,5-dimethyl-4-methylthiophenyl N-methylcarbamate"	217-991-2	2032-65-7	Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H301H400H410	GHS06GHS09Dgr	H301H410				CLP00
006-024-00-8	proxan-sodium (ISO); sodium O-isopropyldithiocarbonate	205-443-5	140-93-2	Acute Tox. 4 *Skin Irrit. 2Aquatic Chronic 2	H302H315H411	GHS07GHS09Wng	H302H315H411				CLP00
006-025-00-3	"allethrin; (RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1RS,3RS;1RS,3SR)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; bioallethrin; (RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate [1]S-bioallethrin; (S)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate [2]esbiothrin; (RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate  [3]"	209-542-4 [1]249-013-5 [2]249-013-5 [3]	584-79-2 [1]28434-00-6 [2]84030-86-4 [3]	Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H332H302H400H410	GHS07GHS09Wng	H332H302H410			C	CLP00
006-026-00-9	"carbofuran (ISO); 2,3-dihydro-2,2-dimethylbenzofuran-7-yl N-methylcarbamate"	216-353-0	1563-66-2	Acute Tox. 2 *Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1	H330H300H400H410	GHS06GHS09Dgr	H330H300H410				CLP00
006-028-00-X	"dinobuton (ISO); 2-(1-methylpropyl)-4,6-dinitrophenyl isopropyl carbonate"	213-546-1	973-21-7	Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H301H400H410	GHS06GHS09Dgr	H301H410				CLP00
006-029-00-5	"dioxacarb (ISO); 2-(1,3-dioxolan-2-yl)phenyl N-methylcarbamate"	230-253-4	6988-21-2	Acute Tox. 3 *Aquatic Chronic 2	H301H411	GHS06GHS09Dgr	H301H411				CLP00
006-030-00-0	EPTC (ISO); S-ethyl dipropylthiocarbamate	212-073-8	759-94-4	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
006-031-00-6	formetanate (ISO); 3-[(EZ)-dimethylaminomethyleneamino]phenyl methylcarbamate	244-879-0	22259-30-9	Acute Tox. 2 *Acute Tox. 2 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H330H300H317H400H410	GHS06GHS09Dgr	H330H300H317H410				CLP00
006-032-00-1	monolinuron (ISO); 3-(4-chlorophenyl)-1-methoxy-1-methylurea	217-129-5	1746-81-2	Acute Tox. 4 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H302H373 **H400H410	GHS08GHS07GHS09Wng	H302H373 **H410				CLP00
006-033-00-7	"metoxuron (ISO); 3-(3-chloro-4-methoxyphenyl)-1,1-dimethylurea"	243-433-2	19937-59-8	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
006-034-00-2	pebulate (ISO); N-butyl-N-ethyl-S-propylthiocarbamate	214-215-4	1114-71-2	Acute Tox. 4 *Aquatic Chronic 2	H302H411	GHS07GHS09Wng	H302H411				CLP00
006-035-00-8	"pirimicarb (ISO); 5,6-dimethyl-2-dimethylamino-pyrimidin-4-yl N,N-dimethylcarbamate"	245-430-1	23103-98-2	Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H301H400H410	GHS06GHS09Dgr	H301H410				CLP00
006-036-00-3	benzthiazuron (ISO); 1-benzothiazol-2-yl-3-methylurea	217-685-9	1929-88-0	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
006-037-00-9	promecarb (ISO); 3-isopropyl-5-methylphenyl N-methylcarbamate	220-113-0	2631-37-0	Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H301H400H410	GHS06GHS09Dgr	H301H410				CLP00
006-038-00-4	"sulfallate (ISO); 2-chloroallyl N,N-dimethyldithiocarbamate"	202-388-9	95-06-7	Carc. 1BAcute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H350H302H400H410	GHS08GHS07GHS09Dgr	H350H302H410				CLP00
006-039-00-X	"tri-allate (ISO); S-2,3,3-trichloroallyl diisopropylthiocarbamate"	218-962-7	2303-17-5	Acute Tox. 4 *STOT RE 2 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H373 **H317H400H410	GHS08GHS07GHS09Wng	H302H373 **H317H410				CLP00
006-040-00-5	3-methylpyrazol-5-yl-dimethylcarbamate; monometilan		2532-43-6	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *	H331H311H301	GHS06Dgr	H331H311H301				CLP00
006-041-00-0	dimethylcarbamoyl chloride	201-208-6	79-44-7	Carc. 1BAcute Tox. 3 *Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Irrit. 2	H350H331H302H335H315H319	GHS06GHS08Dgr	H350H331H302H319H335H315		"Carc. 1B; H350: C ? 0,001 %"		CLP00
006-042-00-6	"monuron (ISO); 3-(4-chlorophenyl)-1,1-dimethylurea"	205-766-1	150-68-5	Carc. 2Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H351H302H400H410	GHS08GHS07GHS09Wng	H351H302H410				CLP00
006-043-00-1	"3-(4-chlorophenyl)-1,1-dimethyluronium trichloroacetate; monuron-TCA"		140-41-0	Carc. 2Skin Irrit. 2Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H351H315H319H400H410	GHS08GHS07GHS09Wng	H351H319H315H410				CLP00
006-044-00-7	"isoproturon (ISO); 3-(4-isopropylphenyl)-1,1-dimethylurea"	251-835-4	34123-59-6	Carc. 2Aquatic Acute 1Aquatic Chronic 1	H351H400H410	GHS08GHS09Wng	H351H410		M=10		CLP00
006-045-00-2	methomyl (ISO); 1-(methylthio)ethylideneamino N-methylcarbamate	240-815-0	16752-77-5	Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1	H300H400H410	GHS06GHS09Dgr	H300H410		M=100		CLP00/ATP01
006-046-00-8	"bendiocarb (ISO); 2,2-dimethyl-1,3-benzodioxol-4-yl N-methylcarbamate"	245-216-8	22781-23-3	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H331H301H312H400H410	GHS06GHS09Dgr	H331H301H312H410				CLP00
006-047-00-3	bufencarb (ISO); reaction mass of 3-(1-methylbutyl)phenyl N-methylcarbamate and 3-(1-ethylpropyl)phenyl N-methylcarbamate		8065-36-9	Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H311H301H400H410	GHS06GHS09Dgr	H311H301H410				CLP00
006-048-00-9	ethiofencarb (ISO); 2-(ethylthiomethyl)phenyl N-methylcarbamate	249-981-9	29973-13-5	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410				CLP00
006-049-00-4	"dixanthogen; O,O-diethyl dithiobis(thioformate)"	207-944-4	502-55-6	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
006-050-00-X	"1,1-dimethyl-3-phenyluronium trichloroacetate; fenuron-TCA"		4482-55-7	Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H315H400H410	GHS07GHS09Wng	H315H410				CLP00
006-051-00-5	ferbam (ISO); iron tris(dimethyldithiocarbamate)	238-484-2	14484-64-1	STOT SE 3Skin Irrit. 2Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H335H315H319H400H410	GHS07GHS09Wng	H319H335H315H410				CLP00
006-052-00-0	"formetanate hydrochloride; 3-(N,N-dimethylaminomethyleneamino)phenyl N-methylcarbamate"	245-656-0	23422-53-9	Acute Tox. 2 *Acute Tox. 2 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H330H300H317H400H410	GHS06GHS09Dgr	H330H300H317H410				CLP00
006-053-00-6	isoprocarb (ISO); 2-isopropylphenyl N-methylcarbamate	220-114-6	2631-40-5	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410				CLP00
006-054-00-1	"mexacarbate (ISO); 3,5-dimethyl-4-dimethylaminophenyl N-methylcarbamate"	206-249-3	315-18-4	Acute Tox. 2 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H300H312H400H410	GHS06GHS09Dgr	H300H312H410				CLP00
006-055-00-7	"xylylcarb (ISO); 3,4-dimethylphenyl N-methylcarbamate; 3,4-xylyl methylcarbamate; MPMC"	219-364-9	2425-10-7	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410				CLP00
006-056-00-2	metolcarb (ISO); m-tolyl methylcarbamate; MTMC	214-446-0	1129-41-5	Acute Tox. 4 *Aquatic Chronic 2	H302H411	GHS07GHS09Wng	H302H411				CLP00
006-057-00-8	nitrapyrin (ISO); 2-chloro-6-trichloromethylpyridine	217-682-2	1929-82-4	Acute Tox. 4 *Aquatic Chronic 2	H302H411	GHS07GHS09Wng	H302H411				CLP00
006-058-00-3	"noruron (ISO); 1,1-dimethyl-3-(perhydro-4,7-methanoinden-5-yl)urea"		2163-79-3	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
006-059-00-9	"oxamyl (ISO); N',N'-dimethylcarbamoyl(methylthio)methylenamine N-methylcarbamate"	245-445-3	23135-22-0	Acute Tox. 2 *Acute Tox. 2 *Acute Tox. 4 *Aquatic Chronic 2	H330H300H312H411	GHS06GHS09Dgr	H330H300H312H411				CLP00
006-060-00-4	"oxycarboxin (ISO); 2,3-dihydro-6-methyl-5-(N-phenylcarbamoyl)-1,4-oxothiine 4,4-dioxide"	226-066-2	5259-88-1	Acute Tox. 4 *Aquatic Chronic 3	H302H412	GHS07Wng	H302H412				CLP00
006-061-00-X	S-ethyl N-(dimethylaminopropyl)thiocarbamatehydrochloride; prothiocarb hydrochloride	243-193-9	19622-19-6	Acute Tox. 4 *Aquatic Chronic 2	H302H411	GHS07GHS09Wng	H302H411				CLP00
006-062-00-5	"methyl 3,4-dichlorophenylcarbanilate; SWEP."		1918-18-9	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
006-063-00-0	thiobencarb (ISO); S-4-chlorobenzyl diethylthiocarbamate	248-924-5	28249-77-6	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410				CLP00
006-064-00-6	"thiofanox (ISO); 3,3-dimethyl-1-(methylthio)butanone-O-(N-methylcarbamoyl)oxime"	254-346-4	39196-18-4	Acute Tox. 1Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1	H310H300H400H410	GHS06GHS09Dgr	H310H300H410				CLP00
006-065-00-1	"3-chloro-6-cyano-bicyclo(2,2,1)heptan-2-one-O-(N-methylcarbamoyl)oxime; triamid"		15271-41-7	Acute Tox. 2 *Acute Tox. 3 *Aquatic Chronic 2	H300H311H411	GHS06GHS09Dgr	H300H311H411				CLP00
006-066-00-7	vernolate (ISO); S-propyl dipropylthiocarbamate	217-681-7	1929-77-7	Acute Tox. 4 *Aquatic Chronic 2	H302H411	GHS07GHS09Wng	H302H411				CLP00
006-067-00-2	"XMC; 3,5-xylyl methylcarbamate"		2655-14-3	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
006-068-00-8	diazomethane	206-382-7	334-88-3	Carc. 1B	H350	GHS08Dgr	H350				CLP00
006-069-00-3	"thiophanate-methyl (ISO); 1,2-di-(3-methoxycarbonyl-2-thioureido)benzene"	245-740-7	23564-05-8	Muta. 2Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H341H332H317H400H410	GHS08GHS07GHS09Wng	H341H332H317H410				CLP00
006-070-00-9	"furmecyclox (ISO); N-cyclohexyl-N-methoxy-2,5-dimethyl-3-furamide"	262-302-0	60568-05-0	Carc. 2Aquatic Acute 1Aquatic Chronic 1	H351H400H410	GHS08GHS09Wng	H351H410				CLP00
006-071-00-4	cyclooct-4-en-1-yl methyl carbonate	401-620-8	87731-18-8	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
006-072-00-X	"prosulfocarb(ISO); S-benzyl N,N-dipropylthiocarbamate"	401-730-6	52888-80-9	Acute Tox. 4 *Skin Sens. 1Aquatic Chronic 2	H302H317H411	GHS07GHS09Wng	H302H317H411				CLP00
006-073-00-5	3-(dimethylamino)propylurea	401-950-2	31506-43-1	Eye Dam. 1	H318	GHS05Dgr	H318				CLP00
006-074-00-0	2-(3-(prop-1-en-2-yl)phenyl)prop-2-yl isocyanate	402-440-2	2094-99-7	Acute Tox. 2 *STOT RE 2 *Skin Corr. 1BResp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H330H373 **H314H334H317H400H410	GHS06GHS08GHS05GHS09Dgr	H330H314H373 **H334H317H410				CLP00
006-076-00-1	mancozeb (ISO); manganese ethylenebis(dithiocarbamate) (polymeric) complex with zinc salt	-	8018-01-7	Repr. 2Skin Sens. 1Aquatic Acute 1	H361d ***H317H400	GHS08GHS07GHS09Wng	H361d ***H317H400		M=10		CLP00/ATP01
006-077-00-7	maneb (ISO); manganese ethylenebis(dithiocarbamate) (polymeric)	235-654-8	12427-38-2	Repr. 2Acute Tox. 4 *Eye Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H361d ***H332H319H317H400H410	GHS08GHS07GHS09Wng	H361d ***H332H319H317H410		M=10		CLP00/ATP01
006-078-00-2	zineb (ISO); zinc ethylenebis(dithiocarbamate) (polymeric)	235-180-1	12122-67-7	STOT SE 3Skin Sens. 1	H335H317	GHS07Wng	H335H317				CLP00
006-079-00-8	disulfiram; tetraethylthiuramdisulfide	202-607-8	97-77-8	Acute Tox. 4 *STOT RE 2 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H373 **H317H400H410	GHS08GHS07GHS09Wng	H302H373 **H317H410				CLP00
006-080-00-3	tetramethylthiuram monosulphide	202-605-7	97-74-5	Acute Tox. 4 *Skin Sens. 1Aquatic Chronic 2	H302H317H411	GHS07GHS09Wng	H302H317H411				CLP00
006-081-00-9	zinc bis(dibutyldithiocarbamate)	205-232-8	136-23-2	STOT SE 3Skin Irrit. 2Eye Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H335H315H319H317H400H410	GHS07GHS09Wng	H319H335H315H317H410				CLP00
006-082-00-4	zinc bis(diethyldithiocarbamate)	238-270-9	14324-55-1	Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H335H315H319H317H400H410	GHS07GHS09Wng	H302H319H335H315H317H410				CLP00
006-083-00-X	butocarboxim (ISO); 3-(methylthio)-2-butanone O-[(methylamino)carbonyl]oxime	252-139-3	34681-10-2	Flam. Liq. 3Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H226H331H311H301H319H400H410	GHS02GHS06GHS09Dgr	H226H331H311H301H319H410				CLP00
006-084-00-5	"carbosulfan (ISO); 2,3-dihydro-2,2-dimethyl-7-benzofuryl [(dibutylamino)thio]methylcarbamate"	259-565-9	55285-14-8	Acute Tox. 2 *Acute Tox. 3 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H330H301H317H400H410	GHS06GHS09Dgr	H330H301H317H410				CLP00/ATP01
006-085-00-0	fenobucarb (ISO); 2-butylphenyl methylcarbamate	223-188-8	3766-81-2	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410				CLP00
006-086-00-6	fenoxycarb (ISO); ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate	276-696-7	72490-01-8	Carc. 2Aquatic Acute 1Aquatic Chronic 1	H351H400H410	GHS08GHS09Wng	H351H410		M=1M=10000		CLP00/ATP06
006-087-00-1	"furathiocarb (ISO); 2,3-dihydro-2,2-dimethyl-7-benzofuryl 2,4-dimethyl-6-oxa-5-oxo-3-thia-2,4-diazadecanoate"	265-974-3	65907-30-4	Acute Tox. 2 *Acute Tox. 3 *STOT RE 2 *Skin Irrit. 2Eye Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H330H301H373 **H315H319H317H400H410	GHS06GHS08GHS09Dgr	H301H330H315H319H317H373 **H410		M=100		CLP00/ATP01corr
006-088-00-7	"benfuracarb (ISO); ethyl N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl- ?-alaninate"	-	82560-54-1	Repr. 2Acute Tox. 3 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H361f ***H331H302H400H410	GHS06GHS08GHS09Dgr	H361f ***H331H302H410				CLP00/ATP01
006-090-00-8	2-(3-iodoprop-2-yn-1-yloxy)ethyl phenylcarbamate	408-010-0	88558-41-2	Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 3	H332H318H412	GHS05GHS07Dgr	H332H318H412				CLP00
006-091-00-3	propineb (ISO); polymeric zinc propylenebis(dithiocarbamate)	-	9016-72-2	Acute Tox. 4 *STOT RE 2 *Skin Sens. 1Aquatic Acute 1	H332H373 **H317H400	GHS08GHS07GHS09Wng	H332H373 **H317H400				ATP01
006-092-00-9	tert-butyl (1S)-N-[1-((2S)-2-oxiranyl)-2-phenylethyl]carbamate	425-420-5	98737-29-2	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				ATP01
006-093-00-4	"2,2'-dithio di(ethylammonium)-bis(dibenzyldithiocarbamate)"	427-180-7	-	Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H317H400H410	GHS07GHS09Wng	H302H317H410				ATP01
006-094-00-X	O-isobutyl-N-ethoxy carbonylthiocarbamate	434-350-4	103122-66-3	Flam. Liq. 3Carc. 1BMuta. 1BAcute Tox. 4 *STOT RE 2 *Skin Sens. 1Aquatic Chronic 2	H226H350H340H302H373 **H317H411	GHS02GHS08GHS07GHS09Dgr	H226H350H340H302H373 **H317H411				ATP01
006-095-00-5	fosetyl-aluminium (ISO); aluminium triethyl triphosphonate	254-320-2	39148-24-8	Eye Dam. 1	H318	GHS05Dgr	H318				ATP01
006-096-00-0	chlorpropham (ISO); isopropyl 3-chlorocarbanilate	202-925-7	101-21-3	Carc. 2STOT RE 2 *Aquatic Chronic 2	H351H373 **H411	GHS08GHS09Wng	H351H373 **H411				ATP01
006-097-00-6	1-phenyl-3-(p-toluenesulfonyl)urea	424-620-1	13909-63-2	Acute Tox. 4 *STOT RE 2 *Aquatic Chronic 3	H302H373 **H412	GHS08GHS07Wng	H302H373 **H412				ATP01
006-098-00-1	"tert-butyl (1R,5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamate"	429-170-8	134575-17-0	Acute Tox. 4 *STOT RE 2 *Eye Dam. 1Skin Sens. 1	H302H373 **H318H317	GHS05GHS08GHS07Dgr	H302H318H317H373 **				ATP01/ATP01corr
006-099-00-7	N-(p-toluenesulfonyl)-N'-(3-(p-toluenesulfonyloxy)phenyl)urea; 3-({[(4-methylphenyl)sulfonyl]carbamoyl}amino)phenyl 4-methylbenzenesulfonate	432-520-2	232938-43-1	Aquatic Chronic 2	H411	GHS09	H411				ATP01
006-101-00-6	"reaction mass of: N,N''-(methylenedi-4,1-phenylene)bis[N'-phenylurea]; N-(4-[[4-[[(phenylamino)carbonyl]amino]phenylmethyl]phenyl]-N'-cyclohexylurea; N,N''-(methylenedi-4,1-phenylene)bis[N'-cyclohexylurea]"	423-070-8	-	Aquatic Chronic 4	H413	-	H413				ATP01
006-102-00-1	O-hexyl-N-ethoxycarbonylthiocarbamate	432-750-3	-	Carc. 1BMuta. 1BAcute Tox. 4 *STOT RE 2 *Skin Sens. 1Aquatic Chronic 2	H350H340H302H373 **H317H411	GHS08GHS07GHS09Dgr	H350H340H302H373 **H317H411				ATP01
006-103-00-7	"N,N''-(methylenedi-4,1-phenylene)bis[N'-octyl]urea"	445-760-8	-	Eye Dam. 1Resp. Sens. 1Aquatic Acute 1Aquatic Chronic 1	H318H334H400H410	GHS05GHS08GHS09Dgr	H318H334H410		M=100		ATP01
007-001-00-5	"ammonia, anhydrous"	231-635-3	7664-41-7	Flam. Gas 2Press. GasAcute Tox. 3 *Skin Corr. 1BAquatic Acute 1	H221H331H314H400	GHS04GHS06GHS05GHS09Dgr	H221H331H314H400			U	CLP00
007-001-01-2	ammonia ....%	215-647-6	1336-21-6	Skin Corr. 1BAquatic Acute 1	H314H400	GHS05GHS09Dgr	H314H400		STOT SE 3; H335: C ? 5 %	B	CLP00
007-002-00-0	nitrogen dioxide [1]dinitrogen tetraoxide  [2]	233-272-6 [1]234-126-4 [2]	10102-44-0 [1]10544-72-6 [2]	Ox. Gas 1Press. GasAcute Tox. 2 *Skin Corr. 1B	H270H330H314	GHS04GHS03GHS06GHS05Dgr	H270H330H314		"*STOT SE 3; H335: C ? 0,5 %"	5 	CLP00/ATP01
007-003-00-6	chlormequat chloride (ISO); 2-chloroethyltrimethylammonium chloride	213-666-4	999-81-5	Acute Tox. 4 *Acute Tox. 4 *	H312H302	GHS07Wng	H312H302				CLP00
007-004-00-1	nitric acid ... %	231-714-2	7697-37-2	Ox. Liq. 2Skin Corr. 1A	H272H314	GHS03GHS05Dgr	H272H314	EUH071	Ox. Liq. 2; H272: C ? 99 %Ox. Liq. 3; H272: 65 % ? C < 99 %Skin Corr. 1A; H314: C ? 20 %Skin Corr. 1B; H314: 5 % ? C < 20 %	B	CLP00/ATP07
007-006-00-2	ethyl nitrite	203-722-6	109-95-5	Flam. Gas 1Press. GasAcute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *	H220H332H312H302	GHS02GHS04GHS07Dgr	H220H332H312H302			U	CLP00
007-007-00-8	ethyl nitrate	210-903-3	625-58-1	Unst. Expl.	H200	GHS01Dgr	H200				CLP00/ATP01corr
007-008-00-3	hydrazine	206-114-9	302-01-2	Flam. Liq. 3Carc. 1BAcute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H226H350H331H311H301H314H317H400H410	GHS02GHS06GHS08GHS05GHS09Dgr	H226H350H331H311H301H314H317H410		Skin Corr. 1B; H314: C ? 10 %Skin Irrit. 2; H315: 3 % ? C < 10 %Eye Irrit. 2; H319: 3 % ? C < 10 %		CLP00
007-009-00-9	dicyclohexylammonium nitrite	221-515-9	3129-91-7	Acute Tox. 4 *Acute Tox. 4 *	H332H302	GHS07Wng	H332H302		*		CLP00
007-010-00-4	sodium nitrite	231-555-9	7632-00-0	Ox. Sol. 3Acute Tox. 3 *Aquatic Acute 1	H272H301H400	GHS03GHS06GHS09Dgr	H272H301H400		*		CLP00
007-011-00-X	potassium nitrite	231-832-4	7758-09-0	Ox. Sol. 2Acute Tox. 3 *Aquatic Acute 1	H272H301H400	GHS03GHS06GHS09Dgr	H272H301H400		*		CLP00
007-012-00-5	"N,N-dimethylhydrazine"	200-316-0	57-14-7	Flam. Liq. 2Carc. 1BAcute Tox. 3 *Acute Tox. 3 *Skin Corr. 1BAquatic Chronic 2	H225H350H331H301H314H411	GHS02GHS06GHS08GHS05GHS09Dgr	H225H350H331H301H314H411				CLP00
007-013-00-0	"1,2-dimethylhydrazine"		540-73-8	Carc. 1BAcute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Aquatic Chronic 2	H350H331H311H301H411	GHS06GHS08GHS09Dgr	H350H331H311H301H411		"Carc. 1B; H350: C ? 0,01 %"		CLP00
007-014-00-6	salts of hydrazine			Carc. 1BAcute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350H331H311H301H317H400H410	GHS06GHS08GHS09Dgr	H350H331H311H301H317H410			A	CLP00
007-015-00-1	O-ethylhydroxylamine	402-030-3	624-86-2	Flam. Liq. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 1Eye Irrit. 2Skin Sens. 1Aquatic Acute 1	H225H331H311H301H372 **H319H317H400	GHS02GHS06GHS08GHS09Dgr	H225H331H311H301H372 **H319H317H400				CLP00
007-016-00-7	butyl nitrite	208-862-1	544-16-1	Flam. Liq. 2Acute Tox. 3 *Acute Tox. 3 *	H225H331H301	GHS02GHS06Dgr	H225H331H301				CLP00
007-017-00-2	isobutyl nitrite	208-819-7	542-56-3	Flam. Liq. 2Carc. 1BMuta. 2Acute Tox. 4 *Acute Tox. 4 *	H225H350H341H332H302	GHS02GHS08GHS07Dgr	H225H350H341H332H302				CLP00
007-018-00-8	sec-butyl nitrite	213-104-8	924-43-6	Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *	H225H332H302	GHS02GHS07Dgr	H225H332H302				CLP00
007-019-00-3	tert-butyl nitrite	208-757-0	540-80-7	Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *	H225H332H302	GHS02GHS07Dgr	H225H332H302				CLP00
007-020-00-9	"pentyl nitrite [1]‘amyl nitrite’, mixed isomers  [2]"	207-332-7 [1]203-770-8 [2]	463-04-7 [1]110-46-3 [2]	Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *	H225H332H302	GHS02GHS07Dgr	H225H332H302				CLP00
007-021-00-4	"hydrazobenzene; 1,2-diphenylhydrazine"	204-563-5	122-66-7	Carc. 1BAcute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H350H302H400H410	GHS08GHS07GHS09Dgr	H350H302H410				CLP00
007-022-00-X	hydrazine bis(3-carboxy-4-hydroxybenzensulfonate)	405-030-1		Carc. 1BAcute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Chronic 3	H350H302H314H317H412	GHS08GHS05GHS07Dgr	H350H302H314H317H412				CLP00
007-023-00-5	"sodium 3,5-bis(3-(2,4-di-tert-pentylphenoxy)propylcarbamoyl)benzenesulfonate"	405-510-0		Skin Irrit. 2Skin Sens. 1	H315H317	GHS07Wng	H315H317				CLP00
007-024-00-0	2-(decylthio)ethylammonium chloride	405-640-8	36362-09-1	STOT RE 2 *Skin Irrit. 2Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H373 **H315H318H400H410	GHS08GHS05GHS09Dgr	H373 **H315H318H410				CLP00
007-025-00-6	(4-hydrazinophenyl)-N-methylmethanesulfonamide hydrochloride	406-090-1	81880-96-8	Muta. 2Acute Tox. 3 *STOT RE 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H341H301H372 **H317H400H410	GHS06GHS08GHS09Dgr	H341H301H372 **H317H410				CLP00
007-026-00-1	"oxo-((2,2,6,6-tetramethylpiperidin-4-yl)amino)carbonylacetohydrazide"	413-230-5	122035-71-6	Eye Dam. 1Skin Sens. 1	H318H317	GHS05GHS07Dgr	H318H317				CLP00
007-027-00-7	"1,6-bis(3,3-bis((1-methylpentylidenimino)propyl)ureido)hexane"	420-190-2	771478-66-1	Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H312H302H373 **H314H317H400H410	GHS08GHS05GHS07GHS09Dgr	H312H302H373 **H314H317H410				CLP00
007-028-00-2	hydroxylammonium nitrate	236-691-2	13465-08-2	Expl. 1.1 ****Carc. 2Acute Tox. 3 *Acute Tox. 4 *STOT RE 2 *Skin Irrit. 2Eye Irrit. 2Skin Sens. 1Aquatic Acute 1	H201H351H311H302H373 **H315H319H317H400	GHS01GHS06GHS08GHS09Dgr	H201H351H311H302H373 **H319H315H317H400				ATP01
007-029-00-8	diethyldimethylammonium hydroxide	419-400-5	95500-19-9	Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1A	H312H302H314	GHS05GHS07Dgr	H312H302H314				ATP01
008-001-00-8	oxygen	231-956-9	7782-44-7	Ox. Gas 1Press. Gas	H270	GHS03GHS04Dgr	H270			U	CLP00
008-003-00-9	hydrogen peroxide solution ...%	231-765-0	7722-84-1	Ox. Liq. 1Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1A	H271H332H302H314	GHS03GHS05GHS07Dgr	H271H332H302H314		Ox. Liq. 1; H271: C ? 70 %****Ox. Liq. 2; H272: 50 % ? C < 70 % *****Skin Corr. 1A; H314: C ? 70 %Skin Corr. 1B; H314: 50 % ? C < 70 %Skin Irrit. 2; H315: 35 % ? C < 50 %Eye Dam. 1; H318: 8 % ? C < 50 %Eye Irrit. 2; H319: 5 % ? C < 8 %STOT SE 3; H335; C ? 35 %	B	CLP00
009-001-00-0	fluorine	231-954-8	7782-41-4	Ox. Gas 1Press. GasAcute Tox. 2 *Skin Corr. 1A	H270H330H314	GHS04GHS03GHS06GHS05Dgr	H270H330H314				CLP00/ATP01
009-002-00-6	hydrogen fluoride	231-634-8	7664-39-3	Acute Tox. 1Acute Tox. 2 *Acute Tox. 2 *Skin Corr. 1A	H310H330H300H314	GHS06GHS05Dgr	H330H310H300H314				CLP00
009-003-00-1	hydrofluoric acid ... %	231-634-8	7664-39-3	Acute Tox. 1Acute Tox. 2 *Acute Tox. 2 *Skin Corr. 1A	H310H330H300H314	GHS06GHS05Dgr	H330H310H300H314		"Skin Corr. 1A; H314: C ? 7 %Skin Corr. 1B; H314: 1 % ? C < 7 %Eye Irrit. 2; H319: 0,1 % ? C < 1 %"	B	CLP00
009-004-00-7	sodium fluoride	231-667-8	7681-49-4	Acute Tox. 3 *Skin Irrit. 2Eye Irrit. 2	H301H315H319	GHS06Dgr	H301H319H315	EUH032			CLP00
009-005-00-2	potassium fluoride	232-151-5	7789-23-3	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *	H331H311H301	GHS06Dgr	H331H311H301				CLP00
009-006-00-8	ammonium fluoride	235-185-9	12125-01-8	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *	H331H311H301	GHS06Dgr	H331H311H301				CLP00
009-007-00-3	sodium bifluoride; sodium hydrogen difluoride	215-608-3	1333-83-1	Acute Tox. 3 *Skin Corr. 1B	H301H314	GHS06GHS05Dgr	H301H314		"*Skin Corr. 1B; H314: C ? 1 %Skin Irrit. 2; H315: 0,1 % ? C < 1 %Eye Irrit. 2; H319: 0,1 % ? C < 1 %"		CLP00
009-008-00-9	potassium bifluoride; potassium hydrogen difluoride	232-156-2	7789-29-9	Acute Tox. 3 *Skin Corr. 1B	H301H314	GHS06GHS05Dgr	H301H314		"*Skin Corr. 1B; H314: C ? 1 %Skin Irrit. 2; H315: 0,1 % ? C < 1 %Eye Irrit. 2; H319: 0,1 % ? C < 1 %"		CLP00
009-009-00-4	ammonium bifluoride; ammonium hydrogen difluoride	215-676-4	1341-49-7	Acute Tox. 3 *Skin Corr. 1B	H301H314	GHS06GHS05Dgr	H301H314		"*Skin Corr. 1B; H314: C ? 1 %Skin Irrit. 2; H315: 0,1 % ? C < 1 %Eye Irrit. 2; H319: 0,1 % ? C < 1 %"		CLP00
009-010-00-X	fluoroboric acid ... %	240-898-3	16872-11-0	Skin Corr. 1B	H314	GHS05Dgr	H314		Skin Corr. 1B; H314: C ? 25 %Skin Irrit. 2; H315: 10 % ? C < 25 %Eye Irrit. 2; H319: 10 % ? C < 25 %	B	CLP00
009-011-00-5	fluorosilicic acid ... %	241-034-8	16961-83-4	Skin Corr. 1B	H314	GHS05Dgr	H314			B	CLP00
009-012-00-0	alkali fluorosilicates(Na) [1]alkali fluorosilicates(K) [2]alkali fluorosilicates(NH4)  [3]	240-934-8 [1]240-896-2 [2]240-968-3 [3]	16893-85-9 [1]16871-90-2 [2]16919-19-0 [3]	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *	H331H311H301	GHS06Dgr	H331H311H301		*	A	CLP00
009-013-00-6	"fluorosilicates, with the exception of those specified elsewhere in this annex"			Acute Tox. 4 *	H302	GHS07Wng	H302		*	A	CLP00
009-014-00-1	lead hexafluorosilicate	247-278-1	25808-74-6	Repr. 1AAcute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H360DfH332H302H373 **H400H410	GHS08GHS07GHS09Dgr	H360DfH332H302H373 **H410			1 	CLP00
009-015-00-7	sulphuryl difluoride	220-281-5	2699-79-8	Press. GasAcute Tox. 3 *STOT RE 2 *Aquatic Acute 1	H331H373 **H400	GHS04GHS06GHS08GHS09Dgr	H331H373 **H400			U	CLP00
009-016-00-2	trisodium hexafluoroaluminate [1]trisodium hexafluoroaluminate (cryolite) [2]	237-410-6 [1]239-148-8 [2]	13775-53-6 [1]15096-52-3 [2]	Acute Tox. 4STOT RE 1Aquatic Chronic 2	H332H372H411	GHS07GHS08GHS09Dgr	H372H332H411				CLP00/ATP03
009-017-00-8	potassium mu-fluoro-bis(triethylaluminium)	400-040-2	12091-08-6	Flam. Sol. 1Water-react. 1Acute Tox. 4 *Skin Corr. 1A	H228H260H332H314	GHS02GHS05GHS07Dgr	H228H260H332H314	EUH014		T	CLP00
009-018-00-3	magnesium hexafluorosilicate	241-022-2	16949-65-8	Acute Tox. 3 *	H301	GHS06Dgr	H301		*		CLP00
011-001-00-0	sodium	231-132-9	7440-23-5	Water-react. 1Skin Corr. 1B	H260H314	GHS02GHS05Dgr	H260H314	EUH014			CLP00
011-002-00-6	sodium hydroxide; caustic soda	215-185-5	1310-73-2	Skin Corr. 1A	H314	GHS05Dgr	H314		"Skin Corr. 1A; H314: C ? 5 %Skin Corr. 1B; H314: 2 % ? C < 5 %Skin Irrit. 2; H315: 0,5 % ? C < 2 %Eye Irrit. 2; H319: 0,5 % ? C < 2 %"		CLP00
011-003-00-1	sodium peroxide	215-209-4	1313-60-6	Ox. Sol. 1Skin Corr. 1A	H271H314	GHS03GHS05Dgr	H271H314				CLP00
011-004-00-7	sodium azide	247-852-1	26628-22-8	Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1	H300H400H410	GHS06GHS09Dgr	H300H400H410	EUH032			CLP00
011-005-00-2	sodium carbonate	207-838-8	497-19-8	Eye Irrit. 2	H319	GHS07Wng	H319				CLP00
011-006-00-8	sodium cyanate	213-030-6	917-61-3	Acute Tox. 4 *Aquatic Chronic 3	H302H412	GHS07Wng	H302H412				CLP00
011-007-00-3	propoxycarbazone-sodium		181274-15-7	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410		M=10		CLP00
012-001-00-3	magnesium powder (pyrophoric)	231-104-6	7439-95-4	Pyr. Sol. 1Water-react. 1	H250H260	GHS02Dgr	H260H250			T	CLP00
012-002-00-9	"magnesium, powder or turnings"	231-104-6		Flam. Sol. 1Self-heat. 1Water-react. 2	H228H252H261	GHS02Dgr	H228H261H252			T	CLP00
012-003-00-4	magnesium alkyls			Pyr. Liq. 1Water-react. 1Skin Corr. 1B	H250H260H314	GHS02GHS05Dgr	H250H260H314	EUH014		A	CLP00
012-004-00-X	aluminium-magnesium-carbonate-hydroxide-perchlorate-hydrate	422-150-1	-	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				ATP01
013-001-00-6	aluminium powder (pyrophoric)	231-072-3	7429-90-5	Pyr. Sol. 1Water-react. 2	H250H261	GHS02Dgr	H261H250			T	CLP00
013-002-00-1	aluminium powder (stabilised)	231-072-3	7429-90-5	Flam. Sol. 1Water-react. 2	H228H261	GHS02Dgr	H261H228			T	CLP00/ATP01
013-003-00-7	"aluminium chloride, anhydrous"	231-208-1	7446-70-0	Skin Corr. 1B	H314	GHS05Dgr	H314				CLP00
013-004-00-2	aluminium alkyls			Pyr. Liq. 1Water-react. 1Skin Corr. 1B	H250H260H314	GHS02GHS05Dgr	H250H260H314	EUH014		A	CLP00
013-005-00-8	diethyl(ethyldimethylsilanolato)aluminium	401-160-8	55426-95-4	Pyr. Liq. 1Water-react. 1Skin Corr. 1A	H250H260H314	GHS02GHS05Dgr	H260H250H314	EUH014			CLP00
013-006-00-3	"(ethyl-3-oxobutanoato-O'1,O'3)(2-dimethylaminoethanolato)(1-methoxypropan-2-olato)aluminium(III), dimerised"	402-370-2		Flam. Liq. 3Eye Dam. 1	H226H318	GHS02GHS05Dgr	H226H318				CLP00
013-007-00-9	"poly(oxo(2-butoxyethyl-3-oxobutanoato-O'1,O'3)aluminium)"	403-430-0		Eye Dam. 1	H318	GHS05Dgr	H318				CLP00
013-008-00-4	di-n-octylaluminium iodide	408-190-0	7585-14-0	Pyr. Liq. 1Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1	H250H314H400H410	GHS02GHS05GHS09Dgr	H250H314H410	EUH014			CLP00
013-009-00-X	"sodium((n-butyl)x(ethyl)y-1,5-dihydro)aluminate) x = 0,5, y = 1,5"	418-720-2		Flam. Sol. 1Pyr. Sol. 1Water-react. 1Acute Tox. 4 *Skin Corr. 1A	H228H250H260H332H314	GHS02GHS05GHS07Dgr	H228H260H250H332H314	EUH014		T	CLP00
013-010-00-5	"hydroxy aluminium bis(2,4,8,10-tetra-tert-butyl-6-hydroxy-12H-dibenzo[d,g][1.3.2]dioxaphosphocin-6-oxide)"	430-650-4	151841-65-5	Aquatic Chronic 2	H411	GHS09	H411				ATP01
014-001-00-9	trichlorosilane	233-042-5	10025-78-2	Flam. Liq. 1Pyr. Liq. 1Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1A	H224H250H332H302H314	GHS02GHS05GHS07Dgr	H224H250H332H302H314	EUH014EUH029	*STOT SE 3; H335: C ? 1 %	T	CLP00
014-002-00-4	silicon tetrachloride	233-054-0	10026-04-7	STOT SE 3Skin Irrit. 2Eye Irrit. 2	H335H315H319	GHS07Wng	H319H335H315	EUH014			CLP00
014-003-00-X	dimethyldichlorosilane	200-901-0	75-78-5	Flam. Liq. 2STOT SE 3Skin Irrit. 2Eye Irrit. 2	H225H335H315H319	GHS02GHS07Dgr	H225H319H335H315				CLP00
014-004-00-5	trichloro(methyl)silane; methyltrichlorosilane	200-902-6	75-79-6	Flam. Liq. 2STOT SE 3Skin Irrit. 2Eye Irrit. 2	H225H335H315H319	GHS02GHS07Dgr	H225H319H335H315	EUH014	Skin Irrit. 2; H315: C ? 1 %Eye Irrit. 2; H319: C ? 1 %STOT SE 3; H335: C ? 1 %		CLP00
014-005-00-0	tetraethyl silicate; ethyl silicate	201-083-8	78-10-4	Flam. Liq. 3Acute Tox. 4 *STOT SE 3Eye Irrit. 2	H226H332H335H319	GHS02GHS07Wng	H226H332H319H335				CLP00
014-006-00-6	"bis(4-fluorophenyl)-methyl-(1,2,4-triazol-4-ylmethyl)silane hydrochloride"	401-380-4		Eye Irrit. 2Aquatic Chronic 2	H319H411	GHS07GHS09Wng	H319H411				CLP00
014-007-00-1	triethoxyisobutylsilane	402-810-3	17980-47-1	Skin Irrit. 2	H315	GHS07Wng	H315				CLP00
014-008-00-7	(chloromethyl)bis(4-fluorophenyl)methylsilane	401-200-4	85491-26-5	Aquatic Chronic 2	H411	GHS09	H411				CLP00
014-009-00-2	isobutylisopropyldimethoxysilane	402-580-4	111439-76-0	Flam. Liq. 3Acute Tox. 4 *Skin Irrit. 2	H226H332H315	GHS02GHS07Wng	H226H332H315				CLP00
014-010-00-8	disodium metasilicate	229-912-9	6834-92-0	STOT SE 3Skin Corr. 1B	H335H314	GHS05GHS07Dgr	H314H335				CLP00
014-011-00-3	cyclohexyldimethoxymethylsilane	402-140-1	17865-32-6	Skin Irrit. 2Aquatic Chronic 2	H315H411	GHS07GHS09Wng	H315H411				CLP00
014-012-00-9	bis(3-(trimethoxysilyl)propyl)amine	403-480-3		Eye Dam. 1Aquatic Chronic 2	H318H411	GHS05GHS09Dgr	H318H411				CLP00
014-013-00-4	"?-hydroxypoly(methyl-(3-(2,2,6,6-tetramethylpiperidin-4-yloxy)propyl)siloxane)"	404-920-7		Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1BAquatic Chronic 2	H312H302H314H411	GHS05GHS07GHS09Dgr	H312H302H314H411				CLP00
014-014-00-X	"etacelasil (ISO); 6-(2-chloroethyl)-6-(2-methoxyethoxy)-2,5,7,10-tetraoxa-6-silaundecane"	253-704-7	37894-46-5	Repr. 1BAcute Tox. 4 *STOT RE 2 *	H360D ***H302H373 **	GHS08GHS07Dgr	H360D ***H302H373 **				CLP00
014-015-00-5	?-trimethylsilanyl-?-trimethylsiloxypoly[oxy(methyl-3-(2-(2-methoxypropoxy)propoxy)propylsilanediyl]-co-oxy(dimethylsilane))	406-420-4	69430-40-6	Aquatic Chronic 4	H413		H413				CLP00
014-016-00-0	"reaction mass of: 1,3-dihex-5-en-1-yl-1,1,3,3-tetramethyldisiloxane; 1,3-dihex-n-en-1-yl-1,1,3,3-tetramethyldisiloxane"	406-490-6		Aquatic Chronic 2	H411	GHS09	H411				CLP00
014-017-00-6	"flusilazole (ISO); bis(4-fluorophenyl)(methyl)(1H-1,2,4-triazol-1-ylmethyl)silane"		85509-19-9	Carc. 2Repr. 1BAcute Tox. 4 *Aquatic Chronic 2	H351H360D ***H302H411	GHS08GHS07GHS09Dgr	H351H360D ***H302H411				CLP00
014-018-00-1	octamethylcyclotetrasiloxane	209-136-7	556-67-2	Repr. 2Aquatic Chronic 4	H361f ***H413	GHS08Wng	H361f ***H413				CLP00
014-019-00-7	"reaction mass of: 4-[[bis-(4-fluorophenyl)methylsilyl]methyl]-4H-1,2,4-triazole; 1-[[bis-(4-fluorophenyl)methylsilyl]methyl]-1H-1,2,4-triazole"	403-250-2		Carc. 2Repr. 1BAcute Tox. 4 *Aquatic Chronic 2	H351H360D ***H302H411	GHS08GHS07GHS09Dgr	H351H360D ***H302H411				CLP00
014-020-00-2	"bis(1,1-dimethyl-2-propynyloxy)dimethylsilane"	414-960-7	53863-99-3	Acute Tox. 4 *	H332	GHS07Wng	H332				CLP00
014-021-00-8	tris(isopropenyloxy)phenyl silane	411-340-8	52301-18-5	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H400H410				CLP00
014-022-00-3	reaction product of: (2-hydroxy-4-(3-propenoxy)benzophenone and triethoxysilane) with (hydrolysis product of silica and methyltrimethoxysilane)	401-530-9		Flam. Sol. 1Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *STOT SE 1	H228H332H312H302H370 **	GHS02GHS08GHS07Dgr	H228H370 **H332H312H302			T	CLP00
014-023-00-9	"?, ?-dihydroxypoly(hex-5-en-1-ylmethylsiloxane)hoxysilane with (hydrolysis product of silica and methyltrimethoxysilane)iazole"	408-160-7	125613-45-8	Aquatic Chronic 2	H411	GHS09	H411				CLP00
014-024-00-4	1-((3-(3-chloro-4-fluorophenyl)propyl)dimethylsilanyl)-4-ethoxybenzene	412-620-2	121626-74-2	Aquatic Chronic 2	H411	GHS09	H411				CLP00
014-025-00-X	"4-[3-(diethoxymethylsilylpropoxy)-2,2,6,6-tetramethyl]piperidine"	411-400-3	102089-33-8	Acute Tox. 4 *STOT RE 2 *Skin Irrit. 2Eye Dam. 1Aquatic Chronic 3	H302H373 **H315H318H412	GHS08GHS05GHS07Dgr	H302H373 **H315H318H412				CLP00
014-026-00-5	dichloro-(3-(3-chloro-4-fluorophenyl)propyl)methylsilane	407-180-3	770722-36-6	Skin Corr. 1A	H314	GHS05Dgr	H314				CLP00
014-027-00-0	chloro(3-(3-chloro-4-fluorophenyl)propyl)dimethylsilane	410-270-5	770722-46-8	Skin Corr. 1A	H314	GHS05Dgr	H314				CLP00
014-028-00-6	?-[3-(1-oxoprop-2-eny)l-1-oxypropyl]dimethoxysilyloxy-?-[3(1-oxoprop-2-enyl)-1-oxypropyl]dimethoxysilyl poly(dimethylsiloxane)	415-290-8	193159-06-7	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
014-029-00-1	"O,O'-(ethenylmethylsilylene)di[(4-methylpentan-2-one)oxime]"	421-870-1	156145-66-3	Repr. 2Acute Tox. 4 *STOT RE 2 *	H361f ***H302H373 **	GHS08GHS07Wng	H361f ***H302H373 **				CLP00
014-030-00-7	"[(dimethylsilylene)bis((1,2,3,3a,7a-?)-1H-inden-1-ylidene)dimethyl]hafnium"	422-060-0	137390-08-0	Acute Tox. 2 *	H300	GHS06Dgr	H300				CLP00
014-031-00-2	bis(1-methylethyl)-dimethoxysilane	421-540-7	18230-61-0	Flam. Liq. 3Skin Irrit. 2Skin Sens. 1Aquatic Chronic 3	H226H315H317H412	GHS02GHS07Wng	H226H315H317H412				CLP00
014-032-00-8	dicyclopentyldimethoxysilane	404-370-8	126990-35-0	Skin Irrit. 2Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H315H318H400H410	GHS05GHS09Dgr	H315H318H410				CLP00
014-033-00-3	2-methyl-3-(trimethoxysilyl)propyl-2-propenoate hydrolysis product with silica	419-030-4	125804-20-8	Flam. Liq. 2STOT SE 3Eye Irrit. 2	H225H336H319	GHS02GHS07Dgr	H225H319H336				ATP01
014-034-00-9	3-hexylheptamethyltrisiloxane	428-700-5	1873-90-1	Acute Tox. 4 *Aquatic Chronic 4	H332H413	GHS07Wng	H332H413				ATP01
014-035-00-4	"2-(3,4-epoxycyclohexyl)ethyltriethoxy silane"	425-050-4	10217-34-2	Skin Sens. 1Aquatic Chronic 3	H317H412	GHS07Wng	H317H412				ATP01
014-036-00-X	(4-ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane	405-020-7	105024-66-6	Repr. 1BAquatic Acute 1Aquatic Chronic 1	H360F ***H400H410	GHS08GHS09Dgr	H360F ***H410		M=1000		ATP01
014-037-00-5	"2-butanone-O,O',O''-(phenylsilylidyne)trioxime"	433-360-6	34036-80-1	STOT RE 2 *Skin Sens. 1Aquatic Chronic 3	H373 **H317H412	GHS08GHS07Wng	H373 **H317H412				ATP01
014-038-00-0	S-(3-(triethoxysilyl)propyl)octanethioate	436-690-9	220727-26-4	Skin Sens. 1	H317	GHS07Wng	H317				ATP01
014-039-00-6	"(2,3-dimethylbut-2-yl)-trimethoxysilane"	439-360-2	142877-45-0	Skin Irrit. 2Eye Dam. 1Aquatic Chronic 3	H315H318H412	GHS05Dgr	H315H318H412				ATP01
014-041-00-7	"N,N-bis(trimethylsilyl)aminopropylmethyldiethoxysilane"	445-890-5	201290-01-9	Acute Tox. 4 *Skin Sens. 1	H302H317	GHS07Wng	H302H317				ATP01
014-042-00-2	"reaction mass of: O,O',O'',O'''-silanetetrayl tetrakis(4-methyl-2-pentanone oxime) (3 stereoisomers)"	423-010-0	-	Eye Dam. 1	H318	GHS05Dgr	H318				ATP01
014-043-00-8	"reaction product of amorphous silica (50-85 %), butyl (1-methylpropyl) magnesium (3-15 %), tetraethyl orthosilicate (5-15 %) and titanium tetrachloride (5-20 %)"	432-200-2		STOT SE 3Skin Irrit. 2Eye Dam. 1Aquatic Chronic 3	H335H315H318H412	GHS05GHS07Dgr	H315H318H335H412				ATP01/ATP01corr
014-044-00-3	3-[(4'-acetoxy-3'-methoxyphenyl) propyl]trimethoxysilane	433-050-0	-	Aquatic Chronic 2	H411	GHS09	H411				ATP01
014-045-00-9	magnesium sodium fluoride silicate	442-650-1	-	STOT RE 2 *	H373 **	GHS08Wng	H373 **				ATP01
015-001-00-1	white phosphorus	231-768-7	12185-10-3	Pyr. Sol. 1Acute Tox. 2 *Acute Tox. 2 *Skin Corr. 1AAquatic Acute 1	H250H330H300H314H400	GHS02GHS06GHS05GHS09Dgr	H250H330H300H314H400				CLP00
015-002-00-7	red phosphorus	231-768-7	7723-14-0	Flam. Sol. 1Aquatic Chronic 3	H228H412	GHS02Dgr	H228H412				CLP00
015-003-00-2	calcium phosphide; tricalcium diphosphide	215-142-0	1305-99-3	Water-react. 1Acute Tox. 1Acute Tox. 2Acute Tox. 3Eye Dam. 1Aquatic Acute 1	H260H330H300H311H318H400	GHS02GHS06GHS05GHS09Dgr	H260H300H311H330H318H400	EUH029EUH032	M=100		CLP00/ATP07
015-004-00-8	aluminium phosphide	244-088-0	20859-73-8	Water-react. 1Acute Tox. 1Acute Tox. 2Acute Tox. 3Aquatic Acute 1	H260H330H300H311H400	GHS02GHS06GHS09Dgr	H260H300H311H330H400	EUH029EUH032	M=100		CLP00/ATP05
015-005-00-3	magnesium phosphide; trimagnesium diphosphide	235-023-7	12057-74-8	Water-react. 1Acute Tox. 1Acute Tox. 2Acute Tox. 3Aquatic Acute 1	H260H330H300H311H400	GHS02GHS06GHS09Dgr	H260H300H311H330H400	EUH029EUH032	M=100		CLP00/ATP05
015-006-00-9	trizinc diphosphide; zinc phosphide	215-244-5	1314-84-7	Water-react. 1Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1	H260H300H400H410	GHS02GHS06GHS09Dgr	H260H300H410	EUH029EUH032	M=100	T	CLP00/ATP01
015-007-00-4	phosphorus trichloride	231-749-3	7719-12-2	Acute Tox. 2 *Acute Tox. 2 *STOT RE 2 *Skin Corr. 1A	H330H300H373 **H314	GHS06GHS08GHS05Dgr	H330H300H373 **H314	EUH014EUH029			CLP00
015-008-00-X	phosphorus pentachloride	233-060-3	10026-13-8	Acute Tox. 2 *Acute Tox. 4 *STOT RE 2 *Skin Corr. 1B	H330H302H373 **H314	GHS06GHS08GHS05Dgr	H330H302H373 **H314	EUH014EUH029			CLP00
015-009-00-5	phosphoryl trichloride	233-046-7	10025-87-3	Acute Tox. 2 *Acute Tox. 4 *STOT RE 1Skin Corr. 1A	H330H302H372 **H314	GHS06GHS08GHS05Dgr	H330H372 **H302H314	EUH014EUH029			CLP00
015-010-00-0	phosphorus pentoxide	215-236-1	1314-56-3	Skin Corr. 1A	H314	GHS05Dgr	H314				CLP00
015-011-00-6	"phosphoric acid ... %, orthophosphoric acid ... %"	231-633-2	7664-38-2	Skin Corr. 1B	H314	GHS05Dgr	H314		Skin Corr. 1B; H314: C ? 25 %Skin Irrit. 2; H315: 10 % ? C < 25 %Eye Irrit. 2; H319: 10 % ? C < 25 %	B	CLP00
015-012-00-1	tetraphosphorus trisulphide; phosphorus sesquisulphid	215-245-0	1314-85-8	Flam. Sol. 2Water-react. 1Acute Tox. 4 *Aquatic Acute 1	H228H260H302H400	GHS02GHS07GHS09Dgr	H228H260H302H400			T	CLP00
015-013-00-7	triethyl phosphate	201-114-5	78-40-0	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
015-014-00-2	tributyl phosphate	204-800-2	126-73-8	Carc. 2Acute Tox. 4 *Skin Irrit. 2	H351H302H315	GHS08GHS07Wng	H351H302H315				CLP00
015-015-00-8	"tricresyl phosphate (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-); tritolyl phosphate (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-)"	201-103-5	78-30-8	STOT SE 1Aquatic Chronic 2	H370 **H411	GHS08GHS09Dgr	H370 **H411		"STOT SE 1; H370: C ? 1 %STOT SE 2; H371: 0,2 % ? C < 1 %"	C	CLP00
015-016-00-3	"tricresyl phosphate (m-m-m-, m-m-p-, m-p-p-, p-p-p-); tritolyl phosphate (m-m-m-, m-m-p-, m-p-p-, p-p-p-)"	201-105-6	78-32-0	Acute Tox. 4 *Acute Tox. 4 *Aquatic Chronic 2	H312H302H411	GHS07GHS09Wng	H312H302H411		*	C	CLP00
015-019-00-X	"dichlorvos (ISO); 2,2-dichlorovinyl dimethyl phosphate"	200-547-7	62-73-7	Acute Tox. 2 *Acute Tox. 3 *Acute Tox. 3 *Skin Sens. 1Aquatic Acute 1	H330H311H301H317H400	GHS06GHS09Dgr	H330H311H301H317H400		M=1000		CLP00/ATP01
015-020-00-5	mevinphos (ISO); 2-methoxycarbonyl-1-methylvinyl dimethyl phosphate	232-095-1	7786-34-7	Acute Tox. 1Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1	H310H300H400H410	GHS06GHS09Dgr	H310H300H410		M=10000		CLP00
015-021-00-0	"trichlorfon (ISO); dimethyl 2,2,2-trichloro-1-hydroxyethylphosphonate"	200-149-3	52-68-6	Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H317H400H410	GHS07GHS09Wng	H302H317H400H410		M=1000		CLP00
015-022-00-6	phosphamidon (ISO); 2-chloro-2-diethylcarbamoyl-1-methylvinyl dimethyl phosphate	236-116-5	13171-21-6	Muta. 2Acute Tox. 2 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H341H300H311H400H410	GHS06GHS08GHS09Dgr	H341H300H311H410				CLP00
015-023-00-1	pyrazoxon; diethyl 3-methylpyrazol-5-yl phosphate		108-34-9	Acute Tox. 1Acute Tox. 2 *Acute Tox. 2 *	H310H330H300	GHS06Dgr	H330H310H300				CLP00
015-024-00-7	"triamiphos (ISO); 5-amino-3-phenyl-1,2,4-triazol-1-yl-N,N,N',N'-tetramethylphosphonic diamide"		1031-47-6	Acute Tox. 1Acute Tox. 2 *	H310H300	GHS06Dgr	H310H300				CLP00
015-025-00-2	TEPP (ISO); tetraethyl pyrophosphate	203-495-3	107-49-3	Acute Tox. 1Acute Tox. 2 *Aquatic Acute 1	H310H300H400	GHS06GHS09Dgr	H310H300H400				CLP00
015-026-00-8	schradan (ISO); octamethylpyrophosphoramide	205-801-0	152-16-9	Acute Tox. 1Acute Tox. 2 *	H310H300	GHS06Dgr	H310H300				CLP00
015-027-00-3	"sulfotep (ISO); O,O,O,O-tetraethyl dithiopyrophosphate"	222-995-2	3689-24-5	Acute Tox. 1Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1	H310H300H400H410	GHS06GHS09Dgr	H310H300H410		M=1000		CLP00
015-028-00-9	"demeton-O (ISO); O,O-diethyl-O-2-ethylthioethyl phosphorothioate"	206-053-8	298-03-3	Acute Tox. 1Acute Tox. 2 *Aquatic Acute 1	H310H300H400	GHS06GHS09Dgr	H310H300H400				CLP00
015-029-00-4	demeton-S (ISO); diethyl-S-2-ethylthioethyl phosphorothioate	204-801-8	126-75-0	Acute Tox. 1Acute Tox. 2 *	H310H300	GHS06Dgr	H310H300				CLP00
015-030-00-X	"demeton-O-methyl (ISO); O-2-ethylthioethyl O,O-dimethyl phosphorothioate"	212-758-1	867-27-6	Acute Tox. 3 *	H301	GHS06Dgr	H301				CLP00
015-031-00-5	demeton-S-methyl (ISO); S-2-ethylthioethyl dimethyl phosphorothioate	213-052-6	919-86-8	Acute Tox. 3 *Acute Tox. 3 *Aquatic Chronic 2	H311H301H411	GHS06GHS09Dgr	H311H301H411				CLP00
015-032-00-0	"prothoate (ISO); O,O-diethyl isopropylcarbamoylmethyl phosphorodithioate"	218-893-2	2275-18-5	Acute Tox. 1Acute Tox. 2 *Aquatic Chronic 3	H310H300H412	GHS06Dgr	H310H300H412				CLP00
015-033-00-6	"phorate (ISO); O,O-diethyl ethylthiomethyl phosphorodithioate"	206-052-2	298-02-2	Acute Tox. 1Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1	H310H300H400H410	GHS06GHS09Dgr	H310H300H410		M=1000		CLP00
015-034-00-1	"parathion (ISO); O,O-diethyl O-4-nitrophenyl phosphorothioate"	200-271-7	56-38-2	Acute Tox. 2 *Acute Tox. 2 *Acute Tox. 3 *STOT RE 1Aquatic Acute 1Aquatic Chronic 1	H330H300H311H372 **H400H410	GHS06GHS08GHS09Dgr	H330H300H311H372 **H410		M=100		CLP00
015-035-00-7	"parathion - methyl (ISO); O,O-dimethyl O-4-nitrophenyl phosphorothioate"	206-050-1	298-00-0	Flam. Liq. 3Acute Tox. 2 *Acute Tox. 2 *Acute Tox. 3 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H226H330H300H311H373 **H400H410	GHS02GHS06GHS08GHS09Dgr	H226H330H300H311H373 **H410		M=100		CLP00
015-036-00-2	O-ethyl O-4-nitrophenyl phenylphosphonothioate; EPN	218-276-8	2104-64-5	Acute Tox. 1Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1	H310H300H400H410	GHS06GHS09Dgr	H310H300H410				CLP00
015-037-00-8	"phenkapton (ISO); S-(2,5-dichlorophenylthiomethyl) O,O-diethyl phosphorodithioate"	218-892-7	2275-14-1	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H331H311H301H400H410	GHS06GHS09Dgr	H331H311H301H410				CLP00
015-038-00-3	"coumaphos (ISO); O-3-chloro-4-methylcoumarin-7-yl O,O-diethyl phosphorothioate"	200-285-3	56-72-4	Acute Tox. 2 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H300H312H400H410	GHS06GHS09Dgr	H300H312H410				CLP00
015-039-00-9	"azinphos-methyl (ISO); O,O-dimethyl-4-oxobenzotriazin-3-ylmethyl phosphorodithioate"	201-676-1	86-50-0	Acute Tox. 2 *Acute Tox. 2 *Acute Tox. 3 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H330H300H311H317H400H410	GHS06GHS09Dgr	H330H300H311H317H410				CLP00
015-040-00-4	"diazinon (ISO); O,O-diethyl O-2-isopropyl-6-methylpyrimidin-4-yl phosphorothioate"	206-373-8	333-41-5	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H400H410				CLP00
015-041-00-X	"malathion (ISO); 1,2-bis(ethoxycarbonyl)ethyl O,O-dimethyl phosphorodithioate; [containing ? 0.03 % isomalathion]"	204-497-7	121-75-5	Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H317H400H410	GHS07GHS09Wng	H302H317H410		M=1000		CLP00/ATP01
015-042-00-5	"chlorthion; O-(3-chloro-4-nitrophenyl) O,O-dimethyl phosphorothioate"	207-902-5	500-28-7	Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H332H312H302H400H410	GHS07GHS09Wng	H332H312H302H410		M=100		CLP00
015-043-00-0	"phosnichlor (ISO); O-4-chloro-3-nitrophenyl O,O-dimethyl phosphorothioate"		5826-76-6	Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *	H332H312H302	GHS07Wng	H332H312H302				CLP00
015-044-00-6	"carbophenothion (ISO); 4-chlorophenylthiomethyl O,O-diethyl phosphorodithioate"	212-324-1	786-19-6	Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H311H301H400H410	GHS06GHS09Dgr	H311H301H410				CLP00
015-045-00-1	"mecarbam (ISO); N-ethoxycarbonyl-N-methylcarbamoylmethyl O,O-diethyl phosphorodithioate"	219-993-9	2595-54-2	Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H311H301H400H410	GHS06GHS09Dgr	H311H301H400H410				CLP00
015-046-00-7	"oxydemeton-methyl; S-2-(ethylsulphinyl)ethyl O,O-dimethyl phosphorothioate"	206-110-7	301-12-2	Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1	H311H301H400	GHS06GHS09Dgr	H311H301H400				CLP00
015-047-00-2	"ethion (ISO); O,O,O',O'-tetraethyl S,S'-methylenedi (phosphorodithioate); diethion"	209-242-3	563-12-2	Acute Tox. 3 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H301H312H400H410	GHS06GHS09Dgr	H301H312H410		M=10000		CLP00
015-048-00-8	"fenthion (ISO); O,O-dimethyl-O-(4-methylthion-m-tolyl) phosphorothioate"	200-231-9	55-38-9	Muta. 2Acute Tox. 3 *Acute Tox. 4 *Acute Tox. 4 *STOT RE 1Aquatic Acute 1Aquatic Chronic 1	H341H331H312H302H372 **H400H410	GHS06GHS08GHS09Dgr	H341H331H312H302H372 **H410		M=100		CLP00/ATP01
015-049-00-3	endothion (ISO); S-5-methoxy-4-oxopyran-2-ylmethyl dimethyl phosphorothioate	220-472-3	2778-04-3	Acute Tox. 3 *Acute Tox. 3 *	H311H301	GHS06Dgr	H311H301				CLP00
015-050-00-9	"thiometon (ISO); S-2-ethylthioethyl O,O-dimethyl phosphorodithioate"	211-362-6	640-15-3	Acute Tox. 3 *Acute Tox. 4 *	H301H312	GHS06Dgr	H301H312				CLP00
015-051-00-4	"dimethoate (ISO); O,O-dimethyl methylcarbamoylmethyl phosphorodithioate"	200-480-3	60-51-5	Acute Tox. 4 *Acute Tox. 4 *	H312H302	GHS07Wng	H312H302				CLP00
015-052-00-X	"fenchlorphos (ISO); O,O-dimethyl O-2,4,5-trichlorophenyl phosphorothioate"	206-082-6	299-84-3	Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H312H302H400H410	GHS07GHS09Wng	H312H302H410				CLP00
015-053-00-5	"menazon (ISO); S-[(4,6-diamino-1,3,5-triazin-2-yl)methyl] O,O-dimethyl phosphorodithioate"	201-123-4	78-57-9	Acute Tox. 4 *Aquatic Chronic 3	H302H412	GHS07Wng	H302H412				CLP00
015-054-00-0	"fenitrothion (ISO); O,O-dimethyl O-4-nitro-m-tolyl phosphorothioate"	204-524-2	122-14-5	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410				CLP00
015-055-00-6	"naled (ISO); 1,2-dibromo-2,2-dichloroethyl dimethyl phosphate"	206-098-3	300-76-5	Acute Tox. 4 *Acute Tox. 4 *Skin Irrit. 2Eye Irrit. 2Aquatic Acute 1	H312H302H315H319H400	GHS07GHS09Wng	H312H302H319H315H400		M=1000		CLP00
015-056-00-1	"azinphos-ethyl (ISO); O,O-diethyl 4-oxobenzotriazin-3-ylmethyl phosphorodithioate"	220-147-6	2642-71-9	Acute Tox. 2 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H300H311H400H410	GHS06GHS09Dgr	H300H311H410		M=100		CLP00/ATP01
015-057-00-7	"formothion (ISO); N-formyl-N-methylcarbamoylmethyl O,O-dimethyl phosphorodithioate"	219-818-6	2540-82-1	Acute Tox. 4 *Acute Tox. 4 *	H312H302	GHS07Wng	H312H302				CLP00
015-058-00-2	"morphothion (ISO); O,O-dimethyl-S-(morpholinocarbonylmethyl) phosphorodithioate"	205-628-0	144-41-2	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H331H311H301H400H410	GHS06GHS09Dgr	H331H311H301H410				CLP00
015-059-00-8	"vamidothion (ISO); O,O-dimethyl S-2-(1-methylcarbamoylethylthio) ethyl phosphorothioate"	218-894-8	2275-23-2	Acute Tox. 3 *Acute Tox. 4 *Aquatic Acute 1	H301H312H400	GHS06GHS09Dgr	H301H312H400				CLP00
015-060-00-3	"disulfoton (ISO); O,O-diethyl 2-ethylthioethyl phosphorodithioate"	206-054-3	298-04-4	Acute Tox. 1Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1	H310H300H400H410	GHS06GHS09Dgr	H310H300H410				CLP00
015-061-00-9	dimefox (ISO); tetramethylphosphorodiamidic fluoride	204-076-8	115-26-4	Acute Tox. 1Acute Tox. 2 *	H310H300	GHS06Dgr	H310H300				CLP00
015-062-00-4	"mipafox (ISO); N,N'- di-isopropylphosphorodiamidic fluoride"	206-742-3	371-86-8	STOT SE 1	H370 **	GHS08Dgr	H370 **				CLP00
015-063-00-X	"dioxathion (ISO); 1,4-dioxan-2,3-diyl-O,O,O',O'-tetraethyl di(phosphorodithioate)"	201-107-7	78-34-2	Acute Tox. 2 *Acute Tox. 2 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H330H300H311H400H410	GHS06GHS09Dgr	H330H300H311H410		M=1000		CLP00
015-064-00-5	"bromophos-ethyl (ISO); O-4-bromo-2,5-dichlorophenyl O,O-diethyl phosphorothioate"	225-399-0	4824-78-6	Acute Tox. 3 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H301H312H400H410	GHS06GHS09Dgr	H301H312H410				CLP00
015-065-00-0	"S-[2-(ethylsulphinyl)ethyl] O,O-dimethyl phosphorodithioate"		2703-37-9	Acute Tox. 1Acute Tox. 2 *Acute Tox. 2 *Aquatic Chronic 2	H310H330H300H411	GHS06GHS09Dgr	H330H310H300H411				CLP00
015-066-00-6	"omethoate (ISO); O,O-dimethyl S-methylcarbamoylmethyl phosphorothioate"	214-197-8	1113-02-6	Acute Tox. 3 *Acute Tox. 4 *Aquatic Acute 1	H301H312H400	GHS06GHS09Dgr	H301H312H400				CLP00
015-067-00-1	"phosalone (ISO); S-(6-chloro-2-oxobenzoxazolin-3-ylmethyl) O,O-diethyl phosphorodithioate"	218-996-2	2310-17-0	Acute Tox. 3 *Acute Tox. 4 *Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H301H332H312H317H400H410	GHS06GHS09Dgr	H301H332H312H317H410		M=1000		CLP00/ATP01
015-068-00-7	"dichlofenthion (ISO); O-,4-dichlorophenyl O,O-diethyl phosphorothioate"	202-564-5	97-17-6	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H400H410				CLP00
015-069-00-2	"methidathion (ISO); 2,3-dihydro-5-methoxy-2-oxo-1,3,4-thiadiazol-3-ylmethyl-O,O-dimethylphosphorodithioate"	213-449-4	950-37-8	Acute Tox. 2 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H300H312H400H410	GHS06GHS09Dgr	H300H312H410				CLP00
015-070-00-8	"cyanthoate (ISO); S-(N-(1-cyano-1-methylethyl)carbamoylmethyl) O,O-diethyl phosphorothioate"	223-099-4	3734-95-0	Acute Tox. 2 *Acute Tox. 3 *	H300H311	GHS06Dgr	H300H311				CLP00
015-071-00-3	"chlorfenvinphos (ISO); 2-chloro-1-(2,4 dichlorophenyl) vinyl diethyl phosphate"	207-432-0	470-90-6	Acute Tox. 2 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H300H311H400H410	GHS06GHS09Dgr	H300H311H410				CLP00
015-072-00-9	monocrotophos (ISO); dimethyl-1-methyl-2-(methylcarbamoyl)vinyl phosphate	230-042-7	6923-22-4	Muta. 2Acute Tox. 2 *Acute Tox. 2 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H341H330H300H311H400H410	GHS06GHS08GHS09Dgr	H341H330H300H311H410				CLP00
015-073-00-4	dicrotophos (ISO); (Z)-2-dimethylcarbamoyl-1-methylvinyl dimethyl phosphate	205-494-3	141-66-2	Acute Tox. 2 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H300H311H400H410	GHS06GHS09Dgr	H300H311H410				CLP00
015-074-00-X	crufomate (ISO); 4-tert-butyl-2-chlorophenyl methyl methylphosphoramidate	206-083-1	299-86-5	Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H312H302H400H410	GHS07GHS09Wng	H312H302H410				CLP00
015-075-00-5	"S-[2-(isopropylsulphinyl)ethyl] O,O-dimethyl phosphorothioate"		2635-50-9	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *	H331H311H301	GHS06Dgr	H331H311H301				CLP00
015-076-00-0	"potasan; O,O-diethyl O-(4-methylcoumarin-7-yl) phosphorothioate"		299-45-6	Acute Tox. 1Acute Tox. 2 *Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1	H310H330H300H400H410	GHS06GHS09Dgr	H330H310H300H410		M=1000		CLP00
015-077-00-6	"2,2-dichlorovinyl 2-ethylsulphinylethyl methyl phosphate"		7076-53-1	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *	H331H311H301	GHS06Dgr	H331H311H301				CLP00
015-078-00-1	demeton-S-methylsulphon (ISO); S-2-ethylsulphonylethyl dimethyl phosphorothioate	241-109-5	17040-19-6	Acute Tox. 3 *Acute Tox. 4 *Aquatic Chronic 2	H301H312H411	GHS06GHS09Dgr	H301H312H411				CLP00
015-079-00-7	"acephate (ISO); O,S-dimethyl acetylphosphoramidothioate"	250-241-2	30560-19-1	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
015-080-00-2	"amidithion (ISO); 2-methoxyethylcarbamoylmethyl O,O-dimethyl phosphorodithioate"		919-76-6	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
015-081-00-8	"O,O,O',O'-tetrapropyl dithiopyrophosphate"	221-817-0	3244-90-4	Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H312H302H400H410	GHS07GHS09Wng	H312H302H410				CLP00
015-082-00-3	"azothoate (ISO); O-4-(4-chlorophenylazo)phenyl O,O-dimethyl phosphorothioate"	227-419-3	5834-96-8	Acute Tox. 4 *Acute Tox. 4 *	H332H302	GHS07Wng	H332H302				CLP00
015-083-00-9	"bensulide (ISO); O,O-diisopropyl 2-phenylsulphonylaminoethyl phosphorodithioate"	212-010-4	741-58-2	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410				CLP00
015-084-00-4	"chlorpyrifos (ISO); O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate"	220-864-4	2921-88-2	Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H301H400H410	GHS06GHS09Dgr	H301H400H410		M=10000		CLP00
015-085-00-X	"chlorphonium chloride (ISO); tributyl (2,4-dichlorobenzyl) phosphonium chloride"	204-105-4	115-78-6	Acute Tox. 3 *Acute Tox. 4 *Skin Irrit. 2Eye Irrit. 2	H301H312H315H319	GHS06Dgr	H301H312H319H315				CLP00
015-086-00-5	"coumithoate (ISO); O,O-diethyl O-,8,9,10-tetrahydro-6-oxo-benzo(c)chromen-3-yl phosphorothioate"		572-48-5	Acute Tox. 3 *	H301	GHS06Dgr	H301				CLP00
015-087-00-0	"cyanophos (ISO); O-4-cyanophenyl O,O-dimethyl phosphorothioate"	220-130-3	2636-26-2	Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H312H302H400H410	GHS07GHS09Wng	H312H302H410				CLP00
015-088-00-6	"dialifos (ISO); 2-chloro-1-phthalimidoethyl O,O-diethyl phosphorodithioate"	233-689-3	10311-84-9	Acute Tox. 2 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H300H311H400H410	GHS06GHS09Dgr	H300H311H400H410				CLP00
015-089-00-1	"ethoate-methyl (ISO); ethylcarbamoylmethyl O,O-dimethyl phosphorodithioate"	204-121-1	116-01-8	Acute Tox. 4 *Acute Tox. 4 *	H312H302	GHS07Wng	H312H302				CLP00
015-090-00-7	"fensulfothion (ISO); O,O-diethyl O-4-methylsulfinylphenyl phosphorothioate"	204-114-3	115-90-2	Acute Tox. 1Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1	H310H300H400H410	GHS06GHS09Dgr	H310H300H410				CLP00
015-091-00-2	fonofos (ISO); O-ethyl phenyl ethylphosphonodithioate	213-408-0	944-22-9	Acute Tox. 1Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1	H310H300H400H410	GHS06GHS09Dgr	H310H300H410				CLP00
015-092-00-8	"phosacetim (ISO); O,O-bis(4-chlorophenyl) N-acetimidoylphosphoramidothioate"	223-874-7	4104-14-7	Acute Tox. 1Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1	H310H300H400H410	GHS06GHS09Dgr	H310H300H410				CLP00
015-093-00-3	"leptophos (ISO); O-4-bromo-2,5-dichlorophenyl O-methyl phenylphosphorothioate"	244-472-8	21609-90-5	Acute Tox. 3 *Acute Tox. 4 *STOT SE 1Aquatic Acute 1Aquatic Chronic 1	H301H312H370 **H400H410	GHS06GHS08GHS09Dgr	H301H370 **H312H410				CLP00
015-094-00-9	"mephosfolan (ISO); diethyl 4-methyl-1,3-dithiolan-2-ylidenephosphoramidate"	213-447-3	950-10-7	Acute Tox. 1Acute Tox. 2 *Aquatic Chronic 2	H310H300H411	GHS06GHS09Dgr	H310H300H411				CLP00
015-095-00-4	"methamidophos (ISO); O,S-dimethyl phosphoramidothioate"	233-606-0	10265-92-6	Acute Tox. 2 *Acute Tox. 2 *Acute Tox. 3 *Aquatic Acute 1	H330H300H311H400	GHS06GHS09Dgr	H330H300H311H400				CLP00
015-096-00-X	"oxydisulfoton (ISO); O, O-diethyl S-2-ethylsulphinylethyl phosphorodithioate"	219-679-1	2497-07-6	Acute Tox. 2 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H300H311H400H410	GHS06GHS09Dgr	H300H311H410		M=10		CLP00
015-097-00-5	phenthoate (ISO); ethyl 2-(dimethoxyphosphinothioylthio)-2-phenylacetate	219-997-0	2597-03-7	Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H312H302H400H410	GHS07GHS09Wng	H312H302H410		M=100		CLP00
015-098-00-0	"trichloronate (ISO); O-ethyl O-2,4,5-trichlorophenyl ethylphosphonothioate"	206-326-1	327-98-0	Acute Tox. 2 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H300H311H400H410	GHS06GHS09Dgr	H300H311H410				CLP00
015-099-00-6	"pirimiphos-ethyl (ISO); O,O-diethyl O-2-diethylamino-6-methylpyrimidin-4-yl phosphorothioate"	245-704-0	23505-41-1	Acute Tox. 3 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H301H312H400H410	GHS06GHS09Dgr	H301H312H410				CLP00
015-100-00-X	phoxim (ISO); ?-(diethoxyphosphinothioylimino) phenylacetonitrile	238-887-3	14816-18-3	Repr. 2Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H361f ***H302H317H400H410	GHS08GHS07GHS09Wng	H361f ***H302H317H410		M=1000		CLP00/ATP01
015-101-00-5	"phosmet (ISO); O,O-dimethyl phthalimidomethyl S-phosphorodithioate"	211-987-4	732-11-6	Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H312H302H400H410	GHS07GHS09Wng	H312H302H410		M=100		CLP00
015-102-00-0	tris(2-chloroethyl)phosphate	204-118-5	115-96-8	Carc. 2Repr. 1BAcute Tox. 4 *Aquatic Chronic 2	H351H360F ***H302H411	GHS08GHS07GHS09Dgr	H351H360F ***H302H411				CLP00/ATP01
015-103-00-6	phosphorus tribromide	232-178-2	7789-60-8	STOT SE 3Skin Corr. 1B	H335H314	GHS05GHS07Dgr	H314H335	EUH014			CLP00
015-104-00-1	diphosphorus pentasulphide; phosphorus pentasulphide	215-242-4	1314-80-3	Flam. Sol. 1Water-react. 1Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1	H228H260H332H302H400	GHS02GHS07GHS09Dgr	H228H260H332H302H400	EUH029		T	CLP00
015-105-00-7	triphenyl phosphite	202-908-4	101-02-0	Skin Irrit. 2Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H315H319H400H410	GHS07GHS09Wng	H319H315H410		Skin Irrit. 2; H315: C ? 5 %Eye Irrit. 2; H319: C ? 5 %		CLP00
015-106-00-2	hexamethylphosphoric triamide; hexamethylphosphoramide	211-653-8	680-31-9	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340		"Carc. 1B; H350: C ? 0,01 %"		CLP00
015-107-00-8	"ethoprophos (ISO); ethyl-S,S-dipropyl phosphorodithioate"	236-152-1	13194-48-4	Acute Tox. 1Acute Tox. 2 *Acute Tox. 3 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H310H330H301H317H400H410	GHS06GHS09Dgr	H330H310H301H317H410				CLP00
015-108-00-3	"bromophos (ISO); O-4-bromo-2,5-dichlorophenyl O,O-dimethyl phosphorothioate"	218-277-3	2104-96-3	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410		M=100		CLP00
015-109-00-9	crotoxyphos (ISO); 1-phenylethyl 3-(dimethoxyphosphinyloxy) isocrotonate	231-720-5	7700-17-6	Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H311H301H400H410	GHS06GHS09Dgr	H311H301H410		M=10		CLP00
015-110-00-4	cyanofenphos (ISO); O-4-cyanophenyl O-ethyl phenylphosphonothioate		13067-93-1	Acute Tox. 3 *Acute Tox. 4 *STOT SE 1Eye Irrit. 2Aquatic Chronic 2	H301H312H370 **H319H411	GHS06GHS08GHS09Dgr	H301H370 **H312H319H411				CLP00
015-111-00-X	"phosfolan (ISO); diethyl 1,3-dithiolan-2-ylidenephosphoramidate"	213-423-2	947-02-4	Acute Tox. 1Acute Tox. 2 *	H310H300	GHS06Dgr	H310H300				CLP00
015-112-00-5	"thionazin (ISO); O,O-diethyl O-pyrazin-2-yl phosphorothioate"	206-049-6	297-97-2	Acute Tox. 1Acute Tox. 2 *	H310H300	GHS06Dgr	H310H300				CLP00
015-113-00-0	"tolclofos-methyl (ISO); O-(2,6-dichloro-p-tolyl)-O,O-dimethyl thiophosphate"	260-515-3	57018-04-9	Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410				ATP01
015-114-00-6	"chlormephos (ISO); S-chloromethyl O,O-diethyl phosphorodithioate"	246-538-1	24934-91-6	Acute Tox. 1Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1	H310H300H400H410	GHS06GHS09Dgr	H300H310H410		M=10		CLP00/ATP01corr
015-115-00-1	"chlorthiophos (ISO); [isomeric reaction mass in which O-2,5-dichlorophenyl-4-methylthiophenyl O,O-diethyl phosphorothioate predominates]"	244-663-6	21923-23-9	Acute Tox. 2 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H300H311H400H410	GHS06GHS09Dgr	H300H311H410		M=1000		CLP00/ATP01corr
015-116-00-7	"demephion-O (ISO); O,O-dimethyl O-2-methylthioethyl phosphorothioate"	211-666-9	682-80-4	Acute Tox. 2 *Acute Tox. 3 *	H300H311	GHS06Dgr	H300H311				CLP00
015-117-00-2	"demephion-S (ISO); O,O-dimethyl S-2-methylthioethyl phosphorothioate"	219-971-9	2587-90-8	Acute Tox. 2 *Acute Tox. 3 *	H300H311	GHS06Dgr	H300H311				CLP00
015-118-00-8	demeton		8065-48-3	Acute Tox. 1Acute Tox. 2 *Aquatic Acute 1	H310H300H400	GHS06GHS09Dgr	H310H300H400				CLP00
015-119-00-3	dimethyl 4-(methylthio)phenyl phosphate		3254-63-5	Acute Tox. 1Acute Tox. 2 *	H310H300	GHS06Dgr	H310H300				CLP00
015-120-00-9	"ditalimfos (ISO); O,O-diethyl phthalimidophosphonothioate"	225-875-8	5131-24-8	Skin Irrit. 2Skin Sens. 1	H315H317	GHS07Wng	H315H317				CLP00
015-121-00-4	"edifenphos (ISO); O-ethyl S,S-diphenyl phosphorodithioate"	241-178-1	17109-49-8	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H331H301H312H317H400H410	GHS06GHS09Dgr	H331H301H312H317H410				CLP00
015-122-00-X	"etrimfos (ISO); O-6-ethoxy-2-ethylpyrimidin-4-yl O,O-dimethylphosphorothioate"	253-855-9	38260-54-7	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410		M=10		CLP00
015-123-00-5	fenamiphos (ISO); ethyl-4-methylthio-m-tolyl isopropyl phosphoramidate	244-848-1	22224-92-6	Acute Tox. 2Acute Tox. 2Acute Tox. 2Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H330H310H300H319H400H410	GHS06GHS09Dgr	H300H310H330H319H410		M=100M=100		CLP00/ATP05
015-124-00-0	"fosthietan (ISO); diethyl 1,3-dithietan-2-ylidenephosphoramidate"	244-437-7	21548-32-3	Acute Tox. 1Acute Tox. 2 *	H310H300	GHS06Dgr	H310H300				CLP00
015-125-00-6	"glyphosine (ISO); N,N-bis(phosphonomethyl)glycine"	219-468-4	2439-99-8	Eye Dam. 1	H318	GHS05Dgr	H318				CLP00
015-126-00-1	"heptenophos (ISO); 7-chlorobicyclo(3.2.0)hepta-2,6-dien-6-yl dimethyl phosphate"	245-737-0	23560-59-0	Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H301H400H410	GHS06GHS09Dgr	H301H410		M=100		CLP00
015-127-00-7	iprobenfos (ISO); S-benzyl diisopropyl phosphorothioate	247-449-0	26087-47-8	Acute Tox. 4 *Aquatic Chronic 2	H302H411	GHS07GHS09Wng	H302H411				CLP00
015-128-00-2	"IPSP; S-ethylsulphinylmethyl O,O-diisopropylphosphorodithioate"		5827-05-4	Acute Tox. 1Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H310H301H400H410	GHS06GHS09Dgr	H310H301H410		M=100		CLP00
015-129-00-8	isofenphos (ISO); O-ethyl O-2-isopropoxycarbonylphenyl-isopropylphosphoramidothioate	246-814-1	25311-71-1	Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H311H301H400H410	GHS06GHS09Dgr	H311H301H410		M=100		CLP00
015-130-00-3	"isothioate (ISO); S-2-isopropylthioethyl O,O-dimethyl phosphorodithioate"		36614-38-7	Acute Tox. 3 *Acute Tox. 3 *	H311H301	GHS06Dgr	H311H301				CLP00
015-131-00-9	"isoxathion (ISO); O,O-diethyl O-5-phenylisoxazol-3-ylphosphorothioate"	242-624-8	18854-01-8	Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H311H301H400H410	GHS06GHS09Dgr	H311H301H410				CLP00
015-132-00-4	"S-(chlorophenylthiomethyl) O,O-dimethylphosphorodithioate; methylcarbophenothione"		953-17-3	Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H311H301H400H410	GHS06GHS09Dgr	H311H301H410		M=1000		CLP00
015-133-00-X	"piperophos (ISO); S-2-methylpiperidinocarbonylmethyl-O,O-dipropyl phosphorodithioate"		24151-93-7	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410		M=10		CLP00
015-134-00-5	"pirimiphos-methyl (ISO); O-(2-diethylamino-6-methylpyrimidin-4-yl) O,O-dimethyl phosphorothioate"	249-528-5	29232-93-7	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410				CLP00
015-135-00-0	profenofos (ISO); O-(4-bromo-2-chlorophenyl) O-ethyl S-propyl phosphorothioate	255-255-2	41198-08-7	Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H332H312H302H400H410	GHS07GHS09Wng	H332H312H302H410		M=1000		CLP00
015-136-00-6	trans-isopropyl-3-[[(ethylamino)methoxyfosfinothioyl]oxy]crotonate; isopropyl 3-[[(ethylamino)methoxyphosphinothioyl]oxy]isocrotonate; propetamphos (ISO)	250-517-2	31218-83-4	Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H301H400H410	GHS06GHS09Dgr	H301H410		M=100		CLP00
015-137-00-1	"pyrazophos (ISO); O,O-diethyl O-(6-ethoxycarbonyl-5-methylpyrazolo[2,3-a]pyrimidin-2-yl) phosphorothioate"	236-656-1	13457-18-6	Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H332H302H400H410	GHS07GHS09Wng	H332H302H410				CLP00
015-138-00-7	"quinalphos (ISO); O,O-diethyl-O-quinoxalin-2-yl phosphorothioate"	237-031-6	13593-03-8	Acute Tox. 3 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H301H312H400H410	GHS06GHS09Dgr	H301H312H410		M=1000		CLP00
015-139-00-2	"terbufos (ISO); S-tert-butylthiomethyl O,O-diethylphosphorodithioate"	235-963-8	13071-79-9	Acute Tox. 1Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1	H310H300H400H410	GHS06GHS09Dgr	H310H300H410		M=1000		CLP00
015-140-00-8	"triazophos (ISO); O,O-diethyl-O-1-phenyl-1H-1,2,4-triazol-3-yl phosphorothioate"	245-986-5	24017-47-8	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H331H301H312H400H410	GHS06GHS09Dgr	H331H301H312H410		M=100		CLP00/ATP01
015-141-00-3	"ethylenediammonium O,O-bis(octyl) phosphorodithioate, mixed isomers"	400-520-1		Acute Tox. 4 *Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1	H302H314H400H410	GHS05GHS07GHS09Dgr	H314H302H410				CLP00
015-142-00-9	butyl (dialkyloxy(dibutoxyphosphoryloxy))titanium (trialkyloxy)titanium phosphate	401-100-0		Flam. Liq. 2Eye Irrit. 2Aquatic Chronic 2	H225H319H411	GHS02GHS07GHS09Dgr	H225H319H411			T	CLP00
015-143-00-4	"reaction mass of 2-chloroethyl chloropropyl 2-chloroethylphosphonate, mixture reaction mass of isomers and 2-chloroethyl chloropropyl 2-chloropropylphosphonate, reaction mass of isomers"	401-740-0		Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
015-144-00-X	reaction mass of pentyl methylphosphinate and 2-methylbutyl methylphosphinate	402-090-0	87025-52-3	Skin Corr. 1B	H314	GHS05Dgr	H314				CLP00
015-145-00-5	"reaction mass of copper(I) O,O-diisopropyl phosphorodithioate and copper(I) O-isopropyl O-(4-methylpent-2-yl) phosphorodithioate and copper(I) O,O-bis(4-methylpent-2-yl) phosphorodithioate"	401-520-4		Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
015-146-00-0	"S-(tricyclo(5.2.1.02,6)deca-3-en-8(or 9)-yl O-(isopropyl or isobutyl or 2-ethylhexyl) O-(isopropyl or isobutyl or 2-ethylhexyl) phosphorodithioate"	401-850-9		Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
015-147-00-6	reaction mass of C12-14-tert-alkylammonium diphenyl phosphorothioate and dinonyl sulphide (or disulphide)	400-930-0		Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Chronic 2	H315H318H317H411	GHS05GHS07GHS09Dgr	H315H318H317H411				CLP00
015-148-00-1	2-(diphosphonomethyl)succinic acid	403-070-4	51395-42-7	Skin Corr. 1BSkin Sens. 1	H314H317	GHS05GHS07Dgr	H314H317				CLP00
015-149-00-7	reaction mass of: hexyldioctylphosphineoxide; dihexyloctylphosphineoxide; trioctylphosphineoxide	403-470-9		Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1	H314H400H410	GHS05GHS09Dgr	H314H410				CLP00
015-150-00-2	"(2-(1,3-dioxolan-2-yl)ethyl)triphenylphosphonium bromide"	404-940-6	86608-70-0	Acute Tox. 4 *STOT RE 2 *Eye Dam. 1Aquatic Chronic 3	H302H373 **H318H412	GHS08GHS05GHS07Dgr	H302H318H373 **H412				CLP00
015-151-00-8	tris(isopropyl/tert-butylphenyl) phosphate	405-010-2		Aquatic Chronic 2	H411	GHS09	H411				CLP00
015-152-00-3	"dioxabenzofos (ISO); 2-methoxy-4H-1,3,2-benzodioxaphosphorin 2-sulphide"	223-292-3	3811-49-2	Acute Tox. 3 *Acute Tox. 3 *STOT SE 1Aquatic Chronic 2	H311H301H370 **H411	GHS06GHS08GHS09Dgr	H311H301H370 **H411				CLP00
015-153-00-9	"isazofos (ISO); O-(5-chloro-1-isopropyl-1,2,4-triazol-3-yl) O,O-diethyl phosphorothioate"	255-863-8	42509-80-8	Acute Tox. 2 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H330H311H301H373 **H317H400H410	GHS06GHS08GHS09Dgr	H330H311H301H373 **H317H410				CLP00
015-154-00-4	ethephon; 2-chloroethylphosphonic acid	240-718-3	16672-87-0	Acute Tox. 3Acute Tox. 4Acute Tox. 4Skin Corr. 1CAquatic Chronic 2	H311H332H302H314H411	GHS06GHS05GHS09Dgr	H302H311H332H314H411	EUH071	STOT SE 3; H335: C ? 5 %		CLP00/ATP06
015-155-00-X	glufosinate ammonium (ISO); ammonium 2-amino-4-(hydroxymethylphosphinyl)butyrate	278-636-5	77182-82-2	Repr. 1BAcute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *	H360FdH332H312H302H373 **	GHS08GHS07Dgr	H360FdH332H312H302H373 **				CLP00/ATP01
015-156-00-5	methyl 3-[(dimethoxyphosphinothioyl)oxy]methacrylate [1]methacrifos (ISO); methyl (E)-3-[(dimethoxyphosphinothioyl)oxy]methacrylate  [2]	250-366-9 [1]250-366-9 [2]	30864-28-9 [1]62610-77-9 [2]	Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H317H400H410	GHS07GHS09Wng	H302H317H410				CLP00
015-157-00-0	phosphonic acid [1]phosphorous acid  [2]	237-066-7 [1]233-663-1 [2]	13598-36-2 [1]10294-56-1 [2]	Acute Tox. 4 *Skin Corr. 1A	H302H314	GHS05GHS07Dgr	H302H314				CLP00
015-158-00-6	(?-cyclopentadienyl)(?-cumenyl)iron(1+)hexafluorophosphate(1-)	402-340-9	32760-80-8	Aquatic Chronic 3	H412		H412				CLP00
015-159-00-1	hydroxyphosphonoacetic acid	405-710-8	23783-26-8	Acute Tox. 4 *STOT RE 2 *Skin Corr. 1BSkin Sens. 1	H302H373 **H314H317	GHS08GHS05GHS07Dgr	H302H373 **H314H317				CLP00
015-160-00-7	vanadyl pyrophosphate	406-260-5	58834-75-6	Eye Irrit. 2Skin Sens. 1Aquatic Chronic 3	H319H317H412	GHS07Wng	H319H317H412				CLP00
015-161-00-2	divanadyl pyrophosphate	407-130-0	65232-89-5	Acute Tox. 4 *Eye Dam. 1Skin Sens. 1Aquatic Chronic 2	H302H318H317H411	GHS05GHS07GHS09Dgr	H302H318H317H411				CLP00
015-162-00-8	"vanadium(IV) oxide hydrogen phosphate hemihydrate, lithium, zinc, molybdenum, iron and chlorine-doped"	407-350-7		Acute Tox. 4 *STOT RE 2 *Eye Dam. 1Aquatic Chronic 2	H332H373 **H318H411	GHS08GHS05GHS07GHS09Dgr	H332H373 **H318H411				CLP00
015-163-00-3	"bis(2,6-dimethoxybenzoyl)-2,4,4-trimethylpentylphosphinoxide"	412-010-6	145052-34-2	Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410				CLP00
015-164-00-9	"calcium P,P'-(1-hydroxyethylene)bis(hydrogen phosphonate)dihydrate"	400-480-5	36669-85-9	Aquatic Chronic 3	H412		H412				CLP00
015-165-00-4	"reaction mass of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate; diphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate"	404-986-7		Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H318H400H410	GHS05GHS09Dgr	H318H410				CLP00
015-166-00-X	"3,9-bis(2,6-di-tert-butyl-4-methylphenoxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane"	410-290-4	80693-00-1	Aquatic Chronic 4	H413		H413				CLP00
015-167-00-5	3-(hydroxyphenylphosphinyl)propanoic acid	411-200-6	14657-64-8	Eye Dam. 1	H318	GHS05Dgr	H318				CLP00
015-168-00-0	"fosthiazate (ISO); (RS)-S-sec-butyl-O-ethyl-2-oxo-1,3-thiazolidin-3-ylphosphonothioate"		98886-44-3	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H331H301H312H317H400H410	GHS06GHS09Dgr	H331H301H312H317H410	EUH070			CLP00
015-169-00-6	tributyltetradecylphosphonium tetrafluoroborate	413-520-1		Acute Tox. 4 *STOT RE 2 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H373 **H314H317H400H410	GHS08GHS05GHS07GHS09Dgr	H302H373 **H314H317H410				CLP00
015-170-00-1	"reaction mass of: di-(1-octane-N,N,N-trimethylammonium) octylphosphate; 1-octane-N,N,N-trimethylammonium di-octylphosphate; 1-octane-N,N,N-trimethylammonium octylphosphate"	407-490-9		Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1B	H312H302H314	GHS05GHS07Dgr	H312H302H314				CLP00
015-171-00-7	"O,O,O-tris(2(or 4)-C9-10-isoalkylphenyl) phosphorothioate"	406-940-1		Aquatic Chronic 2	H411	GHS09	H411				CLP00
015-172-00-2	reaction mass of: bis(isotridecylammonium)mono(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate; isotridecylammonium bis(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate	406-240-6		Flam. Liq. 3Skin Corr. 1BAquatic Chronic 2	H226H314H411	GHS02GHS05GHS09Dgr	H226H314H411				CLP00
015-173-00-8	"methyl [2-(1,1-dimethylethyl)-6-methoxypyrimidin-4-yl]ethylphosphonothioate"	414-080-3	117291-73-3	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410				CLP00
015-174-00-3	"1-chloro-N,N-diethyl-1,1-diphenyl-1-(phenylmethyl)phosphoramine"	411-370-1	82857-68-9	Acute Tox. 3 *Eye Dam. 1Aquatic Chronic 2	H301H318H411	GHS06GHS05GHS09Dgr	H301H318H411				CLP00
015-175-00-9	tert-butyl (triphenylphosphoranylidene) acetate	412-880-7	35000-38-5	Acute Tox. 3 *STOT RE 2 *Eye Irrit. 2Skin Sens. 1Aquatic Chronic 2	H301H373 **H319H317H411	GHS06GHS08GHS09Dgr	H301H373 **H319H317H411				CLP00
015-176-00-4	"P,P,P',P'-tetrakis-(o-methoxyphenyl)propane-1,3-diphosphine"	413-430-2	116163-96-3	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
015-177-00-X	((4-phenylbutyl)hydroxyphosphoryl)acetic acid	412-170-7	83623-61-4	STOT RE 2 *Eye Dam. 1Skin Sens. 1	H373 **H318H317	GHS08GHS05Dgr	H373 **H318H317				CLP00
015-178-00-5	"(R)-?-phenylethylammonium (-)-(1R, 2S)-(1,2-epoxypropyl)phosphonate monohydrate"	418-570-8	25383-07-7	Repr. 2Aquatic Chronic 2	H361f ***H411	GHS08GHS09Wng	H361f ***H411				CLP00
015-179-00-0	"UVCB condensation product of: tetrakis-hydroxymethylphosphonium chloride, urea and distilled hydrogenated C16-18 tallow alkylamine"	422-720-8	166242-53-1	Carc. 2Acute Tox. 4 *STOT RE 2 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H351H302H373 **H314H317H400H410	GHS08GHS05GHS07GHS09Dgr	H351H302H373 **H314H317H410				CLP00
015-180-00-6	"[R-(R*,S*)]-[[2-methyl-1-(1-oxopropoxy)propoxy]-(4-phenylbutyl)phosphinyl] acetic acid, (-)-cinchonidine (1:1) salt"	415-820-8	137590-32-0	Eye Dam. 1Skin Sens. 1Aquatic Chronic 3	H318H317H412	GHS05GHS07Dgr	H318H317H412				CLP00
015-181-00-1	phosphine	232-260-8	7803-51-2	Flam. Gas 1Press. GasAcute Tox. 2 *Skin Corr. 1BAquatic Acute 1	H220H330H314H400	GHS02GHS04GHS06GHS05GHS09Dgr	H220H330H314H400			U	CLP00
015-182-00-7	tetrapropan-2-yl (dichloromethanediyl)bis(phosphonate)	430-630-5	10596-22-2	Acute Tox. 4 *Eye Irrit. 2Skin Sens. 1	H302H319H317	GHS07Wng	H302H319H317				ATP01/ATP01corr
015-183-00-2	(1-hydroxydodecylidene)diphosphonic acid	425-230-2	16610-63-2	Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1	H314H400H410	GHS05GHS09Dgr	H314H410				ATP01
015-184-00-8	"Salts of glyphosate, with the exception of those specified elsewhere in this Annex"			Aquatic Chronic 2	H411	GHS09	H411			A	CLP00
015-186-00-9	"chlorpyrifos-methyl (ISO),; O, O-dimethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate"	227-011-5	5598-13-0	Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410		M=10000		CLP00
015-187-00-4	"reaction mass of: tetrasodium(((2-hydroxyethyl)imino)bis(methylene))bisphosphonate, N-oxide; trisodium ((tetrahydro-2-hydroxy-4H-1,4,2-oxazaphosphorin-4-yl)-methyl)phosphonate, N-oxide, P-oxide"	417-540-1		Eye Dam. 1Aquatic Chronic 2	H318H411	GHS05GHS09Dgr	H318H411				CLP00
015-189-00-5	"phenyl bis(2,4,6-trimethylbenzoyl)-phosphine oxide"	423-340-5	162881-26-7	Skin Sens. 1Aquatic Chronic 4	H317H413	GHS07Wng	H317H413				CLP00
015-190-00-0	"bis(2,4-dicumylphenyl) neopentyl diphosphite; 3,9-bis[2,4-bis(1-methyl-1-phenylethyl)phenoxy]-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane"	421-920-2	154862-43-8	Aquatic Chronic 4	H413	-	H413				ATP01
015-191-00-6	dodecyldiphenyl phosphate	431-760-5	27460-02-2	Skin Irrit. 2Aquatic Chronic 3	H315H412	GHS07Wng	H315H412				ATP01
015-192-00-1	"tetrakis(2,6-dimethylphenyl)-m-phenylene biphosphate"	432-770-2	139189-30-3	Skin Sens. 1	H317	GHS07Wng	H317				ATP01/ATP06
015-193-00-7	"triphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluoro-N-methyl-1-butanesulfonamide (1:1)"	442-960-7	332350-93-3	Acute Tox. 3 *Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H301H318H400H410	GHS05GHS06GHS09Dgr	H301H318H410				ATP01
015-194-00-2	tetrabutyl-phosphonium nonafluoro-butane-1-sulfonate	444-440-5	220689-12-3	Acute Tox. 4 *Aquatic Chronic 3	H302H412	GHS07Wng	H302H412				ATP01
015-195-00-8	reaction mass of: potassium o-toluenephosphonate; potassium m-toluenephosphonate; potassium p-toluenephosphonate	433-860-4	-	Eye Irrit. 2Skin Sens. 1Aquatic Chronic 3	H319H317H412	GHS07Wng	H319H317H412				ATP01
015-196-00-3	reaction mass of: dimethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate; diethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate; methyl ethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate	435-960-3	-	Carc. 1BMuta. 1BSkin Sens. 1	H350H340H317	GHS08GHS07Dgr	H350H340H317				ATP01
015-197-00-9	"bis(2,4,4-trimethylpentyl)dithiophosphonic acid"	420-160-9	107667-02-7	Flam. Liq. 3Acute Tox. 3 *Acute Tox. 4 *Skin Corr. 1BAquatic Chronic 2	H226H331H302H314H411	GHS02GHS06GHS05GHS09Dgr	H226H331H302H314H411				ATP01
015-198-00-4	(4-phenylbutyl)phosphinic acid	420-450-5	86552-32-1	Carc. 2Eye Dam. 1	H351H318	GHS05GHS08Dgr	H351H318				ATP01
015-199-00-X	tris[2-chloro-1-(chloromethyl)ethyl] phosphate	237-159-2	13674-87-8	Carc. 2	H351	GSH08Wng	H351				ATP03
015-200-00-3	indium phosphide	244-959-5	22398-80-7	Carc. 1BRepr. 2STOT RE 1	H350H361fH372 (lungs)	GHS08Dgr	H350H361fH372 (lungs)		"STOT RE 1; H372:  C ?0,1 %Carc 1B; H350:  C ?0,01 %STOT RE 2; H373:  0,01 % ? C < 0,1 %"		ATP03
015-201-00-9	trixylyl phosphate	246-677-8	25155-23-1	Repr. 1B	H360F	GHS08Dgr	H360F				ATP03
015-202-00-4	tris(nonylphenyl) phosphite	247-759-6	26523-78-4	Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410				ATP03
015-203-00-X	"diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide"	278-355-8	75980-60-8	Repr. 2	H361f (causing atrophy of the testes)	GHS08Wng	H361f (causing atrophy of the testes)				ATP03
016-001-00-4	hydrogen sulphide	231-977-3	7783-06-4	Flam. Gas 1Press. GasAcute Tox. 2 *Aquatic Acute 1	H220H330H400	GHS02GHS04GHS06GHS09Dgr	H220H330H400			U	CLP00
016-002-00-X	barium sulphide	244-214-4	21109-95-5	Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1	H332H302H400	GHS07GHS09Wng	H332H302H400	EUH031			CLP00
016-003-00-5	barium polysulphides	256-814-3	50864-67-0	STOT SE 3Skin Irrit. 2Eye Irrit. 2Aquatic Acute 1	H335H315H319H400	GHS07GHS09Wng	H319H335H315H400	EUH031			CLP00
016-004-00-0	calcium sulphide	243-873-5	20548-54-3	STOT SE 3Skin Irrit. 2Eye Irrit. 2Aquatic Acute 1	H335H315H319H400	GHS07GHS09Wng	H319H335H315H400	EUH031			CLP00
016-005-00-6	calcium polysulphides	215-709-2	1344-81-6	STOT SE 3Skin Irrit. 2Eye Irrit. 2Aquatic Acute 1	H335H315H319H400	GHS07GHS09Wng	H319H335H315H400	EUH031			CLP00
016-006-00-1	dipotassium sulphide; potassium sulphide	215-197-0	1312-73-8	Skin Corr. 1BAquatic Acute 1	H314H400	GHS05GHS09Dgr	H314H400	EUH031			CLP00
016-007-00-7	potassium polysulphides	253-390-1	37199-66-9	Skin Corr. 1BAquatic Acute 1	H314H400	GHS05GHS09Dgr	H314H400	EUH031			CLP00
016-008-00-2	ammonium polysulphides	232-989-1	9080-17-5	Skin Corr. 1BAquatic Acute 1	H314H400	GHS05GHS09Dgr	H314H400	EUH031	EUH031: C ? 1 %		CLP00
016-009-00-8	disodium sulfide; sodium sulfide	215-211-5	1313-82-2	Acute Tox. 3 *Acute Tox. 4 *Skin Corr. 1BAquatic Acute 1	H311H302H314H400	GHS06GHS05GHS09Dgr	H311H302H314H400				CLP00/ATP01
016-010-00-3	sodium polysulphides	215-686-9	1344-08-7	Acute Tox. 3 *Skin Corr. 1BAquatic Acute 1	H301H314H400	GHS06GHS05GHS09Dgr	H301H314H400	EUH031			CLP00
016-011-00-9	sulphur dioxide	231-195-2	7446-09-5	Press. GasAcute Tox. 3 *Skin Corr. 1B	H331H314	GHS04GHS06GHS05Dgr	H331H314		*	5 U	CLP00
016-012-00-4	disulphur dichloride; sulfur monochloride	233-036-2	10025-67-9	Acute Tox. 3 *Acute Tox. 4 *Skin Corr. 1AAquatic Acute 1	H301H332H314H400	GHS06GHS05GHS09Dgr	H301H332H314H400	EUH014EUH029	STOT SE 3; H335: C ? 1 %		CLP00
016-013-00-X	sulphur dichloride	234-129-0	10545-99-0	STOT SE 3Skin Corr. 1BAquatic Acute 1	H335H314H400	GHS05GHS07GHS09Dgr	H314H335H400	EUH014	STOT SE 3; H335: C ? 5 %		CLP00
016-014-00-5	sulphur tetrachloride		13451-08-6	Skin Corr. 1BAquatic Acute 1	H314H400	GHS05GHS09Dgr	H314H400	EUH014	STOT SE 3; H335: C ? 5 %		CLP00
016-015-00-0	thionyl dichloride; thionyl chloride	231-748-8	7719-09-7	Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1A	H332H302H314	GHS05GHS07Dgr	H332H302H314	EUH014EUH029	STOT SE 3; H335: C ? 1 %		CLP00
016-016-00-6	sulphuryl chloride	232-245-6	7791-25-5	STOT SE 3Skin Corr. 1B	H335H314	GHS05GHS07Dgr	H314H335	EUH014			CLP00
016-017-00-1	chlorosulphonic acid	232-234-6	7790-94-5	STOT SE 3Skin Corr. 1A	H335H314	GHS05GHS07Dgr	H314H335	EUH014			CLP00
016-018-00-7	fluorosulphonic acid	232-149-4	7789-21-1	Acute Tox. 4 *Skin Corr. 1A	H332H314	GHS05GHS07Dgr	H332H314				CLP00
016-019-00-2	oleum ... % SO3			STOT SE 3Skin Corr. 1A	H335H314	GHS05GHS07Dgr	H314H335	EUH014		B	CLP00
016-020-00-8	sulphuric acid ... %	231-639-5	7664-93-9	Skin Corr. 1A	H314	GHS05Dgr	H314		Skin Corr. 1A; H314: C ? 15 %Skin Irrit. 2; H315: 5 % ? C < 15 %Eye Irrit. 2; H319: 5 % ? C < 15 %	B	CLP00
016-021-00-3	methanethiol; methyl mercaptan	200-822-1	74-93-1	Flam. Gas 1Press. GasAcute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H220H331H400H410	GHS02GHS04GHS06GHS09Dgr	H220H331H410			U	CLP00
016-022-00-9	ethanethiol; ethyl mercaptan	200-837-3	75-08-1	Flam. Liq. 2Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H225H332H400H410	GHS02GHS07GHS09Dgr	H225H332H410				CLP00
016-023-00-4	dimethyl sulphate	201-058-1	77-78-1	Carc. 1BMuta. 2Acute Tox. 2 *Acute Tox. 3 *Skin Corr. 1BSkin Sens. 1	H350H341H330H301H314H317	GHS06GHS08GHS05Dgr	H350H341H330H301H314H317		"Carc. 1B; H350: C ? 0,01 %Muta. 2; H341: C ? 0,01 %STOT SE 3; H335: C ? 5 %"		CLP00
016-024-00-X	dimexano (ISO); bis(methoxythiocarbonyl) disulphide	215-993-8	1468-37-7	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410				CLP00
016-025-00-5	"disul (ISO); 2-(2,4-dichlorophenoxy)ethyl hydrogensulphate; 2,4-DES"	205-259-5	149-26-8	Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1	H302H315H318	GHS05GHS07Dgr	H302H315H318				CLP00
016-026-00-0	sulphamidic acid; sulphamic acid; sulfamic acid	226-218-8	5329-14-6	Skin Irrit. 2Eye Irrit. 2Aquatic Chronic 3	H315H319H412	GHS07Wng	H319H315H412				CLP00
016-027-00-6	diethyl sulphate	200-589-6	64-67-5	Carc. 1BMuta. 1BAcute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1B	H350H340H332H312H302H314	GHS05GHS08GHS07Dgr	H350H340H332H312H302H314				CLP00
016-028-00-1	sodium dithionite; sodium hydrosulphite	231-890-0	7775-14-6	Self-heat. 1Acute Tox. 4 *	H251H302	GHS02GHS07Dgr	H251H302	EUH031			CLP00
016-029-00-7	"p-toluenesulphonic acid, containing more than 5 % H2SO4"			Skin Corr. 1B	H314	GHS05Dgr	H314		Skin Corr. 1B; H314: C ? 25 %Skin Irrit. 2; H315: 10 % ? C < 25 %Eye Irrit. 2; H319: 10 % ? C < 25 %		CLP00
016-030-00-2	p-toluenesulphonic acid (containing a maximum of 5 % H2SO4)	203-180-0	104-15-4	STOT SE 3Skin Irrit. 2Eye Irrit. 2	H335H315H319	GHS07Wng	H319H335H315		STOT SE 3; H335: C ? 20 %		CLP00
016-031-00-8	"tetrahydrothiophene-1,1-dioxide; sulpholane"	204-783-1	126-33-0	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
016-032-00-3	"1,3-propanesultone; 1,2-oxathiolane 2,2-dioxide"	214-317-9	1120-71-4	Carc. 1BAcute Tox. 4 *Acute Tox. 4 *	H350H312H302	GHS08GHS07Dgr	H350H312H302		"Carc. 1B; H350: C ? 0,01 %"		CLP00
016-033-00-9	dimethylsulfamoylchloride	236-412-4	13360-57-1	Carc. 1BAcute Tox. 2 *Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1B	H350H330H312H302H314	GHS06GHS05GHS08Dgr	H350H330H312H302H314				CLP00
016-034-00-4	"tetrasodium 3,3'-(piperazine-1,4-diylbis((6-chloro-1,3,5-triazine-2,4-diyl)imino(2-acetamido)-4,1-phenyleneazo))bis(naphthalene-1,5-disulphonate)"	400-010-9	81898-60-4	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
016-035-00-X	"pentasodium 5-anilino-3-(4-(4-(6-chloro-4-(3-sulphonatoanilino)-1,3,5-triazin-2-ylamino)-2,5-dimethylphenylazo)-2,5-disulphonatophenylazo)-4-hydroxynaphthalene-2,7-disulphonate"	400-120-7		Eye Irrit. 2	H319	GHS07Wng	H319				CLP00
016-036-00-5	"tetrasodium 5-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-4-hydroxy-2,3-azodinaphthalene-1,2,5,7-disulphonate"	400-130-1		Resp. Sens. 1Aquatic Chronic 2	H334H411	GHS08GHS09Dgr	H334H411				CLP00
016-037-00-0	disodium 1-amino-4-(4-benzenesulphonamido-3-sulphonatoanilino)anthraquinone-2-sulphonate	400-350-8	85153-93-1	Eye Dam. 1Aquatic Chronic 3	H318H412	GHS05Dgr	H318H412				CLP00
016-038-00-6	"disodium 6-((4-chloro-6-(N-methyl)-2-toluidino)-1,3,5-triazin-2-ylamino)-1-hydroxy-2-(4-methoxy-2-sulphonatophenylazo)naphthalene-3-sulphonate"	400-380-1	86393-35-3	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
016-039-00-1	"tetrasodium 2-(6-chloro-4-(4-(2,5-dimethyl-4-(2,5-disulphonatophenylazo)phenylazo)-3-ureidoanilino)-1,3,5-triazin-2-ylamino)benzene-1,4-disulphonate"	400-430-2		Skin Sens. 1	H317	GHS07Wng	H317				CLP00
016-040-00-7	"reaction mass of disodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(2,4-dihydroxyphenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and disodium 6-(2,4-diaminophenylazo)-3-(4-(4-(2,4-diaminophenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and trisodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(7-(2,4-dihydroxyphenylazo)-1-hydroxy-3-sulphonato-2-naphthylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate"	400-570-4		Eye Irrit. 2	H319	GHS07Wng	H319				CLP00
016-041-00-2	"calcium 2,5-dichloro-4-(4-((5-chloro-4-methyl-2-sulphonatophenyl)azo)-5-hydroxy-3-methylpyrazol-1-yl)benzenesulphonate"	400-710-4		Acute Tox. 4 *	H332	GHS07Wng	H332				CLP00
016-042-00-8	"tetrasodium 5-benzamido-3-(5-(4-fluoro-6-(1-sulphonato-2-naphthylamino)-1,3,5-triazin-2-ylamino)-2-sulphonatophenylazo)-4-hydroxynaphthalene-2,7- disulphonate"	400-790-0	85665-97-0	Skin Irrit. 2Eye Irrit. 2Skin Sens. 1	H315H319H317	GHS07Wng	H319H315H317				CLP00
016-043-00-3	dilithium 6-acetamido-4-hydroxy-3-(4-((2-sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2-sulphonate	401-010-1		Skin Sens. 1	H317	GHS07Wng	H317				CLP00
016-044-00-9	"disodium S,S-hexane-1,6-diyldi(thiosulphate) dihydrate"	401-320-7		Skin Sens. 1Aquatic Chronic 3	H317H412	GHS07Wng	H317H412				CLP00
016-045-00-4	"lithium sodium hydrogen 4-amino-6-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-sulphonatophenylazo)-5-hydroxy-3-(4-(2-(sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2,7-disulphonate"	401-560-2	108624-00-6	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
016-046-00-X	sodium hydrogensulphate	231-665-7	7681-38-1	Eye Dam. 1	H318	GHS05Dgr	H318				CLP00
016-047-00-5	"hexasodium 7-(4-(4-(4-(2,5-disulphonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)-2-methylphenylazo)-7-sulphonatonaphthylazo)naphthalene-1,3,5- trisulphonate"	401-650-1	85665-96-9	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
016-048-00-0	"sodium 3,5-dichloro-2-(5-cyano-2,6-bis(3-hydroxypropylamino)-4-methylpyridin-3-ylazo)benzenesulphonate"	401-870-8		Eye Dam. 1Aquatic Chronic 3	H318H412	GHS05Dgr	H318H412				CLP00
016-049-00-6	calcium octadecylxylenesulphonate	402-040-8		Skin Corr. 1BAquatic Chronic 2	H314H411	GHS05GHS09Dgr	H314H411				CLP00
016-050-00-1	"potassium sodium 5-(4-chloro-6-(N-(4-(4-chloro-6-(5-hydroxy-2,7-disulphonato-6-(2-sulphonatophenylazo)-4-naphthylamino)-1,3,5-triazin-2-ylamino) phenyl-N-methyl)amino)-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(2-sulphonatophenylazo)naphthalene-2,7-disulphonat"	402-150-6		Eye Irrit. 2Skin Sens. 1	H319H317	GHS07Wng	H319H317				CLP00
016-051-00-7	"trisodium 7-(4-(6-fluoro-4-(2-(2-vinylsulphonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6- trisulphonate"	402-170-5	106359-91-5	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
016-052-00-2	benzyltributylammonium 4-hydroxynaphthalene-1-sulphonate	402-240-5	102561-46-6	Acute Tox. 4 *Aquatic Chronic 2	H332H411	GHS07GHS09Wng	H332H411				CLP00
016-053-00-8	(C16 or C18-n-alkyl)(C16 or C18-n-alkyl)ammonium 2-((C16 or C18-n-alkyl)(C16 or C18-n-alkyl)carbamoyl)benzenesulphonate	402-460-1		Skin Irrit. 2Skin Sens. 1Aquatic Chronic 4	H315H317H413	GHS07Wng	H315H317H413				CLP00
016-054-00-3	"sodium 4-(2,4,4-trimethylpentylcarbonyloxy)benzenesulfonate"	400-030-8		Acute Tox. 3 *Acute Tox. 4 *STOT SE 3STOT RE 1Eye Irrit. 2Skin Sens. 1	H331H302H335H372 **H319H317	GHS06GHS08Dgr	H331H372 **H302H319H335H317				CLP00
016-055-00-9	"tetrasodium 4-amino-3,6-bis(5-(6-chloro-4-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxynaphthalene-2,7-sulfonate (containing > 35 % sodium chloride and sodium acetate)"	400-510-7		Eye Dam. 1Skin Sens. 1	H318H317	GHS05GHS07Dgr	H318H317				CLP00
016-056-00-4	potassium hydrogensulphate	231-594-1	7646-93-7	STOT SE 3Skin Corr. 1B	H335H314	GHS05GHS07Dgr	H314H335				CLP00
016-057-00-X	styrene-4-sulfonyl chloride	404-770-2	2633-67-2	Skin Irrit. 2Eye Dam. 1Skin Sens. 1	H315H318H317	GHS05GHS07Dgr	H315H318H317				CLP00
016-058-00-5	"thionyl chloride, reaction products with 1,3,4-thiadiazol-2,5-dithiol, tert-nonanethiol and C12-14-tert-alkylamine"	404-820-3		Skin Irrit. 2Skin Sens. 1Aquatic Chronic 3	H315H317H412	GHS07Wng	H315H317H412				CLP00
016-059-00-0	"N,N,N',N'-tetramethyldithiobis(ethylene)diamine dihydrochloride"	405-300-9	17339-60-5	Acute Tox. 4 *Eye Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H319H317H400H410	GHS07GHS09Wng	H302H319H317H410				CLP00
016-060-00-6	diammonium peroxodisulphate; ammonium persulphate	231-786-5	7727-54-0	Ox. Sol. 3Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Irrit. 2Resp. Sens. 1Skin Sens. 1	H272H302H335H315H319H334H317	GHS03GHS08GHS07Dgr	H272H302H319H335H315H334H317				CLP00
016-061-00-1	dipotassium peroxodisulphate; potassium persulphate	231-781-8	7727-21-1	Ox. Sol. 3Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Irrit. 2Resp. Sens. 1Skin Sens. 1	H272H302H335H315H319H334H317	GHS03GHS08GHS07Dgr	H272H302H319H335H315H334H317				CLP00
016-062-00-7	"bensultap (ISO); 1,3-bis(phenylsulfonylthio)-2-(N,N-dimethylamino)propane"		17606-31-4	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410				CLP00
016-063-00-2	sodium metabisulphite	231-673-0	7681-57-4	Acute Tox. 4 *Eye Dam. 1	H302H318	GHS05GHS07Dgr	H302H318	EUH031			CLP00
016-064-00-8	sodium hydrogensulphite … %; sodium bisulphite … %	231-548-0	7631-90-5	Acute Tox. 4 *	H302	GHS07Wng	H302	EUH031		B	CLP00
016-065-00-3	sodium 1-amino-4-[2-methyl-5-(4-methylphenylsulfonylamino)phenylamino]anthraquinone-2-sulfonate	400-100-8	84057-97-6	Aquatic Chronic 2	H411	GHS09	H411				CLP00
016-066-00-9	"tetrasodium [5-((4-amino-6-chloro-1,3,5-triazin-2-yl)amino)-2-((2-hydroxy-3,5-disulfonatophenylazo)-2- sulfonatobenzylidenehydrazino)benzoate]copper(II)"	404-070-7	116912-62-0	Aquatic Chronic 3	H412		H412				CLP00
016-067-00-4	(4-methylphenyl)mesitylene sulfonate	407-530-5	67811-06-7	Aquatic Chronic 4	H413		H413				CLP00
016-068-00-X	"sodium 3,5-bis(tetradecyloxycarbonyl)benzenesulfinate"	407-720-8	155160-86-4	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				CLP00
016-069-00-5	"3,5-bis-(tetradecyloxycarbonyl)benzenesulfinic acid"	407-990-7	141915-64-2	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				CLP00
016-070-00-0	"4-benzyloxy-4'-(2,3-epoxy-2-methylprop-1-yloxy)diphenylsulfone"	408-220-2		Aquatic Chronic 4	H413		H413				CLP00
016-071-00-6	"trisodium 3-amino-6,13-dichloro-10-((3-((4-chloro-6-(2-sulfophenylamino)-1,3,5-triazin-2-yl)amino)propyl) amino)-4,11-triphenoxydioxazinedisulfonate"	410-130-3	136248-03-8	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
016-072-00-1	3-amino-4-hydroxy-N-(2-methoxyethyl)-benzenesulfonamide	411-520-6	112195-27-4	Eye Dam. 1Skin Sens. 1Aquatic Chronic 2	H318H317H411	GHS05GHS07GHS09Dgr	H318H317H411				CLP00
016-073-00-7	tetrakis(phenylmethyl)thioperoxydi(carbothioamide)	404-310-0	10591-85-2	Aquatic Chronic 4	H413		H413				CLP00
016-074-00-2	6-fluoro-2-methyl-3-(4-methylthiobenzyl)indene	405-410-7		Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Chronic 2	H315H318H317H411	GHS05GHS07GHS09Dgr	H315H318H317H411				CLP00
016-075-00-8	"2,2'-diallyl-4,4'-sulfonyldiphenol"	411-570-9	41481-66-7	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				CLP00
016-076-00-3	"2,3-bis((2-mercaptoethyl)thio)-1-propanethiol"	411-290-7	131538-00-6	Acute Tox. 4 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H302H373 **H400H410	GHS08GHS07GHS09Wng	H302H373 **H410				CLP00
016-077-00-9	2-chloro-p-toluenesulfochloride	412-890-1	42413-03-6	Skin Corr. 1BSkin Sens. 1Aquatic Chronic 3	H314H317H412	GHS05GHS07Dgr	H314H317H412				CLP00
016-078-00-4	"4-methyl-N,N-bis(2-(((4-methylphenyl)sulfonyl)amino)ethyl)benzenesulfonamide"	413-300-5	56187-04-3	Aquatic Chronic 4	H413						CLP00
016-079-00-X	"N,N-bis(2-(p-toluenesulfonyloxy)ethyl)-p-toluenesulfonamide"	412-920-3	16695-22-0	Skin Sens. 1Aquatic Chronic 4	H317H413	GHS07Wng	H317H413				CLP00
016-080-00-5	sodium 2-anilino-5-(2-nitro-4-(N-phenylsulfamoyl))anilinobenzenesulfonate	412-320-1	31361-99-6	Eye Dam. 1Aquatic Chronic 3	H318H412	GHS05Dgr	H318H412				CLP00
016-081-00-0	hexahydrocyclopenta[c]pyrrole-1-(1H)-ammonium N-ethoxycarbonyl-N-(p-tolylsulfonyl)azanide	418-350-1		Muta. 2Acute Tox. 4 *Eye Irrit. 2Skin Sens. 1Aquatic Chronic 2	H341H302H319H317H411	GHS08GHS07GHS09Wng	H341H302H319H317H411				CLP00
016-082-00-6	"ethoxysulfuron (ISO); 1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethoxyphenoxysulfonyl)urea"		126801-58-9	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
016-083-00-1	"acibenzolar-S-methyl; benzo[1,2,3]thiadiazole-7-carbothioic acid S-methyl ester"	420-050-0	135158-54-2	STOT SE 3Skin Irrit. 2Eye Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H335H315H319H317H400H410	GHS07GHS09Wng	H319H335H315H317H410				CLP00
016-084-00-7	"prosulfuron (ISO); 1-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3-[2-(3,3,3-trifluoropropyl)phenylsulfonyl]urea"	-	94125-34-5	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410		M=100		CLP00/ATP01
016-085-00-2	"flazasulfuron (ISO); 1-(4,6-dimethoxypyrimidin-2-yl)-3-(3-trifluoromethyl-2-pyridylsulfonyl)urea"		104040-78-0	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
016-086-00-8	"tetrasodium 10-amino-6,13-dichloro-3-(3-(4-(2,5-disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate"	402-590-9	109125-56-6	Eye Dam. 1	H318	GHS05Dgr	H318				CLP00
016-087-00-3	"reaction mass of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate; diphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate; propylene carbonate"	403-490-8	104558-95-4	Eye Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H319H317H400H410	GHS07GHS09Wng	H319H317H410				CLP00
016-088-00-9	"4-(bis(4-(diethylamino)phenyl)methyl)benzene-1,2-dimethanesulfonic acid"	407-280-7	71297-11-5	Aquatic Chronic 3	H412		H412				CLP00
016-089-00-4	"reaction mass of esters of 5,5',6,6',7,7'-hexahydroxy-3,3,3',3'-tetramethyl-1,1'-spirobiindan and 2-diazo-1,2-dihydro-1-oxo-5-sulfonaphthalene"	413-840-1		Self-react. C ****Aquatic Chronic 4	H242H413	GHS02Dgr	H242H413				CLP00
016-090-00-X	4-methyl-N-(methylsulfonyl)benzenesulfonamide	415-040-8	14653-91-9	Acute Tox. 4 *STOT SE 3Eye Dam. 1	H302H335H318	GHS05GHS07Dgr	H302H335H318				CLP00
016-091-00-5	"C12-14-tert-alkyl ammonium 1-amino-9,10-dihydro-9,10-dioxo-4-(2,4,6-trimethylanilino)-anthracen-2-sulfonate"	414-110-5		Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H318H400H410	GHS05GHS09Dgr	H318H410				CLP00
016-092-00-0	"reaction mass of: 4,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol; 4,8-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol; 5,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol"	427-050-1		Repr. 2Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H361fH315H317H400H410	GHS08GHS07GHS09Wng	H315H317H361fH410				ATP01/ATP01corr
016-093-00-6	"reaction mass of: 4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinol-4-yl-tris(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate); 4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinolbis(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate) (2:1)"	414-770-4	140698-96-0	Self-react. C ****Carc. 2	H242H351	GHS02GHS08Dgr	H242H351				CLP00
016-094-00-1	sulfur	231-722-6	7704-34-9	Skin Irrit. 2	H315	GHS07Wng	H315				ATP01
016-095-00-7	"reaction mass of: reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:2); Reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:3)"	417-980-4		Self-react. C ****Carc. 2	H242H351	GHS02GHS08Dgr	H242H351				CLP00
016-096-00-2	"thifensulfuron-methyl (ISO); methyl 3-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl)thiophene-2-carboxylate"		79277-27-3	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
016-097-00-8	1-amino-2-methyl-2-propanethiol hydrochloride	434-480-1	32047-53-3	Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Chronic 3	H302H314H317H412	GHS05GHS07Dgr	H302H314H317H412				ATP01
017-001-00-7	chlorine	231-959-5	7782-50-5	Ox. Gas 1Press. GasAcute Tox. 3 *STOT SE 3Skin Irrit. 2Eye Irrit. 2Aquatic Acute 1	H270H331H335H315H319H400	GHS03GHS04GHS06GHS09Dgr	H270H331H315H319H335H400		M=100	U	CLP00/ATP01corr
017-002-00-2	hydrogen chloride	231-595-7	7647-01-0	Press. GasAcute Tox. 3 *Skin Corr. 1A	H331H314	GHS04GHS06GHS05Dgr	H331H314			5 U	CLP00
017-002-01-X	hydrochloric acid ... %	231-595-7		STOT SE 3Skin Corr. 1B	H335H314	GHS05GHS07Dgr	H314H335		Skin Corr. 1B; H314: C ? 25 %Skin Irrit. 2; H315: 10 % ? C < 25 %Eye Irrit. 2; H319: 10 % ? C < 25 %STOT SE 3; H335: C ? 10 %	B	CLP00
017-003-00-8	barium chlorate	236-760-7	13477-00-4	Ox. Sol. 1Acute Tox. 4 *Acute Tox. 4 *Aquatic Chronic 2	H271H332H302H411	GHS03GHS07GHS09Dgr	H271H332H302H411				CLP00
017-004-00-3	potassium chlorate	223-289-7	3811-04-9	Ox. Sol. 1Acute Tox. 4 *Acute Tox. 4 *Aquatic Chronic 2	H271H332H302H411	GHS03GHS07GHS09Dgr	H271H332H302H411				CLP00
017-005-00-9	sodium chlorate	231-887-4	7775-09-9	Ox. Sol. 1Acute Tox. 4 *Aquatic Chronic 2	H271H302H411	GHS03GHS07GHS09Dgr	H271H302H411				CLP00
017-006-00-4	perchloric acid ... %	231-512-4	7601-90-3	Ox. Liq. 1Skin Corr. 1A	H271H314	GHS03GHS05Dgr	H271H314		Skin Corr. 1A; H314: C ? 50 %Skin Corr. 1B; H314: 10 % ? C < 50 %Skin Irrit. 2; H315: 1 % ? C < 10 %Eye Irrit. 2; H319: 1 % ? C < 10 %Ox. Liq. 1; H271: C > 50 %Ox. Liq. 2; H272: C ? 50 %	B	CLP00
017-007-00-X	barium perchlorate	236-710-4	13465-95-7	Ox. Sol. 1Acute Tox. 4 *Acute Tox. 4 *	H271H332H302	GHS03GHS07Dgr	H271H332H302				CLP00
017-008-00-5	potassium perchlorate	231-912-9	7778-74-7	Ox. Sol. 1Acute Tox. 4 *	H271H302	GHS03GHS07Dgr	H271H302				CLP00
017-009-00-0	ammonium perchlorate; [containing ? 80 % of 0-30 µm particles]	232-235-1	7790-98-9	Expl. 1.1Ox. Sol. 1	H201H271	GHS01Dgr	H201H271			T	CLP00/ATP01
017-010-00-6	sodium perchlorate	231-511-9	7601-89-0	Ox. Sol. 1Acute Tox. 4 *	H271H302	GHS03GHS07Dgr	H271H302				CLP00
017-011-00-1	"sodium hypochlorite, solution ... % Cl active"	231-668-3	7681-52-9	Skin Corr. 1BAquatic Acute 1	H314H400	GHS05GHS09Dgr	H314H400	EUH031	EUH031: C ? 5 %	B	CLP00
017-012-00-7	calcium hypochlorite	231-908-7	7778-54-3	Ox. Sol. 2Acute Tox. 4 *Skin Corr. 1BAquatic Acute 1	H272H302H314H400	GHS03GHS05GHS07GHS09Dgr	H272H302H314H400	EUH031	"Skin Corr. 1B; H314: C = 5 %Skin Irrit. 2; H315: 1 % = C < 5 %Eye Dam. 1; H318: 3 % = C < 5 %Eye Irrit. 2; H319: 0,5 % = C < 3 %M=10"	T	CLP00/ATP01corr
017-013-00-2	calcium chloride	233-140-8	10043-52-4	Eye Irrit. 2	H319	GHS07Wng	H319				CLP00
017-014-00-8	ammonium chloride	235-186-4	12125-02-9	Acute Tox. 4 *Eye Irrit. 2	H302H319	GHS07Wng	H302H319				CLP00
017-015-00-3	(2-(aminomethyl)phenyl)acetylchloride hydrochloride	417-410-4	61807-67-8	Acute Tox. 4 *Skin Corr. 1ASkin Sens. 1	H302H314H317	GHS05GHS07Dgr	H302H314H317				CLP00
017-016-00-9	methyltriphenylphosphonium chloride	418-400-2	1031-15-8	Acute Tox. 4 *Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1Aquatic Chronic 2	H312H302H315H318H411	GHS05GHS07GHS09Dgr	H312H302H315H318H411				CLP00
017-017-00-4	"(Z)-13-docosenyl-N,N-bis(2-hydroxyethyl)-N-methyl-ammonium-chloride"	426-210-6	120086-58-0	Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1	H314H400H410	GHS05GHS09Dgr	H314H410				CLP00
017-018-00-X	"N,N,N-trimethyl-2,3-bis(stearoyloxy)propylammonium chloride"	405-660-7		Aquatic Chronic 2	H411	GHS09	H411				CLP00
017-019-00-5	"(R)-1,2,3,4-tetrahydro-6,7-dimethoxy-1-veratrylisoquinoline hydrochloride"	415-110-8	54417-53-7	Acute Tox. 4 *Aquatic Chronic 3	H302H412	GHS07Wng	H302H412				CLP00
017-020-00-0	ethyl propoxy aluminium chloride	421-790-7	13014-29-4	Water-react. 1Skin Corr. 1A	H260H314	GHS02GHS05Dgr	H260H314	EUH014			CLP00
017-021-00-6	behenamidopropyl-dimethyl-(dihydroxypropyl) ammonium chloride	423-420-1	136920-10-0	Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H318H317H400H410	GHS05GHS07GHS09Dgr	H318H317H410				CLP00
017-023-00-7	"[phosphinyldynetris(oxy)] tris[3-aminopropyl-2-hydroxy-N,N-dimethyl-N-(C6-18)-alkyl] trichlorides"	425-520-9	197179-61-6	Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H318H400H410	GHS05GHS09Dgr	H318H410				ATP01
017-026-00-3	chlorine dioxide	233-162-8	10049-04-4	Ox. Gas 1Press. GasAcute Tox. 2 *Skin Corr. 1BAquatic Acute 1	H270H330H314H400	GHS04GHS03GHS06GHS05GHS09Dgr	H270H330H314H400	EUH006	M=10	5	CLP00/ATP01corr
017-026-01-0	chlorine dioxide … %	233-162-8	10049-04-4	Acute Tox. 3 *Skin Corr. 1BAquatic Acute 1	H301H314H400	GHS06GHS05GHS09Dgr	H301H314H400		"Skin Corr. 1B; H314: C = 5 %Skin Irrit. 2; H315: 1 % = C < 5 %Eye Dam. 1; H318: 3 % = C < 5 %Eye Irrit. 2; H319: 0,3 % = C < 3 %STOT SE 3; H335: C = 3 %M=10"	B	CLP00/ATP01corr
019-001-00-2	potassium	231-119-8	7440-09-7	Water-react. 1Skin Corr. 1B	H260H314	GHS02GHS05Dgr	H260H314	EUH014			CLP00
019-002-00-8	potassium hydroxide; caustic potash	215-181-3	1310-58-3	Acute Tox. 4 *Skin Corr. 1A	H302H314	GHS05GHS07Dgr	H302H314		"Skin Corr. 1A; H314: C ? 5 %Skin Corr. 1B; H314: 2 % ? C < 5 %Skin Irrit. 2; H315: 0,5 % ? C < 2 %Eye Irrit. 2; H319: 0,5 % ? C < 2 %"		CLP00
019-003-00-3	"potassium (E,E)-hexa-2,4-dienoate"	246-376-1	24634-61-5	Eye Irrit. 2	H319	GHS07Wng	H319				ATP07
020-001-00-X	calcium	231-179-5	7440-70-2	Water-react. 2	H261	GHS02Dgr	H261				CLP00
020-002-00-5	calcium cyanide	209-740-0	592-01-8	Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1	H300H400H410	GHS06GHS09Dgr	H300H410	EUH032			CLP00
020-003-00-0	reaction mass of: dicalcium (bis(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)dihydroxide; tri-calcium (tris(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)tri-hydroxide; poly[calcium ((2-hydroxy-5-tetra-propenyl-phenylmethyl)methylamine)hydroxide]	420-470-4		Skin Irrit. 2Eye Irrit. 2Skin Sens. 1	H315H319H317	GHS07Wng	H319H315H317				CLP00
022-001-00-5	titanium tetrachloride	231-441-9	7550-45-0	Skin Corr. 1B	H314	GHS05Dgr	H314	EUH014			CLP00
022-002-00-0	titanium(4+) oxalate	403-260-7		Eye Dam. 1	H318	GHS05Dgr	H318				CLP00
022-003-00-6	"bis(?5-cyclopentadienyl)-bis(2,6-difluoro-3-[pyrrol-1-yl]-phenyl)titanium"	412-000-1	125051-32-3	Flam. Sol. 1Repr. 2STOT RE 2 *Aquatic Chronic 2	H228H361f ***H373 **H411	GHS02GHS08GHS09Dgr	H228H361f ***H373 **H411			T	CLP00
022-004-00-1	potassium titanium oxide (K2Ti6O13)	432-240-0	12056-51-8	Carc. 2	H351	GHS08Wng	H351				ATP01/ATP01corr
022-005-00-7	"[N-(1,1-dimethylethyl)-1,1-dimethyl-1-[(1,2,3,4,5-?)-2,3,4,5-tetramethyl-2,4-cyclopentadien-1-yl]silanaminato(2-)-?N][(1,2,3,4-?)-1,3-pentadiene]-titanium"	419-840-8	169104-71-6	Flam. Sol. 1 ****Skin Corr. 1BSkin Sens. 1Aquatic Chronic 4	H228H314H317H413	GHS02GHS05GHS07Dgr	H228H314H317H413				ATP01
023-001-00-8	divanadium pentaoxide; vanadium pentoxide	215-239-8	1314-62-1	Muta. 2Repr. 2Acute Tox. 4 *Acute Tox. 4 *STOT SE 3STOT RE 1Aquatic Chronic 2	H341H361d ***H332H302H335H372 **H411	GHS08GHS07GHS09Dgr	H341H361d ***H372 **H332H302H335H411				CLP00
024-001-00-0	chromium (VI) trioxide	215-607-8	1333-82-0	Ox. Sol. 1Carc. 1AMuta. 1BRepr. 2Acute Tox. 2 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 1Skin Corr. 1AResp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H271H350H340H361f ***H330H311H301H372 **H314H334H317H400H410	GHS03GHS06GHS08GHS05GHS09Dgr	H271H350H340H361f ***H330H311H301H372 **H314H334H317H410		STOT SE 3; H335: C ? 1 %		CLP00
024-002-00-6	potassium dichromate	231-906-6	7778-50-9	Ox. Sol. 2Carc. 1BMuta. 1BRepr. 1BAcute Tox. 2 *Acute Tox. 3 *Acute Tox. 4 *STOT RE 1Skin Corr. 1BResp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H272H350H340H360FDH330H301H312H372 **H314H334H317H400H410	GHS03GHS06GHS08GHS05GHS09Dgr	H272H350H340H360FDH330H301H372 **H312H314H334H317H410		STOT SE 3; H335: C ? 5 %	3 	CLP00
024-003-00-1	ammonium dichromate	232-143-1	7789-09-5	Ox. Sol. 2 ****Carc. 1BMuta. 1BRepr. 1BAcute Tox. 2 *Acute Tox. 3 *Acute Tox. 4 *STOT RE 1Skin Corr. 1BResp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H272H350H340H360FDH330H301H312H372 **H314H334H317H400H410	GHS03GHS06GHS08GHS05GHS09Dgr	H272H350H340H360FDH330H301H372 **H312H314H334H317H410		"STOT SE 3; H335: C ? 5 %Resp. Sens.; H334: C ? 0,2 %Skin Sens.; H317: C ? 0,2 %"	3 G	CLP00
024-004-00-7	sodium dichromate	234-190-3	10588-01-9	Ox. Sol. 2Carc. 1BMuta. 1BRepr. 1BAcute Tox. 2 *Acute Tox. 3 *Acute Tox. 4 *STOT RE 1Skin Corr. 1BResp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H272H350H340H360FDH330H301H312H372 **H314H334H317H400H410	GHS03GHS06GHS05GHS08GHS09Dgr	H272H301H312H330H314H334H317H340H350H360FDH372 **H410		"Resp. Sens. 1; H334: C = 0,2 %Skin Sens. 1; H317: C = 0,2 %STOT SE 3; H335: C = 5 %"	3	CLP00/ATP01corr
024-005-00-2	chromyl dichloride; chromic oxychloride	239-056-8	14977-61-8	Ox. Liq. 1Carc. 1BMuta. 1BSkin Corr. 1ASkin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H271H350iH340H314H317H400H410	GHS03GHS08GHS05GHS07GHS09Dgr	H271H350iH340H314H317H410		"Skin Corr. 1A; H314: C ? 10 %Skin Corr. 1B; H314: 5 % ? C < 10 %Skin Irrit. 2; H315: 0,5 % ? C < 5 %Eye Irrit. 2; H319: 0,5 % ? C < 5 %STOT SE 3; H335: 0,5 % ? C < 5 %Skin Sens. 1; H317: C ? 0,5 %"	3 T	CLP00
024-006-00-8	potassium chromate	232-140-5	7789-00-6	Carc. 1BMuta. 1BSTOT SE 3Skin Irrit. 2Eye Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH340H335H315H319H317H400H410	GHS08GHS07GHS09Dgr	H350iH340H319H335H315H317H410		"Skin Sens. 1; H317: C ? 0,5 %"	3 	CLP00
024-007-00-3	zinc chromates including zinc potassium chromate			Carc. 1AAcute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350H302H317H400H410	GHS08GHS07GHS09Dgr	H350H302H317H410			A	CLP00
024-008-00-9	calcium chromate	237-366-8	13765-19-0	Carc. 1BAcute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H350H302H400H410	GHS08GHS07GHS09Dgr	H350H302H410				CLP00
024-009-00-4	strontium chromate	232-142-6	7789-06-2	Carc. 1BAcute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H350H302H400H410	GHS08GHS07GHS09Dgr	H350H302H400H410				CLP00
024-010-00-X	dichromium tris(chromate); chromium III chromate; chromic chromate	246-356-2	24613-89-6	Ox. Sol. 1Carc. 1BSkin Corr. 1ASkin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H271H350H314H317H400H410	GHS03GHS08GHS05GHS07GHS09Dgr	H271H350H314H317H410			T	CLP00
024-011-00-5	"ammonium bis(1-(3,5-dinitro-2-oxidophenylazo)-3-(N-phenylcarbamoyl)-2-naphtholato)chromate(1-)"	400-110-2	109125-51-1	Self-react. C ****Aquatic Acute 1Aquatic Chronic 1	H242H400H410	GHS02GHS09Dgr	H242H410				CLP00
024-012-00-0	trisodium bis(7-acetamido-2-(4-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)chromate(1-)	400-810-8		Muta. 2	H341	GHS08Wng	H341				CLP00
024-013-00-6	"trisodium (6-anilino-2-(5-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)(4-sulphonato-1,1'-azodi-2,2'naphtholato)chromate(1-)"	402-500-8		Eye Dam. 1Aquatic Chronic 2	H318H411	GHS05GHS09Dgr	H318H411				CLP00
024-014-00-1	trisodium bis(2-(5-chloro-4-nitro-2-oxidophenylazo)-5-sulphonato-1-naphtholato)chromate(1-)	402-870-0	93952-24-0	Eye Dam. 1Aquatic Chronic 3	H318H412	GHS05Dgr	H318H412				CLP00
024-015-00-7	disodium (3-methyl-4-(5-nitro-2-oxidophenylazo)-1-phenylpyrazololato)(1-(3-nitro-2-oxido-5-sulfonatophenylazo)-2-naphtholato)chromate(1-)	404-930-1		Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 2	H332H318H411	GHS05GHS07GHS09Dgr	H332H318H411				CLP00
024-016-00-2	tetradecylammonium bis(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-)	405-110-6	88377-66-6	STOT RE 2 *Aquatic Chronic 4	H373 **H413	GHS08Wng	H373 **H413				CLP00
024-017-00-8	"Chromium (VI) compounds, with the exception of barium chromate and of compounds specified elsewhere in this Annex"			Carc. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH317H400H410	GHS08GHS07GHS09Dgr	H350iH317H410			A	CLP00
024-018-00-3	sodium chromate	231-889-5	7775-11-3	Carc. 1BMuta. 1BRepr. 1BAcute Tox. 2 *Acute Tox. 3 *Acute Tox. 4 *STOT RE 1Skin Corr. 1BResp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350H340H360FDH330H301H312H372 **H314H334H317H400H410	GHS06GHS08GHS05GHS09Dgr	H350H340H360FDH330H301H372 **H312H314H334H317H410		"Resp. Sens.; H334: C ? 0,2 %Skin Sens.; H317: C ? 0,2 %"	3 	CLP00
024-019-00-9	"Main component: acetoacetic acid anilide/3-amino-1-hydroxybenzene (ATAN-MAP): trisodium {}{6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}}-{}{6''-[1-(phenylcarbamoyl)ethylazo]-5'''-(phenylsulfamoyl)-3''-sulfonatonaphthalene-2''-azobenzene-1'',2'''-diolato}}chromate (III); by-product 1: acetoacetic acid anilide/acetoacetic acid anilide (ATAN-ATAN): trisodium bis{}{6-[1-(phenylcarbamoyl)ethylazo]-5'-(phenylsulfonyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}}chromate (III); by-product 2: 3-amino-1-hydroxybenzene/3-amino-1-hydroxybenzene (MAP-MAP): trisodium bis{}{6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}} chromate (III)"	419-230-1		Skin Sens. 1Aquatic Chronic 3	H317H412	GHS07Wng	H317H412				CLP00
024-020-00-4	"trisodium bis[(3'-nitro-5'-sulfonato(6-amino-2-[4-(2-hydroxy-1-naphtylazo)phenylsulfonylamino]pyrimidin-5-azo)benzene-2',4-diolato)]chromate (III)"	418-220-4		Skin Sens. 1Aquatic Chronic 3	H317H412	GHS07Wng	H317H412				CLP00
024-021-00-X	"potassium tetrasodium bis[(N,N'-n)-1'-(phenylcarbamoyl)-3,5-disulfonatobenzeneazo-1'-prop-1'-ene-2,2'-diolato]chromate(III)"	425-830-4	-	Eye Dam. 1	H318	GHS05Dgr	H318				ATP01
025-001-00-3	manganese dioxide	215-202-6	1313-13-9	Acute Tox. 4 *Acute Tox. 4 *	H332H302	GHS07Wng	H332H302				CLP00
025-002-00-9	potassium permanganate	231-760-3	7722-64-7	Ox. Sol. 2Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H272H302H400H410	GHS03GHS07GHS09Dgr	H272H302H410				CLP00
025-003-00-4	manganese sulphate	232-089-9	7785-87-7	STOT RE 2 *Aquatic Chronic 2	H373 **H411	GHS08GHS09Wng	H373 **H411				CLP00
025-004-00-X	"bis(N,N',N''-trimethyl-1,4,7-triazacyclononane)-trioxo-dimanganese (IV) di(hexafluorophosphate) monohydrate"	411-760-1	116633-53-5	Aquatic Chronic 2	H411	GHS09	H411				CLP00
025-005-00-5	"reaction mass of: tri-sodium [29H, 31H-phthalocyanine-C,C,C-trisulfonato (6-)-N29,N30,N31,N32] manganate (3-); tetrasodium [29H,31H-phthalocyanine-C,C,C,C-tetrasulfonato (6-)-N29,N30,N31,N32], manganate (3-); pentasodium [29H,31H-phthalocyanine-C,C,C,C,C-pentasulfonato (6-)-N29,N30,N31,N32] manganate (3-)"	417-660-4		Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
026-001-00-6	(?-cumene)-(?-cyclopentadienyl)iron(II) hexafluoroantimonate	407-840-0	100011-37-8	Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 3	H302H318H412	GHS05GHS07Dgr	H302H318H412				CLP00
026-002-00-1	(?-cumene)-(?-cyclopentadienyl)iron(II) trifluoromethane-sulfonate	407-880-9	117549-13-0	Acute Tox. 4 *Aquatic Chronic 3	H302H412	GHS07Wng	H302H412				CLP00
026-003-00-7	iron (II) sulfate	231-753-5	7720-78-7	Acute Tox. 4 *Skin Irrit. 2Eye Irrit. 2	H302H315H319	GHS07Wng	H302H319H315				ATP01
026-003-01-4	"iron (II) sulfate (1:1) heptahydrate; sulfuric acid, iron(II) salt (1:1), heptahydrate; ferrous sulfate heptahydrate"	231-753-5	7782-63-0	Acute Tox. 4 *Skin Irrit. 2Eye Irrit. 2	H302H315H319	GHS07Wng	H302H319H315		Skin Irrit. 2; H315: C ? 25 %		ATP01
026-004-00-2	potassium ferrite	430-010-4	12160-44-0	Skin Corr. 1BSkin Sens. 1	H314H317	GHS05GHS07Dgr	H314H317				ATP01
027-001-00-9	cobalt	231-158-0	7440-48-4	Resp. Sens. 1Skin Sens. 1Aquatic Chronic 4	H334H317H413	GHS08Dgr	H334H317H413				CLP00
027-002-00-4	cobalt oxide	215-154-6	1307-96-6	Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H317H400H410	GHS07GHS09Wng	H302H317H410		M=10		CLP00/ATP01
027-003-00-X	cobalt sulfide	215-273-3	1317-42-6	Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410		M=10		CLP00/ATP01
027-004-00-5	cobalt dichloride	231-589-4	7646-79-9	Carc. 1BMuta. 2Repr. 1BAcute Tox. 4 *Resp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH341H360F ***H302H334H317H400H410	GHS08GHS07GHS09Dgr	H350iH341H360F ***H302H334H317H410		"Carc. 1B; H350i: C ? 0,01 %M=10"	1 	CLP00/ATP01
027-005-00-0	cobalt sulfate	233-334-2	10124-43-3	Carc. 1BMuta. 2Repr. 1BAcute Tox. 4 *Resp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH341H360F ***H302H334H317H400H410	GHS08GHS07GHS09Dgr	H350iH341H360F ***H302H334H317H410		"Carc. 1B; H350i: C ? 0,01 %M=10"	1 	CLP00/ATP01
027-006-00-6	cobalt di(acetate)	200-755-8	71-48-7	Carc. 1BMuta. 2Repr. 1BResp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH341H360F ***H334H317H400H410	GHS08GHS09Dgr	H334H317H341H350iH360F ***H410		"Carc. 1B; H350i: C = 0,01 %M=10"	1	ATP01/ATP01corr
027-007-00-1	"zinc hexacyanocobaltate(III), tertiary butyl alcohol/polypropylene glycol complex"	425-240-7	-	Eye Dam. 1Aquatic Chronic 2	H318H411	GHS05GHS09Dgr	H318H411				ATP01
027-008-00-7	"complex of cobalt(III)-bis(N-phenyl-4-(5-ethylsulfonyl-2-hydroxyphenylazo)-3-hydroxynaphthylamide), hydrated (n H2O, 2"	427-390-9	-	Skin Sens. 1	H317	GHS07Wng	H317				ATP01
027-009-00-2	cobalt dinitrate	233-402-1	10141-05-6	Carc. 1BMuta. 2Repr. 1BResp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH341H360F ***H334H317H400H410	GHS08GHS09Dgr	H334H317H341H350iH360F ***H410		"Carc. 1B; H350i: C = 0,01 %M=10"	1	ATP01/ATP01corr
027-010-00-8	cobalt carbonate	208-169-4	513-79-1	Carc. 1BMuta. 2Repr. 1BResp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH341H360F ***H334H317H400H410	GHS08GHS09Dgr	H350iH341H360F ***H334H317H410		"Carc. 1B; H350i: C ? 0,01 %M=10"	1 	ATP01
028-001-00-1	tetracarbonylnickel; nickel tetracarbonyl	236-669-2	13463-39-3	Flam. Liq. 2Carc. 2Repr. 1BAcute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1	H225H351H360D ***H330H400H410	GHS02GHS06GHS08GHS09Dgr	H225H351H360D ***H330H410				CLP00
028-002-00-7	nickel	231-111-4	7440-02-0	Carc. 2STOT RE 1Skin Sens. 1	H351H372 **H317	GHS08GHS07Dgr	H351H372 **H317			7 S	CLP00/ATP01
028-002-01-4	nickel powder; [particle diameter < 1 mm]	231-111-4	7440-02-0	Carc. 2STOT RE 1Skin Sens. 1Aquatic Chronic 3	H351H372 **H317H412	GHS08GHS07Dgr	H351H372 **H317H412				ATP01
028-003-00-2	nickel monoxide [1]nickel oxide [2]bunsenite  [3]	215-215-7 [1]234-323-5 [2]	1313-99-1 [1]11099-02-8 [2]34492-97-2 [3]	Carc. 1ASTOT RE 1Skin Sens. 1Aquatic Chronic 4	H350iH372 **H317H413	GHS08GHS07Dgr	H350iH372 **H317H413				CLP00/ATP01
028-004-00-8	nickel dioxide	234-823-3	12035-36-8	Carc. 1ASTOT RE 1Skin Sens. 1Aquatic Chronic 4	H350iH372 **H317H413	GHS08GHS07Dgr	H350iH372 **H317H413				CLP00/ATP01
028-005-00-3	dinickel trioxide	215-217-8	1314-06-3	Carc. 1ASTOT RE 1Skin Sens. 1Aquatic Chronic 4	H350iH372 **H317H413	GHS08GHS07Dgr	H350iH372 **H317H413				CLP00/ATP01
028-006-00-9	nickel (II) sulfide [1]nickel sulfide [2]millerite  [3]	240-841-2 [1]234-349-7 [2]	16812-54-7 [1]11113-75-0 [2]1314-04-1 [3]	Carc. 1AMuta. 2STOT RE 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH341H372 **H317H400H410	GHS08GHS07GHS09Dgr	H350iH341H372 **H317H410				CLP00/ATP01
028-007-00-4	trinickel disulfide; nickel subsulfide [1]heazlewoodite  [2]	234-829-6 [1]	12035-72-2 [1]12035-71-1 [2]	Carc. 1AMuta. 2STOT RE 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH341H372 **H317H400H410	GHS08GHS07GHS09Dgr	H350iH341H372 **H317H410				CLP00/ATP01
028-008-00-X	nickel dihydroxide [1]nickel hydroxide  [2]	235-008-5 [1]234-348-1 [2]	12054-48-7 [1]11113-74-9 [2]	Carc. 1AMuta. 2Repr. 1BAcute Tox. 4 *Acute Tox. 4 *STOT RE 1Skin Irrit. 2Resp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH341H360D ***H332H302H372 **H315H334H317H400H410	GHS08GHS07GHS09Dgr	H350iH360D ***H341H372 **H332H302H315H334H317H410				CLP00/ATP01
028-009-00-5	nickel sulfate	232-104-9	7786-81-4	Carc. 1AMuta. 2Repr. 1BAcute Tox. 4 *Acute Tox. 4 *STOT RE 1Skin Irrit. 2Resp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH341H360D ***H332H302H372 **H315H334H317H400H410	GHS08GHS07GHS09Dgr	H302H332H315H334H317H341H350iH360D ***H372 **H410		"STOT RE 1; H372: C = 1 %STOT RE 2; H373: 0,1 % = C < 1 %Skin Irrit. 2; H315: C = 20 %Skin Sens. 1; H317: C = 0,01 %M=1"		CLP00/ATP01corr
028-010-00-0	"nickel carbonate; basic nickel carbonate; carbonic acid, nickel (2+) salt [1]carbonic acid, nickel salt [2][µ-[carbonato(2-)-O:O’]] dihydroxy trinickel [3][carbonato(2-)] tetrahydroxytrinickel  [4]"	222-068-2 [1]240-408-8 [2]265-748-4 [3]235-715-9 [4]	3333-67-3 [1]16337-84-1 [2]65405-96-1 [3]12607-70-4 [4]	Carc. 1AMuta. 2Repr. 1BAcute Tox. 4 *Acute Tox. 4 *STOT RE 1Skin Irrit. 2Resp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH341H360D ***H332H302H372 **H315H334H317H400H410	GHS08GHS07GHS09Dgr	H350iH341H360D ***H372 **H332H302H315H334H317H410				CLP00/ATP01
028-011-00-6	nickel dichloride	231-743-0	7718-54-9	Carc. 1AMuta. 2Repr. 1BAcute Tox. 3 *Acute Tox. 3 *STOT RE 1Skin Irrit. 2Resp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH341H360D ***H331H301H372 **H315H334H317H400H410	GHS06GHS08GHS09Dgr	H301H331H315H334H317H341H350iH360D ***H372 **H410		"STOT RE 1; H372: C = 1 %STOT RE 2; H373: 0,1 % < C < 1 %Skin Irrit. 2; H315: C = 20 %Skin Sens. 1; H317: C = 0,01 %M=1"		ATP01/ATP01corr
028-012-00-1	"nickel dinitrate [1]nitric acid, nickel salt [2]"	236-068-5 [1]238-076-4 [2]	13138-45-9 [1]14216-75-2 [2]	Ox. Sol. 2Carc. 1AMuta. 2Repr. 1BAcute Tox. 4 *Acute Tox. 4 *STOT RE 1Skin Irrit. 2Eye Dam. 1Resp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H272H350iH341H360D ***H332H302H372 **H315H318H334H317H400H410	GHS03GHS05GHS08GHS07GHS09Dgr	H272H302H332H315H318H334H317H341H350iH360D ***H372 **H410		"STOT RE 1; H372: C = 1 %STOT RE 2; H373: 0,1 % < C < 1 %Skin Irrit. 2; H315: C = 20 %Skin Sens. 1; H317: C = 0,01 %M=1"		ATP01/ATP01corr
028-013-00-7	nickel matte	273-749-6	69012-50-6	Carc. 1ASTOT RE 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH372 **H317H400H410	GHS08GHS07GHS09Dgr	H350iH372 **H317H410				ATP01
028-014-00-2	"slimes and sludges, copper electrolytic refining, decopperised, nickel sulfate"	295-859-3	92129-57-2	Carc. 1AMuta. 2Repr. 1BAcute Tox. 4 *Acute Tox. 4 *STOT RE 1Skin Irrit. 2Resp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH341H360D ***H332H302H372 **H315H334H317H400H410	GHS08GHS07GHS09Dgr	H350iH341H360D ***H372 **H332H302H315H334H317H410		"STOT RE 1; H372: C ? 1 %STOT RE 2; H373: 0,1 % ? C < 1 %Skin Sens. 1; H317: C ? 0,01 %M=1"		ATP01
028-015-00-8	"slimes and sludges, copper electrolyte refining, decopperised"	305-433-1	94551-87-8	Carc. 1AMuta. 2Repr. 1ASTOT RE 1Resp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH341H360D ***H372 **H334H317H400H410	GHS08GHS09Dgr	H350iH341H360D ***H372 **H334H317H410				ATP01
028-016-00-3	"nickel diperchlorate; perchloric acid, nickel(II) salt"	237-124-1	13637-71-3	Carc. 1AMuta. 2Repr. 1BSTOT RE 1Skin Corr. 1BResp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH341H360D ***H372 **H314H334H317H400H410	GHS05GHS08GHS09Dgr	H350iH341H360D ***H372 **H314H334H317H410		"STOT RE 1; H372: C ? 1 %STOT RE 2; H373: 0,1 % ? C < 1 %Skin Sens. 1; H317: C ? 0,01 %M=1"		ATP01
028-017-00-9	nickel dipotassium bis(sulfate) [1]diammonium nickel bis(sulfate)  [2]	237-563-9 [1]239-793-2 [2]	13842-46-1 [1]15699-18-0 [2]	Carc. 1AMuta. 2Repr. 1BAcute Tox. 4 *Acute Tox. 4 *STOT RE 1Resp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH341H360D ***H332H302H372 **H334H317H400H410	GHS08GHS07GHS09Dgr	H350iH341H360D ***H372 **H332H302H334H317H410		"STOT RE 1; H372: C ? 1 %STOT RE 2; H373: 0,1 % ? C < 1 %Skin Sens. 1; H317: C ? 0,01 %M=1"		ATP01
028-018-00-4	nickel bis(sulfamidate); nickel sulfamate	237-396-1	13770-89-3	Carc. 1AMuta. 2Repr. 1BSTOT RE 1Resp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH341H360D ***H372 **H334H317H400H410	GHS08GHS09Dgr	H350iH341H360D ***H372 **H334H317H410		"STOT RE 1; H372: C ? 1 %STOT RE 2; H373: 0,1 % ? C < 1 %Skin Sens. 1; H317: C ? 0,01 %M=1"		ATP01
028-019-00-X	nickel bis(tetrafluoroborate)	238-753-4	14708-14-6	Carc. 1AMuta. 2Repr. 1BSTOT RE 1Resp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH341H360D ***H372 **H334H317H400H410	GHS08GHS09Dgr	H350iH341H360D ***H372 **H334H317H410		"STOT RE 1; H372: C ? 1 %STOT RE 2; H373: 0,1 % ? C < 1 %Skin Sens. 1; H317: C ? 0,01 %M=1"		ATP01
028-021-00-0	"nickel diformate [1]formic acid, nickel salt [2]formic acid, copper nickel salt  [3]"	222-101-0 [1]239-946-6 [2]268-755-0 [3]	3349-06-2 [1]15843-02-4 [2]68134-59-8 [3]	Carc. 1AMuta. 2Repr. 1BSTOT RE 1Resp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH341H360D ***H372 **H334H317H400H410	GHS08GHS09Dgr	H350iH341H360D ***H372 **H334H317H410		"STOT RE 1; H372: C ? 1 %STOT RE 2; H373: 0,1 % ? C < 1 %Skin Sens. 1; H317: C ? 0,01 %M=1"		ATP01
028-022-00-6	nickel di(acetate) [1]nickel acetate [2]	206-761-7 [1]239-086-1 [2]	373-02-4 [1]14998-37-9 [2]	Carc. 1AMuta. 2Repr. 1BAcute Tox. 4 *Acute Tox. 4 *STOT RE 1Resp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH341H360D ***H332H302H372 **H334H317H400H410	GHS08GHS07GHS09Dgr	H302H332H334H317H341H350iH360D ***H372 **H410		"STOT RE 1; H372: C = 1 %STOT RE 2; H373: 0,1 % = C < 1 %Skin Sens. 1; H317: C = 0,01 %M=1"		ATP01/ATP01corr
028-024-00-7	nickel dibenzoate	209-046-8	553-71-9	Carc. 1AMuta. 2Repr. 1BSTOT RE 1Resp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH341H360D ***H372 **H334H317H400H410	GHS08GHS09Dgr	H350iH341H360D ***H372 **H334H317H410		"STOT RE 1; H372: C ? 1 %STOT RE 2; H373: 0,1 % ? C < 1 %Skin Sens. 1; H317: C ? 0,01 %M=1"		ATP01
028-025-00-2	nickel bis(4-cyclohexylbutyrate)	223-463-2	3906-55-6	Carc. 1AMuta. 2Repr. 1BSTOT RE 1Resp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH341H360D ***H372 **H334H317H400H410	GHS08GHS09Dgr	H350iH341H360D ***H372 **H334H317H410		"STOT RE 1; H372: C ? 1 %STOT RE 2; H373: 0,1 % ? C < 1 %Skin Sens. 1; H317: C ? 0,01 %M=1"		ATP01
028-026-00-8	nickel(II) stearate; nickel(II) octadecanoate	218-744-1	2223-95-2	Carc. 1AMuta. 2Repr. 1BSTOT RE 1Resp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH341H360D ***H372 **H334H317H400H410	GHS08GHS09Dgr	H350iH341H360D ***H372 **H334H317H410		"STOT RE 1; H372: C ? 1 %STOT RE 2; H373: 0,1 % ? C < 1 %Skin Sens. 1; H317: C ? 0,01 %M=1"		ATP01
028-027-00-3	nickel dilactate	-	16039-61-5	Carc. 1AMuta. 2Repr. 1BSTOT RE 1Resp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH341H360D ***H372 **H334H317H400H410	GHS08GHS09Dgr	H350iH341H360D ***H372 **H334H317H410		"STOT RE 1; H372: C ? 1 %STOT RE 2; H373: 0,1 % ? C < 1 %Skin Sens. 1; H317: C ? 0,01 %M=1"		ATP01
028-028-00-9	nickel(II) octanoate	225-656-7	4995-91-9	Carc. 1AMuta. 2Repr. 1BSTOT RE 1Skin Corr. 1AResp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH341H360D ***H372 **H314H334H317H400H410	GHS05GHS08GHS09Dgr	H350iH341H360D ***H372 **H314H334H317H410		"STOT RE 1; H372: C ? 1 %STOT RE 2; H373: 0,1 % ? C < 1 %Skin Sens. 1; H317: C ? 0,01 %M=1"		ATP01
028-029-00-4	nickel difluoride [1]nickel dibromide [2]nickel diiodide [3]nickel potassium fluoride  [4]	233-071-3 [1]236-665-0 [2]236-666-6 [3]	10028-18-9 [1]13462-88-9 [2]13462-90-3 [3]11132-10-8 [4]	Carc. 1AMuta. 2Repr. 1BSTOT RE 1Resp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH341H360D ***H372 **H334H317H400H410	GHS08GHS09Dgr	H350iH341H360D ***H372 **H334H317H410		"STOT RE 1; H372: C ? 1 %STOT RE 2; H373: 0,1 % ? C < 1 %Skin Sens. 1; H317: C ? 0,01 %M=1"		ATP01
028-030-00-X	nickel hexafluorosilicate	247-430-7	26043-11-8	Carc. 1AMuta. 2Repr. 1BSTOT RE 1Resp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH341H360D ***H372 **H334H317H400H410	GHS08GHS09Dgr	H350iH341H360D ***H372 **H334H317H410		"STOT RE 1; H372: C ? 1 %STOT RE 2; H373: 0,1 % ? C < 1 %Skin Sens. 1; H317: C ? 0,01 %M=1"		ATP01
028-031-00-5	nickel selenate	239-125-2	15060-62-5	Carc. 1AMuta. 2Repr. 1BSTOT RE 1Resp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH341H360D ***H372 **H334H317H400H410	GHS08GHS09Dgr	H350iH341H360D ***H372 **H334H317H410		"STOT RE 1; H372: C ? 1 %STOT RE 2; H373: 0,1 % ? C < 1 %Skin Sens. 1; H317: C ? 0,01 %M=1"		ATP01
028-032-00-0	"nickel hydrogen phosphate [1]nickel bis(dihydrogen phosphate) [2]trinickel bis(orthophosphate) [3]dinickel diphosphate [4]nickel bis(phosphinate) [5]nickel phosphinate [6]phosphoric acid, calcium nickel salt [7]diphosphoric acid, nickel(II) salt  [8]"	238-278-2 [1]242-522-3 [2]233-844-5 [3]238-426-6 [4]238-511-8 [5]252-840-4 [6]	14332-34-4 [1]18718-11-1 [2]10381-36-9 [3]14448-18-1 [4]14507-36-9 [5]36026-88-7 [6]17169-61-8 [7]19372-20-4 [8]	Carc. 1ASTOT RE 1Resp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH372 **H334H317H400H410	GHS08GHS09Dgr	H350iH372 **H334H317H410				ATP01
028-033-00-6	diammonium nickel hexacyanoferrate	-	74195-78-1	Carc. 1ASTOT RE 1Resp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH372 **H334H317H400H410	GHS08GHS09Dgr	H350iH372 **H334H317H410				ATP01
028-034-00-1	nickel dicyanide	209-160-8	557-19-7	Carc. 1ASTOT RE 1Resp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH372 **H334H317H400H410	GHS08GHS09Dgr	H350iH372 **H334H317H410	EUH032			ATP01
028-035-00-7	nickel chromate	238-766-5	14721-18-7	Carc. 1ASTOT RE 1Resp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH372 **H334H317H400H410	GHS08GHS09Dgr	H350iH372 **H334H317H410				ATP01
028-036-00-2	"nickel(II) silicate [1]dinickel orthosilicate [2]nickel silicate (3:4) [3]silicic acid, nickel salt [4]trihydrogen hydroxybis[orthosilicato(4-)]trinickelate(3-)  [5]"	244-578-4 [1]237-411-1 [2]250-788-7 [3]253-461-7 [4]235-688-3 [5]	21784-78-1 [1]13775-54-7 [2]31748-25-1 [3]37321-15-6 [4]12519-85-6 [5]	Carc. 1ASTOT RE 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH372 **H317H400H410	GHS08GHS07GHS09Dgr	H350iH372 **H317H410				ATP01
028-037-00-8	dinickel hexacyanoferrate	238-946-3	14874-78-3	Carc. 1ASTOT RE 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH372 **H317H400H410	GHS08GHS07GHS09Dgr	H350iH372 **H317H410				ATP01
028-038-00-3	trinickel bis(arsenate); nickel(II) arsenate	236-771-7	13477-70-8	Carc. 1ASTOT RE 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350H372 **H317H400H410	GHS08GHS07GHS09Dgr	H350H372 **H317H410				ATP01
028-039-00-9	"nickel oxalate [1]oxalic acid, nickel salt  [2]"	208-933-7 [1]243-867-2 [2]	547-67-1 [1]20543-06-0 [2]	Carc. 1ASTOT RE 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH372 **H317H400H410	GHS08GHS07GHS09Dgr	H350iH372 **H317H410				ATP01
028-040-00-4	nickel telluride	235-260-6	12142-88-0	Carc. 1ASTOT RE 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH372 **H317H400H410	GHS08GHS07GHS09Dgr	H350iH372 **H317H410				ATP01
028-041-00-X	trinickel tetrasulfide	-	12137-12-1	Carc. 1ASTOT RE 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH372 **H317H400H410	GHS08GHS07GHS09Dgr	H350iH372 **H317H410				ATP01
028-042-00-5	trinickel bis(arsenite)	-	74646-29-0	Carc. 1ASTOT RE 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH372 **H317H400H410	GHS08GHS07GHS09Dgr	H350iH372 **H317H410				ATP01
028-043-00-0	cobalt nickel gray periclase; C.I. Pigment Black 25; C.I. 77332 [1]cobalt nickel dioxide [2]cobalt nickel oxide  [3]	269-051-6 [1]261-346-8 [2]	68186-89-0 [1]58591-45-0 [2]12737-30-3 [3]	Carc. 1ASTOT RE 1Skin Sens. 1	H350iH372 **H317	GHS08GHS07Dgr	H350iH372 **H317				ATP01
028-044-00-6	nickel tin trioxide; nickel stannate	234-824-9	12035-38-0	Carc. 1ASTOT RE 1Skin Sens. 1	H350iH372 **H317	GHS08GHS07Dgr	H350iH372 **H317				ATP01
028-045-00-1	nickel triuranium decaoxide	239-876-6	15780-33-3	Carc. 1ASTOT RE 1Skin Sens. 1	H350iH372 **H317	GHS08GHS07Dgr	H350iH372 **H317				ATP01
028-046-00-7	nickel dithiocyanate	237-205-1	13689-92-4	Carc. 1AMuta. 2Repr. 1BSTOT RE 1Resp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH341H360D ***H372 **H334H317H400H410	GHS08GHS09Dgr	H350iH341H360D ***H372 **H334H317H410	EUH032	"STOT RE 1; H372: C ? 1 %STOT RE 2; H373: 0,1 % ? C < 1 %Skin Sens. 1; H317: C ? 0,01 %M=1"		ATP01
028-047-00-2	nickel dichromate	239-646-5	15586-38-6	Carc. 1AMuta. 2Repr. 1BSTOT RE 1Resp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH341H360D ***H372 **H334H317H400H410	GHS08GHS09Dgr	H350iH341H360D ***H372 **H334H317H410		"STOT RE 1; H372: C ? 1 %STOT RE 2; H373: 0,1 % ? C < 1 %Skin Sens. 1; H317: C ? 0,01 %M=1"		ATP01
028-048-00-8	nickel(II) selenite	233-263-7	10101-96-9	Carc. 1ASTOT RE 1Resp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH372 **H334H317H400H410	GHS08GHS09Dgr	H350iH372 **H334H317H410				ATP01
028-049-00-3	nickel selenide	215-216-2	1314-05-2	Carc. 1ASTOT RE 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH372 **H317H400H410	GHS08GHS07GHS09Dgr	H350iH372 **H317H410				ATP01
028-050-00-9	"silicic acid, lead nickel salt"	-	68130-19-8	Carc. 1ARepr. 1ASTOT RE 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH360DfH372 **H317H400H410	GHS08GHS07GHS09Dgr	H350iH360DfH372 **H317H410				ATP01
028-051-00-4	nickel diarsenide [1]nickel arsenide  [2]	235-103-1 [1]248-169-1 [2]	12068-61-0 [1]27016-75-7 [2]	Carc. 1ASTOT RE 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH372 **H317H400H410	GHS08GHS07GHS09Dgr	H350iH372 **H317H410				ATP01
028-052-00-X	nickel barium titanium primrose priderite; C.I. Pigment Yellow 157; C.I. 77900	271-853-6	68610-24-2	Carc. 1ASTOT RE 1Skin Sens. 1	H350iH372 **H317	GHS08GHS07Dgr	H317H350iH372 **				ATP01/ATP01corr
028-053-00-5	"nickel dichlorate [1]nickel dibromate [2]ethyl hydrogen sulfate, nickel(II) salt  [3]"	267-897-0 [1]238-596-1 [2]275-897-7 [3]	67952-43-6 [1]14550-87-9 [2]71720-48-4 [3]	Carc. 1AMuta. 2Repr. 1BSTOT RE 1Resp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH341H360D ***H372 **H334H317H400H410	GHS08GHS09Dgr	H350iH341H360D ***H372 **H334H317H410		"STOT RE 1; H372: C ? 1 %STOT RE 2; H373: 0,1 % ? C < 1 %Skin Sens. 1; H317: C ? 0,01 %1M=1"		ATP01
028-054-00-0	"nickel(II) trifluoroacetate [1]nickel(II) propionate [2]nickel bis(benzenesulfonate) [3]nickel(II) hydrogen citrate [4]citric acid, ammonium nickel salt [5]citric acid, nickel salt [6]nickel bis(2-ethylhexanoate) [7]2-ethylhexanoic acid, nickel salt [8]dimethylhexanoic acid nickel salt [9]nickel(II) isooctanoate [10]nickel isooctanoate [11]nickel bis(isononanoate) [12]nickel(II) neononanoate [13]nickel(II) isodecanoate [14]nickel(II) neodecanoate [15]neodecanoic acid, nickel salt [16]nickel(II) neoundecanoate [17]bis(.sc.d.sc.-gluconato-O1,O2)nickel [18]nickel 3,5-bis(tert-butyl)-4-hydroxybenzoate (1:2) [19]nickel(II) palmitate [20](2-ethylhexanoato-O)(isononanoato-O)nickel [21](isononanoato-O)(isooctanoato-O)nickel [22](isooctanoato-O)(neodecanoato-O)nickel [23](2-ethylhexanoato-O)(isodecanoato-O)nickel [24](2-ethylhexanoato-O)(neodecanoato-O)nickel [25](isodecanoato-O)(isooctanoato-O)nickel [26](isodecanoato-O)(isononanoato-O)nickel [27](isononanoato-O)(neodecanoato-O)nickel [28]fatty acids, C6-19-branched, nickel salts [29]fatty acids, C8-18 and C18-unsaturated, nickel salts [30]2,7-naphthalenedisulfonic acid, nickel(II) salt [31]"	240-235-8 [1]222-102-6 [2]254-642-3 [3]242-533-3 [4]242-161-1 [5]245-119-0 [6]224-699-9 [7]231-480-1 [8]301-323-2 [9]249-555-2 [10]248-585-3 [11]284-349-6 [12]300-094-6 [13]287-468-1 [14]287-469-7 [15]257-447-1 [16]300-093-0 [17]276-205-6 [18]258-051-1 [19]237-138-8 [20]287-470-2 [21]287-471-8 [22]284-347-5 [23]284-351-7 [24]285-698-7 [25]285-909-2 [26]284-348-0 [27]287-592-6 [28]294-302-1 [29]283-972-0 [30]	16083-14-0 [1]3349-08-4 [2]39819-65-3 [3]18721-51-2 [4]18283-82-4 [5]22605-92-1 [6]4454-16-4 [7]7580-31-6 [8]93983-68-7 [9]29317-63-3 [10]27637-46-3 [11]84852-37-9 [12]93920-10-6 [13]85508-43-6 [14]85508-44-7 [15]51818-56-5 [16]93920-09-3 [17]71957-07-8 [18]52625-25-9 [19]13654-40-5 [20]85508-45-8 [21]85508-46-9 [22]84852-35-7 [23]84852-39-1 [24]85135-77-9 [25]85166-19-4 [26]84852-36-8 [27]85551-28-6 [28]91697-41-5 [29]84776-45-4 [30]72319-19-8 [31]	Carc. 1AMuta. 2Repr. 1BSTOT RE 1Resp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH341H360D ***H372 **H334H317H400H410	GHS08GHS09Dgr	H350iH341H360D ***H372 **H334H317H410		"STOT RE 1; H372: C ? 1 %STOT RE 2; H373: 0,1 % ? C < 1 %Skin Sens. 1; H317: C ? 0,01 %M=1"		ATP01
028-055-00-6	nickel(II) sulfite [1]nickel tellurium trioxide [2]nickel tellurium tetraoxide [3]molybdenum nickel hydroxide oxide phosphate  [4]	231-827-7 [1]239-967-0 [2]239-974-9 [3]268-585-7 [4]	7757-95-1 [1]15851-52-2 [2]15852-21-8 [3]68130-36-9 [4]	Carc. 1ASTOT RE 1Resp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH372 **H334H317H400H410	GHS08GHS09Dgr	H350iH372 **H334H317H410				ATP01
028-056-00-1	nickel boride (NiB) [1]dinickel boride [2]trinickel boride [3]nickel boride [4]dinickel silicide [5]nickel disilicide [6]dinickel phosphide [7]nickel boron phosphide  [8]	234-493-0 [1]234-494-6 [2]234-495-1 [3]235-723-2 [4]235-033-1 [5]235-379-3 [6]234-828-0 [7]	12007-00-0 [1]12007-01-1 [2]12007-02-2 [3]12619-90-8 [4]12059-14-2 [5]12201-89-7 [6]12035-64-2 [7]65229-23-4 [8]	Carc. 1ASTOT RE 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH372 **H317H400H410	GHS08GHS07GHS09Dgr	H350iH372 **H317H410				ATP01
028-057-00-7	"dialuminium nickel tetraoxide [1]nickel titanium trioxide [2]nickel titanium oxide [3]nickel divanadium hexaoxide [4]cobalt dimolybdenum nickel octaoxide [5]nickel zirkonium trioxide [6]molybdenum nickel tetraoxide [7]nickel tungsten tetraoxide [8]olivine, nickel green [9]lithium nickel dioxide [10]molybdenum nickel oxide [11]"	234-454-8 [1]234-825-4 [2]235-752-0 [3]257-970-5 [4]268-169-5 [5]274-755-1 [6]238-034-5 [7]238-032-4 [8]271-112-7 [9]	12004-35-2 [1]12035-39-1 [2]12653-76-8 [3]52502-12-2 [4]68016-03-5 [5]70692-93-2 [6]14177-55-0 [7]14177-51-6 [8]68515-84-4 [9]12031-65-1 [10]12673-58-4 [11]	Carc. 1ASTOT RE 1Skin Sens. 1	H350iH372 **H317	GHS08GHS07Dgr	H350iH372 **H317				ATP01
028-058-00-2	cobalt lithium nickel oxide	442-750-5	-	Carc. 1AAcute Tox. 2 *STOT RE 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350iH330H372 **H317H400H410	GHS06GHS08GHS09Dgr	H350iH330H372 **H317H410				ATP01
029-001-00-4	copper chloride; copper (I) chloride; cuprous chloride	231-842-9	7758-89-6	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H400H410				CLP00
029-002-00-X	dicopper oxide; copper (I) oxide	215-270-7	1317-39-1	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410				CLP00
029-003-00-5	"Naphthenic acids, copper salts; copper naphthenate"	215-657-0	1338-02-9	Flam. Liq. 3Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H226H302H400H410	GHS02GHS07GHS09Wng	H226H302H410				CLP00
029-004-00-0	copper sulphate	231-847-6	7758-98-7	Acute Tox. 4 *Skin Irrit. 2Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H302H315H319H400H410	GHS07GHS09Wng	H302H319H315H410				CLP00
029-005-00-6	"(tris(chloromethyl)phthalocyaninato)copper(II), reaction products with N-methylpiperazine and methoxyacetic acid"	401-260-1		Eye Irrit. 2	H319	GHS07Wng	H319				CLP00
029-006-00-1	tris(octadec-9-enylammonium) (trisulfonatophthalocyaninato)copper(II)	403-210-4		Eye Dam. 1Aquatic Chronic 2	H318H411	GHS05GHS09Dgr	H318H411				CLP00
029-007-00-7	"(trisodium (2-((3-(6-(2-chloro-5-sulfonato)anilino)-4-(3-carboxypyridinio)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)phenylmethylazo)-4-sulfonatobenzoato)copper(3-)) hydroxide"	404-670-9	89797-01-3	Skin Sens. 1	H317	GHS07Wng	H317			G	CLP00
029-008-00-2	copper(II) methanesulfonate	405-400-2	54253-62-2	Acute Tox. 4 *Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H302H318H400H410	GHS05GHS07GHS09Dgr	H302H318H410				CLP00
029-009-00-8	phthalocyanine-N-[3-(diethylamino)propyl]sulfonamide copper complex	413-650-9	93971-95-0	Aquatic Chronic 3	H412		H412				CLP00
029-010-00-3	reaction mass of compounds from (dodecakis(p-tolylthio)phthalocyaninato)copper(II) to (hexadecakis(p-tolylthio)phthalocyaninato)copper(II)	407-700-9	101408-30-4	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
029-011-00-9	"sodium [29H,31H-phthalocyaninato-(2-)-N29,N30,N31,N32]-((3-(N-methyl-N-(2-hydroxyethyl)amino)propyl)amino)sulfonyl-sulfonato, copper complex"	412-730-0	150522-10-4	Skin Corr. 1B	H314	GHS05Dgr	H314				CLP00
029-012-00-4	sodium ((N-(3-trimethylammoniopropyl)sulfamoyl)methylsulfonatophthalocyaninato)copper(II)	407-340-2	124719-24-0	Eye Dam. 1	H318	GHS05Dgr	H318				CLP00
029-013-00-X	"trisodium(2-(?-(3-(4-chloro-6-(2-(2-(vinylsulfonyl)ethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)benzylidenehydrazino)-4-sulfonatobenzoato)copper(II)"	407-580-8	130201-51-3	Eye Dam. 1	H318	GHS05Dgr	H318				CLP00/ATP01
029-014-00-5	"reaction mass of:  2,2'-[[cis-1,2-cyclohexanediylbis(nitrilomethylidene)]bis[phenolate]](2-)N,N',O,O'-copper complex; 2,2'-[[trans-1,2-cyclohexanediylbis(nitrilomethylidyne)]bis[phenolate]](2-)N,N',O,O'-copper complex"	419-610-7	171866-24-3	STOT RE 2 *Aquatic Chronic 2	H373 **H411	GHS08GHS09Wng	H373 **H411				ATP01
030-001-00-1	zinc powder - zinc dust (pyrophoric)	231-175-3	7440-66-6	Pyr. Sol. 1Water-react. 1Aquatic Acute 1Aquatic Chronic 1	H250H260H400H410	GHS02GHS09Dgr	H260H250H410			T	CLP00
030-001-01-9	zinc powder - zinc dust (stabilised)	231-175-3	7440-66-6	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
030-003-00-2	zinc chloride	231-592-0	7646-85-7	Acute Tox. 4 *Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1	H302H314H400H410	GHS05GHS07GHS09Dgr	H302H314H410		STOT SE 3; H335: C ? 5 %		CLP00
030-004-00-8	dimethylzinc [1]diethylzinc  [2]	208-884-1 [1]209-161-3 [2]	544-97-8 [1]557-20-0 [2]	Pyr. Liq. 1Water-react. 1Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1	H250H260H314H400H410	GHS02GHS05GHS09Dgr	H250H260H314H410	EUH014			CLP00
030-005-00-3	diamminediisocyanatozinc	401-610-3		Acute Tox. 4 *Eye Dam. 1Resp. Sens. 1Skin Sens. 1Aquatic Acute 1	H302H318H334H317H400	GHS05GHS08GHS07GHS09Dgr	H302H318H334H317H400				CLP00
030-006-00-9	"zinc sulphate (hydrous) (mono-, hexa- and hepta hydrate) [1]zinc sulphate (anhydrous)  [2]"	231-793-3 [1]231-793-3 [2]	7446-19-7 [1]7733-02-0 [2]	Acute Tox. 4 *Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H302H318H400H410	GHS05GHS07GHS09Dgr	H302H318H410				CLP00
030-007-00-4	"bis(3,5-di-tert-butylsalicylato-O1,O2)zinc"	403-360-0	42405-40-3	Flam. Sol. 1Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H228H302H400H410	GHS02GHS07GHS09Dgr	H228H302H410			T	CLP00
030-008-00-X	hydroxo(2-(benzenesulfonamido)benzoato)zinc(II)	403-750-0	113036-91-2	Acute Tox. 4 *Aquatic Chronic 2	H332H411	GHS07GHS09Wng	H332H411				CLP00
030-009-00-5	zinc-bis(4-(n-octyloxycarbonylamino)salicylate) dihydrate	417-130-2	-	Eye Dam. 1Aquatic Chronic 2	H318H411	GHS05GHS09Dgr	H318H411				ATP01
030-010-00-0	"2-dodec-1-enylbutanedioic acid, 4-methyl ester zinc salt"	430-740-3	-	Aquatic Chronic 2	H411	GHS09	H411				ATP01
030-011-00-6	trizinc bis(orthophosphate)	231-944-3	7779-90-0	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
030-012-00-1	aluminium-magnesium-zinc-carbonate-hydroxide	423-570-6	169314-88-9	Aquatic Chronic 4	H413	-	H413				ATP01/ATP05
030-013-00-7	zinc oxide	215-222-5	1314-13-2	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
030-015-00-8	tetrazinc(2+)bis(hexacyanocobalt(3+))diacetate	440-060-9	-	Aquatic Chronic 2	H411	GHS09	H411				ATP01
031-001-00-4	gallium arsenide	215-114-8	1303-00-0	Carc. 1BRepr. 1BSTOT RE 1	H350H360FH372 (respiratory and haematopoietic systems)	GHS08Dgr	H350H360FH372 (respiratory and haematopoietic systems)				ATP05/ATP07
033-001-00-X	arsenic	231-148-6	7440-38-2	Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H331H301H400H410	GHS06GHS09Dgr	H331H301H410				CLP00
033-002-00-5	"arsenic compounds, with the exception of those specified elsewhere in this Annex"			Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H331H301H400H410	GHS06GHS09Dgr	H331H301H410		*	1 A	CLP00
033-003-00-0	diarsenic trioxide; arsenic trioxide	215-481-4	1327-53-3	Carc. 1AAcute Tox. 2 *Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1	H350H300H314H400H410	GHS06GHS08GHS05GHS09Dgr	H350H300H314H410				CLP00
033-004-00-6	diarsenic pentaoxide; arsenic pentoxide; arsenic oxide	215-116-9	1303-28-2	Carc. 1AAcute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H350H331H301H400H410	GHS06GHS08GHS09Dgr	H350H331H301H410				CLP00
033-005-00-1	arsenic acid and its salts with the exception of those specified elsewhere in this Annex	-	-	Carc. 1AAcute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H350H331H301H400H410	GHS06GHS08GHS09Dgr	H350H331H301H410			A	CLP00/ATP01
033-006-00-7	arsine	232-066-3	7784-42-1	Flam. Gas 1Press. GasAcute Tox. 2 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H220H330H373 **H400H410	GHS02GHS04GHS06GHS08GHS09Dgr	H220H330H373 **H410			U	CLP00
033-007-00-2	tert-butylarsine	423-320-6	4262-43-5	Pyr. Liq. 1Acute Tox. 2 *	H250H330	GHS02GHS06Dgr	H250H330				CLP00
034-001-00-2	selenium	231-957-4	7782-49-2	Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Chronic 4	H331H301H373 **H413	GHS06GHS08Dgr	H331H301H373 **H413				CLP00
034-002-00-8	selenium compounds with the exception of cadmium sulphoselenide and those specified elsewhere in this Annex	-	-	Acute Tox. 3 *Acute Tox. 3 *STOT RE 2Aquatic Acute 1Aquatic Chronic 1	H331H301H373 **H400H410	GHS06GHS08GHS09Dgr	H331H301H373 **H410			A	CLP00/ATP01
034-003-00-3	sodium selenite	233-267-9	10102-18-8	Acute Tox. 2 *Acute Tox. 3 *Skin Sens. 1Aquatic Chronic 2	H300H331H317H411	GHS06GHS09Dgr	H300H331H317H411	EUH031			CLP00
035-001-00-5	bromine	231-778-1	7726-95-6	Acute Tox. 2 *Skin Corr. 1AAquatic Acute 1	H330H314H400	GHS06GHS05GHS09Dgr	H330H314H400				CLP00
035-002-00-0	hydrogen bromide	233-113-0	10035-10-6	Press. GasSTOT SE 3Skin Corr. 1A	H335H314	GHS04GHS05GHS07Dgr	H314H335			U	CLP00
035-002-01-8	hydrobromic acid ... %			STOT SE 3Skin Corr. 1B	H335H314	GHS05GHS07Dgr	H314H335		Skin Corr. 1B; H314: C ? 40 %Skin Irrit. 2; H315: 10 % ? C < 40 %Eye Irrit. 2; H319: 10 % ? C < 40 %STOT SE 3; H335: C ? 10 %	B	CLP00
035-003-00-6	potassium bromate	231-829-8	7758-01-2	Ox. Sol. 1Carc. 1BAcute Tox. 3 *	H271H350H301	GHS03GHS06GHS08Dgr	H271H350H301				CLP00
035-004-00-1	2-hydroxyethylammonium perbromide	407-440-6		Ox. Sol. 2 ****Acute Tox. 4 *Skin Corr. 1ASkin Sens. 1Aquatic Acute 1	H272H302H314H317H400	GHS03GHS05GHS07GHS09Dgr	H272H302H314H317H400				CLP00
040-001-00-3	zirconium powder (pyrophoric)	231-176-9	7440-67-7	Pyr. Sol. 1Water-react. 1	H250H260	GHS02Dgr	H260H250			T	CLP00
040-002-00-9	zirconium powder (non pyrophoric)			Self-heat. 1	H251	GHS02Dgr	H251			T	CLP00
040-003-00-4	"reaction product of 3,5-di-tert-butylsalicylic acid and zirconium oxychloride, dehydrated, basic Zr : DTBS = 1.0 : 1.0 to 1.0 : 1.5"	430-610-6	226996-19-6	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				ATP01
042-001-00-9	molybdenum trioxide	215-204-7	1313-27-5	Carc. 2STOT SE 3Eye Irrit. 2	H351H335H319	GHS08GHS07Wng	H351H319H335				CLP00/ATP01
042-002-00-4	tetrakis(dimethylditetradecylammonium) hexa-?-oxotetra-?3-oxodi-?5-oxotetradecaoxooctamolybdate(4-)	404-760-8	117342-25-3	Acute Tox. 3 *Eye Dam. 1	H331H318	GHS06GHS05Dgr	H331H318				CLP00/ATP01
042-003-00-X	tetrakis(trimethylhexadecylammonium) hexa-mu-oxotetra-mu3-oxodi-mu5-oxotetradecaoxooctamolybdate(4-)	404-860-1	116810-46-9	Flam. Sol. 1Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H228H318H400H410	GHS02GHS05GHS09Dgr	H228H318H410			T	CLP00
042-004-00-5	Reaction product of ammonium molybdate and C12-C24-diethoxylated alkylamine (1:5-1:3)	412-780-3		Skin Irrit. 2Skin Sens. 1Aquatic Chronic 2	H315H317H411	GHS07GHS09Wng	H315H317H411				CLP00
042-005-00-0	"reaction mass of: mono- and di-glycerols of canola oil; canola oil acid amide of branched 1,3-propanediamine,N-[3-(tridecyloxy)-propyl]; N,N-diorgano dithiocarbamate molybdenum complex"	434-240-6	-	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				ATP01
046-001-00-X	tetraammine palladium (II) hydrogen carbonate	425-270-0	134620-00-1	Acute Tox. 4 *STOT RE 2 *Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H373 **H318H317H400H410	GHS05GHS08GHS07GHS09Dgr	H302H373 **H318H317H410				ATP01
047-001-00-2	silver nitrate	231-853-9	7761-88-8	Ox. Sol. 2Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1	H272H314H400H410	GHS03GHS05GHS09Dgr	H272H314H410				CLP00/ATP01
047-002-00-8	"polyphosphoric acid, copper, sodium, magnesium, calcium, silver and zinc salt"	416-850-4	-	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				ATP01
048-001-00-5	"cadmium compounds, with the exception of cadmium sulphoselenide (xCdS.yCdSe), reaction mass of cadmium sulphide with zinc sulphide (xCdS.yZnS), reaction mass of cadmium sulphide with mercury sulphide (xCdS.yHgS), and those specified elsewhere in this Annex"			Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H332H312H302H400H410	GHS07GHS09Wng	H332H312H302H410		*	1 A	CLP00
048-002-00-0	cadmium (non-pyrophoric) [1]cadmium oxide (non-pyrophoric)  [2]	231-152-8 [1]215-146-2 [2]	7440-43-9 [1]1306-19-0 [2]	Carc. 1BMuta. 2Repr. 2Acute Tox. 2 *STOT RE 1Aquatic Acute 1Aquatic Chronic 1	H350H341H361fdH330H372 **H400H410	GHS06GHS08GHS09Dgr	H350H341H361fdH330H372 **H410				CLP00
048-003-00-6	cadmium diformate; cadmiumformate	224-729-0	4464-23-7	Carc. 2Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H351H331H301H373 **H400H410	GHS06GHS08GHS09Dgr	H331H301H351H373 **H410		"*STOT RE 2; H373: C ? 0,25 %"		CLP00
048-004-00-1	cadmium cyanide	208-829-1	542-83-6	Carc. 2Acute Tox. 1Acute Tox. 2 *Acute Tox. 2 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H351H310H330H300H373 **H400H410	GHS06GHS08GHS09Dgr	H330H310H300H351H373 **H410	EUH032	"STOT RE 2; H373: C ? 0,1 %EUH032: C ? 1 %"		CLP00
048-005-00-7	cadmiumhexafluorosilicate(2-); cadmium fluorosilica	241-084-0	17010-21-8	Carc. 2Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H351H331H301H373 **H400H410	GHS06GHS08GHS09Dgr	H331H301H351H373 **H410		"*STOT RE 2; H373: C ? 0,1 %"		CLP00
048-006-00-2	cadmium fluoride	232-222-0	7790-79-6	Carc. 1BMuta. 1BRepr. 1BAcute Tox. 2 *Acute Tox. 3 *STOT RE 1Aquatic Acute 1Aquatic Chronic 1	H350H340H360FDH330H301H372 **H400H410	GHS06GHS08GHS09Dgr	H350H340H360FDH330H301H372 **H410		"Carc. 1B; H350: C ? 0,01 %* oralSTOT RE 1; H372: C ? 7 %STOT RE 2: 0,1 % ? C < 7 %"		CLP00
048-007-00-8	cadmium iodide	232-223-6	7790-80-9	Carc. 2Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H351H331H301H373 **H400H410	GHS06GHS08GHS09Dgr	H331H301H351H373 **H410		"*STOT RE 2; H373: C ? 0,1 %"		CLP00
048-008-00-3	cadmium chloride	233-296-7	10108-64-2	Carc. 1BMuta. 1BRepr. 1BAcute Tox. 2 *Acute Tox. 3 *STOT RE 1Aquatic Acute 1Aquatic Chronic 1	H350H340H360FDH330H301H372 **H400H410	GHS06GHS08GHS09Dgr	H350H340H360FDH330H301H372 **H410		"Carc. 1B; H350: C ? 0,01 %* oralSTOT RE 1; H372: C ? 7 %STOT RE 2; H373: 0,1 % ? C < 7 %"		CLP00
048-009-00-9	cadmium sulphate	233-331-6	10124-36-4	Carc. 1BMuta. 1BRepr. 1BAcute Tox. 2 *Acute Tox. 3 *STOT RE 1Aquatic Acute 1Aquatic Chronic 1	H350H340H360FDH330H301H372 **H400H410	GHS06GHS08GHS09Dgr	H350H340H360FDH330H301H372 **H410		"Carc. 1B; H350: C ? 0,01 %* oralSTOT RE 1; H372: C ? 7 %STOT RE 2; H373: 0,1 % ? C < 7 %"		CLP00
048-010-00-4	cadmium sulphide	215-147-8	1306-23-6	Carc. 1BMuta. 2Repr. 2Acute Tox. 4 *STOT RE 1Aquatic Chronic 4	H350H341H361fdH302H372 **H413	GHS08GHS07Dgr	H350H341H361fdH372 **H302H413		"*STOT RE 1; H372: C ? 10 %STOT RE 2; H373: 0,1 % ? C < 10 %"	1 	CLP00
048-011-00-X	cadmium (pyrophoric)	231-152-8	7440-43-9	Pyr. Sol. 1Carc. 1BMuta. 2Repr. 2Acute Tox. 2 *STOT RE 1Aquatic Acute 1Aquatic Chronic 1	H250H350H341H361fdH330H372 **H400H410	GHS02GHS06GHS08GHS09Dgr	H250H350H341H361fdH330H372 **H410				CLP00
050-001-00-5	tin tetrachloride; stannic chloride	231-588-9	7646-78-8	Skin Corr. 1BAquatic Chronic 3	H314H412	GHS05Dgr	H314H412		STOT SE 3; H335: C ? 5 %		CLP00
050-002-00-0	cyhexatin (ISO); hydroxytricyclohexylstannane; tri(cyclohexyl)tin hydroxide	236-049-1	13121-70-5	Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H332H312H302H400H410	GHS07GHS09Wng	H332H312H302H410		M=1000		CLP00/ATP01
050-003-00-6	fentin acetate (ISO); triphenyltin acetate	212-984-0	900-95-8	Carc. 2Repr. 2Acute Tox. 2 *Acute Tox. 3 *Acute Tox. 3 *STOT SE 3STOT RE 1Skin Irrit. 2Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H351H361d ***H330H311H301H335H372 **H315H318H400H410	GHS06GHS05GHS08GHS09Dgr	H351H361d ***H330H311H301H372 **H335H315H318H410		M=10		CLP00/ATP01
050-004-00-1	fentin hydroxide (ISO); triphenyltin hydroxide	200-990-6	76-87-9	Carc. 2Repr. 2Acute Tox. 2 *Acute Tox. 3 *Acute Tox. 3 *STOT SE 3STOT RE 1Skin Irrit. 2Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H351H361d ***H330H311H301H335H372 **H315H318H400H410	GHS06GHS05GHS08GHS09Dgr	H351H361d ***H330H311H301H372 **H335H315H318H410		M=10		CLP00/ATP01
050-005-00-7	"trimethyltin compounds, with the exception of those specified elsewhere in this Annex"			Acute Tox. 1Acute Tox. 2 *Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1	H310H330H300H400H410	GHS06GHS09Dgr	H330H310H300H410		*	1 A	CLP00
050-006-00-2	"triethyltin compounds, with the exception of those specified elsewhere in this Annex"			Acute Tox. 1Acute Tox. 2 *Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1	H310H330H300H400H410	GHS06GHS09Dgr	H330H310H300H410		*	1 A	CLP00
050-007-00-8	"tripropyltin compounds, with the exception of those specified elsewhere in this Annex"			Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H331H311H301H400H410	GHS06GHS09Dgr	H331H311H301H410		*	1 A	CLP00
050-008-00-3	"tributyltin compounds, with the exception of those specified elsewhere in this Annex"			Repr. 1BAcute Tox. 3Acute Tox. 4 *STOT RE 1Skin Irrit. 2Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H360FDH301H312H372 **H315H319H400H410	GHS06GHS08GHS09Dgr	H312H301H315H319H360FDH372 **H410		"*STOT RE 1; H372: C ? 1 %STOT RE 2; H373: 0,25 % ? C < 1 %Skin Irrit. 2; H315: C ? 1 %Eye Irrit. 2; H319: C ? 1 %M=10"	1 A	CLP00/ATP07
050-009-00-9	fluorotripentylstannane [1]hexapentyldistannoxane  [2]	243-546-7 [1]247-143-7 [2]	20153-49-5 [1]25637-27-8 [2]	Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H332H312H302H400H410	GHS07GHS09Wng	H332H312H302H410		*	1 	CLP00
050-010-00-4	fluorotrihexylstannane	243-547-2	20153-50-8	Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H332H312H302H400H410	GHS07GHS09Wng	H332H312H302H410		*	1 	CLP00
050-011-00-X	"triphenyltin compounds, with the exception of those specified elsewhere in this Annex"	-	-	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H331H311H301H400H410	GHS06GHS09Dgr	H331H311H301H410		*M=100	1 A	CLP00/ATP01
050-012-00-5	tetracyclohexylstannane [1]chlorotricyclohexylstannane [2]butyltricyclohexylstannane  [3]	215-910-5 [1]221-437-5 [2]230-358-5 [3]	1449-55-4 [1]3091-32-5 [2]7067-44-9 [3]	Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H332H312H302H400H410	GHS07GHS09Wng	H332H312H302H410		*	1 A	CLP00
050-013-00-0	"trioctyltin compounds, with the exception of those specified elsewhere in this Annex"			STOT SE 3Skin Irrit. 2Eye Irrit. 2Aquatic Chronic 4	H335H315H319H413	GHS07Wng	H319H335H315H413		Skin Irrit. 2; H315: C ? 1 %Eye Irrit. 2; H319: C ? 1 %STOT SE 3; H335: C ? 1 %	1 A	CLP00
050-017-00-2	fenbutatin oxide (ISO); bis(tris(2-methyl-2-phenylpropyl)tin)oxide	236-407-7	13356-08-6	Acute Tox. 2 *Skin Irrit. 2Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H330H315H319H400H410	GHS06GHS09Dgr	H330H319H315H410				CLP00
050-018-00-8	tin(II) methanesulphonate	401-640-7	53408-94-9	Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Chronic 2	H302H314H317H411	GHS05GHS07GHS09Dgr	H314H302H317H411				CLP00/ATP01
050-019-00-3	"azocyclotin (ISO); 1-(tricyclohexylstannyl)-1H-1,2,4-triazole"	255-209-1	41083-11-8	Acute Tox. 2 *Acute Tox. 3 *STOT SE 3Skin Irrit. 2Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H330H301H335H315H318H400H410	GHS06GHS05GHS09Dgr	H330H301H335H315H318H410				CLP00
050-020-00-9	trioctylstannane	413-320-4	869-59-0	STOT RE 1Skin Irrit. 2Aquatic Chronic 4	H372 **H315H413	GHS08GHS07Dgr	H372 **H315H413				CLP00
050-021-00-4	dichlorodioctyl stannane	222-583-2	3542-36-7	Acute Tox. 3 *STOT RE 1Aquatic Chronic 3	H331H372 **H412	GHS06GHS08Dgr	H331H372 **H412				ATP01
050-022-00-X	dibutyltin dichloride; (DBTC)	211-670-0	683-18-1	Muta. 2Repr. 1BAcute Tox. 2 *Acute Tox. 3 *Acute Tox. 4 *STOT RE 1Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1	H341H360FDH330H301H312H372 **H314H400H410	GHS06GHS05GHS08GHS09Dgr	H341H360FDH330H301H312H372 **H314H410		"Skin Corr. 1B; H314: C ? 5 %Skin Irrit. 2; H315: 0,01 % ? C < 5 %Eye Dam. 1; H318: 3 % ? C < 5 %Eye Irrit. 2; H319: 0,01 % ? C < 3 %M=10"		ATP01
050-023-00-5	"reaction mass of: bis[(2-ethyl-1-oxohexyl)oxy]dioctyl stannane; bis[((2-ethyl-1-oxohexyl)oxy)dioctylstannyl]oxide; bis(1-phenyl-1,3-decanedionyl)dioctyl stannane; ((2-ethyl-1-oxohexyl)oxy)-(1-phenyl-1,3-decanedionyl)dioctyl stannane"	422-920-5	-	STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H373 **H400H410	GHS08GHS09Wng	H373 **H410		M=10		ATP01
050-024-00-0	reaction mass of: tri-p-tolyltin hydroxide; hexa-p-tolyl-distannoxane	432-230-6	-	Acute Tox. 4 *STOT RE 1Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H372 **H315H318H317H400H410	GHS05GHS08GHS07GHS09Dgr	H372 **H302H315H318H317H410				ATP01
050-025-00-6	trichloromethylstannane	213-608-8	993-16-8	Repr. 2	H361d	GHS08Wng	H361d				ATP05
050-026-00-1	"2-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-methyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate"	260-828-5	57583-34-3	Repr. 2	H361d	GHS08Wng	H361d				ATP05
050-027-00-7	"2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate"	239-622-4	15571-58-1	Repr. 1B	H360D	GHS08Dgr	H360D				ATP05
050-028-00-2	"2-ethylhexyl 10-ethyl-4,4-dimethyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate"	260-829-0	57583-35-4	Repr. 2Acute Tox. 4STOT RE 1Skin Sens. 1A	"H361dH302H372 (nervous system, immune system)H317"	GHS08GHS07Dgr	"H302H317H361dH372 (nervous system, immune system)"				ATP06
050-029-00-8	dimethyltin dichloride	212-039-2	753-73-1	Repr. 2Acute Tox. 2Acute Tox. 3Acute Tox. 3STOT RE 1Skin Corr. 1B	"H361dH330H311H301H372 (nervous system, immune system)H314"	GHS08GHS06GHS05Dgr	"H301H311H330H314H361dH372 (nervous system, immune system)"	EUH071			ATP06
051-001-00-8	antimony trichloride	233-047-2	10025-91-9	Skin Corr. 1BAquatic Chronic 2	H314H411	GHS05GHS09Dgr	H314H411		STOT SE 3; H335: C ? 5 %		CLP00
051-002-00-3	antimony pentachloride	231-601-8	7647-18-9	Skin Corr. 1BAquatic Chronic 2	H314H411	GHS05GHS09Dgr	H314H411		STOT SE 3; H335: C ? 5 %		CLP00
051-003-00-9	"antimony compounds, with the exception of the tetroxide (Sb2O4), pentoxide (Sb2O5), trisulphide (Sb2S3), pentasulphide (Sb2S5) and those specified elsewhere in this Annex"			Acute Tox. 4 *Acute Tox. 4 *Aquatic Chronic 2	H332H302H411	GHS07GHS09Wng	H332H302H411		*	1 A	CLP00
051-004-00-4	antimony trifluoride	232-009-2	7783-56-4	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Aquatic Chronic 2	H331H311H301H411	GHS06GHS09Dgr	H331H311H301H411				CLP00
051-005-00-X	antimony trioxide	215-175-0	1309-64-4	Carc. 2	H351	GHS08Wng	H351				CLP00
051-006-00-5	diphenyl(4-phenylthiophenyl)sulfonium hexafluoroantimonate	403-500-0		Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410				CLP00
051-007-00-0	bis(4-dodecylphenyl)iodonium hexafluoroantimonate	404-420-9	71786-70-4	Skin Sens. 1Aquatic Chronic 3	H317H412	GHS07Wng	H317H412				CLP00
053-001-00-3	iodine	231-442-4	7553-56-2	Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1	H332H312H400	GHS07GHS09Wng	H332H312H400				CLP00
053-002-00-9	hydrogen iodide	233-109-9	10034-85-2	Press. GasSkin Corr. 1A	H314	GHS04GHS05Dgr	H314		"Skin Corr. 1A; H314: C ? 10 %Skin Corr. 1B; H314: 0,2 % ? C < 10 %Skin Irrit. 2; H315: 0,02 % ? C < 0,2 %Eye Irrit. 2; H319: 0,02 % ? C < 0,2 %STOT SE 3; H335: C ? 0,02 %"	5 U	CLP00
053-002-01-6	hydriodic acid ... %			Skin Corr. 1B	H314	GHS05Dgr			Skin Corr. 1B; H314: C ? 25 %Skin Irrit. 2; H315: 10 % ? C < 25 %Eye Irrit. 2; H319: 10 % ? C < 25 %	B	CLP00
053-003-00-4	iodoxybenzene		696-33-3	Expl. 1.1 ****	****	****	****				CLP00/ATP01corr
053-004-00-X	calcium iodoxybenzoate			Expl. 1.1 ****	****	****	****			C	CLP00/ATP01corr
053-005-00-5	(4-(1-methylethyl)phenyl)-(4-methylphenyl)iodonium tetrakis(pentafluorophenyl)borate (1-)	422-960-3	178233-72-2	Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H312H302H373 **H400H410	GHS08GHS07GHS09Wng	H312H302H373 **H410				CLP00
056-001-00-1	barium peroxide	215-128-4	1304-29-6	Ox. Sol. 2Acute Tox. 4 *Acute Tox. 4 *	H272H332H302	GHS03GHS07Dgr	H272H332H302				CLP00
056-002-00-7	"barium salts, with the exception of barium sulphate, salts of 1-azo-2-hydroxynaphthalenyl aryl sulphonic acid, and of salts specified elsewhere in this Annex"			Acute Tox. 4 *Acute Tox. 4 *	H332H302	GHS07Wng	H332H302		*	1 A	CLP00
056-003-00-2	barium carbonate	208-167-3	513-77-9	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
056-004-00-8	barium chloride	233-788-1	10361-37-2	Acute Tox. 3 *Acute Tox. 4 *	H301H332	GHS06Dgr	H301H332				CLP00
064-001-00-8	gadolinium(III)sulfite trihydrate	456-900-2	51285-81-5	Aquatic Chronic 2	H411	GHS09	H411				ATP01
072-001-00-4	hafnium tetra-n-butoxide	411-740-2	22411-22-9	Eye Dam. 1Skin Sens. 1	H318H317	GHS05GHS07Dgr	H318H317				CLP00
074-001-00-X	hexasodium tungstate hydrate	412-770-9	12141-67-2	Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 3	H302H318H412	GHS05GHS07Dgr	H302H318H412				CLP00
074-002-00-5	"Reaction products of tungsten hexachloride with 2-methylpropan-2-ol, nonylphenol and pentane-2,4-dione"	408-250-6		Flam. Liq. 2Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H225H332H314H317H400H410	GHS02GHS05GHS07GHS09Dgr	H225H332H314H317H410				CLP00
076-001-00-5	osmium tetraoxide; osmic acid	244-058-7	20816-12-0	Acute Tox. 1Acute Tox. 2 *Acute Tox. 2 *Skin Corr. 1B	H310H330H300H314	GHS06GHS05Dgr	H330H310H300H314				CLP00
078-001-00-0	tetrachloroplatinates with the exception of those specified elsewhere in this Annex			Acute Tox. 3 *Eye Dam. 1Resp. Sens. 1Skin Sens. 1	H301H318H334H317	GHS06GHS05GHS08Dgr	H301H318H334H317			A	CLP00
078-002-00-6	diammonium tetrachloroplatinate	237-499-1	13820-41-2	Acute Tox. 3 *Skin Irrit. 2Eye Dam. 1Resp. Sens. 1Skin Sens. 1	H301H315H318H334H317	GHS06GHS05GHS08Dgr	H301H315H318H334H317				CLP00
078-003-00-1	disodium tetrachloroplatinate	233-051-4	10026-00-3	Acute Tox. 3 *Skin Irrit. 2Eye Dam. 1Resp. Sens. 1Skin Sens. 1	H301H315H318H334H317	GHS06GHS05GHS08Dgr	H301H315H318H334H317				CLP00
078-004-00-7	dipotassium tetrachloroplatinate	233-050-9	10025-99-7	Acute Tox. 3 *Skin Irrit. 2Eye Dam. 1Resp. Sens. 1Skin Sens. 1	H301H315H318H334H317	GHS06GHS05GHS08Dgr	H301H315H318H334H317				CLP00
078-005-00-2	hexachloroplatinates with the exception of those specified elsewhere in this Annex			Acute Tox. 3 *Eye Dam. 1Resp. Sens. 1Skin Sens. 1	H301H318H334H317	GHS06GHS05GHS08Dgr	H301H318H334H317			A	CLP00
078-006-00-8	disodium hexachloroplatinate	240-983-5	16923-58-3	Acute Tox. 3 *Eye Dam. 1Resp. Sens. 1Skin Sens. 1	H301H318H334H317	GHS06GHS05GHS08Dgr	H301H318H334H317				CLP00
078-007-00-3	dipotassium hexachloroplatinate	240-979-3	16921-30-5	Acute Tox. 3 *Eye Dam. 1Resp. Sens. 1Skin Sens. 1	H301H318H334H317	GHS06GHS05GHS08Dgr	H301H318H334H317				CLP00
078-008-00-9	diammonium hexachloroplatinate	240-973-0	16919-58-7	Acute Tox. 3 *Eye Dam. 1Resp. Sens. 1Skin Sens. 1	H301H318H334H317	GHS06GHS05GHS08Dgr	H301H318H334H317				CLP00
078-009-00-4	hexachloroplatinic acid	241-010-7	16941-12-1	Acute Tox. 3 *Skin Corr. 1BResp. Sens. 1Skin Sens. 1	H301H314H334H317	GHS06GHS05GHS08Dgr	H301H314H334H317				CLP00
078-010-00-X	tetraammine platinum (II) hydrogen carbonate	426-730-3	123439-82-7	Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 3	H302H318H412	GHS05GHS07Dgr	H302H318H412				ATP01
078-011-00-5	hydroxydisulfito platinum(II) acid	423-310-1	61420-92-6	Acute Tox. 4 *STOT RE 2 *Skin Corr. 1AResp. Sens. 1Skin Sens. 1Aquatic Chronic 3	H302H373H314H334H317H412	GHS05GHS08GHS07Dgr	H302H373H314H334H317H412				ATP01
078-012-00-0	platinum(IV) nitrate/nitric acid solution	432-400-1	-	Skin Corr. 1AAquatic Acute 1Aquatic Chronic 1	H314H400H410	GHS05GHS09Dgr	H314H410				ATP01
080-001-00-0	mercury	231-106-7	7439-97-6	Repr. 1BAcute Tox. 2 *STOT RE 1Aquatic Acute 1Aquatic Chronic 1	H360D ***H330H372 **H400H410	GHS06GHS08GHS09Dgr	H360D ***H330H372 **H410				CLP00/ATP01
080-002-00-6	inorganic compounds of mercury with the exception of mercuric sulphide and those specified elsewhere in this Annex			Acute Tox. 1Acute Tox. 2 *Acute Tox. 2 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H310H330H300H373 **H400H410	GHS06GHS08GHS09Dgr	H330H310H300H373 **H410		"*STOT RE 2; H373: C ? 0,1 %"	1 A	CLP00
080-003-00-1	dimercury dichloride; mercurous chloride; calomel	233-307-5	10112-91-1	Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H302H335H315H319H400H410	GHS07GHS09Wng	H302H319H335H315H410				CLP00
080-004-00-7	organic compounds of mercury with the exception of those specified elsewhere in this Annex			Acute Tox. 1Acute Tox. 2 *Acute Tox. 2 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H310H330H300H373 **H400H410	GHS06GHS08GHS09Dgr	H330H310H300H373 **H410		"*STOT RE 2; H373: C ? 0,1 %"	1 A	CLP00
080-005-00-2	mercury difulminate; mercuric fulminate; fulminate of mercury	211-057-8	628-86-4	Unst. Expl.Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H200H331H311H301H373 **H400H410	GHS01GHS06GHS08GHS09Dgr	H200H331H311H301H373 **H400H410				CLP00
080-005-01-X	mercury difulminate; mercuric fulminate; fulminate of mercury [? 20 % phlegmatiser]	211-057-8	628-86-4	Expl. 1.1Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H201H331H311H301H373 **H400H410	GHS01GHS06GHS08GHS09Dgr	H201H331H311H301H373 **H400H410				CLP00
080-006-00-8	dimercury dicyanide oxide; mercuric oxycyanide	215-629-8	1335-31-5	Expl. 1.1Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2Aquatic Acute 1Aquatic Chronic 1	H201H331H311H301H373 **H400H410	GHS01GHS06GHS08GHS09Dgr	H201H331H311H301H373 **H410				CLP00/ATP01
080-007-00-3	dimethylmercury [1]diethylmercury  [2]	209-805-3 [1]211-000-7 [2]	593-74-8 [1]627-44-1 [2]	Acute Tox. 1Acute Tox. 2 *Acute Tox. 2 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H310H330H300H373 **H400H410	GHS06GHS08GHS09Dgr	H330H310H300H373 **H410		"*STOT RE 2; H373: C ? 0,05 %"	1 	CLP00
080-008-00-9	phenylmercury nitrate [1]phenylmercury hydroxide [2]basic phenylmercury nitrate  [3]	200-242-9 [1]202-866-7 [2]	55-68-5 [1]100-57-2 [2]8003-05-2 [3]	Acute Tox. 3 *STOT RE 1Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1	H301H372 **H314H400H410	GHS06GHS08GHS05GHS09Dgr	H301H372 **H314H410				CLP00
080-009-00-4	2-methoxyethylmercury chloride	204-659-7	123-88-6	Acute Tox. 3 *STOT RE 1Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1	H301H372 **H314H400H410	GHS06GHS08GHS05GHS09Dgr	H301H372 **H314H410				CLP00
080-010-00-X	mercury dichloride; mercuric chloride	231-299-8	7487-94-7	Muta. 2Repr. 2Acute Tox. 2 *STOT RE 1Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1	H341H361f ***H300H372 **H314H400H410	GHS06GHS05GHS08GHS09Dgr	H341H361f ***H300H372 **H314H410				CLP00/ATP01
080-011-00-5	phenylmercury acetate	200-532-5	62-38-4	Acute Tox. 3 *STOT RE 1Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1	H301H372 **H314H400H410	GHS06GHS08GHS05GHS09Dgr	H301H372 **H314H410				CLP00
081-001-00-3	thallium	231-138-1	7440-28-0	Acute Tox. 2 *Acute Tox. 2 *STOT RE 2 *Aquatic Chronic 4	H330H300H373 **H413	GHS06GHS08Dgr	H330H300H373 **H413				CLP00
081-002-00-9	"thallium compounds, with the exception of those specified elsewhere in this Annex"			Acute Tox. 2 *Acute Tox. 2 *STOT RE 2 *Aquatic Chronic 2	H330H300H373 **H411	GHS06GHS08GHS09Dgr	H330H300H373 **H411			A	CLP00
081-003-00-4	dithallium sulphate; thallic sulphate	231-201-3	7446-18-6	Acute Tox. 2 *STOT RE 1Skin Irrit. 2Aquatic Chronic 2	H300H372 **H315H411	GHS06GHS08GHS09Dgr	H300H372 **H315H411				CLP00
082-001-00-6	lead compounds with the exception of those specified elsewhere in this Annex			Repr. 1AAcute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H360DfH332H302H373 **H400H410	GHS08GHS07GHS09Dgr	H360DfH332H302H373 **H410		"Repr. 2; H361f: C ? 2,5 %*STOT RE 2; H373: C ? 0,5 %"	1 A	CLP00
082-002-00-1	lead alkyls			Repr. 1AAcute Tox. 1Acute Tox. 2 *Acute Tox. 2 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H360DfH310H330H300H373 **H400H410	GHS06GHS08GHS09Dgr	H360DfH330H310H300H373 **H410		"Repr. 1A; H360D: C ? 0,1 %*STOT RE 2; H373: C ? 0,05 %"	1 A	CLP00
082-003-00-7	lead diazide; lead azide	236-542-1	13424-46-9	Unst. Expl.Repr. 1AAcute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H200H360DfH332H302H373 **H400H410	GHS01GHS08GHS07GHS09Dgr	H200H360DfH332H302H373 **H410			1 	CLP00
082-003-01-4	lead diazide; lead azide [? 20 % phlegmatiser]	236-542-1	13424-46-9	Expl. 1.1Repr. 1AAcute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H201H360DfH332H302H373 **H400H410	GHS01GHS08GHS07GHS09Dgr	H201H360DfH332H302H373 **H410			1 	CLP00
082-004-00-2	lead chromate	231-846-0	7758-97-6	Carc. 1BRepr. 1ASTOT RE 2Aquatic Acute 1Aquatic Chronic 1	H350H360DfH373 **H400H410	GHS08GHS09Dgr	H350H360DfH373 **H410			1 	CLP00/ATP01
082-005-00-8	lead di(acetate)	206-104-4	301-04-2	Repr. 1ASTOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H360DfH373 **H400H410	GHS08GHS09Dgr	H360DfH373 **H410			1 	CLP00
082-006-00-3	trilead bis(orthophosphate)	231-205-5	7446-27-7	Repr. 1ASTOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H360DfH373 **H400H410	GHS08GHS09Dgr	H360DfH373 **H410			1 	CLP00
082-007-00-9	"lead acetate, basic"	215-630-3	1335-32-6	Carc. 2Repr. 1ASTOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H351H360DfH373 **H400H410	GHS08GHS09Dgr	H351H360DfH373 **H410			1 	CLP00
082-008-00-4	lead(II) methanesulphonate	401-750-5	17570-76-2	Repr. 1AAcute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Skin Irrit. 2Eye Dam. 1	H360DfH332H302H373 **H315H318	GHS08GHS05GHS07Dgr	H360DfH332H302H373 **H315H318			1 	CLP00
082-009-00-X	"lead sulfochromate yellow; C.I. Pigment Yellow 34; [This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77603.]"	215-693-7	1344-37-2	Carc. 1BRepr. 1ASTOT RE 2Aquatic Acute 1Aquatic Chronic 1	H350H360DfH373 **H400H410	GHS08GHS09Dgr	H350H360DfH373 **H410			1 	CLP00/ATP01
082-010-00-5	"lead chromate molybdate sulfate red; C.I. Pigment Red 104; [This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77605.]"	235-759-9	12656-85-8	Carc. 1BRepr. 1ASTOT RE 2Aquatic Acute 1Aquatic Chronic 1	H350H360DfH373 **H400H410	GHS08GHS09Dgr	H350H360DfH373 **H410			1 	CLP00/ATP01
082-011-00-0	lead hydrogen arsenate	232-064-2	7784-40-9	Carc. 1ARepr. 1AAcute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H350H360DfH331H301H373 **H400H410	GHS06GHS08GHS09Dgr	H350H360DfH331H301H373 **H410			1 	CLP00
082-012-00-6	barium calcium cesium lead samarium strontium bromide chloride fluoride iodide europium doped	431-780-4	199876-46-5	Acute Tox. 4 *STOT RE 2 *Aquatic Chronic 2	H302H373 **H411	GHS08GHS07GHS09Wng	H302H373 **H411				ATP01
092-001-00-8	uranium	231-170-6	7440-61-1	Acute Tox. 2 *Acute Tox. 2 *STOT RE 2 *Aquatic Chronic 4	H330H300H373 **H413	GHS06GHS08Dgr	H330H300H373 **H413				CLP00
092-002-00-3	uranium compounds with the exception of those specified elsewhere in this Annex	-	-	Acute Tox. 2 *Acute Tox. 2 *STOT RE 2Aquatic Chronic 2	H330H300H373 **H411	GHS06GHS08GHS09Dgr	H330H300H373 **H411			A	CLP00/ATP01
601-001-00-4	methane	200-812-7	74-82-8	Flam. Gas 1Press. Gas	H220	GHS02GHS04Dgr	H220			U	CLP00
601-002-00-X	ethane	200-814-8	74-84-0	Flam. Gas 1Press. Gas	H220	GHS02GHS04Dgr	H220			U	CLP00
601-003-00-5	propane	200-827-9	74-98-6	Flam. Gas 1Press. Gas	H220	GHS02GHS04Dgr	H220			U	CLP00
601-004-00-0	butane [1]and isobutane  [2]	203-448-7 [1]200-857-2 [2]	106-97-8 [1]75-28-5 [2]	Flam. Gas 1Press. Gas	H220	GHS02GHS04Dgr	H220			C U	CLP00
601-004-01-8	"butane (containing ? 0,1 % butadiene (203-450-8)) [1]isobutane (containing ? 0,1 % butadiene (203-450-8))  [2]"	203-448-7 [1]200-857-2 [2]	106-97-8 [1]75-28-5 [2]	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS02GHS04GHS08Dgr	H220H350H340			C S U	CLP00
601-005-00-6	"2,2-dimethylpropane; neopentane"	207-343-7	463-82-1	Flam. Gas 1Press. GasAquatic Chronic 2	H220H411	GHS02GHS04GHS09Dgr	H220H411			U	CLP00
601-006-00-1	pentane	203-692-4	109-66-0	Flam. Liq. 2Asp. Tox. 1STOT SE 3Aquatic Chronic 2	H225H304H336H411	GHS02GHS08GHS07GHS09Dgr	H225H304H336H411	EUH066		C	CLP00
601-007-00-7	"hexane (containing < 5 % n-hexane (203-777-6)); 2-methylpentane [1]3-methylpentane [2]2,2-dimethylbutane [3]2,3-dimethylbutane  [4]"	203-523-4 [1]202-481-4 [2]200-906-8 [3]201-193-6 [4]	107-83-5 [1]96-14-0 [2]75-83-2 [3]79-29-8 [4]	Flam. Liq. 2Asp. Tox. 1STOT SE 3Skin Irrit. 2Aquatic Chronic 2	H225H304H336H315H411	GHS02GHS08GHS07GHS09Dgr	H225H304H315H336H411			C	CLP00/ATP01
601-008-00-2	"heptane; n-heptane [1]2,4-dimethylpentane [2]2,2,3-trimethylbutane [3]3,3-dimethylpentane [4]2,3-dimethylpentane [5]3-methylhexane [6]2,2-dimethylpentane [7]2-methylhexane [8]3-ethylpentane [9]isoheptane [10]"	205-563-8 [1]203-548-0 [2]207-346-3 [3]209-230-8 [4]209-280-0 [5]209-643-3 [6]209-680-5 [7]209-730-6 [8]210-529-0 [9]250-610-8 [10]	142-82-5 [1]108-08-7 [2]464-06-2 [3]562-49-2 [4]565-59-3 [5]589-34-4 [6]590-35-2 [7]591-76-4 [8]617-78-7 [9]31394-54-4 [10]	Flam. Liq. 2Asp. Tox. 1STOT SE 3Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H225H304H336H315H400H410	GHS02GHS08GHS07GHS09Dgr	H225H304H315H336H410			C	CLP00/ATP01
601-009-00-8	"octane; n-octane [1]2,2,4-trimethylpentane [2]2,3,3-trimethylpentane [3]3,3-dimethylhexane [4]2,2,3-trimethylpentane [5]2,3,4-trimethylpentane [6]3,4-dimethylhexane [7]2,3-dimethylhexane [8]2,4-dimethylhexane [9]4-methylheptane [10]3-methylheptane [11]2,2-dimethylhexane [12]2,5-dimethylhexane [13]2-methylheptane [14]2,2,3,3-tetramethylbutane [15]3-ethyl-2-methylpentane [16]3-ethylhexane [17]3-ethyl-3-methylpentane [18]isooctane [19]"	203-892-1 [1]208-759-1 [2]209-207-2 [3]209-243-9 [4]209-266-4 [5]209-292-6 [6]209-504-7 [7]209-547-1 [8]209-649-6 [9]209-650-1 [10]209-660-6 [11]209-689-4 [12]209-745-8 [13]209-747-9 [14]209-855-6 [15]210-187-2 [16]210-621-0 [17]213-923-0 [18]247-861-0 [19]	111-65-9 [1]540-84-1 [2]560-21-4 [3]563-16-6 [4]564-02-3 [5]565-75-3 [6]583-48-2 [7]584-94-1 [8]589-43-5 [9]589-53-7 [10]589-81-1 [11]590-73-8 [12]592-13-2 [13]592-27-8 [14]594-82-1 [15]609-26-7 [16]619-99-8 [17]1067-08-9 [18]26635-64-3 [19]	Flam. Liq. 2Asp. Tox. 1STOT SE 3Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H225H304H336H315H400H410	GHS02GHS08GHS07GHS09Dgr	H225H304H315H336H410			C	CLP00/ATP01
601-010-00-3	ethylene	200-815-3	74-85-1	Flam. Gas 1Press. GasSTOT SE 3	H220H336	GHS02GHS04GHS07Dgr	H220H336			U	CLP00
601-011-00-9	propene; propylene	204-062-1	115-07-1	Flam. Gas 1Press. Gas	H220	GHS02GHS04Dgr	H220			U	CLP00
601-012-00-4	"but-1-ene [1]butene, mixed-1-and-2-isomers [2]2-methylpropene [3](Z)-but-2-ene [4](E)-but-2-ene  [5]"	203-449-2 [1]203-452-9 [2]204-066-3 [3]209-673-7 [4]210-855-3 [5]	106-98-9 [1]107-01-7 [2]115-11-7 [3]590-18-1 [4]624-64-6 [5]	Flam. Gas 1Press. Gas	H220	GHS02GHS04Dgr	H220			C U	CLP00
601-013-00-X	"1,3-butadiene; buta-1,3-diene"	203-450-8	106-99-0	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS02GHS04GHS08Dgr	H220H350H340			D U	CLP00
601-014-00-5	"isoprene (stabilised); 2-methyl-1,3-butadiene"	201-143-3	78-79-5	Flam. Liq. 1Carc. 1BMuta. 2Aquatic Chronic 3	H224H350H341H412	GHS02GHS08Dgr	H224H350H341H412			D	CLP00
601-015-00-0	acetylene; ethyne	200-816-9	74-86-2	Flam. Gas 1Press. Gas	H220	GHS02GHS04Dgr	H220	EUH006		U	CLP00
601-016-00-6	cyclopropane	200-847-8	75-19-4	Flam. Gas 1Press. Gas	H220	GHS02GHS04Dgr	H220			U	CLP00
601-017-00-1	cyclohexane	203-806-2	110-82-7	Flam. Liq. 2Asp. Tox. 1STOT SE 3Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H225H304H336H315H400H410	GHS02GHS08GHS07GHS09Dgr	H225H304H315H336H410				CLP00
601-018-00-7	methylcyclohexane	203-624-3	108-87-2	Flam. Liq. 2Asp. Tox. 1STOT SE 3Skin Irrit. 2Aquatic Chronic 2	H225H304H336H315H411	GHS02GHS08GHS07GHS09Dgr	H225H304H315H336H411				CLP00
601-019-00-2	"1,4-dimethylcyclohexane"	209-663-2	589-90-2	Flam. Liq. 2Asp. Tox. 1STOT SE 3Skin Irrit. 2Aquatic Chronic 2	H225H304H336H315H411	GHS02GHS08GHS07GHS09Dgr	H225H304H315H336H411				CLP00
601-020-00-8	benzene	200-753-7	71-43-2	Flam. Liq. 2Carc. 1AMuta. 1BAsp. Tox. 1STOT RE 1Skin Irrit. 2Eye Irrit. 2	H225H350H340H304H372 **H315H319	GHS02GHS08GHS07Dgr	H225H350H340H372 **H304H319H315			E	CLP00
601-021-00-3	toluene	203-625-9	108-88-3	Flam. Liq. 2Repr. 2Asp. Tox. 1STOT SE 3STOT RE 2 *Skin Irrit. 2	H225H361d ***H304H336H373 **H315	GHS02GHS08GHS07Dgr	H225H361d ***H304H373 **H315H336				CLP00
601-022-00-9	o-xylene [1]p-xylene [2]m-xylene [3]xylene  [4]	202-422-2 [1]203-396-5 [2]203-576-3 [3]215-535-7 [4]	95-47-6 [1]106-42-3 [2]108-38-3 [3]1330-20-7 [4]	Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *Skin Irrit. 2	H226H332H312H315	GHS02GHS07Wng	H226H332H312H315		*	C	CLP00
601-023-00-4	ethylbenzene	202-849-4	100-41-4	Flam. Liq. 2Acute Tox. 4 *Asp. Tox. 1STOT RE 2	H225H332H304H373 (hearing organs)	GHS02GHS07GHS08Dgr	H225H332H373 (hearing organs)H304				CLP00/ATP06
601-024-00-X	cumene [1]propylbenzene  [2]	202-704-5 [1]203-132-9 [2]	98-82-8 [1]103-65-1 [2]	Flam. Liq. 3Asp. Tox. 1STOT SE 3Aquatic Chronic 2	H226H304H335H411	GHS02GHS08GHS07GHS09Dgr	H226H304H335H411			C	CLP00
601-025-00-5	"mesitylene; 1,3,5-trimethylbenzene"	203-604-4	108-67-8	Flam. Liq. 3STOT SE 3Aquatic Chronic 2	H226H335H411	GHS02GHS07GHS09Wng	H226H335H411		STOT SE 3; H335: C ? 25 %		CLP00
601-026-00-0	styrene	202-851-5	100-42-5	Flam. Liq. 3Repr. 2Acute Tox. 4 *STOT RE 1Skin Irrit. 2Eye Irrit. 2	H226H361dH332H372 (hearing organs)H315H319	GHS02GHS08GHS07Dgr	H226H332H315H319H361dH372 (hearing organs)		*	D	CLP00/ATP06
601-027-00-6	2-phenylpropene; ?-methylstyrene	202-705-0	98-83-9	Flam. Liq. 3STOT SE 3Eye Irrit. 2Aquatic Chronic 2	H226H335H319H411	GHS02GHS07GHS09Wng	H226H319H335H411		STOT SE 3; H335: C ? 25 %		CLP00
601-028-00-1	2-methylstyrene; 2-vinyltoluene	210-256-7	611-15-4	Acute Tox. 4 *Aquatic Chronic 2	H332H411	GHS07GHS09Wng	H332H411				CLP00
601-029-00-7	"dipentene; limonene [1](R)-p-mentha-1,8-diene; d-limonene [2](S)-p-mentha-1,8-diene; l-limonene [3]trans-1-methyl-4-(1-methylvinyl)cyclohexene [4](±)-1-methyl-4-(1-methylvinyl)cyclohexene  [5]"	205-341-0 [1]227-813-5 [2]227-815-6 [3]229-977-3 [4]231-732-0 [5]	138-86-3 [1]5989-27-5 [2]5989-54-8 [3]6876-12-6 [4]7705-14-8 [5]	Flam. Liq. 3Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H226H315H317H400H410	GHS02GHS07GHS09Wng	H226H315H317H410			C	CLP00
601-030-00-2	cyclopentane	206-016-6	287-92-3	Flam. Liq. 2Aquatic Chronic 3	H225H412	GHS02Dgr	H225H412				CLP00
601-031-00-8	"2,4,4-trimethylpent-1-ene"	203-486-4	107-39-1	Flam. Liq. 2Aquatic Chronic 2	H225H411	GHS02GHS09Dgr	H225H411				CLP00
601-032-00-3	benzo[a]pyrene; benzo[def]chrysene	200-028-5	50-32-8	Carc. 1BMuta. 1BRepr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350H340H360FDH317H400H410	GHS08GHS07GHS09Dgr	H350H340H360FDH317H410		"Carc. 1B; H350: C ? 0,01 %"		CLP00
601-033-00-9	benz[a]anthracene	200-280-6	56-55-3	Carc. 1BAquatic Acute 1Aquatic Chronic 1	H350H400H410	GHS08GHS09Dgr	H350H410		M=100		CLP00/ATP01
601-034-00-4	benz[e]acephenanthrylene	205-911-9	205-99-2	Carc. 1BAquatic Acute 1Aquatic Chronic 1	H350H400H410	GHS08GHS09Dgr	H350H410				CLP00
601-035-00-X	benzo[j]fluoranthene	205-910-3	205-82-3	Carc. 1BAquatic Acute 1Aquatic Chronic 1	H350H400H410	GHS08GHS09Dgr	H350H410				CLP00
601-036-00-5	benzo[k]fluoranthene	205-916-6	207-08-9	Carc. 1BAquatic Acute 1Aquatic Chronic 1	H350H400H410	GHS08GHS09Dgr	H350H410				CLP00
601-037-00-0	n-hexane	203-777-6	110-54-3	Flam. Liq. 2Repr. 2Asp. Tox. 1STOT SE 3STOT RE 2 *Skin Irrit. 2Aquatic Chronic 2	H225H361f ***H304H336H373 **H315H411	GHS02GHS08GHS07GHS09Dgr	H225H361f ***H304H373 **H315H336H411		STOT RE 2; H373: C ? 5 %		CLP00
601-041-00-2	"dibenz[a,h]anthracene"	200-181-8	53-70-3	Carc. 1BAquatic Acute 1Aquatic Chronic 1	H350H400H410	GHS08GHS09Dgr	H350H410		"Carc. 1B; H350: C ? 0,01 %M=100"		CLP00/ATP01
601-042-00-8	biphenyl; diphenyl	202-163-5	92-52-4	STOT SE 3Skin Irrit. 2Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H335H315H319H400H410	GHS07GHS09Wng	H319H335H315H410				CLP00
601-043-00-3	"1,2,4-trimethylbenzene"	202-436-9	95-63-6	Flam. Liq. 3Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Irrit. 2Aquatic Chronic 2	H226H332H335H315H319H411	GHS02GHS07GHS09Wng	H226H332H319H335H315H411				CLP00
601-044-00-9	"3a,4,7,7a-tetrahydro-4,7-methanoindene"	201-052-9	77-73-6	Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Irrit. 2Aquatic Chronic 2	H225H332H302H335H315H319H411	GHS02GHS07GHS09Dgr	H225H332H302H319H335H315H411				CLP00
601-045-00-4	"1,2,3,4-tetrahydronaphthalene"	204-340-2	119-64-2	Skin Irrit. 2Eye Irrit. 2Aquatic Chronic 2	H315H319H411	GHS07GHS09Wng	H319H315H411	EUH019			CLP00
601-046-00-X	"7-methylocta-1,6-diene"	404-210-7	42152-47-6	Flam. Liq. 3Aquatic Acute 1Aquatic Chronic 1	H226H400H410	GHS02GHS09Wng	H226H410				CLP00
601-047-00-5	"m-mentha-1,3(8)-diene"	404-150-1	17092-80-7	Skin Irrit. 2Aquatic Chronic 2	H315H411	GHS07GHS09Wng	H315H411				CLP00
601-048-00-0	chrysene	205-923-4	218-01-9	Carc. 1BMuta. 2Aquatic Acute 1Aquatic Chronic 1	H350H341H400H410	GHS08GHS09Dgr	H350H341H410				CLP00
601-049-00-6	benzo[e]pyrene	205-892-7	192-97-2	Carc. 1BAquatic Acute 1Aquatic Chronic 1	H350H400H410	GHS08GHS09Dgr	H350H410				CLP00
601-051-00-7	4-phenylbut-1-ene	405-980-7	768-56-9	Skin Irrit. 2Aquatic Chronic 2	H315H411	GHS07GHS09Wng	H315H411				CLP00
601-052-00-2	naphthalene	202-049-5	91-20-3	Carc. 2Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H351H302H400H410	GHS07GHS08GHS09Wng	H351H302H410				CLP00
601-053-00-8	"nonylphenol [1]4-nonylphenol, branched  [2]"	246-672-0 [1]284-325-5 [2]	25154-52-3 [1]84852-15-3 [2]	Repr. 2Acute Tox. 4 *Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1	H361fdH302H314H400H410	GHS08GHS05GHS07GHS09Dgr	H361fdH302H314H410				CLP00
601-054-00-3	reaction mass of isomers of: dibenzylbenzene; dibenzyl(methyl)benzene; dibenzyl(dimethyl)benzene; dibenzyl(trimethyl)benzene	405-570-8		Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
601-055-00-9	reaction mass of isomers of: mono-(2-tetradecyl)naphthalenes; di-(2-tetradecyl)naphthalenes; tri-(2-tetradecyl)naphthalenes	410-190-0	132983-41-6	Eye Irrit. 2Aquatic Chronic 4	H319H413	GHS07Wng	H319H413				CLP00
601-056-00-4	reaction mass of isomers of: methyldiphenylmethane; dimethyldiphenylmethane	405-470-4	73807-39-3	Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H315H400H410	GHS07GHS09Wng	H315H410				CLP00
601-057-00-X	N-dodecyl-[3-(4-(dimethylamino)benzamido)-propyl]dimethylammonium tosylate	421-130-8	156679-41-3	Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H318H317H400H410	GHS05GHS07GHS09Dgr	H318H317H410				CLP00
601-058-00-5	di-L-para-menthene	417-870-6	83648-84-4	Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H315H317H400H410	GHS07GHS09Wng	H315H317H410				CLP00
601-059-00-0	methyl 2-benzylidene-3-oxobutyrate	420-940-9	15768-07-7	Skin Irrit. 2Eye Irrit. 2Aquatic Chronic 2	H315H319H411	GHS07GHS09Wng	H319H315H411				CLP00
601-060-00-6	"1,2-bis[4-fluoro-6-{}{4-sulfo-5-(2-(4-sulfonaphtalene-3-ylazo)-1-hydroxy-3,6-disulfo-8-aminonaphthalene-7-ylazo)phenylamino}}-1,3,5-triazin-2ylamino]ethane; x-sodium, y-potassium salts x = 7,755 y = 0,245"	417-610-1	155522-09-1	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
601-061-00-1	"(ethyl-1,2-ethanediyl)[-2-[[[(2-hydroxyethyl)methylamino]acetyl]-propyl]?-(nonylphenoxy)poly]oxy-(methyl-1,2-ethanediyl)"	418-960-8		Skin Corr. 1BSkin Sens. 1Aquatic Chronic 2	H314H317H411	GHS05GHS07GHS09Dgr	H314H317H411				CLP00
601-062-00-7	reaction mass of: branched triacontane; branched dotriacontane; branched tetratriacontane; branched hexatriacontane	417-030-9	151006-59-6	Aquatic Chronic 4	H413		H413				CLP00
601-063-00-2	reaction mass of isomers of branched tetracosane	417-060-2	151006-61-0	Acute Tox. 4 *Aquatic Chronic 4	H332H413	GHS07Wng	H332H413				CLP00
601-064-00-8	branched hexatriacontane	417-070-7	151006-62-1	Aquatic Chronic 4	H413		H413				CLP00
601-065-00-3	"reaction mass of: (1'?,3'?,6'?)-2,2,3',7',7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane); (1'?,3'?,6'?)-2,2,3',7',7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane)"	416-930-9	-	Skin Irrit. 2Aquatic Chronic 2	H315H411	GHS07GHS09Wng	H315H411				CLP00/ATP01
601-066-00-9	1-(4-(trans-4-heptylcyclohexyl)phenyl)ethanone	426-820-2	78531-60-9	Skin Sens. 1Aquatic Chronic 4	H317H413	GHS07Wng	H317H413				CLP00
601-067-00-4	triethyl arsenate	427-700-2	15606-95-8	Carc. 1AAcute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H350H331H301H400H410	GHS06GHS08GHS09Dgr	H350H331H301H410				CLP00
601-068-00-X	"1,2-diacetoxybut-3-ene"	421-720-5	18085-02-4	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
601-069-00-5	"2-ethyl-1-(2-(1,3-dioxanyl)ethyl)-pyridinium bromide"	422-680-1	287933-44-2	Aquatic Chronic 3	H412		H412				CLP00
601-070-00-0	reaction mass of: branched icosane; branched docosane; branched tetracosane	417-050-8	151006-58-5	Acute Tox. 4 *Aquatic Chronic 4	H332H413	GHS07Wng	H332H413				ATP01
601-071-00-6	1-dimethoxymethyl-2-nitro-benzene	423-830-9	20627-73-0	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				CLP00
601-072-00-1	reaction mass of: 1-(4-isopropylphenyl)-1-phenylethane; 1-(3-isopropylphenyl)-1-phenylethane; 1-(2-isopropylphenyl)-1-phenylethane	430-690-2	52783-21-8	Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H315H400H410	GHS07GHS09Wng	H315H410				ATP01
601-073-00-7	"1-bromo-3,5-difluorobenzene"	416-710-2	461-96-1	Flam. Liq. 3Acute Tox. 4 *STOT RE 2 *Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H226H302H373 **H315H317H400H410	GHS02GHS08GHS07GHS09Wng	H226H302H373 **H315H317H410				CLP00
601-074-00-2	"reaction mass of: 4-(2,2,3-trimethylcyclopent-3-en-1-yl)-1-methyl-2-oxabicyclo[2.2.2]octane; 1-(2,2,3-trimethylcyclopent-3-en-1-yl)-5-methyl-6-oxabicyclo[3.2.1]octane; spiro[cyclohex-3-en-1-yl-[(4,5,6,6a-tetrahydro-3,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]furan]; spiro[cyclohex-3-en-1-yl-[4,5,6,6a-tetrahydro-4,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]]furan]"	422-040-1		Skin Irrit. 2Eye Irrit. 2Aquatic Chronic 2	H315H319H411	GHS07GHS09Wng	H319H315H411				CLP00
601-075-00-8	"4,4'-bis(N-carbamoyl-4-methylbenzenesulfonamide)diphenylmethane"	418-770-5	151882-81-4	Carc. 2	H351	GHS08Wng	H351				ATP01
601-076-00-3	ethynyl cyclopropane	425-430-1	6746-94-7	Flam. Liq. 2Skin Irrit. 2Eye Dam. 1Aquatic Chronic 3	H225H315H318H412	GHS02GHS05Dgr	H225H315H318H412				ATP01
601-077-00-9	"reaction mass of: 1-heptyl-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octane; 1-nonyl-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octane"	426-510-7	196965-91-0	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				ATP01
601-078-00-4	"reaction mass of: 1,7-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]bicyclo[2.2.1]heptane; 2,3-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]bicyclo[2.2.1]heptane"	427-040-5	-	Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1	H314H400H410	GHS05GHS09Dgr	H314H410				ATP01
601-079-00-X	"reaction mass of: trans-trans-cyclohexadeca-1,9-diene; cis-trans-cyclohexadeca-1,9-diene"	429-620-3	-	Skin Irrit. 2Skin Sens. 1Aquatic Chronic 4	H315H317H413	GHS07Wng	H315H317H413				ATP01
601-080-00-5	"reaction mass of: sec-butylphenyl(phenyl)methane, mixed isomers; 1-(sec-butylphenyl(phenyl)-2-phenylethane, mixed isomers; 1-(sec-butylphenyl-1-phenylethane, mixed isomers"	431-100-6	-	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				ATP01
601-081-00-0	"cyclohexadeca-1,9-diene"	431-730-1	4277-06-9	Skin Irrit. 2Skin Sens. 1Aquatic Chronic 4	H315H317H413	GHS07Wng	H315H317H413				ATP01
601-082-00-6	reaction mass of: endo-2-methyl-exo-3-methyl-exo-2-[(exo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane; exo-2-methyl-exo-3-methyl-endo-2-[(endo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane	434-420-4	-	Skin Irrit. 2Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H315H318H400H410	GHS05GHS09Dgr	H315H318H410				ATP01
601-083-00-1	5-endo-hexyl-bicyclo[2.2.1]hept-2-ene	435-000-3	22094-83-3	Asp. Tox. 1Skin Irrit. 2Aquatic Chronic 4	H304H315H413	GHS08GHS07Dgr	H304H315H413				ATP01
601-084-00-7	reaction mass of: 5-endo-butyl-bicyclo[2.2.1]hept-2-ene; 5-exo-butyl-bicyclo[2.2.1]hept-2-ene (80:20)	435-180-3	-	Asp. Tox. 1Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H304H315H400H410	GHS08GHS07GHS09Dgr	H304H315H410				ATP01
601-085-00-2	isopentane; 2-methylbutane	201-142-8	78-78-4	Flam. Liq. 1Asp. Tox. 1STOT SE 3Aquatic Chronic 2	H224H304H336H411	GHS02GHS08GHS07GHS09Dgr	H224H304H336H411	EUH066			CLP00
601-087-00-3	"2,4,4-trimethylpentene"	246-690-9	25167-70-8	Flam. Liq. 2Asp. Tox. 1STOT SE 3	H225H304H336	GHS02GHS07GHS08Dgr	H225H336H304			D	ATP05
601-088-00-9	4-vinylcyclohexene	202-848-9	100-40-3	Carc. 2	H351	GHS08Wng	H351				ATP06
601-089-00-4	muscalure; cis-tricos-9-ene	248-505-7	27519-02-4	Skin Sens. 1B	H317	GHS07Wng	H317				ATP06
602-001-00-7	chloromethane; methyl chloride	200-817-4	74-87-3	Flam. Gas 1Press. GasCarc. 2STOT RE 2 *	H220H351H373 **	GHS02GHS04GHS08Dgr	H220H351H373 **			U	CLP00
602-002-00-2	bromomethane; methylbromide	200-813-2	74-83-9	Press. GasMuta. 2Acute Tox. 3 *Acute Tox. 3 *STOT SE 3STOT RE 2 *Skin Irrit. 2Eye Irrit. 2Aquatic Acute 1Ozone 1	H341H331H301H335H373H315H319H400H420	GHS04GHS06GHS08GHS09Dgr	H341H331H301H373 **H319H335H315H400H420			U	CLP00/ATP02
602-003-00-8	dibromomethane	200-824-2	74-95-3	Acute Tox. 4 *Aquatic Chronic 3	H332H412	GHS07Wng	H332H412		*		CLP00
602-004-00-3	dichloromethane; methylene chloride	200-838-9	75-09-2	Carc. 2	H351	GHS08Wng	H351				CLP00
602-005-00-9	methyl iodide; iodomethane	200-819-5	74-88-4	Carc. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 4 *STOT SE 3Skin Irrit. 2	H351H331H301H312H335H315	GHS06GHS08Dgr	H351H312H331H301H335H315				CLP00
602-006-00-4	chloroform; trichloromethane	200-663-8	67-66-3	Carc. 2Repr. 2Acute Tox. 3Acute Tox. 4STOT RE 1Skin Irrit. 2Eye Irrit. 2	H351H361dH331H302H372H315H319	GHS06GHS08Dgr	H302H331H315H319H351H361dH372		*STOT RE 2; H373: C ? 5 %		CLP00/ATP05
602-007-00-X	bromoform; tribromomethane	200-854-6	75-25-2	Acute Tox. 3 *Acute Tox. 4 *Skin Irrit. 2Eye Irrit. 2Aquatic Chronic 2	H331H302H315H319H411	GHS06GHS09Dgr	H331H302H319H315H411				CLP00/ATP01
602-008-00-5	carbon tetrachloride; tetrachloromethane	200-262-8	56-23-5	Carc. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 1Aquatic Chronic 3Ozone 1	H351H331H311H301H372 **H412H420	GHS06GHS08Dgr	H351H331H311H301H372 **H412H420		"*STOT RE 1; H372: C ? 1 %STOT RE 2; H373: 0,2 % ? C < 1 %"		CLP00/ATP02
602-009-00-0	chloroethane	200-830-5	75-00-3	Flam. Gas 1Press. GasCarc. 2Aquatic Chronic 3	H220H351H412	GHS02GHS04GHS08Dgr	H220H351H412			U	CLP00
602-010-00-6	"1,2-dibromoethane"	203-444-5	106-93-4	Carc. 1BAcute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT SE 3Skin Irrit. 2Eye Irrit. 2Aquatic Chronic 2	H350H331H311H301H335H315H319H411	GHS06GHS08GHS09Dgr	H350H331H311H301H319H335H315H411		*		CLP00
602-011-00-1	"1,1-dichloroethane"	200-863-5	75-34-3	Flam. Liq. 2Acute Tox. 4 *STOT SE 3Eye Irrit. 2Aquatic Chronic 3	H225H302H335H319H412	GHS02GHS07Dgr	H225H302H319H335H412		*		CLP00
602-012-00-7	"1,2-dichloroethane; ethylene dichloride"	203-458-1	107-06-2	Flam. Liq. 2Carc. 1BAcute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Irrit. 2	H225H350H302H335H315H319	GHS02GHS08GHS07Dgr	H225H350H302H319H335H315				CLP00
602-013-00-2	"1,1,1-trichloroethane; methyl chloroform"	200-756-3	71-55-6	Acute Tox. 4 *Ozone 1	H332H420	GHS07Wng	H332H420			F	CLP00/ATP02
602-014-00-8	"1,1,2-trichloroethane"	201-166-9	79-00-5	Carc. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *	H351H332H312H302	GHS08GHS07Wng	H351H332H312H302	EUH066	*		CLP00
602-015-00-3	"1,1,2,2-tetrachloroethane"	201-197-8	79-34-5	Acute Tox. 1Acute Tox. 2 *Aquatic Chronic 2	H310H330H411	GHS06GHS09Dgr	H330H310H411				CLP00
602-016-00-9	"1,1,2,2-tetrabromoethane"	201-191-5	79-27-6	Acute Tox. 2 *Eye Irrit. 2Aquatic Chronic 3	H330H319H412	GHS06Dgr	H330H319H412				CLP00
602-017-00-4	pentachloroethane	200-925-1	76-01-7	Carc. 2STOT RE 1Aquatic Chronic 2	H351H372 **H411	GHS08GHS09Dgr	H351H372 **H411		"STOT RE 1; H372: C ? 1 %STOT RE 2; H373: 0,2 % ? C < 1 %"		CLP00
602-018-00-X	1-chloropropane [1]2-chloropropane  [2]	208-749-7 [1]200-858-8 [2]	540-54-5 [1]75-29-6 [2]	Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *	H225H332H312H302	GHS02GHS07Dgr	H225H332H312H302			C	CLP00
602-019-00-5	1-bromopropane; n-propyl bromide	203-445-0	106-94-5	Flam. Liq. 2Repr. 1BSTOT SE 3STOT SE 3STOT RE 2 *Skin Irrit. 2Eye Irrit. 2	H225H360FDH335H336H373 **H315H319	GHS02GHS08GHS07Dgr	H225H360FDH373 **H319H335H315H336				CLP00
602-020-00-0	"1,2-dichloropropane; propylene dichloride"	201-152-2	78-87-5	Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *	H225H332H302	GHS02GHS07Dgr	H225H332H302				CLP00
602-021-00-6	"1,2-dibromo-3-chloropropane"	202-479-3	96-12-8	Carc. 1BMuta. 1BRepr. 1AAcute Tox. 3 *STOT RE 2 *Aquatic Chronic 3	H350H340H360F ***H301H373 **H412	GHS06GHS08Dgr	H350H340H360F ***H301H373 **H412				CLP00
602-022-00-1	1-chloropentane [1]2-chloropentane [2]3-chloropentane  [3]	208-846-4 [1]210-885-7 [2]210-467-4 [3]	543-59-9 [1]625-29-6 [2]616-20-6 [3]	Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *	H225H332H312H302	GHS02GHS07Dgr	H225H332H312H302			C	CLP00
602-023-00-7	vinyl chloride; chloroethylene	200-831-0	75-01-4	Flam. Gas 1Press. GasCarc. 1A	H220H350	GHS02GHS08Dgr	H220H350			D U	CLP00
602-024-00-2	bromoethylene	209-800-6	593-60-2	Flam. Gas 1Press. GasCarc. 1B	H220H350	GHS02GHS08Dgr	H220H350			U	CLP00
602-025-00-8	"1,1-dichloroethylene; vinylidene chloride"	200-864-0	75-35-4	Flam. Liq. 1Carc. 2Acute Tox. 4 *	H224H351H332	GHS02GHS08GHS07Dgr	H224H351H332		*	D	CLP00
602-026-00-3	"1,2-dichloroethylene [1]cis-dichloroethylene [2]trans-dichloroethylene  [3]"	208-750-2 [1]205-859-7 [2]205-860-2 [3]	540-59-0 [1]156-59-2 [2]156-60-5 [3]	Flam. Liq. 2Acute Tox. 4 *Aquatic Chronic 3	H225H332H412	GHS02GHS07Dgr	H225H332H412		*	C	CLP00
602-027-00-9	trichloroethylene; trichloroethene	201-167-4	79-01-6	Carc. 1BMuta. 2STOT SE 3Skin Irrit. 2Eye Irrit. 2Aquatic Chronic 3	H350H341H336H315H319H412	GHS08GHS07Dgr	H350H341H319H315H336H412				CLP00
602-028-00-4	tetrachloroethylene	204-825-9	127-18-4	Carc. 2Aquatic Chronic 2	H351H411	GHS08GHS09Wng	H351H411				CLP00
602-029-00-X	3-chloropropene; allyl chloride	203-457-6	107-05-1	Flam. Liq. 2Carc. 2Muta. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *STOT SE 3STOT RE 2 *Skin Irrit. 2Eye Irrit. 2Aquatic Acute 1	H225H351H341H332H312H302H335H373 **H315H319H400	GHS02GHS08GHS07GHS09Dgr	H225H351H341H332H312H302H373 **H319H335H315H400			D	CLP00
602-030-00-5	"1,3-dichloropropene [1](Z)-1,3-dichloropropene  [2]"	208-826-5 [1]233-195-8 [2]	542-75-6 [1]10061-01-5 [2]	Flam. Liq. 3Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 4 *Asp. Tox. 1STOT SE 3Skin Irrit. 2Eye Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H226H311H301H332H304H335H315H319H317H400H410	GHS02GHS06GHS08GHS09Dgr	H226H311H301H332H304H319H335H315H317H410			C D	CLP00/ATP01
602-031-00-0	"1,1-dichloropropene"	209-253-3	563-58-6	Flam. Liq. 2Acute Tox. 3 *Aquatic Chronic 3	H225H301H412	GHS02GHS06Dgr	H225H301H412				CLP00
602-032-00-6	3-chloro-2-methylpropene	209-251-2	563-47-3	Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Chronic 2	H225H332H302H314H317H411	GHS02GHS05GHS07GHS09Dgr	H225H332H302H314H317H411				CLP00
602-033-00-1	chlorobenzene	203-628-5	108-90-7	Flam. Liq. 3Acute Tox. 4 *Aquatic Chronic 2	H226H332H411	GHS02GHS07GHS09Wng	H226H332H411		*		CLP00
602-034-00-7	"1,2-dichlorobenzene; o-dichlorobenzene"	202-425-9	95-50-1	Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H302H335H315H319H400H410	GHS07GHS09Wng	H302H319H335H315H410		*		CLP00
602-035-00-2	"1,4-dichlorobenzene; p-dichlorobenzene"	203-400-5	106-46-7	Carc. 2Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H351H319H400H410	GHS08GHS09Wng	H351H319H410				CLP00
602-036-00-8	"chloroprene (stabilised); 2-chlorobuta-1,3-diene (stabilised)"	204-818-0	126-99-8	Flam. Liq. 2Carc. 1BAcute Tox. 4 *Acute Tox. 4 *STOT SE 3STOT RE 2 *Skin Irrit. 2Eye Irrit. 2	H225H350H332H302H335H373 **H315H319	GHS02GHS08GHS07Dgr	H225H350H332H302H373 **H319H335H315			D	CLP00
602-037-00-3	?-chlorotoluene; benzyl chloride	202-853-6	100-44-7	Carc. 1BAcute Tox. 3 *Acute Tox. 4 *STOT SE 3STOT RE 2 *Skin Irrit. 2Eye Dam. 1	H350H331H302H335H373 **H315H318	GHS06GHS08GHS05Dgr	H350H331H302H373 **H335H315H318				CLP00
602-038-00-9	"?,?,?-trichlorotoluene; benzotrichloride"	202-634-5	98-07-7	Carc. 1BAcute Tox. 3 *Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Dam. 1	H350H331H302H335H315H318	GHS06GHS08GHS05Dgr	H350H331H302H335H315H318				CLP00
602-039-00-4	polychlorobiphenyls; PCB	215-648-1	1336-36-3	STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H373 **H400H410	GHS08GHS09Wng	H373 **H410		"STOT RE 2; H373: C ? 0,005 %"	C	CLP00
602-040-00-X	2-chlorotoluene [1]3-chlorotoluene [2]4-chlorotoluene [3]chlorotoluene  [4]	202-424-3 [1]203-580-5 [2]203-397-0 [3]246-698-2 [4]	95-49-8 [1]108-41-8 [2]106-43-4 [3]25168-05-2 [4]	Acute Tox. 4 *Aquatic Chronic 2	H332H411	GHS07GHS09Wng	H332H411			C	CLP00
602-041-00-5	penthachloronaphthalene	215-320-8	1321-64-8	Acute Tox. 4 *Acute Tox. 4 *Skin Irrit. 2Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H312H302H315H319H400H410	GHS07GHS09Wng	H312H302H319H315H410			C	CLP00
602-042-00-0	"1,2,3,4,5,6-hexachlorcyclohexanes with the exception of those specified elsewhere in this Annex"			Carc. 2Acute Tox. 3 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H351H301H312H400H410	GHS06GHS08GHS09Dgr	H351H301H312H410			A C	CLP00
602-043-00-6	"lindane (ISO); ?-HCH or ?-BHC; ?-1,2,3,4,5,6-hexachlorocyclohexane"	200-401-2	58-89-9	Lact.Acute Tox. 3 *Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H362H301H332H312H373 **H400H410	GHS06GHS08GHS09Dgr	H301H332H312H373 **H362H410		M=10		CLP00
602-044-00-1	camphechlor (ISO); toxaphene	232-283-3	8001-35-2	Carc. 2Acute Tox. 3 *Acute Tox. 4 *STOT SE 3Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H351H301H312H335H315H400H410	GHS06GHS08GHS09Dgr	H351H301H312H335H315H410				CLP00
602-045-00-7	"DDT (ISO); clofenotane (INN); dicophane; 1,1,1-trichloro-2,2-bis(4-chlorophenyl)ethane; dichlorodiphenyltrichloroethane"	200-024-3	50-29-3	Carc. 2Acute Tox. 3 *STOT RE 1Aquatic Acute 1Aquatic Chronic 1	H351H301H372 **H400H410	GHS06GHS08GHS09Dgr	H351H301H372 **H410				CLP00
602-046-00-2	"heptachlor (ISO); 1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-4,7-methanoindene"	200-962-3	76-44-8	Carc. 2Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H351H311H301H373 **H400H410	GHS06GHS08GHS09Dgr	H351H311H301H373 **H410				CLP00
602-047-00-8	"chlordane (ISO); 1,2,4,5,6,7,8,8-octachloro-3a,4,7,7a-tetrahydro-4,7-methanoindan"	200-349-0	57-74-9	Carc. 2Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H351H312H302H400H410	GHS08GHS07GHS09Wng	H351H312H302H410				CLP00
602-048-00-3	aldrin (ISO)	206-215-8	309-00-2	Carc. 2Acute Tox. 3 *Acute Tox. 3 *STOT RE 1Aquatic Acute 1Aquatic Chronic 1	H351H311H301H372 **H400H410	GHS06GHS08GHS09Dgr	H351H311H301H372 **H410				CLP00
602-049-00-9	dieldrin (ISO)	200-484-5	60-57-1	Carc. 2Acute Tox. 1Acute Tox. 3 *STOT RE 1Aquatic Acute 1Aquatic Chronic 1	H351H310H301H372 **H400H410	GHS06GHS08GHS09Dgr	H351H310H301H372 **H410				CLP00
602-050-00-4	"isodrin; (1?,4?,4a?,5?,8?,8a?)-1,2,3,4,10,10-hexachloro-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethanonaphthalene"	207-366-2	465-73-6	Acute Tox. 1Acute Tox. 2 *Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1	H310H330H300H400H410	GHS06GHS09Dgr	H330H310H300H410		M=100		CLP00/ATP01
602-051-00-X	"endrin (ISO); 1,2,3,4,10,10-hexachloro-6,7-epoxy-1,4,4a,5,6,7,8,8a-octahydro-1,4:5,8-dimethanonaphthalene"	200-775-7	72-20-8	Acute Tox. 2 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H300H311H400H410	GHS06GHS09Dgr	H300H311H410				CLP00
602-052-00-5	"endosulfan (ISO); 1,2,3,4,7,7-hexachloro-8,9,10-trinorborn-2-en-5,6-ylenedimethylene sulfite; 1,4,5,6,7,7-hexachloro-8,9,10-trinorborn-5-en-2,3-ylenedimethylene sulfite"	204-079-4	115-29-7	Acute Tox. 2 *Acute Tox. 2 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H330H300H312H400H410	GHS06GHS09Dgr	H330H300H312H410				CLP00/ATP01
602-053-00-0	"isobenzan (ISO); 1,3,4,5,6,7,8,8-octachloro-1,3,3a,4,7,7a-hexahydro-4,7-methanoisobenzofuran"	206-045-4	297-78-9	Acute Tox. 1Acute Tox. 2 *Aquatic Acute 1	H310H300H400	GHS06GHS09Dgr	H310H300H400				CLP00
602-054-00-6	3-iodpropene; allyl iodide	209-130-4	556-56-9	Flam. Liq. 2Skin Corr. 1B	H225H314	GHS02GHS05Dgr	H225H314				CLP00/ATP01
602-055-00-1	bromoethane; ethyl bromide	200-825-8	74-96-4	Flam. Liq. 2Carc. 2Acute Tox. 4 *Acute Tox. 4 *	H225H351H332H302	GHS02GHS08GHS07Dgr	H225H351H332H302				CLP00
602-056-00-7	"?,?,?-trifluorotoluene; benzotrifluoride"	202-635-0	98-08-8	Flam. Liq. 2Aquatic Chronic 2	H225H411	GHS02GHS09Dgr	H225H411				CLP00
602-057-00-2	?-bromotoluene; benzyl bromide	202-847-3	100-39-0	STOT SE 3Skin Irrit. 2Eye Irrit. 2	H335H315H319	GHS07Wng	H319H335H315				CLP00
602-058-00-8	"?,?-dichlorotoluene; benzylidene chloride; benzal chloride"	202-709-2	98-87-3	Carc. 2Acute Tox. 3 *Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Dam. 1	H351H331H302H335H315H318	GHS06GHS08GHS05Dgr	H351H331H302H335H315H318				CLP00
602-059-00-3	1-chlorobutane; butyl chloride	203-696-6	109-69-3	Flam. Liq. 2	H225	GHS02Dgr	H225				CLP00
602-060-00-9	bromobenzene	203-623-8	108-86-1	Flam. Liq. 3Skin Irrit. 2Aquatic Chronic 2	H226H315H411	GHS02GHS07GHS09Wng	H226H315H411				CLP00
602-061-00-4	hexafluoropropene; hexafluoropropylene	204-127-4	116-15-4	Press. GasAcute Tox. 4 *STOT SE 3	H332H335	GHS07Wng	H332H335			U	CLP00
602-062-00-X	"1,2,3-trichloropropane"	202-486-1	96-18-4	Carc. 1BRepr. 1BAcute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *	H350H360F ***H332H312H302	GHS08GHS07Dgr	H350H360F ***H332H312H302			D	CLP00
602-063-00-5	"heptachlor epoxide; 2,3-epoxy-1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-4,7-methanoindane"	213-831-0	1024-57-3	Carc. 2Acute Tox. 3 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H351H301H373 **H400H410	GHS06GHS08GHS09Dgr	H351H301H373 **H410				CLP00
602-064-00-0	"1,3-dichloro-2-propanol"	202-491-9	96-23-1	Carc. 1BAcute Tox. 3 *Acute Tox. 4 *	H350H301H312	GHS06GHS08Dgr	H350H301H312				CLP00
602-065-00-6	hexachlorobenzene	204-273-9	118-74-1	Carc. 1BSTOT RE 1Aquatic Acute 1Aquatic Chronic 1	H350H372 **H400H410	GHS08GHS09Dgr	H350H372 **H410				CLP00
602-066-00-1	tetrachloro-p-benzoquinone	204-274-4	118-75-2	Skin Irrit. 2Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H315H319H400H410	GHS07GHS09Wng	H319H315H410				CLP00
602-067-00-7	"1,3-dichlorbenzene"	208-792-1	541-73-1	Acute Tox. 4 *Aquatic Chronic 2	H302H411	GHS07GHS09Wng	H302H411				CLP00
602-068-00-2	ethylene bis(trichloroacetate)	219-732-9	2514-53-6	Skin Irrit. 2	H315	GHS07Wng	H315				CLP00
602-069-00-8	dichloroacetylene		7572-29-4	Unst. Expl.Carc. 2STOT RE 2 *	H200H351H373 **	GHS01GHS08Wng	H200H351H373 **				CLP00
602-070-00-3	"3-chloro-4,5,?, ?,?-pentafluorotoluene"	401-930-3	77227-99-7	Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1	H226H332H302H400	GHS02GHS07GHS09Wng	H226H332H302H400				CLP00
602-071-00-9	"bromobenzylbromotoluene, reaction mass of isomers"	402-210-1	99688-47-8	STOT RE 2 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H373 **H317H400H410	GHS08GHS07GHS09Wng	H373 **H317H410				CLP00
602-072-00-4	"dichloro [(dichlorophenyl)methyl]methylbenzene, reaction mass of isomers; (dichlorophenyl)(dichlorotolyl)methane, reaction mass of isomers (IUPAC)"	278-404-3	76253-60-6	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
602-073-00-X	"1,4-dichlorobut-2-ene"	212-121-8	764-41-0	Carc. 1BAcute Tox. 2 *Acute Tox. 3 *Acute Tox. 3 *Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1	H350H330H311H301H314H400H410	GHS06GHS08GHS05GHS09Dgr	H350H330H311H301H314H410		"Carc. 1B; H350: C ? 0,01 %STOT SE 3; H335: C ? 5 %"		CLP00
602-074-00-5	pentachlorobenzene	210-172-0	608-93-5	Flam. Sol. 1Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H228H302H400H410	GHS02GHS07GHS09Dgr	H228H302H410			T	CLP00
602-075-00-0	"4,4,5,5-tetrachloro-1,3-dioxolan-2-one"	404-060-2	22432-68-4	Acute Tox. 2 *Acute Tox. 4 *Skin Corr. 1B	H330H302H314	GHS06GHS05Dgr	H330H302H314				CLP00
602-076-00-6	"2,3,4-trichlorobut-1-ene"	219-397-9	2431-50-7	Carc. 2Acute Tox. 3 *Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H351H331H302H335H315H319H400H410	GHS06GHS08GHS09Dgr	H351H331H302H319H335H315H410		"Carc. 2; H351: C ? 0,1 %"		CLP00/ATP01
602-077-00-1	"dodecachloropentacyclo[5.2.1.02,6.03,9.05,8]decane; mirex"	219-196-6	2385-85-5	Carc. 2Repr. 2Lact.Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H351H361fdH362H312H302H400H410	GHS08GHS07GHS09Wng	H351H361fdH362H312H302H410				CLP00
602-078-00-7	hexachlorocyclopentadiene	201-029-3	77-47-4	Acute Tox. 2 *Acute Tox. 3 *Acute Tox. 4 *Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1	H330H311H302H314H400H410	GHS06GHS05GHS09Dgr	H330H311H302H314H410				CLP00
602-079-00-2	"2,3-dichloropropene; 2,3-dichloropropylene"	201-153-8	78-88-6	Flam. Liq. 2Muta. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Dam. 1Aquatic Chronic 3	H225H341H332H312H302H335H315H318H412	GHS02GHS08GHS05GHS07Dgr	H225H341H332H312H302H335H315H318H412				CLP00
602-080-00-8	"alkanes, C10-13, chloro; chlorinated paraffins, C10-13"	287-476-5	85535-84-8	Carc. 2Aquatic Acute 1Aquatic Chronic 1	H351H400H410	GHS08GHS09Wng	H351H410	EUH066			CLP00/ATP01
602-081-00-3	"2-chloro-4,5-difluorobenzoic acid"	405-380-5		Acute Tox. 4 *Acute Tox. 4 *Eye Dam. 1Skin Sens. 1	H312H302H318H317	GHS05GHS07Dgr	H312H302H318H317				CLP00
602-082-00-9	"2,2,6,6-tetrakis(bromomethyl)-4-oxaheptane-1,7-diol"	408-020-5	109678-33-3	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				CLP00
602-083-00-4	"diphenyl ether, pentabromo derivative pentabromodiphenyl ether"	251-084-2	32534-81-9	Lact.STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H362H373 **H400H410	GHS08GHS09Wng	H373 **H362H410				CLP00
602-084-00-X	"1,1-dichloro-1-fluoroethane"	404-080-1	1717-00-6	Aquatic Chronic 3Ozone 1	H412H420	GHS07Wng	H412H420				CLP00/ATP02
602-085-00-5	2-bromopropane	200-855-1	75-26-3	Flam. Liq. 2Repr. 1ASTOT RE 2 *	H225H360F ***H373 **	GHS02GHS08Dgr	H225H360F ***H373 **	EUH066			CLP00
602-086-00-0	trifluoroiodomethane; trifluoromethyl iodide	219-014-5	2314-97-8	Muta. 2	H341	GHS08Wng	H341				CLP00
602-087-00-6	"1,2,4-trichlorobenzene"	204-428-0	120-82-1	Acute Tox. 4 *Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H302H315H400H410	GHS07GHS09Wng	H302H315H410				CLP00
602-088-00-1	"2,3-dibromopropan-1-ol; 2,3-dibromo-1-propanol"	202-480-9	96-13-9	Carc. 1BRepr. 2Acute Tox. 3 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Chronic 3	H350H361f ***H311H332H302H412	GHS08GHS07Dgr	H350H361f ***H311H332H302H412				CLP00
602-089-00-7	4-bromo-2-chlorofluorobenzene	405-580-2	60811-21-4	Acute Tox. 4 *Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H302H315H400H410	GHS07GHS09Wng	H302H315H410				CLP00
602-090-00-2	1-allyl-3-chloro-4-fluorobenzene	406-630-6	121626-73-1	Skin Irrit. 2Aquatic Chronic 2	H315H411	GHS07GHS09Wng	H315H411				CLP00
602-091-00-8	"1,3-dichloro-4-fluorobenzene"	406-160-1	1435-48-9	Acute Tox. 4 *STOT RE 2 *Skin Irrit. 2Aquatic Chronic 2	H302H373 **H315H411	GHS08GHS07Wng	H302H373 **H315H411				CLP00
602-092-00-3	"1-bromo-3,4,5-trifluorobenzene"	418-480-9	138526-69-9	Flam. Liq. 3Carc. 2Skin Irrit. 2Eye Dam. 1Aquatic Chronic 2	H226H351H315H318H411	GHS02GHS08GHS05GHS09Dgr	H226H351H315H318H411				CLP00
602-093-00-9	"?, ?,?,4-tetrachlorotoluene; p-chlorobenzotrichloride"	226-009-1	5216-25-1	Carc. 1BRepr. 2Acute Tox. 4 *Acute Tox. 4 *STOT SE 3STOT RE 1Skin Irrit. 2	H350H361f ***H312H302H335H372 **H315	GHS08GHS07Dgr	H350H361f ***H372 **H312H302H335H315				CLP00
602-094-00-4	diphenylether; octabromo derivate	251-087-9	32536-52-0	Repr. 1B	H360Df	GHS08Dgr	H360Df				CLP00
602-095-00-X	"alkanes, C14-17, chloro; chlorinated paraffins, C14-17"	287-477-0	85535-85-9	Lact.Aquatic Acute 1Aquatic Chronic 1	H362H400H410	GHS09Wng	H362H410	EUH066			ATP01
602-096-00-5	malachite green hydrochloride [1]malachite green oxalate  [2]	209-322-8 [1]219-441-7 [2]	569-64-2 [1]2437-29-8 [2]	Repr. 2Acute Tox. 4 *Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H361d ***H302H318H400H410	GHS08GHS05GHS07GHS09Dgr	H361d ***H302H318H410				CLP00
602-097-00-0	"1-bromo-9-(4,4,5,5,5-pentafluoropentylthio)nonane"	422-850-5	148757-89-5	Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410				CLP00
602-098-00-6	2-(3-bromophenoxy)tetrahydro-2H-pyran	429-030-6	57999-49-2	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				ATP01
602-099-00-1	3-(4-fluorophenyl)-2-methylpropionylchloride	426-370-7	-	Acute Tox. 4 *Skin Corr. 1AAquatic Chronic 3	H302H314H412	GHS05GHS07Dgr	H314H302H412	EUH014EUH029			ATP01
602-100-00-5	"reaction mass of: (R,R)-1,1,1,2,2,3,4,5,5,5-decafluoropentane; (S,S)-1,1,1,2,2,3,4,5,5,5-decafluoropentane"	420-640-8	-	Aquatic Chronic 3	H412	-	H412				ATP01
602-101-00-0	2-chloro-4-fluoro-5-nitrophenyl (isobutyl)carbonate	427-020-6	141772-37-4	STOT RE 2 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H373 **H317H400H410	GHS08GHS07GHS09Wng	H373 **H317H410				ATP01
602-102-00-6	"1,1,1,3,3-pentafluorobutane"	430-250-1	406-58-6	Flam. Liq. 2	H225	GHS02Dgr	H225				ATP01
602-103-00-1	1-(chlorophenylmethyl)-2-methylbenzene	431-450-1	41870-52-4	Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H315H400H410	GHS07GHS09Wng	H315H410				ATP01
602-104-00-7	"1,1,2,2,3,3,4-heptafluorocyclopentane"	430-710-1	15290-77-4	Aquatic Chronic 3	H412	-	H412				ATP01
602-105-00-2	"sodium 1,1,2,2,3,3,4,4,4-nonafluoro-1-butanesulfinate"	422-100-7	102061-82-5	Eye Dam. 1Skin Sens. 1	H318H317	GHS05GHS07Dgr	H318H317				ATP01
602-106-00-8	"2-bromo-4,6-difluoroaniline"	429-430-0	444-14-4	Acute Tox. 4 *Aquatic Chronic 2	H302H411	GHS07GHS09Wng	H302H411				ATP01
602-107-00-3	"3,3,4,4-tetrafluoro-4-iodo-1-butene"	439-500-2	33831-83-3	Acute Tox. 4 *Skin Irrit. 2Aquatic Chronic 2	H302H315H411	GHS07GHS09Wng	H302H315H411				ATP01
602-108-00-9	"(2,3,5,6-tetrafluorophenyl)methanol"	443-840-7	4084-38-2	Acute Tox. 4 *Eye Irrit. 2Skin Sens. 1	H302H319H317	GHS07Wng	H302H319H317				ATP01
602-109-00-4	"Hexabromocyclododecane [1]1,2,5,6,9,10-hexabromocyclododecane [2]"	247-148-4 [1]221-695-9 [2]	25637-99-4 [1]3194-55-6 [2]	Repr. 2Lact.	H361H362	GHS08Wng	H361H362				ATP03
603-001-00-X	methanol	200-659-6	67-56-1	Flam. Liq. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT SE 1	H225H331H311H301H370 **	GHS02GHS06GHS08Dgr	H225H331H311H301H370 **		*STOT SE 1; H370: C ? 10 %STOT SE 2; H371: 3 % ? C < 10 %		CLP00
603-002-00-5	ethanol; ethyl alcohol	200-578-6	64-17-5	Flam. Liq. 2	H225	GHS02Dgr	H225				CLP00
603-003-00-0	propan-1-ol; n-propanol	200-746-9	71-23-8	Flam. Liq. 2STOT SE 3Eye Dam. 1	H225H336H318	GHS02GHS05GHS07Dgr	H225H318H336				CLP00
603-004-00-6	butan-1-ol; n-butanol	200-751-6	71-36-3	Flam. Liq. 3Acute Tox. 4 *STOT SE 3STOT SE 3Skin Irrit. 2Eye Dam. 1	H226H302H335H336H315H318	GHS02GHS05GHS07Dgr	H226H302H335H315H318H336				CLP00
603-005-00-1	2-methylpropan-2-ol; tert-butyl alcohol	200-889-7	75-65-0	Flam. Liq. 2Acute Tox. 4 *STOT SE 3Eye Irrit. 2	H225H332H335H319	GHS02GHS07Dgr	H225H332H319H335				CLP00/ATP01
603-006-00-7	"pentanol isomers, with the exception fo those specified elsewhere in this Annex"	250-378-8		Flam. Liq. 3Acute Tox. 4 *STOT SE 3	H226H332H335	GHS02GHS07Wng	H226H332H335	EUH066		C	CLP00
603-007-00-2	2-methylbutan-2-ol; tert-pentanol	200-908-9	75-85-4	Flam. Liq. 2Acute Tox. 4 *STOT SE 3Skin Irrit. 2	H225H332H335H315	GHS02GHS07Dgr	H225H332H335H315				CLP00
603-008-00-8	4-methylpentan-2-ol; methyl isobutyl carbinol	203-551-7	108-11-2	Flam. Liq. 3STOT SE 3	H226H335	GHS02GHS07Wng	H226H335		STOT SE 3; H335: C ? 25 %		CLP00
603-009-00-3	cyclohexanol	203-630-6	108-93-0	Acute Tox. 4 *Acute Tox. 4 *STOT SE 3Skin Irrit. 2	H332H302H335H315	GHS07Wng	H332H302H335H315				CLP00
603-010-00-9	"2-methylcyclohexanol, mixed isomers [1]cis-2-methylcyclohexanol [2]trans-2-methylcyclohexanol  [3]"	209-512-0 [1]231-187-9 [2]231-186-3 [3]	583-59-5 [1]7443-70-1 [2]7443-52-9 [3]	Acute Tox. 4 *	H332	GHS07Wng	H332			C	CLP00
603-011-00-4	2-methoxyethanol; ethylene glycol monomethyl ether	203-713-7	109-86-4	Flam. Liq. 3Repr. 1BAcute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *	H226H360FDH332H312H302	GHS02GHS08GHS07Dgr	H226H360FDH332H312H302				CLP00
603-012-00-X	2-ethoxyethanol; ethylene glycol monoethyl ether	203-804-1	110-80-5	Flam. Liq. 3Repr. 1BAcute Tox. 3Acute Tox. 4	H226H360FDH331H302	GHS02GHS08GHS06Dgr	H226H360FDH331H302				CLP00/ATP03
603-013-00-5	2-isopropoxyethanol; ethylene glycol monoisopropyl ether	203-685-6	109-59-1	Acute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2	H332H312H319	GHS07Wng	H332H312H319				CLP00
603-014-00-0	2-butoxyethanol; ethylene glycol monobutyl ether; butyl cellosolve	203-905-0	111-76-2	Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Skin Irrit. 2Eye Irrit. 2	H332H312H302H315H319	GHS07Wng	H332H312H302H319H315				CLP00
603-015-00-6	allyl alcohol	203-470-7	107-18-6	Flam. Liq. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT SE 3Skin Irrit. 2Eye Irrit. 2Aquatic Acute 1	H225H331H311H301H335H315H319H400	GHS02GHS06GHS09Dgr	H225H331H311H301H319H335H315H400				CLP00
603-016-00-1	4-hydroxy-4-methylpentan-2-one; diacetone alcohol	204-626-7	123-42-2	Eye Irrit. 2	H319	GHS07Wng	H319		Eye Irrit. 2; H319: C ? 10 %		CLP00
603-018-00-2	furfuryl alcohol	202-626-1	98-00-0	Carc. 2Acute Tox. 3 *Acute Tox. 4 *Acute Tox. 4 *STOT SE 3STOT RE 2 *Eye Irrit. 2	H351H331H312H302H335H373 **H319	GHS06GHS08Dgr	H351H331H312H302H373 **H319H335				CLP00/ATP01
603-019-00-8	dimethyl ether	204-065-8	115-10-6	Flam. Gas 1Press. Gas	H220	GHS02GHS04Dgr	H220			U	CLP00
603-020-00-3	ethyl methyl ether		540-67-0	Flam. Gas 1Press. Gas	H220	GHS02GHS04Dgr	H220			U	CLP00
603-021-00-9	methyl vinyl ether	203-475-4	107-25-5	Flam. Gas 1Press. Gas	H220	GHS02GHS04Dgr	H220			D U	CLP00
603-022-00-4	diethyl ether; ether	200-467-2	60-29-7	Flam. Liq. 1Acute Tox. 4 *STOT SE 3	H224H302H336	GHS02GHS07Dgr	H224H302H336	EUH019EUH066			CLP00
603-023-00-X	ethylene oxide; oxirane	200-849-9	75-21-8	Flam. Gas 1Press. GasCarc. 1BMuta. 1BAcute Tox. 3 *STOT SE 3Skin Irrit. 2Eye Irrit. 2	H220H350H340H331H335H315H319	GHS02GHS04GHS06GHS08Dgr	H220H331H315H319H340H350H335			U	CLP00/ATP01corr
603-024-00-5	"1,4-dioxane"	204-661-8	123-91-1	Flam. Liq. 2Carc. 2STOT SE 3Eye Irrit. 2	H225H351H335H319	GHS02GHS08GHS07Dgr	H225H351H319H335	EUH019EUH066		D	CLP00
603-025-00-0	tetrahydrofuran	203-726-8	109-99-9	Flam. Liq. 2Carc. 2STOT SE 3Eye Irrit. 2	H225H351H335H319	GHS02GHS07GHS08Dgr	H225H351H319H335	EUH019	STOT SE 3; H335:  C ? 25 %Eye Irrit.2; H319:  C ? 25 %		CLP00/ATP03
603-026-00-6	"1-chloro-2,3-epoxypropane; epichlorhydrin"	203-439-8	106-89-8	Flam. Liq. 3Carc. 1BAcute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Skin Corr. 1BSkin Sens. 1	H226H350H331H311H301H314H317	GHS02GHS06GHS08GHS05Dgr	H226H350H331H311H301H314H317		*		CLP00
603-027-00-1	ethanediol; ethylene glycol	203-473-3	107-21-1	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
603-028-00-7	2-chloroethanol; ethylene chlorohydrin	203-459-7	107-07-3	Acute Tox. 1Acute Tox. 2 *Acute Tox. 2 *	H310H330H300	GHS06Dgr	H330H310H300				CLP00
603-029-00-2	bis(2-chloroethyl) ether	203-870-1	111-44-4	Carc. 2Acute Tox. 1Acute Tox. 2 *Acute Tox. 2 *	H351H310H330H300	GHS06GHS08Dgr	H351H330H310H300				CLP00/ATP01
603-030-00-8	2-aminoethanol; ethanolamine	205-483-3	141-43-5	Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1B	H332H312H302H314	GHS05GHS07Dgr	H332H312H302H314		STOT SE 3; H335: C ? 5 %		CLP00
603-031-00-3	"1,2-dimethoxyethane; ethylene glycol dimethyl ether; EGDME"	203-794-9	110-71-4	Flam. Liq. 2Repr. 1BAcute Tox. 4 *	H225H360FDH332	GHS02GHS08GHS07Dgr	H225H360FDH332	EUH019			CLP00
603-032-00-9	ethylene dinitrate; ethylene glycol dinitrate	211-063-0	628-96-6	Unst. Expl.Acute Tox. 1Acute Tox. 2 *Acute Tox. 2 *STOT RE 2	H200H310H330H300H373 **	GHS01GHS06GHS08Dgr	H200H330H310H300H373 **				CLP00/ATP01
603-033-00-4	oxydiethylene dinitrate; diethylene glycol dinitrate; digol dinitrate	211-745-8	693-21-0	Acute Tox. 1Acute Tox. 2 *Acute Tox. 2 *STOT RE 2 *Aquatic Chronic 3Unst. Expl	H310H330H300H373 **H412H200	GHS01GHS06GHS08Dgr	H200H330H310H300H373 **H412				CLP00
603-033-01-1	oxydiethylene dinitrate; diethylene glycol dinitrate; digol dinitrate; [>25 % phlegmatiser]	211-745-8	693-21-0	Expl. 1.1Acute Tox. 1Acute Tox. 2 *Acute Tox. 2 *STOT RE 2 *Aquatic Chronic 3	H201H310H330H300H373 **H412	GHS01GHS06GHS08Dgr	H201H330H310H300H373 **H412				CLP00
603-034-00-X	glycerol trinitrate; nitroglycerine	200-240-8	55-63-0	Unst. Expl.Acute Tox. 1Acute Tox. 2 *Acute Tox. 2 *STOT RE 2 *Aquatic Chronic 2	H200H310H330H300H373 **H411	GHS01GHS06GHS08GHS09Dgr	H200H330H310H300H373 **H411				CLP00
603-034-01-7	glycerol trinitrate; nitroglycerine; [>40 % phlegmatiser]	200-240-8	55-63-0	Expl. 1.1Acute Tox. 1Acute Tox. 2 *Acute Tox. 2 *STOT RE 2 *Aquatic Chronic 2	H201H310H330H300H373 **H411	GHS01GHS06GHS08GHS09Dgr	H201H330H310H300H373 **H411				CLP00
603-035-00-5	pentaerythritol tetranitrate; P.E.T.N.	201-084-3	78-11-5	Unst. Expl.	H200	GHS01Dgr	H200				CLP00
603-035-01-2	pentaerythritol tetranitrate; pentaerythrite tetranitrate; P.E.T.N.; [>20 % phlegmatiser]	201-084-3	78-11-5	Expl. 1.1	H201	GHS01Dgr	H201			T	CLP00
603-036-00-0	mannitol hexanitrate; nitromannite	239-924-6	15825-70-4	Unst. Expl.	H200	GHS01Dgr	H200				CLP00
603-036-01-8	mannitol hexanitrate; nitromannite; [>40 % phlegmatiser]	239-924-6	15825-70-4	Expl. 1.1	H201	GHS01Dgr	H201				CLP00
603-037-00-6	cellulose nitrate; nitrocellulose	-	-	Expl. 1.1	H201	GHS01Dgr	H201			T	CLP00/ATP01
603-038-00-1	"allyl glycidyl ether; allyl 2,3-epoxypropyl ether; prop-2-en-1-yl 2,3-epoxypropyl ether"	203-442-4	106-92-3	Flam. Liq. 3Carc. 2Muta. 2Repr. 2Acute Tox. 4 *Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Chronic 3	H226H351H341H361f ***H332H302H335H315H318H317H412	GHS02GHS08GHS05GHS07Dgr	H226H351H341H361f ***H332H302H335H315H318H317H412				CLP00
603-039-00-7	"butyl glycidyl ether; butyl 2,3-epoxypropyl ether"	219-376-4	2426-08-6	Flam. Liq. 3Carc. 2Muta. 2Acute Tox. 4 *Acute Tox. 4 *STOT SE 3Skin Sens. 1Aquatic Chronic 3	H226H351H341H332H302H335H317H412	GHS02GHS08GHS07Wng	H226H351H341H332H302H335H317H412				CLP00
603-040-00-2	sodium methanolate; sodium methoxide [1]potassium methanolate; potassium methoxide [2]lithium methanolate; lithium methoxide  [3]	204-699-5 [1]212-736-1 [2]212-737-7 [3]	124-41-4 [1]865-33-8 [2]865-34-9 [3]	Skin Corr. 1BSelf-heat 1	H314H251	GHS02GHS05Dgr	H251H314	EUH014		T	CLP00
603-041-00-8	potassium ethanolate; potassium ethoxide [1]sodium ethanolate; sodium ethoxide  [2]	213-029-0 [1]205-487-5 [2]	917-58-8 [1]141-52-6 [2]	Skin Corr. 1BSelf-heat 1	H314H251	GHS02GHS05Dgr	H251H314	EUH014		T	CLP00
603-042-00-3	aluminium-tri-isopropoxide	209-090-8	555-31-7	Flam. Sol. 1	H228	GHS02Dgr	H228			T	CLP00
603-043-00-9	"triarimol (ISO); 2,4-dichloro-?-(pyrimidin-5-yl) benzhydryl alcohol"		26766-27-8	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
603-044-00-4	"dicofol (ISO); 2,2,2-trichloro-1,1-bis(4-chlorophenyl)ethanol"	204-082-0	115-32-2	Acute Tox. 4 *Acute Tox. 4 *Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H312H302H315H317H400H410	GHS07GHS09Wng	H312H302H315H317H410				CLP00
603-045-00-X	diisopropyl ether [1]dipropyl ether  [2]	203-560-6 [1]203-869-6 [2]	108-20-3 [1]111-43-3 [2]	Flam. Liq. 2STOT SE 3	H225H336	GHS02GHS07Dgr	H225H336	EUH019EUH066		C	CLP00
603-046-00-5	bis(chloromethyl) ether; oxybis(chloromethane)	208-832-8	542-88-1	Flam. Liq. 2Carc. 1AAcute Tox. 2 *Acute Tox. 3 *Acute Tox. 4 *	H225H350H330H311H302	GHS02GHS06GHS08Dgr	H225H350H330H311H302		"Carc. 1A; H350: C ? 0,001 %"		CLP00/ATP01
603-047-00-0	"2-dimethylaminoethanol; N,N-dimethylethanolamine"	203-542-8	108-01-0	Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1B	H226H332H312H302H314	GHS02GHS05GHS07Dgr	H226H332H312H302H314		STOT SE 3; H335: C ? 5 %		CLP00
603-048-00-6	"2-diethylaminoethanol; N,N-diethylethanolamine"	202-845-2	100-37-8	Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1B	H226H332H312H302H314	GHS02GHS05GHS07GHS09Dgr	H226H332H312H302H314		STOT SE 3; H335: C ? 5 %		CLP00
603-049-00-1	"chlorfenethol (ISO); 1,1-bis (4-chlorophenyl) ethanol"	201-246-3	80-06-8	Acute Tox. 4 *Aquatic Chronic 2	H302H411	GHS07GHS09Wng	H302H411				CLP00
603-050-00-7	1-(2-Butoxypropoxy)propan-2-ol	246-011-6	24083-03-2	Acute Tox. 4 *Acute Tox. 4 *	H312H302	GHS07Wng	H312H302				CLP00
603-051-00-2	2-ethylbutan-1-ol	202-621-4	97-95-0	Acute Tox. 4 *Acute Tox. 4 *	H312H302	GHS07Wng	H312H302				CLP00
603-052-00-8	3-butoxypropan-2-ol; propylene glycol monobutyl ether	225-878-4	5131-66-8	Skin Irrit. 2Eye Irrit. 2	H315H319	GHS07Wng	H319H315				CLP00
603-053-00-3	"2-methylpentane-2,4-diol"	203-489-0	107-41-5	Skin Irrit. 2Eye Irrit. 2	H315H319	GHS07Wng	H319H315				CLP00
603-054-00-9	di-n-butyl ether; dibutyl ether	205-575-3	142-96-1	Flam. Liq. 3STOT SE 3Skin Irrit. 2Eye Irrit. 2Aquatic Chronic 3	H226H335H315H319H412	GHS02GHS07Wng	H226H319H335H315H412		STOT SE 3; H335: C ? 10 %		CLP00
603-055-00-4	"propylene oxide; 1,2-epoxypropane; methyloxirane"	200-879-2	75-56-9	Flam. Liq. 1Carc. 1BMuta. 1BAcute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Irrit. 2	H224H350H340H332H312H302H335H315H319	GHS02GHS08GHS07Dgr	H224H350H340H332H312H302H319H335H315				CLP00
603-056-00-X	"[(p-tolyloxy)methyl]oxirane [1][(m-tolyloxy)methyl]oxirane [2]2,3-epoxypropyl o-tolyl ether [3][(tolyloxy)methyl]oxirane; cresyl glycidyl ether  [4]"	218-574-8 [1]218-575-3 [2]218-645-3 [3]247-711-4 [4]	2186-24-5 [1]2186-25-6 [2]2210-79-9 [3]26447-14-3 [4]	Muta. 2Skin Irrit. 2Skin Sens. 1Aquatic Chronic 2	H341H315H317H411	GHS08GHS07GHS09Wng	H341H315H317H411			C	CLP00
603-057-00-5	benzyl alcohol	202-859-9	100-51-6	Acute Tox. 4 *Acute Tox. 4 *	H332H302	GHS07Wng	H332H302				CLP00
603-058-00-0	"1,3-propylene oxide"	207-964-3	503-30-0	Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *	H225H332H312H302	GHS02GHS07Dgr	H225H332H312H302				CLP00
603-059-00-6	hexan-1-ol	203-852-3	111-27-3	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
603-060-00-1	"2,2'-bioxirane; 1,2:3,4-diepoxybutane"	215-979-1	1464-53-5	Carc. 1BMuta. 1BAcute Tox. 2 *Acute Tox. 3 *Acute Tox. 3 *Skin Corr. 1B	H350H340H330H311H301H314	GHS06GHS08GHS05Dgr	H350H340H330H311H301H314				CLP00
603-061-00-7	tetrahydro-2-furylmethanol; tetrahydrofurfuryl alcohol	202-625-6	97-99-4	Repr. 1BEye Irrit. 2	H360DfH319	GHS08 GHS07Dgr	H319H360Df				CLP00/ATP06
603-062-00-2	"tetrahydrofuran-2,5-diyldimethanol"	203-239-0	104-80-3	STOT SE 3Skin Irrit. 2Eye Irrit. 2	H335H315H319	GHS07Wng	H319H335H315		STOT SE 3; H335: C ? 10 %		CLP00
603-063-00-8	"2,3-epoxypropan-1-ol; glycidol; oxiranemethanol"	209-128-3	556-52-5	Carc. 1BMuta. 2Repr. 1BAcute Tox. 3 *Acute Tox. 4 *Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Irrit. 2	H350H341H360F ***H331H312H302H335H315H319	GHS06GHS08Dgr	H350H341H360F ***H331H312H302H319H335H315				CLP00
603-064-00-3	1-methoxy-2-propanol; monopropylene glycol methyl ether	203-539-1	107-98-2	Flam. Liq. 3STOT SE 3	H226H336	GHS02GHS07Wng	H226H336				CLP00/ATP01
603-065-00-9	"resorcinol diglycidyl ether; 1,3-bis(2,3-epoxypropoxy)benzene"	202-987-5	101-90-6	Carc. 2Muta. 2Acute Tox. 4 *Acute Tox. 4 *Skin Irrit. 2Eye Irrit. 2Skin Sens. 1Aquatic Chronic 3	H351H341H312H302H315H319H317H412	GHS08GHS07Wng	H351H341H312H302H319H315H317H412				CLP00
603-066-00-4	"1,2-epoxy-4-epoxyethylcyclohexane; 4-vinylcyclohexene diepoxide"	203-437-7	106-87-6	Carc. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *	H351H331H311H301	GHS06GHS08Dgr	H351H331H311H301		*		CLP00/ATP01
603-067-00-X	"phenyl glycidyl ether; 2,3-epoxypropyl phenyl ether; 1,2-epoxy-3-phenoxypropane"	204-557-2	122-60-1	Carc. 1BMuta. 2Acute Tox. 4 *STOT SE 3Skin Irrit. 2Skin Sens. 1Aquatic Chronic 3	H350H341H332H335H315H317H412	GHS08GHS07Dgr	H350H341H332H335H315H317H412				CLP00
603-068-00-5	"2,3-epoxypropyl-2-ethylcyclohexyl ether; ethylcyclohexylglycidyl ether"		130014-35-6	Skin Irrit. 2Eye Irrit. 2Skin Sens. 1	H315H319H317	GHS07Wng	H319H315H317				CLP00
603-069-00-0	"2,4,6-tris(dimethylaminomethyl)phenol"	202-013-9	90-72-2	Acute Tox. 4 *Skin Irrit. 2Eye Irrit. 2	H302H315H319	GHS07Wng	H302H319H315				CLP00
603-070-00-6	2-amino-2-methylpropanol	204-709-8	124-68-5	Skin Irrit. 2Eye Irrit. 2Aquatic Chronic 3	H315H319H412	GHS07Wng	H319H315H412				CLP00
603-071-00-1	"2,2'-iminodiethanol; diethanolamine"	203-868-0	111-42-2	Acute Tox. 4 *STOT RE 2 *Skin Irrit. 2Eye Dam. 1	H302H373 **H315H318	GHS08GHS05GHS07Dgr	H302H373 **H315H318				CLP00
603-072-00-7	"1,4-bis(2,3 epoxypropoxy)butane; butanedioldiglycidyl ether"	219-371-7	2425-79-8	Acute Tox. 4 *Acute Tox. 4 *Skin Irrit. 2Eye Irrit. 2Skin Sens. 1	H332H312H315H319H317	GHS07Wng	H332H312H319H315H317				CLP00
603-073-00-2	"bis-[4-(2,3-epoxipropoxi)phenyl]propane"	216-823-5	1675-54-3	Skin Irrit. 2Eye Irrit. 2Skin Sens. 1	H315H319H317	GHS07Wng	H319H315H317		Eye Irrit. 2; H319: C ? 5 %Skin Irrit. 2; H315: C ? 5 %		CLP00
603-074-00-8	reaction product: bisphenol-A-(epichlorhydrin); epoxy resin (number average molecular weight ? 700)	500-033-5	25068-38-6	Skin Irrit. 2Eye Irrit. 2Skin Sens. 1Aquatic Chronic 2	H315H319H317H411	GHS07GHS09Wng	H319H315H317H411		Eye Irrit. 2; H319: C ? 5 %Skin Irrit. 2; H315: C ? 5 %		CLP00
603-075-00-3	chlormethyl methyl ether; chlorodimethyl ether	203-480-1	107-30-2	Flam. Liq. 2Carc. 1AAcute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *	H225H350H332H312H302	GHS02GHS08GHS07Dgr	H225H350H332H312H302				CLP00
603-076-00-9	"but-2-yne-1,4-diol; 2-butyne-1,4-diol"	203-788-6	110-65-6	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 4 *STOT RE 2 *Skin Corr. 1BSkin Sens. 1	H331H301H312H373 **H314H317	GHS06GHS05GHS08Dgr	H314H331H301H312H373 **H317		Skin Corr. 1B; H314: C ? 50 %Skin Irrit. 2; H315: 25 % ? C < 50 %Eye Irrit. 2; H319: 25 % ? C < 50 %	D	CLP00
603-077-00-4	1-dimethylaminopropan-2-ol; dimepranol (INN)	203-556-4	108-16-7	Flam. Liq. 3Acute Tox. 4 *Skin Corr. 1B	H226H302H314	GHS02GHS05GHS07Dgr	H226H302H314				CLP00
603-078-00-X	prop-2-yn-1-ol; propargyl alcohol	203-471-2	107-19-7	Flam. Liq. 3Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Skin Corr. 1BAquatic Chronic 2	H226H331H311H301H314H411	GHS02GHS06GHS05GHS09Dgr	H226H331H311H301H314H411				CLP00
603-079-00-5	"2,2'-(methylimino)diethanol; N-methyldiethanolamine"	203-312-7	105-59-9	Eye Irrit. 2	H319	GHS07Wng	H319				CLP00
603-080-00-0	2-methylaminoethanol; N-methylethanolamine; N-methyl-2-ethanolamine; N-methyl-2-amino ethanol; 2-(methylamino)ethanol	203-710-0	109-83-1	Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1B	H312H302H314	GHS05GHS07Dgr	H312H302H314		STOT SE 3; H335: C ? 5 %		CLP00
603-081-00-6	"2,2'-thiodiethanol; thiodiglycol"	203-874-3	111-48-8	Eye Irrit. 2	H319	GHS07Wng	H319				CLP00
603-082-00-1	1-aminopropan-2-ol; isopropanolamine	201-162-7	78-96-6	Skin Corr. 1B	H314	GHS05Dgr	H314				CLP00
603-083-00-7	"1,1'-iminodipropan-2-ol; di-isopropanolamine"	203-820-9	110-97-4	Eye Irrit. 2	H319	GHS07Wng	H319				CLP00
603-084-00-2	styrene oxide; (epoxyethyl)benzene; phenyloxirane	202-476-7	96-09-3	Carc. 1BAcute Tox. 4 *Eye Irrit. 2	H350H312H319	GHS08GHS07Dgr	H350H312H319				CLP00
603-085-00-8	"bronopol (INN); 2-bromo-2-nitropropane-1,3-diol"	200-143-0	52-51-7	Acute Tox. 4 *Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Dam. 1Aquatic Acute 1	H312H302H335H315H318H400	GHS05GHS07GHS09Dgr	H312H302H335H315H318H400		M=10		CLP00/ATP01
603-086-00-3	ethirimol (ISO); 5-butyl-2-ethylamino-6-methylpyrimidin-4-ol	245-949-3	23947-60-6	Acute Tox. 4 *	H312	GHS07Wng	H312				CLP00
603-087-00-9	"2-ethylhexane-1,3-diol; octylene glycol; ethoexadiol"	202-377-9	94-96-2	Eye Dam. 1	H318	GHS05Dgr	H318				CLP00
603-088-00-4	2-(octylthio)ethanol; 2-hydroxyethyl octyl sulphide	222-598-4	3547-33-9	Eye Dam. 1	H318	GHS05Dgr	H318				CLP00
603-089-00-X	"7,7-dimethyl-3-oxa-6-azaoctan-1-ol"	400-390-6		Acute Tox. 4 *Skin Corr. 1A	H302H314	GHS05GHS07Dgr	H314H302				CLP00
603-090-00-5	2-(2-bromoethoxy)anisole	402-010-4	4463-59-6	Acute Tox. 4 *Aquatic Chronic 3	H302H412	GHS07Wng	H302H412				CLP00
603-091-00-0	exo-1-methyl-4-(1-methylethyl)-7-oxabicyclo[2.2.1]heptan-2-ol	402-470-6	87172-89-2	Acute Tox. 4 *Eye Dam. 1	H302H318	GHS05GHS07Dgr	H302H318				CLP00
603-092-00-6	2-methyl-4-phenylpentanol	402-770-7	92585-24-5	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				CLP00
603-093-00-1	cinmethylin (ISO); exo-(±)-1-methyl-2-(2-methylbenzyloxy)-4-isopropyl-7-oxabicyclo(2.2.1)heptane	402-410-9	87818-31-3	Acute Tox. 4 *Aquatic Chronic 2	H332H411	GHS07GHS09Dgr	H332H411				CLP00
603-094-00-7	"1,3-bis(2,3-epoxypropoxy)-2,2-dimethylpropane"	241-536-7	17557-23-2	Skin Irrit. 2Skin Sens. 1	H315H317	GHS07Wng	H315H317				CLP00
603-095-00-2	2-(propyloxy)ethanol; EGPE	220-548-6	2807-30-9	Acute Tox. 4 *Eye Irrit. 2	H312H319	GHS07Wng	H312H319				CLP00
603-096-00-8	2-(2-butoxyethoxy)ethanol; diethylene glycol monobutyl ether	203-961-6	112-34-5	Eye Irrit. 2	H319	GHS07Wng	H319				CLP00
603-097-00-3	"1,1',1'-nitrilotripropan-2-ol; triisopropanolamine"	204-528-4	122-20-3	Eye Irrit. 2	H319	GHS07Wng	H319				CLP00/ATP05
603-098-00-9	2-phenoxyethanol	204-589-7	122-99-6	Acute Tox. 4 *Eye Irrit. 2	H302H319	GHS07Wng	H302H319				CLP00
603-099-00-4	"3-(N-methyl-N-(4-methylamino-3-nitrophenyl)amino)propane-1,2-diol hydrochloride"	403-440-5	93633-79-5	Acute Tox. 4 *Aquatic Chronic 3	H302H412	GHS07Wng	H302H412				CLP00
603-100-00-8	"1,2-dimethoxypropane"	404-630-0	7778-85-0	Flam. Liq. 2	H225	GHS02Dgr	H225	EUH019			CLP00
603-101-00-3	"tetrahydro-2-isobutyl-4-methylpyran-4-ol, mixed isomers (cis and trans)"	405-040-6		Eye Irrit. 2	H319	GHS07Wng	H319				CLP00
603-102-00-9	"1,2-epoxybutane"	203-438-2	106-88-7	Flam. Liq. 2Carc. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Irrit. 2	H225H351H332H312H302H335H315H319	GHS02GHS08GHS07Dgr	H225H302H312H332H315H319H351H335				CLP00/ATP07
603-103-00-4	"oxirane, mono[(C12-14-alkyloxy)methyl] derivs."	271-846-8	68609-97-2	Skin Irrit. 2Skin Sens. 1	H315H317	GHS07Wng	H315H317				CLP00
603-104-00-X	"fenarimol (ISO); 2,4'-dichloro-?-(pyrimidin-5-yl)benzhydryl alcohol"	262-095-7	60168-88-9	Repr. 2Lact.Aquatic Chronic 2	H361fdH362H411	GHS08GHS09Wng	H361fdH362H411				CLP00
603-105-00-5	furan	203-727-3	110-00-9	Flam. Liq. 1Carc. 1BMuta. 2Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Skin Irrit. 2Aquatic Chronic 3	H224H350H341H332H302H373 **H315H412	GHS02GHS08GHS07Dgr	H224H350H341H332H302H373 **H315H412	EUH019			CLP00
603-106-00-0	2-methoxypropanol	216-455-5	1589-47-5	Flam. Liq. 3Repr. 1BSTOT SE 3Skin Irrit. 2Eye Dam. 1	H226H360D ***H335H315H318	GHS02GHS08GHS05GHS07Dgr	H226H360D ***H335H315H318				CLP00
603-107-00-6	2-(2-methoxyethoxy)ethanol; diethylene glycol monomethyl ether	203-906-6	111-77-3	Repr. 2	H361d ***	GHS08Wng	H361d ***				CLP00
603-108-00-1	2-methylpropan-1-ol; iso-butanol	201-148-0	78-83-1	Flam. Liq. 3STOT SE 3STOT SE 3Skin Irrit. 2Eye Dam. 1	H226H335H336H315H318	GHS02GHS05GHS07Dgr	H226H335H315H318H336				CLP00
603-109-00-7	"reaction mass of: 1-ethoxy-1,1,2,3,3,3-hexafluoro-2-(trifluoromethyl)propane; 1-ethoxy-1,1,2,2,3,3,4,4,4-nonafluorobutane"	425-340-0	-	Aquatic Chronic 4	H413	-	H413				ATP01
603-110-00-2	"reaction mass of: cis-2-isobutyl-5-methyl 1,3-dioxane; trans-2-isobutyl-5-methyl 1,3-dioxane"	426-130-1	166301-21-9	Skin Irrit. 2Aquatic Chronic 3	H315H412	GHS07Wng	H315H412				ATP01
603-111-00-8	"reaction mass of: 1-(1,1-dimethylpropyl)-4-ethoxy-cis-cyclohexane; 1-(1,1-dimethylpropyl)-4-ethoxy-trans-cyclohexane"	426-530-6	-	Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H315H400H410	GHS07GHS09Wng	H315H410				ATP01
603-112-00-3	cyclopentyl 2-phenylethyl ether	428-340-9	-	Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H315H400H410	GHS07GHS09Wng	H315H410				ATP01
603-113-00-9	6-glycidyloxynapht-1-yl oxymethyloxirane	429-960-2	27610-48-6	Muta. 2Acute Tox. 4 *Skin Irrit. 2Skin Sens. 1Aquatic Chronic 3	H341H312H315H317H412	GHS08GHS07Wng	H341H312H315H317H412				ATP01
603-114-00-4	"9-(2-propenyloxy)tricyclo[5.2.1.0(2,6)]dec-3(or-4-)-ene"	430-830-2	26912-64-1	Skin Irrit. 2Aquatic Chronic 2	H315H411	GHS07GHS09Wng	H315H411				ATP01
603-115-00-X	"reaction mass of: O,O',O''-(methylsilanetriyl)tris(4-methyl-2-pentanone oxime) (3 stereoisomers)"	423-580-0	-	STOT RE 2 *Aquatic Chronic 4	H373 **H413	GHS08Wng	H373 **H413				ATP01
603-116-00-5	"(Z)-(2,4-difluorophenyl)piperidin-4-ylmethanone oxime monohydrochloride"	424-740-2	138271-16-6	Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 3	H302H318H412	GHS05GHS07Dgr	H302H318H412				ATP01
603-117-00-0	propan-2-ol; isopropyl alcohol; isopropanol	200-661-7	67-63-0	Flam. Liq. 2STOT SE 3Eye Irrit. 2	H225H336H319	GHS02GHS07Dgr	H225H319H336				CLP00
603-118-00-6	6-dimethylaminohexan-1-ol	404-680-3	1862-07-3	Acute Tox. 4 *Skin Corr. 1BAquatic Chronic 3	H302H314H412	GHS05GHS07Dgr	H302H314H412				CLP00
603-119-00-1	"1,1'-(1,3-phenylenedioxy)bis(3-(2-(prop-2-enyl)phenoxy)propan-2-ol)"	405-840-5		Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410				CLP00
603-120-00-7	2-methyl-5-phenylpentanol	405-890-8	25634-93-9	Skin Irrit. 2Eye Irrit. 2	H315H319	GHS07Wng	H319H315				CLP00
603-121-00-2	"4-[4-(1,3-dihydroxyprop-2-yl)phenylamino]-1,8-dihydroxy-5-nitroanthraquinone"	406-057-1	114565-66-1	Carc. 2Skin Sens. 1Aquatic Chronic 4	H351H317H413	GHS08GHS07Wng	H351H317H413				CLP00
603-122-00-8	sodium 2-ethylhexanolate	406-150-7	38411-13-1	Flam. Sol. 1Skin Corr. 1BAquatic Chronic 3	H228H314H412	GHS02GHS05Dgr	H228H314H412			T	CLP00
603-123-00-3	"4-methyl-8-methylenetricyclo[3.3.1.13,7]decan-2-ol"	406-330-5	122760-84-3	Skin Irrit. 2Skin Sens. 1Aquatic Chronic 2	H315H317H411	GHS07GHS09Wng	H315H317H411				CLP00
603-124-00-9	"1,4-bis[2-(vinyloxy)ethoxy]benzene"	406-900-3	84563-49-5	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
603-125-00-4	"2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)pent-4-en-2-ol"	407-850-5	89544-40-1	Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 2	H302H318H411	GHS05GHS07GHS09Dgr	H302H318H411				CLP00
603-126-00-X	2-((4-methyl-2-nitrophenyl)amino)ethanol	408-090-7	100418-33-5	Acute Tox. 4 *Skin Sens. 1Aquatic Chronic 3	H302H317H412	GHS07Wng	H302H317H412				CLP00
603-127-00-5	butan-2-ol [1](S)-butan-2-ol [2](R)-butan-2-ol [3](±)-butan-2-ol  [4]	201-158-5 [1]224-168-1 [2]238-967-8 [3]240-029-8 [4]	78-92-2 [1]4221-99-2 [2]14898-79-4 [3]15892-23-6 [4]	Flam. Liq. 3STOT SE 3STOT SE 3Eye Irrit. 2	H226H335H336H319	GHS02GHS07Wng	H226H319H335H336			C	CLP00/ATP01
603-128-00-0	2-(phenylmethoxy)naphthalene	405-490-3	613-62-7	Aquatic Chronic 4	H413		H413				CLP00
603-129-00-6	1-tert-butoxypropan-2-ol	406-180-0	57018-52-7	Flam. Liq. 3Eye Dam. 1	H226H318	GHS02GHS05Dgr	H226H318				CLP00
603-130-00-1	reaction mass of isomers of: ?-((dimethyl)biphenyl)-?-hydroxypoly(oxyethylene)	406-325-8		Acute Tox. 4 *Aquatic Chronic 3	H302H412	GHS07Wng	H302H412				CLP00
603-131-00-7	reaction mass of: 1-deoxy-1-[methyl-(1-oxododecyl)amino]-D-glucitol; 1-deoxy-1-[methyl-(1-oxotetradecyl)amino]-D-glucitol (3:1)	407-290-1		Eye Dam. 1	H318	GHS05Dgr	H318				CLP00
603-132-00-2	"2-hydroxymethyl-9-methyl-6-(1-methylethyl)-1,4-dioxaspiro[4.5]decane"	408-200-3	63187-91-7	Skin Irrit. 2Eye Dam. 1Aquatic Chronic 3	H315H318H412	GHS05Dgr	H315H318H412				CLP00
603-133-00-8	"reaction mass of: 3-[(4-amino-2-chloro-5-nitrophenyl)amino]-propane-1,2-diol; 3,3'-(2-chloro-5-nitro-1,4-phenylenediimino)bis(propan-1,2-diol)"	408-240-1		Acute Tox. 4 *Aquatic Chronic 3	H302H412	GHS07Wng	H302H412				CLP00
603-134-00-3	"reaction mass of substituted dodecyl and/or tetradecyl, diphenyl ethers. The substance is produced by the Friedel Crafts reaction. The catalyst is removed from the reaction product. Diphenyl ether is substituted by C1-C10 alkyl groups. The alkyl groups are bonded randomly between C1 and C6. Linear C12 and C14, 50/50 used."	410-450-3		Aquatic Chronic 4	H413		H413				CLP00
603-135-00-9	"bis[[2,2',2''-nitrilotris-[ethanolato]]-1-N,O]-bis[2-(2-methoxyethoxy)ethoxy]-titanium"	410-500-4		Eye Dam. 1Aquatic Chronic 2	H318H411	GHS05GHS09Dgr	H318H411				CLP00
603-136-00-4	3-((4-(bis(2-hydroxyethyl)amino)-2-nitrophenyl)amino)-1-propanol	410-910-3	104226-19-9	Skin Sens. 1Aquatic Chronic 3	H317H412	GHS07Wng	H317H412				CLP00
603-137-00-X	reaction mass of: 1-deoxy-1-[methyl-(1-oxohexadecyl)amino]-D-glucitol; 1-deoxy-1-[methyl-(1-oxooctadecyl)amino]-D-glucitol	411-130-6		Eye Dam. 1	H318	GHS05Dgr	H318				CLP00
603-138-00-5	"3-(2,2-dimethyl-3-hydroxypropyl)toluene; (alt.): 2,2-dimethyl-3-(3-methylphenyl)propanol"	403-140-4	103694-68-4	Aquatic Chronic 3	H412		H412				CLP00
603-139-00-0	bis(2-methoxyethyl) ether	203-924-4	111-96-6	Flam. Liq. 3Repr. 1B	H226H360FD	GHS02GHS08Dgr	H226H360FD	EUH019			CLP00
603-140-00-6	"2,2' -oxybisethanol; diethylene glycol"	203-872-2	111-46-6	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
603-141-00-1	reaction mass of: dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethylethanoxy)]pentadecane; dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethylethanoxy)]heptadecane	413-780-6		Aquatic Chronic 3	H412		H412				CLP00
603-142-00-7	2-(2-(2-hydroxyethoxy)ethyl)-2-aza-bicyclo[2.2.1]heptane	407-360-1	116230-20-7	Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Skin Irrit. 2Eye Dam. 1	H312H302H373 **H315H318	GHS06GHS08GHS05Dgr	H312H302H373 **H315H318				CLP00
603-143-00-2	"R-2,3-epoxy-1-propanol"	404-660-4	57044-25-4	Self-react. C ****Carc. 1BMuta. 2Repr. 1BAcute Tox. 3 *Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1B	H242H350H341H360F ***H331H312H302H314	GHS02GHS06GHS08GHS05Dgr	H242H350H341H360F ***H331H312H302H314				CLP00
603-144-00-8	"reaction mass of: 2,6,9-trimethyl-2,5,9-cyclododecatrien-1-ol; 6,9-dimethyl-2-methylen-5,9-cyclododecadien-1-ol"	413-530-6	111850-00-1	Aquatic Chronic 2	H411	GHS09	H411				CLP00
603-145-00-3	"2-isopropyl-2-(1-methylbutyl)-1,3-dimethoxypropane"	406-970-5	129228-11-1	Skin Irrit. 2Aquatic Chronic 2	H315H411	GHS07GHS09Wng	H315H411				CLP00
603-146-00-9	2-[(2-[2-(dimethylamino)ethoxy]ethyl)methylamino]ethanol	406-080-7	83016-70-0	Acute Tox. 4 *Skin Corr. 1BAquatic Chronic 3	H302H314H412	GHS05GHS07Dgr	H302H314H412				CLP00
603-147-00-4	(-)-trans-4-(4'-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine	406-030-4	105812-81-5	Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 2	H302H318H411	GHS05GHS07GHS09Dgr	H302H318H411				CLP00
603-148-00-X	"1,4-bis[(vinyloxy)methyl]cyclohexane"	413-370-7	17351-75-6	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				CLP00
603-149-00-5	reaction mass of diastereoisomers of 1-(1-hydroxyethyl)-4-(1-methylethyl)cyclohexane	407-640-3	63767-86-2	Skin Irrit. 2Eye Irrit. 2Aquatic Chronic 2	H315H319H411	GHS07GHS09Wng	H319H315H411				CLP00
603-150-00-0	"(±) trans-3,3-dimethyl-5-(2,2,3-trimethyl-cyclopent-3-en-1-yl)-pent-4-en-2-ol"	411-580-3	107898-54-4	Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H315H400H410	GHS07GHS09Wng	H315H410				CLP00
603-151-00-6	"(±)-2-(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-1-ol"	413-570-4		Aquatic Chronic 3	H412		H412				CLP00
603-152-00-1	2-(4-tert-butylphenyl)ethanol	410-020-5	5406-86-0	Repr. 2STOT RE 2 *Eye Dam. 1Aquatic Chronic 2	H361f ***H373 **H318H411	GHS08GHS05GHS09Dgr	H361f ***H373 **H318H411				CLP00
603-153-00-7	"3-((2-nitro-4-(trifluoromethyl)phenyl)amino)propane-1,2-diol"	410-010-0	104333-00-8	Acute Tox. 4 *Aquatic Chronic 3	H302H412	GHS07Wng	H302H412				CLP00
603-154-00-2	1-[(2-tert-butyl)cyclohexyloxy]-2-butanol	412-300-2	139504-68-0	Aquatic Chronic 2	H411	GHS09	H411				CLP00
603-156-00-3	"2-(2,4-dichlorophenyl)-2-(2-propenyl)oxirane"	411-210-0	89544-48-9	Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H315H317H400H410	GHS07GHS09Wng	H315H317H410				CLP00
603-157-00-9	"6,9-bis(hexadecyloxymethyl)-4,7-dioxanonane-1,2,9-triol"	411-450-6	143747-72-2	Aquatic Chronic 4	H413		H413				CLP00
603-158-00-4	"reaction mass of 4 diastereoisomers of 2,7-dimethyl-10-(1-methylethyl)-1-oxaspiro[4.5]deca-3,6-diene"	412-460-3		Skin Irrit. 2Aquatic Chronic 2	H315H411	GHS07GHS09Wng	H315H411				CLP00
603-159-00-X	2-cyclododecylpropan-1-ol	411-410-8	118562-73-5	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
603-160-00-5	"1,2-diethoxypropane"	412-180-1	10221-57-5	Flam. Liq. 2	H225	GHS02Dgr	H225	EUH019			CLP00
603-161-00-0	"1,3-diethoxypropane"	413-140-6	3459-83-4	Flam. Liq. 3	H226	GHS02Wng	H226				CLP00
603-162-00-6	"?[2-[[[(2-hydroxyethyl)methylamino]acetyl]amino]propyl]-?-(nonylphenoxy)poly[oxo(methyl-1,2-ethanediyl)]"	413-420-8	144736-29-8	Skin Corr. 1BSkin Sens. 1Aquatic Chronic 2	H314H317H411	GHS05GHS07GHS09Dgr	H314H317H411				CLP00
603-163-00-1	"2-phenyl-1,3-propanediol"	411-810-2	1570-95-2	Eye Dam. 1	H318	GHS05Dgr	H318				CLP00
603-164-00-7	"2-butyl-4-chloro-4,5-dihydro-5-hydroxymethyl-1-[2'-(2-triphenylmethyl-1,2,3,4-2H-tetrazol-5-yl)-1,1'-biphenyl-4-methyl]-1H-imidazole"	412-420-5	133909-99-6	Aquatic Chronic 4	H413		H413				CLP00
603-165-00-2	"reaction mass of: 4-allyl-2,6-bis(2,3-epoxypropyl)phenol; 4-allyl-6-[3-[6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol; 4-allyl-6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol; 4-allyl-6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol"	417-470-1		Muta. 2Skin Sens. 1	H341H317	GHS08GHS07Wng	H341H317				CLP00
603-166-00-8	"R-1-chloro-2,3-epoxypropane"	424-280-2	51594-55-9	Flam. Liq. 3Carc. 1BAcute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Skin Corr. 1BSkin Sens. 1	H226H350H331H311H301H314H317	GHS02GHS06GHS08GHS05Dgr	H226H350H331H311H301H314H317				CLP00
603-167-00-3	"3,3',5,5'-tetra-tert-butylbiphenyl-2,2'-diol"	407-920-5	6390-69-8	Aquatic Chronic 4	H413	GHS05Dgr	H413				CLP00
603-168-00-9	"3-(2-ethylhexyloxy)propane-1,2-diol"	408-080-2	70445-33-9	Eye Dam. 1Aquatic Chronic 3	H318H412	GHS05Dgr	H318H412				CLP00
603-169-00-4	(±)-trans-4-(4-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine	415-550-0	109887-53-8	Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 2	H302H318H411	GHS05GHS07GHS09Dgr	H302H318H411				CLP00
603-170-00-X	reaction mass of: 2-methyl-1-(6-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol; 2-methyl-1-(1-methylbicyclo[2.2.1]hept-5-en-2-yl)-pent-1-en-3-ol; 2-methyl-1-(5-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol	415-990-3	67739-11-1	Eye Irrit. 2Aquatic Chronic 2	H319H411	GHS07GHS09Wng	H319H411				CLP00
603-171-00-5	5-thiazolylmethanol	414-780-9	38585-74-9	Eye Dam. 1Aquatic Chronic 3	H318H412	GHS05Dgr	H318H412				CLP00
603-172-00-0	"mono-2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl)piperazinium-1-yl]ethoxy)ethanol trans-butenedioate"	415-180-1	773058-82-5	Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 2	H302H318H411	GHS05GHS07GHS09Dgr	H302H318H411				CLP00
603-173-00-6	"4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]octane"	421-750-9	57280-22-5	Eye Irrit. 2Skin Sens. 1	H319H317	GHS07Wng	H319H317				CLP00
603-174-00-1	4-cyclohexyl-2-methyl-2-butanol	420-630-3	83926-73-2	Eye Dam. 1Aquatic Chronic 2	H318H411	GHS05GHS09Dgr	H318H411				CLP00
603-175-00-7	"2-(2-hexyloxyethoxy)ethanol; DEGHE; diethylene glycol monohexyl ether; 3,6-dioxa-1-dodecanol; hexyl carbitol; 3,6-dioxadodecan-1-ol"	203-988-3	112-59-4	Acute Tox. 4 *Eye Dam. 1	H312H318	GHS05GHS07Dgr	H312H318				CLP00
603-176-00-2	"1,2-bis(2-methoxyethoxy)ethane; TEGDME; triethylene glycol dimethyl ether; triglyme"	203-977-3	112-49-2	Repr. 1B	H360Df	GHS08Dgr	H360Df	EUH019			CLP00
603-177-00-8	1-ethoxypropan-2-ol; 2PG1EE; 1-ethoxy-2-propanol; propylene glycol monoethyl ether [1]2-ethoxy-1-methylethyl acetate; 2PG1EEA  [2]	216-374-5 [1]259-370-9 [2]	1569-02-4 [1]54839-24-6 [2]	Flam. Liq. 3STOT SE 3	H226H336	GHS02GHS07Wng	H226H336				CLP00
603-178-00-3	2-hexyloxyethanol; ethylene glycol monohexyl ether; n-hexylglycol	203-951-1	112-25-4	Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1B	H312H302H314	GHS05GHS07Dgr	H312H302H314				CLP00
603-179-00-9	ergocalciferol (ISO); Vitamin D2	200-014-9	50-14-6	Acute Tox. 2 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 1	H330H311H301H372 **	GHS06GHS08Dgr	H330H311H301H372 **				CLP00
603-180-00-4	colecalciferol; Vitamin D3	200-673-2	67-97-0	Acute Tox. 2 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 1	H330H311H301H372 **	GHS06GHS08Dgr	H330H311H301H372 **				CLP00
603-181-00-X	tert-butyl methyl ether; MTBE; 2-methoxy-2-methylpropane	216-653-1	1634-04-4	Flam. Liq. 2Skin Irrit. 2	H225H315	GHS02GHS07Dgr	H225H315				CLP00
603-182-00-5	"reaction product of: saturated, monounsaturated and multiple unsaturated long-chained partly estrified alcohols of vegetable origin (Brassica napus L., Brassica rapa L., Helianthus annuus L., Glycine hispida, Gossypium hirsutum L., Cocos nucifera L., Elaeis guineensis) with O,O-diisobutyldithiophosphate and 2-ethylhexylamine and hydrogen peroxide"	428-630-5	-	Skin Sens. 1	H317	GHS07Wng	H317				ATP01
603-183-00-0	2-[2-(2-butoxyethoxy)ethoxy]ethanol; TEGBE; triethylene glycol monobutyl ether; butoxytriethylene glycol	205-592-6	143-22-6	Eye Dam. 1	H318	GHS05Dgr	H318		Eye Dam. 1; H318: C ? 30 %Eye Irrit. 2; H319: 20 % ? C < 30 %		CLP00
603-184-00-6	"2-(hydroxymethyl)-2-[[2-hydroxy-3-(isooctadecyloxy)propoxy]methyl]-1,3-propanediol"	416-380-1	146925-83-9	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
603-185-00-1	"2,4-dichloro-3-ethyl-6-nitrophenol"	420-740-1	99817-36-4	Acute Tox. 3 *Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H301H318H317H400H410	GHS06GHS05GHS09Dgr	H301H318H317H410				CLP00
603-186-00-7	"trans-(5RS,6SR)-6-amino-2,2-dimethyl-1,3-dioxepan-5-ol"	419-050-3	79944-37-9	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
603-187-00-2	"2-((4,6-bis(4-(2-(1-methylpyridinium-4-yl)vinyl)phenylamino)-1,3,5-triazin-2-yl)(2-hydroxyethyl)amino)ethanol dichloride"	419-360-9	163661-77-6	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
603-188-00-8	"reaction mass of: 6,7-epoxy-1,2,3,4,5,6,7,8-octahydro-1,1,2,4,4,7-hexamethylnaphthalene; 7,8-epoxy-1,2,3,4,6,7,8,8a-octahydro-1,1,2,4,4,7-hexamethylnaphthalene"	426-970-9	-	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				ATP01
603-189-00-3	"reaction mass of complexes of: titanium, 2,2'-oxydiethanol, ammonium lactate, nitrilotris(2-propanol) and ethylene glycol"	405-250-8		Aquatic Chronic 2	H411	GHS09	H411				CLP00
603-190-00-9	"8,8-dimethyl-7-isopropyl-6,10-dioxaspiro[4.5]decane"	424-030-2	62406-73-9	Skin Irrit. 2Aquatic Chronic 3	H315H412	GHS07Wng	H315H412				ATP01
603-191-00-4	"2-(4,6-bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl)-5-(3-((2-ethylhexyl)oxy)-2-hydroxypropoxy)phenol"	419-740-4	137658-79-8	Aquatic Chronic 4	H413		H413				CLP00
603-192-00-X	"(E,E)-3,7,11-trimethyldodeca-1,4,6,10-tetraen-3-ol"	423-240-1	125474-34-2	Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H315H318H317H400H410	GHS05GHS07GHS09Dgr	H315H318H317H410				ATP01
603-193-00-5	"disodium 9,10-anthracenedioxide"	426-030-8	46492-07-3	Skin Corr. 1A	H314	GHS05Dgr	H314				ATP01
603-194-00-0	2-(2-aminoethylamino)ethanol; (AEEA)	203-867-5	111-41-1	Repr. 1BSkin Corr. 1BSkin Sens. 1	H360DfH314H317	GHS05GHS08GHS07Dgr	H314H317H360Df		STOT SE 3; H335: C = 5 %		ATP01/ATP01corr
603-195-00-6	"2-[4-(4-methoxyphenyl)-6-phenyl-1,3,5-triazin-2-yl]-phenol"	430-810-3	154825-62-4	Aquatic Chronic 3	H412		H412				CLP00
603-196-00-1	2-(7-ethyl-1H-indol-3-yl)ethanol	431-020-1	41340-36-7	Acute Tox. 4 *STOT RE 2 *Aquatic Chronic 2	H302H373 **H411	GHS08GHS07GHS09Wng	H302H373 **H411				CLP00
603-197-00-7	"tebuconazole (ISO); 1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol"	403-640-2	107534-96-3	Repr. 2Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H361d ***H302H400H410	GHS08GHS07GHS09Wng	H302H361d ***H410		M=1M=10		CLP00/ATP07
603-199-00-8	"etoxazol (ISO); (RS)-5-tert-butyl-2-[2-(2,6-difluorophenyl)-4,5-dihydro-1,3-oxazol-4-yl]phenetole"		153233-91-1	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410		M=100		CLP00
603-200-00-1	1-pentanol [1]3-pentanol  [2]	200-752-1 [1]209-526-7 [2]	71-41-0 [1]584-02-1 [2]	Flam. Liq. 3Acute Tox. 4 *STOT SE 3Skin Irrit. 2	H226H332H335H315	GHS02GHS07Wng	H226H332H335H315				ATP01
603-201-00-7	"(E)-(7R,11R)-3,7,11,15-tetramethylhexadec-2-ene-1-ol"	416-120-5	-	Skin Irrit. 2Aquatic Chronic 4	H315H413	GHS07Wng	H315H413				ATP01
603-202-00-2	"4,4,5,5,5-pentafluoropentan-1-ol"	421-360-9	148043-73-6	Acute Tox. 4 *Aquatic Chronic 3	H302H412	GHS07Wng	H302H412				ATP01
603-203-00-8	"(1R,3S,7R,8R,10R,13R)-5,5,7,9,9,13-hexamethyl-4,6-dioxatetracyclo[6.5.1.01,10.03,7]tetradecane"	427-580-1	-	Skin Irrit. 2	H315	GHS07Wng	H315				ATP01
603-204-00-3	"reaction mass of: 2,2'-(heptane-1,7-diyl)bis-1,3-dioxolane; 2,2'-(heptane-1,6-diyl)bis-1,3-dioxolane"	428-110-8	-	Aquatic Chronic 3	H412	-	H412				ATP01
603-205-00-9	(1S-cis)-4-(2-amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-methanol hydrochloride	426-200-1	172015-79-1	Acute Tox. 4 *STOT RE 1Eye Dam. 1Skin Sens. 1Aquatic Chronic 3	H302H372 **H318H317H412	GHS05GHS08GHS07Dgr	H372 **H302H318H317H412				ATP01
603-206-00-4	"2,2-dichloro-1,3-benzodioxol"	426-850-6	2032-75-9	Flam. Liq. 3Acute Tox. 4 *Skin Corr. 1ASkin Sens. 1	H226H302H314H317	GHS02GHS05GHS07Dgr	H226H314H302H317	EUH014			ATP01
603-207-00-X	"2-isobutyl-2-isopropyl-1,3-dimethoxypropane"	430-800-9	129228-21-3	Skin Irrit. 2Aquatic Chronic 2	H315H411	GHS07GHS09Wng	H315H411				ATP01
603-208-00-5	"1,2-diethoxyethane"	211-076-1	629-14-1	Flam. Liq. 2Repr. 1AEye Irrit. 2	H225H360DfH319	GHS02GHS08GHS07Dgr	H225H360DfH319	EUH019			ATP01
603-209-00-0	"spinosad (ISO) (reaction mass of spinosyn A and spinosyn D in ratios between 95:5 to 50:50); reaction mass of 50-95% of (2R,3aS,5aR,5bS,9S,13S,14R,16aS,16bR)-2-(6-deoxy-2,3,4-tri-O-methyl-?-.sc.l.sc.-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-?-.sc.d.sc.-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-14-methyl-1H-8-oxacyclododeca[b]as-indacene-7,15-dione and 50-5% (2S,3aR,5aS,5bS,9S,13S,14R,16aS,16bS)-2-(6-deoxy-2,3,4-tri-O-methyl-?-.sc.l.sc.-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-?-.sc.d.sc.-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-4,14-dimethyl-1H-8-oxacyclododeca[b]as-indacene-7,15-dione [1]spinosyn A [2]spinosyn D  [3]"		131929-60-7 [2]131929-63-0 [3]	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410		M=10		ATP01
603-210-00-6	"2,4-diethyl-1,5-pentanediol"	429-310-8	57987-55-0	Eye Dam. 1	H318	GHS05Dgr	H318				ATP01
603-211-00-1	"2,3-epoxypropyltrimethylammonium chloride ...%; glycidyl trimethylammonium chloride ...%"	221-221-0	3033-77-0	Carc. 1BMuta. 2Repr. 2Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Eye Dam. 1Skin Sens. 1Aquatic Chronic 3	H350H341H361f ***H312H302H373 **H318H317H412	GHS05GHS08GHS07Dgr	H350H341H361f ***H312H302H373 **H318H317H412			B	ATP01
603-212-00-7	"1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6-c]pyran; galaxolide; (HHCB)"	214-946-9	1222-05-5	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				ATP01
603-213-00-2	2-methoxy-2-methylbutane; tert-amyl methyl ether	213-611-4	994-05-8	Flam. Liq. 2Acute Tox. 4 *STOT SE 3	H225H302H336	GHS02GHS07Dgr	H225H302H336				ATP01
603-214-00-8	"1,1-diisopropoxycyclohexane"	413-740-8	1132-95-2	Skin Corr. 1B	H314	GHS05Dgr	H314				ATP01
603-215-00-3	"1-hydroxy-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate)"	418-330-2	162241-33-0	Expl. 1.1 ****Acute Tox. 4 *STOT RE 2 *Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H201H302H373 **H318H317H400H410	GHS01GHS05GHS08GHS07GHS09Dgr	H201H302H373 **H318H317H410				ATP01
603-216-00-9	"cis-1-amino-2,3-dihydro-1H-inden-2-ol"	422-660-2	7480-35-5	Eye Dam. 1Skin Sens. 1Aquatic Chronic 3	H318H317H412	GHS05GHS07Dgr	H318H317H412				ATP01
603-217-00-4	"2,4,6-tri-tert-butylphenyl 2-butyl-2-ethyl-1,3-propanediolphosphite"	423-560-1	161717-32-4	Skin Sens. 1Aquatic Chronic 4	H317H413	GHS07Wng	H317H413				ATP01
603-220-00-0	1-{benzyl[2-(2-methoxyphenoxy)ethyl]amino}-3-(9H-carbazol-4-yloxy)propan-2-ol	432-890-5	72955-94-3	Aquatic Chronic 4	H413	-	H413				ATP01
603-221-00-6	"1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride; [containing < 0.1 % 4-chloroaniline (EC No 203-401-0)]"	433-580-2	214353-17-0	Acute Tox. 4 *Skin Corr. 1BAquatic Chronic 2	H302H314H411	GHS05GHS07GHS09Dgr	H302H314H411				ATP01
603-221-01-3	"1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride; [containing ? 0.1 % 4-chloroaniline (EC No 203-401-0)]"	433-580-2	214353-17-0	Carc. 1BAcute Tox. 4 *Skin Corr. 1BAquatic Chronic 2	H350H302H314H411	GHS05GHS08GHS07GHS09Dgr	H350H302H314H411				ATP01
603-222-00-1	"(2R,3S,4R,5R,7R,9R,10R,11S,12S,13R)-10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-1-oxacyclotetradecane"	433-820-6	118058-74-5	Eye Irrit. 2	H319	GHS07Wng	H319				ATP01
603-223-00-7	"2-cyclopentylidene cyclopentanol; 1,1'-bi(cyclopentyliden)-2-ol"	434-270-1	6261-30-9	Skin Irrit. 2Eye Dam. 1Aquatic Chronic 3	H315H318H412	GHS05Dgr	H315H318H412				ATP01
603-224-00-2	"3-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluoro-2-(trifluoromethyl)-hexane"	435-790-1	297730-93-9	Aquatic Chronic 4	H413	-	H413				ATP01
603-225-00-8	"erythromycin A9-oxime (E); (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-((2,6-didesoxy-3-C-methyl-3-O-methyl-?-L-ribo-hexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-?-.sc.d.sc.-xylohexapiranosyl)oxy)oxacyclotetradecan-2-ona-10-oxime (E)"	437-070-0	13127-18-9	Aquatic Chronic 2	H411	GHS09	H411				ATP01
603-226-00-3	"4,4'(4-(4-methoxyphenyl)-1,3,5-triazin-2,4-diyl)bisbenzene-1,3-diol"	444-500-0	1440-00-2	Aquatic Chronic 3	H412	-	H412				ATP01
603-227-00-9	"?-hydro-?-[[[(1,1-dimethylethyl)dioxy]carbonyl]oxy]-poly[oxy(methyl-1,2-ethanediyl)] ether with 2,2-bis(hydroxymethyl)-1,3-propanediol (4:1); reaction product of: ?-hydro-?-((chlorocarbonyl)oxy)-poly(oxy(methyl-1,2-ethanediyl)) ether with 2,2-bis(hydroxymethyl)-1,3-propanediol with potassium 1,1-dimethylethylperoxalate"	445-060-2	203574-04-3	****Aquatic Acute 1Aquatic Chronic 1	****H400H410	****GHS09Wng	****H410				ATP01
603-228-00-4	"(+/-)-(R*,R*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran; 6-fluoro-2-(2-oxiranyl)chromane"	419-620-1	-	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				ATP01
603-229-00-X	sodium (Z)-3-chloro-3-(4-chlorophenyl)-1-hydroxy-2-propene-1-sulfonate	420-800-7	-	Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H315H318H317H400H410	GHS05GHS07GHS09Dgr	H315H318H317H410				ATP01
603-230-00-5	"2,6,6,7,8,8-hexamethyldecahydro-2H-indeno[4,5-b]furan"	440-030-5	-	Skin Irrit. 2Eye Dam. 1Aquatic Chronic 4	H315H318H413	GHS05Dgr	H315H318H413				ATP01
603-231-00-0	"(S)-1,1-diphenyl-1,2-propanediol"	443-220-6	-	Aquatic Chronic 3	H412	-	H412				ATP01
603-232-00-6	"3,3,8,8,10,10-hexamethyl-9-[1-(4-oxiranylmethoxy-phenyl)-ethoxy]-1,5-dioxa-9-aza-spiro[5.5]undecane"	444-420-6	-	Aquatic Chronic 4	H413	-	H413				ATP01
603-233-00-1	"reaction mass of: 4-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol; 4-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol; 1-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol; 1-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol; (E)-4-(3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol; (E)-4-(3a,4,5,6,7,7a-hexahydro-3H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol"	444-430-0	-	Aquatic Chronic 2	H411	GHS09	H411				ATP01
603-234-00-7	"(1R,4R)-4-methoxy-2,2,7,7-tetramethyltricyclo(6.2.1.0(1,6))undec-5-ene"	444-480-3	-	Skin Irrit. 2Aquatic Chronic 2	H315H411	GHS07GHS09Wng	H315H411				ATP01
604-001-00-2	phenol; carbolic acid; monohydroxybenzene; phenylalcohol	203-632-7	108-95-2	Muta. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Skin Corr. 1B	H341H331H311H301H373 **H314	GHS06GHS08GHS05Dgr	H341H331H311H301H373 **H314		*Skin Corr. 1B; H314: C ? 3 %Skin Irrit. 2; H315: 1 % ? C < 3 %Eye Irrit. 2; H319: 1 % ? C < 3 %		CLP00
604-002-00-8	pentachlorophenol	201-778-6	87-86-5	Carc. 2Acute Tox. 2 *Acute Tox. 3 *Acute Tox. 3 *STOT SE 3Skin Irrit. 2Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H351H330H311H301H335H315H319H400H410	GHS06GHS08GHS09Dgr	H351H330H311H301H319H335H315H410				CLP00
604-003-00-3	sodium pentachlorophenolate [1]potassium pentachlorophenolate  [2]	205-025-2 [1]231-911-3 [2]	131-52-2 [1]7778-73-6 [2]	Carc. 2Acute Tox. 2 *Acute Tox. 3 *Acute Tox. 3 *STOT SE 3Skin Irrit. 2Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H351H330H311H301H335H315H319H400H410	GHS06GHS08GHS09Dgr	H351H330H311H301H319H335H315H410				CLP00
604-004-00-9	m-cresol [1]o-cresol [2]p-cresol [3]mix-cresol  [4]	203-577-9 [1]202-423-8 [2]203-398-6 [3]215-293-2 [4]	108-39-4 [1]95-48-7 [2]106-44-5 [3]1319-77-3 [4]	Acute Tox. 3 *Acute Tox. 3 *Skin Corr. 1B	H311H301H314	GHS06GHS05Dgr	H311H301H314		*	C	CLP00
604-005-00-4	"1,4-dihydroxybenzene; hydroquinone; quinol"	204-617-8	123-31-9	Carc. 2Muta. 2Acute Tox. 4 *Eye Dam. 1Skin Sens. 1Aquatic Acute 1	H351H341H302H318H317H400	GHS05GHS08GHS07GHS09Dgr	H351H341H302H318H317H400		M=10		CLP00/ATP01
604-006-00-X	"3,4-xylenol [1]2,5-xylenol [2]2,4-xylenol [3]2,3-xylenol [4]2,6-xylenol [5]xylenol [6]2,4(or 2,5)-xylenol  [7]"	202-439-5 [1]202-461-5 [2]203-321-6 [3]208-395-3 [4]209-400-1 [5]215-089-3 [6]276-245-4 [7]	95-65-8 [1]95-87-4 [2]105-67-9 [3]526-75-0 [4]576-26-1 [5]1300-71-6 [6]71975-58-1 [7]	Acute Tox. 3 *Acute Tox. 3 *Skin Corr. 1BAquatic Chronic 2	H311H301H314H411	GHS06GHS05GHS09Dgr	H311H301H314H411			C	CLP00
604-007-00-5	2-naphthol	205-182-7	135-19-3	Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1	H332H302H400	GHS07GHS09Wng	H332H302H400				CLP00
604-008-00-0	2-chlorophenol [1]4-chlorophenol [2]3-chlorophenol [3]chlorophenol  [4]	202-433-2 [1]203-402-6 [2]203-582-6 [3]246-691-4 [4]	95-57-8 [1]106-48-9 [2]108-43-0 [3]25167-80-0 [4]	Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Chronic 2	H332H312H302H411	GHS07GHS09Wng	H332H312H302H411			C	CLP00
604-009-00-6	"pyrogallol; 1,2,3-trihydroxybenzene"	201-762-9	87-66-1	Muta. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Chronic 3	H341H332H312H302H412	GHS08GHS07Wng	H341H332H312H302H412		*		CLP00
604-010-00-1	"resorcinol; 1,3-benzenediol"	203-585-2	108-46-3	Acute Tox. 4 *Skin Irrit. 2Eye Irrit. 2Aquatic Acute 1	H302H315H319H400	GHS07GHS09Wng	H302H319H315H400		*		CLP00
604-011-00-7	"2,4-dichlorophenol"	204-429-6	120-83-2	Acute Tox. 3 *Acute Tox. 4 *Skin Corr. 1BAquatic Chronic 2	H311H302H314H411	GHS06GHS05GHS09Dgr	H311H302H314H411				CLP00
604-012-00-2	4-chloro-o-cresol; 4-chloro-2-methyl phenol	216-381-3	1570-64-5	Acute Tox. 3 *Skin Corr. 1AAquatic Acute 1	H331H314H400	GHS06GHS05GHS09Dgr	H331H314H400		STOT SE 3; H335: C ? 1 %		CLP00
604-013-00-8	"2,3,4,6-tetrachlorophenol"	200-402-8	58-90-2	Acute Tox. 3 *Skin Irrit. 2Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H301H315H319H400H410	GHS06GHS09Dgr	H301H319H315H410		*Eye Irrit. 2; H319: C ? 5 %Skin Irrit. 2; H315: C ? 5 %		CLP00
604-014-00-3	chlorocresol; 4-chloro-m-cresol; 4-chloro-3-methylphenol	200-431-6	59-50-7	Acute Tox. 4 *Acute Tox. 4 *Eye Dam. 1Skin Sens. 1Aquatic Acute 1	H312H302H318H317H400	GHS05GHS07GHS09Dgr	H312H302H318H317H400		*		CLP00
604-015-00-9	"2,2'-methylenebis-(3,4,6-trichlorophenol); hexachlorophene"	200-733-8	70-30-4	Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H311H301H400H410	GHS06GHS09Dgr	H311H301H410		*		CLP00
604-016-00-4	"1,2-dihydroxybenzene; pyrocatechol"	204-427-5	120-80-9	Acute Tox. 4 *Acute Tox. 4 *Skin Irrit. 2Eye Irrit. 2	H312H302H315H319	GHS07Wng	H312H302H319H315				CLP00
604-017-00-X	"2,4,5-trichlorophenol"	202-467-8	95-95-4	Acute Tox. 4 *Skin Irrit. 2Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H302H315H319H400H410	GHS07GHS09Wng	H302H319H315H410		*Eye Irrit. 2; H319: C ? 5 %Skin Irrit. 2; H315: C ? 5 %		CLP00
604-018-00-5	"2,4,6-trichlorophenol"	201-795-9	88-06-2	Carc. 2Acute Tox. 4 *Skin Irrit. 2Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H351H302H315H319H400H410	GHS08GHS07GHS09Wng	H351H302H319H315H410				CLP00
604-019-00-0	dichlorophen (ISO)	202-567-1	97-23-4	Acute Tox. 4 *Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H302H319H400H410	GHS07GHS09Wng	H302H319H410				CLP00
604-020-00-6	2-phenylphenol (ISO); biphenyl-2-ol; 2-hydroxybiphenyl	201-993-5	90-43-7	STOT SE 3Skin Irrit. 2Eye Irrit. 2Aquatic Acute 1	H335H315H319H400	GHS07GHS09Wng	H319H335H315H400				CLP00
604-021-00-1	"sodium 2-biphenylate; 2-phenylphenol, sodium salt"	205-055-6	132-27-4	Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Dam. 1Aquatic Acute 1	H302H335H315H318H400	GHS05GHS07GHS09Wng	H302H335H315H318H400				CLP00
604-022-00-7	"2,2-dimethyl-1,3-benzodioxol-4-ol"	400-900-7	22961-82-6	Eye Dam. 1	H318	GHS05Dgr	H318				CLP00
604-023-00-2	"2,4-dichloro-3-ethylphenol"	401-060-4		Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1	H314H400H410	GHS05GHS09Dgr	H314H410				CLP00
604-024-00-8	"4,4-isobutylethylidenediphenol"	401-720-1	6807-17-6	Repr. 1BEye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H360F ***H319H400H410	GHS08GHS09Dgr	H360F ***H319H410				CLP00
604-025-00-3	"2,5-bis(1,1-dimethylbutyl)hydroquinone"	400-220-0		Aquatic Chronic 2	H411	GHS09	H411				CLP00
604-026-00-9	"2,2-spirobi(6-hydroxy-4,4,7-trimethylchromane)"	400-270-3		Aquatic Chronic 2	H411	GHS09	H411				CLP00
604-027-00-4	"2-methyl-5-(1,1,3,3-tetramethylbutyl)hydroquinone"	400-530-6		Eye Dam. 1Skin Sens. 1Aquatic Chronic 2	H318H317H411	GHS05GHS07GHS09Dgr	H318H317H411				CLP00
604-028-00-X	4-amino-3-fluorophenol	402-230-0	399-95-1	Carc. 1BAcute Tox. 4 *Skin Sens. 1Aquatic Chronic 2	H350H302H317H411	GHS08GHS07GHS09Dgr	H350H302H317H411				CLP00
604-029-00-5	1-naphtol	201-969-4	90-15-3	Acute Tox. 4 *Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Dam. 1	H312H302H335H315H318	GHS05GHS07Dgr	H312H302H335H315H318				CLP00
604-030-00-0	"bisphenol A; 4,4’-isopropylidenediphenol"	201-245-8	80-05-7	Repr. 2STOT SE 3Eye Dam. 1Skin Sens. 1	H361f ***H335H318H317	GHS05GHS08GHS07Dgr	H318H317H361f ***H335				CLP00/ATP01corr
604-031-00-6	guaiacol	201-964-7	90-05-1	Acute Tox. 4 *Skin Irrit. 2Eye Irrit. 2	H302H315H319	GHS07Wng	H302H319H315				CLP00
604-032-00-1	thymol	201-944-8	89-83-8	Acute Tox. 4 *Skin Corr. 1BAquatic Chronic 2	H302H314H411	GHS05GHS07GHS09Dgr	H302H314H411				CLP00
604-033-00-7	isobutyl but-3-enoate	401-170-2	24342-03-8	Flam. Liq. 3	H226	GHS02Wng	H226				CLP00
604-034-00-2	"4,4'-thiodi-o-cresol"	403-330-7	24197-34-0	Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H318H400H410	GHS05GHS09Dgr	H318H410				CLP00
604-035-00-8	"4-nonylphenol, reaction products with formaldehyde and dodecane-1-thiol"	404-160-6		Skin Sens. 1Aquatic Chronic 4	H317H413	GHS07Wng	H317H413				CLP00
604-036-00-3	"4,4'-oxybis(ethylenethio)diphenol"	404-590-4	90884-29-0	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				CLP00
604-037-00-9	"3,5-xylenol; 3,5-dimethylphenol"	203-606-5	108-68-9	Acute Tox. 3 *Acute Tox. 3 *Skin Corr. 1B	H311H301H314	GHS06GHS05Dgr	H311H301H314				CLP00
604-038-00-4	"4-chloro-3,5-dimethylphenol [1]chloroxylenol  [2]"	201-793-8 [1]215-316-6 [2]	88-04-0 [1]1321-23-9 [2]	Acute Tox. 4 *Skin Irrit. 2Eye Irrit. 2Skin Sens. 1	H302H315H319H317	GHS07Wng	H302H319H315H317				CLP00
604-039-00-X	ethyl 2-[4-[(6-chlorobenzoxazol-2-yl)oxy]phenoxy]propionate; fenoxaprop-ethyl	266-362-9	66441-23-4	Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410				CLP00
604-040-00-5	fomesafen (ISO); 5-[2-chloro-4-(trifluoromethyl)phenoxy]-N-(methylsulphonyl)-2-nitrobenzamide	276-439-9	72178-02-0	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
604-041-00-0	acifluorfen (ISO); 5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoic acid  [1]sodium 5-[2-chloro-4-(trifluoromethyl) phenoxy]-2-nitrobenzoate; acifluorfen-sodium  [2]	256-634-5 [1]263-560-7 [2]	50594-66-6 [1]62476-59-9 [2]	Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H302H315H318H400H410	GHS05GHS07GHS09Dgr	H302H315H318H410				CLP00
604-042-00-6	4-nitrosophenol	203-251-6	104-91-6	Muta. 2Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 2	H341H302H318H411	GHS08GHS05GHS07GHS09Dgr	H341H302H318H411				CLP00
604-043-00-1	monobenzone; 4-hydroxyphenyl benzyl ether; hydroquinone monobenzyl ether	203-083-3	103-16-2	Eye Irrit. 2Skin Sens. 1	H319H317	GHS07Wng	H319H317				CLP00
604-044-00-7	mequinol; 4-methoxyphenol; hydroquinone monomethyl ether	205-769-8	150-76-5	Acute Tox. 4 *Eye Irrit. 2Skin Sens. 1	H302H319H317	GHS07Wng	H302H319H317				CLP00
604-045-00-2	"2,3,5-trimethylhydroquinone"	211-838-3	700-13-0	Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H332H335H315H318H317H400H410	GHS05GHS07GHS09Dgr	H332H335H315H318H317H410				CLP00
604-046-00-8	4-(4-isopropoxyphenylsulfonyl)phenol	405-520-5	95235-30-6	Aquatic Chronic 2	H411	GHS09	H411				CLP00
604-047-00-3	4-(4-tolyloxy)biphenyl	405-730-7	51601-57-1	STOT RE 2 *Aquatic Chronic 4	H373 **H413	GHS08Wng	H373 **H413				CLP00
604-048-00-9	"4,4',4''-(ethan-1,1,1-triyl)triphenol"	405-800-7	27955-94-8	Aquatic Chronic 2	H411	GHS09	H411				CLP00
604-049-00-4	4-4'-methylenebis(oxyethylenethio)diphenol	407-480-4	93589-69-6	Aquatic Chronic 2	H411	GHS09	H411				CLP00
604-051-00-5	"3,5-bis((3,5-di-tert-butyl-4-hydroxy)benzyl)-2,4,6-trimethylphenol"	401-110-5	87113-78-8	Aquatic Chronic 3	H412		H412				CLP00
604-052-00-0	"2,2'-methylenebis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol)"	403-800-1	103597-45-1	Aquatic Chronic 4	H413		H413				CLP00
604-053-00-6	"2-methyl-4-(1,1-dimethylethyl)-6-(1-methyl-pentadecyl)-phenol"	410-760-9	157661-93-3	Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H315H317H400H410	GHS07GHS09Wng	H315H317H410				CLP00
604-054-00-1	"reaction mass of: 2-methoxy-4-(tetrahydro-4-methylene-2H-pyran-2-yl)-phenol; 4-(3,6-dihydro-4-methyl-2H-pyran-2-yl)-2-methoxyphenol"	412-020-0		Skin Sens. 1Aquatic Chronic 3	H317H412	GHS07Wng	H317H412				CLP00
604-055-00-7	"2,2'-((3,3',5,5'-tetramethyl-(1,1'-biphenyl)-4,4'-diyl)-bis(oxymethylene))-bis-oxirane"	413-900-7	85954-11-6	Carc. 2Skin Sens. 1	H351H317	GHS08GHS07Wng	H351H317				CLP00/ATP01
604-056-00-2	"2-(2-hydroxy-3,5-dinitroanilino)ethanol"	412-520-9	99610-72-7	Flam. Sol. 2Repr. 2Acute Tox. 4 *	H228H361f ***H302	GHS02GHS07GHS08Dgr	H228H361f ***H302				CLP00
604-057-00-8	"reaction mass of: isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-(n)-dodecylphenol; isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-(n)-tetracosylphenol; isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-5,6-didodecyl-phenol. n = 5 or 6"	401-680-5		Aquatic Chronic 2	H411	GHS09	H411				CLP00
604-058-00-3	"1,2-bis(3-methylphenoxy)ethane"	402-730-9	54914-85-1	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
604-059-00-9	2-n-hexadecylhydroquinone	406-400-5		STOT RE 2 *Skin Irrit. 2Skin Sens. 1Aquatic Chronic 4	H373 **H315H317H413	GHS08GHS07Wng	H373 **H315H317H413				CLP00
604-060-00-4	"9,9-bis(4-hydroxyphenyl)fluorene"	406-950-6	3236-71-3	Skin Irrit. 2Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H315H319H400H410	GHS07GHS09Wng	H319H315H410				CLP00
604-061-00-X	reaction mass of: 2-chloro-5-sec-tetradecylhydroquinones where sec-tetradecyl = 1-methyltridecyl; 1-ethyldodecyl; 1-propylundecyl; 1-butyldecyl; 1-pentylnonyl; 1-hexyloctyl	407-740-7		Skin Irrit. 2Skin Sens. 1Aquatic Chronic 3	H315H317H412	GHS07Wng	H315H317H412				CLP00
604-062-00-5	"2,4-dimethyl-6-(1-methyl-pentadecyl)phenol"	411-220-5		Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H315H317H400H410	GHS07GHS09Wng	H315H317H410				CLP00
604-063-00-0	"5,6-dihydroxyindole"	412-130-9	3131-52-0	Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 2	H302H318H411	GHS05GHS07GHS09Dgr	H302H318H411				CLP00
604-064-00-6	"2-(4,6-diphenyl-1,3,5-triazin-2-yl)-5-((hexyl)oxy)-phenol"	411-380-6	147315-50-2	Aquatic Chronic 4	H413		H413				CLP00
604-065-00-1	"4,4',4''-(1-methylpropan-1-yl-3-ylidene)tris(2-cyclohexyl-5-methylphenol)"	407-460-5	111850-25-0	Aquatic Chronic 2	H411	GHS09	H411				CLP00
604-066-00-7	"reaction mass of: phenol, 6-(1,1-dimethylethyl)-4-tetrapropyl-2-[(2-hydroxy-5-tetra-propylphenyl)methyl (C41-compound) and methane, 2,2'-bis[6-(1,1-dimethyl-ethyl)-1-hydroxy-4-tetrapropyl-phenyl)]- (C45-compound); 2,6-bis(1,1-dimethylethyl)-4-tetra-propyl-phenol and 2-(1,1-dimethylethyl)-4-tetrapropyl-phenol; 2,6-bis[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylphenyl)methyl]-4-(tetrapropyl)phenol and 2-[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylphenylmethyl]-6-[1-hydroxy-4-tetrapropylphenyl)methyl]-4-(tetrapropyl)phenol"	414-550-8		Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
604-067-00-2	"reaction mass of: 2,2'-[[(2-hydroxyethyl)imino]bis(methylene)bis[4-dodecylphenol]; formaldehyde, oligomer with 4-dodecyl phenol and 2-aminoethanol(n = 2); formaldehyde, oligomer with 4-dodecyl phenol and 2-aminoethanol(n = 3, 4 and higher)"	414-520-4		Skin Irrit. 2Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H315H318H400H410	GHS05GHS09Dgr	H315H318H410				CLP00
604-068-00-8	(±)-4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]-1-hydroxyethyl]phenol hydrochloride	415-170-5	90274-24-1	Acute Tox. 4 *Acute Tox. 4 *Skin Sens. 1	H332H302H317	GHS07Wng	H332H302H317				CLP00
604-069-00-3	2-(1-methylpropyl)-4-tert-butylphenol	421-740-4	51390-14-8	Skin Corr. 1BAquatic Chronic 2	H314H411	GHS05GHS09Dgr	H314H411				CLP00
604-070-00-9	"triclosan; 2,4,4'-trichloro-2'-hydroxy-diphenyl-ether; 5-chloro-2-(2,4-dichlorophenoxy)phenol"	222-182-2	3380-34-5	Skin Irrit. 2Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H315H319H400H410	GHS07GHS09Wng	H319H315H410		M=100		CLP00
604-071-00-4	"4,4'-(1-{4-[1-(4-hydroxyphenyl)-1-methylethyl]phenyl}ethylidene)diphenol"	425-600-3	110726-28-8	Aquatic Chronic 4	H413	-	H413				ATP01
604-072-00-X	"1,2-bis(phenoxymethyl)benzene"	428-620-0	10403-74-4	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				ATP01
604-073-00-5	(E)-3-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol	428-010-4	82413-20-5	Carc. 2Repr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H351H360F ***H317H400H410	GHS08GHS07GHS09Dgr	H351H360F ***H317H410				ATP01
604-074-00-0	"tetrabromobisphenol-A; 2,2',6,6'-tetrabromo-4,4'-isopropylidenediphenol"	201-236-9	79-94-7	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				ATP01
604-075-00-6	"4-(1,1,3,3-tetramethylbutyl)phenol; 4-tert-octylphenol"	205-426-2	140-66-9	Skin Irrit. 2Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H315H318H400H410	GHS05GHS09Dgr	H315H318H410		M=10		ATP01
604-076-00-1	phenolphthalein	201-004-7	77-09-8	Carc. 1BMuta. 2Repr. 2	H350H341H361f ***	GHS08Dgr	H341H350H361f ***		Carc. 1B; H350: C = 1 %		ATP01/ATP01corr
604-077-00-7	2-benzotriazol-2-yl-4-methyl-6-(2-methylallyl)phenol	419-750-9	98809-58-6	Aquatic Chronic 4	H413	-	H413				ATP01
604-079-00-8	"4,4'-(1,3-phenylene-bis(1-methylethylidene))bis-phenol"	428-970-4	13595-25-0	Repr. 2Skin Sens. 1Aquatic Chronic 2	H361f ***H317H411	GHS08GHS07GHS09Wng	H317H361f ***H411				ATP01/ATP01corr
604-080-00-3	4-fluoro-3-trifluoromethylphenol	432-560-0	61721-07-1	Acute Tox. 4 *Skin Corr. 1ASkin Sens. 1Aquatic Chronic 2	H332H314H317H411	GHS05GHS07GHS09Dgr	H332H314H317H411				ATP01
604-081-00-9	"1,1-bis(4-hydroxyphenyl)-1-phenylethane"	433-130-5	1571-75-1	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				ATP01
604-082-00-4	2-chloro-6-fluoro-phenol	433-890-8	2040-90-6	Muta. 1BRepr. 2Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Chronic 2	H340H361f ***H302H314H317H411	GHS05GHS08GHS07GHS09Dgr	H340H361f ***H302H314H317H411				ATP01
604-083-00-X	"4,4'-sulfonylbisphenol, polymer with ammonium chloride(NH4Cl), pentachlorophosphorane and phenol"	439-270-3	260408-02-4	Aquatic Chronic 4	H413	-	H413				ATP01
604-084-00-5	"1-ethoxy-2,3-difluorobenzene"	441-000-4	121219-07-6	Acute Tox. 4 *Aquatic Chronic 3	H302H412	GHS07Wng	H302H412				ATP01
604-087-00-1	"reaction mass of: 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)monoester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol; 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)diester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol; 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)triester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol"	433-640-8	-	Pyr. Sol. 1Aquatic Chronic 4	H250H413	GHS02Dgr	H250H413	EUH044			ATP01
604-089-00-2	2-methyl-5-tert-butylthiophenol	444-970-7	-	Flam. Liq. 3Repr. 2Asp. Tox. 1STOT SE 3STOT RE 2 *Skin Irrit. 2Eye Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H226H361d ***H304H336H373 **H315H319H317H400H410	GHS02GHS08GHS07GHS09Dgr	H226H361d ***H373 **H304H319H315H317H336H410				ATP01
604-090-00-8	4-tert-butylphenol	202-679-0	98-54-4	Repr. 2Skin Irrit. 2Eye Dam. 1	H361fH315H318	GHS08GHS05Dgr	H315H318H361f				ATP06
604-091-00-3	etofenprox (ISO); 2-(4-ethoxyphenyl)-2-methylpropyl 3-phenoxybenzyl ether	407-980-2	80844-07-1	Lact.Aquatic Acute 1Aquatic Chronic 1	H362H400H410	GHS09Wng	H362H410		M=100M=1000		ATP06
604-092-00-9	"phenol, dodecyl-, branched [1]phenol, 2-dodecyl-, branched; phenol, 3-dodecyl-, branched; phenol, 4-dodecyl-, branched; phenol, (tetrapropenyl) derivatives [2]"	310-154-3 [1]	121158-58-5 [1]74499-35-7 [2]	Skin Corr. 1CAquatic Acute 1Aquatic Chronic 1	H314H400H410	GHS05GHS09Dgr	H314H410		M=10M=10		ATP07
605-001-00-5	formaldehyde …%	200-001-8	50-00-0	Carc. 1BMuta. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Skin Corr. 1BSkin Sens. 1	H350H341H331H311H301H314H317	GHS08GHS06GHS05Dgr	H301H311H331H314H317H341H350		"Skin Corr. 1B; H314: C = 25 %Skin Irrit. 2; H315: 5 % = C < 25 %Eye Irrit. 2; H319: 5 % = C < 25 %STOT SE 3; H335: C = 5 %Skin Sens. 1; H317: C = 0,2 %"	B D	CLP00/ATP06
605-002-00-0	"1,3,5-trioxan; trioxymethylene"	203-812-5	110-88-3	Flam. Sol. 1Repr. 2STOT SE 3	H228H361d ***H335	GHS02GHS08GHS07Dgr	H228H361d ***H335			T	CLP00
605-003-00-6	acetaldehyde; ethanal	200-836-8	75-07-0	Flam. Liq. 1Carc. 2STOT SE 3Eye Irrit. 2	H224H351H335H319	GHS02GHS08GHS07Dgr	H224H351H319H335				CLP00
605-004-00-1	"2,4,6-trimethyl-1,3,5-trioxane; paraldehyde"	204-639-8	123-63-7	Flam. Liq. 3	H226	GHS02Wng	H226				CLP00/ATP01
605-005-00-7	"2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane; metaldehyde"	203-600-2	108-62-3	Flam. Sol. 2Acute Tox. 4 *	H228H302	GHS02GHS07Wng	H228H302				CLP00/ATP01corr
605-006-00-2	butyraldehyde	204-646-6	123-72-8	Flam. Liq. 2	H225	GHS02Dgr	H225				CLP00
605-007-00-8	"1,1-dimethoxyethane; dimethyl acetal"	208-589-8	534-15-6	Flam. Liq. 2	H225	GHS02Dgr	H225				CLP00
605-008-00-3	acrolein; prop-2-enal; acrylaldehyde	203-453-4	107-02-8	Flam. Liq. 2Acute Tox. 1Acute Tox. 2Acute Tox. 3Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1	H225H330H300H311H314H400H410	GHS02GHS06GHS05GHS09Dgr	H225H300H311H330H314H410	EUH071	M=100M=1	D	CLP00/ATP06
605-009-00-9	crotonaldehyde; 2-butenal [1](E)-2-butenal; (E)-crotonaldehyde  [2]	224-030-0 [1]204-647-1 [2]	4170-30-3 [1]123-73-9 [2]	Flam. Liq. 2Muta. 2Acute Tox. 2 *Acute Tox. 3 *Acute Tox. 3 *STOT SE 3STOT RE 2 *Skin Irrit. 2Eye Dam. 1Aquatic Acute 1	H225H341H330H311H301H335H373 **H315H318H400	GHS02GHS06GHS08GHS05GHS09Dgr	H225H341H330H311H301H373 **H335H315H318H400				CLP00
605-010-00-4	2-furaldehyde	202-627-7	98-01-1	Carc. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Irrit. 2	H351H331H301H312H335H315H319	GHS06GHS08Dgr	H351H331H301H312H319H335H315				CLP00/ATP01
605-011-00-X	2-chlorobenzaldehyde; o-chlorobenzaldehyde	201-956-3	89-98-5	Skin Corr. 1B	H314	GHS05Dgr	H314				CLP00
605-012-00-5	benzaldehyde	202-860-4	100-52-7	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
605-013-00-0	"chloralose (INN); (R)-1,2-O-(2,2,2-trichloroethylidene)-?-D-glucofuranose; glucochloralose; anhydroglucochloral"	240-016-7	15879-93-3	Acute Tox. 4 *Acute Tox. 4 *	H332H302	GHS07Wng	H332H302				CLP00
605-014-00-6	"chloral hydrate; 2,2,2-trichloroethane-1,1-diol"	206-117-5	302-17-0	Acute Tox. 3 *Skin Irrit. 2Eye Irrit. 2	H301H315H319	GHS06Dgr	H301H319H315				CLP00
605-015-00-1	"1,1-diethoxyethane; acetal"	203-310-6	105-57-7	Flam. Liq. 2Skin Irrit. 2Eye Irrit. 2	H225H315H319	GHS02GHS07Dgr	H225H319H315				CLP00
605-016-00-7	glyoxal … %; ethandial … %	203-474-9	107-22-2	Muta. 2Acute Tox. 4 *Skin Irrit. 2Eye Irrit. 2Skin Sens. 1	H341H332H315H319H317	GHS07GHS08Wng	H341H332H319H315H317		*	B	CLP00
605-017-00-2	"1,3-dioxolane"	211-463-5	646-06-0	Flam. Liq. 2	H225	GHS02Dgr	H225				CLP00
605-018-00-8	propanal; propionaldehyde	204-623-0	123-38-6	Flam. Liq. 2STOT SE 3Skin Irrit. 2Eye Irrit. 2	H225H335H315H319	GHS02GHS07Dgr	H225H319H335H315				CLP00
605-019-00-3	citral	226-394-6	5392-40-5	Skin Irrit. 2Skin Sens. 1	H315H317	GHS07Wng	H315H317				CLP00
605-020-00-9	"safrole; 5-allyl-1,3-benzodioxole"	202-345-4	94-59-7	Carc. 1BMuta. 2Acute Tox. 4 *	H350H341H302	GHS08GHS07Dgr	H350H341H302				CLP00
605-021-00-4	"formaldehyde, reaction products with butylphenol"	294-145-9	91673-30-2	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
605-022-00-X	"glutaral; glutaraldehyde; 1,5-pentanedial"	203-856-5	111-30-8	Acute Tox. 3 *Acute Tox. 3 *Skin Corr. 1BResp. Sens. 1Skin Sens. 1Aquatic Acute 1	H331H301H314H334H317H400	GHS06GHS08GHS05GHS09Dgr	H331H301H314H334H317H400		"*Skin Corr. 1B; H314: C ? 10 %Skin Irrit. 2; H315: 0,5 % ? C < 10 %Eye Dam.; H318: 2 % ? C < 10 %Eye Irrit. 2; H319: 0,5 % ? C < 2 %STOT SE; H335: C ? 0,5 %Skin Sens. 1; H317: C ? 0,5 %"		CLP00
605-023-00-5	5-chloro-2-(4-chlorophenoxy)phenol	429-290-0	3380-30-1	Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H318H400H410	GHS05GHS09Dgr	H318H410				ATP01
605-024-00-0	2-bromo-5-hydroxy-4-methoxybenzaldehyde	426-540-0	2973-59-3	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				ATP01
605-025-00-6	chloroacetaldehyde	203-472-8	107-20-0	Carc. 2Acute Tox. 2 *Acute Tox. 3 *Acute Tox. 3 *Skin Corr. 1BAquatic Acute 1	H351H330H311H301H314H400	GHS06GHS08GHS05GHS09Dgr	H351H330H311H301H314H400		STOT SE 3; H335: C ? 5 %		CLP00
605-026-00-1	"2,5,7,7-tetramethyloctanal"	405-690-0	114119-97-0	Skin Irrit. 2Skin Sens. 1Aquatic Chronic 2	H315H317H411	GHS07GHS09Wng	H315H317H411				CLP00
605-027-00-7	"reaction mass of: 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-6-carboxaldehyde; 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-5-carboxaldehyde"	410-480-7		Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				CLP00
605-028-00-2	?-methyl-3-(1-methylethyl)-benzenepropanal	412-050-4	125109-85-5	Aquatic Chronic 2	H411	GHS09	H411				CLP00
605-029-00-8	2-cyclohexylpropanal	412-270-0	2109-22-0	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				CLP00
605-030-00-3	1-(p-methoxyphenyl)acetaldehyde oxime	411-510-1	3353-51-3	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
605-031-00-9	"reaction mass of: 2,2-dimethoxyethanal [(this component is considered to be anhydrous in terms of identity, structure and composition. However, 2,2-dimethoxyethanal will exist in a hydrated form. 60 % anhydrous is equivalent to 70.4 % hydrate; water(Including free water and water in hydrated 2,2-dimethoxyethanal)]"	421-890-0		Skin Sens. 1	H317	GHS07Wng	H317				CLP00
605-032-00-4	3-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-(E)-2-propenal	425-370-4	93957-50-7	Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410				ATP01
605-033-00-X	"reaction mass of: 3,7,11-trimethyl-cis-6,10-dodecadienal; 3,7,11-trimethyl-trans-6,10-dodecadienal"	425-910-9	32480-08-3	Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H315H400H410	GHS07GHS09Wng	H315H410				ATP01
605-034-00-5	"reaction mass of: (1RS,2RS,3SR,6RS,9SR)-9-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde; (1RS,2RS,3RS,6RS,8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde; (1RS,2RS,4SR,6RS,8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-4-carbaldehyde"	429-860-9	-	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				ATP01
605-035-00-0	"(E)-3-(4-(4-fluorophenyl)-5-methoxymethyl-2,6-bis(1-methoxymethyl)pyridin-3-yl)prop-2-enal"	426-330-9	177964-68-0	Eye Irrit. 2Skin Sens. 1Aquatic Chronic 4	H319H317H413	GHS07Wng	H319H317H413				ATP01
605-036-00-6	2-bromomalonaldehyde	430-470-6	2065-75-0	Acute Tox. 4 *Eye Dam. 1	H302H318	GHS05GHS07Dgr	H302H318				ATP01
605-037-00-1	trans-3-[2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde; 3-[(E)-2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde	421-800-1	120578-03-2	Aquatic Chronic 4	H413	-	H413				ATP01
605-038-00-7	3-methyl-5-phenylpentan-1-al	433-900-0	55066-49-4	Acute Tox. 4 *Skin Irrit. 2Skin Sens. 1Aquatic Chronic 2	H302H315H317H411	GHS07GHS09Wng	H302H315H317H411				ATP01
605-039-00-2	"3,4-dihydroxy-5-nitrobenzaldehyde"	441-810-8	116313-85-0	Acute Tox. 4 *Eye Dam. 1Skin Sens. 1	H302H318H317	GHS05GHS07Dgr	H302H318H317				ATP01
606-001-00-8	acetone; propan-2-one; propanone	200-662-2	67-64-1	Flam. Liq. 2STOT SE 3Eye Irrit. 2	H225H336H319	GHS02GHS07Dgr	H225H319H336	EUH066			CLP00
606-002-00-3	butanone; ethyl methyl ketone	201-159-0	78-93-3	Flam. Liq. 2STOT SE 3Eye Irrit. 2	H225H336H319	GHS02GHS07Dgr	H225H319H336	EUH066			CLP00
606-003-00-9	heptan-3-one; butyl ethyl ketone	203-388-1	106-35-4	Flam. Liq. 3Acute Tox. 4 *Eye Irrit. 2	H226H332H319	GHS02GHS07Wng	H226H332H319				CLP00
606-004-00-4	4-methylpentan-2-one; isobutyl methyl ketone	203-550-1	108-10-1	Flam. Liq. 2Acute Tox. 4 *STOT SE 3Eye Irrit. 2	H225H332H335H319	GHS02GHS07Dgr	H225H332H319H335	EUH066			CLP00
606-005-00-X	"2,6-dimethylheptan-4-one; di-isobutyl ketone"	203-620-1	108-83-8	Flam. Liq. 3STOT SE 3	H226H335	GHS02GHS07Wng	H226H335		STOT SE 3; H335: C ? 10 %		CLP00
606-006-00-5	pentan-3-one; diethyl ketone	202-490-3	96-22-0	Flam. Liq. 2STOT SE 3STOT SE 3	H225H335H336	GHS02GHS07Dgr	H225H335H336	EUH066			CLP00
606-007-00-0	3-methylbutan-2-one; methyl isopropyl ketone	209-264-3	563-80-4	Flam. Liq. 2	H225	GHS02Dgr	H225				CLP00
606-009-00-1	4-methylpent-3-en-2-one; mesityl oxide	205-502-5	141-79-7	Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *	H226H332H312H302	GHS02GHS07Wng	H226H332H312H302		*		CLP00
606-010-00-7	cyclohexanone	203-631-1	108-94-1	Flam. Liq. 3Acute Tox. 4 *	H226H332	GHS02GHS07Wng	H226H332				CLP00
606-011-00-2	2-methylcyclohexanone	209-513-6	583-60-8	Flam. Liq. 3Acute Tox. 4 *	H226H332	GHS02GHS07Wng	H226H332				CLP00
606-012-00-8	"3,5,5-trimethylcyclohex-2-enone; isophorone"	201-126-0	78-59-1	Carc. 2Acute Tox. 4 *Acute Tox. 4 *STOT SE 3Eye Irrit. 2	H351H312H302H335H319	GHS08GHS07Wng	H351H312H302H319H335		STOT SE 3; H335: C ? 10 %		CLP00
606-013-00-3	p-benzoquinone; quinone	203-405-2	106-51-4	Acute Tox. 3 *Acute Tox. 3 *STOT SE 3Skin Irrit. 2Eye Irrit. 2Aquatic Acute 1	H331H301H335H315H319H400	GHS06GHS09Dgr	H331H301H319H335H315H400		M=10		CLP00/ATP01
606-014-00-9	"chlorophacinone (ISO); 2-(2-(4-chlorophenyl)phenylacetyl)indan-1,3-dione"	223-003-0	3691-35-8	Acute Tox. 1Acute Tox. 2 *Acute Tox. 3 *STOT RE 1Aquatic Acute 1Aquatic Chronic 1	H310H300H331H372 **H400H410	GHS06GHS08GHS09Dgr	H310H300H331H372 **H410				CLP00
606-016-00-X	"pindone (ISO); 2-pivaloylindan-1,3-dione"	201-462-8	83-26-1	Acute Tox. 3 *STOT RE 1Aquatic Acute 1Aquatic Chronic 1	H301H372 **H400H410	GHS06GHS08GHS09Dgr	H301H372 **H410				CLP00
606-017-00-5	diketene; diketen	211-617-1	674-82-8	Flam. Liq. 3Acute Tox. 4 *	H226H332	GHS02GHS07Wng	H226H332			D	CLP00
606-018-00-0	"dichlone (ISO); 2,3-dichloro-1,4-naphthoquinone"	204-210-5	117-80-6	Acute Tox. 4 *Skin Irrit. 2Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H302H315H319H400H410	GHS07GHS09Wng	H302H319H315H410				CLP00
606-019-00-6	"chlordecone (ISO); perchloropentacyclo[5,3,0,02,6,03,9,04,8]decan-5-one; decachloropentacyclo[5,2,1,02,6,03,9,05,8]decan-4-one"	205-601-3	143-50-0	Carc. 2Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H351H311H301H400H410	GHS06GHS08GHS09Dgr	H351H311H301H410				CLP00
606-020-00-1	5-methylheptan-3-one	208-793-7	541-85-5	Flam. Liq. 3STOT SE 3Eye Irrit. 2	H226H335H319	GHS02GHS07Wng	H226H319H335		STOT SE 3; H335: C ? 10 %		CLP00
606-021-00-7	N-methyl-2-pyrrolidone; 1-methyl-2-pyrrolidone	212-828-1	872-50-4	Repr. 1BSTOT SE 3Skin Irrit. 2Eye Irrit. 2	H360D ***H335H315H319	GHS08GHS07Dgr	H360D ***H319H335H315		Repr. 1B; H360D: C ? 5 %STOT SE 3; H335: C ? 10 %		CLP00/ATP01
606-022-00-2	1-phenyl-3-pyrazolidone	202-155-1	92-43-3	Acute Tox. 4 *Aquatic Chronic 2	H302H411	GHS07GHS09Wng	H302H411				CLP00
606-023-00-8	4-methoxy-4-methylpentan-2-one	203-512-4	107-70-0	Flam. Liq. 3Acute Tox. 4 *	H226H332	GHS02GHS07Wng	H226H332				CLP00
606-024-00-3	heptan-2-one; methyl amyl ketone	203-767-1	110-43-0	Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *	H226H332H302	GHS02GHS07Wng	H226H332H302				CLP00
606-025-00-9	cyclopentanone	204-435-9	120-92-3	Flam. Liq. 3Skin Irrit. 2Eye Irrit. 2	H226H315H319	GHS02GHS07Wng	H226H319H315				CLP00
606-026-00-4	5-methylhexan-2-one; isoamyl methyl ketone	203-737-8	110-12-3	Flam. Liq. 3Acute Tox. 4 *	H226H332	GHS02GHS07Wng	H226H332				CLP00
606-027-00-X	heptan-4-one; di-n-propyl ketone	204-608-9	123-19-3	Flam. Liq. 3Acute Tox. 4 *	H226H332	GHS02GHS07Wng	H226H332				CLP00
606-028-00-5	"2,4-dimethylpentan-3-one; di-isopropyl ketone"	209-294-7	565-80-0	Flam. Liq. 2Acute Tox. 4 *	H225H332	GHS02GHS07Dgr	H225H332				CLP00
606-029-00-0	"pentane-2,4-dione; acetylacetone"	204-634-0	123-54-6	Flam. Liq. 3Acute Tox. 4 *	H226H302	GHS02GHS07Wng	H226H302				CLP00
606-030-00-6	hexan-2-one; methyl butyl ketone; butyl methyl ketone; methyl-n-butyl ketone	209-731-1	591-78-6	Flam. Liq. 3Repr. 2STOT SE 3STOT RE 1	H226H361f ***H336H372 **	GHS02GHS08GHS07Dgr	H226H361f ***H372 **H336				CLP00
606-031-00-1	"3-propanolide; 1,3-propiolactone"	200-340-1	57-57-8	Carc. 1BAcute Tox. 2 *Skin Irrit. 2Eye Irrit. 2	H350H330H315H319	GHS06GHS08Dgr	H350H330H319H315				CLP00
606-032-00-7	hexachloroacetone	204-129-5	116-16-5	Acute Tox. 4 *Aquatic Chronic 2	H302H411	GHS07GHS09Wng	H302H411				CLP00
606-033-00-2	"2-(3,4-dichlorophenyl)-4-methyl-1,2,4-oxadiazolidinedione; methazole"	243-761-6	20354-26-1	Acute Tox. 4 *Acute Tox. 4 *Skin Irrit. 2Eye Irrit. 2Aquatic Chronic 2	H312H302H315H319H411	GHS07GHS09Wng	H312H302H319H315H411				CLP00
606-034-00-8	"metribuzin (ISO); 4-amino-6-tert-butyl-3-methylthio-1,2,4-triazin-5(4H)-one; 4-amino-4,5-dihydro-6-(1,1-dimethylethyl)-3-methylthio-1,2,4-triazin-5-one"	244-209-7	21087-64-9	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410		M=10		CLP00/ATP01
606-035-00-3	chloridazon (ISO); 5-amino-4-chloro-2-phenylpyridazine-3-(2H)-one; pyrazon	216-920-2	1698-60-8	Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410				CLP00
606-036-00-9	"quinomethionate; chinomethionat (ISO); 6-methyl-1,3-dithiolo(4,5-b)quinoxalin-2-one"	219-455-3	2439-01-2	Repr. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Eye Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H361f ***H332H312H302H373 **H319H317H400H410	GHS08GHS07GHS09Wng	H361f ***H332H312H302H373 **H319H317H410				CLP00
606-037-00-4	"triadimefon (ISO); 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butanone"	256-103-8	43121-43-3	Acute Tox. 4 *Skin Sens. 1Aquatic Chronic 2	H302H317H411	GHS07GHS09Wng	H302H317H411				CLP00
606-038-00-X	"diphacinone (ISO); 2-diphenylacetylindan-1,3-dione"	201-434-5	82-66-6	Acute Tox. 2 *STOT RE 1	H300H372 **	GHS06GHS08Dgr	H300H372 **				CLP00
606-039-00-5	"5(or 6)-tert-butyl-2'-chloro-6'-ethylamino-3',7'-dimethylspiro(isobenzofuran-1(1H),9'-xanthene)-3-one"	400-680-2		Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H332H400H410	GHS07GHS09Wng	H332H410				CLP00
606-040-00-0	(N-benzyl-N-ethyl)amino-3-hydroxyacetophenone hydrochloride	401-840-4	55845-90-4	Eye Dam. 1Aquatic Chronic 2	H318H411	GHS05GHS09Dgr	H318H411				CLP00
606-041-00-6	2-methyl-1-(4-methylthiophenyl)-2-morpholinopropan-1-one	400-600-6	71868-10-5	Acute Tox. 4 *Aquatic Chronic 2	H302H411	GHS07GHS09Wng	H302H411				CLP00
606-042-00-1	acetophenone	202-708-7	98-86-2	Acute Tox. 4 *Eye Irrit. 2	H302H319	GHS07Wng	H302H319				CLP00
606-043-00-7	"2,4-di-tert-butylcyclohexanone"	405-340-7	13019-04-0	Skin Irrit. 2Aquatic Chronic 2	H315H411	GHS07GHS09Wng	H315H411				CLP00
606-044-00-2	"2,4,6-trimethylbenzophenone"	403-150-9	954-16-5	Acute Tox. 4 *Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H302H319H400H410	GHS07GHS09Wng	H302H319H410				CLP00
606-045-00-8	"oxadiazon (ISO); 3-[2,4-dichloro-5-(1-methylethoxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one"	243-215-7	19666-30-9	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
606-046-00-3	reaction mass of cis- and trans-cyclohexadec-8-en-1-one	401-700-2	3100-36-5	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
606-047-00-9	2-benzyl-2-dimethylamino-4-morpholinobutyrophenone	404-360-3	119313-12-1	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
606-048-00-4	"2'-anilino-3'-methyl-6'-dipentylaminospiro(isobenzofuran-1(1H),9'-xanthen)-3-one"	406-480-1		Aquatic Chronic 4	H413		H413				CLP00
606-049-00-X	4-(trans-4-propylcyclohexyl)acetophenone	406-700-6	78531-61-0	Skin Sens. 1Aquatic Chronic 4	H317H413	GHS07Wng	H317H413				CLP00
606-050-00-5	"6-anilino-1-benzoyl-4-(4-tert-pentylphenoxy)naphto[1,2,3-de]quinoline-2,7-(3H)-dione"	412-480-2	72453-58-8	Aquatic Chronic 2	H411	GHS09	H411				CLP00
606-051-00-0	4-pentylcyclohexanone	406-670-4	61203-83-6	Aquatic Chronic 2	H411	GHS09	H411				CLP00
606-052-00-6	"4-(N,N-dibutylamino)-2-hydroxy-2'-carboxybenzophenone"	410-410-5	54574-82-2	Aquatic Chronic 3	H412		H412				CLP00
606-053-00-1	"flurtamone (ISO); (RS)-5-methylamino-2-phenyl-4-(?, ?,?-trifluoro-m-tolyl)furan-3(2H)-one"		96525-23-4	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
606-054-00-7	"isoxaflutole (ISO); 5-cyclopropyl-1,2-oxazol-4-yl ?, ?,?-trifluoro-2-mesyl-p-tolyl ketone"		141112-29-0	Repr. 2Aquatic Acute 1Aquatic Chronic 1	H361d ***H400H410	GHS08GHS09Wng	H361d ***H410		M=10M=100		CLP00/ATP07
606-055-00-2	"1-(2,3-dihydro-1,3,3,6-tetramethyl-1-(1-methylethyl)-1H-inden-5-yl)ethanone"	411-180-9	92836-10-7	Acute Tox. 4 *STOT RE 2 *Aquatic Chronic 2	H302H373 **H411	GHS08GHS07GHS09Wng	H302H373 **H411				CLP00
606-056-00-8	"4-chloro-3',4'-dimethoxybenzophenone"	404-610-1	116412-83-0	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
606-057-00-3	4-propylcyclohexanone	406-810-4	40649-36-3	Skin Irrit. 2Aquatic Chronic 3	H315H412	GHS07Wng	H315H412				CLP00
606-058-00-9	"4'-fluoro-2,2-dimethoxyacetophenone"	407-500-1	21983-80-2	Skin Sens. 1Aquatic Chronic 3	H317H412	GHS07Wng	H317H412				CLP00
606-059-00-4	"2,4-difluoro-?-(1H-1,2,4-triazol-1-yl)acetophenone hydrochloride"	412-390-3	86386-75-6	Acute Tox. 4 *Eye Dam. 1Skin Sens. 1	H302H318H317	GHS05GHS07Dgr	H302H318H317				CLP00
606-060-00-X	"reaction mass of: trans-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane; cis-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane"	412-950-7		Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
606-061-00-5	(3-chlorophenyl)-(4-methoxy-3-nitrophenyl)methanone	423-290-4	66938-41-8	Muta. 2Aquatic Acute 1Aquatic Chronic 1	H341H400H410	GHS08GHS09Wng	H341H410				CLP00
606-062-00-0	tetrahydrothiopyran-3-carboxaldehyde	407-330-8	61571-06-0	Repr. 1BEye Dam. 1Aquatic Chronic 3	H360D ***H318H412	GHS08GHS05Dgr	H360D ***H318H412				CLP00
606-063-00-6	(E)-3-(2-chlorophenyl)-2-(4-fluorophenyl)propenal	410-980-5	112704-51-5	Eye Irrit. 2Skin Sens. 1	H319H317	GHS07Wng	H319H317				CLP00
606-064-00-1	"pregn-5-ene-3,20-dione bis(ethylene ketal)"	407-450-0	7093-55-2	Aquatic Chronic 4	H413		H413				CLP00
606-065-00-7	1-(4-morpholinophenyl)butan-1-one	413-790-0		Aquatic Chronic 2	H411	GHS09	H411				CLP00
606-066-00-2	"(E)-5[(4-chlorophenyl)methylene]-2,2-dimethylcyclopentanone"	410-440-9	164058-20-2	Aquatic Chronic 2	H411	GHS09	H411				CLP00
606-067-00-8	"reaction mass of: 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-4-yl)ethanone; 1-(2,3,5,6,7,8-hexahydro-1,1-dimethyl-1H-benz(f)inden-4-yl)ethanone; 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-5-yl)ethanone; 1-(2,3,6,7,8,9-hexahydro-3,3-dimethyl-1H-benz(g)inden-5-yl)ethanone"	414-870-8	96792-67-5	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
606-068-00-3	"2,7,11-trimethyl-13-(2,6,6-trimethylcyclohex-1-en-1-yl)tridecahexaen-2,4,6,8,10,12-al"	415-770-7	1638-05-7	STOT RE 2 *Skin Sens. 1Aquatic Chronic 3	H373 **H317H412	GHS08GHS07Wng	H373 **H317H412				CLP00
606-069-00-9	"spiro[1,3-dioxolane-2,5'-(4',4',8',8'-tetramethyl-hexahydro-3',9'-methanonaphthalene)]"	415-460-1	154171-76-3	Aquatic Chronic 2	H411	GHS09	H411				CLP00
606-070-00-4	"butroxydim (ISO); 5-(3-butyryl-2,4,6-trimethylphenyl)-2-[1-(ethoxyimino)propyl]-3-hydroxycyclohex-2-en-1-one"	414-790-3	138164-12-2	Repr. 2Acute Tox. 4 *Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H361fdH302H315H400H410	GHS08GHS07GHS09Wng	H361fdH302H315H410				CLP00
606-071-00-X	"17-spiro(5,5-dimethyl-1,3-dioxan-2-yl)androsta-1,4-diene-3-one"	421-050-3	13258-43-0	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
606-072-00-5	"3-acetyl-1-phenyl-pyrrolidine-2,4-dione"	421-600-2	719-86-8	STOT RE 2 *Aquatic Chronic 2	H373 **H411	GHS08GHS09Wng	H373 **H411				CLP00
606-073-00-0	"4,4'-bis(dimethylamino)benzophenone; Michler's ketone"	202-027-5	90-94-8	Carc. 1BMuta. 2Eye Dam. 1	H350H341H318	GHS08GHS05Dgr	H350H341H318				CLP00
606-074-00-6	"reaction mass of: (1R*,2S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-1,2,8,8-tetramethylnaphthalene; (2R*,3S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethylnaphthalene"	425-570-1	-	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				ATP01
606-075-00-1	"1-benzyl-5-ethoxyimidazolidine-2,4-dione"	417-340-4	65855-02-9	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
606-076-00-7	"1-((2-quinolinyl-carbonyl)oxy)-2,5-pyrrolidinedione"	418-630-3	136465-99-1	Eye Dam. 1Skin Sens. 1	H318H317	GHS05GHS07Dgr	H318H317				CLP00
606-077-00-2	"(3S,4S)-3-hexyl-4-[(R)-2-hydroxytridecyl]-2-oxetanone"	418-650-2	104872-06-2	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
606-078-00-8	1-octylazepin-2-one	420-040-6	59227-88-2	Skin Corr. 1BSkin Sens. 1Aquatic Chronic 2	H314H317H411	GHS05GHS07GHS09Dgr	H314H317H411				CLP00
606-079-00-3	2-n-butyl-benzo[d]isothiazol-3-one	420-590-7	4299-07-4	Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H314H317H400H410	GHS05GHS07GHS09Dgr	H314H317H410				CLP00
606-081-00-4	"(3?, 5?, 6?)-3-(acetyloxy)-5-bromo-6-hydroxy-androstan-17-one"	419-790-7	4229-69-0	Skin Sens. 1Aquatic Chronic 3	H317H412	GHS07Wng	H317H412				CLP00
606-082-00-X	"reaction mass of: butan-2-one oxime; syn-O,O'-di(butan-2-one oxime)diethoxysilane"	406-930-7		STOT RE 1Skin Sens. 1Aquatic Chronic 3	H372 **H317H412	GHS08GHS07Dgr	H372 **H317H412				CLP00
606-083-00-5	2-chloro-5-sec-hexadecylhydroquinone	407-750-1	137193-60-3	Skin Irrit. 2Eye Irrit. 2Skin Sens. 1Aquatic Chronic 3	H315H319H317H412	GHS07Wng	H319H315H317H412				CLP00
606-084-00-0	"1-(4-methoxy-5-benzofuranyl)-3-phenyl-1,3-propanedione"	414-540-3	484-33-3	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
606-085-00-6	"(1R,4S)-2-azabicyclo[2.2.1]hept-5-en-3-one"	418-530-1	79200-56-9	Acute Tox. 4 *Eye Dam. 1Skin Sens. 1	H302H318H317	GHS05GHS07Dgr	H302H318H317				CLP00
606-086-00-1	"1-(3,3-dimethylcyclohexyl)pent-4-en-1-one"	422-330-8	56973-87-6	Aquatic Chronic 2	H411	GHS09	H411				CLP00
606-087-00-7	6-ethyl-5-fluoro-4(3H)-pyrimidone	422-460-5	137234-87-8	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410				CLP00
606-088-00-2	"2,4,4,7-tetramethyl-6-octen-3-one"	422-520-0	74338-72-0	Skin Irrit. 2Aquatic Chronic 2	H315H411	GHS07GHS09Wng	H315H411				CLP00
606-089-00-8	"reaction mass of: 1,4-diamino-2-chloro-3-phenoxyanthraquinone; 1,4-diamino-2,3-bis-phenoxyanthraquinone"	423-220-2	12223-77-7	Aquatic Chronic 4	H413		H413				CLP00
606-090-00-3	1-[3-[(dimethylamino)methyl]-4-hydroxyphenyl]ethanone	430-920-1	73096-98-7	Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 3	H302H318H412	GHS05GHS07Dgr	H302H318H412				ATP01
606-091-00-9	"6-chloro-5-(2-chloroethyl)-1,3-dihydroindol-2-one"	421-320-0	118289-55-7	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
606-092-00-4	reaction mass of: (E)-oxacyclohexadec-12-en-2-one; (E)-oxacyclohexadec-13-en-2-one; a) (Z)-oxacyclohexadec-(12)-en-2-one and b) (Z)-oxacyclohexadec-(13)-en-2-one	422-320-3		Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
606-093-00-X	"5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one"	414-470-3	95885-13-5	Acute Tox. 4 *Aquatic Chronic 3	H302H412	GHS07Wng	H302H412				ATP01
606-094-00-5	"N-[ethyl(3-methylbutyl)amino]-3-methyl-1-phenyl-spiro[[1]benzo-pyrano[2,3-c]pyrazole-4(1H),1'(3'H)-isobenzofuran]-3'-one"	417-460-7	-	Aquatic Chronic 4	H413	-	H413				ATP01
606-095-00-0	"(R,S)-2-azabicyclo[2.2.1]hept-5-en-3-one"	421-830-3	49805-30-3	Acute Tox. 4 *Skin Sens. 1	H302H317	GHS07Wng	H302H317				ATP01
606-096-00-6	"3-(6-O-(6-desoxy-?-.sc.l.sc.-mannopyranosyl-O-(?-.sc.d.sc.-glucopyranosyl)-(?-.sc.d.sc.-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one"	424-170-4	130603-71-3	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				ATP01
606-097-00-1	"2,2''-dihydroxy-4,4''-(2-hydroxy-propane-1,3-diyldioxy)dibenzophenone"	424-210-0	23911-85-5	Aquatic Chronic 4	H413	-	H413				ATP01
606-098-00-7	"1-benzyl-5-(hexadecyloxy)-2,4-imidazolidinedione"	431-220-9	158574-65-3	Aquatic Chronic 4	H413	-	H413				ATP01
606-099-00-2	5-methoxy-4'-(trifluoromethyl)valerophenone	425-000-1	61718-80-7	Aquatic Chronic 2	H411	GHS09	H411				ATP01
606-100-00-6	2-butyryl-3-hydroxy-5-thiocyclohexan-3-yl-cyclohex-2-en-1-one	425-150-8	94723-86-1	Repr. 1BAcute Tox. 4 *Skin Sens. 1Aquatic Chronic 3	H360F ***H302H317H412	GHS08GHS07Dgr	H360F ***H302H317H412				ATP01
606-101-00-1	"reaction mass of: 1,5-bis[(2-ethylhexyl)amino]-9,10-anthracenedione; 1-[(2-ethylhexyl)amino]-5-[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-anthracenedione; 1,5-bis[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-anthracenedione; 1-[(2-ethylhexyl)amino]-5-[(3-methoxypropyl)amino]-9,10-anthracene dione; 1-[3-[(2-ethylhexyl)oxy]propyl]amino-5-[(3-methoxypropyl)amino]-9,10-anthracenedione; 1,5-bis[(3-methyloxypropyl)amino]-9,10-anthracenedione"	426-050-7	165038-51-7	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				ATP01
606-102-00-7	4-(3-triethoxysilylpropoxy)-2-hydroxybenzophenone	431-490-8	79876-59-8	Aquatic Chronic 2	H411	GHS09	H411				ATP01
606-103-00-2	1-(4-(trans-4-ethylcyclohexyl)phenyl)ethanone	426-460-6	-	Skin Sens. 1	H317	GHS07Wng	H317				ATP01
606-104-00-8	1-(4-(trans-4-pentylcyclohexyl)phenyl)ethanone	426-830-7	78531-59-6	Skin Sens. 1Aquatic Chronic 4	H317H413	GHS07Wng	H317H413				ATP01
606-105-00-3	"3,4,3',4'-tetraphenyl-1,1'-ethandiylbispyrol-2,5-dione"	431-500-0	226065-73-2	Skin Sens. 1Aquatic Chronic 4	H317H413	GHS07Wng	H317H413				ATP01
606-106-00-9	1-(4-(trans-4-butylcyclohexyl)phenyl)ethanone	427-320-7	83626-30-6	Skin Sens. 1Aquatic Chronic 4	H317H413	GHS07Wng	H317H413				ATP01
606-107-00-4	"8-azaspiro[4.5]decane-7,9-dione"	427-770-4	1075-89-4	Acute Tox. 3 *Aquatic Chronic 2	H301H411	GHS06GHS09Dgr	H301H411				ATP01
606-108-00-X	"1,1,1,2,2,4,5,5,5-nonafluoro-4-(trifluoromethyl )-3-pentanone"	436-710-6	756-13-8	Aquatic Chronic 3	H412	-	H412				ATP01
606-109-00-5	2-(4-methyl-3-pentenyl)anthraquinone	428-320-1	71308-16-2	Acute Tox. 4 *Skin Sens. 1Aquatic Chronic 4	H302H317H413	GHS07Wng	H302H317H413				ATP01/ATP01corr
606-110-00-0	5-ethoxy-5H-furan-2-one	428-330-4	2833-30-9	Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Skin Corr. 1BSkin Sens. 1	H312H302H373 **H314H317	GHS05GHS08GHS07Dgr	H314H312H302H373 **H317				ATP01
606-111-00-6	"5-amino-6-methyl-1,3-dihydrobenzoimidazol-2-one"	428-410-9	67014-36-2	Acute Tox. 4 *Skin Sens. 1Aquatic Chronic 2	H302H317H411	GHS07GHS09Wng	H302H317H411				ATP01
606-112-00-1	"(4aR*,8aR*)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-one"	428-690-2	1668-86-6	Acute Tox. 4 *Eye Irrit. 2Aquatic Chronic 3	H302H319H412	GHS07Wng	H302H319H412				ATP01
606-113-00-7	1-[4-(4-benzoylphenylsulfanyl)phenyl]-2-methyl-2-(4-methylphenylsulfonyl)propan-1-one	429-040-0	272460-97-6	Eye Dam. 1Aquatic Chronic 4	H318H413	GHS05Dgr	H318H413				ATP01/ATP01corr
606-114-00-2	"4,4',5,5',6,6',7,7'-octachloro-(2,2')biisoindolyl-1,1',3,3'-tetraone"	429-150-9	67887-47-2	Aquatic Chronic 4	H413	-	H413				ATP01
606-115-00-8	profoxydim (ISO); 2-{(EZ)-1-[(2RS)-2-(4-chlorophenoxy)propoxyimino]butyl}-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-one	-	139001-49-3	Carc. 2Repr. 2Skin Sens. 1	H351H361dH317	GHS08GHS07Wng	H351H361dH317				ATP01
606-116-00-3	tepraloxydim (ISO); (RS)-(EZ)-2-{1-[(2E)-3-chloroallyloxyimino]propyl}-3-hydroxy-5-perhydropyran-4-ylcyclohex-2-en-1-one	-	149979-41-9	Carc. 2Repr. 2	H351H361fd	GHS08Wng	H351H361fd				ATP01
606-117-00-9	"2,6-bis(1,1-dimethylethyl)-4-(phenylenemethylene)cyclohexa-2,5-dien-1-one"	429-460-4	7078-98-0	Skin Sens. 1Aquatic Chronic 4	H317H413	GHS07Wng	H317H413				ATP01
606-118-00-4	"N-(1,3-dimethylbutyl)-N'-(phenyl)-1,4-benzoquinonediimine"	429-640-2	52870-46-9	Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H319H400H410	GHS07GHS09Wng	H319H410				ATP01
606-119-00-X	(E)-3-methyl-5-cyclopentadecen-1-one	429-900-5	-	Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410				ATP01
606-120-00-5	"2,5-dihydroxy-5-methyl-3-(morpholin-4-yl)-2-cyclopenten-1-one"	430-170-5	114625-74-0	Acute Tox. 4 *Aquatic Chronic 3	H302H412	GHS07Wng	H302H412				ATP01
606-121-00-0	"(+)-(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]heptane-3-spiro-1'-(cyclohex-2'-en-4'-one)"	430-460-1	133636-82-5	Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H314H317H400H410	GHS05GHS07GHS09Dgr	H314H317H410				ATP01
606-122-00-6	"3-(2-bromopropionoyl)-4,4-dimethyl-1,3-oxazolan-2-one"	430-820-8	114341-88-7	Acute Tox. 4 *STOT RE 2 *Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H373 **H315H318H317H400H410	GHS05GHS08GHS07GHS09Dgr	H302H373 **H315H318H317H410				ATP01
606-123-00-1	4-hexadecyl-1-phenylpyrazolidin-3-one	430-840-7	-	Skin Sens. 1Aquatic Chronic 4	H317H413	GHS07Wng	H317H413				ATP01
606-124-00-7	"1-cyclopropyl-3-(2-methylthio-4-trifluoromethylphenyl)-1,3-propanedione"	421-080-7	161462-35-7	STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H373 **H400H410	GHS08GHS09Wng	H373 **H410				ATP01
606-125-00-2	"1-benzylimidazolidine-2,4-dione"	421-340-1	6777-05-5	Acute Tox. 4 *	H302	GHS07Wng	H302				ATP01
606-126-00-8	"1,4-bis(2,3-dihydroxypropylamino)anthraquinone"	421-470-7	99788-75-7	Aquatic Chronic 2	H411	GHS09	H411				ATP01
606-128-00-9	"2,2'-(1,3-phenylene)bis[5-chloro-1H-isoindole]-1,3(2H)-dione"	422-650-8	148935-94-8	Aquatic Chronic 4	H413	-	H413				ATP01
606-129-00-4	"5-amino-[2S-di(methylphenyl)amino]-1,6-diphenyl-4Z-hexen-3-one; (2S,4Z)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one"	423-090-7	156732-13-7	Aquatic Chronic 4	H413	-	H413				ATP01
606-130-00-X	"4-(1,4-dioxa-spiro[4.5]dec-8-yl)-cyclohexanone"	423-860-2	56309-94-5	Skin Sens. 1Aquatic Chronic 3	H317H412	GHS07Wng	H317H412				ATP01
606-131-00-5	"cyclic 3-(1,2-ethanediylacetale)-estra-5(10),9(11)-diene-3,17-dione"	427-230-8	5571-36-8	Repr. 1BSTOT RE 2 *Aquatic Chronic 2	H360F ***H373 **H411	GHS08GHS09Dgr	H360F ***H373 **H411				ATP01
606-132-00-0	"(6?)-6,19-epoxyandrost-4-ene-3,17-dione"	433-490-3	6563-83-3	Skin Sens. 1Aquatic Chronic 3	H317H412	GHS07Wng	H317H412				ATP01
606-134-00-1	"androsta-1,4,9(11)-triene-3,17-dione"	433-560-3	15375-21-0	Repr. 2	H361f ***	GHS08Wng	H361f ***				ATP01
606-135-00-7	cyclohexadecanone	438-930-8	2550-52-9	Aquatic Chronic 4	H413	-	H413				ATP01
606-136-00-2	"(3S,6R,9S,12R,15S,18R,21S,24R)-6,18-dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo-tetracosane-2,5,8,11,14,17,20,23-octaone"	444-350-6	133413-70-4	Eye Irrit. 2Aquatic Chronic 4	H319H413	GHS07Wng	H319H413				ATP01
606-137-00-8	"trans-7,7'-dimethyl-(4H,4H')-(2,2')bi[benzo[1,4]thiazinylidene]-3,3'-dione"	444-750-0	211387-26-7	Aquatic Chronic 4	H413	-	H413				ATP01
606-138-00-3	(2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanone	444-800-1	141645-23-0	Flam. Liq. 3Acute Tox. 4 *STOT RE 2 *Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H226H302H373 **H315H318H317H400H410	GHS02GHS05GHS08GHS07GHS09Dgr	H226H302H373 **H315H318H317H410		M=10		ATP01/ATP01corr
606-139-00-9	"(S)-4-(3,4-dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one"	444-830-5	124379-29-9	Aquatic Chronic 4	H413	-	H413				ATP01
606-140-00-4	2-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)phenyl)-2-methylpropan-1-one	444-860-9	474510-57-1	STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H373 **H400H410	GHS08GHS09Wng	H373 **H410				ATP01
606-141-00-X	"sodium 3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro-2-pyridinolate"	418-410-7	-	Eye Irrit. 2	H319	GHS07Wng	H319				ATP01
606-142-00-5	"reaction mass of: (1RS,2SR,7SR,8SR,E) 9 and 10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one; (1RS,2SR,7SR,8SR,Z)-10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one; (1RS,2SR,7SR,8SR,Z)-9-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one"	434-290-9	-	Acute Tox. 4 *Aquatic Chronic 2	H302H411	GHS07GHS09Wng	H302H411				ATP01
606-143-00-0	abamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1]avermectin B1a (purity ?80 %) [2]	_ [1]265-610-3 [2]	71751-41-2 [1]65195-55-3 [2]	Repr. 2Acute Tox. 1Acute Tox. 2STOT RE 1Aquatic Acute 1Aquatic Chronic 1	H361dH330H300H372 (nervous system)H400H410	GHS06GHS08GHS09Dgr	H361dH300H330H372 (nervous system)H410		"STOT RE 1; H372:  C ? 5 %STOT RE 2; H373:  0,5 % ?C<5 %M=10000"		ATP03
606-144-00-6	"acequinocyl (ISO); 3-dodecyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl acetate"	—	57960-19-7	STOT SE 1STOT RE 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H370 (lung) (inhalation)H373 (blood system)H317H400H410	GHS07GHS08GHS09Dgr	H317H370 (lung) (inhalation)H373 (blood system)H410		M=1000		ATP03
606-145-00-1	"sulcotrione (ISO); 2-[2-chloro-4-(methylsulfonyl)benzoyl]cyclohexane-1,3-dione"		99105-77-8	Repr. 2STOT RE 2Skin Sens. 1AAquatic Acute 1Aquatic Chronic 1	H361dH373 (kidneys)H317H400H410	GHS08GHS07GHS09Wng	H317H361dH373 (kidneys)H410		M=1M=10		ATP05
606-146-00-7	tralkoxydim (ISO); 2-(N-ethoxypropanimidoyl)-3-hydroxy-5-mesitylcyclohex-2-en-1-one		87820-88-0	Carc. 2Acute Tox. 4Aquatic Chronic 2	H351H302H411	GHS08GHS07GHS09Wng	H302H351H411				ATP06
606-147-00-2	cycloxydim (ISO); 2-(N-ethoxybutanimidoyl)-3-hydroxy-5-(tetrahydro-2H-thiopyran-3-yl)cyclohex-2-en-1-one	405-230-9	101205-02-1	Repr. 2	H361d	GHS08Wng	H361d				ATP06
606-148-00-8	carvone (ISO); 2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-one [1]d-carvone; (5S)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-one [2]l-carvone; (5R)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-one [3]	202-759-5 [1]218-827-2 [2]229-352-5 [3]	99-49-0 [1]2244-16-8 [2]6485-40-1 [3]	Skin Sens. 1	H317	GHS07Wng	H317				ATP07
606-149-00-3	"tembotrione (ISO); 2-{2-chloro-4-(methylsulfonyl)-3-[(2,2,2-trifluoroethoxy)methyl]benzoyl}cyclohexane-1,3-dione"		335104-84-2	Repr. 2STOT RE 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	"H361dH373 (eyes, kidneys, liver)H317H400H410"	GHS08GHS07GHS09Wng	"H317H361dH373 (eyes, kidneys, liver)H410"		M=100M=10		ATP07
607-001-00-0	formic acid … %	200-579-1	64-18-6	Skin Corr. 1A	H314	GHS05Dgr	H314		Skin Corr. 1A; H314: C ? 90 %Skin Corr. 1B; H314: 10 % ? C < 90 %Skin Irrit. 2; H315: 2 % ? C < 10 %Eye Irrit. 2; H319: 2 % ? C < 10 %	B	CLP00
607-002-00-6	acetic acid … %	200-580-7	64-19-7	Flam. Liq. 3Skin Corr. 1A	H226H314	GHS02GHS05Dgr	H226H314		Skin Corr. 1A; H314: C ? 90 %Skin Corr. 1B; H314: 25 % ? C < 90 %Skin Irrit. 2; H315: 10 % ? C < 25 %Eye Irrit. 2; H319: 10 % ? C < 25 %	B	CLP00
607-003-00-1	chloroacetic acid	201-178-4	79-11-8	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Skin Corr. 1BAquatic Acute 1	H331H311H301H314H400	GHS06GHS05GHS09Dgr	H331H311H301H314H400		STOT SE 3; H335: C ? 5 %		CLP00/ATP01
607-004-00-7	TCA (ISO); trichloroacetic acid	200-927-2	76-03-9	Skin Corr. 1AAquatic Acute 1Aquatic Chronic 1	H314H400H410	GHS05GHS09Dgr	H314H410		STOT SE 3; H335: C ? 1 %		CLP00
607-005-00-2	TCA-sodium (ISO); sodium trichloroacetate	211-479-2	650-51-1	STOT SE 3Aquatic Acute 1Aquatic Chronic 1	H335H400H410	GHS07GHS09Wng	H335H410				CLP00
607-006-00-8	oxalic acid	205-634-3	144-62-7	Acute Tox. 4 *Acute Tox. 4 *	H312H302	GHS07Wng	H312H302		*		CLP00
607-007-00-3	salts of oxalic acid with the exception of those specified elsewhere in this Annex	-	-	Acute Tox. 4 *Acute Tox. 4 *	H312H302	GHS07Wng	H312H302		*	A	CLP00/ATP01
607-008-00-9	acetic anhydride	203-564-8	108-24-7	Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1B	H226H332H302H314	GHS02GHS05GHS07Dgr	H226H332H302H314		Skin Corr. 1B; H314: C ? 25 %Skin Irrit. 2; H315: 5 % ? C < 25 %Eye Dam. 1; H318: 5 % ? C < 25 %Eye Irrit. 2; H319: 1 % ? C < 5 %STOT SE 3; H335: C ? 5 %		CLP00
607-009-00-4	phthalic anhydride	201-607-5	85-44-9	Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Dam. 1Resp. Sens. 1Skin Sens. 1	H302H335H315H318H334H317	GHS08GHS05GHS07Dgr	H302H335H315H318H334H317				CLP00
607-010-00-X	propionic anhydride	204-638-2	123-62-6	Skin Corr. 1B	H314	GHS05Dgr	H314		Skin Corr. 1B; H314: C ? 25 %Skin Irrit. 2; H315: 10 % ? C < 25 %Eye Irrit. 2; H319: 10 % ? C < 25 %		CLP00
607-011-00-5	acetyl chloride	200-865-6	75-36-5	Flam. Liq. 2Skin Corr. 1B	H225H314	GHS02GHS05Dgr	H225H314	EUH014			CLP00
607-012-00-0	benzoyl chloride	202-710-8	98-88-4	Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1	H332H312H302H314H317	GHS05GHS07Dgr	H332H312H302H314H317				CLP00/ATP01
607-013-00-6	dimethyl carbonate	210-478-4	616-38-6	Flam. Liq. 2	H225	GHS02Dgr	H225				CLP00
607-014-00-1	methyl formate	203-481-7	107-31-3	Flam. Liq. 1Acute Tox. 4 *Acute Tox. 4 *STOT SE 3Eye Irrit. 2	H224H332H302H335H319	GHS02GHS07Dgr	H224H332H302H319H335				CLP00
607-015-00-7	ethyl formate	203-721-0	109-94-4	Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *STOT SE 3Eye Irrit. 2	H225H332H302H335H319	GHS02GHS07Dgr	H225H332H302H319H335				CLP00
607-016-00-2	propyl formate [1]isopropyl formate  [2]	203-798-0 [1]210-901-2 [2]	110-74-7 [1]625-55-8 [2]	Flam. Liq. 2STOT SE 3STOT SE 3Eye Irrit. 2	H225H335H336H319	GHS02GHS07Dgr	H225H319H335H336			C	CLP00
607-017-00-8	butyl formate [1]tert-butyl formate [2]isobutyl formate  [3]	209-772-5 [1]212-105-0 [2]208-818-1 [3]	592-84-7 [1]762-75-4 [2]542-55-2 [3]	Flam. Liq. 2STOT SE 3Eye Irrit. 2	H225H335H319	GHS02GHS07Dgr	H225H319H335			C	CLP00
607-018-00-3	isopentyl formate [1]pentyl formate [2]	203-769-2 [1]252-343-2 [2]	110-45-2 [1]35073-27-9 [2]	Flam. Liq. 2STOT SE 3Eye Irrit. 2	H225H335H319	GHS02GHS07Dgr	H225H319H335			C	CLP00
607-019-00-9	methyl chloroformate	201-187-3	79-22-1	Flam. Liq. 2Acute Tox. 2 *Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1B	H225H330H312H302H314	GHS02GHS06GHS05Dgr	H225H330H312H302H314				CLP00
607-020-00-4	ethyl chloroformate	208-778-5	541-41-3	Flam. Liq. 2Acute Tox. 2 *Acute Tox. 4 *Skin Corr. 1B	H225H330H302H314	GHS02GHS06GHS05Dgr	H225H330H302H314				CLP00
607-021-00-X	methyl acetate	201-185-2	79-20-9	Flam. Liq. 2STOT SE 3Eye Irrit. 2	H225H336H319	GHS02GHS07Dgr	H225H319H336	EUH066			CLP00
607-022-00-5	ethyl acetate	205-500-4	141-78-6	Flam. Liq. 2STOT SE 3Eye Irrit. 2	H225H336H319	GHS02GHS07Dgr	H225H319H336	EUH066			CLP00
607-023-00-0	vinyl acetate	203-545-4	108-05-4	Flam. Liq. 2Carc. 2Acute Tox. 4STOT SE 3	H225H351H332H335	GHS02GHS08GHS07Dgr	H225H332H351H335			D	CLP00/ATP05
607-024-00-6	propyl acetate [1]isopropyl acetate  [2]	203-686-1 [1]203-561-1 [2]	109-60-4 [1]108-21-4 [2]	Flam. Liq. 2STOT SE 3Eye Irrit. 2	H225H336H319	GHS02GHS07Dgr	H225H319H336	EUH066		C	CLP00
607-025-00-1	n-butyl acetate	204-658-1	123-86-4	Flam. Liq. 3STOT SE 3	H226H336	GHS02GHS07Wng	H226H336	EUH066			CLP00
607-026-00-7	sec-butyl acetate [1]isobutyl acetate [2]tert-butyl acetate  [3]	203-300-1 [1]203-745-1 [2]208-760-7 [3]	105-46-4 [1]110-19-0 [2]540-88-5 [3]	Flam. Liq. 2	H225	GHS02Dgr	H225	EUH066		C	CLP00
607-027-00-2	methyl propionate	209-060-4	554-12-1	Flam. Liq. 2Acute Tox. 4 *	H225H332	GHS02GHS07Dgr	H225H332				CLP00
607-028-00-8	ethyl propionate	203-291-4	105-37-3	Flam. Liq. 2	H225	GHS02Dgr	H225				CLP00
607-029-00-3	n-butyl propionate [1]sec-butyl propionate [2]tert-butyl propionate [3]	209-669-5 [1]208-746-0 [3]	590-01-2 [1]591-34-4 [2]540-42-1 [3]	Flam. Liq. 3	H226	GHS02Wng	H226			C	CLP00
607-030-00-9	propyl propionate	203-389-7	106-36-5	Flam. Liq. 3Acute Tox. 4 *	H226H332	GHS02GHS07Wng	H226H332				CLP00
607-031-00-4	butyl butyrate	203-656-8	109-21-7	Flam. Liq. 3	H226	GHS02Wng	H226			C	CLP00
607-032-00-X	ethyl acrylate	205-438-8	140-88-5	Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Irrit. 2Skin Sens. 1	H225H332H312H302H335H315H319H317	GHS02GHS07Dgr	H225H332H312H302H319H335H315H317		Skin Irrit. 2; H315: C ? 5 %Eye Irrit. 2; H319: C ? 5 %STOT SE 3; H335: C ? 5 %	D	CLP00
607-033-00-5	n-butyl methacrylate	202-615-1	97-88-1	Flam. Liq. 3STOT SE 3Skin Irrit. 2Eye Irrit. 2Skin Sens. 1	H226H335H315H319H317	GHS02GHS07Wng	H226H319H335H315H317			D	CLP00
607-034-00-0	methyl acrylate; methyl propenoate	202-500-6	96-33-3	Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Irrit. 2Skin Sens. 1	H225H332H312H302H335H315H319H317	GHS02GHS07Dgr	H225H332H312H302H319H335H315H317			D	CLP00
607-035-00-6	methyl methacrylate; methyl 2-methylprop-2-enoate; methyl 2-methylpropenoate	201-297-1	80-62-6	Flam. Liq. 2STOT SE 3Skin Irrit. 2Skin Sens. 1	H225H335H315H317	GHS02GHS07Dgr	H225H335H315H317			D	CLP00
607-036-00-1	2-methoxyethyl acetate; methylglycol acetate	203-772-9	110-49-6	Repr. 1BAcute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *	H360FDH332H312H302	GHS08GHS07Dgr	H360FDH332H312H302				CLP00
607-037-00-7	2-ethoxyethyl acetate; ethylglycol acetate	203-839-2	111-15-9	Flam. Liq. 3Repr. 1BAcute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *	H226H360FDH332H312H302	GHS02GHS08GHS07Dgr	H226H360FDH332H312H302				CLP00/ATP01
607-038-00-2	2-butoxyethyl acetate; butylglycol acetate	203-933-3	112-07-2	Acute Tox. 4 *Acute Tox. 4 *	H332H312	GHS07Wng	H332H312				CLP00
607-039-00-8	"2,4-D (ISO); 2,4-dichlorophenoxyacetic acid"	202-361-1	94-75-7	Acute Tox. 4 *STOT SE 3Eye Dam. 1Skin Sens. 1Aquatic Chronic 3	H302H335H318H317H412	GHS05GHS07Dgr	H302H335H318H317H412				CLP00
607-040-00-3	"salts of 2,4-D"			Acute Tox. 4 *Eye Dam. 1Skin Sens. 1Aquatic Chronic 2	H302H318H317H411	GHS05GHS07GHS09Dgr	H302H318H317H411			A	CLP00
607-041-00-9	"2,4,5-T (ISO); 2,4,5-trichlorophenoxy acetic acid"	202-273-3	93-76-5	Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H302H335H315H319H400H410	GHS07GHS09Wng	H302H319H335H315H410				CLP00
607-042-00-4	"salts and esters of 2,4,5-T; salts and esters of 2,4,5-trichlorophenoxy acetic acid"			Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H302H335H315H319H400H410	GHS07GHS09Wng	H302H319H335H315H410			A	CLP00
607-043-00-X	"dicamba (ISO); 2,5-dichloro-6-methoxybenzoic acid; 3,6-dichloro-2-methoxybenzoic acid"	217-635-6	1918-00-9	Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 3	H302H318H412	GHS05GHS07Dgr	H302H318H412				CLP00
607-044-00-5	"3,6-dichloro-o-anisic acid, compound with dimethylamine (1:1) [1]potassium 3,6-dichloro-o-anisate  [2]"	218-951-7 [1]233-002-7 [2]	2300-66-5 [1]10007-85-9 [2]	Eye Irrit. 2Aquatic Chronic 3	H319H412	GHS07Wng	H319H412				CLP00
607-045-00-0	"dichlorprop (ISO); 2-(2,4-dichlorophenoxy) propionic acid"	204-390-5	120-36-5	Acute Tox. 4 *Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1	H312H302H315H318	GHS05GHS07Dgr	H312H302H315H318				CLP00
607-046-00-6	salts of dichlorprop			Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *	H332H312H302	GHS07Wng	H332H312H302			A	CLP00
607-047-00-1	"fenoprop (ISO); 2-(2,4,5-trichlorophenoxy)propionic acid"	202-271-2	93-72-1	Acute Tox. 4 *Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H302H315H400H410	GHS07GHS09Wng	H302H315H410				CLP00
607-048-00-7	"salts of fenoprop; salts of 2-(2,4,5-trichlorophenoxy)propionic acid"			Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H332H312H302H400H410	GHS07GHS09Wng	H332H312H302H410			A	CLP00
607-049-00-2	mecoprop (ISO); 2-(4-chloro-o-tolyloxy) propionic acid; (RS)-2-(4-chloro-o-tolyloxy)propionic acid [1]2-(4-chloro-2-methylphenoxy)propionic acid  [2]	230-386-8 [1]202-264-4 [2]	7085-19-0 [1]	Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H302H315H318H400H410	GHS05GHS07GHS09Dgr	H302H315H318H410		M=100		CLP00
607-050-00-8	salts of mecoprop			Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H302H315H318H400H410	GHS05GHS07GHS09Dgr	H302H315H318H410			A	CLP00
607-051-00-3	MCPA (ISO); 4-chloro-o-tolyloxyacetic acid	202-360-6	94-74-6	Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H302H315H318H400H410	GHS05GHS07GHS09Dgr	H302H315H318H410				CLP00/ATP01
607-052-00-9	salts and esters of MCPA	-	-	Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H332H312H302H400H410	GHS07GHS09Wng	H332H312H302H410			A	CLP00/ATP01
607-053-00-4	MCPB (ISO); 4-(4-chloro-o-tolyloxy) butyric acid	202-365-3	94-81-5	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
607-054-00-X	salts and esters of MCPB			Acute Tox. 4 *	H302	GHS07Wng	H302			A	CLP00
607-055-00-5	"endothal-sodium (ISO); disodium 7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylate"	204-959-8	129-67-9	Acute Tox. 3 *Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Irrit. 2	H301H312H335H315H319	GHS06Dgr	H301H312H319H335H315				CLP00
607-056-00-0	warfarin (ISO) [1](S)-4-hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyrone [2](R)-4-hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyrone  [3]	201-377-6 [1]226-907-3 [2]226-908-9 [3]	81-81-2 [1]5543-57-7 [2]5543-58-8 [3]	Repr. 1ASTOT RE 1Aquatic Chronic 3	H360D ***H372 **H412	GHS08Dgr	H360D ***H372 **H412				CLP00
607-057-00-6	coumachlor (ISO); 3-[1-(4-chlorophenyl)-3-oxobutyl]-4-hydroxycoumarin	201-378-1	81-82-3	STOT RE 2 *Aquatic Chronic 3	H373 **H412	GHS08Wng	H373 **H412				CLP00
607-058-00-1	coumafuryl (ISO); fumarin; (RS)-3-(1-(2-furyl)-3-oxobutyl)4-hydroxycoumarin; 4-hydroxy-3-[3-oxo-1-(2-furyl) butyl]coumarin	204-195-5	117-52-2	Acute Tox. 3 *STOT RE 1Aquatic Chronic 3	H301H372 **H412	GHS06GHS08Dgr	H301H372 **H412				CLP00
607-059-00-7	"coumatetralyl; 4-hydroxy-3-(1,2,3,4-tetrahydro-1-naphthyl)coumarin"	227-424-0	5836-29-3	Acute Tox. 1Acute Tox. 2 *STOT RE 1Aquatic Chronic 3	H310H300H372 **H412	GHS06GHS08Dgr	H310H300H372 **H412				CLP00
607-060-00-2	"dicoumarol; 4,4'-dihydroxy-3,3'-methylenebis(2H-chromen-2-one)"	200-632-9	66-76-2	Acute Tox. 4 *STOT RE 1Aquatic Chronic 2	H302H372 **H411	GHS08GHS07GHS09Dgr	H372 **H302H411				CLP00
607-061-00-8	acrylic acid; prop-2-enoic acid	201-177-9	79-10-7	Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1AAquatic Acute 1	H226H332H312H302H314H400	GHS02GHS05GHS07GHS09Dgr	H226H332H312H302H314H400		STOT SE 3; H335: C ? 1 %	D	CLP00
607-062-00-3	n-butyl acrylate	205-480-7	141-32-2	Flam. Liq. 3STOT SE 3Skin Irrit. 2Eye Irrit. 2Skin Sens. 1	H226H335H315H319H317	GHS02GHS07Wng	H226H319H335H315H317			D	CLP00
607-063-00-9	isobutyric acid	201-195-7	79-31-2	Acute Tox. 4 *Acute Tox. 4 *	H312H302	GHS07Wng	H312H302				CLP00
607-064-00-4	benzyl chloroformate	207-925-0	501-53-1	Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1	H314H400H410	GHS05GHS09Dgr	H314H410		STOT SE 3; H335: C ? 5 %		CLP00
607-065-00-X	bromoacetic acid	201-175-8	79-08-3	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Skin Corr. 1ASkin Sens. 1Aquatic Acute 1	H331H311H301H314H317H400	GHS06GHS05GHS09Dgr	H331H311H301H314H317H400				CLP00/ATP01
607-066-00-5	dichloroacetic acid	201-207-0	79-43-6	Skin Corr. 1AAquatic Acute 1	H314H400	GHS05GHS09Dgr	H314H400				CLP00
607-067-00-0	dichloroacetyl chloride	201-199-9	79-36-7	Skin Corr. 1AAquatic Acute 1	H314H400	GHS05GHS09Dgr	H314H400				CLP00
607-068-00-6	iodoacetic acid	200-590-1	64-69-7	Acute Tox. 3 *Skin Corr. 1A	H301H314	GHS06GHS05Dgr	H301H314				CLP00
607-069-00-1	ethyl bromoacetate	203-290-9	105-36-2	Acute Tox. 1Acute Tox. 2 *Acute Tox. 2 *	H310H330H300	GHS06Dgr	H330H310H300				CLP00
607-070-00-7	ethyl chloroacetate	203-294-0	105-39-5	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1	H331H311H301H400	GHS06GHS09Dgr	H331H311H301H400				CLP00
607-071-00-2	ethyl methacrylate	202-597-5	97-63-2	Flam. Liq. 2STOT SE 3Skin Irrit. 2Eye Irrit. 2Skin Sens. 1	H225H335H315H319H317	GHS02GHS07Dgr	H225H319H335H315H317			D	CLP00
607-072-00-8	2-hydroxyethyl acrylate	212-454-9	818-61-1	Acute Tox. 3 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1	H311H314H317H400	GHS06GHS05GHS09Dgr	H311H314H317H400		"*Skin Sens. 1; H317: C ? 0,2 %"	D	CLP00
607-073-00-3	4-CPA (ISO); 4-chlorophenoxyacetic acid	204-581-3	122-88-3	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
607-074-00-9	"chlorfenac (ISO); 2,3,6-trichlorophenylacetic acid"	201-599-3	85-34-7	Acute Tox. 4 *Aquatic Chronic 2	H302H411	GHS07GHS09Wng	H302H411				CLP00
607-075-00-4	chlorfenprop-methyl; methyl 2-chloro-3-(4-chlorophenyl)propionate	238-413-5	14437-17-3	Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H312H302H400H410	GHS07GHS09Wng	H312H302H410				CLP00
607-076-00-X	dodine (ISO); dodecylguanidinium acetate	219-459-5	2439-10-3	Acute Tox. 4 *Skin Irrit. 2Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H302H315H319H400H410	GHS07GHS09Wng	H302H319H315H410				CLP00
607-077-00-5	"erbon (ISO); 2-(2,4,5-trichlorophenoxy)ethyl 2,2-dichloropropionate"		136-25-4	Acute Tox. 4 *Aquatic Chronic 2	H302H411	GHS07GHS09Wng	H302H411				CLP00
607-078-00-0	fluenetil (ISO); 2-fluoroethyl biphenyl-4-ylacetate		4301-50-2	Acute Tox. 1Acute Tox. 2 *	H310H300	GHS06Dgr	H310H300				CLP00
607-079-00-6	"kelevan (ISO); ethyl 5-(perchloro-5-hydroxypentacyclo[5,3,0,02,6,03,9,04,8]decan-5-yl)-4-oxopentanoate; ethyl 5-(1,2,3,5,6,7,8,9,10,10-decachloro-4-hydroxypentacyclo(5,2,1,02,6,03,9,05,8)dec-4-yl)-4-oxovalerate"		4234-79-1	Acute Tox. 3 *Acute Tox. 4 *Aquatic Chronic 2	H311H302H411	GHS06GHS09Dgr	H311H302H411				CLP00
607-080-00-1	chloroacetyl chloride	201-171-6	79-04-9	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 1Skin Corr. 1AAquatic Acute 1	H331H311H301H372 **H314H400	GHS06GHS08GHS05GHS09Dgr	H331H311H301H372 **H314H400	EUH014EUH029			CLP00
607-081-00-7	fluoroacetic acid	205-631-7	144-49-0	Acute Tox. 2 *Aquatic Acute 1	H300H400	GHS06GHS09Dgr	H300H400				CLP00
607-082-00-2	"fluoroacetates, soluble"			Acute Tox. 2 *Aquatic Acute 1	H300H400	GHS06GHS09Dgr	H300H400			A	CLP00
607-083-00-8	"2,4-DB (ISO); 4-(2,4-dichlorophenoxy)butyric acid"	202-366-9	94-82-6	Acute Tox. 4 *Aquatic Chronic 2	H302H411	GHS07GHS09Wng	H302H411				CLP00
607-084-00-3	"salts of 2,4-DB"			Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 2	H302H318H411	GHS05GHS07GHS09Dgr	H302H318H411			A	CLP00
607-085-00-9	benzyl benzoate	204-402-9	120-51-4	Acute Tox. 4 *Aquatic Chronic 2	H302H411	GHS07GHS09Wng	H302H411				CLP00/ATP01
607-086-00-4	diallyl phthalate	205-016-3	131-17-9	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410				CLP00
607-088-00-5	methacrylic acid; 2-methylpropenoic acid	201-204-4	79-41-4	Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1A	H312H302H314	GHS05GHS07Dgr	H312H302H314		STOT SE 3; H335: C ? 1 %	D	CLP00
607-089-00-0	propionic acid … %	201-176-3	79-09-4	Skin Corr. 1B	H314	GHS05Dgr	H314		Skin Corr. 1B; H314: C ? 25 %Skin Irrit. 2; H319: 10 % ? C < 25 %Eye Irrit. 2; H319: 10 % ? C < 25 %STOT SE 3; H335: C ? 10 %	B	CLP00
607-090-00-6	thioglycolic acid	200-677-4	68-11-1	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Skin Corr. 1B	H331H311H301H314	GHS06GHS05Dgr	H331H311H301H314		*		CLP00
607-091-00-1	trifluoroacetic acid . . . %	200-929-3	76-05-1	Acute Tox. 4 *Skin Corr. 1AAquatic Chronic 3	H332H314H412	GHS05GHS07Dgr	H332H314H412		*	B	CLP00
607-092-00-7	methyl lactate [1]methyl (±)-lactate [2]methyl (R)-lactate [3]methyl (S)-(-)-lactate  [4]	208-930-0 [1]218-449-8 [2]241-420-6 [3]248-704-9 [4]	547-64-8 [1]2155-30-8 [2]17392-83-5 [3]27871-49-4 [4]	Flam. Liq. 3STOT SE 3Eye Irrit. 2	H226H335H319	GHS02GHS07Wng	H226H319H335			C	CLP00
607-093-00-2	propionyl chloride	201-170-0	79-03-8	Flam. Liq. 2Skin Corr. 1B	H225H314	GHS02GHS05Dgr	H225H314	EUH014		B D	CLP00
607-094-00-8	peracetic acid . . . %	201-186-8	79-21-0	Flam. Liq. 3Org. Perox. D ****Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1AAquatic Acute 1	H226H242H332H312H302H314H400	GHS02GHS05GHS07GHS09Dgr	H226H242H332H312H302H314H400		*STOT SE 3; H335: C ? 1 %	B D	CLP00
607-095-00-3	maleic acid	203-742-5	110-16-7	Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Irrit. 2Skin Sens. 1	H302H335H315H319H317	GHS07Wng	H302H319H335H315H317		"Skin Sens. 1; H317: C ? 0,1 %"		CLP00/ATP01
607-096-00-9	maleic anhydride	203-571-6	108-31-6	Acute Tox. 4 *Skin Corr. 1BResp. Sens. 1Skin Sens. 1	H302H314H334H317	GHS08GHS05GHS07Dgr	H302H314H334H317				CLP00
607-097-00-4	"benzene-1,2,4-tricarboxylic acid 1,2-anhydride; trimellitic anhydride"	209-008-0	552-30-7	STOT SE 3Eye Dam. 1Resp. Sens. 1Skin Sens. 1	H335H318H334H317	GHS08GHS05GHS07Dgr	H335H318H334H317				CLP00
607-098-00-X	"benzene-1,2:4,5-tetracarboxylic dianhydride; benzene-1,2:4,5-tetracarboxylic dianhydride; pyromellitic dianhydride"	201-898-9	89-32-7	Eye Dam. 1Resp. Sens. 1Skin Sens. 1	H318H334H317	GHS08GHS05Dgr	H318H334H317				CLP00
607-099-00-5	"1,2,3,6-tetrahydrophthalic anhydride [1]cis-1,2,3,6-tetrahydrophthalic anhydride [2]3,4,5,6-tetrahydrophthalic anhydride [3]tetrahydrophthalic anhydride  [4]"	201-605-4 [1]213-308-7 [2]219-374-3 [3]247-570-9 [4]	85-43-8 [1]935-79-5 [2]2426-02-0 [3]26266-63-7 [4]	Eye Dam. 1Resp. Sens. 1Skin Sens. 1Aquatic Chronic 3	H318H334H317H412	GHS08GHS05Dgr	H318H334H317H412			C	CLP00
607-100-00-9	"benzophenone-3,3',4,4'-tetracarboxylic dianhydride; 4,4'-carbonyldi(phthalic anhydride)"	219-348-1	2421-28-5	STOT SE 3Eye Irrit. 2	H335H319	GHS07Wng	H319H335		Eye Irrit. 2; H319: C ? 1 %STOT SE 3; H335: C ? 1 %		CLP00
607-101-00-4	"1,4,5,6,7,7-hexachlorobicyclo [2,2,1]hept-5-ene-2,3-dicarboxylic anhydride chlorendic anhydride"	204-077-3	115-27-5	STOT SE 3Skin Irrit. 2Eye Irrit. 2	H335H315H319	GHS07Wng	H319H335H315		Skin Irrit. 2; H315: C ? 1 %Eye Irrit. 2; H319: C ? 1 %STOT SE 3; H335: C ? 1 %		CLP00
607-102-00-X	"cyclohexane-1,2-dicarboxylic anhydride [1]cis-cyclohexane-1,2-dicarboxylic anhydride [2]trans-cyclohexane-1,2-dicarboxylic anhydride  [3]"	201-604-9 [1]236-086-3 [2]238-009-9 [3]	85-42-7 [1]13149-00-3 [2]14166-21-3 [3]	Eye Dam. 1Resp. Sens. 1Skin Sens. 1	H318H334H317	GHS08GHS05Dgr	H318H334H317			C	CLP00
607-103-00-5	succinic anhydride	203-570-0	108-30-5	Acute Tox. 4 *STOT SE 3Eye Irrit. 2	H302H335H319	GHS07Wng	H302H319H335		*Eye Irrit. 2; H319: C ? 1 %STOT SE 3; H335: C ? 1 %		CLP00/ATP01
607-104-00-0	"cyclopentane-1,2,3,4-tetracarboxylic dianhydride"	227-964-7	6053-68-5	STOT SE 3Eye Irrit. 2	H335H319	GHS07Wng	H319H335		Eye Irrit. 2; H319: C ? 1 %STOT SE 3; H335: C ? 1 %		CLP00
607-105-00-6	"8,9,10-trinorborn-5-ene-2,3-dicarboxylic anhydride [1]1,2,3,6-tetrahydro-3,6-methanophthalic anhydride [2](1?,2?,3?,6?)-1,2,3,6-tetrahydro-3,6-methanophthalic anhydride  [3]"	204-957-7 [1]212-557-9 [2]220-384-5 [3]	129-64-6 [1]826-62-0 [2]2746-19-2 [3]	Eye Dam. 1Resp. Sens. 1Skin Sens. 1	H318H334H317	GHS08GHS05Dgr	H318H334H317			C	CLP00
607-106-00-1	"8,9-dinorborn-5-ene-2,3-dicarboxylic anhydride"		123748-85-6	Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Irrit. 2Resp. Sens. 1	H302H335H315H319H334	GHS08GHS07Dgr	H302H319H335H315H334		STOT SE 3; H335: C ? 10 %	C	CLP00
607-107-00-7	2-ethylhexyl acrylate	203-080-7	103-11-7	STOT SE 3Skin Irrit. 2Skin Sens. 1	H335H315H317	GHS07Wng	H335H315H317			D	CLP00
607-108-00-2	"2-hydroxy-1-methylethylacrylate [1]2-hydroxypropylacrylate [2]acrylic acid, monoester with propane-1,2-diol  [3]"	220-852-9 [1]213-663-8 [2]247-118-0 [3]	2918-23-2 [1]999-61-1 [2]25584-83-2 [3]	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Skin Corr. 1BSkin Sens. 1	H331H311H301H314H317	GHS06GHS05Dgr	H331H311H301H314H317		"*Skin Sens. 1; H317: C ? 0,2 %"	C D	CLP00
607-109-00-8	"hexamethylene diacrylate; hexane-1,6-diol diacrylate"	235-921-9	13048-33-4	Skin Irrit. 2Eye Irrit. 2Skin Sens. 1	H315H319H317	GHS07Wng	H319H315H317			D	CLP00
607-110-00-3	pentaerythritol triacrylate	222-540-8	3524-68-3	Skin Irrit. 2Eye Irrit. 2Skin Sens. 1	H315H319H317	GHS07Wng	H319H315H317			D	CLP00
607-111-00-9	"2,2-bis(acryloyloxymethyl)butyl acrylate; trimethylolpropane triacrylate"	239-701-3	15625-89-5	Skin Irrit. 2Eye Irrit. 2Skin Sens. 1	H315H319H317	GHS07Wng	H319H315H317			D	CLP00
607-112-00-4	"2,2-dimethyltrimethylene diacrylate; neopentyl glycol diacrylate"	218-741-5	2223-82-7	Acute Tox. 3 *Skin Irrit. 2Eye Irrit. 2Skin Sens. 1	H311H315H319H317	GHS06Dgr	H311H319H315H317		*	D	CLP00
607-113-00-X	isobutyl methacrylate	202-613-0	97-86-9	Flam. Liq. 3STOT SE 3Skin Irrit. 2Eye Irrit. 2Skin Sens. 1Aquatic Acute 1	H226H335H315H319H317H400	GHS02GHS07GHS09Wng	H226H319H335H315H317H400			D	CLP00
607-114-00-5	ethylene dimethacrylate	202-617-2	97-90-5	STOT SE 3Skin Sens. 1	H335H317	GHS07Wng	H335H317		STOT SE 3; H335: C ? 10 %	D	CLP00
607-115-00-0	isobutyl acrylate	203-417-8	106-63-8	Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *Skin Irrit. 2Skin Sens. 1	H226H332H312H315H317	GHS02GHS07Wng	H226H332H312H315H317			D	CLP00
607-116-00-6	cyclohexyl acrylate	221-319-3	3066-71-5	STOT SE 3Skin Irrit. 2Aquatic Chronic 2	H335H315H411	GHS07GHS09Wng	H335H315H411		STOT SE 3; H335: C ? 10 %	D	CLP00
607-117-00-1	"2,3-epoxypropyl acrylate; glycidyl acrylate"	203-440-3	106-90-1	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Skin Corr. 1BSkin Sens. 1	H331H311H301H314H317	GHS06GHS05Dgr	H331H311H301H314H317		"*Skin Sens. 1; H317: C ? 0,2 %"	D	CLP00
607-118-00-7	"1-methyltrimethylene diacrylate; 1,3-butylene glycol diacrylate"	243-105-9	19485-03-1	Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1	H312H314H317	GHS05GHS07Dgr	H312H314H317			D	CLP00
607-119-00-2	"tetramethylene diacrylate; 1,4-butyleneglycol diacrylate"	213-979-6	1070-70-8	Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1	H312H314H317	GHS05GHS07Dgr	H312H314H317			D	CLP00
607-120-00-8	"2,2'-oxydiethyl diacrylate; diethylene glycol diacrylate"	223-791-6	4074-88-8	Acute Tox. 3 *Skin Irrit. 2Eye Irrit. 2Skin Sens. 1	H311H315H319H317	GHS06Dgr	H311H319H315H317		"*Skin Sens. 1; H317: C ? 0,2 %"	D	CLP00
607-121-00-3	"8,9,10-trinorborn-2-yl acrylate"		10027-06-2	Acute Tox. 4 *Skin Irrit. 2Skin Sens. 1	H312H315H317	GHS07Wng	H312H315H317			D	CLP00
607-122-00-9	pentaerythritol tetraacrylate	225-644-1	4986-89-4	Skin Irrit. 2Eye Irrit. 2Skin Sens. 1	H315H319H317	GHS07Wng	H319H315H317			D	CLP00
607-123-00-4	"2,3-epoxypropyl methacrylate; glycidyl methacrylate"	203-441-9	106-91-2	Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Skin Irrit. 2Eye Irrit. 2Skin Sens. 1	H332H312H302H315H319H317	GHS07Wng	H332H312H302H319H315H317			D	CLP00
607-124-00-X	2-hydroxyethyl methacrylate	212-782-2	868-77-9	Skin Irrit. 2Eye Irrit. 2Skin Sens. 1	H315H319H317	GHS07Wng	H319H315H317			D	CLP00
607-125-00-5	2-hydroxypropyl methacrylate [1]3-hydroxypropyl methacrylate  [2]	213-090-3 [1]220-426-2 [2]	923-26-2 [1]2761-09-3 [2]	Eye Irrit. 2Skin Sens. 1	H319H317	GHS07Wng	H319H317			C D	CLP00
607-126-00-0	"2,2'-(ethylenedioxy)diethyl diacrylate; triethylene glycol diacrylate"	216-853-9	1680-21-3	Skin Irrit. 2Eye Irrit. 2Skin Sens. 1	H315H319H317	GHS07Wng	H319H315H317			D	CLP00
607-127-00-6	2-diethylaminoethyl methacrylate	203-275-7	105-16-8	Acute Tox. 4 *Skin Irrit. 2Eye Irrit. 2Skin Sens. 1	H332H315H319H317	GHS07Wng	H332H319H315H317			D	CLP00
607-128-00-1	2-tert-butylaminoethyl methacrylate	223-228-4	3775-90-4	Skin Irrit. 2Eye Irrit. 2Skin Sens. 1	H315H319H317	GHS07Wng	H319H315H317			D	CLP00
607-129-00-7	ethyl lactate; ethyl DL-lactate [1]ethyl (S)-2-hydroxypropionate; ethyl L-lactate; ethyl-(S)-lactate  [2]	202-598-0 [1]211-694-1 [2]	97-64-3 [1]687-47-8 [2]	Flam. Liq. 3STOT SE 3Eye Dam. 1	H226H335H318	GHS02GHS05GHS07Dgr	H226H335H318			C	CLP00
607-130-00-2	pentyl acetate [1]isopentyl acetate [2]1-methylbutyl acetate [3]2-methylbutyl acetat [4]2(or 3)-methylbutyl acetate  [5]	211-047-3 [1]204-662-3 [2]210-946-8 [3]210-843-8 [4]282-263-3 [5]	628-63-7 [1]123-92-2 [2]626-38-0 [3]624-41-9 [4]84145-37-9 [5]	Flam. Liq. 3	H226	GHS02Wng	H226	EUH066		C	CLP00
607-131-00-8	isopentyl propionate [1]pentyl propionate [2]2-methylbutyl propionate  [3]	203-322-1 [1]210-852-7 [2]219-449-0 [3]	105-68-0 [1]624-54-4 [2]2438-20-2 [3]	Flam. Liq. 3	H226	GHS02Wng	H226			C	CLP00
607-132-00-3	2-dimethylaminoethyl methacrylate	220-688-8	2867-47-2	Acute Tox. 4 *Acute Tox. 4 *Skin Irrit. 2Eye Irrit. 2Skin Sens. 1	H312H302H315H319H317	GHS07Wng	H312H302H319H315H317			D	CLP00
607-133-00-9	monoalkyl or monoaryl or monoalkylaryl esters of acrylic acid with the exception of those specified elsewhere in this Annex			STOT SE 3Skin Irrit. 2Eye Irrit. 2Aquatic Chronic 2	H335H315H319H411	GHS07GHS09Wng	H319H335H315H411		STOT SE 3; H335: C ? 10 %	A	CLP00
607-134-00-4	monoalkyl or monoaryl or monoalkyaryl esters of methacrylic acid with the exception of those specified elsewhere in this Annex			STOT SE 3Skin Irrit. 2Eye Irrit. 2	H335H315H319	GHS07Wng	H319H335H315		STOT SE 3; H335: C ? 10 %	A	CLP00
607-135-00-X	butyric acid	203-532-3	107-92-6	Skin Corr. 1B	H314	GHS05Dgr	H314				CLP00
607-136-00-5	butyryl chloride	205-498-5	141-75-3	Flam. Liq. 2Skin Corr. 1B	H225H314	GHS02GHS05Dgr	H225H314				CLP00
607-137-00-0	methyl acetoacetate	203-299-8	105-45-3	Eye Irrit. 2	H319	GHS07Wng	H319				CLP00
607-138-00-6	butyl chloroformate; chloroformic acid butyl ester	209-750-5	592-34-7	Flam. Liq. 3Acute Tox. 3 *Skin Corr. 1B	H226H331H314	GHS02GHS06GHS05Dgr	H226H331H314				CLP00
607-139-00-1	2-chloropropionic acid	209-952-3	598-78-7	Acute Tox. 4 *Skin Corr. 1A	H302H314	GHS05GHS07Dgr	H302H314				CLP00
607-140-00-7	isobutyryl chloride	201-194-1	79-30-1	Flam. Liq. 2Skin Corr. 1A	H225H314	GHS02GHS05Dgr	H225H314				CLP00
607-141-00-2	oxydiethylene bis(chloroformate)	203-430-9	106-75-2	Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1Aquatic Chronic 2	H302H315H318H411	GHS05GHS07GHS09Dgr	H302H315H318H411				CLP00
607-142-00-8	propyl chloroformate; chloroformic acid propylester; n-propyl chloroformate	203-687-7	109-61-5	Flam. Liq. 2Acute Tox. 3 *Skin Corr. 1B	H225H331H314	GHS02GHS06GHS05Dgr	H225H331H314				CLP00/ATP01
607-143-00-3	valeric acid	203-677-2	109-52-4	Skin Corr. 1BAquatic Chronic 3	H314H412	GHS05Dgr	H314H412				CLP00
607-144-00-9	adipic acid	204-673-3	124-04-9	Eye Irrit. 2	H319	GHS07Wng	H319				CLP00
607-145-00-4	methanesulphonic acid	200-898-6	75-75-2	Skin Corr. 1B	H314	GHS05Dgr	H314				CLP00
607-146-00-X	fumaric acid	203-743-0	110-17-8	Eye Irrit. 2	H319	GHS07Wng	H319				CLP00
607-147-00-5	oxalic acid diethylester; diethyl oxalate	202-464-1	95-92-1	Acute Tox. 4 *Eye Irrit. 2	H302H319	GHS07Wng	H302H319				CLP00
607-148-00-0	guanidinium chloride; guanadine hydrochloride	200-002-3	50-01-1	Acute Tox. 4 *Skin Irrit. 2Eye Irrit. 2	H302H315H319	GHS07Wng	H302H319H315				CLP00
607-149-00-6	urethane (INN); ethyl carbamate	200-123-1	51-79-6	Carc. 1B	H350	GHS08Dgr	H350				CLP00
607-150-00-1	"endothal (ISO); 7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylic acid"	205-660-5	145-73-3	Acute Tox. 3 *Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Irrit. 2	H301H312H335H315H319	GHS06Dgr	H301H312H319H335H315				CLP00
607-151-00-7	propargite (ISO); 2-(4-tert-butylphenoxy) cyclohexyl prop-2-ynyl sulphite	219-006-1	2312-35-8	Carc. 2Acute Tox. 3 *Skin Irrit. 2Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H351H331H315H318H400H410	GHS06GHS08GHS05GHS09Dgr	H351H331H315H318H410		M=10		CLP00
607-152-00-2	"2,3,6-TBA (ISO); 2,3,6-trichlorobenzoic acid"	200-026-4	50-31-7	Acute Tox. 4 *Aquatic Chronic 2	H302H411	GHS07GHS09Wng	H302H411				CLP00
607-153-00-8	"benazolin (ISO); 4-chloro-2,3-dihydro-2-oxo-1,3-benzothiazol-3-ylacetic acid"	223-297-0	3813-05-6	Skin Irrit. 2Eye Irrit. 2Aquatic Chronic 3	H315H319H412	GHS07Wng	H319H315H412				CLP00
607-154-00-3	"ethyl N-benzoyl-N-(3,4-dichlorophenyl)-DL-alaninate; benzoylprop-ethyl (ISO)"	244-845-5	22212-55-1	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410				CLP00
607-155-00-9	"3-(3-amino-5-(1-methylguanidino)-1-oxopentylamino-6-(4-amino-2-oxo-2,3-dihydro-pyrimidin-1-yl)-2,3-dihydro-(6H)-pyran-2-carboxylic acid; blasticidin-s"		2079-00-7	Acute Tox. 2 *	H300	GHS06Dgr	H300				CLP00
607-156-00-4	chlorfenson (ISO); 4-chlorophenyl 4-chlorobenzenesulfonate	201-270-4	80-33-1	Acute Tox. 4 *Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H302H315H400H410	GHS07GHS09Wng	H302H315H410				CLP00
607-157-00-X	"3-(3-biphenyl-4-yl-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxycoumarin; difenacoum"	259-978-4	56073-07-5	Acute Tox. 2 *STOT RE 1Aquatic Acute 1Aquatic Chronic 1	H300H372 **H400H410	GHS06GHS08GHS09Dgr	H300H372 **H410				CLP00
607-158-00-5	sodium salt of chloroacetic acid; sodium chloroacetate	223-498-3	3926-62-3	Acute Tox. 3 *Skin Irrit. 2Aquatic Acute 1	H301H315H400	GHS06GHS09Dgr	H301H315H400				CLP00
607-159-00-0	"chlorobenzilate (ISO); ethyl 2,2-di(4-chlorophenyl)-2-hydroxyacetate; ethyl 4,4'-dichlorobenzilate"	208-110-2	510-15-6	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410				CLP00
607-160-00-6	isobutyl 2-(4-(4-chlorophenoxy)phenoxy)propionate; clofop-isobutyl (ISO)		51337-71-4	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
607-161-00-1	diethanolamine salt of 4-CPA			Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
607-162-00-7	"dalapon; 2,2-dichloropropionic acid [1]dalapon-sodium; sodium 2,2-dichloropropionate  [2]"	200-923-0 [1]204-828-5 [2]	75-99-0 [1]127-20-8 [2]	Skin Irrit. 2Eye Dam. 1Aquatic Chronic 3	H315H318H412	GHS05Dgr	H315H318H412				CLP00/ATP01
607-163-00-2	"3-acetyl-6-methyl-2H-pyran-2,4(3H)-dione; dehydracetic acid"	208-293-9	520-45-6	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
607-164-00-8	"sodium 1-(3,4-dihydro-6-methyl-2,4-dioxo-2H-pyran-3-ylidene)ethonolate; sodium dehydracetate"	224-580-1	4418-26-2	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
607-165-00-3	"diclofop-methyl (ISO); methyl 2-(4-(2,4-dichlorophenoxy)phenoxy)propionate; methyl (RS)-2-[4-(2,4-dichlorophenoxy)phenoxy]propionate"	257-141-8	51338-27-3	Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H317H400H410	GHS07GHS09Wng	H302H317H410				CLP00
607-166-00-9	"medinoterb acetate (ISO); 6-tert-butyl-3-methyl-2,4-dinitrophenyl acetate"	219-634-6	2487-01-6	Acute Tox. 3 *Acute Tox. 4 *	H301H312	GHS06Dgr	H301H312				CLP00
607-167-00-4	sodium 3-chloroacrylate		4312-97-4	Acute Tox. 4 *Acute Tox. 4 *	H312H302	GHS07Wng	H312H302				CLP00
607-168-00-X	"dipropyl 6,7-methylenedioxy-1,2,3,4-tetrahydro-3-methylnaphthalene-1,2-dicarboxylate; propylisome"		83-59-0	Acute Tox. 3 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H311H302H400H410	GHS06GHS09Dgr	H311H302H410				CLP00
607-169-00-5	sodium fluoroacetate	200-548-2	62-74-8	Acute Tox. 1Acute Tox. 2 *Acute Tox. 2 *Aquatic Acute 1	H310H330H300H400	GHS06GHS09Dgr	H330H310H300H400				CLP00
607-170-00-0	"bis(1,2,3-trithiacyclohexyldimethylammonium) oxalate; thiocyclam-oxalate"	250-859-2	31895-22-4	Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H312H302H400H410	GHS07GHS09Wng	H312H302H410				CLP00
607-172-00-1	"4-hydroxy-3-(3-(4'-bromo-4-biphenylyl)-1,2,3,4-tetrahydro-1-naphthyl)coumarin; brodifacoum"	259-980-5	56073-10-0	Acute Tox. 1Acute Tox. 2 *STOT RE 1Aquatic Acute 1Aquatic Chronic 1	H310H300H372 **H400H410	GHS06GHS08GHS09Dgr	H310H300H372 **H410				CLP00
607-173-00-7	dimethyl (3-methyl-4-(5-nitro-3-ethoxycarbonyl-2-thienyl)azo)phenylnitrilodipropionate	400-460-6		Skin Sens. 1Aquatic Chronic 3	H317H412	GHS07Wng	H317H412				CLP00
607-174-00-2	"reaction mass of dodecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate and tetradecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate"	400-580-9		Skin Irrit. 2Aquatic Chronic 2	H315H411	GHS07GHS09Wng	H315H411				CLP00
607-175-00-8	methyl 2-(2-nitrobenzylidene)acetoacetate	400-650-9	39562-27-1	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				CLP00
607-176-00-3	reaction mass of ?-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-?-hydroxypoly(oxyethylene) and ?-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-?-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyloxypoly(oxyethylene)	400-830-7		Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				CLP00
607-177-00-9	"tribenuron-methyl (ISO); methyl 2-[N-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-N-methylcarbamoylsulfamoyl]benzoate"	401-190-1	101200-48-0	Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410		M=100		CLP00/ATP01corr
607-178-00-4	"methyl ?-((4,6-dimethoxypyrimidin-2-yl)ureidosulphonyl)-o-toluate"	401-340-6	83055-99-6	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				CLP00
607-179-00-X	(benzothiazol-2-ylthio)succinic acid	401-450-4	95154-01-1	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
607-180-00-5	potassium 2-hydroxycarbazole-1-carboxylate	401-630-2	96566-70-0	Acute Tox. 4 *STOT SE 3Eye Irrit. 2Aquatic Chronic 3	H302H335H319H412	GHS07Wng	H302H319H335H412				CLP00
607-181-00-0	"3,5-dichloro-2,4-difluorobenzoyl fluoride"	401-800-6	101513-70-6	Acute Tox. 3 *Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Chronic 3	H331H302H314H317H412	GHS06GHS05Dgr	H331H314H302H317H412	EUH029			CLP00
607-182-00-6	methyl 3-sulphamoyl-2-thenoate	402-050-2		Skin Sens. 1	H317	GHS07Wng	H317				CLP00
607-183-00-1	zinc 2-hydroxy-5-C13-18alkylbenzoate	402-280-3		Skin Irrit. 2Eye Irrit. 2Aquatic Chronic 2	H315H319H411	GHS07GHS09Wng	H319H315H411				CLP00
607-184-00-7	"S-(3-trimethoxysilyl)propyl 19-isocyanato-11-(6-isocyanatohexyl)-10,12-dioxo-2,9,11,13-tetraazanonadecanethioate"	402-290-8	85702-90-5	Flam. Liq. 3Resp. Sens. 1Skin Sens. 1	H226H334H317	GHS02GHS08Dgr	H226H334H317				CLP00
607-185-00-2	ethyl trans-3-dimethylaminoacrylate	402-650-4	1117-37-9	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
607-186-00-8	"quinclorac (ISO); 3,7-dichloroquinoline-8-carboxylic acid"	402-780-1	84087-01-4	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
607-187-00-3	"bis(2,2,6,6-tetramethyl-4-piperidyl) succinate"	402-940-0	62782-03-0	Eye Irrit. 2Aquatic Chronic 3	H319H412	GHS07Wng	H319H412				CLP00
607-188-00-9	hydrogen sodium N-carboxylatoethyl-N-octadec-9-enylmaleamate	402-970-4		Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				CLP00
607-189-00-4	trimethylenediaminetetraacetic acid	400-400-9	1939-36-2	Acute Tox. 4 *Eye Dam. 1	H302H318	GHS05GHS07Dgr	H302H318				CLP00/ATP01
607-190-00-X	"methyl acrylamidomethoxyacetate (containing ? 0,1 % acrylamid)"	401-890-7	77402-03-0	Carc. 1BMuta. 1BAcute Tox. 4 *Eye Irrit. 2	H350H340H302H319	GHS08GHS07Dgr	H350H340H302H319				CLP00
607-191-00-5	"isobutyl 3,4-epoxybutyrate"	401-920-9	100181-71-3	Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H315H317H400H410	GHS07GHS09Wng	H315H317H410				CLP00
607-192-00-0	disodium N-carboxymethyl-N-(2-(2-hydroxyethoxy)ethyl)glycinate	402-360-8	92511-22-3	Eye Dam. 1	H318	GHS05Dgr	H318				CLP00
607-194-00-1	propylene carbonate	203-572-1	108-32-7	Eye Irrit. 2	H319	GHS07Wng	H319				CLP00
607-195-00-7	2-methoxy-1-methylethyl acetate	203-603-9	108-65-6	Flam. Liq. 3	H226	GHS02Wng	H226				CLP00/ATP01
607-196-00-2	heptanoic acid	203-838-7	111-14-8	Skin Corr. 1B	H314	GHS05Dgr	H314				CLP00
607-197-00-8	nonanoic acid	203-931-2	112-05-0	Skin Irrit. 2Eye Irrit. 2Aquatic Chronic 3	H315H319H412	GHS07Wng	H315H319H412				CLP00/ATP07
607-198-00-3	"propyl 3,4,5-trihydroxybenzoate"	204-498-2	121-79-9	Acute Tox. 4 *Skin Sens. 1	H302H317	GHS07Wng	H302H317				CLP00
607-199-00-9	"octyl 3,4,5-trihydroxybenzoate"	213-853-0	1034-01-1	Acute Tox. 4 *Skin Sens. 1	H302H317	GHS07Wng	H302H317				CLP00
607-200-00-2	"dodecyl 3,4,5-trihydroxybenzoate"	214-620-6	1166-52-5	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
607-201-00-8	thiocarbonyl chloride	207-341-6	463-71-8	Acute Tox. 3 *Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Irrit. 2	H331H302H335H315H319	GHS06Dgr	H331H302H319H335H315				CLP00
607-203-00-9	"2-ethylhexyl[[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl]thio]acetate"	279-452-8	80387-97-9	Repr. 1BSkin Sens. 1Aquatic Chronic 3	H360D ***H317H412	GHS08GHS07Dgr	H360D ***H317H412				CLP00
607-204-00-4	"(chlorophenyl)(chlorotolyl)methane, mixed isomers"	400-140-6		Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
607-205-00-X	methyl chloroacetate	202-501-1	96-34-4	Flam. Liq. 3Acute Tox. 3 *Acute Tox. 3 *STOT SE 3Skin Irrit. 2Eye Dam. 1	H226H331H301H335H315H318	GHS02GHS06GHS05Dgr	H226H331H301H335H315H318				CLP00
607-206-00-5	isopropyl chloroacetate	203-301-7	105-48-6	Flam. Liq. 3Acute Tox. 3 *STOT SE 3Skin Irrit. 2Eye Irrit. 2	H226H301H335H315H319	GHS02GHS06Dgr	H226H301H319H335H315				CLP00
607-207-00-0	haloxyfop-etotyl (ISO); 2-ethoxyethyl 2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate; haloxyfop-(2-ethoxyethyl)	402-560-5	87237-48-7	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410				CLP00
607-208-00-6	"4,8,12-trimethyltrideca-3,7,11-trienoic acid, mixed isomers"	403-000-2	91853-67-7	Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H315H400H410	GHS07GHS09Wng	H315H410				CLP00
607-209-00-1	"reaction mass of O,O'-diisopropyl (pentathio)dithioformate and O,O'-diisopropyl (trithio)dithioformate and O,O'-diisopropyl (tetrathio)dithioformate"	403-030-6		Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H317H400H410	GHS07GHS09Wng	H302H317H410				CLP00
607-210-00-7	"methyl acrylamidoglycolate (containing ? 0,1 % acrylamide)"	403-230-3	77402-05-2	Carc. 1BMuta. 1BSkin Corr. 1BSkin Sens. 1	H350H340H314H317	GHS08GHS05GHS07Dgr	H350H340H314H317				CLP00
607-211-00-2	methyl 3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionate	403-270-1	6386-39-6	Acute Tox. 4 *Aquatic Chronic 2	H302H411	GHS07GHS09Wng	H302H411				CLP00
607-212-00-8	"poly(oxypropylenecarbonyl-co-oxy(ethylethylene)carbonyl), containing 27 % hydroxyvalerate"	403-300-3		Skin Sens. 1	H317	GHS07Wng	H317				CLP00
607-213-00-3	"ethyl 3,3-bis(tert-pentylperoxy)butyrate"	403-320-2	67567-23-1	Flam. Liq. 3Org. Perox. D ****Aquatic Chronic 2	H226H242H411	GHS02GHS09Dgr	H242H226H411				CLP00/ATP01
607-214-00-9	"N,N-hydrazinodiacetic acid"	403-510-5	19247-05-3	Acute Tox. 3 *STOT RE 2 *Skin Sens. 1Aquatic Chronic 3	H301H373 **H317H412	GHS06GHS08Dgr	H301H373 **H317H412				CLP00
607-215-00-4	3-(3-tert-butyl-4-hydroxyphenyl)propionic acid	403-920-4	107551-67-7	Acute Tox. 4 *Eye Irrit. 2	H302H319	GHS07Wng	H302H319				CLP00
607-216-00-X	"glutamic acid, reaction products with N-(C12-14-alkyl)propylenediamine"	403-950-8	-	Acute Tox. 2 *Acute Tox. 4 *Skin Corr. 1BAquatic Acute 1	H330H302H314H400	GHS06GHS05GHS09Dgr	H330H302H314H400				CLP00/ATP01
607-217-00-5	"2-ethoxyethyl 2-(4-(2,6-dihydro-2,6-dioxo-7-phenyl-1,5-dioxaindacen-3-yl)phenoxy)acetate"	403-960-2		Skin Sens. 1Aquatic Chronic 4	H317H413	GHS07Wng	H317H413				CLP00
607-218-00-0	"dichlorprop-P (ISO); (+)-R-2-(2,4-dichlorophenoxy)propionic acid"	403-980-1	15165-67-0	Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1Skin Sens. 1	H302H315H318H317	GHS05GHS07Dgr	H302H315H318H317				CLP00
607-219-00-6	bis(2-ethylhexyl) dithiodiacetate	404-510-8	62268-47-7	Acute Tox. 4 *Skin Sens. 1Aquatic Chronic 2	H302H317H411	GHS07GHS09Wng	H302H317H411				CLP00
607-221-00-7	6-docosyloxy-1-hydroxy-4-(1-(4-hydroxy-3-methylphenanthren-1-yl)-3-oxo-2-oxaphenalen-1-yl)naphthalene-2-carboxylic acid	404-550-6		Skin Sens. 1Aquatic Chronic 4	H317H413	GHS07Wng	H317H413				CLP00
607-222-00-2	"6-(2,3-dimethylmaleimido)hexyl methacrylate"	404-870-6	63740-41-0	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				CLP00
607-223-00-8	"transfluthrin (ISO); 2,3,5,6-tetrafluorobenzyl trans-2-(2,2-dichlorovinyl)-3,3-dimethylcyclopropanecarboxylate"	405-060-5	118712-89-3	Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H315H400H410	GHS07GHS09Wng	H315H410				CLP00
607-224-00-3	methyl 2-(3-nitrobenzylidene)acetoacetate	405-270-7	39562-17-9	Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410				CLP00
607-225-00-9	3-azidosulfonylbenzoic acid	405-310-3	15980-11-7	STOT RE 2 *Eye Dam. 1Skin Sens. 1Self-React. C ****	H373 **H318H317H241	GHS02GHS08GHS05GHS07Dgr	H241H373 **H318H317				CLP00
607-226-00-4	"reaction mass of 2-acryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate and 2-methacryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate"	405-360-6		Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Chronic 3	H315H318H317H412	GHS05GHS07Dgr	H315H318H317H412				CLP00
607-227-00-X	potassium 2-amino-2-methylpropionate octahydrate	405-560-3	120447-91-8	Acute Tox. 4 *Skin Corr. 1A	H302H314	GHS05GHS07Dgr	H302H314				CLP00
607-228-00-5	bis(2-methoxyethyl) phthalate	204-212-6	117-82-8	Repr. 1B	H360Df	GHS08Dgr	H360Df				CLP00
607-229-00-0	diethylcarbamoyl chloride	201-798-5	88-10-8	Carc. 2Acute Tox. 4 *Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Irrit. 2	H351H332H302H335H315H319	GHS08GHS07Wng	H351H332H302H319H335H315				CLP00
607-230-00-6	2-ethylhexanoic acid	205-743-6	149-57-5	Repr. 2	H361d ***	GHS08Wng	H361d ***				CLP00
607-231-00-1	"clopyralid (ISO); 3,6-dichloropyridine-2-carboxylic acid"	216-935-4	1702-17-6	Eye Dam. 1	H318	GHS05Dgr	H318				CLP00/ATP01
607-232-00-7	pyridate (ISO); O-(6-chloro-3-phenylpyridazin-4-yl) S-octyl thiocarbonate	259-686-7	55512-33-9	Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H315H317H400H410	GHS07GHS09Wng	H315H317H410				CLP00
607-233-00-2	hexyl acrylate	219-698-5	2499-95-8	STOT SE 3Skin Irrit. 2Eye Irrit. 2Skin Sens. 1Aquatic Chronic 2	H335H315H319H317H411	GHS07GHS09Wng	H319H335H315H317H411				CLP00
607-234-00-8	flurenol (ISO); 9-hydroxy-9H-fluorene-9-carboxylic acid	207-397-1	467-69-6	Aquatic Chronic 2	H411	GHS09	H411				CLP00
607-235-00-3	mecrilate; methyl 2-cyanoacrylate	205-275-2	137-05-3	STOT SE 3Skin Irrit. 2Eye Irrit. 2	H335H315H319	GHS07Wng	H319H335H315		STOT SE 3; H335: C ? 10 %		CLP00
607-236-00-9	ethyl 2-cyanoacrylate	230-391-5	7085-85-0	STOT SE 3Skin Irrit. 2Eye Irrit. 2	H335H315H319	GHS07Wng	H319H335H315		STOT SE 3; H335: C ? 10 %		CLP00
607-237-00-4	benzyl 2-chloro-4-(trifluoromethyl)thiazole-5-carboxylate; flurazole	276-942-3	72850-64-7	Aquatic Chronic 2	H411	GHS09	H411				CLP00
607-238-00-X	tau-fluvalinate (ISO); cyano-(3-phenoxyphenyl)methyl N-[2-chloro-4-(trifluoromethyl)phenyl]-D-valinate		102851-06-9	Acute Tox. 4 *Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H302H315H400H410	GHS07GHS09Wng	H302H315H410				CLP00
607-239-00-5	"fenpropathrin (ISO); ?-cyano-3-phenoxybenzyl 2,2,3,3-tetramethylcyclopropanecarboxylate"	254-485-0	39515-41-8	Acute Tox. 2 *Acute Tox. 3 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H330H301H312H400H410	GHS06GHS09Dgr	H330H301H312H410				CLP00
607-240-00-0	"cis-1,2,3,6-tetrahydro-4-methylphthalic anhydride [1]1,2,3,6-tetrahydro-4-methylphthalic anhydride [2]1,2,3,6-tetrahydro-3-methylphthalic anhydride [3]tetrahydromethylphthalic anhydride [4]1,2,3,6-tetrahydromethylphthalic anhydride [5]tetrahydro-4-methylphthalic anhydride [6]2,3,5,6-tetrahydro-2-methylphthalic anhydride  [7]"	216-906-6 [1]222-323-8 [2]226-247-6 [3]234-290-7 [4]247-830-1 [5]251-823-9 [6]255-853-3 [7]	1694-82-2 [1]3425-89-6 [2]5333-84-6 [3]11070-44-3 [4]26590-20-5 [5]34090-76-1 [6]42498-58-8 [7]	Eye Dam. 1Resp. Sens. 1Skin Sens. 1	H318H334H317	GHS08GHS05Dgr	H318H334H317			C	CLP00
607-241-00-6	hexahydro-4-methylphthalic anhydride [1]hexahydromethylphthalic anhydride [2]hexahydro-1-methylphthalic anhydride [3]hexahydro-3-methylphthalic anhydride  [4]	243-072-0 [1]247-094-1 [2]256-356-4 [3]260-566-1 [4]	19438-60-9 [1]25550-51-0 [2]48122-14-1 [3]57110-29-9 [4]	Eye Dam. 1Resp. Sens. 1Skin Sens. 1	H318H334H317	GHS08GHS05Dgr	H318H334H317			C	CLP00
607-242-00-1	tetrachlorophthalic anhydride	204-171-4	117-08-8	Eye Dam. 1Resp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H318H334H317H400H410	GHS08GHS05GHS09Dgr	H318H334H317H410				CLP00
607-243-00-7	"sodium 3,6-dichloro-o-anisate [1]3,6-dichloro-o-anisic acid, compound with 2,2'-iminodiethanol (1:1) [2]3,6-dichloro-o-anisic acid, compound with 2-aminoethanol (1:1)  [3]"	217-846-3 [1]246-590-5 [2]258-527-9 [3]	1982-69-0 [1]25059-78-3 [2]53404-28-7 [3]	Aquatic Chronic 3	H412		H412				CLP00
607-244-00-2	isooctyl acrylate	249-707-8	29590-42-9	STOT SE 3Skin Irrit. 2Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H335H315H319H400H410	GHS07GHS09Wng	H319H335H315H410		STOT SE 3; H335: C ? 10 %		CLP00
607-245-00-8	tert-butyl acrylate	216-768-7	1663-39-4	Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *STOT SE 3Skin Irrit. 2Skin Sens. 1Aquatic Chronic 2	H225H332H312H302H335H315H317H411	GHS02GHS07GHS09Dgr	H225H302H312H332H315H317H335H411			D	CLP00/ATP01corr
607-246-00-3	allyl methacrylate; 2-methyl-2-propenoic acid 2-propenyl ester	202-473-0	96-05-9	Flam. Liq. 3Acute Tox. 3 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1	H226H331H312H302H400	GHS02GHS06GHS09Dgr	H226H331H312H302H400				CLP00
607-247-00-9	dodecyl methacrylate	205-570-6	142-90-5	STOT SE 3Skin Irrit. 2Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H335H315H319H400H410	GHS07GHS09Wng	H319H335H315H410		STOT SE 3; H335: C ? 10 %		CLP00
607-248-00-4	naptalam-sodium (ISO); sodium N-naphth-1-ylphthalamate	205-073-4	132-67-2	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
607-249-00-X	"(1-methyl-1,2-ethanediyl)bis[oxy(methyl-2,1-ethanediyl)] diacrylate"	256-032-2	42978-66-5	STOT SE 3Skin Irrit. 2Eye Irrit. 2Skin Sens. 1Aquatic Chronic 2	H335H315H319H317H411	GHS07GHS09Wng	H319H335H315H317H411		STOT SE 3; H335: C ? 10 %		CLP00
607-250-00-5	"4H-3,1-benzoxazine-2,4(1H)-dione"	204-255-0	118-48-9	Eye Irrit. 2Skin Sens. 1	H319H317	GHS07Wng	H319H317				CLP00
607-251-00-0	2-methoxypropyl acetate	274-724-2	70657-70-4	Flam. Liq. 3Repr. 1BSTOT SE 3	H226H360D ***H335	GHS02GHS08GHS07Dgr	H226H360D ***H335				CLP00
607-252-00-6	"lambda-cyhalothrin (ISO); reaction mass of (S)-?-cyano-3-phenoxybenzyl(Z)-(1R)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate and (R)-?-cyano-3-phenoxybenzyl (Z)-(1S)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate (1:1)"	415-130-7	91465-08-6	Acute Tox. 2 *Acute Tox. 3 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H330H301H312H400H410	GHS06GHS09Dgr	H330H301H312H410		M=10000		CLP00/ATP01
607-253-00-1	"cyfluthrin (ISO); ?-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate"	269-855-7	68359-37-5	Acute Tox. 2 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H300H331H400H410	GHS06GHS09Dgr	H300H331H410		M=1000		CLP00/ATP01
607-254-00-7	"?-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate; beta-cyfluthrin"	269-855-7	68359-37-5	Acute Tox. 2 *Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1	H330H300H400H410	GHS06GHS09Dgr	H330H300H410				CLP00
607-255-00-2	"fluroxypyr (ISO); 4-amino-3,5-dichloro-6-fluoro-2-pyridyloxyacetic acid"		69377-81-7	Aquatic Chronic 3	H412		H412				CLP00
607-256-00-8	azoxystrobin (ISO); methyl (E)-2-{}{2-[6-(2-cyanophenoxy)pyrimidin-4-yloxy]phenyl}}-3-methoxyacrylate		131860-33-8	Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H331H400H410	GHS06GHS09Dgr	H331H410				CLP00
607-257-00-3	isopropyl propionate	211-300-8	637-78-5	Flam. Liq. 2	H225	GHS02Dgr	H225				CLP00
607-258-00-9	"dodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-3-(4-methoxybenzoyl)acetamido)-4-chlorobenzoate"	403-990-6	70950-45-7	Aquatic Chronic 4	H413		H413				CLP00
607-259-00-4	"methyl 2R,3S-(-)-3-(4-methoxyphenyl)oxiranecarboxylate"	404-130-2	105560-93-8	Eye Dam. 1Skin Sens. 1Aquatic Chronic 3	H318H317H412	GHS05GHS07Dgr	H318H317H412				CLP00
607-260-00-X	ethyl 2-(3-nitrobenzylidene)acetoacetate	404-490-0	39562-16-8	Eye Dam. 1Skin Sens. 1Aquatic Chronic 3	H318H317H412	GHS05GHS07Dgr	H318H317H412				CLP00
607-261-00-5	"iso(C10-C14)alkyl (3,5-di-tert-butyl-4-hydroxyphenyl)methylthioacetate"	404-800-4	118832-72-7	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
607-262-00-0	"7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid"	405-050-0	86393-33-1	Acute Tox. 4 *Aquatic Chronic 3	H302H412	GHS07Wng	H302H412				CLP00
607-263-00-6	"potassium iron(III) 1,3-propanediamine-N,N,N',N'-tetraacetate hemihydrate"	405-680-6		Self-heat. 2 ****Aquatic Chronic 2	H252H411	GHS02GHS09Wng	H252H411				CLP00
607-264-00-1	2-chloro-4-(methylsulfonyl)benzoic acid	406-520-8	53250-83-2	Eye Dam. 1	H318	GHS05Dgr	H318				CLP00
607-265-00-7	"ethyl-2-chloro-2,2-diphenylacetate"	406-580-5	52460-86-3	Skin Irrit. 2Aquatic Chronic 3	H315H412	GHS07Wng	H315H412				CLP00
607-266-00-2	"reaction mass of: hydroxyaluminium bis[2-hydroxy-3,5-di-tert-butylbenzoate]; 3,5-di-tert-butyl-salicylic acid"	406-890-0	130296-87-6	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410				CLP00
607-267-00-8	"tert-butyl (5S,6R,7R)-3-bromomethyl-5,8-dioxo-7-(2-(2-phenylacetamido)-5-thia-1-azabicyclo[4.2.0] oct-2-ene-2-carboxylate"	407-620-4	33610-13-8	Resp. Sens. 1Skin Sens. 1Aquatic Chronic 3	H334H317H412	GHS08Dgr	H334H317H412				CLP00
607-268-00-3	2-methylpropyl (R)-2-hydroxypropanoate	407-770-0	61597-96-4	Eye Irrit. 2	H319	GHS07Wng	H319				CLP00
607-269-00-9	(R)-2-(4-hydroxyphenoxy)propanoic acid	407-960-3	94050-90-5	Eye Dam. 1	H318	GHS05Dgr	H318				CLP00
607-270-00-4	"3,9-bis(2-(3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionyloxy-1,1-dimethylethyl)-2,4,8,10- tetraoxaspiro[5.5]undecane"	410-730-5	90498-90-1	Acute Tox. 4 *	H312	GHS07Wng	H312				CLP00
607-271-00-X	2-isopropyl-5-methylcyclohexyloxycarbonyloxy-2-hydroxypropane	417-420-9	156324-82-2	Eye Irrit. 2Aquatic Chronic 2	H319H411	GHS07GHS09Wng	H319H411				CLP00
607-272-00-5	"fluroxypyr-meptyl (ISO); methylheptyl, O-(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetate [1]fluroxypyr-butometyl (ISO); 2-butoxy-1-methylethyl, O-(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetate  [2]"	279-752-9 [1]	81406-37-3 [1]154486-27-8 [2]	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
607-273-00-0	"ammonium 7-(2,6-dimethyl-8-(2,2-dimethylbutyryloxy)-1,2,6,7,8,8a-hexahydro-1-naphthyl)-3,5-dihydroxyheptanoate"	404-520-2		Aquatic Chronic 3	H412		H412				CLP00
607-274-00-6	2-(N-benzyl-N-methylamino)ethyl 3-amino-2-butenoate	405-350-1	54527-73-0	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				CLP00
607-275-00-1	sodium benzoyloxybenzene-4-sulfonate	405-450-5	66531-87-1	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
607-276-00-7	"bis[(1-methylimidazol)-(2-ethyl-hexanoate)], zinc complex"	405-635-0		Skin Irrit. 2Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H315H318H400H410	GHS05GHS09Dgr	H315H318H410				CLP00
607-277-00-2	reaction mass of: 2-(hexylthio)ethylamine hydrochloride; sodium propionate	405-720-2		Acute Tox. 4 *Eye Dam. 1Skin Sens. 1Aquatic Chronic 2	H302H318H317H411	GHS05GHS07GHS09Dgr	H302H318H317H411				CLP00
607-278-00-8	reaction mass of isomers of: sodium phenethylnaphthalenesulfonate; sodium naphthylethylbenzenesulfonate	405-760-0		Eye Dam. 1Skin Sens. 1Aquatic Chronic 3	H318H317H412	GHS05GHS07Dgr	H318H317H412				CLP00
607-279-00-3	reaction mass of n-octadecylaminodiethyl bis(hydrogen maleate); n-octadecylaminodiethyl hydrogen maleate hydrogenphthalate	405-960-8		Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				CLP00
607-280-00-9	sodium 4-chloro-1-hydroxybutane-1-sulfonate	406-190-5	54322-20-2	Acute Tox. 4 *Eye Irrit. 2Skin Sens. 1	H302H319H317	GHS07Wng	H302H319H317				CLP00
607-281-00-4	"reaction mass of branched and linear C7-C9 alkyl 3-[3-(2H-benzotriazol-2-yl)-5-(1,1-dimethylethyl)-4-hydroxyphenyl]propionates"	407-000-3	127519-17-9	Aquatic Chronic 2	H411	GHS09	H411				CLP00
607-282-00-X	2-acetoxymethyl-4-benzyloxybut-1-yl acetate	407-140-5	131266-10-9	Aquatic Chronic 3	H412		H412				CLP00
607-283-00-5	E-ethyl-4-oxo-4-phenylcrotonate	408-040-4	15121-89-8	Acute Tox. 4 *Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H312H302H315H318H317H400H410	GHS05GHS07GHS09Dgr	H312H302H315H318H317H410				CLP00
607-284-00-0	"reaction mass of: sodium 3,3'-(1,4-phenylenebis(carbonylimino-3,1-propanediylimino))bis(10-amino-6,13-dichloro-4,11-triphenodioxazinedisulfonate); lithium 3,3'-(1,4-phenylenebis-(carbonylimino-3,1-propanediyl-imino))bis(10-amino-6,13-dichloro)-4,11-triphenodioxazinedisulfonate (9:1)"	410-040-4	136213-76-8	Aquatic Chronic 2	H411	GHS09	H411				CLP00
607-285-00-6	"reaction mass of: 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonic acid; sodium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate; potassium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate"	410-065-0		Skin Sens. 1	H317	GHS07Wng					CLP00
607-286-00-1	"reaction mass of: sodium/potassium 7-[[[3-[[4-((2-hydroxy-naphthyl)azo)phenyl]azo]phenyl]sulfonyl]amino]-naphthalene-1,3-disulfonate"	410-070-8	141880-36-6	Skin Sens. 1Aquatic Chronic 3	H317H412	GHS07Wng	H317H412				CLP00
607-287-00-7	"O'-methyl O-(1-methyl-2-methacryloyloxy-ethyl)-1,2,3,6-tetrahydrophthalate"	410-140-8		Aquatic Chronic 3	H412		H412				CLP00
607-288-00-2	"Tetrasodium (c-(3-(1-(3-(e-6-dichloro-5-cyanopyrimidin-f-yl(methyl)amino)propyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)-4-sulfonatophenylsulfamoyl)phthalocyanine-a,b,d-trisulfonato(6-))nickelato II, where a is 1 or 2 or 3 or 4,b is 8 or 9 or 10 or 11,c is 15 or 16 or 17 or 18, d is 22 or 23 or 24 or 25 and where e and f together are 2 and 4 or 4 and 2 respectively"	410-160-7	148732-74-5	Eye Irrit. 2Skin Sens. 1Aquatic Chronic 3	H319H317H412	GHS07Wng	H319H317H412				CLP00
607-289-00-8	"3-(3-(4-(2,4-bis(1,1-dimethylpropyl)phenoxy)butylaminocarbonyl-4-hydroxy-1-naphthalenyl)thio)propanoic acid"	410-370-9	105488-33-3	Aquatic Chronic 4	H413		H413				CLP00
607-290-00-3	reaction mass (ratio not known) of: ammonium 1-C14-C18-alkyloxycarbonyl-2-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate; ammonium 2-C14-C18-alkyloxycarbonyl-1-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate	410-540-2		Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H315H317H400H410	GHS07GHS09Wng	H315H317H410				CLP00
607-291-00-9	dodecyl-?-(C5/C6-cycloalkyl)alkyl carboxylate	410-630-1	104051-92-5	Aquatic Chronic 4	H413		H413				CLP00
607-292-00-4	reaction mass of: [1-(methoxymethyl)-2-(C12-alkoxy)-ethoxy]acetic acid; [1-(methoxymethyl)-2-(C14-alkoxy)-ethoxy]acetic acid	410-640-6		Skin Irrit. 2Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H315H318H400H410	GHS05GHS09Dgr	H315H318H410				CLP00
607-293-00-X	"reaction mass of: N-aminoethylpiperazonium mono-2,4,6-trimethylnonyldiphenyl ether di-sulfonate; N-aminoethylpiperazonium di-2,4,6-trimethylnonyldiphenyl ether di-sulfonate"	410-650-0		Eye Dam. 1Skin Sens. 1Aquatic Chronic 2	H318H317H411	GHS05GHS07GHS09Dgr	H318H317H411				CLP00
607-294-00-5	sodium 2-benzoyloxy-1-hydroxyethane-sulfonate	410-680-4		Skin Sens. 1	H317	GHS07Wng	H317				CLP00
607-295-00-0	"reaction mass of: tetrasodium phosphonoethane-1,2-dicarboxylate; hexasodium phosphonobutane-1,2,3,4-tetracarboxylate"	410-800-5		Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				CLP00
607-296-00-6	reaction mass of: pentaerythriol tetraesters with heptanoic acid and 2-ethylhexanoic acid	410-830-9		Aquatic Chronic 4	H413		H413				CLP00
607-297-00-1	"(E-E)-3,3'-(1,4-phenylenedimethylidene)bis(2-oxobornane-10-sulfonic acid)"	410-960-6	92761-26-7	Eye Dam. 1	H318	GHS05Dgr	H318				CLP00
607-298-00-7	2-(trimethylammonium)ethoxycarboxybenzene-4-sulfonate	411-010-3		Skin Sens. 1	H317	GHS07Wng	H317				CLP00
607-299-00-2	methyl 3-(acetylthio)-2-methyl-propanoate	411-040-7	97101-46-7	Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H317H400H410	GHS07GHS09Wng	H302H317H410				CLP00
607-300-00-6	"trisodium [2-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-5-(b-sulfamoyl-c, d-sulfonatophthalocyanin-a-yl-K4,N29,N30,N31,N32-sulfonylamino)benzoato(5-)]cuprate(II) where a = 1,2,3,4 b = 8,9,10,11 c = 15,16,17,18 d = 22,23,24,25"	411-430-7		Eye Dam. 1Skin Sens. 1	H318H317	GHS05GHS07Dgr	H318H317				CLP00
607-301-00-1	reaction mass of: dodecanoic acid; poly(1-7)lactate esters of dodecanoic acid	411-860-5		Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				CLP00
607-302-00-7	reaction mass of: tetradecanoic acid; poly(1-7)lactate esters of tetradecanoic acid	411-910-6		Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Chronic 2	H315H318H317H411	GHS05GHS07GHS09Dgr	H315H318H317H411				CLP00
607-303-00-2	"1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid"	413-760-7	93107-30-3	Repr. 2Aquatic Chronic 3	H361f ***H412	GHS08Wng	H361f ***H412				CLP00
607-304-00-8	fluazifop-butyl (ISO); butyl (RS)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate	274-125-6	69806-50-4	Repr. 1BAquatic Acute 1Aquatic Chronic 1	H360D ***H400H410	GHS08GHS09Dgr	H360D ***H410				CLP00
607-305-00-3	fluazifop-P-butyl (ISO); butyl (R)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate		79241-46-6	Repr. 2Aquatic Acute 1Aquatic Chronic 1	H361d ***H400H410	GHS08GHS09Wng	H361d ***H410				CLP00
607-306-00-9	"chlozolinate (ISO); ethyl (RS)-3-(3,5-dichlorophenyl)-5-methyl-2,4-dioxo-oxazolidine-5-carboxylate"	282-714-4	84332-86-5	Carc. 2Aquatic Chronic 2	H351H411	GHS08GHS09Wng	H351H411				CLP00
607-307-00-4	"vinclozolin (ISO); N-3,5-dichlorophenyl-5-methyl-5-vinyl-1,3-oxazolidine-2,4-dione"	256-599-6	50471-44-8	Carc. 2Repr. 1BSkin Sens. 1Aquatic Chronic 2	H351H360FDH317H411	GHS08GHS07GHS09Dgr	H351H360FDH317H411				CLP00
607-308-00-X	"esters of 2,4-D"			Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H317H400H410	GHS07GHS09Wng	H302H317H410			A	CLP00
607-309-00-5	"carfentrazone-ethyl (ISO); ethyl (RS)-2-chloro-3-[2-chloro-4-fluoro-5-[4-difluoromethyl-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazol-1-yl]phenyl]propionate"		128639-02-1	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
607-310-00-0	kresoxim-methyl (ISO); methyl (E)-2-methoxyimino-[2-(o-tolyloxymethyl)phenyl]acetate		143390-89-0	Carc. 2Aquatic Acute 1Aquatic Chronic 1	H351H400H410	GHS08GHS09Wng	H351H410				CLP00
607-311-00-6	benazolin-ethyl; ethyl 4-chloro-2-oxo-2H-benzothiazole-3-acetate	246-591-0	25059-80-7	Aquatic Chronic 2	H411	GHS09	H411				CLP00
607-312-00-1	methoxyacetic acid	210-894-6	625-45-6	Repr. 1BAcute Tox. 4 *Skin Corr. 1B	H360FDH302H314	GHS08GHS05GHS07Dgr	H360FDH302H314		STOT SE 3; H335: C ? 5 %		CLP00
607-313-00-7	neodecanoyl chloride	254-875-0	40292-82-8	Acute Tox. 2 *Acute Tox. 4 *Skin Corr. 1B	H330H302H314	GHS06GHS06Dgr	H330H302H314		STOT SE 3; H335: C ? 5 %		CLP00
607-314-00-2	"ethofumesate (ISO); (±)-2-ethoxy-2,3-dihydro-3,3-dimethylbenzofuran-5-yl methanesulfonate"	247-525-3	26225-79-6	Aquatic Chronic 2	H411	GHS09	H411				CLP00
607-315-00-8	glyphosate (ISO); N-(phosphonomethyl)glycine	213-997-4	1071-83-6	Eye Dam. 1Aquatic Chronic 2	H318H411	GHS05GHS09Dgr	H318H411				CLP00
607-316-00-3	glyphosate-trimesium; glyphosate-trimethylsulfonium		81591-81-3	Acute Tox. 4 *Aquatic Chronic 2	H302H411	GHS07GHS09Wng	H302H411				CLP00
607-317-00-9	bis(2-ethylhexyl) phthalate; di-(2-ethylhexyl) phthalate; DEHP	204-211-0	117-81-7	Repr. 1B	H360FD	GHS08Dgr	H360FD				CLP00
607-318-00-4	dibutyl phthalate; DBP	201-557-4	84-74-2	Repr. 1BAquatic Acute 1	H360DfH400	GHS08GHS09Dgr	H360DfH400				CLP00
607-319-00-X	"deltamethrin (ISO); (S)-?-cyano-3-phenoxybenzyl (1R, 3R)-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylate"	258-256-6	52918-63-5	Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H331H301H400H410	GHS06GHS09Dgr	H331H301H410		M=1000000		CLP00/ATP01
607-320-00-5	"bis[4-(ethenyloxy)butyl] 1,3-benzenedicarboxylate"	413-930-0	130066-57-8	Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410				CLP00
607-321-00-0	(S)-methyl-2-chloropropionate	412-470-8	73246-45-4	Flam. Liq. 3STOT RE 2 *Eye Irrit. 2	H226H373 **H319	GHS02GHS08Wng	H226H373 **H319				CLP00
607-322-00-6	"4-(4,4-dimethyl-3-oxo-pyrazolidin-1-yl)-benzoic acid"	413-120-7	107144-30-9	Acute Tox. 4 *Aquatic Chronic 2	H302H411	GHS07GHS09Wng	H302H411				CLP00
607-323-00-1	"2-(1-(2-hydroxy-3,5-di-tert-pentyl-phenyl)ethyl)-4,6-di-tert-pentylphenyl acrylate"	413-850-6	123968-25-2	Aquatic Chronic 4	H413		H413				CLP00
607-324-00-7	"reaction mass of: N,N-di(hydrogenated alkyl C14-C18)phtalamic acid; dihydrogenated alkyl (C14-C18)amine"	413-800-3		Aquatic Chronic 4	H413		H413				CLP00
607-325-00-2	(S)-2-chloropropionic acid	411-150-5	29617-66-1	Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1A	H312H302H314	GHS05GHS07Dgr	H312H302H314				CLP00
607-326-00-8	"reaction mass of: isobutyl hydrogen 2-(?-2,4,6-trimethylnon-2-enyl)succinate; isobutyl hydrogen 2-(ß-2,4,6-trimetyhylnon-2-enyl)succinate"	410-720-0	141847-13-4	Eye Dam. 1Aquatic Chronic 2	H318H411	GHS05GHS09Dgr	H318H411				CLP00
607-327-00-3	"2-(2-iodoethyl)-1,3-propanediol diacetate"	411-780-0	127047-77-2	Acute Tox. 4 *Aquatic Chronic 2	H302H411	GHS07GHS09Wng	H302H411				CLP00
607-328-00-9	methyl 4-bromomethyl-3-methoxybenzoate	410-310-1	70264-94-7	Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H315H318H317H400H410	GHS05GHS07GHS09Dgr	H315H318H317H410				CLP00
607-329-00-4	"reaction mass of: sodium 2-(C12-18-n-alkyl)amino-1,4-butandioate; sodium 2-octadecenyl-amino-1,4-butandioate"	411-250-9		Skin Sens. 1	H317	GHS07Wng	H317				CLP00
607-330-00-X	"(S)-2,3-dihydro-1H-indole-2-carboxylic acid"	410-860-2	79815-20-6	Repr. 2STOT RE 2 *Skin Sens. 1	H361f ***H373 **H317	GHS08GHS07Wng	H361f ***H373 **H317				CLP00
607-331-00-5	"reaction mass of: bis(2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-1,10-decanedioate; 1,8-bis[(2,2,6,6-tetramethyl-4-((2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-decan-1,10-dioyl)piperidin-1-yl)oxy]octane"	406-750-9		Aquatic Chronic 4	H413		H413				CLP00
607-332-00-0	cyclopentyl chloroformate	411-460-0	50715-28-1	Flam. Liq. 3Acute Tox. 3 *Acute Tox. 4 *STOT RE 2 *Eye Dam. 1Skin Sens. 1	H226H331H302H373 **H318H317	GHS02GHS06GHS08GHS05Dgr	H226H331H302H373 **H318H317				CLP00
607-333-00-6	"reaction mass of: dodecyl N-(2,2,6,6-tetramethylpiperidin-4-yl)-?-alaninate; tetradecyl N-(2,2,6,6-tetramethylpiperidin-4-yl)-?-alaninate"	405-670-1		Acute Tox. 4 *STOT RE 2 *Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1	H302H373 **H314H400H410	GHS08GHS05GHS07GHS09Dgr	H302H373 **H314H410				CLP00
607-334-00-1	"ethyl 1-ethyl-6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate"	405-880-3	100501-62-0	Skin Sens. 1Aquatic Chronic 3	H317H412	GHS07Wng	H317H412				CLP00
607-335-00-7	methyl (R)-2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate	406-250-0	72619-32-0	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410				CLP00
607-336-00-2	"4-methyl-8-methylenetricyclo[3.3.1.13,7]dec-2-yl acetate"	406-560-6	122760-85-4	Skin Irrit. 2Skin Sens. 1Aquatic Chronic 2	H315H317H411	GHS07GHS09Wng	H315H317H411				CLP00
607-337-00-8	di-tert-(C12-14)-alkylammonium 2-benzothiazolylthiosuccinate	406-052-4	125078-60-6	Flam. Liq. 3Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1Aquatic Chronic 2	H226H302H315H318H411	GHS02GHS05GHS07GHS09Dgr	H226H302H315H318H411				CLP00
607-338-00-3	2-methylpropyl 2-hydroxy-2-methylbut-3-enoate	406-235-9	72531-53-4	Skin Irrit. 2Eye Irrit. 2	H315H319	GHS07Wng	H319H315				CLP00
607-339-00-9	"2,3,4,5-tetrachlorobenzoylchloride"	406-760-3	42221-52-3	Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1	H302H314H317	GHS05GHS07Dgr	H302H314H317				CLP00
607-340-00-4	"1,3-bis(4-benzoyl-3-hydroxyphenoxy)prop-2-yl acetate"	406-990-4		Aquatic Chronic 2	H411	GHS09	H411				CLP00
607-341-00-X	(9S)-9-amino-9-deoxyerythromycin	406-790-7	26116-56-3	Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H318H400H410	GHS05GHS09Dgr	H318H410				CLP00
607-342-00-5	4-chlorobutyl veratrate	410-950-1	69788-75-6	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				CLP00
607-343-00-0	"4,7-methanooctahydro-1H-indene-diyldimethyl bis(2-carboxybenzoate)"	407-410-2		Aquatic Chronic 4	H413		H413				CLP00
607-344-00-6	reaction mass of: 3-(N-(3-dimethylaminopropyl)-(C4-8)perfluoroalkylsulfonamido)propionic acid; N-[dimethyl-3-(C4-8-perfluoroalkylsulfonamido)propylammonium propionate; 3-(N-(3-dimethyl-propylammonium)-(C4-8)perfluoroalkylsulfonamido)propionic acid propionate	407-810-7		STOT RE 2 *	H373 **	GHS08Wng	H373 **				CLP00
607-345-00-1	"potassium 2-(2,4-dichlorophenoxy)-(R)-propionate"	413-580-9	113963-87-4	Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1Skin Sens. 1	H302H315H318H317	GHS05GHS07Dgr	H302H315H318H317				CLP00
607-346-00-7	3-icosyl-4-henicosylidene-2-oxetanone	401-210-9	83708-14-9	Aquatic Chronic 4	H413		H413				CLP00
607-347-00-2	"sodium (R)-2-(2,4-dichlorophenoxy)propionate"	413-340-3	119299-10-4	Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1Skin Sens. 1	H302H315H318H317	GHS05GHS07Dgr	H302H315H318H317				CLP00
607-348-00-8	"magnesium bis((R)-2-(2,4-dichlorophenoxy)propionate)"	413-360-2		Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1Skin Sens. 1	H302H315H318H317	GHS05GHS07Dgr	H302H315H318H317				CLP00
607-349-00-3	"mono-(tetrapropylammonium) hydrogen 2,2'-dithiobisbenzoate"	411-270-8		Aquatic Chronic 3	H412		H412				CLP00
607-350-00-9	"bis(4-(1,2-bis(ethoxycarbonyl)ethylamino)-3-methylcyclohexyl)methane"	412-060-9	136210-32-7	Skin Sens. 1Aquatic Chronic 3	H317H412	GHS07Wng	H317H412				CLP00
607-351-00-4	"methyl O-(4-amino-3,5-dichloro-6-fluoropyridin-2-yloxy)acetate"	407-550-4	69184-17-4	Aquatic Chronic 2	H411	GHS09	H411				CLP00
607-352-00-X	"4,4'-oxydiphthalic anhydride"	412-830-4	1823-59-2	Aquatic Chronic 3	H412		H412				CLP00
607-353-00-5	"reaction mass of: ethyl exo-tricyclo[5.2.1.02,6]decane-endo-2-carboxylate; ethyl endo-tricyclo[5.2.1.02,6]decane-exo-2-carboxylate"	407-520-0	80657-64-3	Skin Irrit. 2Aquatic Chronic 2	H315H411	GHS07GHS09Wng	H315H411				CLP00
607-354-00-0	ethyl 2-cyclohexylpropionate	412-280-5	2511-00-4	Aquatic Chronic 2	H411	GHS09	H411				CLP00
607-355-00-6	p-tolyl 4-chlorobenzoate	411-530-0	15024-10-9	Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410				CLP00
607-356-00-1	"ethyl trans-2,2,6-trimethylcyclohexanecarboxylate"	412-540-8		Skin Irrit. 2Aquatic Chronic 2	H315H411	GHS07GHS09Wng	H315H411				CLP00
607-357-00-7	reaction mass of: trans-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran; cis-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran	412-450-9	131766-73-9	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
607-358-00-2	"(1S,3S,5R,6R)-(4-nitrophenylmethyl)-1-dioxo-6-phenylacetamido-penam-3-carboxylate"	412-670-5	54275-93-3	Resp. Sens. 1	H334	GHS08Dgr	H334				CLP00
607-359-00-8	"(1S,4R,6R,7R)-(4-nitrophenylmethyl)3-methylene-1-oxo-7-phenylacetamido-cepham-4-carboxylateido-penam-3-carboxylate"	412-800-0	76109-32-5	Resp. Sens. 1	H334	GHS08Dgr	H334				CLP00
607-360-00-3	sodium 3-acetoacetylamino-4-methoxytolyl-6-sulfonate	411-680-7	133167-77-8	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
607-361-00-9	methyl (R)-2-(4-hydroxyphenoxy)propionate	411-950-4	96562-58-2	Eye Dam. 1Aquatic Chronic 3	H318H412	GHS05Dgr	H318H412				CLP00
607-362-00-4	reaction mass of: (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)hexadec-4-enoate; (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)tetradec-4-enoate; (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)hexadec-4-enoate; (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)tetradec-4-enoate	413-500-2		Skin Irrit. 2Eye Dam. 1Aquatic Chronic 2	H315H318H411	GHS05GHS09Dgr	H315H318H411				CLP00
607-363-00-X	methyl-3-methoxyacrylate	412-900-4	5788-17-0	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
607-364-00-5	"3-phenyl-7-[4-(tetrahydrofurfuryloxy)phenyl]-1,5-dioxa-s-indacen-2,6-dione"	413-330-9	134724-55-3	Aquatic Chronic 4	H413		H413				CLP00
607-365-00-0	"2-(2-amino-1,3-thiazol-4-yl)-(Z)-2-methoxyiminoacetyl chloride hydrochloride"	410-620-7	119154-86-8	Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1	H302H314H317	GHS05GHS07Dgr	H302H314H317				CLP00
607-366-00-6	"3,5-dimethylbenzoyl chloride"	413-010-9	6613-44-1	Skin Corr. 1BSkin Sens. 1	H314H317	GHS05GHS07Dgr	H314H317				CLP00
607-367-00-1	"potassium bis(N-carboxymethyl)-N-methyl-glycinato-(2-)N,O,O,N)-ferrate-(1-) monohydrate"	411-640-9	153352-59-1	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
607-368-00-7	"1-(N,N-dimethylcarbamoyl)-3-tert-butyl-5-carbethoxymethylthio-1H-1,2,4-triazole"	411-650-3	110895-43-7	Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H331H301H400H410	GHS06GHS09Dgr	H331H301H410				CLP00
607-369-00-2	"reaction mass of: trans-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid; cis-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid"	411-660-8	147027-04-1	Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1Skin Sens. 1	H302H315H318H317	GHS05GHS07Dgr	H302H315H318H317				CLP00
607-370-00-8	"2-[[2-(acetyloxy)-3-(1,1-dimethyl-ethyl)-5-methylphenyl]methyl]-6-(1,1-dimethylethyl)-4-methylphenol"	412-210-3	41620-33-1	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
607-371-00-3	"3-ethyl 5-methyl 4-(2-chlorophenyl)-1,4-dihydro-2-[2-(1,3-dihydro-1,3-dioxo-(2H)isoindol-2-yl)-ethoxymethyl]-6-methyl-3,5-pyridinedicarboxylate"	413-410-3	88150-62-3	Aquatic Chronic 4	H413		H413				CLP00
607-372-00-9	ethoxylated bis phenol A di-(norbornene carboxylate)	412-410-0		Aquatic Chronic 3	H412		H412				CLP00
607-373-00-4	(±) tetrahydrofurfuryl (R)-2-[4-(6-chloroquinoxalin-2-yloxy)phenyloxy]propionate	414-200-4	119738-06-6	Muta. 2Repr. 1BAcute Tox. 4 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H341H360DfH302H373 **H400H410	GHS08GHS07GHS09Dgr	H341H360DfH302H373 **H410				CLP00
607-374-00-X	"5-amino-2,4,6-triiodo-1,3-benzenedicarbonyldichloride"	417-220-1	37441-29-5	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				CLP00
607-375-00-5	"reaction mass of: cis-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin; trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin"	421-960-0	90035-08-8	Acute Tox. 1Acute Tox. 2 *Acute Tox. 2 *STOT RE 1Aquatic Acute 1Aquatic Chronic 1	H310H330H300H372 **H400H410	GHS06GHS08GHS09Dgr	H330H310H300H372 **H410				CLP00
607-376-00-0	"benzyl 2,4-dibromobutanoate"	420-710-8	23085-60-1	Repr. 2Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H361f ***H315H317H400H410	GHS08GHS07GHS09Wng	H361f ***H315H317H410				CLP00
607-377-00-6	trans-4-cyclohexyl-L-proline monohydrochloride	419-160-1	90657-55-9	Repr. 2Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1Skin Sens. 1	H361f ***H302H315H318H317	GHS08GHS05GHS07Dgr	H361f ***H302H315H318H317				CLP00
607-378-00-1	ammonium (Z)-?-methoxyimino-2-furylacetate	405-990-1	97148-39-5	Flam. Sol. 2	H228	GHS02Dgr	H228			T	CLP00
607-379-00-7	"reaction mass of: 2-[N-(2-hydroxyethyl)stearamido]ethyl stearate; sodium [bis[2-(stearoyloxy)ethyl]amino]methylsulfonate; sodium [bis(2-hydroxyethyl)amino]methylsulfonate; N,N-bis(2-hydroxyethyl)stearamide"	401-230-8		Aquatic Chronic 3	H412		H412				CLP00
607-380-00-2	"reaction mass of: ammonium-1,2-bis(hexyloxycarbonyl)ethanesulfonate; ammonium-1-hexyloxycarbonyl-2-octyloxycarbonylethanesulfonate; ammonium-2-hexyloxycarbonyl-1-octyloxycarbonylethanesulfonate"	407-320-3		Skin Irrit. 2Eye Dam. 1Aquatic Chronic 3	H315H318H412	GHS05Dgr	H315H318H412				CLP00
607-381-00-8	"reaction mass of triesters of 2,2-bis(hydroxymethyl)butanol with C7-alkanoic acids and 2-ethylhexanoic acid"	413-710-4		Aquatic Chronic 4	H413		H413				CLP00
607-382-00-3	2-((4-amino-2-nitrophenyl)amino)benzoic acid	411-260-3	117907-43-4	Eye Dam. 1Skin Sens. 1Aquatic Chronic 3	H318H317H412	GHS05GHS07Dgr	H318H317H412				CLP00
607-383-00-9	"reaction mass of: 2,2,6,6-tetramethylpiperidin-4-yl-hexadecanoate; 2,2,6,6-tetramethylpiperidin-4-yl-octadecanoate"	415-430-8	86403-32-9	Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H318H317H400H410	GHS05GHS07GHS09Dgr	H318H317H410				CLP00
607-384-00-4	"reaction mass of: esters of C14-C15 branched alcohols with 3,5-di-t-butyl-4-hydroxyphenyl propionic acid; C15 branched and linear alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoate; C13 branched and linear alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoate"	413-750-2	171090-93-0	Aquatic Chronic 4	H413		H413				CLP00
607-385-00-X	Copolymer of vinyl-alcohol and vinyl acetate partially acetilized with 4-(2-(4-formylphenyl)ethenyl)-1-methylpyridinium methylsulfate	414-590-6	125229-74-5	Aquatic Chronic 2	H411	GHS09	H411				CLP00
607-386-00-5	reaction mass of: tetradecanoic acid (42.5-47.5 %); poly(1-7)lactate esters of tetradecanoic acid (52.5-57.5 %)	412-580-6	174591-51-6	Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H315H318H317H400H410	GHS05GHS07GHS09Dgr	H315H318H317H410				CLP00
607-387-00-0	reaction mass of: dodecanoic acid (35-40 %); poly(1-7)lactate esters of dodecanoic acid (60-65 %)	412-590-0	58856-63-6	Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H315H318H317H400H410	GHS05GHS07GHS09Dgr	H315H318H317H410				CLP00
607-388-00-6	4-ethylamino-3-nitrobenzoic acid	412-090-2	2788-74-1	Acute Tox. 4 *Skin Sens. 1Aquatic Chronic 3	H302H317H412	GHS07Wng	H302H317H412				CLP00
607-389-00-1	"trisodium N,N-bis(carboxymethyl)-3-amino-2-hydroxypropionate"	414-130-4	119710-96-2	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
607-390-00-7	"1,2,3,4-tetrahydro-6-nitro-quinoxaline"	414-270-6	41959-35-7	Acute Tox. 4 *Aquatic Chronic 2	H302H411	GHS07GHS09Wng	H302H411				CLP00
607-391-00-2	"dimethylcyclopropane-1,1-dicarboxylate"	414-240-2	6914-71-2	Aquatic Chronic 3	H412		H412				CLP00
607-392-00-8	"2-phenoxyethyl 4-((5-cyano-1,6-dihydro-2-hydroxy-1,4-dimethyl-6-oxo-3-pyridinyl)azo)benzoate"	414-260-1	88938-37-8	Aquatic Chronic 4	H413		H413				CLP00
607-393-00-3	3-(cis-1-propenyl)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	415-750-8	106447-44-3	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
607-394-00-9	5-methylpyrazine-2-carboxylic acid	413-260-9	5521-55-1	Eye Dam. 1	H318	GHS05Dgr	H318				CLP00
607-395-00-4	reaction mass of: sodium 1-tridecyl-4-allyl-(2 or 3)-sulfobutanedioate; sodium 1-dodecyl-4-allyl-(2 or 3)-sulfobutanedioate	410-230-7		Skin Corr. 1BSkin Sens. 1Aquatic Chronic 2	H314H317H411	GHS05GHS07GHS09Dgr	H314H317H411				CLP00
607-396-00-X	"bis(1,2,2,6,6-pentamethyl-4-piperidinyl) 2-(4-methoxybenzylidene)malonate"	414-840-4	147783-69-5	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
607-397-00-5	reaction mass of: Ca salicylates (branched C10-14 and C18-30 alkylated); Ca phenates (branched C10-14 and C18-30 alkylated); Ca sulfurised phenates (branched C10-14 and C18-30 alkylated)	415-930-6	-	Repr. 2Skin Sens. 1	H361f ***H317	GHS08GHS07Wng	H361f ***H317				CLP00/ATP01
607-398-00-0	"ethyl N-(5-chloro-3-(4-(diethylamino)-2-methylphenylimino)-4-methyl-6-oxo-1,4-cyclohexadienyl)carbamate"	414-820-5	125630-94-6	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
607-399-00-6	"2,2-dimethyl 3-methyl-3-butenyl propanoate"	415-610-6	104468-21-5	Skin Irrit. 2Aquatic Chronic 3	H315H412	GHS07Wng	H315H412				CLP00
607-400-00-X	methyl 3-[[(dibutylamino)thioxomethyl]thio]propanoate	414-400-1	32750-89-3	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
607-401-00-5	ethyl 3-hydroxy-5-oxo-3-cyclohexene-1-carboxylate	414-450-4	88805-65-6	Skin Irrit. 2Eye Dam. 1Skin Sens. 1	H315H318H317	GHS05GHS07Dgr	H315H318H317				CLP00
607-402-00-0	methyl N-(phenoxycarbonyl)-L-valinate	414-500-5	153441-77-1	Aquatic Chronic 3	H412		H412				CLP00
607-403-00-6	"reaction mass of: bis(1S,2S,4S)-(1-benzyl-4-tert-butoxycarboxamido-2-hydroxy-5-phenyl)pentylammonium succinate; isopropyl alcohol"	414-810-0		STOT RE 2 *Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H373 **H318H400H410	GHS08GHS05GHS09Dgr	H373 **H318H410				CLP00
607-404-00-1	"reaction mass of: ((Z)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid; di-((E)-3,7-dimethyl-2,6-octadienyl) butandioate; di-((Z)-3,7-dimethyl-2,6-octadienyl) butandioate; (Z)-3,7-dimethyl-2,6-octadienyl butandioate; ((E)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid"	415-190-4		Skin Sens. 1	H317	GHS07Wng	H317				CLP00
607-405-00-7	2-hexyldecyl-p-hydroxybenzoate	415-380-7	148348-12-3	Aquatic Chronic 2	H411	GHS09	H411				CLP00
607-406-00-2	"potassium 2,5-dichlorobenzoate"	415-700-5	184637-62-5	Acute Tox. 4 *Eye Dam. 1	H302H318	GHS05GHS07Dgr	H302H318				CLP00
607-407-00-8	ethyl 2-carboxy-3-(2-thienyl)propionate	415-680-8	143468-96-6	Skin Irrit. 2Eye Dam. 1Skin Sens. 1	H315H318H317	GHS05GHS07Dgr	H315H318H317				CLP00
607-408-00-3	potassium N-(4-fluorophenyl)glycinate	415-710-1	184637-63-6	STOT RE 2 *Eye Dam. 1Skin Sens. 1Aquatic Chronic 3	H373 **H318H317H412	GHS08GHS05GHS07Dgr	H373 **H318H317H412				CLP00
607-409-00-9	"reaction mass of: (3R)-[1S-(1?, 2?, 6?-((2S)-2-methyl-1-oxo-butoxy)-8a?)hexahydro-2,6-dimethyl-1-naphthalene]-3,5-dihydroxyheptanoic acid; inert biomass from Aspergillus terreus"	415-840-7		Skin Sens. 1Aquatic Chronic 3	H317H412	GHS07Wng	H317H412				CLP00
607-410-00-4	mono[2-(dimethylamino)ethyl]monohydrogen-2-(hexadec-2-enyl)butanedioate and/or mono[2-(dimethylamino)ethyl]monohydrogen-3-(hexadec-2-enyl)butanedioate	415-880-5	779343-34-9	Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H315H318H317H400H410	GHS05GHS07GHS09Dgr	H315H318H317H410				CLP00
607-411-00-X	"oxiranemethanol, 4-methylbenzene-sulfonate, (S)-"	417-210-7	70987-78-9	Carc. 1BMuta. 2Eye Dam. 1Skin Sens. 1Aquatic Chronic 2	H350H341H318H317H411	GHS08GHS05GHS07GHS09Dgr	H350H341H318H317H411				CLP00
607-412-00-5	ethyl 2-(1-cyanocyclohexyl)acetate	415-970-4	133481-10-4	Acute Tox. 4 *STOT RE 2 *Aquatic Chronic 3	H302H373 **H412	GHS08GHS07Wng	H302H373 **H412				CLP00
607-413-00-0	trans-4-phenyl-L-proline	416-020-1	96314-26-0	Repr. 2Skin Sens. 1	H361f ***H317	GHS08GHS07Wng	H361f ***H317				CLP00
607-414-00-6	"tris(2-ethylhexyl)-4,4',4''-(1,3,5-triazine-2,4,6-triyltriimino)tribenzoate"	402-070-1	88122-99-0	Aquatic Chronic 4	H413		H413				CLP00
607-415-00-1	"poly-(methyl methacrylate)-co-(butylmethacrylate)-co-(4-acryloxybutyl-isopropenyl-?, ?-dimethylbenzyl carbamate)-co-(maleicanhydride)"	419-590-1		Flam. Sol. 1Skin Sens. 1	H228H317	GHS02GHS07Dgr	H228H317			T	CLP00
607-416-00-7	4-(2-carboxymethylthio)ethoxy-1-hydroxy-5-isobutyloxycarbonylamino-N-(3-dodecyloxypropyl)-2-naphthamide	420-730-7		Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
607-417-00-2	3-chloropropyl chloroformiate	425-770-9	628-11-5	Acute Tox. 3 *Acute Tox. 4 *STOT RE 2 *Skin Irrit. 2Eye Dam. 1Skin Sens. 1	H331H302H373 **H315H318H317	GHS06GHS05GHS08Dgr	H331H302H373 **H315H318H317				ATP01
607-418-00-8	2-ethylhexyl 4-aminobenzoate	420-170-3	26218-04-2	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
607-419-00-3	"(3'-carboxymethyl-5-(2-(3-ethyl-3H-benzothiazol-2-ylidene)-1-methyl-ethylidene)-4,4'-dioxo-2'-thioxo-(2,5')bithiazolidinyliden-3-yl)-acetic acid"	422-240-9	166596-68-5	Eye Dam. 1Skin Sens. 1	H318H317	GHS05GHS07Dgr	H318H317				CLP00
607-420-00-9	"2,2-bis(hydroxymethyl)butanoic acid"	424-090-1	10097-02-6	Eye Dam. 1Aquatic Chronic 3	H318H412	GHS05Dgr	H318H412				CLP00
607-421-00-4	"cypermethrin cis/trans +/- 40/60; (RS)-?-cyano-3-phenoxybenzyl (1RS,3RS;1RS,3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate"	257-842-9	52315-07-8	Acute Tox. 4 *Acute Tox. 4 *STOT SE 3Aquatic Acute 1Aquatic Chronic 1	H332H302H335H400H410	GHS07GHS09Wng	H332H302H335H410				CLP00
607-422-00-X	"?-cypermethrin (ISO); racemate comprising (R)-?-cyano-3-phenoxybenzyl (1S,3S)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate; (S)-?-cyano-3-phenoxybenzyl (1R,3R)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate"	257-842-9	67375-30-8	Acute Tox. 3 *STOT SE 3STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H301H335H373 **H400H410	GHS06GHS08GHS09Dgr	H301H373 **H335H410		M=1000		CLP00/ATP01
607-423-00-5	esters of mecoprop and of mecoprop-P			Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H317H400H410	GHS07GHS09Wng	H302H317H410			A	CLP00
607-424-00-0	"trifloxystrobin (ISO); (E,E)-?-methoxyimino-{}{2-[[[[1-[3-(trifluoromethyl)phenyl]ethylidene]amino]oxy]methyl]benzeneacetic acid methyl ester"		141517-21-7	Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410				CLP00
607-425-00-6	"metalaxyl (ISO); methyl-N-(2,6-dimethylphenyl)-N-(methoxyacetyl)-DL-alaninate"	260-979-7	57837-19-1	Acute Tox. 4 *Skin Sens. 1Aquatic Chronic 3	H302H317H412	GHS07Wng	H302H317H412				CLP00
607-426-00-1	"1,2-benzenedicarboxylic acid, dipentylester, branched and linear [1]n-pentyl-isopentylphthalate [2]di-n-pentyl phthalate [3]diisopentylphthalate  [4]"	284-032-2 [1]205-017-9 [3]210-088-4 [4]	84777-06-0 [1]131-18-0 [3]605-50-5 [4]	Repr. 1BAquatic Acute 1	H360FDH400	GHS08GHS09Dgr	H360FDH400				CLP00
607-427-00-7	"bromoxynil heptanoate (ISO); 2,6-dibromo-4-cyanophenyl heptanoate"	260-300-4	56634-95-8	Repr. 2Acute Tox. 4 *Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H361d ***H332H302H317H400H410	GHS08GHS07GHS09Wng	H361d ***H332H302H317H410				CLP00
607-428-00-2	tetrasodium ethylene diamine tetraacetate	200-573-9	64-02-8	Acute Tox. 4 *Eye Dam. 1	H302H318	GHS05GHS07Dgr	H302H318				ATP01
607-429-00-8	edetic acid; (EDTA)	200-449-4	60-00-4	Eye Irrit. 2	H319	GHS07Wng	H319				ATP01
607-430-00-3	BBP; benzyl butyl phthalate	201-622-7	85-68-7	Repr. 1BAquatic Acute 1Aquatic Chronic 1	H360DfH400H410	GHS08GHS09Dgr	H360DfH410				CLP00
607-431-00-9	"prallethrin (ISO); ETOC; 2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate"	245-387-9	23031-36-9	Acute Tox. 3 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H331H302H400H410	GHS06GHS09Dgr	H331H302H410				CLP00
607-432-00-4	S-metolachlor; reaction mass of (S)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (80-100 %) [1](R)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (0-20 %)  [2]		87392-12-9 [1]178961-20-1 [2]	Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410				CLP00
607-433-00-X	"cypermethrin cis/trans +/- 80/20; (RS)-?-cyano-3-phenoxybenzyl (1RS; 3RS; 1RS, 3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate"	257-842-9	52315-07-8	Acute Tox. 4 *STOT SE 3Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H335H315H317H400H410	GHS07GHS09Wng	H302H335H315H317H410				CLP00
607-434-00-5	mecoprop-P [1] and its salts; (R)-2-(4-chloro-2-methylphenoxy)propionic acid	240-539-0	16484-77-8	Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 2	H302H318H411	GHS05GHS07GHS09Dgr	H302H318H411				CLP00
607-435-00-0	"2S-isopropyl-5R-methyl-1R-cyclohexyl 2,2-dihydroxyacetate"	416-810-6	111969-64-3	STOT RE 2 *Eye Dam. 1Aquatic Chronic 2	H373 **H318H411	GHS08GHS05GHS09Dgr	H373 **H318H411				CLP00
607-436-00-6	2-hydroxy-3-(2-ethyl-4-methylimidazoyl)propyl neodecanoate	417-350-9		Skin Irrit. 2Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H315H318H400H410	GHS05GHS09Dgr	H315H318H410				CLP00
607-437-00-1	3-(4-aminophenyl)-2-cyano-2-propenoic acid	417-480-6	252977-62-1	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
607-438-00-7	methyl-2-[(aminosulfonyl)methyl]benzoate	419-010-5	112941-26-1	Acute Tox. 4 *Eye Irrit. 2	H302H319	GHS07Wng	H302H319				CLP00
607-439-00-2	methyl tetrahydro-2-furancarboxylate	420-670-1	37443-42-8	Eye Dam. 1	H318	GHS05Dgr	H318				CLP00
607-440-00-8	methyl 2-aminosulfonyl-6-(trifluoromethyl)pyridine-3-c arboxylate	421-220-7	144740-59-0	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				CLP00
607-441-00-3	3-[3-(2-dodecyloxy-5-methylphenylcarbamoyl)-4-hydroxy-1-naphthylthio]propionic acid	421-490-6	167684-63-1	Aquatic Chronic 4	H413		H413				CLP00
607-442-00-9	benzyl [hydroxy-(4-phenylbutyl)phosphinyl] acetate	416-050-5	87460-09-1	Eye Dam. 1	H318	GHS05Dgr	H318				CLP00
607-444-00-X	"reaction mass of: cis-1,4-dimethylcyclohexyl dibenzoate; trans-1,4-dimethylcyclohexyl dibenzoate"	416-230-3	35541-81-2	Aquatic Chronic 4	H413		H413				CLP00
607-445-00-5	Iron (III) tris(4-methylbenzenesulfonate)	420-960-8	77214-82-5	Eye Dam. 1	H318	GHS05Dgr	H318				CLP00
607-446-00-0	methyl 2-[4-(2-chloro-4-nitrophenylazo)-3-(1-oxopropyl)amino]phenylaminopropionate	416-240-8	155522-12-6	Skin Sens. 1Aquatic Chronic 4	H317H413	GHS07Wng	H317H413				CLP00
607-447-00-6	sodium 4-[4-(4-hydroxyphenylazo)phenylamino]-3-nitrobenzenesulfonate	416-370-5	156738-27-1	Skin Sens. 1Aquatic Chronic 3	H317H412	GHS07Wng	H317H412				CLP00
607-448-00-1	"2,3,5,6-tetrafluorobenzoic acid"	416-800-1	652-18-6	Skin Irrit. 2Eye Dam. 1	H315H318	GHS05Dgr	H315H318				CLP00
607-449-00-7	"reaction mass of: 4,4',4''-[(2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,3,5-triyl)tris[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]trisbenzenediazoniumtri[bis(2-methylpropyl)naphthalenesulfonate]; 4,4',4'',4'''-[[5,5'-[carbonylbis[imino(1,5,5-trimethyl-3,1-cyclohexanediyl)methylene]]-2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,1',3,3'-tetrayl]tetrakis[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]tetrakisbenzenediazoniumtetra[bis(2-methylpropyl)naphthalenesulfonate]"	417-080-1		Self-react. D ****Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H242H317H400H410	GHS02GHS07GHS09Dgr	H242H317H410				CLP00
607-450-00-2	2-mercaptobenzothiazolyl-(Z)-(2-aminothiazol-4-yl)-2-(tert-butoxycarbonyl) isopropoxyiminoacetate	419-040-9	89604-92-2	Aquatic Chronic 4	H413		H413				CLP00
607-451-00-8	"4-[4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]-6-[3-(4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]phenylcarbonylamino]benzenesulfonic acid, sodium salt"	417-640-5	161935-19-9	Eye Dam. 1Skin Sens. 1	H318H317	GHS05GHS07Dgr	H318H317				CLP00
607-453-00-9	"4-benzyl-2,6-dihydroxy-4-aza-heptylene bis(2,2-dimethyloctanoate)"	418-100-1	172964-15-7	Skin Sens. 1Aquatic Chronic 4	H317H413	GHS07Wng	H317H413				CLP00
607-454-00-4	"reaction mass of: trans-2-(1-methylethyl)-1,3-dioxane-5-carboxylic acid; cis-2-(1-methylethyl)-1,3-dioxane-5-carboxylic acid"	418-170-3	116193-72-7	Eye Dam. 1Aquatic Chronic 3	H318H412	GHS05Dgr	H318H412				CLP00
607-455-00-X	"1-amino-4-(3-[4-chloro-6-(2,5-di-sulfophenylamino)-1,3,5-triazin-2-ylamino]-2,2-dimethyl-propylamino)-anthraquinone-2-sulfonic acid, sodium/lithiumsalt"	419-520-8	172890-93-6	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
607-456-00-5	"3-amino-4-chlorobenzoic acid, hexadecyl ester"	419-700-6	143269-74-3	Aquatic Chronic 2	H411	GHS09	H411				CLP00
607-457-00-0	"tetrasodium dihydrogen 1,1''-dihydroxy-8,8''-[p-phenylbis(imino-{}{6-[4-(2-aminoethyl)piperazin-1-yl]}}-1,3,5-triazine-4,2-diyl-imino)]bis(2,2'-azonaphthalene-1',3,6-trisulfonate)"	420-350-1	172277-97-3	Eye Dam. 1Aquatic Chronic 2	H318H411	GHS05GHS09Dgr	H318H411				CLP00
607-458-00-6	"reaction mass of: 2-ethyl-[2,6-dibromo-4-[1-[3,5-dibromo-4-(2-hydroxyethoxy)phenyl]-1-methylethyl]phenoxy]propenoate; 2,2'-diethyl-[4,4'-bis(2,6-dibromophenoxy)-1-methylethylidene] dipropenoate; 2,2'-[(1-methylethylidene)bis[[2,6-dibromo-4,1-phenylene)oxy]ethanol]]"	420-850-1		Aquatic Chronic 2	H411	GHS09	H411				CLP00
607-459-00-1	"isopentyl 4-{}{2-[5-cyano-1,2,3,6-tetrahydro-1-(2-isopropoxyethoxy-carbonylmethyl)-4-methyl-2,6-dioxo-3-pyridylidene]hydrazino}}benzoate"	418-930-4		Aquatic Chronic 4	H413		H413				CLP00
607-460-00-7	3-tridecyloxy-propyl-ammonium 9-octadecenoate	418-990-1	778577-53-0	STOT RE 2 *Skin Irrit. 2Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H373 **H315H319H400H410	GHS08GHS07GHS09Wng	H373 **H319H315H410				CLP00
607-461-00-2	"reaction mass of: pentasodium 2-{}{4-{}{3-methyl-4-[6-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}}-6-[3-(2-sulfato-ethanesulfonyl)-phenylamino]-1,3,5-triazin-2-ylamino}}-benzene-1,4-disulfonate; pentasodium 2-{}{4-{}{3-methyl-4-[7-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}}-6-[3-(2-sulfato-ethanesulfonyl)-phenylamino]-1,3,5-triazin-2-ylamino}}-benzene-1,4-disulfonate"	421-160-1		Aquatic Chronic 3	H412		H412				CLP00
607-462-00-8	reaction mass of: 1-hexyl acetate; 2-methyl-1-pentyl acetate; 3-methyl-1-pentyl acetate; 4-methyl-1-pentyl acetate; other mixed linear and branched C6-alkyl acetates	421-230-1	88230-35-7	Aquatic Chronic 2	H411	GHS09	H411				CLP00
607-463-00-3	3-(phenothiazin-10-yl)propionic acid	421-260-5	362-03-8	Aquatic Chronic 2	H411	GHS09	H411				CLP00
607-464-00-9	"reaction mass of: 7-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid; 5-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid"	421-280-4		Aquatic Chronic 3	H412		H412				CLP00
607-465-00-4	"tris(2-hydroxyethyl)ammonium 7-{}{4-[4-(2-cyanoamino-4-hydroxy-6-oxidopyrimidin-5-ylazo)benzamido]-2-ethoxy-phenylazo}}naphthalene-1,3-disulfonate"	421-440-3	778583-04-3	Aquatic Chronic 3	H412		H412				CLP00
607-466-00-X	"reaction mass of: phenyl 1-(1-[2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl]-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate; phenyl 2-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate; phenyl 3-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate"	421-480-1		Aquatic Chronic 2	H411	GHS09	H411				CLP00
607-467-00-5	"1,1,3,3-tetrabutyl-1,3-ditinoxydicaprylate"	419-430-9	56533-00-7	Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1	H312H302H373 **H314H400H410	GHS08GHS05GHS07GHS09Dgr	H312H302H373 **H314H410				CLP00
607-468-00-0	"reaction mass of: monosodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate; disodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate; trisodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate; tetrasodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate"	419-450-8		Skin Sens. 1	H317	GHS07Wng	H317				CLP00
607-469-00-6	"disodium 7-((4,6-bis(3-diethylaminopropylamino)-1,3,5-triazine-2-yl)amino)-4-hydroxy-3-(4-(4-sulfonatophenylazo)phenylazo)-2-naphthalene sulfonate"	419-460-2	120029-06-3	Aquatic Chronic 3	H412		H412				CLP00
607-470-00-1	"potassium sodium 6,13-dichloro-3,10-bis{}{2-[4-[3-(2-hydroxysulphonyloxyethanesulfonyl)phenylamino]-6-(2,5-disulfonatophenylamino)-1,3,5-triazin-2-ylamino]ethylamino}}benzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate"	414-100-0	154336-20-6	Eye Dam. 1Aquatic Chronic 3	H318H412	GHS05Dgr	H318H412				CLP00
607-471-00-7	"1,6-bis((dibenzylthiocarbamoyl)disulfanyl)hexane"	429-280-6	151900-44-6	Aquatic Chronic 4	H413	-	H413				ATP01
607-473-00-8	"pentaerythritol, dipentaerythritol, fatty acids, C6-10, mixed esters with adipic acid, heptanoic acid and isostearic acid"	426-590-3	187412-41-5	Skin Sens. 1	H317	GHS07Wng	H317				ATP01
607-474-00-3	(4-(4-(4-dimethylaminobenzyliden-1-yl)-3-methyl-5-oxo-2-pyrazolin-1-yl)benzoic acid	410-430-4	117573-89-4	Aquatic Chronic 4	H413		H413				CLP00
607-475-00-9	"reaction mass of: tetrasodium 7-(4-[4-chloro-6-[methyl-(3-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate; tetrasodium 7-(4-[4-chloro-6-[methyl-(4-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate (1:1)"	412-940-2	148878-18-6	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
607-476-00-4	"trisodium N,N-bis(carboxymethyl)-?-alanine"	414-070-9	129050-62-0	Skin Corr. 1BAquatic Chronic 3	H314H412	GHS05Dgr	H314H412				CLP00
607-477-00-X	(1?5?6?)-6-nitro-3-benzyl-3-azabicyclo[3.1.0]hexane methanesulfonate salt	426-740-8	-	Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 2	H302H318H411	GHS05GHS07GHS09Dgr	H302H318H411				ATP01
607-478-00-5	tetramethylammonium hydrogen phthalate	416-900-5	79723-02-7	Acute Tox. 3 *STOT RE 2 *Aquatic Acute 1	H301H373 **H400	GHS06GHS08GHS09Dgr	H301H373 **H400				CLP00
607-479-00-0	"hexadecyl 4-chloro-3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxopentamido]benzoate"	418-550-9	168689-49-4	Aquatic Chronic 4	H413		H413				CLP00
607-480-00-6	"1,2-benzenedicarboxylic acid; di-C7-11-branched and linear alkylesters"	271-084-6	68515-42-4	Repr. 1B	H360Df	GHS08Dgr	H360Df				CLP00
607-481-00-1	reaction mass of: trihexyl citrate; dihexyloctyl citrate; dioctylhexyl citrate; dihexyldecyl citrate	430-290-8	-	Aquatic Chronic 4	H413	-	H413				ATP01
607-482-00-7	N-[1-(S)-ethoxycarbonyl-3-phenylpropyl]-.sc.l.sc.-alanyl-N-carboxyanhydride	430-360-8	84793-24-8	Eye Dam. 1Skin Sens. 1	H318H317	GHS05GHS07Dgr	H318H317				ATP01
607-483-00-2	"1,2-benzenedicarboxylic acid; di-C6-8-branched alkylesters, C7-rich"	276-158-1	71888-89-6	Repr. 1B	H360D ***	GHS08Dgr	H360D ***				ATP01
607-484-00-8	"ethyl 2-{[3-acetylamino-4-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)phenyl]ethylamino}propionate"	430-480-0	221452-67-1	Aquatic Chronic 4	H413	-	H413				ATP01
607-485-00-3	"(3S-trans)-phenyl-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-piperidinecarboxylate"	430-510-2	-	Aquatic Chronic 4	H413	-	H413				ATP01
607-486-00-9	"potassium sodium 5'-(6-chloro-4-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-4'-hydroxy-2,3'-azodinaphthalene-1,2',5,7'-disulfonate"	402-110-8	110081-40-8	Aquatic Chronic 3	H412	-	H412				ATP01
607-487-00-4	"reaction mass of: disodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-hydroxy-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate; trisodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-oxido-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate"	402-660-9		Repr. 1BAquatic Chronic 3	H360D ***H412	GHS08Dgr	H360D ***H412				CLP00
607-488-00-X	ethyl (2-acetylamino-5-fluoro-4-isothiocyanatophenoxy)acetate	414-210-9	147379-38-2	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
607-489-00-5	"reaction mass of: 2-ethylhexyl linolenate, linoleate and oleate; 2-ethylhexyl epoxyoleate; 2-ethylhexyl diepoxylinoleate; 2-ethylhexyl triepoxylinolenate"	414-890-7	71302-79-9	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
607-490-00-0	N-[2-hydroxy-3-(C12-16-alkyloxy)propyl]-N-methyl glycinate	415-060-7		Eye Dam. 1Skin Sens. 1	H318H317	GHS05GHS07Dgr	H318H317				CLP00
607-491-00-6	"reaction mass of: diester of 4,4'-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:2); triester of 4,4'-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:3)"	427-140-9	-	Carc. 2	H351	GHS08Wng	H351				ATP01
607-492-00-1	"2-(1-(3',3'-dimethyl-1'-cyclohexyl)ethoxy)-2-methyl propyl propanoate"	415-490-5	141773-73-1	Aquatic Chronic 2	H411	GHS09	H411				CLP00
607-493-00-7	"methyl (3aR,4R,7aR)-2-methyl-4-(1S,2R,3-triacetoxypropyl)-3a,7a-dihydro-4H-pyrano[3,4-d]oxazole-6-carboxylate"	415-670-3	78850-37-0	Eye Dam. 1	H318	GHS05Dgr	H318				CLP00
607-494-00-2	bis(2-ethylhexyl)octylphosphonate	417-170-0	52894-02-7	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
607-495-00-8	sodium 4-sulfophenyl-6-((1-oxononyl)amino)hexanoate	417-550-6	168151-92-6	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
607-496-00-3	"2,2'-methylenebis(4,6-di-tert-butyl-phenyl)-2-ethylhexyl phosphite"	418-310-3	126050-54-2	Aquatic Chronic 4	H413		H413				CLP00
607-497-00-9	cerium oxide isostearate	419-760-3		Aquatic Chronic 4	H413		H413				CLP00
607-498-00-4	"(E)-3,7-dimethyl-2,6-octadienylhexadecanoate"	421-370-3	3681-73-0	Skin Irrit. 2Aquatic Chronic 4	H315H413	GHS07Wng	H315H413				CLP00
607-499-00-X	"bis(dimethyl-(2-hydroxyethyl)ammonium) 1,2-ethanediyl-bis(2-hexadecenylsuccinate)"	421-660-1		Eye Dam. 1Skin Sens. 1Aquatic Chronic 2	H318H317H411	GHS05GHS07GHS09Dgr	H318H317H411				CLP00
607-500-00-3	"calcium 2,2,bis[(5-tetrapropylene-2-hydroxy)phenyl]ethanoate"	421-670-4		Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H315H400H410	GHS07GHS09Wng	H315H410				CLP00
607-501-00-9	reaction mass of: triphenylthiophosphate and tertiary butylated phenyl derivatives	421-820-9	192268-65-8	Aquatic Chronic 4	H413		H413				CLP00
607-502-00-4	"(N-benzyl-N,N,N-tributyl)ammonium 4-dodecylbenzenesulfonate"	422-200-0	178277-55-9	Acute Tox. 4 *Skin Corr. 1BAquatic Chronic 2	H302H314H411	GHS05GHS07GHS09Dgr	H314H302H411				CLP00
607-503-00-X	"2,4,6-tri-n-propyl-2,4,6-trioxo-1,3,5,2,4,6-trioxatriphosphorinane"	422-210-5	68957-94-8	Skin Corr. 1B	H314	GHS05Dgr	H314				CLP00
607-504-00-5	"diammonium 1-hydroxy-2-(4-(4-carboxyphenylazo)-2,5-dimethoxyphenylazo)-7-amino-3-naphthalenesulfonate"	422-670-7		Repr. 2Acute Tox. 3 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H361fH301H373 **H400H410	GHS06GHS08GHS09Dgr	H301H361fH373 **H410				ATP01/ATP01corr
607-505-00-0	"pentasodium 7-(4-(4-(5-amino-4-sulfonato-2-(4-((2-(sulfonato-ethoxy)sulfonyl)phenylazo)phenylamino)-6-chloro-1,3,5-triazin-2-yl)amino-2-ureidophenylazo)naphtalene-1,3,6-trisulfonate"	422-930-1		Aquatic Chronic 3	H412		H412				CLP00
607-506-00-6	"reaction mass of: strontium (4-chloro-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl)benzenesulfonate; disodium (4-chloro-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl)benzenesulfonate"	422-970-8		Aquatic Chronic 2	H411	GHS09	H411				CLP00
607-507-00-1	"potassium,sodium 2,4-diamino-3-[4-(2-sulfonatoethoxysulfonyl)phenylazo]-5-[4-(2-sulfonatoethoxysulfonyl)-2-sulfonatophenylazo]-benzenesulfonate"	422-980-2	187026-95-5	Eye Dam. 1	H318	GHS05Dgr	H318				CLP00
607-508-00-7	"disodium 3,3'-[iminobis[sulfonyl-4,1-phenylene-(5-hydroxy-3-methylpyrazole-1,4-diyl)azo-4,1-phenylenesulfonylimino-(4-amino-6-hydroxypyrimidine-2,5-diyl)azo-4,1-phenylenesulfonylimino(4-amino-6-hydroxypyrimidine-2,5-diyl)azo]bis(benzenesulfonate)]"	423-110-4		Eye Dam. 1	H318	GHS05Dgr	H318				CLP00
607-509-00-2	2-phenoxyethyl 4-aminobenzoate	430-880-5	88938-23-2	Aquatic Chronic 2	H411	GHS09	H411				ATP01
607-510-00-8	"(2S,5R)-6,6-dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide"	427-200-4	76646-91-8	Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1Skin Sens. 1	H302H315H318H317	GHS05GHS07Dgr	H302H315H318H317				ATP01
607-511-00-3	reaction mass of: 4-[(3-decyloxypropyl)(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)amino]-4-oxobutyric acid; 4-[(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)(3-octyloxypropyl)amino]-4-oxobutyric acid	423-750-4	-	Eye Irrit. 2Aquatic Chronic 2	H319H411	GHS07GHS09Wng	H319H411				ATP01
607-512-00-9	"trisodium 2,4-diamino-3,5-bis-[4-(2-sulfonatoethoxy)sulfonyl)phenylazo]benzenesulfonate"	423-970-0	182926-43-8	Aquatic Chronic 3	H412		H412				CLP00
607-513-00-4	"reaction mass of: Trisodium 4-benzoylamino-6-(6-ethenesulfonyl-1-sulfato-naphthalen-2-ylazo)-5-hydroxynaphthalene-2,7-disulfonate; 5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthyl)azo)naphthalene-2,7-disulfonic acid sodium salt; 5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthyl)azo)naphthalene-2,7-disulfonic acid"	423-200-3		Eye Dam. 1Skin Sens. 1Aquatic Chronic 3	H318H317H412	GHS05GHS07Dgr	H318H317H412				CLP00
607-514-00-X	potassium N-(1-methoxy-1-oxobut-2-en-3-yl)valinate	427-240-2	134841-35-3	Skin Sens. 1	H317	GHS07Wng	H317				ATP01
607-515-00-5	reaction mass of: disodium hexyldiphenyl ether disulphonate; disodium dihexyldiphenyl ether disulphonate	429-650-7	147732-60-3	Eye Irrit. 2Aquatic Chronic 2	H319H411	GHS07GHS09Wng	H319H411				CLP00
607-516-00-0	"N,N'-bis(trifluoroacetyl)-S,S'-bis L-homocysteine"	429-670-6	105996-54-1	Eye Dam. 1Skin Sens. 1	H318H317	GHS05GHS07Dgr	H318H317				CLP00
607-517-00-6	(S)-?-(acetylthio)benzenepropanoic acid	430-300-0	76932-17-7	Acute Tox. 4 *Eye Dam. 1Skin Sens. 1	H302H318H317	GHS05GHS07Dgr	H302H318H317				CLP00
607-518-00-1	3-oxoandrost-4-ene-17-ß-carboxylic acid	414-990-0	302-97-6	Repr. 2Aquatic Chronic 4	H361fH413	GHS08Wng	H361fH413				ATP01/ATP01corr
607-519-00-7	"poly-[((4-((4-ethyl-ethylene)amino)phenyl)-((4-(ethyl-(2-oxyethylene)amino)phenyl)methinyl)cyclohexa-2,5-dienylidene)-N-ethyl-N-(2-hydroxyethyl)ammonium acetate]"	427-280-0	176429-27-9	STOT SE 3Skin Irrit. 2Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H335H315H318H400H410	GHS05GHS07GHS09Dgr	H335H315H318H410				ATP01
607-520-00-2	"reaction mass of: sodium 4,5-dihydro-2-[(propionato)(C6-18)alkyl]-3H-imidazolium-N-ethylphosphate; disodium 4,5-dihydro-2-[(dipropionato)(C6-18)alkyl]-3H-imidazolium-N-ethylphosphate"	427-740-0	-	Eye Dam. 1Skin Sens. 1	H318H317	GHS05GHS07Dgr	H318H317				ATP01
607-521-00-8	"tetraethyl N,N'-(methylenedicyclohexane-4,1-diyl)bis-.sc.dl.sc.-aspartate"	429-270-1	136210-30-5	Skin Sens. 1Aquatic Chronic 3	H317H412	GHS07Wng	H317H412				ATP01
607-522-00-3	"sodium salt of the polymer of: sodium 2-methyl-buta-1,3-diene-1-sulfonate with acrylic acid and 2-hydroxyethyl-2-methylacrylate"	429-720-7	184246-86-4	Aquatic Chronic 3	H412	-	H412				ATP01
607-523-00-9	"reaction mass of mono to tetra(lithium and/or sodium)3-amino-10-[4-(4-amino-3-sulfonatoanilino)-6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to tetra(lithium and/or sodium)3-amino-10-[4,6-bis(4-amino-3-sulfonatoanilino)-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to penta(lithium and/or sodium)10,10´-diamino-6,6',13,13´-tetrachloro-3,3'-[6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10-amino-6,6',13,13'-tetrachloro-10´[4-(4-amino-3-sulfonatoanilino)-[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10,10'-diamino-6,6',3,3'[(2-sulfonato)-1,4-phenylenediiminobis[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate"	430-200-7	-	Eye Dam. 1Aquatic Chronic 3	H318H412	GHS05Dgr	H318H412				ATP01
607-524-00-4	tall oil 2-[(tetrahydro-2H-pyran-2-yl) thio]ethyl esters	430-310-5	-	Aquatic Chronic 4	H413		H413				ATP01
607-525-00-X	(Z)-2-methoxymino-2-[2-(tritylamino)thiazol-4-yl]acetic acid	431-520-1	64485-90-1	Flam. Sol. 1 ****Carc. 2Aquatic Chronic 3	H228H351H412	GHS02GHS08Dgr	H228H351H412				ATP01
607-526-00-5	"cartap (ISO); 1,3-bis(carbamoylthio)-2-(dimethylamino)propane"		15263-53-3	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
607-527-00-0	"reaction mass of: 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-tridecafluorooctyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heptdecafluorodecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-pentacosafluorotetradecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heptadecafluorodecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate"	423-180-6		STOT RE 2 *	H373 **	GHS08Wng	H373 **				CLP00
607-528-00-6	(S)-3-methyl-2-(2-oxotetrahydropyrimidine-1-yl)butyric acid	430-900-2	192725-50-1	Eye Dam. 1	H318	GHS05Dgr	H318				ATP01
607-529-00-1	benzyl cis-4-ammonium-4'-toluenesulfonato-1-cyclohexanecarboxylate	426-070-6	67299-45-0	Aquatic Chronic 3	H412	-	H412				ATP01
607-530-00-7	"reaction mass of isomers of: C7-9-alkyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate"	406-040-9	125643-61-0	Aquatic Chronic 4	H413	-	H413				ATP01
607-531-00-2	"methyl 3-amino-4,6-dibromo-2-methyl-benzoate"	425-190-6	119916-05-1	STOT RE 2 *Aquatic Chronic 2	H373 **H411	GHS08GHS09Wng	H373 **H411				ATP01
607-532-00-8	"(S)-1-[2-tert-butoxycarbonyl-3-(2-methoxyethoxy)propyl]-1-cyclopentanecarboxylic acid, cyclohexylamine salt"	425-510-4	167944-94-7	Aquatic Chronic 3	H412	-	H412				ATP01
607-533-00-3	"pentasodium monohydrogen 6-chloro-3,10-bis[2-[4-chloro-6-(2,4-disulfophenylamino)-1,3,5-triazin-2-yl-amino]ethylamino]-13-ethylbenzo[5.6][1.4]oxazino[2,3-b]phenoxazine-4,11-disulfonate"	414-910-4	-	Eye Dam. 1Skin Sens. 1	H318H317	GHS05GHS07Dgr	H318H317				ATP01
607-534-00-9	ethyl 2-(3-benzoylphenyl)propanoate	414-920-9	60658-04-0	Acute Tox. 3 *STOT RE 1Skin Sens. 1Aquatic Chronic 2	H301H372 **H317H411	GHS06GHS08GHS09Dgr	H301H372 **H317H411				ATP01
607-535-00-4	potassium 4-iodo-2-sulfonato-benzoic acid	426-620-5	-	Eye Dam. 1Aquatic Chronic 3	H318H412	GHS05Dgr	H318H412				ATP01
607-536-00-X	"(2,6-xylyloxy) acetic acid"	430-910-7	13335-71-2	Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 3	H302H318H412	GHS05GHS07Dgr	H302H318H412				ATP01
607-537-00-5	isopropylammonium 2-(3-benzoylphenyl)propionate	417-970-1	-	Acute Tox. 3 *Acute Tox. 4 *STOT RE 1Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H301H312H372 **H318H400H410	GHS06GHS05GHS08GHS09Dgr	H301H312H372 **H318H410				ATP01
607-539-00-6	propyl((4-(5-oxo-3-propylisoxazolidin-4-ylidenmethin)phenyl)propoxycarbonylmethyleneamino)acetate	431-000-2	198705-81-6	Aquatic Chronic 4	H413	-	H413				ATP01
607-540-00-1	1-(mercaptomethyl)cyclopropylacetic acid	420-240-3	162515-68-6	Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Chronic 2	H312H302H314H317H411	GHS05GHS07GHS09Dgr	H314H312H302H317H411				ATP01
607-541-00-7	"[(1-methyl-1,2-ethanediyl)bis[nitrilobis(methylene)]]tetrakis(phosphonic acid)"	421-940-1	28698-31-9	Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H318H400H410	GHS05GHS09Dgr	H318H410				ATP01
607-542-00-2	methyl 2-(4-butanesulfonamidophenoxy)tetradecanoate	422-110-1	-	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				ATP01
607-543-00-8	"poly-[((4-((4-(ethyl-ethylene)amino)phenyl)-(4-(ethyl-(2-oxyethylene)amino)phenyl)methinyl)-3-methylcyclohexa-2,5-dienylidene)-N-ethyl-N-(2-hydroxyethyl)ammonium acetate]"	427-480-8	176429-22-4	STOT SE 3Skin Irrit. 2Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H335H315H318H400H410	GHS05GHS07GHS09Dgr	H335H315H318H410				ATP01
607-544-00-3	"ethyl 6,8-difluoro-1-(formylmethylamino)-1,4-dihydro-7-(4-methyl)piperazin-1-yl)-4-oxo-quinoline-3-carboxylate"	427-490-2	158585-86-5	Aquatic Chronic 3	H412	-	H412				ATP01
607-545-00-9	"1,2-dimethyl-3-(1-methylethenyl)cyclopentyl acetate"	424-070-0	94346-09-5	Skin Irrit. 2Aquatic Chronic 2	H315H411	GHS07GHS09Wng	H315H411				ATP01
607-546-00-4	reaction mass of: methyl {[5-acetylamino-4-(2-chloro-4-nitrophenylazo)phenyl]methoxycarbonylmethylamino}acetate; methyl {[5-acetylamino-4-(2-chloro-4-nitrophenylazo)phenyl]ethoxycarbonylmethylamino}acetate	424-290-7	188070-47-5	Skin Sens. 1	H317	GHS07Wng	H317				ATP01
607-547-00-X	"18-methylnonadecyl 2,2-dimethylpropanoate"	424-370-1	125496-22-2	Skin Irrit. 2Skin Sens. 1Aquatic Chronic 4	H315H317H413	GHS07Wng	H315H317H413				ATP01/ATP01corr
607-548-00-5	"1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethanone methanesulfonate"	431-010-7	154486-26-7	Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 2	H302H318H411	GHS05GHS07GHS09Dgr	H302H318H411				ATP01
607-549-00-0	"methyl (E)-2((3-(1,3-benzodioxol-5-yl)-2-methyl-1-propenyl)amino)benzoate"	424-430-7	125778-19-0	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				ATP01
607-550-00-6	2-amino-4-bromo-5-chlorobenzoic acid	424-700-4		Eye Dam. 1Aquatic Chronic 3	H318H412	GHS05Dgr	H318H412				ATP01/ATP01corr
607-551-00-1	tetrabutylammonium 2-amino-6-iodopurinate	424-710-9	156126-48-6	Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Chronic 2	H312H302H373 **H315H318H317H411	GHS05GHS08GHS07GHS09Dgr	H312H302H373 **H315H318H317H411				ATP01
607-552-00-7	hexadecyl 3-amino-4-isopropoxybenzoate	424-830-1	-	Aquatic Chronic 4	H413	-	H413				ATP01
607-553-00-2	"7-amino-4-hydroxy-2-naphthalenesulfonic acid, coupled with 5 (or 8) -amino-8 (or 5)-[[4-[[4-[[4-amino-6(or 7)-sulfo-1-naphthyl]azo]phenyl]amino]-3-sulfophenyl]azo]-2-naphthalenesulfonic acid and 4-hydroxy-7-(phenylamino)-2-naphthalenesulfonic acid, sodium salt"	424-850-0	-	Eye Dam. 1	H318	GHS05Dgr	H318				ATP01
607-554-00-8	"2,4-diamino-5-[4-[(2-sulfoxyl ethyl)sulfonyl]phenylazo]benzenesulfonic acid"	424-870-1	27624-67-5	Expl. 1.1Eye Dam. 1Aquatic Chronic 3	H201H318H412	GHS01GHS05Dgr	H201H318H412				ATP01
607-555-00-3	"1,1,3,3-tetramethylbutylperoxypivalate"	424-980-8	22288-41-1	Flam. Liq. 2Org. Perox. DSkin Irrit. 2Skin Sens. 1Aquatic Chronic 2	H225H242H315H317H411	GHS02GHS07GHS09Dgr	H225H242H315H317H411				ATP01
607-556-00-9	2-acetoxymethylene-4-acetylphenylacetate	425-160-2	24085-06-1	Acute Tox. 4 *STOT RE 2 *Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H373 **H318H317H400H410	GHS05GHS08GHS07GHS09Dgr	H302H373 **H318H317H410				ATP01
607-557-00-4	"salt of: (1S-cis)-1-amino-2,3-dihydro-1H-inden-2-ol and [R-[R*R*]]-2,3-dihydroxybutanedioic acid"	425-210-3	169939-84-8	Skin Sens. 1	H317	GHS07Wng	H317				ATP01
607-558-00-X	"2S-isopropyl-5R-methyl-1R-cyclohexyl (2R,5S)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-[1.3]-oxathiolane-2-carboxylate"	425-250-1	147027-10-9	Aquatic Chronic 2	H411	GHS09	H411				ATP01
607-559-00-5	"coconut oil, reaction products with glycerol esters of 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoic acid"	425-400-6	179986-09-5	Aquatic Chronic 4	H413	-	H413				ATP01
607-560-00-0	"(R,S)-2-butyloctanedioic acid"	431-210-4	50905-10-7	Eye Dam. 1	H318	GHS05Dgr	H318				ATP01
607-561-00-6	sodium 4-hydroxy-3-(N'-(2-(2-hydroxyethylenesulfonyl)ethylene)ureido)-5-nitrobenzenesulfonate	425-460-3	-	Skin Sens. 1Aquatic Chronic 3	H317H412	GHS07Wng	H317H412				ATP01
607-562-00-1	"reaction mass of: (2R,3R)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium methanesulfonate; (2S,3S)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium methanesulfonate"	425-530-3	98769-75-6	Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 2	H302H318H411	GHS05GHS07GHS09Dgr	H302H318H411				ATP01
607-563-00-7	"5,7-dichloro-4-hydroxyquinoline-3-carboxylic acid"	431-250-2	171850-30-9	Aquatic Chronic 2	H411	GHS09	H411				ATP01
607-564-00-2	"1,6-hexanediammonium, sodium 5-sulfato-1,3-benzenedicarboxylate"	425-730-0	51178-75-7	Skin Sens. 1	H317	GHS07Wng	H317				ATP01
607-565-00-8	"3-ethyl 5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate"	425-820-1	88150-42-9	Acute Tox. 3 *STOT RE 2 *Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H301H373 **H318H400H410	GHS06GHS05GHS08GHS09Dgr	H301H373 **H318H410				ATP01
607-566-00-3	reaction mass of: dodecylphenyl dodecylhydroxybenzenecarboxylate; bis(dodecylphenyl)dodecyl hydroxybenzenedicarboxylate	426-140-6	-	Aquatic Chronic 4	H413	-	H413				ATP01
607-567-00-9	potassium 3-iodo-6-methylbenzenesulfonate	426-300-5	-	Eye Dam. 1	H318	GHS05Dgr	H318				ATP01
607-568-00-4	potassium 2-chloro-3-(benzyloxy)propionate	426-350-8	138666-92-9	Acute Tox. 4 *STOT RE 2 *Eye Dam. 1Skin Sens. 1	H302H373 **H318H317	GHS05GHS08GHS07Dgr	H302H373 **H318H317				ATP01
607-569-00-X	"reaction mass of: sodium 2-amino-4-(2,6-difluoropyrimidin-4-ylamino)benzenesulfonate; sodium 2-amino-4-(4,6-difluoropyrimidin-4-ylamino)benzenesulfonate"	426-470-0	-	Skin Sens. 1	H317	GHS07Wng	H317				ATP01
607-570-00-5	sodium (6R-trans)-7-amino-8-oxo-3-[[[1-(sulfomethyl)-1H-tetrazol-5-yl]thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate monohydrate	426-520-1	71420-85-4	Skin Sens. 1	H317	GHS07Wng	H317				ATP01
607-571-00-0	"2-cyclopentene-1-acetic acid, 3-hydroxy-2-pentyl-, methyl ester acetate"	431-400-7	57374-49-9	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				ATP01
607-572-00-6	diethyl thiophosphoryl (Z)-(2-aminothiazol-4-yl)methoxyimino acetate	426-790-0	162208-27-7	Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H312H302H373 **H317H400H410	GHS08GHS07GHS09Wng	H312H302H373 **H317H410				ATP01
607-573-00-1	"reaction mass of: disodium 7-(2,4-difluoropyrimidin-6-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)naphthalene-2-sulfonate; disodium 7-(4,6-difluoropyrimidin-2-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)naphthalene-2-sulfonate"	426-840-1	-	Eye Dam. 1	H318	GHS05Dgr	H318				ATP01
607-574-00-7	"[1R-(1-?,2?,5?)]-mono[5-methyl-2-(1-methylethyl)cyclohexyl]butanedioate"	426-890-4	77341-67-4	Eye Dam. 1	H318	GHS05Dgr	H318				ATP01
607-575-00-2	"4-(5-(5-[1-(4-carboxyphenyl)hexahydro-2,4,6-trioxopyrimidin-5-ylidene]penta-1,3-dienyl)-1,2,3,4-tetrahydro-6-hydroxy-2,4-dioxopyrimidin-1-yl)benzoic acid-triethylamine salt"	426-900-7	-	STOT SE 3Aquatic Chronic 3	H335H412	GHS07Wng	H335H412				ATP01
607-576-00-8	"branched, octyl 3-[3,5-di(tert-butyl)-4-hydroxyphenyl]propanoate"	427-030-0	-	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				ATP01
607-577-00-3	"(2R*,3S*)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol (1R)-10-camphorsulfonate"	427-100-0	-	Acute Tox. 4 *Eye Dam. 1Skin Sens. 1Aquatic Chronic 3	H302H318H317H412	GHS05GHS07Dgr	H302H318H317H412				ATP01
607-578-00-9	"ethyl 4-((4-diethylamino-2-methylphenyl)imino)-4,5-dihydro-1-isopropyl-5-oxo-1H-pyrazole-3-carboxylate"	427-110-5	-	Acute Tox. 4 *STOT RE 2 *Aquatic Chronic 4	H302H373 **H413	GHS08GHS07Wng	H302H373 **H413				ATP01
607-579-00-4	diethyl[(p-ethoxyanilino)methylene]malonate	431-430-0	103976-28-9	Acute Tox. 4 *Aquatic Chronic 2	H302H411	GHS07GHS09Wng	H302H411				ATP01
607-580-00-X	"ethyl 7-chloro-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate"	422-360-1	100491-29-0	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				ATP01
607-581-00-5	ethyl 2-ethoxy-4-carboxymethylbenzoate	427-630-2	99469-99-5	Eye Dam. 1	H318	GHS05Dgr	H318				ATP01
607-582-00-0	"reaction mass of: tetrasodium 7-(4-(4-fluoro-6-(4-(2-sulfonatoethylsulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate; tetrasodium 7-(4-(4-hydroxy-6-(4-(2-sulfonatoethylsulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate"	427-650-1	-	Aquatic Chronic 3	H412	-	H412				ATP01
607-583-00-6	4-amino-3-[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]-1-naphthalene sulfonic acid	427-680-5	188907-52-0	Eye Dam. 1Skin Sens. 1Aquatic Chronic 3	H318H317H412	GHS05GHS07Dgr	H318H317H412				ATP01
607-584-00-1	"trisodium 3-[2-acetylamino-4-[4-chloro-6-[4-(2-sulfonatoxyethylsulfonyl)phenylamino]-1,3,5-triazine-2-ylamino]phenylazo]naphthalene-1,5-disulfonate"	427-710-7	215612-56-9	Eye Dam. 1Skin Sens. 1Aquatic Chronic 3	H318H317H412	GHS05GHS07Dgr	H318H317H412				ATP01
607-585-00-7	strontium 2-[(2-hydroxy-6-sulfonato-1-naphthyl)azo]naphthalene-1-sulfonate	427-930-3	-	Skin Sens. 1	H317	GHS07Wng	H317				ATP01
607-586-00-2	dodecyl 3-amino-4-chlorobenzoate	428-020-9	6195-20-6	Skin Sens. 1Aquatic Chronic 4	H317H413	GHS07Wng	H317H413				ATP01
607-587-00-8	"ethyl cis-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine-1-carboxylate"	428-030-3	67914-69-6	Acute Tox. 4 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H302H373 **H400H410	GHS08GHS07GHS09Wng	H302H373 **H410				ATP01
607-588-00-3	"reaction mass of: 2-ethylhexyl 2,3,4,5-tetrabromobenzoate; bis(2-ethylhexyl) 3,4,5,6-tetrabromophthalate"	428-050-2	-	Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410				ATP01
607-589-00-9	"tetrakis(1,2,2,6,6-pentamethyl-4-piperidyl)-1,2,3,4-butanetetracarboxylate"	428-070-1	91788-83-9	Acute Tox. 4 *STOT RE 1Aquatic Acute 1Aquatic Chronic 1	H302H372 **H400H410	GHS08GHS07GHS09Dgr	H372 **H302H410				ATP01
607-590-00-4	"hexadecyl 3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxovaleramido]-4-isopropoxybenzoate"	428-140-1	210706-50-6	Aquatic Chronic 4	H413	-	H413				ATP01
607-591-00-X	"reaction mass of: trisodium 5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-sulfooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate; disodium 3-(4-ethenesulfonylphenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxynaphthalene-2,7-disulfonate"	428-400-4		Eye Dam. 1	H318	GHS05Dgr	H318				ATP01/ATP01corr
607-592-00-5	"di(C9-11-alkyl) cyclohexane-1,4-dicarboxylate"	428-870-0	-	Aquatic Chronic 4	H413	-	H413				ATP01
607-593-00-0	4-(2-methylacryloyloxy)phenyl 4-allyloxybenzoate	429-000-2	159235-16-2	Skin Sens. 1Aquatic Chronic 3	H317H412	GHS07Wng	H317H412				ATP01
607-594-00-6	"ethyl (1S,5R,6S)-5-(1-ethylpropoxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylate"	429-020-1	204254-96-6	STOT RE 2 *Skin Sens. 1	H373 **H317	GHS08GHS07Wng	H373 **H317				ATP01
607-595-00-1	N-amidino-N-methylglycine-2-oxopropionate	429-120-5	208535-04-0	Eye Dam. 1	H318	GHS05Dgr	H318				ATP01
607-596-00-7	ethyl 2-(4-phenoxyphenyl)lactate	429-220-9	132584-17-9	Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410				ATP01
607-597-00-2	"tetrasodium 4,4'-bis{4-[4-(2-hydroxyethylamino)-6-(4-sulfonatoanilino)-1,3,5-triazin-2-ylamino]phenylazo}stilbene-2,2'-disulfonate"	429-230-3	-	Eye Dam. 1	H318	GHS05Dgr	H318				ATP01
607-598-00-8	"trisodium 3-amino-4-[4-[4-(2-(2-ethenylsulfonylethoxy)ethylamino)-6-fluoro-1,3,5-triazine-2-ylamino]-2-sulfophenylazo]-5-hydroxynaphthalene-2,7-disulfonate"	429-240-8	212652-59-0	Eye Dam. 1	H318	GHS05Dgr	H318				ATP01
607-599-00-3	"1,1-dimethylpropyl 3,5,5-trimethylperoxyhexanoate"	431-610-9	68860-54-8	Org. Perox. DSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H242H317H400H410	GHS02GHS07GHS09Dgr	H242H317H410				ATP01
607-600-00-7	"(1S,1'R)-[1-(3',3'-dimethyl-1'-cyclohexyl)ethoxycarbonyl]methyl propanoate"	431-700-8	-	Aquatic Chronic 2	H411	GHS09	H411				ATP01
607-601-00-2	"1,4-dihydroxy-2,2,6,6-tetramethyl piperidinium-2-hydroxy-1,2,3-propanetricarboxylate"	429-370-5	220410-74-2	Acute Tox. 4 *	H302	GHS07Wng	H302				ATP01
607-602-00-8	"ethyl (3-cyanomethyl-3,4-dihydro-4-oxophthalazin-1-yl)acetate"	429-680-0	122665-86-5	Skin Sens. 1Aquatic Chronic 3	H317H412	GHS07Wng	H317H412				ATP01
607-603-00-3	"lithium sodium 4,4',4''-(nitrilotris(ethane-2,1-diylimino(6-chloro-1,3,5-triazine-4,2-diyl)imino))tris(5-hydroxy-6-(1-sulfonaphthalene-2-ylazo)-2,7-naphthalene)disulfonate"	429-730-1	193562-37-7	Eye Dam. 1Skin Sens. 1	H318H317	GHS05GHS07Dgr	H318H317				ATP01
607-604-00-9	guanidinium benzoate	429-820-0	26739-54-8	Acute Tox. 4 *	H302	GHS07Wng	H302				ATP01
607-605-00-4	"methyl 4-iodo-2-(3-(4-methoxy-6-methyl-1,3,5-triazine-2-yl)ureidosulfonyl)benzoate"	429-890-2	144550-06-1	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				ATP01
607-606-00-X	(Z)-2-(2-t-butoxycarbonylamino-4-thiazolyl)pent-2-enoic acid	430-100-3	86978-24-7	Acute Tox. 4 *	H302	GHS07Wng	H302				ATP01
607-607-00-5	reaction mass of: calcium bis(C10-14 branched alkyl salicylate); calcium bis(C18-30-alkyl salicylate); calcium C10-14 branched alkylsalicylato-C18-30-alkyl salicylate; calcium bis (C10-14 branched alkyl phenolate); calcium bis (C18-30-alkyl phenolate); calcium C10-14 branched alkylphenolato-C18-30-alkyl phenolate; C10-14 branched alkyl phenol; C18-30-alkyl phenol	430-180-1	-	Skin Irrit. 2Aquatic Chronic 2	H315H411	GHS07GHS09Wng	H315H411				ATP01
607-608-00-0	"pentapotassium 2-(4-{5-[1-(2,5-disulfophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-(2-pyrrolidinone-1-yl)-1,3-pentadienyl}-3-methylcarbamoyl-5-oxopyrazol-1-yl)benzene-1,4-disulfonate"	430-210-1	-	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				ATP01
607-609-00-6	ethyl (3R)-4-cyano-3-hydroxybutanoate	430-220-6	141942-85-0	Eye Irrit. 2	H319	GHS07Wng	H319				ATP01
607-610-00-1	trisodium 4-hydroxy-6-(sulfonatomethylamino)-5-(2-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2-sulfonate	430-280-3	-	Skin Sens. 1	H317	GHS07Wng	H317				ATP01
607-611-00-7	"methyl 3-amino-2,2,3-trimethylbutyrate"	431-720-7	90886-53-6	Acute Tox. 4 *Skin Corr. 1BAquatic Chronic 3	H302H314H412	GHS05GHS07Dgr	H314H302H412				ATP01
607-612-00-2	"reaction mass of: 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanesulfonic acid; ammonium 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanesulfonate"	432-190-1	182176-52-9	Acute Tox. 4 *STOT RE 2 *Eye Dam. 1	H302H373 **H318	GHS05GHS08GHS07Dgr	H302H373 **H318				ATP01
607-613-00-8	reaction mass of: succinic acidmonopersuccinic aciddipersuccinic acidmonomethyl ester of succinic acidmonomethyl ester of persuccinic aciddimethyl succinate glutaric acidmonoperglutaric aciddiperglutaric acidmonomethyl ester of glutaric acidmonomethyl ester of perglutaric aciddimethyl glutarate adipic acidmonoperadipic aciddiperadipic acidmonomethyl ester of adipic acidmonomethyl ester of peradipic aciddimethyl adipatehydrogen peroxidemethanolwater	432-790-1		Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *STOT SE 2Skin Corr. 1B	H332H312H302H371H314	GHS07GHS05GHS08Dgr	H302H312H332H314H371				ATP01/ATP05
607-614-00-3	2-(10-oxo-10H-9-oxa-10-phosphaphenanthren-10-ylmethyl)succinic acid	426-480-5	63562-33-4	Skin Sens. 1Aquatic Chronic 3	H317H412	GHS07Wng	H317H412				ATP01
607-615-00-9	"reaction product of thioglycerol and mercaptoacetic acid consisting mainly of 3-mercapto-1,2-bismercaptoacetoxypropane and oligomers of this substance"	431-120-5	-	Acute Tox. 3 *Acute Tox. 4 *Eye Irrit. 2Skin Sens. 1	H331H302H319H317	GHS06Dgr	H331H302H319H317				ATP01
607-616-00-4	"2,4-dichloro-5-fluorobenzoylchloride"	428-390-1	86393-34-2	STOT SE 3Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Chronic 3	H335H315H318H317H412	GHS05GHS07Dgr	H335H315H318H317H412				ATP01
607-617-00-X	"bis(2-ethylhexyl)-4,5-epoxycyclohexane-1,2-dicarboxylate"	430-700-5	10138-36-0	Skin Sens. 1	H317	GHS07Wng	H317				ATP01
607-618-00-5	"menadione sodium bisulfite; 2-naphthalenesulfonic acid,1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, sodium salt"	204-987-0	130-37-0	Skin Irrit. 2Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H315H319H400H410	GHS07GHS09Wng	H319H315H410				ATP01
607-619-00-0	"menadione nicotinamide bisulfite; 1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalene-2-sulfonic acid, compound with nicotin-3-amide (1:1)"	277-543-7	73581-79-0	Skin Irrit. 2Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H315H319H400H410	GHS07GHS09Wng	H319H315H410				ATP01
607-620-00-6	trisodium nitrilotriacetate	225-768-6	5064-31-3	Carc. 2Acute Tox. 4 *Eye Irrit. 2	H351H302H319	GHS08GHS07Wng	H351H302H319		Carc. 2; H351: C ? 5 %		ATP01
607-621-00-1	milbemectin (ISO); [reaction mass of milbemycin A3 (CAS No 51596-10-2) and milbemycin A4 (CAS No 51596-11-3) (30:70)]	-	-	Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H332H302H400H410	GHS07GHS09Wng	H332H302H410		M=100		ATP01
607-622-00-7	2-ethylhexyl-2-ethylhexanoate	231-057-1	7425-14-1	Repr. 2	H361d ***	GHS08Wng	H361d ***				ATP01
607-623-00-2	diisobutyl phthalate	201-553-2	84-69-5	Repr. 1B	H360Df	GHS08Dgr	H360Df		Repr. 1B; H360Df: C ? 25%Repr. 2; H361f: 5% ? C < 25%		ATP01
607-624-00-8	perfluorooctane sulfonic acid; heptadecafluorooctane-1-sulfonic acid [1]potassium perfluorooctanesulfonate; potassium heptadecafluorooctane-1-sulfonate [2]diethanolamine perfluorooctane sulfonate [3]ammonium perfluorooctane sulfonate; ammonium heptadecafluorooctanesulfonate [4]lithium perfluorooctane sulfonate; lithium heptadecafluorooctanesulfonate  [5]	217-179-8 [1]220-527-1 [2]274-460-8 [3]249-415-0 [4]249-644-6 [5]	1763-23-1 [1]2795-39-3 [2]70225-14-8 [3]29081-56-9 [4]29457-72-5 [5]	Carc. 2Repr. 1BLact.Acute Tox. 4 *Acute Tox. 4 *STOT RE 1Aquatic Chronic 2	H351H360D ***H362H332H302H372 **H411	GHS08GHS07GHS09Dgr	H351H360D ***H372 **H332H302H362H411				ATP01
607-625-00-3	clodinafop-propargyl (ISO)	-	105512-06-9	Acute Tox. 4 *STOT RE 2 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H373 **H317H400H410	GHS08GHS07GHS09Wng	H302H373 **H317H410		"Skin Sens. 1; H317: C ? 0,001 %M=1"		ATP01
607-626-00-9	"ethyl 1-(2,4-dichlorophenyl)-5-(trichloromethyl)-1H-1,2,4-triazole-3-carboxylate"	401-290-5	103112-35-2	Carc. 1BAquatic Acute 1Aquatic Chronic 1	H350H400H410	GHS08GHS09Dgr	H350H410				ATP01
607-627-00-4	"[(4S,5S)-4-benzyl-2-oxo-5-oxazolidinyl]methyl 4-nitrobenzenesulfonate"	416-360-0	162221-28-5	Skin Sens. 1	H317	GHS07Wng	H317				ATP01
607-628-00-X	4-oxo-4-(p-tolyl)butyric acid adduct with 4-ethylmorpholine	419-240-6	171054-89-0	Eye Dam. 1	H318	GHS05Dgr	H318				ATP01
607-629-00-5	[[2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl] acetic acid	419-270-1	123599-82-6	Eye Irrit. 2	H319	GHS07Wng	H319				ATP01
607-630-00-0	"acrylic acid, 3-(trimethoxysilyl)propyl ester"	419-560-6	4369-14-6	Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Chronic 3	H332H314H317H412	GHS05GHS07Dgr	H332H314H317H412				ATP01
607-631-00-6	reaction mass of: 2-(2-((oxo(phenyl)acetyl)oxy)ethoxy)ethyl oxo(phenyl)acetate; (2-(2-hydroxyethoxy)ethyl) oxo(phenyl)acetate	442-300-8	-	Skin Sens. 1	H317	GHS07Wng	H317				ATP01
607-632-00-1	"N-[3-(2,4-di-(1,1-dimethyl-propyl)phenoxy)-propyl]-1-hydroxy-5-(2-methylpropyl-oxycarbonylamino)-naphthamide"	420-210-1	111244-14-5	Aquatic Chronic 4	H413	-	H413				ATP01
607-633-00-7	"trisodium 5-{[4-chloro-6-(1-naphthylamino)-1,3,5-triazin-2-yl]amino}-4-hydroxy-3-[(E)-(4-methoxy-2-sulfonatophenyl)diazenyl]-2,7-naphthalenedisulfonate"	440-480-2	341026-59-3	Eye Dam. 1Skin Sens. 1	H318H317	GHS05GHS07Dgr	H318H317				ATP01
607-634-00-2	(S)-(-)-2-acetoxypropionylchloride; (1S)-2-chloro-1-methyl-2-oxoethyl acetate	420-610-4	36394-75-9	Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1	H302H314H317	GHS05GHS07Dgr	H302H314H317				ATP01
607-635-00-8	trisodium N-(3-propionato)-.sc.l.sc.-aspartate	422-090-4	172737-80-3	Eye Dam. 1	H318	GHS05Dgr	H318				ATP01
607-636-00-3	1-bromo-2-methylpropyl propionate	422-900-6	158894-67-8	Flam. Liq. 3Carc. 2Skin Corr. 1BSkin Sens. 1	H226H351H314H317	GHS02GHS05GHS08GHS07Dgr	H226H351H314H317				ATP01
607-637-00-9	disodium 8-amino-5-{4-[2-(sulfonatoethoxy)sulfonyl]phenylazo}naphthalene-2-sulfonate	423-730-5	250688-43-8	Eye Dam. 1	H318	GHS05Dgr	H318				ATP01
607-638-00-4	2-hydroxybenzoic acid 2-butyloctyl ester	431-090-3	190085-41-7	Aquatic Chronic 4	H413	-	H413				ATP01
607-639-00-X	"2-(2-oxo-5-(1,1,3,3-tetramethylbutyl)-2,3-dihydro-1-benzofuran-3-yl)-4-(1,1,3,3-tetramethylbutyl)phenyl acetate"	431-770-1	216698-07-6	Aquatic Chronic 4	H413	-	H413				ATP01
607-641-00-0	2-(formylamino)-3-thiophenecarboxylic acid; 2-formamido-3-thiophenecarboxylic acid	431-930-9	43028-69-9	Acute Tox. 4 *Skin Sens. 1	H302H317	GHS07Wng	H302H317				ATP01
607-642-00-6	"3,6,9-trithiaundecamethylene-1,11-dimethacrylate"	432-210-7	141631-22-3	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				ATP01
607-643-00-1	dimethyl (2S)-2-hydroxysuccinate	432-310-0	617-55-0	Flam. Liq. 3Eye Dam. 1Skin Sens. 1	H226H318H317	GHS02GHS05GHS07Dgr	H226H318H317				ATP01
607-644-00-7	"methyl 2,2-dimethyl-6-methylenecyclohexanecarboxylate"	432-350-9	81752-87-6	Skin Irrit. 2	H315	GHS07Wng	H315				ATP01
607-645-00-2	"tetrasodium 2-(4-fluoro-6-(methyl-(2-(sulfatoethylsulfonyl)ethyl)amino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-methyl-2-sulfonatophenylazo)naphthalene-1,7-disulfonate"	432-550-6	243858-01-7	Eye Dam. 1	H318	GHS05Dgr	H318				ATP01
607-646-00-8	".sc.d.sc.-erythro-hexanoic acid 2,4-dideoxy-3,5-O-(1-methylethylidene)-1,1-dimethylethylester; tert-butyl 2-[(4R,6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate"	432-960-5	124655-09-0	Acute Tox. 4 *	H302	GHS07Wng	H302				ATP01
607-647-00-3	"5-acetoxy-2-(R,S)butyryloxymethyl-1,3-oxathiolane"	433-530-1	143446-73-5	Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1	H302H317H400	GHS07GHS09Wng	H302H317H400				ATP01
607-649-00-4	[3-(chlorocarbonyl)-2-methylphenyl]acetate	433-690-0	167678-46-8	Skin Corr. 1ASkin Sens. 1	H314H317	GHS05GHS07Dgr	H314H317				ATP01
607-650-00-X	"2-methyl-1,5-pentanediamine-1,3-benzenedicarboxylate"	433-910-5	145153-52-2	Skin Sens. 1	H317	GHS07Wng	H317				ATP01
607-651-00-5	sodium 2-(nonanoyloxy)benzenesulfonate	434-360-9	91125-43-8	Eye Dam. 1Skin Sens. 1	H318H317	GHS05GHS07Dgr	H318H317				ATP01
607-652-00-0	ethyl N2-dodecanoyl-.sc.l.sc.-argininate hydrochloride	434-630-6	60372-77-2	Eye Dam. 1Aquatic Acute 1	H318H400	GHS05GHS09Dgr	H318H400				ATP01
607-653-00-6	tetrakis(bis(2-hydroxyethyl)methylammonium) 3-(4-(7-acetylamino-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-5-methoxy-2-sulfonatophenylazo)-7-(4-amino-3-sulfonatophenylamino)-4-hydroxynaphthalene-2-sulfonate	434-840-8	225786-91-4	Aquatic Chronic 2	H411	GHS09	H411				ATP01
607-654-00-1	(S)-3-hydroxy-?-butyrolactone	434-990-4	7331-52-4	Skin Sens. 1	H317	GHS07Wng	H317				ATP01
607-655-00-7	"ethyl 6,8-dichlorooctanoate"	435-080-1	1070-64-0	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				ATP01
607-656-00-2	"sodium salt of 4-amino-3,6-bis[[5-[[4-chloro-6-[(2-methyl-4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]azo]-5-hydroxy-2,7-naphthalenedisulfonic acid"	435-350-7	141250-43-3	Eye Dam. 1Aquatic Chronic 3	H318H412	GHS05Dgr	H318H412				ATP01
607-657-00-8	"pentasodium 7-(4-(4-(3-(2-sulfatoethanesulfonyl)phenylamino)-6-(4-(2-sulfatoethanesulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate"	436-920-8	172399-10-9	Eye Dam. 1	H318	GHS05Dgr	H318				ATP01
607-658-00-3	"3,10-diamino-6,13-dichloro-2-((6-(((4-(1,1-dimethylethyl)phenyl)sulfonyl)amino)-2-naphthalenyl)sulfonyl)-4,11-triphenodioxazinedisulfonic acid, lithium potassium sodium salt"	440-770-9	371921-63-0	Eye Dam. 1Aquatic Chronic 3	H318H412	GHS05Dgr	H318H412				ATP01
607-659-00-9	"pentasodium N-[5-[[4-[[3-[(aminocarbonyl)amino]-4-[(3,6,8-trisulfonatonaphthalen-2-yl)azo]phenyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]-2-sulfonato-4-[[4-[[-2-(oxysulfonato)ethyl] sulfonyl]phenyl]azo]phenyl]-3-aminopropanoic acid"	442-030-0	321912-47-4	Eye Dam. 1	H318	GHS05Dgr	H318				ATP01
607-660-00-4	"2-{4-[4-[4-fluoro-6-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino]phenylazo]phenylazo}naphthalene-4,6,8-trisulfonate, trisodium salt"	442-230-8	321679-52-1	Eye Dam. 1	H318	GHS05Dgr	H318				ATP01
607-661-00-X	"1,1-dimethylethyl 4'-(bromomethyl)biphenyl-2-carboxylate"	442-850-9	114772-40-6	Skin Sens. 1Aquatic Chronic 4	H317H413	GHS07Wng	H317H413				ATP01
607-662-00-5	methyl 2-(acetylamino)-3-chloropropionate	442-860-3	87333-22-0	Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410				ATP01
607-663-00-0	"bis(2-ethylhexyl) naphthalene-2,6-dicarboxylate"	442-980-6	127474-91-3	Aquatic Chronic 4	H413	-	H413				ATP01
607-664-00-6	methyl 2-chlorosulfonyl-4-(methanesulfonylaminomethyl) benzoate	443-120-2	393509-79-0	Eye Dam. 1Aquatic Chronic 2	H318H411	GHS05GHS09Dgr	H318H411				ATP01
607-665-00-1	trans-methyl-2-ethyl-but-2-enoate	443-150-6	101226-85-1	Flam. Liq. 3	H226	GHS02Wng	H226				ATP01
607-666-00-7	"(2S)-5-(benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-oxopentanoic acid"	443-560-5	88784-33-2	Eye Irrit. 2	H319	GHS07Wng	H319				ATP01
607-667-00-2	chloro-1-ethylcyclohexyl carbonate	444-950-8	99464-83-2	Muta. 2Skin Sens. 1	H341H317	GHS08GHS07Wng	H341H317				ATP01
607-668-00-8	"trans-2-isopropyl-5-carboxy-1,3-dioxane"	445-770-2	42031-28-7	Eye Dam. 1Aquatic Chronic 3	H318H412	GHS05Dgr	H318H412				ATP01
607-669-00-3	"methyl (9-acetoxy-3,8,10-triethyl-7,8,10-trimethyl-1,5-dioxa-9-aza-spiro[5.5]undec-3-yl)octadecanoate"	445-990-9	376588-17-9	Skin Sens. 1Aquatic Chronic 4	H317H413	GHS07Wng	H317H413				ATP01
607-670-00-9	"dibutyl-3-(4-(5-ammonio-2-butyl)benzofuran-3-yl)carbonyl)phenoxy)propyl ammonium oxalate; (5-amino-2-butylbenzofuran-3-yl) [4-(3-dibutylaminopropoxy)phenyl]methanone, dioxalate"	448-700-9	500791-70-8	STOT RE 2 *Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H373 **H318H317H400H410	GHS05GHS08GHS07GHS09Dgr	H373 **H318H317H410		M=10		ATP01
607-671-00-4	"diethyl 1,4-cyclohexanedicarboxylate"	417-310-0	72903-27-6	Aquatic Chronic 2	H411	GHS09	H411				ATP01
607-672-00-X	reaction mass of: 2-hydroxy-3-(methacryloyloxy)propyl  (2-benzoyl)benzoate; 1-hydroxymethyl-2-(methacryloyloxy)ethyl  (2-benzoyl)benzoate; x-hydroxy-y-(methacryloyloxy)propyl(or -ethyl) (2-benzoyl)benzoate	419-000-0	-	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				ATP01
607-673-00-5	"1-ethyl-5,6,7,8-tetrahydroquinolinium tosylate"	419-570-0	-	Acute Tox. 4 *Aquatic Chronic 3	H302H412	GHS07Wng	H302H412				ATP01
607-675-00-6	reaction mass of: cis-9-octadecenedioic acid; cis-9-cis-12-octadecadienedioic acid; hexadecanedioic acid; octadecanedioic acid	422-260-8	-	Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H318H400H410	GHS05GHS09Dgr	H318H410				ATP01
607-676-00-1	"reaction mass of: 2-methylnonanedioic acid; 2,4-dimethyl-4-methoxycarbonylundecanedioic acid; 2,4,6-trimethyl-4,6-dimethoxycarbonyltridecanedioic acid; 8,9-dimethyl-8,9-dimethoxycarbonylhexadecanedioic acid"	423-670-1	-	Eye Dam. 1Skin Sens. 1	H318H317	GHS05GHS07Dgr	H318H317				ATP01
607-677-00-7	"2,5-dioxopyrrolidin-1-yl N-{[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl}-.sc.l.sc.-valinate"	424-660-8	-	STOT RE 2 *Eye Dam. 1Skin Sens. 1	H373 **H318H317	GHS05GHS08GHS07Dgr	H373 **H318H317				ATP01
607-678-00-2	"reaction mass of: ethyl (2R,3R)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate; ethyl (2S,3S)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate"	427-090-8	-	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				ATP01
607-679-00-8	"reaction mass of: 3-{5-[3-(4-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(methyl)ammonium di(acetate); 3-{5-[4-(3-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido]phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate); 3-{5-[3-(4-{1-[3-(dimethylammonio)propyl]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate)"	431-440-5	-	Eye Dam. 1Aquatic Chronic 2	H318H411	GHS05GHS09Dgr	H318H411				ATP01
607-680-00-3	"tert-butyl(6-{2-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]vinyl}(4S,6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetate"	432-810-9	-	Aquatic Chronic 4	H413	-	H413				ATP01
607-681-00-9	"reaction mass of: 9-nonyl-10-octyl-19-carbonyloxyhexadecylnonadecanoic acid; 9-nonyl-10-octyl-19-carbonyloxyoctadecylnonadecanoic acid; dihexadecyl 9-nonyl-10-octylnonadecandioate; 1-octadecyl,19-hexadecyl 9-nonyl-10-octylnonadecandioate; dioctadecyl 9-nonyl-10-octylnonadecandioate"	432-910-2	-	Aquatic Chronic 4	H413	-	H413				ATP01
607-682-00-4	complex reaction mass of Chinese gum rosin post reacted with acrylic acid	434-230-1	144413-22-9	Aquatic Chronic 4	H413	-	H413				ATP01
607-683-00-X	"reaction mass of: methyl 3-((1E)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate; methyl 3-((1Z)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate (20:80)"	435-450-0	-	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				ATP01
607-684-00-5	"alkenes, C12-14, hydroformylation products, distn. residues, C-(hydrogen sulfobutanedioates), disodium salts"	435-660-2	243662-67-1	Skin Irrit. 2Skin Sens. 1	H315H317	GHS07Wng	H315H317				ATP01
607-685-00-0	ammonium 2-cocoyloxyethanesulfonate	441-050-7	-	Skin Irrit. 2Eye Dam. 1	H315H318	GHS05Dgr	H315H318				ATP01
607-686-00-6	"6,6'-bis(diazo-5,5',6,6'-tetrahydro-5,5'-dioxo)[methylene-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulphonyloxy)-6-methyl-2-phenylene]di(naphthalene-1-sulfonate)"	441-550-5	-	Self-react. C ****Carc. 2	H242H351	GHS02GHS08Dgr	H242H351				ATP01
607-687-00-1	"reaction mass of: 2-{3,6-bis-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10%); 2-{3,6-bis-[(2,3-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10%); 2-{3,6-bis-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10%); 2-{3,6-bis-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10%); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20%); 2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20%); 2-{3-[(2,5-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20%); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20%); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20%); 2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20%)"	442-800-6	-	Skin Irrit. 2Aquatic Chronic 2	H315H411	GHS07GHS09Wng	H315H411				ATP01
607-688-00-7	"(R)-1-cyclohexa-1,4-dienyl-1-methoxycarbonyl-methylammoniumchloride"	444-320-2	-	Acute Tox. 4 *	H302	GHS07Wng	H302				ATP01
607-689-00-2	"reaction mass of: methyl 1,4-dimethylcyclohexanecarboxylate (""para-isomer"" including cis- and trans- isomers); methyl 1,3-dimethylcyclohexanecarboxylate (""meta-isomer"" including cis- and trans-isomers)"	444-920-4	-	Aquatic Chronic 3	H412	-	H412				ATP01
607-690-00-8	"dimethyl[2S,2S']-6,6,6'6'-tetramethoxy-2,2'-[N,N'-bis(trifluoracetyl)-S,S'-bi(L-homocysteinyl) diimino]dihexanoate"	432-860-1	255387-46-3	Skin Sens. 1	H317	GHS07Wng	H317				ATP01
607-691-00-3	"magnesium salts, fatty acids, C16-18 and C18 unsaturated, branched and linear"	448-690-6	-	Aquatic Chronic 4	H413	-	H413				ATP01
607-692-00-9	"zinc salts, fatty acids, C16-18 and C18 unsaturated, branched and linear"	446-470-4	-	Aquatic Chronic 4	H413	-	H413				ATP01
607-693-00-4	hexyl 2-(1-(diethylaminohydroxyphenyl)methanoyl)benzoate	443-860-6	302776-68-7	Aquatic Chronic 4	H413	-	H413				ATP01
607-694-00-X	"ethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate"	443-870-0	163520-33-0	Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H317H400H410	GHS07GHS09Wng	H302H317H410				ATP01
607-696-00-0	pentyl formate	211-340-6	638-49-3	Flam. Liq. 3STOT SE 3Eye Irrit. 2	H226H335H319	GHS02GHS07Dgr	H226H319H335			C	CLP00
607-697-00-6	tert-butyl propionate		20487-40-5	Flam. Liq. 2	H225	GHS02Dgr	H225			C	CLP00
607-698-00-1	4-tert-butylbenzoic acid	202-696-3	98-73-7	Repr. 1BAcute Tox. 4STOT RE 1	H360FH302H372	GHS07GHS08Dgr	H360FH372H302				ATP03
607-699-00-7	"bifenthrin (ISO); (2-methylbiphenyl-3-yl)methyl rel-(1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate"		82657-04-3	Carc. 2Acute Tox. 2Acute Tox. 3STOT RE 1Skin Sens. 1BAquatic Acute 1Aquatic Chronic 1	H351H300H331H372 (nervous system)H317H400H410	GHS06GHS08GHS09Dgr	H300H331H317H351H372 (nervous system)H410		M=10000M=100000		ATP05
607-700-00-0	"indoxacarb (ISO); methyl (4aS)-7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [1]reaction mass of (S)- Indoxacarb and (R)- Indoxacarb 75:25; methyl 7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [2]"		173584-44-6 [1]144171-61-9 [2]	Acute Tox. 3Acute Tox. 4STOT RE 1Skin Sens. 1BAquatic Acute 1Aquatic Chronic 1	"H301H332H372 (blood, nervous system, heart)H317H400H410"	GHS06GHS08GHS09Dgr	"H301H332H317H372 (blood, nervous system, heart)H410"		M=1M=1		ATP05
607-702-00-1	dihexyl phthalate	201-559-5	84-75-3	Repr. 1B	H360FD	GHS08Dgr	H360FD				ATP05
607-703-00-7	ammoniumpentadeca- fluorooctanoate	223-320-4	3825-26-1	Carc. 2Repr. 1BLact.Acute Tox. 4Acute Tox. 4STOT RE 1Eye Dam. 1	H351H360DH362H332H302H372 (liver)H318	GHS08GHS07GHS05Dgr	H302H332H318H351H360DH362H372 (liver)				ATP05
607-704-00-2	perfluorooctanoic acid	206-397-9	335-67-1	Carc. 2Repr. 1BLact.Acute Tox. 4Acute Tox. 4STOT RE 1Eye Dam. 1	H351H360DH362H332H302H372 (liver)H318	GHS08GHS07GHS05Dgr	H302H332H318H351H360DH362H372 (liver)				ATP05
607-705-00-8	benzoic acid	200-618-2	65-85-0	STOT RE 1Skin Irrit. 2Eye Dam. 1	H372 (lungs) (inhalation)H315H318 (lungs) (inhalation)	GHS08GHS05Dgr	H315H318 (lungs) (inhalation)H372 (lungs) (inhalation)				ATP06
607-706-00-3	"methyl 2,5-dichlorobenzoate"	220-815-7	2905-69-3	Acute Tox. 4STOT SE 3Aquatic Chronic 2	H302H336H411	GHS07GHS09Wng	H302H336H411				ATP06
607-707-00-9	"fenoxaprop-P-ethyl (ISO); ethyl (2R)-2-{4-[(6-chloro-1,3-benzoxazol-2-yl)oxy]phenoxy}propanoate"		71283-80-2	STOT RE 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H373 (kidneys)H317H400H410	GHS08GHS07GHS09Wng	H317H373 (kidneys)H410		M=1M=1		ATP07
607-708-00-4	octanoic acid	204-677-5	124-07-2	Skin Corr. 1CAquatic Chronic 3	H314H412	GHS05Dgr	H314H412				ATP07
607-709-00-X	decanoic acid	206-376-4	334-48-5	Skin Irrit. 2Eye Irrit. 2Aquatic Chronic 3	H315H319H412	GHS07Wng	H315H319H412				ATP07
607-710-00-5	"1,2-benzenedicarboxylic acid, dihexyl ester, branched and linear"	271-093-5	68515-50-4	Repr. 1B	H360FD	GHS08Dgr	H360FD				ATP07
607-711-00-0	"spirotetramat (ISO); (5s,8s)-3-(2,5-dimethylphenyl)-8-methoxy-2-oxo-1-azaspiro[4,5]dec-3-en-4-yl ethyl carbonate"		203313-25-1	Repr. 2STOT SE 3Eye Irrit. 2Skin Sens. 1AAquatic Acute 1Aquatic Chronic 1	H361fdH335H319H317H400H410	GHS08GHS07GHS09Wng	H319H317H361fdH335H410		M=1M=1		ATP07
607-712-00-6	"dodemorph acetate; 4-cyclododecyl-2,6-dimethylmorpholin-4-ium acetate"	250-778-2	31717-87-0	Repr. 2STOT RE 2Skin Corr. 1CSkin Sens. 1AAquatic Chronic 1	H361dH373 (liver)H314H317H410	GHS08GHS05GHS07GHS09Dgr	H314H317H361dH373 (liver)H410	EUH071	M=1		ATP07
607-713-00-1	"fenpyroximate (ISO); tert-butyl 4-[({(E)-[(1,3-dimethyl-5-phenoxy-1H-pyrazol-4-yl)methylene]amino}oxy)methyl]benzoate"		134098-61-6	Acute Tox. 2Acute Tox. 3Skin Sens. 1BAquatic Acute 1Aquatic Chronic 1	H330H301H317H400H410	GHS06GHS09Dgr	H301H330H317H410		M=100M=1000		ATP07
607-714-00-7	"triflusulfuron-methyl; methyl 2-({[4-(dimethylamino)-6-(2,2,2- trifluoroethoxy)-1,3,5-triazin-2- yl]carbamoyl}sulfamoyl)-3- methylbenzoate"		126535-15-7	Carc. 2Aquatic Acute 1Aquatic Chronic 1	H351H400H410	GHS08GHS09Wng	H351H410		M=100M=10		CLP00/ATP07
607-715-00-2	bifenazate (ISO); isopropyl 2-(4-methoxybiphenyl-3-yl)hydrazinecarboxylate	442-820-5	149877-41-8	STOT RE 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H373H317H400H410	GHS08GHS07GHS09Wng	H317H373H410		M=1M=1		ATP07
608-001-00-3	acetonitrile; cyanomethane	200-835-2	75-05-8	Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2	H225H332H312H302H319	GHS02GHS07Dgr	H225H332H312H302H319				CLP00
608-002-00-9	trichloroacetonitrile	208-885-7	545-06-2	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Aquatic Chronic 2	H331H311H301H411	GHS06GHS09Dgr	H331H311H301H411				CLP00
608-003-00-4	acrylonitrile	203-466-5	107-13-1	Flam. Liq. 2Carc. 1BAcute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT SE 3Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Chronic 2	H225H350H331H311H301H335H315H318H317H411	GHS02GHS06GHS08GHS05GHS09Dgr	H225H350H331H311H301H335H315H318H317H411		*	D	CLP00
608-004-00-X	2-hydroxy-2-methylpropionitrile; 2-cyanopropan-2-ol; acetone cyanohydrin	200-909-4	75-86-5	Acute Tox. 1Acute Tox. 2 *Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1	H310H330H300H400H410	GHS06GHS09Dgr	H330H310H300H410				CLP00
608-005-00-5	n-butyronitrile	203-700-6	109-74-0	Flam. Liq. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *	H225H331H311H301	GHS02GHS06Dgr	H225H331H311H301				CLP00/ATP01
608-006-00-0	"bromoxynil (ISO); 3,5-dibromo-4-hydroxybenzonitrile; bromoxynil phenol"	216-882-7	1689-84-5	Repr. 2Acute Tox. 2 *Acute Tox. 3 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H361d ***H330H301H317H400H410	GHS06GHS08GHS09Dgr	H361d ***H330H301H317H410		M=10		CLP00
608-007-00-6	"ioxynil (ISO); 4-hydroxy-3,5-diiodobenzonitrile"	216-881-1	1689-83-4	Repr. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 4 *STOT RE 2 *Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H361d ***H331H301H312H373 **H319H400H410	GHS06GHS08GHS09Dgr	H361d ***H331H301H312H373 **H319H410		M=10		CLP00
608-008-00-1	chloroacetonitrile	203-467-0	107-14-2	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Aquatic Chronic 2	H331H311H301H411	GHS06GHS09Dgr	H331H311H301H411				CLP00
608-009-00-7	malononitrile	203-703-2	109-77-3	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H331H311H301H400H410	GHS06GHS09Dgr	H331H311H301H410				CLP00
608-010-00-2	methacrylonitrile; 2-methyl-2-propene nitrile	204-817-5	126-98-7	Flam. Liq. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Skin Sens. 1	H225H331H311H301H317	GHS02GHS06Dgr	H225H331H311H301H317		"*Skin Sens. 1; H317: C ? 0,2 %"	D	CLP00
608-011-00-8	oxalonitrile; cyanogen	207-306-5	460-19-5	Flam. Gas 1Press. GasAcute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H220H331H400H410	GHS02GHS04GHS06GHS09Dgr	H220H331H410			U	CLP00/ATP01corr
608-012-00-3	benzonitrile	202-855-7	100-47-0	Acute Tox. 4 *Acute Tox. 4 *	H312H302	GHS07Wng	H312H302				CLP00
608-013-00-9	2-chlorobenzonitrile	212-836-5	873-32-5	Acute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2	H312H302H319	GHS07Wng	H312H302H319				CLP00
608-014-00-4	chlorothalonil (ISO); tetrachloroisophthalonitrile	217-588-1	1897-45-6	Carc. 2Acute Tox. 2 *STOT SE 3Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H351H330H335H318H317H400H410	GHS06GHS05GHS08GHS09Dgr	H351H330H335H318H317H410		M=10		CLP00/ATP01
608-015-00-X	"dichlobenil (ISO); 2,6-dichlorobenzonitrile"	214-787-5	1194-65-6	Acute Tox. 4 *Aquatic Chronic 2	H312H411	GHS07GHS09Wng	H312H411				CLP00
608-016-00-5	"1,4-Dicyano-2,3,5,6-tetra-chloro-benzene"	401-550-8	1897-41-2	Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410				CLP00
608-017-00-0	"bromoxynil octanoate (ISO); 2,6-dibromo-4-cyanophenyl octanoate"	216-885-3	1689-99-2	Repr. 2Acute Tox. 3 *Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H361d ***H331H302H317H400H410	GHS06GHS08GHS09Dgr	H361d ***H331H302H317H410		M=10		CLP00
608-018-00-6	"ioxynil octanoate (ISO); 4-cyano-2,6-diiodophenyl octanoate"	223-375-4	3861-47-0	Repr. 2Acute Tox. 3 *Eye Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H361d ***H301H319H317H400H410	GHS06GHS08GHS09Dgr	H361d ***H301H319H317H410		M=10		CLP00
608-019-00-1	"2,2'-dimethyl-2,2'-azodipropiononitrile; ADZN"	201-132-3	78-67-1	Self-react. CAcute Tox. 4 *Acute Tox. 4 *Aquatic Chronic 3	H242H332H302H412	GHS02GHS07Dgr	H242H332H302H412			T	CLP00
608-020-00-7	diphenoxymethylenecyanamide	427-300-8	79463-77-7	Eye Dam. 1Aquatic Chronic 3	H318H412	GHS05Dgr	H318H412				ATP01
608-021-00-2	3-(2-(diaminomethyleneamino)thiazol-4-ylmethylthio)propionitrile	403-710-2	76823-93-3	Acute Tox. 4 *Skin Sens. 1	H302H317	GHS07Wng	H302H317				CLP00
608-022-00-8	"3,7-dimethyloctanenitrile"	403-620-3	40188-41-8	Skin Irrit. 2Skin Sens. 1Aquatic Chronic 2	H315H317H411	GHS07GHS09Wng	H315H317H411				CLP00
608-023-00-3	"fenbuconazole (ISO); 4-(4-chlorophenyl)-2-phenyl-2-[(1H-1,2,4-triazol-1-yl)methyl]butanenitrile"	406-140-2	114369-43-6	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
608-024-00-9	"2-(4-(N-butyl-N-phenethylamino)phenyl)ethylene-1,1,2-tricarbonitrile"	407-650-8	97460-76-9	Aquatic Chronic 4	H413		H413				CLP00
608-025-00-4	"2-nitro-4,5-bis(benzyloxy)phenylacetonitrile"	410-970-0	117568-27-1	Aquatic Chronic 4	H413		H413				CLP00
608-026-00-X	"3-cyano-3,5,5-trimethylcyclohexanone"	411-490-4	7027-11-4	Acute Tox. 4 *STOT RE 2 *Skin Sens. 1Aquatic Chronic 3	H302H373 **H317H412	GHS08GHS07Wng	H302H373 **H317H412				CLP00
608-027-00-5	"reaction mass of: 3-(4-ethylphenyl)-2,2-dimethylpropanenitrile; 3-(2-ethylphenyl)-2,2-dimethylpropanenitrile; 3-(3-ethylphenyl)-2,2-dimethylpropanenitrile"	412-660-0		Aquatic Chronic 2	H411	GHS09	H411				CLP00
608-028-00-0	4-(2-cyano-3-phenylamino-acryloyloxymethyl)-cyclohexyl-methyl 2-cyano-3-phenylamino)-acrylate	413-510-7	147374-67-2	STOT RE 2 *Skin Sens. 1Aquatic Chronic 2	H373 **H317H411	GHS08GHS09Wng	H373 **H317H411				CLP00
608-029-00-6	"1,2-dihydro-6-hydroxy-4-methyl-1-[3-(1-methylethoxy)propyl]-2-oxo-3-pyridinecarbonitrile"	411-990-2	68612-94-2	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
608-030-00-1	"N-acetyl-N-[5-cyano-3-(2-dibutylamino-4-phenylthyazol-5-yl-methylene)-4-methyl-2,6-dioxo-1,2,3,6-tetrahydropyridin-1-yl]benzamide"	412-340-0	147741-93-3	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
608-031-00-7	2-benzyl-2-methyl-3-butenitrile	407-870-4	97384-48-0	Acute Tox. 4 *Aquatic Chronic 3	H302H412	GHS07Wng	H302H412				CLP00
608-032-00-2	acetamiprid (ISO); (E)-N1-[(6-chloro-3-pyridyl)methyl]-N2-cyano-N1-methylacetamidine	-	135410-20-7	Acute Tox. 4 *Aquatic Chronic 3	H302H412	GHS07Wng	H302H412				ATP01
608-033-00-8	"N-butyl-3-(2-chloro-4-nitrophenylhydrazono)-1-cyano-2-methylprop-1-ene-1,3-dicarboximide"	407-970-8	75511-91-0	Skin Sens. 1Aquatic Chronic 3	H317H412	GHS07Wng	H317H412				CLP00
608-034-00-3	chlorfenapyr (ISO); 4-bromo-2-(4-chlorophenyl)-1-ethoxymethyl-5-trifluoromethylpyrrole-3-carbonitrile	-	122453-73-0	Acute Tox. 3 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H331H302H400H410	GHS06GHS09Dgr	H331H302H410		M=100		CLP00/ATP01
608-035-00-9	"(±)-?-[(2-acetyl-5-methylphenyl)-amino]-2,6-dichlorobenzene-aceto-nitrile"	419-290-9		Skin Sens. 1Aquatic Chronic 4	H317H413	GHS07Wng	H317H413				CLP00
608-036-00-4	3-(2-{}{4-[2-(4-cyanophenyl)vinyl]phenyl}}vinyl)benzonitrile	419-060-8	79026-02-1	Aquatic Chronic 4	H413		H413				CLP00
608-037-00-X	"reaction mass of: (E)-2,12-tridecadiennitrile; (E)-3,12-tridecadiennitrile; (Z)-3,12-tridecadiennitrile"	422-190-8		Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
608-038-00-5	"2,2,4-trimethyl-4-phenyl-butane-nitrile"	422-580-8	75490-39-0	Acute Tox. 4 *Aquatic Chronic 2	H302H411	GHS07GHS09Wng	H302H411				CLP00
608-039-00-0	2-phenylhexanenitrile	423-460-8	3508-98-3	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410				CLP00
608-040-00-6	"4,4'-dithiobis(5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile)"	423-490-1	130755-46-3	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
608-041-00-1	"4'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-ene-3-yl)methyl)(1,1'-biphenyl)-2-carbonitrile"	423-500-4	138401-24-8	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
608-042-00-7	"(S)-2,2-diphenyl-2-(3-pyrrolidinyl)acetonitrile hydrobromide"	421-810-4	194602-27-2	Acute Tox. 4 *Eye Dam. 1Skin Sens. 1Aquatic Chronic 2	H302H318H317H411	GHS05GHS07GHS09Dgr	H302H318H317H411				ATP01
608-043-00-2	3-(cis-3-hexenyloxy)propanenitril	415-220-6	142653-61-0	Acute Tox. 3 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H331H302H400H410	GHS06GHS09Dgr	H331H302H410				CLP00
608-044-00-8	2-cyclohexylidene-2-phenylacetonitrile	423-740-1	10461-98-0	Acute Tox. 4 *Aquatic Chronic 2	H302H411	GHS07GHS09Wng	H302H411				ATP01
608-046-00-9	"5-(4-chloro-2-nitro-phenylazo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-pyridine-3-carbonitrile"	425-310-7	77889-90-8	Aquatic Chronic 4	H413	-	H413				ATP01
608-047-00-4	2-piperidin-1-yl-benzonitrile	427-330-1	72752-52-4	Aquatic Chronic 2	H411	GHS09	H411				ATP01
608-048-00-X	1-(3-cyclopentyloxy-4-methoxyphenyl)-4-oxo-cyclohexanecarbonitrile	427-450-4	152630-47-2	Acute Tox. 4 *STOT RE 2 *Skin Sens. 1Aquatic Chronic 2	H302H373 **H317H411	GHS08GHS07GHS09Wng	H302H373 **H317H411				ATP01
608-049-00-5	"2-(4-(4-(butyl-(1-methylhexyl)amino)phenyl)-3-cyano-5-oxo-1,5-dihydropyrrol-2-ylidene)propandinitrile"	429-180-2	157362-53-3	Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410				ATP01
608-050-00-0	reaction mass of: 5-(2-cyano-4-nitrophenylazo)-2-(2-(2-hydroxyethoxy)ethylamino)-4-methyl-6-phenylaminonicotinonitrile; 5-(2-cyano-4-nitrophenylazo)-6-(2-(2-hydroxyethoxy)ethylamino)-4-methyl-2-phenylaminonicotinonitrile	429-760-5	-	Aquatic Chronic 4	H413	-	H413				ATP01
608-051-00-6	(R)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile	430-760-2	219861-18-4	Acute Tox. 4 *Skin Sens. 1Aquatic Chronic 2	H302H317H411	GHS07GHS09Wng	H302H317H411				ATP01
608-052-00-1	(S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile	430-770-7	128173-52-4	Acute Tox. 4 *Skin Sens. 1Aquatic Chronic 2	H302H317H411	GHS07GHS09Wng	H302H317H411				ATP01
608-053-00-7	"(R,S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile"	430-780-1	103146-25-4	Acute Tox. 4 *Skin Sens. 1Aquatic Chronic 2	H302H317H411	GHS07GHS09Wng	H302H317H411				ATP01
608-054-00-2	"(R,S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile hemisulfate"	430-790-6	-	Acute Tox. 4 *Eye Dam. 1Skin Sens. 1Aquatic Chronic 2	H302H318H317H411	GHS05GHS07GHS09Dgr	H302H318H317H411				ATP01
608-055-00-8	"fipronil (ISO); 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile"	-	120068-37-3	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 1Aquatic Acute 1Aquatic Chronic 1	H331H311H301H372 **H400H410	GHS06GHS08GHS09Dgr	H331H311H301H372 **H410		M=10		ATP01
608-056-00-3	N-methyl-N-cyanomethylmorpholiniummethylsulfate	429-340-1	-	Acute Tox. 4 *Eye Dam. 1	H302H318	GHS05GHS07Dgr	H302H318				ATP01
608-057-00-9	4-(cyanomethyl)-4-methylmorpholin-4-ium hydrogen sulfate	431-200-1	208538-34-5	Acute Tox. 4 *Eye Dam. 1Skin Sens. 1	H302H318H317	GHS05GHS07Dgr	H302H318H317				ATP01/ATP01corr
608-058-00-4	esfenvalerate (ISO); (S)-a-cyano-3-phenoxybenzyl-(S)-2-(4-chlorophenyl)-3-methylbutyrate		66230-04-4	Acute Tox. 3 *Acute Tox. 3 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H331H301H317H400H410	GHS06GHS09Dgr	H301H331H317H410		M=10000		CLP00/ATP01corr
608-059-00-X	"5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile"	421-240-6	120068-79-3	Aquatic Chronic 2	H411	GHS09	H411				ATP01
608-060-00-5	5-methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile	421-300-1	138564-59-7	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				ATP01
608-062-00-6	2-fluoro-4-hydroxybenzonitrile	422-810-7	82380-18-5	Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 2	H302H318H411	GHS05GHS07GHS09Dgr	H302H318H411				ATP01
608-063-00-1	(S)-?-hydroxy-3-phenoxy-benzeneacetonitrile	441-070-6	61826-76-4	Acute Tox. 3 *Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H301H318H317H400H410	GHS06GHS05GHS09Dgr	H301H318H317H410				ATP01
608-064-00-7	cyanomethyltrimethylammoniummethylsulfate	433-720-2	-	Aquatic Chronic 3	H412	-	H412				ATP01
608-065-00-2	salts of bromoxynil with the exception of those specified elsewhere in this Annex			Repr. 2Acute Tox. 2 *Acute Tox. 3 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H361d ***H330H301H317H400H410	GHS06GHS08GHS09Dgr	H361d ***H330H301H317H410		M=10	A	CLP00
608-066-00-8	salts of ioxynil with the exception of those specified elsewhere in this Annex			Repr. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 4 *STOT RE 2 *Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H361d ***H331H301H312H373 **H319H400H410	GHS06GHS08GHS09Dgr	H361d ***H331H301H312H373 **H319H410		M=10	A	CLP00
609-001-00-6	1-nitropropane	203-544-9	108-03-2	Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *	H226H332H312H302	GHS02GHS07Wng	H226H332H312H302		*		CLP00
609-002-00-1	2-nitropropane	201-209-1	79-46-9	Flam. Liq. 3Carc. 1BAcute Tox. 4 *Acute Tox. 4 *	H226H350H332H302	GHS02GHS08GHS07Dgr	H226H350H332H302				CLP00
609-003-00-7	nitrobenzene	202-716-0	98-95-3	Carc. 2Repr. 1BAcute Tox. 3Acute Tox. 3Acute Tox. 3STOT RE 1Aquatic Chronic 3	H351H360FH331H311H301H372 (blood)H412	GHS06GHS08Dgr	H331H311H301H351H360FH372H412				CLP00/ATP05
609-004-00-2	"dinitrobenzene [1]1,4-dinitrobenzene [2]1,3-dinitrobenzene [3]1,2-dinitrobenzene  [4]"	246-673-6 [1]202-833-7 [2]202-776-8 [3]208-431-8 [4]	25154-54-5 [1]100-25-4 [2]99-65-0 [3]528-29-0 [4]	Acute Tox. 1Acute Tox. 2 *Acute Tox. 2 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H310H330H300H373 **H400H410	GHS06GHS08GHS09Dgr	H330H310H300H373 **H410				CLP00
609-005-00-8	"1,3,5-trinitrobenzene"	202-752-7	99-35-4	Expl. 1.1Acute Tox. 1Acute Tox. 2 *Acute Tox. 2 *STOT RE 2Aquatic Acute 1Aquatic Chronic 1	H201H310H330H300H373 **H400H410	GHS01GHS06GHS08GHS09Dgr	H201H330H310H300H373 **H410				CLP00/ATP01
609-006-00-3	4-nitrotoluene	202-808-0	99-99-0	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Chronic 2	H331H311H301H373 **H411	GHS06GHS08GHS09Dgr	H331H311H301H373 **H411				CLP00
609-007-00-9	"2,4-dinitrotoluene [1]dinitrotoluene  [2]"	204-450-0 [1]246-836-1 [2]	121-14-2 [1]25321-14-6 [2]	Carc. 1BMuta. 2Repr. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H350H341H361f ***H331H311H301H373 **H400H410	GHS06GHS08GHS09Dgr	H350H341H361f ***H331H311H301H373 **H410				CLP00/ATP01
609-008-00-4	"2,4,6-trinitrotoluene; TNT"	204-289-6	118-96-7	Expl. 1.1Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Chronic 2	H201H331H311H301H373 **H411	GHS01GHS06GHS08GHS09Dgr	H201H331H311H301H373 **H411				CLP00
609-009-00-X	"2,4,6-trinitrophenol; picric acid"	201-865-9	88-89-1	Expl. 1.1Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *	H201H331H311H301	GHS01GHS06Dgr	H201H331H311H301				CLP00/ATP01
609-010-00-5	salts of picric acid			Unst. Expl.Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *	H200H331H311H301	GHS01GHS06Dgr	H200H331H311H301			T	CLP00
609-011-00-0	"2,4,6-trinitroanisole"		606-35-9	Expl. 1.1Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Chronic 2	H201H332H312H302H411	GHS01GHS07GHS09Wng	H201H332H312H302H411				CLP00
609-012-00-6	"2,4,6-trinitro-m-cresol"	210-027-1	602-99-3	Expl. 1.1Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *	H201H332H312H302	GHS01GHS07Wng	H201H332H312H302				CLP00
609-013-00-1	"2,4,6-trinitro-m-xylene"	211-187-5	632-92-8	Expl. 1.1Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *	H201H332H312H302H373 **	GHS01GHS08GHS07Wng	H201H332H312H302H373 **				CLP00
609-015-00-2	4-nitrophenol; p-nitrophenol	202-811-7	100-02-7	Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *	H332H312H302H373 **	GHS08GHS07Wng	H332H312H302H373 **				CLP00
609-016-00-8	"dinitrophenol (reaction mass of isomers) [1]2,4(or 2,6)-dinitrophenol  [2]"	247-096-2 [1]275-732-9 [2]	25550-58-7 [1]71629-74-8 [2]	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H331H311H301H373 **H400H410	GHS06GHS08GHS09Dgr	H331H311H301H373 **H410				CLP00
609-018-00-9	"2,4,6-trinitroresorcinol; styphnic acid"	201-436-6	82-71-3	Expl. 1.1Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *	H201H332H312H302	GHS01GHS07Dgr	H201H332H312H302				CLP00/ATP01
609-019-00-4	"lead 2,4,6-trinitro-m-phenylene dioxide; lead 2,4,6-trinitroresorcinoxide; lead styphnate"	239-290-0	15245-44-0	Repr. 1AAcute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1Unst. Expl	H360DfH332H302H373 **H400H410H200	GHS01GHS08GHS07GHS09Dgr	H200H360DfH332H302H373 **H410			1 	CLP00
609-019-01-1	"lead 2,4,6-trinitro-m-phenylene dioxide; lead 2,4,6-trinitroresorcinoxide; lead styphnate (? 20 % phlegmatiser)"	239-290-0	15245-44-0	Expl. 1.1Repr. 1AAcute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H201H360DfH332H302H373 **H400H410	GHS01GHS08GHS07GHS09Dgr	H201H360DfH332H302H373 **H410			1 	CLP00
609-020-00-X	"DNOC (ISO); 4,6-dinitro-o-cresol"	208-601-1	534-52-1	Muta. 2Acute Tox. 1Acute Tox. 2 *Acute Tox. 2 *Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H341H310H330H300H315H318H317H400H410	GHS06GHS08GHS05GHS07GHS09Dgr	H341H330H310H300H315H318H317H410	EUH044			CLP00
609-021-00-5	"sodium salt of DNOC; sodium 4,6-dinitro-o-cresolate [1]potassium salt of DNOC; potassium 4,6-dinitro-o-cresolate  [2]"	219-007-7 [1]	2312-76-7 [1]5787-96-2 [2]	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H331H311H301H373 **H400H410	GHS06GHS08GHS09Dgr	H331H311H301H373 **H410				CLP00
609-022-00-0	"ammonium salt of DNOC; ammonium 4,6-dinitro-o-tolyl oxide"	221-037-0	2980-64-5	Acute Tox. 1Acute Tox. 2 *Acute Tox. 2 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H310H330H300H373 **H400H410	GHS06GHS08GHS09Dgr	H330H310H300H373 **H410				CLP00
609-023-00-6	"dinocap (ISO); (RS)-2,6-dinitro-4-octylphenyl crotonates and (RS)-2,4-dinitro-6-octylphenyl crotonates in which “octyl” is a reaction mass of 1-methylheptyl, 1-ethylhexyl and 1-propylpentyl groups"	254-408-0	39300-45-3	Repr. 1BAcute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H360D ***H332H302H373 **H315H317H400H410	GHS08GHS07GHS09Dgr	H360D ***H332H302H373 **H315H317H410		M=100		CLP00/ATP01
609-024-00-1	"binapacryl (ISO); 2-sec-butyl-4,6-dinitrophenyl-3-methylcrotonate"	207-612-9	485-31-4	Repr. 1BAcute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H360D ***H312H302H400H410	GHS08GHS07GHS09Dgr	H360D ***H312H302H410				CLP00
609-025-00-7	"dinoseb (ISO); 6-sec-butyl-2,4-dinitrophenol"	201-861-7	88-85-7	Repr. 1BAcute Tox. 3 *Acute Tox. 3 *Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H360DfH311H301H319H400H410	GHS06GHS08GHS09Dgr	H360DfH311H301H319H410	EUH044			CLP00
609-026-00-2	"salts and esters of dinoseb, with the exception of those specified elsewhere in this Annex"			Repr. 1BAcute Tox. 3 *Acute Tox. 3 *Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H360DfH311H301H319H400H410	GHS06GHS08GHS09Dgr	H360DfH311H301H319H410	EUH044		A	CLP00
609-027-00-8	"dinocton; reaction mass of isomers: methyl 2-octyl-4,6-dinitrophenyl carbonate, methyl 4-octyl-2,6-dinitrophenyl carbonate"		63919-26-6	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410				CLP00
609-028-00-3	"dinex (ISO); 2-cyclohexyl-4,6-dinitrophenol"	205-042-5	131-89-5	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H331H311H301H400H410	GHS06GHS09Dgr	H331H311H301H410				CLP00
609-029-00-9	salts and esters of dinex			Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H331H311H301H400H410	GHS06GHS09Dgr	H331H311H301H410			A	CLP00
609-030-00-4	"dinoterb (ISO); 2-tert-butyl-4,6-dinitrophenol"	215-813-8	1420-07-1	Repr. 1BAcute Tox. 2 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H360D ***H300H311H400H410	GHS06GHS08GHS09Dgr	H360D ***H300H311H410	EUH044			CLP00
609-031-00-X	salts and esters of dinoterb			Repr. 1BAcute Tox. 2 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H360D ***H300H311H400H410	GHS06GHS08GHS09Dgr	H360D ***H300H311H410			A	CLP00
609-032-00-5	"bromofenoxim (ISO); 3,5-dibromo-4-hydroxybenzaldehyde-O-(2,4-dinitrophenyl)-oxime"	236-129-6	13181-17-4	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410				CLP00
609-033-00-0	"dinosam (ISO); 2-(1-methylbutyl)-4,6-dinitrophenol"		4097-36-3	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H331H311H301H400H410	GHS06GHS09Dgr	H331H311H301H410				CLP00
609-034-00-6	salts and esters of dinosam			Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H331H311H301H400H410	GHS06GHS09Dgr	H331H311H301H410			A	CLP00
609-035-00-1	nitroethane	201-188-9	79-24-3	Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *	H226H332H302	GHS02GHS07Wng	H226H332H302		*		CLP00
609-036-00-7	nitromethane	200-876-6	75-52-5	Flam. Liq. 3Acute Tox. 4 *	H226H302	GHS02GHS07Wng	H226H302		*		CLP00
609-037-00-2	5-nitroacenaphthene	210-025-0	602-87-9	Carc. 1B	H350	GHS08Dgr	H350				CLP00
609-038-00-8	2-nitronaphthalene	209-474-5	581-89-5	Carc. 1BAquatic Chronic 2	H350H411	GHS08GHS09Dgr	H350H411				CLP00
609-039-00-3	4-nitrobiphenyl	202-204-7	92-93-3	Carc. 1BAquatic Chronic 2	H350H411	GHS08GHS09Dgr	H350H411				CLP00
609-040-00-9	"nitrofen (ISO); 2,4-dichlorophenyl 4-nitrophenyl ether"	217-406-0	1836-75-5	Carc. 1BRepr. 1BAcute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H350H360D ***H302H400H410	GHS08GHS07GHS09Dgr	H350H360D ***H302H410				CLP00
609-041-00-4	"2,4-dinitrophenol"	200-087-7	51-28-5	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Acute 1	H331H311H301H373 **H400	GHS06GHS08GHS09Dgr	H331H311H301H373 **H400				CLP00
609-042-00-X	"pendimethalin (ISO); N-(1-ethylpropyl)-2,6-dinitro-3,4-xylidine"	254-938-2	40487-42-1	Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410				CLP00
609-043-00-5	quintozene (ISO); pentachloronitrobenzene	201-435-0	82-68-8	Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410				CLP00
609-044-00-0	"tecnazene (ISO); 1,2,4,5-tetrachloro-3-nitrobenzene"	204-178-2	117-18-0	Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H317H400H410	GHS07GHS09Wng	H302H317H410				CLP00
609-045-00-6	"reaction mass of: 4,6-dinitro-2-(3-octyl)phenyl methyl carbonate and 4,6-dinitro-2-(4-octyl)phenyl methyl carbonate; dinocton-6"		8069-76-9	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410				CLP00
609-046-00-1	"trifluralin (ISO) (containing < 0.5 ppm NPDA); ?,?,?-trifluoro-2,6-dinitro-N,N-dipropyl-p-toluidine (containing < 0.5 ppm NPDA); 2,6-dinitro-N,N-dipropyl-4-trifluoromethylaniline (containing < 0.5 ppm NPDA); N,N-dipropyl-2,6-dinitro-4-trifluoromethylaniline (containing < 0.5 ppm NPDA)"	216-428-8	1582-09-8	Carc. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H351H317H400H410	GHS08GHS07GHS09Wng	H351H317H410		M=10		CLP00/ATP01
609-047-00-7	2-nitroanisole	202-052-1	91-23-6	Carc. 1BAcute Tox. 4 *	H350H302	GHS08GHS07Dgr	H350H302				CLP00
609-048-00-2	sodium 3-nitrobenzenesulphonate	204-857-3	127-68-4	Eye Irrit. 2Skin Sens. 1	H319H317	GHS07Wng	H319H317				CLP00
609-049-00-8	"2,6-dinitrotoluene"	210-106-0	606-20-2	Carc. 1BMuta. 2Repr. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Chronic 3	H350H341H361f ***H331H311H301H373 **H412	GHS06GHS08Dgr	H350H341H361f ***H331H311H301H373 **H412				CLP00
609-050-00-3	"2,3-dinitrotoluene"	210-013-5	602-01-7	Carc. 1BMuta. 2Repr. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H350H341H361f ***H331H311H301H373 **H400H410	GHS06GHS08GHS09Dgr	H350H341H361f ***H331H311H301H373 **H410				CLP00
609-051-00-9	"3,4-dinitrotoluene"	210-222-1	610-39-9	Carc. 1BMuta. 2Repr. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Chronic 2	H350H341H361f ***H331H311H301H373 **H411	GHS06GHS08GHS09Dgr	H350H341H361f ***H331H311H301H373 **H411				CLP00
609-052-00-4	"3,5-dinitrotoluene"	210-566-2	618-85-9	Carc. 1BMuta. 2Repr. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Chronic 3	H350H341H361f ***H331H311H301H373 **H412	GHS06GHS08Dgr	H350H341H361f ***H331H311H301H373 **H412				CLP00
609-053-00-X	hydrazine-trinitromethane	414-850-9		Expl. 1.1 ****Self-react. ACarc. 1BAcute Tox. 3 *Acute Tox. 3 *Skin Sens. 1	H201H240H350H331H301H317	GHS01GHS06GHS08Dgr	H201H240H350H331H301H317				CLP00
609-054-00-5	"2,3-dinitrophenol [1]2,5-dinitrophenol [2]2,6-dinitrophenol [3]3,4-dinitrophenol [4]salts of dinitrophenol  [5]"	200-628-7 [1]206-348-1 [2]209-357-9 [3]209-415-3 [4]	66-56-8 [1]329-71-5 [2]573-56-8 [3]577-71-9 [4]	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Chronic 2	H331H311H301H373 **H411	GHS06GHS08GHS09Dgr	H331H311H301H373 **H411				CLP00
609-055-00-0	"2,5-dinitrotoluene"	210-581-4	619-15-8	Carc. 1BMuta. 2Repr. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Chronic 2	H350H341H361f ***H331H311H301H373 **H411	GHS06GHS08GHS09Dgr	H350H341H361f ***H331H311H301H373 **H411				CLP00
609-056-00-6	"2,2-dibromo-2-nitroethanol"	412-380-9	69094-18-4	Expl. 1.1Carc. 2Acute Tox. 4 *STOT RE 2 *Skin Corr. 1ASkin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H201H351H302H373 **H314H317H400H410	GHS01GHS08GHS05GHS07GHS09Dgr	H201H351H302H373 **H314H317H410		*STOT SE 3; H335: C ? 1 %	T	CLP00
609-057-00-1	"3-chloro-2,4-difluoronitrobenzene"	411-980-8	3847-58-3	Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H314H317H400H410	GHS05GHS07GHS09Dgr	H302H314H317H410				CLP00
609-058-00-7	"2-nitro-2-phenyl-1,3-propanediol"	410-360-4	5428-02-4	Acute Tox. 4 *Acute Tox. 4 *STOT RE 1Skin Sens. 1Aquatic Chronic 2	H312H302H372 **H317H411	GHS08GHS07GHS09Dgr	H372 **H312H302H317H411	EUH070			CLP00
609-059-00-2	2-chloro-6-(ethylamino)-4-nitrophenol	411-440-1	131657-78-8	Acute Tox. 4 *Skin Sens. 1Aquatic Chronic 2	H302H317H411	GHS07GHS09Wng	H302H317H411				CLP00
609-060-00-8	4-[(3-hydroxypropyl)amino]-3-nitrophenol	406-305-9	92952-81-3	Skin Irrit. 2Aquatic Chronic 2	H315H411	GHS07GHS09Wng	H315H411				CLP00
609-061-00-3	"(E,Z)-4-chlorophenyl(cyclopropyl)ketone O-(4-nitrophenylmethyl)oxime"	406-100-4	94097-88-8	Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410				CLP00
609-062-00-9	2-bromo-2-nitropropanol	407-030-7	24403-04-1	Acute Tox. 3 *Acute Tox. 4 *STOT RE 2 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H311H302H373 **H314H317H400H410	GHS06GHS08GHS05GHS09Dgr	H311H302H373 **H314H317H410				CLP00
609-063-00-4	2-[(4-chloro-2-nitrophenyl)amino]ethanol	413-280-8	59320-13-7	Acute Tox. 4 *Aquatic Chronic 2	H302H411	GHS07GHS09Wng	H302H411				CLP00
609-064-00-X	"mesotrione (ISO); 2-[4-(methylsulfonyl)-2-nitrobenzoyl]-1,3-cyclohexanedione"		104206-82-8	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
609-065-00-5	2-nitrotoluene	201-853-3	88-72-2	Carc. 1BMuta. 1BRepr. 2Acute Tox. 4 *Aquatic Chronic 2	H350H340H361f ***H302H411	GHS08GHS07GHS09Dgr	H350H340H361f ***H302H411				CLP00
609-066-00-0	"lithium sodium 3-amino-10-{}{4-(10-amino-6,13-dichloro-4,11-disulfonatobenzo[5,6][1,4]oxazino[2,3-b]phenoxazine-3-ylamino)-6-[methyl(2-sulfonato-ethyl)amino]-1,3,5-triazin-2-ylamino}}-6,13-dichlorobenzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate"	418-870-9	154212-58-5	Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *STOT SE 2 **	H332H312H302H371 **	GHS08GHS07Dgr	H332H312H302H371 **				CLP00
609-067-00-6	"sodium and potassium 4-(3-aminopropylamino)-2,6-bis[3-(4-methoxy-2-sulfophenylazo)-4-hydroxy-2-sulfo-7-naphthylamino]-1,3,5-triazine"	416-280-6	156769-97-0	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
609-068-00-1	"musk xylene; 5-tert-butyl-2,4,6-trinitro-m-xylene"	201-329-4	81-15-2	Expl. 1.1Carc. 2Aquatic Acute 1Aquatic Chronic 1	H201H351H400H410	GHS01GHS08GHS09Wng	H201H351H410			T	CLP00
609-069-00-7	"musk ketone; 3,5-dinitro-2,6-dimethyl-4-tert-butylacetophenone; 4'-tert-butyl-2',6'-dimethyl-3',5'-dinitroacetophenone"	201-328-9	81-14-1	Carc. 2Aquatic Acute 1Aquatic Chronic 1	H351H400H410	GHS08GHS09Wng	H351H410				ATP01
609-070-00-2	"1,4-dichloro-2-(1,1,2,3,3,3-hexafluoropropoxy)-5-nitrobenzene"	415-580-4	130841-23-5	Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H317H400H410	GHS07GHS09Wng	H302H317H410				CLP00
609-071-00-8	"reaction mass of: 2-methylsulfanyl-4,6-bis-(2-hydroxy-4-methoxy-phenyl)-1,3,5-triazine; 2-(4,6-bis-methylsulfanyl-1,3,5-triazin-2-yl)-5-methoxy-phenol"	423-520-3	156137-33-6	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
609-072-00-3	4-mesyl-2-nitrotoluene	430-550-0	1671-49-4	Repr. 2Acute Tox. 4 *Skin Sens. 1Aquatic Chronic 3	H361f ***H302H317H412	GHS08GHS07Wng	H302H317H361f ***H412				ATP01/ATP01corr
609-073-00-9	"lithium potassium sodium N,N''-bis{6-[7-[4-(4-chloro-1,3,5-triazin-2-yl)amino-4-(2-ureidophenylazo)]naphthalene-1,3,6-trisulfonato]}-N'-(2-aminoethyl)piperazine"	427-850-9	-	Skin Sens. 1	H317	GHS07Wng	H317				ATP01
610-001-00-3	trichloronitromethane; chloropicrin	200-930-9	76-06-2	Acute Tox. 2 *Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Irrit. 2	H330H302H335H315H319	GHS06Dgr	H330H302H319H335H315				CLP00
610-002-00-9	"1,1-dichloro-1-nitroethane"	209-854-0	594-72-9	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *	H331H311H301	GHS06Dgr	H331H311H301				CLP00
610-003-00-4	chlorodinitrobenzene			Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H331H311H301H373 **H400H410	GHS06GHS08GHS09Dgr	H331H311H301H373 **H410			C	CLP00
610-004-00-X	"2-chloro-1,3,5-trinitrobenzene"	201-864-3	88-88-0	Expl. 1.1Acute Tox. 1Acute Tox. 2 *Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1	H201H310H330H300H400H410	GHS01GHS06GHS09Dgr	H201H330H310H300H410				CLP00
610-005-00-5	1-chloro-4-nitrobenzene	202-809-6	100-00-5	Carc. 2Muta. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Chronic 2	H351H341H331H311H301H373 **H411	GHS06GHS08GHS09Dgr	H351H341H331H311H301H373 **H411				CLP00
610-006-00-0	chloronitroanilines with the exception of those specified elsewhere in this Annex			Acute Tox. 1Acute Tox. 2 *Acute Tox. 2 *STOT RE 2 *Aquatic Chronic 2	H310H330H300H373 **H411	GHS06GHS08GHS09Dgr	H330H310H300H373 **H411			A C	CLP00
610-007-00-6	1-chloro-1-nitropropane	209-990-0	600-25-9	Acute Tox. 4 *Acute Tox. 4 *	H332H302	GHS07Wng	H332H302		*		CLP00
610-008-00-1	"2,6-dichloro-4-nitroanisole"	403-350-6	17742-69-7	Acute Tox. 3 *Aquatic Chronic 2	H301H411	GHS06GHS09Dgr	H301H411				CLP00
610-009-00-7	2-chloro-4-nitroaniline	204-502-2	121-87-9	Acute Tox. 4 *Aquatic Chronic 2	H302H411	GHS07GHS09Wng	H302H411				CLP00
610-010-00-2	2-bromo-1-(2-furyl)-2-nitroethylene	406-110-9	35950-52-8	Acute Tox. 4 *STOT RE 2 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H373 **H314H317H400H410	GHS08GHS05GHS07GHS09Dgr	H302H373 **H314H317H410				CLP00
611-001-00-6	azobenzene	203-102-5	103-33-3	Carc. 1BMuta. 2Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H350H341H332H302H373 **H400H410	GHS08GHS07GHS09Dgr	H350H341H332H302H373 **H410				CLP00
611-002-00-1	azoxybenzene	207-802-1	495-48-7	Acute Tox. 4 *Acute Tox. 4 *	H332H302	GHS07Wng	H332H302				CLP00
611-003-00-7	fenaminosulf (ISO); sodium 4-dimethylaminobenzenediazosulphonate	205-419-4	140-56-7	Acute Tox. 3 *Acute Tox. 4 *Aquatic Chronic 3	H301H312H412	GHS06Dgr	H301H312H412				CLP00
611-004-00-2	methyl-ONN-azoxymethyl acetate; methyl azoxy methyl acetate	209-765-7	592-62-1	Carc. 1BRepr. 1B	H350H360D ***	GHS08Dgr	H350H360D ***				CLP00
611-005-00-8	"disodium {}{5-[(4'-((2,6-hydroxy-3-((2-hydroxy-5-sulphophenyl)azo)phenyl)azo)(1,1'-biphenyl)-4-yl)azo]salicylato(4-)}}cuprate(2-); CI Direct Brown 95"	240-221-1	16071-86-6	Carc. 1B	H350	GHS08Dgr	H350				CLP00
611-006-00-3	"4-o-tolylazo-o-toluidine; 4-amino-2',3-dimethylazobenzene; fast garnet GBC base; AAT; o-aminoazotoluene"	202-591-2	97-56-3	Carc. 1BSkin Sens. 1	H350H317	GHS08Dgr	H350H317				CLP00
611-007-00-9	"tricyclazole (ISO); 5-methyl-1,2,4-triazolo(3,4-b)benzo-1,3-thiazole"	255-559-5	41814-78-2	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
611-008-00-4	4-aminoazobenzene; 4-phenylazoaniline	200-453-6	60-09-3	Carc. 1BAquatic Acute 1Aquatic Chronic 1	H350H400H410	GHS08GHS09Dgr	H350H410				CLP00
611-009-00-X	sodium (1-(5-(4-(4-anilino-3-sulphophenylazo)-2-methyl-5-methylsulphonamidophenylazo)-4-hydroxy-2-oxido-3-(phenylazo)phenylazo)-5-nitro-4-sulphonato-2-naphtholato)iron(II)	401-220-3		Acute Tox. 4 *Aquatic Chronic 3	H332H412	GHS07Wng	H332H412				CLP00
611-010-00-5	"2'-(2-cyano-4,6-dinitrophenylazo)-5'-(N,N-dipropylamino)propionanilide"	403-010-7	106359-94-8	Skin Sens. 1Aquatic Chronic 3	H317H412	GHS07Wng	H317H412				CLP00
611-011-00-0	"N,N,N',N'-tetramethyl-3,3'-(propylenebis(iminocarbonyl-4,1-phenylenazo(1,6-dihydro-2-hydroxy-4-methyl-6-oxopyridine-3,1-diyl)))di(propylammonium) dilactate"	403-340-1		Eye Dam. 1Aquatic Chronic 2	H318H411	GHS05GHS09Dgr	H318H411				CLP00
611-012-00-6	"reaction mass of 2,2-iminodiethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and 2-methylaminoethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and N,N-diethylpropane-1,3-diamine 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate"	403-410-1	114565-65-0	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
611-013-00-1	trilithium-1-hydroxy-7-(3-sulfonatoanilino)-2-(3-methyl-4-(2-methoxy-4-(3-sulfonatophenylazo)phenylazo)phenylazo)naphthalene-3-sulfonate	403-650-7	117409-78-6	Expl. 1.3 ****Aquatic Chronic 2	H203H411	GHS01GHS09Dgr	H203H411				CLP00
611-014-00-7	"(tetrasodium 1-(4-(3-acetamido-4-(4'-nitro-2,2'-disulfonatostilben-4-ylazo)anilino)-6-(2,5-disulfonatoanilino)-1,3,5-triazin-2-yl)-3-carboxypyridinium) hydroxide"	404-250-5	115099-55-3	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
611-015-00-2	"tetrasodium 4-amino-5-hydroxy-6-(4-(2-(2-(sulfonatooxy)ethylsulfonyl)ethylcarbamoyl)phenylazo)-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate"	404-320-5	116889-78-2	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
611-016-00-8	"reaction mass of 1,1'-((dihydroxyphenylene)bis(azo-3,1-phenylenazo(1-(3-dimethylaminopropyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))dipyridinium dichloride dihydrochloride, mixed isomers and 1-(1-(3-dimethylaminopropyl)-5-(3-((4-(1-(3-dimethylaminopropyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-5-pyridinio-3-pyridylazo)phenylazo)-2,4(or2,6 or3,5)-dihydroxyphenylazo)phenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-3-pyridyl)pyridinium dichloride"	404-540-1		Skin Sens. 1	H317	GHS07Wng	H317				CLP00
611-017-00-3	"2-(4-(diethylaminopropylcarbamoyl)phenylazo)-3-oxo-N-(2,3-dihydro-2-oxobenzimidazol-5-yl)butyramide"	404-910-2		Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				CLP00
611-018-00-9	tetraammonium 5-(4-(7-amino-1-hydroxy-3-sulfonato-2-naphthylazo)-6-sulfonato-1-naphthylazo)isophthalate	405-130-5		Skin Sens. 1	H317	GHS07Wng	H317				CLP00
611-019-00-4	"tetralithium 6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalene-2,7-disulfonate"	405-150-4	106028-58-4	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
611-020-00-X	"tetrakis(tetramethylammonium) 6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalene-2,7-disulfonate"	405-170-3	116340-05-7	Acute Tox. 3 *Skin Sens. 1Aquatic Chronic 3	H301H317H412	GHS06Dgr	H301H317H412				CLP00
611-021-00-5	2-(4-(4-cyano-3-methylisothiazol-5-ylazo)-N-ethyl-3-methylanilino)ethyl acetate	405-480-9		Acute Tox. 4 *STOT RE 2 *Skin Irrit. 2Aquatic Chronic 4	H302H373 **H315H413	GHS08GHS07Wng	H302H373 **H315H413				CLP00
611-022-00-0	4-dimethylaminobenzenediazonium 3-carboxy-4-hydroxybenzenesulfonate	404-980-4		Self-react. CAcute Tox. 3 *Acute Tox. 3 *Acute Tox. 4 *STOT RE 2 *Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H242H331H301H312H373 **H318H317H400H410	GHS02GHS06GHS08GHS05GHS09Dgr	H242H331H301H312H373 **H318H317H410			T	CLP00
611-023-00-6	"disodium 7-(4,6-dichloro-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo) naphthalene-2-sulfonate"	404-600-7		Skin Sens. 1	H317	GHS07Wng	H317				CLP00
611-024-00-1	"Benzidine based azo dyes; 4,4'-diarylazobiphenyl dyes, with the exception of those specified elsewhere in this Annex"			Carc. 1B	H350	GHS08Dgr	H350			A	CLP00
611-025-00-7	"disodium 4-amino-3-[[4'-[(2,4-diaminophenyl)azo][1,1'-biphenyl]-4-yl]azo]-5-hydroxy-6-(phenylazo)naphtalene-2,7-disulphonate; C.I. Direct Black 38"	217-710-3	1937-37-7	Carc. 1BRepr. 2	H350H361d ***	GHS08Dgr	H350H361d ***				CLP00
611-026-00-2	"tetrasodium 3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis[5-amino-4-hydroxynaphthalene-2,7-disulphonate]; C.I. Direct Blue 6"	220-012-1	2602-46-2	Carc. 1BRepr. 2	H350H361d ***	GHS08Dgr	H350H361d ***				CLP00
611-027-00-8	"disodium 3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis(4-aminonaphthalene-1-sulphonate); C.I. Direct Red 28"	209-358-4	573-58-0	Carc. 1BRepr. 2	H350H361d ***	GHS08Dgr	H350H361d ***				CLP00
611-028-00-3	"C,C'-azodi(formamide)"	204-650-8	123-77-3	Resp. Sens. 1	H334	GHS08Dgr	H334			G	CLP00/ATP01corr
611-029-00-9	"o-dianisidine based azo dyes; 4,4'-diarylazo-3,3'-dimethoxybiphenyl dyes with the exception of those mentioned elsewhere in this Annex"			Carc. 1B	H350	GHS08Dgr	H350			A	CLP00
611-030-00-4	"o-tolidine based dyes; 4,4'-diarylazo-3,3'-dimethylbiphenyl dyes, with the exception of those mentioned elsewhere in this Annex"			Carc. 1B	H350	GHS08Dgr	H350			A	CLP00
611-031-00-X	"4,4'-(4-iminocyclohexa-2,5-dienylidenemethylene)dianiline hydrochloride; C.I. Basic Red 9"	209-321-2	569-61-9	Carc. 1B	H350	GHS08Dgr	H350				CLP00
611-032-00-5	"1,4,5,8-tetraaminoanthraquinone; C.I. Disperse Blue 1"	219-603-7	2475-45-8	Carc. 1BSkin Irrit. 2Eye Dam. 1Skin Sens. 1	H350H315H318H317	GHS08GHS05GHS07Dgr	H350H315H318H317				CLP00
611-033-00-0	"hexasodium [4,4''-azoxybis(2,2'-disulfonatostilbene-4,4'-diylazo)]-bis[5'-sulfonatobenzene-2,2'- diolato-O(2),O(2),N(1)]-copper(II)"	400-020-3	82027-60-9	Aquatic Chronic 2	H411	GHS09	H411				CLP00
611-034-00-6	"N-(5-(bis(2-methoxyethyl)amino)-2-((5-nitro-2,1-benzisothiazol-3-yl)azo)phenylacetamide"	402-430-8	105076-77-5	Aquatic Chronic 4	H413		H413				CLP00
611-035-00-1	"tetralithium 6-amino-4-hydroxy-3-[7-sulfonato-4-(5-sulfonato-2-naphthylazo)-1-naphthylazo]naphthalene-2,7-disulfonate"	403-660-1	107246-80-0	Aquatic Chronic 2	H411	GHS09	H411				CLP00/ATP01
611-036-00-7	"2-(4-(5,6(or 6,7)-dichloro-1,3-benzothiazol-2-ylazo)-N-methyl-m-toluidino)ethyl acetate"	405-440-0		Skin Sens. 1	H317	GHS07Wng	H317				CLP00
611-037-00-2	"3(or 5)-(4-(N-benzyl-N-ethylamino)-2-methylphenylazo)-1,4-dimethyl-1,2,4-triazolium methylsulphate"	406-055-0	124584-00-5	Acute Tox. 4 *Eye Dam. 1Skin Sens. 1Aquatic Chronic 2	H302H318H317H411	GHS05GHS07GHS09Dgr	H302H318H317H411				CLP00
611-038-00-8	"trisodium 1-hydroxynaphthalene-2-azo-4'(5',5''-dimethylbiphenyl)-4''-azo(4''-phenylsulfonyloxybenzene)- 2',2'',4-trisulfonate"	406-820-9		Eye Irrit. 2	H319	GHS07Wng	H319				CLP00
611-039-00-3	"7-[((4,6-dichloro-1,3,5-triazin-2-yl)amino)-4-hydroxy-3-(4-((2-sulfoxy)ethyl)sulfonyl)phenylazo]naphthalene-2-sulfonic acid"	407-050-6	117715-57-8	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
611-040-00-9	"3-(5-acetylamino-4-(4-[4,6-bis(3-diethylaminopropylamino)-1,3,5-triazin-2-ylamino]phenylazo)-2-(2-methoxyethoxy)phenylazo)-6-amino-4-hydroxy-2-naphthalenesulfonic acid"	407-670-7	115099-58-6	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
611-041-00-4	"2-[[4[[4,6-bis[[3-(diethylamino)propyl]amino]-1,3,5-triazine-2-yl]amino]phenyl]azo]-N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-oxobutanamide"	407-680-1	98809-11-1	Eye Dam. 1Skin Sens. 1Aquatic Chronic 2	H318H317H411	GHS05GHS07GHS09Dgr	H318H317H411				CLP00
611-042-00-X	"trisodium 5-amino-3-[5-(2-bromoacryloylamino)-2-sulfonatophenylazo]-4-hydroxy-6-(4-vinylsulfonylphenylazo)naphthalene-2,7-disulfonate"	411-770-6	136213-71-3	Aquatic Chronic 3	H412		H412				CLP00
611-043-00-5	"reaction mass of: trisodium N(1')-N(2):N(1''')-N(2'')-?-6-[2-amino-4-(or 6)-hydroxy-(or 4-amino-2-hydroxy)phenylazo]-6''-(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'-azobenzene-1,2'-diolato-O(1),O(2'))-chromate; trisodium N(1')-N(2):N(1''')-N(2'')-?-6,6''-bis(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'azobenzene-1,2'-diolato-O(1),O(2'))-chromate; trisodium N(1')-N(2):N(1''')-N(2'')-?-6,6''-bis[2-amino-4-(or 6)-hydroxy-(or 4-amino-2-hydroxy)phenylazo]5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'azobenzene-1,2'-diolato-O(1),O(2'))-chromate (2:1:1)"	402-850-1		Eye Dam. 1Aquatic Chronic 3	H318H412	GHS05Dgr	H318H412				CLP00
611-044-00-0	"reaction mass of: tert-alkyl(C12-C14)ammonium bis[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-chromate(1-); tert-alkyl(C12-C14)ammonium bis[1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphthalenolato(2-)]-chromate(1-); tert-alkyl(C12-C14)ammonium bis[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-chromate(1-); tert-alkyl(C12-C14)ammonium [[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]]-chromate(1-); tert-alkyl(C12-C14)ammonium [[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]]-chromate(1-); tert-alkyl(C12-C14)ammonium ((1-(4(or 5)-nitro-2-oxidophenylazo)-2-naphtholato)(1-(3-nitro-2-oxido-5-pentylphenylazo)-2-naphtholato))chromate(1-)"	403-720-7	117527-94-3	Aquatic Chronic 2	H411	GHS09	H411				CLP00
611-045-00-6	2-[4-[N-(4-acetoxybutyl)-N-ethyl]amino-2-methylphenylazo]-3-acetyl-5-nitrothiophene	404-830-8		Aquatic Chronic 4	H413		H413				CLP00
611-046-00-1	"4,4'-diamino-2-methylazobenzene"	407-590-2	43151-99-1	Acute Tox. 3 *STOT RE 2 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H301H373 **H317H400H410	GHS06GHS08GHS09Dgr	H301H373 **H317H410				CLP00
611-047-00-7	"reaction mass of: 2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorobenzothiazole; 2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorobenzothiazole (1:1)"	407-890-3	111381-11-4	Aquatic Chronic 4	H413		H413				CLP00
611-048-00-2	"reaction mass of: 2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorobenzothiazole; 2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorobenzothiazole (1:1)"	407-900-6	111381-12-5	Aquatic Chronic 4	H413		H413				CLP00
611-049-00-8	"reaction mass of 7-[4-(3-diethylaminopropylamino)-6-(3-diethylammoniopropylamino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-phenylazophenylazo)-naphthalene-2-sulfonate, acetic acid, lactic acid (2:1:1)"	408-000-6	118658-98-3	STOT RE 2 *Skin Sens. 1Aquatic Chronic 3	H373 **H317H412	GHS08Wng	H373 **H317H412				CLP00
611-050-00-3	reaction mass of: pentasodium 7-amino-3-[[4-[[4-[[4-[[4-[(6-amino-1-hydroxy-3-sulfonato-2-naphthyl)azo]-7-sulfonato-1-naphthyl]azo]phenyl]amino]-3-sulfonatophenyl]azo]-6-sulfonato-1-naphthyl]azo]-4-hydroxynaphthalen-2-sulfonate; pentasodium 7-amino-8-[4-[4-[4-[4-(2-amino-5-hydroxy-7-sulfonato-naphthalen-1-ylazo)-7-sulfonatonaphthalen-1-ylazo]-phenylamino]-3-sulfonato-phenylazo]-6-sulfonato-naphthalen-1-ylazo]-4-hydroxy-naphthalene-2-sulfonate; pentasodium 7-amino-8-[4-[4-[4-[4-(6-amino-1-hydroxy-3-sulfonato-naphthalen-1-ylazo)-7-sulfonatonaphthalen-1-ylazo]-phenylamino]-3-sulfonato-phenylazo]-6-sulfonato-naphthalen-1-ylazo]-4-hydroxy-naphthalene-2-sulfonate; tetrasodium 7-amino-4-hydroxy-3-[4-[4-[4-(4-hydroxy-7-sulfonato-naphthalen-1-ylazo)-2-sulfonato-phenylamino]phenylazo]-6-sulfonato-naphthalen-1-ylazo]naphthalene-2-sulfonate; tetrasodium 7-amino-4-hydroxy-3-[4-[4-[4-(4-amino-7-sulfonato-naphthalen-1-ylazo)-2-sulfonato-phenylamino]phenylazo]-6-sulfonato-naphthalen-1-ylazo]naphthalene-2-sulfonate	415-350-3	-	Eye Dam. 1Aquatic Chronic 3	H318H412	GHS05Dgr	H318H412				ATP01
611-051-00-9	2-(4-(N-ethyl-N-(2-hydroxy)ethyl)amino-2-methylphenyl)azo-6-methoxy-3-methyl-benzothiazolium chloride	411-110-7	136213-74-6	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
611-052-00-4	"monosodium aqua-[5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalensulfonate], iron complex"	400-720-9		Aquatic Chronic 3	H412		H412				CLP00
611-053-00-X	"2,2'-azobis[2-methylpropionamidine] dihydrochloride"	221-070-0	2997-92-4	Acute Tox. 4 *Skin Sens. 1	H302H317	GHS07Wng	H302H317				CLP00
611-055-00-0	C.I. Disperse Yellow 3; N-[4-[(2-hydroxy-5-methylphenyl)azo]phenyl]acetamide	220-600-8	2832-40-8	Carc. 2Skin Sens. 1	H351H317	GHS08GHS07Wng	H351H317				CLP00
611-056-00-6	C.I. Solvent Yellow 14; 1-phenylazo-2-naphthol	212-668-2	842-07-9	Carc. 2Muta. 2Skin Sens. 1Aquatic Chronic 4	H351H341H317H413	GHS08GHS07Wng	H351H341H317H413				CLP00
611-057-00-1	"6-hydroxy-1-(3-isopropoxypropyl)-4-methyl-2-oxo-5-[4-(phenylazo)phenylazo]-1,2-dihydro-3-pyridinecarbonitrile"	400-340-3	85136-74-9	Carc. 1BAquatic Chronic 4	H350H413	GHS08Wng	H350H413				CLP00
611-058-00-7	"(6-(4-hydroxy-3-(2-methoxyphenylazo)-2-sulfonato-7-naphthylamino)-1,3,5-triazin-2,4-diyl)bis[(amino-1-methylethyl)ammonium] formate"	402-060-7	108225-03-2	Carc. 1BEye Dam. 1Aquatic Chronic 2	H350H318H411	GHS08GHS05GHS09Dgr	H350H318H411				CLP00
611-059-00-2	"octasodium 2-(6-(4-chloro-6-(3-(N-methyl-N-(4-chloro-6-(3,5-disulfonato-2-naphthylazo)-1-hydroxy-6-naphthylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,5-disulfonato-1-hydroxy-2-naphthylazo)naphthalene-1,5-disulfonate"	412-960-1	148878-21-1	Eye Dam. 1Skin Sens. 1Aquatic Chronic 3	H318H317H412	GHS05GHS07Dgr	H318H317H412				CLP00
611-060-00-8	"reaction mass of: sodium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophthalate; ammonium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophthalate; 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonaphthalen-2-ylazo]-isophthalic acid"	413-180-4	187285-15-0	Eye Dam. 1	H318	GHS05Dgr	H318				CLP00
611-061-00-3	"disodium 5-[5-[4-(5-chloro-2,6-difluoropyrimidin-4-ylamino)benzamido]-2-sulfonatophenylazo]-1-ethyl-6-hydroxy-4-methyl-2-oxo-3-pyridylmethylsulfonate"	412-530-3		Eye Dam. 1Skin Sens. 1	H318H317	GHS05GHS07Dgr	H318H317				CLP00
611-062-00-9	"octasodium 2-(8-(4-chloro-6-(3-((4-chloro-6-(3,6-disulfonato-2-(1,5-disulfonatonaphthalen-2-ylazo)-1-hydroxynaphthalen-8-ylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,6-disulfonato-1-hydroxynaphthalen-2-ylazo)naphthalene-1,5-disulfonate"	413-550-5		Skin Irrit. 2Eye Dam. 1	H315H318	GHS05Dgr	H315H318				CLP00
611-063-00-4	"trisodium [4'-(8-acetylamino-3,6-disulfonato-2-naphthylazo)-4''-(6-benzoylamino-3-sulfonato-2-naphthylazo)-biphenyl-1,3',3'',1'''-tetraolato-O,O',O'',O''']copper(II)"	413-590-3	164058-22-4	Carc. 1B	H350	GHS08Dgr	H350				CLP00
611-064-00-X	"4-(3,4-dichlorophenylazo)-2,6-di-sec-butyl-phenol"	410-600-8	124719-26-2	STOT RE 2 *Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H373 **H315H400H410	GHS08GHS07GHS09Wng	H373 **H315H410				CLP00
611-065-00-5	"4-(4-nitrophenylazo)-2,6-di-sec-butyl-phenol"	410-610-2	111850-24-9	STOT RE 2 *Skin Irrit. 2Eye Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H373 **H315H319H317H400H410	GHS08GHS07GHS09Wng	H373 **H319H315H317H410				CLP00
611-066-00-0	"tetrasodium 5-[4-chloro-6-(N-ethyl-anilino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(1,5-disulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate"	411-540-5	130201-57-9	Eye Dam. 1Skin Sens. 1Aquatic Chronic 2	H318H317H411	GHS05GHS07GHS09Dgr	H318H317H411				CLP00
611-067-00-6	reaction mass of: bis(tris(2-(2-hydroxy(1-methyl)ethoxy)ethyl)ammonium) 7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo)naphthalene-2-sulfonate; bis(tris(2-(2-hydroxy(2-methyl)ethoxy)ethyl)ammonium) 7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo)naphthalene-2-sulfonate	406-910-8	-	Acute Tox. 4 *Aquatic Chronic 3	H302H412	GHS07Wng	H302H412				CLP00/ATP01
611-068-00-1	"tetrasodium 4-amino-3,6-bis(5-[4-chloro-6-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino]-2-sulfonatophenylazo)-5-hydroxynaphthalene-2,7-disulfonate"	400-690-7	85665-98-1	Aquatic Chronic 2	H411	GHS09	H411				CLP00
611-069-00-7	"N,N-di-[poly(oxyethylene)-co-poly(oxypropylene)]-4-[(3,5-dicyano-4-methyl-2-thienyl)azo)]-3-methylaniline"	413-380-1		Aquatic Chronic 2	H411	GHS09	H411				CLP00
611-070-00-2	"reaction mass of: disodium (6-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-); trisodium bis(5-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)chromate(1-)"	405-665-4		Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410				CLP00
611-071-00-8	tris(tetramethylammonium) 5-hydroxy-1-(4-sulphonatophenyl)-4-(4-sulphonatophenylazo)pyrazole-3-carboxylate	406-073-9	131013-81-5	Acute Tox. 3 *Aquatic Chronic 3	H301H412	GHS06Dgr	H301H412				CLP00
611-072-00-3	"2,4-bis[2,2'-[2-(N,N-dimethylamino)ethyloxycarbonyl]phenylazo]-1,3-dihydroxybenzene, dihydrochloride"	407-010-8	118208-02-9	Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 2	H302H318H411	GHS05GHS07GHS09Dgr	H302H318H411				CLP00
611-073-00-9	"dimethyl 3,3'-(N-(4-(4-bromo-2,6-dicyanophenylazo)-3-hydroxyphenyl)imino)dipropionate"	407-310-9	122630-55-1	Aquatic Chronic 4	H413		H413				CLP00
611-074-00-4	"reaction mass of: sodium/potassium (3-(4-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)copper(II); sodium/potassium (3-(4-(5-(5-chloro-4,6-difluoropyrimidin-2-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)copper(II)"	407-100-7		Skin Sens. 1	H317	GHS07Wng	H317				CLP00
611-075-00-X	"reaction mass of: tris(3,5,5-trimethylhexylammonium) 4-amino-3-(4-(4-(2-amino-4-hydroxyphenylazo)anilino)-3-sulfonatophenylazo)-5,6-dihydro-5-oxo-6-phenylhydrazononaphthalene-2,7-disulfonate; tris(3,5,5-trimethylhexylammonium) 4-amino-3-(4-(4-(4-amino-2-hydroxyphenylazo)anilino)-3-sulfonatophenylazo)-5,6-dihydro-5-oxo-6-phenylhydrazononaphthalene-2,7-disulfonate (2:1)"	406-000-0		Eye Dam. 1Aquatic Chronic 2	H318H411	GHS05GHS09Dgr	H318H411				CLP00
611-076-00-5	"3-(2,6-dichloro-4-nitrophenylazo)-1-methyl-2-phenylindole"	406-280-4	117584-16-4	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
611-077-00-0	"dilithium disodium (5,5'-diamino-(?-4,4'-dihydroxy-1:2-?-2,O4,O4',-3,3'-[3,3'-dihydroxy-1:2-?-2-O3,O3'-biphenyl-4,4'-ylenebisazo-1:2-(N3,N4-?:N3',N4'-?)]-dinaphthalene-2,7-disulfonato(8)))dicuprate(2-)"	407-230-4	126637-70-5	Acute Tox. 4 *Skin Sens. 1	H302H317	GHS07Wng	H302H317				CLP00
611-078-00-6	"(2,2'-(3,3'-dioxidobiphenyl-4,4'-diyldiazo)bis(6-(4-(3-(diethylamino)propylamino)-6-(3-(diethylammonio)propylamino)-1,3,5-triazin-2-ylamino)-3-sulfonato-1-naphtholato))dicopper(II) acetate lactate"	407-240-9	159604-94-1	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				CLP00
611-079-00-1	"disodium 7-[4-chloro-6-(N-ethyl-o-toluidino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)-2-naphthalenesulfonate"	410-390-8	147703-64-8	Eye Dam. 1	H318	GHS05Dgr	H318				CLP00
611-080-00-7	sodium 3-(2-acetamido-4-(4-(2-hydroxybutoxy)phenylazo)phenylazo)benzenesulfonate	410-150-2	147703-65-9	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
611-081-00-2	"tetrasodium [7-(2,5-dihydroxy-KO2-7-sulfonato-6-[4-(2,5,6-trichloro-pyrimidin-4-ylamino)phenylazo]-(N1,N7-N)-1-naphthylazo)-8-hydroxy-KO8-naphthalene-1,3,5-trisulfonato(6-)]cuprate(II)"	411-470-5	141048-13-7	Skin Sens. 1Aquatic Chronic 3	H317H412	GHS07Wng	H317H412				CLP00
611-082-00-8	reaction mass of: pentasodium bis(1-(3(or 5)-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato)ferrate(1-); pentasodium [(1-(3-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato)-(5-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato]ferrate(1-)	407-570-3		Aquatic Chronic 2	H411	GHS09	H411				CLP00
611-083-00-3	"reaction mass of: 2-[N-ethyl-4-[(5,6-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate; 2-[N-ethyl-4-[(6,7-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate (1:1)"	411-560-4		STOT RE 1Skin Sens. 1Aquatic Chronic 2	H372 **H317H411	GHS08GHS07GHS09Dgr	H372 **H317H411				CLP00
611-085-00-4	reaction mass of: 3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-(2-hydroxy-ethylamino)-4-methyl-6-[3-(2-phenoxyethoxy)propylamino]pyridine; 3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-(2-hydroxy-ethylamino)-4-methyl-2-[3-(2-phenoxyethoxy)propylamino]pyridine; 3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-amino-4-methyl-6-[3-(3-hydroxypropoxy)propylamino]pyridine; 3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-amino-4-methyl-2-[3-(3-methoxypropoxy)propylamino]pyridine	411-880-4		Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				CLP00
611-086-00-X	"monolithium 5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalenesulfonate], iron complex, monohydrate"	411-360-7		Aquatic Chronic 3	H412		H412				CLP00
611-087-00-5	"reaction mass of: 3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxyl-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-phenoxyethane; 3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxy-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-ethyloxy-2-(ethylphenol)"	411-710-9		Aquatic Chronic 4	H413		H413				CLP00
611-088-00-0	"reaction mass of: trilithium 4-amino-3-((4-((4-((2-amino-4-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulfonate; trilithium 4-amino-3-((4-((4-((4-amino-2-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulfonate"	411-890-9		Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 3	H302H318H412	GHS05GHS07Dgr	H302H318H412				CLP00
611-089-00-6	2-((4-(ethyl-(2-hydroxyethyl)amino)-2-methylphenyl)azo)-6-methoxy-3-methyl-benzothiazolium methylsulfate	411-100-2	136213-73-5	STOT RE 2 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H373 **H317H400H410	GHS08GHS07GHS09Wng	H373 **H317H410				CLP00
611-090-00-1	"2,5-dibutoxy-4-(morpholin-4-yl)benzenediazonium 4-methylbenzenesulfonate"	413-290-2	93672-52-7	Self-react. CAcute Tox. 4 *Eye Dam. 1Skin Sens. 1Aquatic Chronic 3	H242H302H318H317H412	GHS02GHS05GHS07Dgr	H242H302H318H317H412			T	CLP00
611-091-00-7	"sodium (1.0-1.95)/lithium (0.05-1) 5-((5-((5-chloro-6-fluoro-pyrimidin-4-yl)amino)-2-sulfonatophenyl)azo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-3-pyridinemethylsulfonate"	413-470-0	134595-59-8	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
611-092-00-2	"tert-(dodecyl/tetradecyl)-ammonium bis(3-(4-((5-(1,1-dimethyl-propyl)-2-hydroxy-3-nitrophenyl)azo)-3-methyl-5-hydroxy-(1H)pyrazol-1-yl)benzenesulfonamidato)chromate"	413-210-6		Aquatic Chronic 2	H411	GHS09	H411				CLP00
611-093-00-8	"sodium 2-(4-(4-fluoro-6-(2-sulfo-ethylamino)-[1,3,5]triazin-2-ylamino)-2-ureido-phenylazo)-5-(4-sulfophenylazo)benzene-1-sulfonate"	410-770-3	146177-84-6	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
611-094-00-3	"reaction mass of: 2-[2-acetylamino-4-[N,N-bis[2-ethoxy-carbonyloxy)ethyl]amino]phenylazo]-5,6-dichloro-1,3-benzothiazole; 2-[2-acetylamino-4-[N,N-bis[2-ethoxy-carbonyloxy)ethyl]amino]phenylazo]-6,7-dichloro-1,3-benzotriazole (1:1)"	411-600-0	143145-93-1	Aquatic Chronic 4	H413		H413				CLP00
611-095-00-9	"hexasodium 1,1'-[(1-amino-8-hydroxy-3,6-disulfonate-2,7-naphthalenediyl)bis(azo(4-sulfonate-1,3-phenyl)imino[6-[(4-chloro-3-sulfonatophenyl)amino]-1,3,5-triazin-2,4-diyl]]]bis[3-carboxypyridinium] dihydroxide"	412-240-7	89797-03-5	Aquatic Chronic 2	H411	GHS09	H411				CLP00
611-096-00-4	methyl N-[3-acetylamino)-4-(2-cyano-4-nitrophenylazo)phenyl]-N-[(1-methoxy)acetyl]glycinate	413-040-2	149850-30-6	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
611-097-00-X	"reaction mass of iron complexes of: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-(5-amino-sulfonyl-2-hydroxyphenylazo)benzene and: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-[4-(4-nitro-2-sulfophenylamino)phenylazo]benzene (n=2,5,6)"	414-150-3		Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				CLP00
611-098-00-5	"tetrakis(tetramethylammonium)3,3'-(6-(2-hydroxyethylamino)1,3,5-triazine-2,4-diylbisimino(2-methyl-4,1-phenyleneazo))bisnaphthalene-1,5-disulfonate"	405-950-3	131013-83-7	Acute Tox. 3 *Aquatic Chronic 3	H301H412	GHS06Dgr	H301H412				CLP00
611-099-00-0	"(methylenebis(4,1-phenylenazo(1-(3-(dimethylamino)propyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))-1,1'-dipyridinium dichloride dihydrochloride"	401-500-5	118658-99-4	Carc. 1BAquatic Chronic 2	H350H411	GHS08GHS09Dgr	H350H411				CLP00
611-100-00-4	"potassium sodium 3,3'-(3(or4)-methyl-1,2-phenylenebis(imino(6-chloro)-1,3,5-triazine-4,2-diylimino(2-acetamido-5-methoxy)-4,1-phenylenazo)dinaphthalene-1,5-disulfonate"	403-810-6	140876-13-7	Eye Dam. 1	H318	GHS05Dgr	H318				CLP00
611-101-00-X	2'-(4-chloro-3-cyano-5-formyl-2-thienyl)azo-5'-diethylaminoacetanilide	405-200-5	104366-25-8	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
611-102-00-5	"reaction product of: C.I. Leuco Sulfur Black 1 and reaction mass of: disodium-4-{4-[8-amino-1-hydroxy-7-(4-sulfamoylphenylazo)-3,6-disulfonato-2-naphthylazo]phenylsulfonylamino}benzendiazoniumchlorid; disodium-4-{4-[2,6-dihydroxy-3-(8-hydroxy-3,6-disulfonato-1-naphthylazo)phenylazo]phenylsulfonylamino}benzen-diazoniumchlorid"	424-500-7	-	Aquatic Chronic 3	H412	-	H412				ATP01
611-103-00-0	trisodium (1-(3-carboxylato-2-oxido-5-sulfonatophenylazo)-5-hydroxy-7-sulfonatonaphthalen-2-amido)nickel(II)	407-110-1		Eye Dam. 1Skin Sens. 1Aquatic Chronic 2	H318H317H411	GHS05GHS07GHS09Dgr	H318H317H411				CLP00
611-104-00-6	"reaction mass of: trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2or 6)-(4-(4-nitro-2-sulfonatoanilino)phenylazo)phenolato)ferrate(1-); trisodium bis(2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)ferrate(1-); trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4 or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2 or 6)-(4-nitro-2-sulfonatophenylazo)phenolato)ferrate(1-); trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4 or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2 or 6)-(3-sulfonatophenylazo)phenolato)ferrate(1-); disodium 3,3'-(2,4-dihydroxy-1,3(or 1,5 or 3,5)-phenylenediazo)dibenzenesulfonate"	406-870-1		Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				CLP00
611-105-00-1	"sodium 4-(4-chloro-6-(N-ethylanilino)-1,3,5-triazin-2-ylamino)-2-(1-(2-chlorophenyl)-5-hydroxy-3-methyl-1H-pyrazol-4-ylazo)benzenesulfonate"	407-800-2	136213-75-7	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				CLP00
611-106-00-7	"hexasodium 4,4'-dihydroxy-3,3'-bis[2-sulfonato-4-(4-sulfonatophenylazo)phenylazo]-7,7'[p-phenylenebis[imino(6-chloro-1,3,5-triazine-4,2-diyl)imino]]dinaphthalene-2-sulfonate"	410-180-6	157627-99-1	Eye Dam. 1	H318	GHS05Dgr	H318				CLP00
611-107-00-2	"potassium sodium 4-(4-chloro-6-(3,6-disulfonato-7-(5,8-disulfonato-naphthalen-2-ylazo)-8-hydroxy-naphthalen-1-ylamino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-(2-sulfatoethanesulfonyl)-phenylazo)-naphthalene-1,7-disulfonate"	412-490-7		Skin Sens. 1	H317	GHS07Wng	H317				CLP00
611-108-00-8	disodium 5-((4-((4-chloro-3-sulfonatophenyl)azo)-1-naphthyl)azo)-8-(phenylamino)-1-naphthalenesulfonate	413-600-6	6527-62-4	Aquatic Chronic 3	H412		H412				CLP00
611-109-00-3	"Reaction products of: copper(II) sulfate and tetrasodium 2,4-bis[6-(2-methoxy-5-sulfonatophenylazo)-5-hydroxy-7-sulfonato-2-naphthylamino]-6-(2-hydroxyethylamino)-1,3,5-triazine (2:1)"	407-710-3		Aquatic Chronic 2	H411	GHS09	H411				CLP00
611-110-00-9	"tetra-sodium/lithium 4,4'-bis-(8-amino-3,6-disulfonato-1-naphthol-2-ylazo)-3-methylazobenzene"	408-210-8	124605-82-9	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				CLP00
611-111-00-4	disodium 2-[[4-(2-chloroethylsulfonyl)phenyl]-[(2-hydroxy-5-sulfo-3-[3-[2-(2-(sulfooxy)ethylsulfonyl)ethylazo]-4-sulfobenzoato(3-)cuprate(1-)	414-230-8		Skin Sens. 1	H317	GHS07Wng	H317				CLP00
611-112-00-X	"tetrasodium 4-hydroxy-5-[4-[3-(2-sulfatoethanesulfonyl)phenylamino]-6-morpholin-4-yl-1,3,5-triazin-2-ylamino]-3-(1-sulfonatonaphthalen-2-ylazo)naphthalene-2,7-disulfonate"	413-070-6		Skin Sens. 1	H317	GHS07Wng	H317				CLP00
611-113-00-5	"lithium sodium (2-(((5-((2,5-dichlorophenyl)azo)-2-hydroxyphenyl)methylene)amino)benzoato(2-))(2-((4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo)-5-sulfobenzoato(3-)) chromate(2-)"	414-280-0	149626-00-6	Aquatic Chronic 2	H411	GHS09	H411				CLP00
611-114-00-0	"lithium sodium (4-((5-chloro-2-hydroxyphenyl)azo)-2,4-dihydro-5-methyl-3H-pyrazol-3-onato(2-))(3-((4,5-dihydro-3-methyl-1-(4-methylphenyl)-5-oxo-1H-pyrazol-4-yl)azo)-4-hydroxy-5-nitrobenzenesulfonato(3-)) chromate(2-)"	414-250-7	149564-66-9	Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 3	H302H318H412	GHS05GHS07Dgr	H302H318H412				CLP00
611-115-00-6	trilithium bis(4-((4-(diethylamino)-2-hydroxyphenyl)azo)-3-hydroxy-1-naphthalenesulfonato(3-))chromate(3-)	414-290-5	149564-65-8	Acute Tox. 4 *Aquatic Chronic 3	H302H412	GHS07Wng	H302H412				CLP00
611-116-00-1	"reaction mass of: trisodium 5-{}{4-chloro-6-[2-(2,6-dichloro-5-cyanopyrimidin-4-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}}-4-hydroxy-3-(1-sulfonatonaphthalene-2-ylazo)-naphthalene-2,7-disulfonate; trisodium 5-{}{4-chloro-6-[2-(2,6-dichloro-5-cyanopyrimidin-4-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}}-4-hydroxy-3-(1-sulfonatonaphthalene-2-ylazo)-naphthalene-2,7-disulfonate; trisodium 5-{}{4-chloro-6-[2-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate; trisodium 5-{}{4-chloro-6-[2-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate"	414-620-8		Eye Dam. 1Skin Sens. 1	H318H317	GHS05GHS07Dgr	H318H317				CLP00
611-117-00-7	"1,3-bis{}{6-fluoro-4-[1,5-disulfo-4-(3-aminocarbonyl-1-ethyl-6-hydroxy-4-methyl-pyrid-2-on-5-ylazo)-phenyl-2-ylamino]-1,3,5-triazin-2-ylamino}}propane lithium-, sodium salt"	415-100-3	149850-29-3	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
611-118-00-2	"sodium 1,2-bis[4-[4-{}{4-(4-sulfophenylazo)-2-sulfophenylazo}}-2-ureido-phenyl-amino]-6-fluoro-1,3,5-triazin-2-ylamino]-propane, sodium salt"	413-990-8		Skin Sens. 1	H317	GHS07Wng	H317				CLP00
611-119-00-8	"tetrasodium 4-[4-chloro-6-(4-methyl-2-sulfophenylamino)-1,3,5-triazin-2-ylamino]-6-(4,5-dimethyl-2-sulfophenylazo)-5-hydroxynaphthalene-2,7-disulfonate"	415-400-4	148878-22-2	Eye Dam. 1Skin Sens. 1	H318H317	GHS05GHS07Dgr	H318H317				CLP00
611-120-00-3	"5-{}{4-[5-amino-2-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-sulfo-phenylamino]-6-chloro-1,3,5-triazin-2-ylamino}}-4-hydroxy-3-(1-sulfo-naphthalen-2-ylazo)-naphthalene-2,7-disulfonicacid sodium salt"	418-340-7	157707-94-3	Eye Dam. 1Aquatic Chronic 3	H318H412	GHS05Dgr	H318H412				CLP00
611-121-00-9	"Main component 6 (isomer): asym. 1:2 Cr(III)-complex of: A: 3-hydroxy-4-(2-hydroxy-naphthalene-1-ylazo)naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)phenylazo]naphthalene-2-ol; Main component 8 (isomer): asym. 1:2 Cr-complex of: A: 3-hydroxy-4-(2-hydroxy-naphthalene-1-ylazo)-naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)-phenylazo]-naphthalene-2-ol"	417-280-9	30785-74-1	Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H318H400H410	GHS05GHS09Dgr	H318H410				CLP00
611-122-00-4	"hexasodium (di[N-(3-(4-[5-(5-amino-3-methyl-1-phenylpyrazol-4-yl-azo)-2,4-disulfo-anilino]-6-chloro-1,3,5-triazin-2-ylamino)phenyl)-sulfamoyl](di-sulfo)-phthalocyaninato)nickel"	417-250-5	151436-99-6	Eye Dam. 1Skin Sens. 1	H318H317	GHS05GHS07Dgr	H318H317				CLP00
611-123-00-X	"3-(2,4-bis(4-((5-(4,6-bis(2-aminopropylamino)-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-disulfonaphthalen-3-yl)azo)phenylamino)-1,3,5-triazin-6-ylamino)propyldiethylammonium lactate"	424-310-4	178452-66-9	Eye Dam. 1	H318	GHS05Dgr	H318				CLP00
611-124-00-5	"reaction mass of: pentasodium 5-amino-3-(5-{}{4-chloro-6-[4-(2-sulfoxyethoxysulfonato)phenylamino]-1,3,5-triazin-2-ylamino}}-2-sulfonatophenylazo)-6-[5-(2,3-dibromopropionylamino)-2-sulfonatophenylazo]-4-hydroxynaphthalene-2,7-disulfonate; pentasodium 5-amino-6-[5-(2-bromoacryloylamino)-2-sulfonatophenylazo]-3-(5-{}{4-chloro-6-[4-(2-sulfoxyethoxysulfonato)phenylamino]-1,3,5-triazin-2-ylamino}}-2-sulfonatophenylazo)-4-hydroxynaphthalene-2,7-disulfonate; tetrasodium 5-amino-3-[5-{}{4-chloro-6-[4-(vinylsulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}}-2-sulfonatophenylazo]-6-[5-(2,3-dibromopropionylamino)-2-sulfonatophenylazo]-4-hydroxynaphthalene-2,7-disulfonate"	424-320-9		Eye Dam. 1Aquatic Chronic 2	H318H411	GHS05GHS09Dgr	H318H411				CLP00
611-125-00-0	"reaction mass of: Disodium 6-[3-carboxy-4,5-dihydro-5-oxo-4-sulfonatophenyl)pyrazolin-4-yl-azo]-3-[2-oxido-4-(ethensulfonyl)-5-methoxyphenylazo]-4-oxidonaphthalene-2-sulfonate copper (II) complex; Disodium 6-[3-carboxy-4,5-dihydro-5-oxo-4-sulfonatophenyl)pyrazolin-4-yl-azo]-3-[2-oxido-4-(2-hydroxyethylsulfonyl)-5-methoxyphenylazo]-4-oxidonaphthalene-2-sulfonate copper (II) complex"	423-940-7		Eye Dam. 1Aquatic Chronic 2	H318H411	GHS05GHS09Dgr	H318H411				CLP00
611-126-00-6	"2,6-bis-(2-(4-(4-amino-phenylamino)-phenylazo)-1,3-dimethyl-3H-imidazolium)-4-dimethylamino-1,3,5-triazine, dichloride"	424-120-1	174514-06-8	Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H318H400H410	GHS05GHS09Dgr	H318H410				CLP00
611-127-00-1	"pentasodium 4-amino-6-(5-(4-(2-ethyl-phenylamino)-6-(2-sulfatoethanesulfonyl)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate"	423-790-2		Eye Dam. 1Skin Sens. 1Aquatic Chronic 3	H318H317H412	GHS05GHS07Dgr	H318H317H412			G	CLP00
611-128-00-7	"N,N'-bis{}{6-chloro-4-[6-(4-vinylsulfonylphenylazo)-2,7-disulfonicacid-5-hydroxynapht-4-ylamino]-1,3,5-triazin-2-yl}}-N-(2-hydroxyethyl)ethane-1,2-diamine, sodium salt"	419-500-9	171599-85-2	Eye Dam. 1Skin Sens. 1	H318H317	GHS05GHS07Dgr	H318H317				CLP00
611-129-00-2	"reaction mass of: 5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-2-[(3-phosphonophenyl)azo]benzoic acid; 5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-3-[(3-phosphonophenyl)azo]benzoic acid"	418-230-9	163879-69-4	Expl. 1.3 ****Repr. 2STOT RE 2 *Skin Sens. 1Aquatic Chronic 2	H203H361f ***H373 **H317H411	GHS01GHS08GHS07GHS09Dgr	H203H361f ***H373 **H317H411				CLP00
611-130-00-8	"tetra-ammonium 2-[6-[7-(2-carboxylato-phenylazo)-8-hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy-1,3,5-triazin-2-ylamino]benzoate"	418-520-5	183130-96-3	Eye Irrit. 2Aquatic Chronic 3	H319H412	GHS07Wng	H319H412				CLP00/ATP01
611-131-00-3	2-[2-hydroxy-3-(2-chlorophenyl)carbamoyl-1-naphthylazo]-7-[2-hydroxy-3-(3-methylphenyl)carbamoyl-1-naphthylazo]fluoren-9-one	420-580-2	151798-26-4	Repr. 1BAquatic Chronic 4	H360D ***H413	GHS08Dgr	H360D ***H413				CLP00
611-132-00-9	"pentasodium bis{}{7-[4-(1-butyl-5-cyano-1,2-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)phenylsulfonylamino]-5'-nitro-3,3'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato}} chromate (III)"	419-210-2	178452-71-6	Eye Dam. 1Aquatic Chronic 3	H318H412	GHS05Dgr	H318H412				CLP00
611-133-00-4	"Product by process iron complex of azo dyestuffs obtained by coupling a mixture of diazotized 2-amino-1-hydroxybenzene-4-sulfanilide and 2-amino-1-hydroxybenzene-4-sulfonamide with resorcin, the obtained mixture being subsequently submitted to a second coupling reaction with a mixture of diazotized 3-aminobenzene-1-sulfonic acid (metanilic acid) and 4'-amino-4-nitro-1,1'-diphenylamine-2-sulfonic acid and metallization with ferric chloride, sodium salt"	419-260-5		Eye Dam. 1Aquatic Chronic 2	H318H411	GHS05GHS09Dgr	H318H411				CLP00
611-134-00-X	"trisodium 2-{}{?[2-hydroxy-3-[4-chloro-6-[4-(2,3-dibromopropionylamino)-2-sulfonatophenylamino]-1,3,5-triazin-2-ylamino]-5-sulfonatophenylazo]-benzylidenehydrazino}}-4-sulfonatobenzoate, copper complex"	423-770-3		Eye Dam. 1Aquatic Chronic 2	H318H411	GHS05GHS09Dgr	H318H411				CLP00
611-135-00-5	"Reaction product of: 2-[[4-amino-2-ureidophenylazo]-5-[(2-(sulfooxy)ethyl)sulfonyl]]benzenesulfonic acid with 2,4,6-trifluoropyrimidine and partial hydrolysis to the corresponding vinylsulfonyl derivative,mixed potassium/sodium salt"	424-250-9		Eye Dam. 1Aquatic Chronic 3	H318H412	GHS05Dgr	H318H412				CLP00
611-136-00-0	"2-{}{4-(2-ammoniopropylamino)-6-[4-hydroxy-3-(5-methyl-2-methoxy-4-sulfamoylphenylazo)-2-sulfonatonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}}-2-aminopropyl formate"	424-260-3		Repr. 2Eye Dam. 1Aquatic Chronic 2	H361f ***H318H411	GHS05GHS08GHS09Dgr	H361f ***H318H411				CLP00
611-137-00-6	"6-tert-butyl-7-chloro-3-tridecyl-7,7a-dihydro-1H-pyrazolo[5,1-c]-1,2,4-triazole"	419-870-1	159038-16-1	Aquatic Chronic 4	H413		H413				CLP00
611-138-00-1	"2-(4-aminophenyl)-6-tert-butyl-1H-pyrazolo[1,5-b][1,2,4]triazole"	415-910-7	152828-25-6	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				CLP00
611-139-00-7	reaction product of: C.I. Leuco Sulfur Black 1 with (3-chloro-2-hydroxypropyl)trimethylammonium chloride	424-510-1	-	Eye Dam. 1Aquatic Chronic 2	H318H411	GHS05GHS09Dgr	H318H411				ATP01
611-140-00-2	"azafenidin (ISO); 2-(2,4-dichloro-5-prop-2-ynyloxyphenyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one"		68049-83-2	Repr. 1BSTOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H360DfH373 **H400H410	GHS08GHS09Dgr	H360DfH373 **H410		M=1000		CLP00
611-141-00-8	"5-(4-[4-[4-(3,5-dicarboxy-phenyl-azo)phenylamino]-6-morpholin-4-yl-1,3,5-triazin-2-ylamino]phenylazo)isophthalic acid, mixed monosodium and diammonium salt"	414-410-6	-	Eye Dam. 1Skin Sens. 1	H318H317	GHS05GHS07Dgr	H318H317				ATP01
611-142-00-3	"product-by-process definition polyazodyestuff obtained by coupling 4-[4-(1-amino-8-hydroxy-3,6-disulfo-2-naphthylazo)phenylsulfonylamino]benzenediazonium with reaction mass of 4-carboxybenzenediazonium and diphenylamine-3-sulfo-4,4'-bisdiazonium, and further coupling of the obtained compounds with reaction mass of naphth-2-ol and 3-aminophenol, sodium salts; sodium chloride"	425-740-5	-	Eye Dam. 1Aquatic Chronic 3	H318H412	GHS05Dgr	H318H412				ATP01
611-143-00-9	"reaction mass of: trisodium 2-(2-[?-(2-carboxylato-?-O-4-sulfonatophenylazo)benzylidene]hydrazino-?-N')-6-(2,6-difluoropyrimidin-4-ylamino)-4-sulfonatophenolatocuprate (II); trisodium 2-(2-[?-(2-carboxylato-?-O-4-sulfonatophenylazo)benzylidene]hydrazino-?-N')-6-(4,6-difluoropyrimidin-2-ylamino)-4-sulfonatophenolatocuprate (II)"	428-260-4	-	Eye Dam. 1	H318	GHS05Dgr	H318				ATP01
611-144-00-4	"reaction mass of: 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt; 7-amino-3-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxy-8-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt; 7-amino-8-[4-(2-sulfoxyethylsulfonyl)-phenylazo]-4-hydroxy-3-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt; 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt"	429-070-4	214362-06-8	Eye Dam. 1	H318	GHS05Dgr	H318				ATP01
611-145-00-X	"reaction mass of: tetrasodium 3-(1,5-disulfonatonaphthalene-2-ylazo)-4-hydroxy-7-{4-chloro-6-[4-(2-sulfoxyethylsulfonyl)phenylamino]-1,3,5-triazine-2-ylamino}naphthalene-2-sulfonate; 3-(2,5-disulfophenylazo)-4-hydroxy-7-{4-chloro-6-[4-(2-sulfoxyethylsulfonyl)phenylamino]-1,3,5-triazine-2-ylamino}naphthalene-2-sulfonic acid, sodium salt"	429-440-5	-	Eye Dam. 1	H318	GHS05Dgr	H318				ATP01
611-146-00-5	"reaction mass of: pentasodium 3-(4-(4-(7-(2,4-diamino-5-sulfonato-3-(4-sulfonatophenylazo)phenylazo)-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-2-sulfonatophenylamino)phenylazo)-4-hydroxy-6-(2-oxo-1-phenylcarbamoylpropylazo)naphthalene-2-sulfonate; pentasodium 6-((2,4-diamino-5-sulfonatophenyl)azo)-3-((4-((4-((7-((2,4-diamino-5-sulfonatophenyl)azo)-1-hydroxy-3-sulfonatonaphthalen-2-yl)azo)phenyl)amino)-2-sulfonatophenyl)azo)-4-hydroxynaphthalene-2-sulfonate; pentasodium 6-((2,4-diamino-5-sulfonato-3-((4-sulfonatophenyl)azo)phenyl)azo)-3-((4-((4-((1,7-dihydroxy-3-sulfonatonaphthalen-2-yl)azo)-2-sulfonatophenyl)amino)phenyl)azo)-4-hydroxynaphthalene-2-sulfonate; hexasodium 6-((2,4-diamino-5-sulfonatophenyl)azo)-3-((4-((4-((7-((2,4-diamino-5-sulfonato-3-((4-sulfonatophenyl)azo)phenyl)azo)-1-hydroxy-3-sulfonatonaphthalen-2-yl)azo)-2-sulfonatophenyl)amino)phenyl)azo)-4-hydroxynaphthalene-2-sulfonate"	430-070-1	-	Aquatic Chronic 2	H411	GHS09	H411				ATP01
611-147-00-0	"sodium, potassium, lithium 5-amino-3,6-bis(5-(4-chloro-6-(methyl-(2-methylaminoacetyl)amino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-4-hydroxynaphthalene-2,7-disulfonate"	430-090-0	205764-96-1	Eye Dam. 1Skin Sens. 1	H318H317	GHS05GHS07Dgr	H318H317				ATP01
611-148-00-6	"reaction mass of: 2-(3-(2,6-dichloro-4-nitrophenylazo)carbazol-9-yl)ethanol; 2-(2-(3-(2,6-dichloro-4-nitro-phenylazo)-carbazol-9-yl)-ethoxy)ethanol; 3-(2,6-dichloro-4-nitrophenylazo)carbazol"	429-590-1	-	Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410				ATP01
611-149-00-1	"2-(2-chloroacetoxy)ethyl 3-((4-(2,5-dichloro-4-fluorosulfonylphenylazo)-3-methylphenyl)ethylamino)propionate"	427-570-7	193486-83-8	Aquatic Chronic 2	H411	GHS09	H411				ATP01
611-150-00-7	"tetralithium 2-[6-[7-[2-(carboxylato)phenylazo]-8-hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy-1,3,5-triazine-2-ylamino]benzoate"	440-460-3	-	Eye Irrit. 2Aquatic Chronic 3	H319H412	GHS07Wng	H319H412				ATP01
611-151-00-2	"chrysoidine; 4-(phenylazo)benzene-1,3-diamine"	207-803-7	495-54-5	Muta. 2Acute Tox. 4 *Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H341H302H315H400H410	GHS08GHS07GHS09Wng	H341H302H315H410				ATP01
611-152-00-8	"chrysoidine monohydrochloride; 4-phenylazophenylene-1,3-diamine monohydrochloride [1]chrysoidine monoacetate; 4-(phenylazo)benzene-1,3-diamine monoacetate [2]chrysoidine acetate; 4-(phenylazo)benzene-1,3-diamine acetate [3]chrysoidine-p-dodecylbenzenesulfonate; dodecylbenzenesulfonic acid, compound with 4-(phenylazo)benzene-1,3-diamine (1:1) [4]chrysoidine dihydrochloride; 4-(phenylazo)benzene-1,3-diamine dihydrochloride [5]chrysoidine sulfate; bis[4-(phenylazo)benzene-1,3-diamine] sulfate  [6]"	208-545-8 [1]278-290-5 [2]279-116-0 [3]264-409-8 [4]281-549-5 [5]282-432-1 [6]	532-82-1 [1]75660-25-2 [2]79234-33-6 [3]63681-54-9 [4]83968-67-6 [5]84196-22-5 [6]	Muta. 2Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H341H302H315H318H400H410	GHS05GHS08GHS07GHS09Dgr	H341H302H315H318H410				ATP01
611-153-00-3	"chrysoidine C10-14-alkyl derivatives; benzenesulfonic acid, mono-C10-14-alkyl derivatives, compounds with 4-(phenylazo)-1,3-benzenediamine [1]chrysoidine compound with dibutylnaphthalene sulfonic acid; dibutylnaphthalenesulfonic acid, compound with 4-(phenylazo)benzene-1,3-diamine (1:1)  [2]"	286-946-7 [1]304-236-8 [2]	85407-90-5 [1]94247-67-3 [2]	Muta. 2Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1	H341H302H315H318	GHS05GHS08GHS07Dgr	H341H302H315H318				ATP01
611-154-00-9	"trisodium 5-benzamido-4-hydroxy-3-(4-methyl-2-sulfonatophenylazo)naphthalene-2,7-disulfonate"	403-670-6	92408-46-3	Aquatic Chronic 3	H412	-	H412				ATP01
611-155-00-4	"4,4'-oxybis(benzenesulfonylazide)"	431-850-4	7456-68-0	Expl. 1.1 ****STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H201H373 **H400H410	GHS01GHS08GHS09Dgr	H201H373 **H410				ATP01
611-156-00-X	"triammonium 4-[4-[7-(4-carboxylatoanilino)-1-hydroxy-3-sulfonato-2-naphthylazo]-2,5-dimethoxyphenylazo]benzoate"	432-270-4	221354-37-6	Repr. 2STOT RE 2 *Aquatic Chronic 2	H361f ***H373 **H411	GHS08GHS09Wng	H361f ***H373 **H411				ATP01
611-157-00-5	"benzenesulfonic acid, 3,3'-(methylenebis((dihydroxyphenylene)azo))bis-, potassium sodium salt; potassium sodium 3-[(E)-(6-{3,4-dihydroxy-2-[(Z)-(3-sulfonatophenyl)diazenyl]benzyl}-2,3-dihydroxyphenyl)diazenyl]benzenesulfonate"	432-590-4	243869-48-9	Eye Irrit. 2Aquatic Chronic 3	H319H412	GHS07Wng	H319H412				ATP01
611-158-00-0	"reaction product of: 2,3,4,2',3',4'-hexahydroxy-5,5'-diacethyl-diphenylmethane and 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonylchloride and 3-diazo-3,4-dihydro-6-methoxy-4-oxo-1-naphthalenesulfonylchloride"	421-520-8	-	****Aquatic Chronic 4	****H413	****	****H413				ATP01
611-159-00-6	"disodium 4-amino-6-((4-((4-(2,4-diaminophenyl)azo)phenylsulfamoyl)phenyl)azo)-5-hydroxy-3-((4-nitrophenyl)azo)naphthalene-2,7-disulfonate"	421-880-6	-	Eye Dam. 1Aquatic Chronic 3	H318H412	GHS05Dgr	H318H412				ATP01
611-160-00-1	"reaction mass of: 1,1,1-tris(phenyl-4'-(3''-diazo-3'',4''-dihydro-4''-oxo-naphthalene-1''-sulfonato)ethane; 1,1,1-tris(phenyl-4'-(6''-diazo-5'',6''-dihydro-5''-oxo-naphthalene-1''-sulfonato)ethane; reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (2:1); reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (1:2)"	422-760-6	-	****Aquatic Chronic 4	****H413	****	****H413				ATP01
611-161-00-7	"trisodium [1,2'-(2-(8-amino-3,5-disulfonatonaphthalene)azo)-(4'-nitrobenzene)diolato-O,O,N][(Z)-2,2-((phenylcarbamoylprop-1'-enyl)azo)-5-sulfamoylbenzene)diolato-O,O,N]chromate(III)"	423-100-1	-	Eye Dam. 1	H318	GHS05Dgr	H318				ATP01
611-162-00-2	"2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diolbis(methanesulfonate)"	429-600-4	-	Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 2	H302H318H411	GHS05GHS07GHS09Dgr	H302H318H411				ATP01
611-163-00-8	"2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diol sulfate"	429-610-9	-	Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 2	H302H318H411	GHS05GHS07GHS09Dgr	H302H318H411				ATP01
611-164-00-3	"reaction mass of: 2,2’-dimethyl-2,2’-azobutanenitrile; 2-methylpentanenitrile-2-azo-2’-(2’-methylpropanenitrile); 2,2’-dimethyl-2,2’-azoheptanenitrile; 2-methylheptanenitrile-2-azo-2’-(2’-methylpropanenitrile); 2-methylheptanenitrile-2-azo-2’-(2’-methylbutanenitrile)"	429-710-2		Self-react. DAcute Tox. 4 *Aquatic Chronic 2	H242H302H411	GHS02GHS07GHS09Dgr	H242H302H411				ATP01/ATP01corr
611-165-00-9	"reaction mass of: tetrasodium 4-amino-6-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate; tetrasodium 4-amino-6-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate"	431-830-5	-	Aquatic Chronic 3	H412	-	H412				ATP01
611-166-00-4	"reaction mass of: pentasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate; tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; tetrasodium 4-amino-5-hydroxy-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate"	432-100-9	-	Eye Dam. 1Aquatic Chronic 3	H318H412	GHS05Dgr	H318H412				ATP01
611-167-00-X	"sodium bis[tris(2-hydroxyethyl)ammonium][6-anilino-4'-(4,8-disulfonato-2-naphthylazo)-5'-methyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cuprate(II)"	435-240-9	-	Aquatic Chronic 3	H412	-	H412				ATP01
611-168-00-5	"reaction mass of: 3-[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-5-[[4-chloro-6-[[8-hydroxy-3,6-disulfo-7-[(2-sulfophenyl)azo]-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid; 3,5-bis[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid"	435-440-6	-	Eye Dam. 1	H318	GHS05Dgr	H318				ATP01
611-169-00-0	sodium 5-(2-carboxyphenylazo)-6-hydroxynaphthalene-2-sulfonate	435-800-2	-	Aquatic Chronic 3	H412	-	H412				ATP01
611-170-00-6	reaction mass of: trisodium 2-((1-(2-hydroxy-?-O-5-(2-sulfonatoethansulfonyl)phenylazo-?-N2)-1-phenylmethyl)azo-?-N1)-4-sulfonatobenzoate(5-)-?-O)cuprate(II); disodium 2-((1-(5-ethenesulfonyl-2-hydroxy-?-O-phenylazo-?-N2)-1-phenylmethyl)azo-?-N1)-4-sulfonatobenzoate-?-O-(5-))cuprate(II)	435-880-9	-	Aquatic Chronic 3	H412	-	H412				ATP01
611-171-00-1	"reaction mass of: trisodium 3-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate; trisodium 3-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate"	436-890-6	-	Eye Dam. 1Aquatic Chronic 3	H318H412	GHS05Dgr	H318H412				ATP01
611-172-00-7	"reaction mass of: triammonium 6-amino-3-((2,5-diethoxy-4-(3-phosphonophenyl)azo)phenyl)azo-4-hydroxy-2-naphthalenesulfonate; diammonium 3-((4-((7-amino-1-hydroxy-3-sulfo-naphthalen-2-yl)azo)-2,5-diethoxyphenyl)azo)benzoate"	438-310-7	-	Self-react. C ****Repr. 2Acute Tox. 4 *STOT RE 2 *Aquatic Chronic 3	H242H361f ***H302H373 **H412	GHS02GHS08GHS07Dgr	H242H361f ***H302H373 **H412				ATP01
611-173-00-2	"reaction mass of: 3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(2-sulfonatooxyethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, trisodium salt; 3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, disodium salt"	440-510-4	-	Eye Dam. 1Skin Sens. 1	H318H317	GHS05GHS07Dgr	H318H317				ATP01
611-174-00-8	"reaction mass of: 3-[5-(4-ethenesulfonylbutyrylamino)-2-sulfophenylazo]-5-{4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt; 3-[5-(4-(2-chloroethanesulfonyl)butyrylamino)-2-sulfophenylazo]-5-{4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt"	442-290-5	457624-86-1	Eye Dam. 1	H318	GHS05Dgr	H318				ATP01
611-175-00-3	"reaction mass of: trisodium 5-{4-chloro-6-[N-ethyl-(3-(2-sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; trisodium 5-{4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; disodium 5-{4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[(4-vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; tetrasodium 5-{4-chloro-6-[N-ethyl-3-(2-(sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2,7-disulfonate"	444-050-5	-	Eye Dam. 1Aquatic Chronic 3	H318H412	GHS05Dgr	H318H412				ATP01
611-176-00-9	"2,6-bis(2,3,4-trihydroxybenzyl)-p-cresol ester with 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonate"	444-250-2	-	Self-react. C ****Aquatic Chronic 2	H242H411	GHS02GHS09Dgr	H242H411				ATP01
611-177-00-4	"reaction mass of: pentasodium bis[6-anilino-3,5'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III); tetrasodium  [6-anilino-3,5'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato][6-anilino-5'-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III); trisodium bis[6-anilino-5'-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III)"	444-290-0	508202-43-5	Eye Dam. 1Skin Sens. 1Aquatic Chronic 3	H318H317H412	GHS05GHS07Dgr	H318H317H412				ATP01
611-178-00-X	"reaction mass of: pentasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate; tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; tetrasodium 4-amino-5-hydroxy-6-[(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; trisodium 4-amino-5-hydroxy-3-[(2-hydroxyethylsulfonyl)-phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[-2-sulfonato-4-(2-hydroxyethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate"	445-280-9	-	Eye Dam. 1Skin Sens. 1Aquatic Chronic 3	H318H317H412	GHS05GHS07Dgr	H318H317H412				ATP01
611-179-00-5	"reaction mass of: pentasodium 2-[[8-[[4-chloro-6-[[4-(2-sulfonato ethylsulfonyl)]phenyl]amino]-1,3,5-triazin-2-yl]amino-1- hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate; 2-[[8-[[4-chloro-6-[[4-[[2-ethenyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate"	450-010-8	-	Eye Dam. 1Skin Sens. 1	H318H317	GHS05GHS07Dgr	H318H317				ATP01
611-180-00-0	"iron, complexes with diazotised 4-aminobenzenesulfonamide,diazotised 3-aminobenzenesulfonic acid, diazotised 3-amino-4-hydroxybenzenesulfonamide,diazotised 3-amino-4-hydroxy-N-phenylbenzenesulfonamide, diazotised 5-amino-2-(phenylamino)benzenesulfonic acid and resorcinol, sodium salts"	417-850-7	-	Aquatic Chronic 2	H411	GHS09	H411				ATP01
612-001-00-9	mono-methylamine [1]di-methylamine [2]tri-methylamine  [3]	200-820-0 [1]204-697-4 [2]200-875-0 [3]	74-89-5 [1]124-40-3 [2]75-50-3 [3]	Flam. Gas 1Press. GasAcute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Dam. 1	H220H332H335H315H318	GHS02GHS04GHS05GHS07Dgr	H220H332H335H315H318		"*Skin Irrit. 2; H315: C ? 5 %Eye Dam. 1; H318: C ? 5 %Eye Irrit. 2; H319: 0,5 % ? C < 5 %STOT SE 3; H335: C ? 5 %"	5 U	CLP00
612-001-01-6	mono-methylamine ... % [1]di-methylamine ... % [2]tri-methylamine ... %  [3]	200-820-0 [1]204-697-4 [2]200-875-0 [3]	74-89-5 [1]124-40-3 [2]75-50-3 [3]	Flam. Liq. 1Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1B	H224H332H302H314	GHS02GHS05GHS07Dgr	H224H332H302H314		*STOT SE 3; H335: C ? 5 %	B	CLP00
612-002-00-4	ethylamine	200-834-7	75-04-7	Flam. Gas 1Press. GasSTOT SE 3Eye Irrit. 2	H220H335H319	GHS02GHS04GHS07Dgr	H220H319H335			U	CLP00
612-003-00-X	diethylamine	203-716-3	109-89-7	Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1A	H225H332H312H302H314	GHS02GHS05GHS07Dgr	H225H332H312H302H314		STOT SE 3; H335: C ? 1 %		CLP00
612-004-00-5	triethylamine	204-469-4	121-44-8	Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1A	H225H332H312H302H314	GHS02GHS05GHS07Dgr	H225H332H312H302H314		STOT SE 3; H335: C ? 1 %		CLP00
612-005-00-0	butylamine	203-699-2	109-73-9	Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1A	H225H332H312H302H314	GHS02GHS05GHS07Dgr	H225H332H312H302H314		STOT SE 3; H335: C ? 1 %		CLP00
612-006-00-6	"ethylenediamine; 1,2-diaminoethane"	203-468-6	107-15-3	Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1BResp. Sens. 1Skin Sens. 1	H226H312H302H314H334H317	GHS02GHS08GHS05GHS07Dgr	H226H312H302H314H334H317				CLP00
612-007-00-1	2-aminopropane; isopropylamine	200-860-9	75-31-0	Flam. Liq. 1STOT SE 3Skin Irrit. 2Eye Irrit. 2	H224H335H315H319	GHS02GHS07Dgr	H224H319H335H315				CLP00
612-008-00-7	aniline	200-539-3	62-53-3	Carc. 2Muta. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 1Eye Dam. 1Skin Sens. 1Aquatic Acute 1	H351H341H331H311H301H372 **H318H317H400	GHS06GHS08GHS05GHS09Dgr	H351H341H331H311H301H372 **H318H317H400		"*STOT RE 1; H372: C ? 1 %STOT RE 2; H373: 0,2 % ? C < 1 %"		CLP00
612-009-00-2	salts of aniline			Carc. 2Muta. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 1Eye Dam. 1Skin Sens. 1Aquatic Acute 1	H351H341H331H311H301H372 **H318H317H400	GHS06GHS08GHS05GHS09Dgr	H351H341H331H311H301H372 **H318H317H400		"*STOT RE 1; H372: C ? 1 %STOT RE 2; H373: 0,2 % ? C < 1 %"	A	CLP00
612-010-00-8	"chloroanilines, with exception of those specified elsewhere in this Annex"			Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H331H311H301H373 **H400H410	GHS06GHS08GHS09Dgr	H331H311H301H373 **H410			C	CLP00
612-011-00-3	4-nitrosoaniline	211-535-6	659-49-4	Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *	H332H312H302	GHS07Wng	H332H312H302				CLP00
612-012-00-9	o-nitroaniline [1]m-nitroaniline [2]p-nitroaniline  [3]	201-855-4 [1]202-729-1 [2]202-810-1 [3]	88-74-4 [1]99-09-2 [2]100-01-6 [3]	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Chronic 3	H331H311H301H373 **H412	GHS06GHS08Dgr	H331H311H301H373 **H412			C	CLP00
612-013-00-4	3-aminobenzene sulphonic acid; metanilic acid	204-473-6	121-47-1	Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *	H332H312H302	GHS07Wng	H332H312H302				CLP00
612-014-00-X	sulphanilic acid; 4-aminobenzenesulphonic acid	204-482-5	121-57-3	Skin Irrit. 2Eye Irrit. 2Skin Sens. 1	H315H319H317	GHS07Wng	H319H315H317				CLP00
612-015-00-5	N-methylaniline	202-870-9	100-61-8	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H331H311H301H373 **H400H410	GHS06GHS08GHS09Dgr	H331H311H301H373 **H410				CLP00
612-016-00-0	"N,N-dimethylaniline"	204-493-5	121-69-7	Carc. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Aquatic Chronic 2	H351H331H311H301H411	GHS06GHS08GHS09Dgr	H351H331H311H301H411				CLP00
612-017-00-6	"N-methyl-N-2,4,6-tetranitroaniline; tetryl"	207-531-9	479-45-8	Expl. 1.1Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2	H201H331H311H301H373 **	GHS01GHS06GHS08Dgr	H201H331H311H301H373 **				CLP00/ATP01
612-018-00-1	"bis(2,4,6-trinitrophenyl)amine; hexyl"	205-037-8	131-73-7	Expl. 1.1Acute Tox. 1Acute Tox. 2 *Acute Tox. 2 *STOT RE 2Aquatic Chronic 2	H201H310H330H300H373 **H411	GHS01GHS06GHS08GHS09Dgr	H201H330H310H300H373 **H411				CLP00/ATP01
612-019-00-7	"dipicrylamine, ammonium salt"	220-639-0	2844-92-0	Expl. 1.1Acute Tox. 1Acute Tox. 2 *Acute Tox. 2 *STOT RE 2Aquatic Chronic 2	H201H310H330H300H373 **H411	GHS01GHS06GHS08GHS09Dgr	H201H330H310H300H373 **H411				CLP00/ATP01
612-020-00-2	1-naphthylamine	205-138-7	134-32-7	Acute Tox. 4 *Aquatic Chronic 2	H302H411	GHS07GHS09Wng	H302H411				CLP00
612-022-00-3	2-naphthylamine	202-080-4	91-59-8	Carc. 1AAcute Tox. 4 *Aquatic Chronic 2	H350H302H411	GHS08GHS07GHS09Dgr	H350H302H411		"Carc. 1A; H350: C ? 0,01 %"		CLP00
612-023-00-9	phenylhydrazine [1]phenylhydrazinium chloride [2]phenylhydrazine hydrochloride [3]phenylhydrazinium sulphate (2:1)  [4]	202-873-5 [1]200-444-7 [2]248-259-0 [3]257-622-2 [4]	100-63-0 [1]59-88-1 [2]27140-08-5 [3]52033-74-6 [4]	Carc. 1BMuta. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 1Skin Irrit. 2Eye Irrit. 2Skin Sens. 1Aquatic Acute 1	H350H341H331H311H301H372 **H315H319H317H400	GHS06GHS08GHS09Dgr	H350H341H331H311H301H372 **H319H315H317H400				CLP00
612-024-00-4	m-toluidine; 3-aminotoluene	203-583-1	108-44-1	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Acute 1	H331H311H301H373 **H400	GHS06GHS08GHS09Dgr	H331H311H301H373 **H400				CLP00
612-025-00-X	"nitrotoluidines, with the exception of those specified elsewhere in this Annex"			Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Chronic 2	H331H311H301H373 **H411	GHS06GHS08GHS09Dgr	H331H311H301H373 **H411			C	CLP00
612-026-00-5	diphenylamine	204-539-4	122-39-4	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H331H311H301H373 **H400H410	GHS06GHS08GHS09Dgr	H331H311H301H373 **H410				CLP00
612-027-00-0	xylidines with the exception of those specified elsewhere in this Annex; dimethyl anilines with the exception of those specified elsewhere in this Annex			Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Chronic 2	H331H311H301H373 **H411	GHS06GHS08GHS09Dgr	H331H311H301H373 **H411			C	CLP00
612-028-00-6	p-phenylenediamine	203-404-7	106-50-3	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Eye Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H331H311H301H319H317H400H410	GHS06GHS09Dgr	H331H311H301H319H317H410				CLP00
612-029-00-1	"benzene-1,4-diamine dihydrochloride; p-phenylenediamine dihydrochloride"	210-834-9	624-18-0	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Eye Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H331H311H301H319H317H400H410	GHS06GHS09Dgr	H331H311H301H319H317H410				CLP00
612-030-00-7	2-methyl-p-phenylenediamine sulphate  [1]2-methyl-p-phenylenediamine sulphate  [2]	210-431-8 [1]228-871-4 [2]	615-50-9 [1]6369-59-1 [2]	Acute Tox. 3 *Acute Tox. 4 *Acute Tox. 4 *Skin Sens. 1Aquatic Chronic 2	H301H332H312H317H411	GHS06GHS09Dgr	H301H332H312H317H411				CLP00
612-031-00-2	"N,N-dimethylbenzene-1,3-diamine [1]4-amino-N,N-dimethylaniline; 3-amino-N,N'-dimethylaniline  [2]"	220-623-3 [1]202-807-5 [2]	2836-04-6 [1]99-98-9 [2]	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *	H331H311H301	GHS06Dgr	H331H311H301			C	CLP00
612-032-00-8	"N,N,N',N'-tetramethyl-p-phenylenediamine"	202-831-6	100-22-1	Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *	H332H312H302	GHS07Wng	H332H312H302				CLP00
612-033-00-3	2-aminophenol	202-431-1	95-55-6	Muta. 2Acute Tox. 4 *Acute Tox. 4 *	H341H332H302	GHS08GHS07Wng	H341H332H302				CLP00
612-034-00-9	"2-amino-4,6-dinitrophenol; picramic acid"	202-544-6	96-91-3	Expl. 1.1Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Chronic 3	H201H332H312H302H412	GHS01GHS07Dgr	H201H332H312H302H412				CLP00/ATP01
612-034-01-6	"2-amino-4,6-dinitrophenol; picramic acid; [? 20 % water]"	202-544-6	96-91-3	Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Chronic 3	H332H312H302H412	GHS07Wng	H332H312H302H412			G	CLP00
612-035-00-4	2-methoxyaniline; o-anisidine	201-963-1	90-04-0	Carc. 1BMuta. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *	H350H341H331H311H301	GHS06GHS08Dgr	H350H341H331H311H301				CLP00
612-036-00-X	"3,3'-dimethoxybenzidine; o-dianisidine"	204-355-4	119-90-4	Carc. 1BAcute Tox. 4 *	H350H302	GHS08GHS07Dgr	H350H302				CLP00
612-037-00-5	"salts of 3,3'-dimethoxybenzidine; salts of o-dianisidine"			Carc. 1BAcute Tox. 4 *	H350H302	GHS08GHS07Dgr	H350H302			A	CLP00
612-038-00-0	2-nitro-p-anisidine; 4-methoxy-2-nitroaniline	202-547-2	96-96-8	Acute Tox. 1Acute Tox. 2 *Acute Tox. 2 *STOT RE 2 *Aquatic Chronic 3	H310H330H300H373 **H412	GHS06GHS08Dgr	H330H310H300H373 **H412				CLP00
612-039-00-6	2-ethoxyaniline; o-phenetidine	202-356-4	94-70-2	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *	H331H311H301H373 **	GHS06GHS08Dgr	H331H311H301H373 **				CLP00
612-040-00-1	"2,4-dinitroaniline"	202-553-5	97-02-9	Acute Tox. 1Acute Tox. 2 *Acute Tox. 2 *STOT RE 2 *Aquatic Chronic 2	H310H330H300H373 **H411	GHS06GHS08GHS09Dgr	H330H310H300H373 **H411				CLP00
612-041-00-7	"4,4'-bi-o-toluidine"	204-358-0	119-93-7	Carc. 1BAcute Tox. 4 *Aquatic Chronic 2	H350H302H411	GHS08GHS07GHS09Dgr	H350H302H411				CLP00
612-042-00-2	"benzidine; 1,1'-biphenyl-4,4'-diamine; 4,4'-diaminobiphenyl; biphenyl-4,4'-ylenediamine"	202-199-1	92-87-5	Carc. 1AAcute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H350H302H400H410	GHS08GHS07GHS09Dgr	H350H302H410		"Carc. 1A; H350: C ? 0,01 %"		CLP00
612-043-00-8	"N,N'-dimethylbenzidine"		2810-74-4	Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *	H332H312H302	GHS07Wng	H332H312H302				CLP00
612-044-00-3	"N,N'-diacetylbenzidine"	210-338-2	613-35-4	Carc. 1BMuta. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *	H350H341H332H312H302	GHS08GHS07Dgr	H350H341H332H312H302				CLP00/ATP01
612-046-00-4	allylamine	203-463-9	107-11-9	Flam. Liq. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Aquatic Chronic 2	H225H331H311H301H411	GHS02GHS06GHS09Dgr	H225H331H311H301H411				CLP00
612-047-00-X	benzylamine	202-854-1	100-46-9	Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1B	H312H302H314	GHS05GHS07Dgr	H312H302H314				CLP00
612-048-00-5	dipropylamine	205-565-9	142-84-7	Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1A	H225H332H312H302H314	GHS02GHS05GHS07Dgr	H225H332H312H302H314		STOT SE 3; H335: C ? 1 %		CLP00
612-049-00-0	di-n-butylamine [1]di-sec-butylamine  [2]	203-921-8 [1]210-937-9 [2]	111-92-2 [1]626-23-3 [2]	Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *	H226H332H312H302	GHS02GHS07Wng	H226H332H312H302				CLP00
612-050-00-6	cyclohexylamine	203-629-0	108-91-8	Flam. Liq. 3Repr. 2Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1B	H226H361f ***H312H302H314	GHS02GHS05GHS08GHS07Dgr	H226H361f ***H312H302H314				CLP00/ATP01corr
612-051-00-1	"4,4'-diaminodiphenylmethane; 4,4'-methylenedianiline"	202-974-4	101-77-9	Carc. 1BMuta. 2STOT SE 1STOT RE 2 *Skin Sens. 1Aquatic Chronic 2	H350H341H370 **H373 **H317H411	GHS08GHS07GHS09Dgr	H350H341H370 **H373 **H317H411				CLP00
612-052-00-7	(S)-sec-butylamine; (S)-2-aminobutane [1](R)-sec-butylamine; (R)-2-aminobutane [2]sec-butylamine; 2-aminobutane  [3]	208-164-7 [1]236-232-6 [2]237-732-7 [3]	513-49-5 [1]13250-12-9 [2]13952-84-6 [3]	Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1AAquatic Acute 1	H225H332H302H314H400	GHS02GHS05GHS07GHS09Dgr	H225H332H302H314H400			C	CLP00
612-053-00-2	N-ethylaniline	203-135-5	103-69-5	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *	H331H311H301H373 **	GHS06GHS08Dgr	H331H311H301H373 **				CLP00
612-054-00-8	"N,N-diethylaniline"	202-088-8	91-66-7	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Chronic 2	H331H311H301H373 **H411	GHS06GHS08GHS09Dgr	H331H311H301H373 **H411		*		CLP00
612-055-00-3	N-methyl-o-toluidine [1]N-methyl-m-toluidine [2]N-methyl-p-toluidine  [3]	210-260-9 [1]211-795-0 [2]210-769-6 [3]	611-21-2 [1]696-44-6 [2]623-08-5 [3]	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Chronic 3	H331H311H301H373 **H412	GHS06GHS08Dgr	H331H311H301H373 **H412			C	CLP00
612-056-00-9	"N,N-dimethyl-p-toluidine [1]N,N-dimethyl-m-toluidine [2]N,N-dimethyl-o-toluidine  [3]"	202-805-4 [1]204-495-6 [2]210-199-8 [3]	99-97-8 [1]121-72-2 [2]609-72-3 [3]	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Chronic 3	H331H311H301H373 **H412	GHS06GHS08Dgr	H331H311H301H373 **H412		*	C	CLP00
612-057-00-4	piperazine; [solid]	203-808-3	110-85-0	Repr. 2Skin Corr. 1BResp. Sens. 1Skin Sens. 1	H361fdH314H334H317	GHS05GHS08Dgr	H361fdH314H334H317				CLP00/ATP01
612-057-01-1	piperazine; [liquid]	203-808-3	110-85-0	Repr. 2Skin Corr. 1BResp. Sens. 1Skin Sens. 1	H361fdH314H334H317	GHS05GHS08Dgr	H361fdH314H334H317				ATP01
612-058-00-X	"2,2'-iminodiethylamine; diethylenetriamine"	203-865-4	111-40-0	Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1	H312H302H314H317	GHS05GHS07Dgr	H312H302H314H317				CLP00
612-059-00-5	"3,6-diazaoctanethylenediamin; triethylenetetramine"	203-950-6	112-24-3	Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Chronic 3	H312H314H317H412	GHS05GHS07Dgr	H312H314H317H412				CLP00
612-060-00-0	"3,6,9-triazaundecamethylenediamine; tetraethylenepentamine"	203-986-2	112-57-2	Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Chronic 2	H312H302H314H317H411	GHS05GHS07GHS09Dgr	H312H302H314H317H411				CLP00
612-061-00-6	"3-aminopropyldimethylamine; N,N-dimethyl-1,3-diaminopropane"	203-680-9	109-55-7	Flam. Liq. 3Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1	H226H302H314H317	GHS02GHS05GHS07Dgr	H226H302H314H317				CLP00
612-062-00-1	"3-aminopropyldiethylamine; N,N-diethyl-1,3-diaminopropane"	203-236-4	104-78-9	Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1	H226H312H302H314H317	GHS02GHS05GHS07Dgr	H226H312H302H314H317				CLP00
612-063-00-7	"3,3'-iminodi(propylamine); dipropylenetriamine"	200-261-2	56-18-8	Acute Tox. 2 *Acute Tox. 3 *Acute Tox. 4 *Skin Corr. 1ASkin Sens. 1	H330H311H302H314H317	GHS06GHS05Dgr	H330H311H302H314H317				CLP00
612-064-00-2	"3,6,9,12-tetra-azatetradecamethylenediamine; pentacthylenehexamine"	223-775-9	4067-16-7	Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H314H317H400H410	GHS05GHS07GHS09Dgr	H314H317H410				CLP00
612-065-00-8	polyethlyenepolyamines with the exception of those specified elsewhere in this Annex			Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H312H302H314H317H400H410	GHS05GHS07GHS09Dgr	H312H302H314H317H410				CLP00
612-066-00-3	dicyclohexylamine	202-980-7	101-83-7	Acute Tox. 4 *Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1	H302H314H400H410	GHS05GHS07GHS09Dgr	H302H314H410				CLP00
612-067-00-9	"3-aminomethyl-3,5,5-trimethylcyclohexylamine"	220-666-8	2855-13-2	Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Chronic 3	H312H302H314H317H412	GHS05GHS07Dgr	H312H302H314H317H412				CLP00
612-068-00-4	"3,3'-dichlorobenzidine; 3,3'-dichlorobiphenyl-4,4'-ylenediamine"	202-109-0	91-94-1	Carc. 1BAcute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350H312H317H400H410	GHS08GHS07GHS09Dgr	H350H312H317H410				CLP00
612-069-00-X	"salts of 3,3'-dichlorobenzidine; salts of 3,3'-dichlorobiphenyl-4,4'-ylenediamine"			Carc. 1BAcute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350H312H317H400H410	GHS08GHS07GHS09Dgr	H350H312H317H410			A	CLP00
612-070-00-5	salts of benzidine [ [1]salts of benzidine [ [2]salts of benzidine [ [3]salts of benzidine [ [4]	208-519-6 [1]208-520-1 [2]244-236-4 [3]252-984-8 [4]	531-85-1 [1]531-86-2 [2]21136-70-9 [3]36341-27-2 [4]	Carc. 1AAcute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H350H302H400H410	GHS08GHS07GHS09Dgr	H350H302H410			A	CLP00
612-071-00-0	salts of 2-naphthylamine [1]salts of 2-naphthylamine [2]	209-030-0 [1]210-313-6 [2]	553-00-4 [1]612-52-2 [2]	Carc. 1AAcute Tox. 4 *Aquatic Chronic 2	H350H302H411	GHS08GHS07GHS09Dgr	H350H302H411			A	CLP00
612-072-00-6	biphenyl-4-ylamine; xenylamine; 4-aminobiphenyl	202-177-1	92-67-1	Carc. 1AAcute Tox. 4 *	H350H302	GHS08GHS07Dgr	H350H302				CLP00
612-073-00-1	salts of biphenyl-4-ylamine; salts of xenylamine; salts of 4-aminobiphenyl			Carc. 1AAcute Tox. 4 *	H350H302	GHS08GHS07Dgr	H350H302			A	CLP00
612-074-00-7	benzyldimethylamine	203-149-1	103-83-3	Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1BAquatic Chronic 3	H226H332H312H302H314H412	GHS02GHS05GHS07Dgr	H226H332H312H302H314H412				CLP00
612-075-00-2	2-aminoethyldimethylamine; 2-dimethylaminoethylamine	203-541-2	108-00-9	Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1A	H225H312H302H314	GHS02GHS05GHS07Dgr	H225H312H302H314				CLP00
612-076-00-8	ethyldimethylamine	209-940-8	598-56-1	Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1B	H225H332H302H314	GHS02GHS05GHS07Dgr	H225H332H302H314				CLP00/ATP01
612-077-00-3	dimethylnitrosoamine; N-nitrosodimethylamine	200-549-8	62-75-9	Carc. 1BAcute Tox. 2 *Acute Tox. 3 *STOT RE 1Aquatic Chronic 2	H350H330H301H372 **H411	GHS06GHS08GHS09Dgr	H350H330H301H372 **H411		"Carc. 1B; H350: C ? 0,001 %"		CLP00
612-078-00-9	"2,2'-dichloro-4,4'-methylenedianiline; 4,4'-methylene bis(2-chloroaniline)"	202-918-9	101-14-4	Carc. 1BAcute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H350H302H400H410	GHS08GHS07GHS09Dgr	H350H302H410				CLP00
612-079-00-4	"salts of 2,2'-dichloro-4,4'-methylenedianiline; salts of 4,4'-methylenebis(2-chloroaniline)"			Carc. 1BAcute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H350H302H400H410	GHS08GHS07GHS09Dgr	H350H302H410			A	CLP00
612-080-00-X	"4-amino-N,N-diethylaniline; N,N-diethyl-p-phenylendiamine"	202-214-1	93-05-0	Acute Tox. 3 *Skin Corr. 1B	H301H314	GHS06GHS05Dgr	H301H314				CLP00
612-081-00-5	"salts of 4,4'-bi-o-toluidine; salts of 3,3'-dimethylbenzidine; salts of o-tolidine [1]salts of 4,4'-bi-o-toluidine; salts of 3,3'-dimethylbenzidine; salts of o-tolidine [2]salts of 4,4'-bi-o-toluidine; salts of 3,3'-dimethylbenzidine; salts of o-tolidine [3]"	210-322-5 [1]265-294-7 [2]277-985-0 [3]	612-82-8 [1]64969-36-4 [2]74753-18-7 [3]	Carc. 1BAcute Tox. 4 *Aquatic Chronic 2	H350H302H411	GHS08GHS07GHS09Dgr	H350H302H411			A	CLP00
612-082-00-0	thiourea; thiocarbamide	200-543-5	62-56-6	Carc. 2Repr. 2Acute Tox. 4 *Aquatic Chronic 2	H351H361d ***H302H411	GHS08GHS07GHS09Wng	H351H361d ***H302H411				CLP00
612-083-00-6	1-methyl-3-nitro-1-nitrosoguanidine	200-730-1	70-25-7	Carc. 1BAcute Tox. 4 *Skin Irrit. 2Eye Irrit. 2Aquatic Chronic 2	H350H332H315H319H411	GHS08GHS07GHS09Dgr	H350H332H319H315H411		"Carc. 1B; H350: C ? 0,01 %"		CLP00/ATP01
612-084-00-1	"dapsone; 4,4'-diamino diphenyl sulfone"	201-248-4	80-08-0	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
612-085-00-7	"4,4'-methylenedi-o-toluidine"	212-658-8	838-88-0	Carc. 1BAcute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350H302H317H400H410	GHS08GHS07GHS09Dgr	H350H302H317H410				CLP00
612-086-00-2	"amitraz (ISO); N,N-bis(2,4-xylyliminomethyl) methylamine"	251-375-4	33089-61-1	Acute Tox. 4 *STOT RE 2 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H373 **H317H400H410	GHS08GHS07GHS09Wng	H302H373 **H317H410		M=10		CLP00
612-087-00-8	guazatine (ISO)		108173-90-6	Acute Tox. 2 *Acute Tox. 4 *Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H330H312H302H335H315H318H400H410	GHS06GHS05GHS09Dgr	H330H312H302H335H315H318H410				CLP00
612-088-00-3	"simazine (ISO); 6-chloro-N,N'-diethyl-1,3,5-triazine-2,4-diamine"	204-535-2	122-34-9	Carc. 2Aquatic Acute 1Aquatic Chronic 1	H351H400H410	GHS08GHS09Wng	H351H410				CLP00
612-089-00-9	"1,5-naphthylenediamine"	218-817-8	2243-62-1	Carc. 2Aquatic Acute 1Aquatic Chronic 1	H351H400H410	GHS08GHS09Wng	H351H410				CLP00
612-090-00-4	"2,2'-(nitrosoimino)bisethanol"	214-237-4	1116-54-7	Carc. 1B	H350	GHS08Dgr	H350				CLP00
612-091-00-X	o-toluidine; 2-aminotoluene	202-429-0	95-53-4	Carc. 1BAcute Tox. 3 *Acute Tox. 3 *Eye Irrit. 2Aquatic Acute 1	H350H331H301H319H400	GHS06GHS08GHS09Dgr	H350H331H301H319H400				CLP00
612-092-00-5	"N,N'-(2,2-dimethylpropylidene)hexamethylenediamine"	401-660-6	1000-78-8	Skin Irrit. 2Skin Sens. 1	H315H317	GHS07Wng	H315H317				CLP00
612-093-00-0	"3,5-dichloro-4-(1,1,2,2-tetrafluoroethoxy)aniline"	401-790-3	104147-32-2	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410				CLP00
612-094-00-6	4-(2-chloro-4-trifluoromethyl)phenoxy-2-fluoroaniline hydrochloride	402-190-4	113674-95-6	Acute Tox. 4 *STOT RE 1STOT RE 2 *Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H372 **H373 **H318H317H400H410	GHS05GHS08GHS07GHS09Dgr	H372 **H302H373 **H318H317H410				CLP00/ATP01
612-095-00-1	benzyl-2-hydroxydodecyldimethylammonium benzoate	402-610-6	113694-52-3	Acute Tox. 4 *Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1	H302H314H400H410	GHS05GHS07GHS09Dgr	H314H302H410				CLP00
612-096-00-7	"4,4'-carbonimidoylbis[N,N-dimethylaniline]"	207-762-5	492-80-8	Carc. 2Acute Tox. 4 *Eye Irrit. 2Aquatic Chronic 2	H351H302H319H411	GHS08GHS07GHS09Wng	H351H302H319H411				CLP00
612-097-00-2	"salts of 4,4'-carbonimidoylbis[N,N-dimethylaniline]"			Carc. 2Acute Tox. 4 *Eye Irrit. 2Aquatic Chronic 2	H351H302H319H411	GHS08GHS07GHS09Wng	H351H302H319H411			A	CLP00
612-098-00-8	nitrosodipropylamine	210-698-0	621-64-7	Carc. 1BAcute Tox. 4 *Aquatic Chronic 2	H350H302H411	GHS08GHS07GHS09Dgr	H350H302H411		"Carc. 1B; H350: C ? 0,001 %"		CLP00/ATP01
612-099-00-3	"4-methyl-m-phenylenediamine; 2,4-toluenediamine"	202-453-1	95-80-7	Carc. 1BMuta. 2Repr. 2Acute Tox. 3 *Acute Tox. 4 *STOT RE 2 *Skin Sens. 1Aquatic Chronic 2	H350H341H361f ***H301H312H373 **H317H411	GHS06GHS08GHS09Dgr	H350H341H361f ***H301H312H373 **H317H411				CLP00/ATP01
612-100-00-7	propylenediamine	201-155-9	78-90-0	Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1A	H226H312H302H314	GHS02GHS05GHS07Dgr	H226H312H302H314				CLP00
612-101-00-2	methenamine; hexamethylenetetramine	202-905-8	100-97-0	Flam. Sol. 2Skin Sens. 1	H228H317	GHS02GHS07Wng	H228H317				CLP00/ATP01
612-102-00-8	"N,N-bis(3-aminopropyl)methylamine"	203-336-8	105-83-9	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 4 *Skin Corr. 1B	H331H311H302H314	GHS06GHS05Dgr	H331H311H302H314				CLP00
612-103-00-3	"N,N,N',N'-tetramethylethylenediamine"	203-744-6	110-18-9	Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1B	H225H332H302H314	GHS02GHS05GHS07Dgr	H225H332H302H314				CLP00
612-104-00-9	hexamethylenediamine	204-679-6	124-09-4	Acute Tox. 4 *Acute Tox. 4 *STOT SE 3Skin Corr. 1B	H312H302H335H314	GHS05GHS07Dgr	H312H302H335H314				CLP00
612-105-00-4	2-piperazin-1-ylethylamine	205-411-0	140-31-8	Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Chronic 3	H312H302H314H317H412	GHS05GHS07Dgr	H312H302H314H317H412				CLP00
612-106-00-X	"2,6-diethylaniline"	209-445-7	579-66-8	Acute Tox. 4 *	H302		H302				CLP00
612-107-00-5	1-phenylethylamine [1]Dl-?-methylbenzylamine  [2]	202-706-6 [1]210-545-8 [2]	98-84-0 [1]618-36-0 [2]	Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1B	H312H302H314	GHS05GHS07Dgr	H312H302H314				CLP00
612-108-00-0	3-aminopropyltriethoxysilane	213-048-4	919-30-2	Acute Tox. 4 *Skin Corr. 1B	H302H314	GHS05GHS07Dgr	H302H314				CLP00
612-109-00-6	bis(2-dimethylaminoethyl)(methyl)amine	221-201-1	3030-47-5	Acute Tox. 3 *Acute Tox. 4 *Skin Corr. 1B	H311H302H314	GHS06GHS05Dgr	H311H302H314				CLP00
612-110-00-1	"2,2'-dimethyl-4,4'-methylenebis(cyclohexylamine)"	229-962-1	6864-37-5	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 4 *Skin Corr. 1AAquatic Chronic 2	H331H311H302H314H411	GHS06GHS05GHS09Dgr	H331H311H302H314H411				CLP00
612-111-00-7	"2-methyl-m-phenylenediamine; 2,6-toluenediamine"	212-513-9	823-40-5	Muta. 2Acute Tox. 4 *Acute Tox. 4 *Skin Sens. 1Aquatic Chronic 2	H341H312H302H317H411	GHS08GHS07GHS09Wng	H341H312H302H317H411				CLP00
612-112-00-2	p-anisidine; 4-methoxyaniline	203-254-2	104-94-9	Acute Tox. 1Acute Tox. 2 *Acute Tox. 2 *STOT RE 2 *Aquatic Acute 1	H310H330H300H373 **H400	GHS06GHS08GHS09Dgr	H330H310H300H373 **H400				CLP00
612-113-00-8	"6-methyl-2,4-bis(methylthio)phenylene-1,3-diamine"	403-240-8	106264-79-3	Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H317H400H410	GHS07GHS09Wng	H302H317H410				CLP00
612-114-00-3	"R,R-2-hydroxy-5-(1-hydroxy-2-(4-phenylbut-2-ylamino)ethyl)benzamide hydrogen 2,3-bis(benzoyloxy)succinate"	404-390-7		Flam. Sol. 1Skin Sens. 1Aquatic Chronic 3	H228H317H412	GHS02GHS07Wng	H228H317H412				CLP00
612-115-00-9	dimethyldioctadecylammonium hydrogen sulfate	404-050-8	123312-54-9	Eye Irrit. 2Aquatic Chronic 4	H319H413	GHS07Wng	H319H413				CLP00
612-116-00-4	C8-18alkylbis(2-hydroxyethyl)ammonium bis(2-ethylhexyl)phosphate	404-690-8	68132-19-4	Acute Tox. 3 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H331H314H317H400H410	GHS06GHS05GHS09Dgr	H331H314H317H410				CLP00
612-117-00-X	"C12-14-tert-alkylamine, methylphosphonic acid salt"	404-750-3	119415-07-5	Acute Tox. 4 *Skin Corr. 1BAquatic Chronic 2	H302H314H411	GHS05GHS07GHS09Dgr	H302H314H411				CLP00
612-118-00-5	"A reaction mass of: (1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium 4-toluenesulfonate; (1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium bromide"	405-080-4		Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H318H400H410	GHS05GHS09Dgr	H318H410				CLP00
612-119-00-0	benzyldimethyloctadecylammonium 3-nitrobenzenesulfonate	405-330-2		Skin Irrit. 2Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H315H318H400H410	GHS05GHS09Dgr	H315H318H410				CLP00
612-120-00-6	aclonifen (ISO); 2-chloro-6-nitro-3-phenoxyaniline	277-704-1	74070-46-5	Carc. 2Skin Sens. 1AAquatic Acute 1Aquatic Chronic 1	H351H317H400H410	GHS08GHS07GHS09Wng	H317H351H410		M=100M=10		CLP00/ATP05
612-121-00-1	"amines, polyethylenepoly-; HEPA"	268-626-9	68131-73-7	Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H312H302H314H317H400H410	GHS05GHS07GHS09Dgr	H312H302H314H317H410				CLP00
612-122-00-7	hydroxylamine  ....% [> 55 % in aqueous solution]	232-259-2	7803-49-8	Unst. Expl.Met. Corr. 1Carc. 2Acute Tox. 4 *Acute Tox. 4 *STOT SE 3STOT RE 2 *Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Acute 1	H200H290H351H312H302H335H373 **H315H318H317H400	GHS01GHS05GHS08GHS07GHS09Dgr	H200H290H351H312H302H373 **H335H315H318H317H400			B	CLP00/ATP01
612-122-01-4	hydroxylamine ...% [? 55% in aqueous solution]	232-259-2	7803-49-8	Met. Corr. 1Carc. 2Acute Tox. 4 *Acute Tox. 4 *STOT SE 3STOT RE 2 *Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Acute 1	H290H351H312H302H335H373 **H315H318H317H400	GHS05GHS08GHS07GHS09Dgr	H290H351H312H302H373 **H335H315H318H317H400			B	ATP01
612-123-00-2	hydroxylammonium chloride; hydroxylamine hydrochloride [1]bis(hydroxylammonium) sulfate; hydroxylamine sulfate (2:1)  [2]	226-798-2 [1]233-118-8 [2]	5470-11-1 [1]10039-54-0 [2]	Met. Corr. 1Carc. 2Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Skin Irrit. 2Eye Irrit. 2Skin Sens. 1Aquatic Acute 1	H290H351H312H302H373 **H315H319H317H400	GHS05GHS08GHS07GHS09Wng	H290H351H312H302H373 **H319H315H317H400				CLP00/ATP01
612-124-00-8	"N,N,N-trimethylanilinium chloride"	205-319-0	138-24-9	Acute Tox. 3 *Acute Tox. 3 *	H311H301	GHS06Dgr	H311H301				CLP00
612-125-00-3	"2-methyl-p-phenylenediamine; 2,5-toluenediamine"	202-442-1	95-70-5	Acute Tox. 3 *Acute Tox. 4 *Acute Tox. 4 *Skin Sens. 1Aquatic Chronic 2	H301H332H312H317H411	GHS06GHS09Dgr	H301H332H312H317H411				CLP00
612-126-00-9	"toluene-2,4-diammonium sulphate; 4-methyl-m-phenylenediamine sulfate"	265-697-8	65321-67-7	Carc. 1BAcute Tox. 3 *Acute Tox. 4 *Eye Irrit. 2Skin Sens. 1Aquatic Chronic 2	H350H301H312H319H317H411	GHS06GHS08GHS09Dgr	H350H301H312H319H317H411				CLP00
612-127-00-4	3-aminophenol	209-711-2	591-27-5	Acute Tox. 4 *Acute Tox. 4 *Aquatic Chronic 2	H332H302H411	GHS07GHS09Wng	H332H302H411				CLP00
612-128-00-X	4-aminophenol	204-616-2	123-30-8	Muta. 2Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H341H332H302H400H410	GHS08GHS07GHS09Wng	H341H332H302H410				CLP00
612-129-00-5	diisopropylamine	203-558-5	108-18-9	Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1B	H225H332H302H314	GHS02GHS05GHS07Dgr	H225H332H302H314		STOT SE 3; H335: C ? 5 %		CLP00
612-130-00-0	"2,6-diamino-3,5-diethyltoluene; 4,6-diethyl-2-methyl-1,3-benzenediamine [1]2,4-diamino-3,5-diethyltoluene; 2,4-diethyl-6-methyl-1,3-benzenediamine [2]diethylmethylbenzenediamine  [3]"	218-255-3 [1]218-256-9 [2]270-877-4 [3]	2095-01-4 [1]2095-02-5 [2]68479-98-1 [3]	Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H312H302H373 **H319H400H410	GHS08GHS07GHS09Wng	H312H302H373 **H319H410			C	CLP00
612-131-00-6	didecyldimethylammonium chloride	230-525-2	7173-51-5	Acute Tox. 4 *Skin Corr. 1B	H302H314	GHS05GHS07Dgr	H302H314				CLP00
612-132-00-1	"N,N'-diphenyl-p-phenylenediamine; N,N'-diphenyl-1,4-benzenediamine"	200-806-4	74-31-7	Skin Sens. 1Aquatic Chronic 3	H317H412	GHS07Wng	H317H412				CLP00
612-133-00-7	(4-ammonio-m-tolyl)ethyl(2-hydroxyethyl)ammonium sulphate; 4-(N-ethyl-N-2-hydroxyethyl)-2-methylphenylenediamine sulphate	247-162-0	25646-77-9	Acute Tox. 3 *STOT RE 2 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H301H373 **H317H400H410	GHS06GHS08GHS09Dgr	H301H373 **H317H410				CLP00
612-134-00-2	N-(2-(4-amino-N-ethyl-m-toluidino)ethyl)methanesulphonamide sesquisulphate; 4-(N-ethyl-N-2-methanesulphonylaminoethyl)-2-methylphenylenediamine sesquisulphate monohydrate	247-161-5	25646-71-3	Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H317H400H410	GHS07GHS09Wng	H302H317H410				CLP00
612-135-00-8	N-2-naphthylaniline; N-phenyl-2-naphthylamine	205-223-9	135-88-6	Carc. 2Skin Irrit. 2Eye Irrit. 2Skin Sens. 1Aquatic Chronic 2	H351H315H319H317H411	GHS08GHS07GHS09Wng	H351H319H315H317H411				CLP00
612-136-00-3	N-isopropyl-N'-phenyl-p-phenylenediamine	202-969-7	101-72-4	Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H317H400H410	GHS07GHS09Wng	H302H317H410		"Skin Sens. 1; H317: C ? 0,1 %"		CLP00
612-137-00-9	4-chloroaniline	203-401-0	106-47-8	Carc. 1BAcute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350H331H311H301H317H400H410	GHS06GHS08GHS09Dgr	H350H331H311H301H317H410				CLP00
612-138-00-4	"furalaxyl (ISO); methyl N-(2,6-dimethylphenyl)-N-(2-furylcarbonyl)-Dl-alaninate"	260-875-1	57646-30-7	Acute Tox. 4 *Aquatic Chronic 3	H302H412	GHS07Wng	H302H412				CLP00
612-139-00-X	mefenacet (ISO); 2-(benzothiazol-2-yloxy)-N-methyl-N-phenylacetamide	277-328-8	73250-68-7	Aquatic Chronic 2	H411	GHS09	H411				CLP00
612-140-00-5	"quaternary ammonium compounds, benzyl-C8-18-alkyldimethyl, chlorides"	264-151-6	63449-41-2	Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1BAquatic Acute 1	H312H302H314H400	GHS05GHS07GHS09Dgr	H312H302H314H400				CLP00
612-141-00-0	"4,4'-methylenebis(2-ethylaniline); 4,4'-methylenebis(2-ethylbenzeneamine)"	243-420-1	19900-65-3	Carc. 2Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H351H302H400H410	GHS08GHS07GHS09Wng	H351H302H410				CLP00
612-142-00-6	biphenyl-2-ylamine	201-990-9	90-41-5	Carc. 2Acute Tox. 4 *Aquatic Chronic 3	H351H302H412	GHS08GHS07Wng	H351H302H412				CLP00
612-143-00-1	"N5,N5-diethyltoluene-2,5-diamine monohydrochloride; 4-diethylamino-2-methylaniline monohydrochloride"	218-130-3	2051-79-8	Acute Tox. 3 *Eye Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H301H319H317H400H410	GHS06GHS09Dgr	H301H319H317H410				CLP00
612-144-00-7	"flumetralin (ISO); N-(2-chloro-6-fluorobenzyl)-N-ethyl-?,?,?-trifluoro-2,6-dinitro-p-toluidine"		62924-70-3	Skin Irrit. 2Eye Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H315H319H317H400H410	GHS07GHS09Wng	H319H315H317H410				CLP00
612-145-00-2	o-phenylenediamine	202-430-6	95-54-5	Carc. 2Muta. 2Acute Tox. 3 *Acute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H351H341H301H332H312H319H317H400H410	GHS06GHS08GHS09Dgr	H351H341H301H332H312H319H317H410				CLP00
612-146-00-8	o-phenylenediamine dihydrochloride	210-418-7	615-28-1	Carc. 2Muta. 2Acute Tox. 3 *Acute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H351H341H301H332H312H319H317H400H410	GHS06GHS08GHS09Dgr	H351H341H301H332H312H319H317H410				CLP00
612-147-00-3	m-phenylenediamine	203-584-7	108-45-2	Muta. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Eye Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H341H331H311H301H319H317H400H410	GHS06GHS08GHS09Dgr	H341H331H311H301H319H317H410				CLP00
612-148-00-9	m-phenylenediamine dihydrochloride	208-790-0	541-69-5	Muta. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Eye Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H341H331H311H301H319H317H400H410	GHS06GHS08GHS09Dgr	H341H331H311H301H319H317H410				CLP00
612-149-00-4	"1,3-diphenylguanidine"	203-002-1	102-06-7	Repr. 2Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Irrit. 2Aquatic Chronic 2	H361f ***H302H335H315H319H411	GHS08GHS07GHS09Wng	H361f ***H302H319H335H315H411				CLP00
612-150-00-X	"spiroxamine (ISO); 8-tert-butyl-1,4-dioxaspiro[4.5]decan-2-ylmethyl(ethyl)(propyl)amine"		118134-30-8	Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H332H312H302H315H317H400H410	GHS07GHS09Wng	H332H312H302H315H317H410				CLP00
612-151-00-5	methyl-phenylene diamine; diaminotoluene; [technical product – reaction mass of 4-methyl-m-phenylene diamine (EC No 202-453-1) and 2-methyl-m-phenylene diamine (EC No 212-513-9)]	-	-	Carc. 1BMuta. 2Repr. 2Acute Tox. 3 *Acute Tox. 4 *STOT RE 2 *Eye Irrit. 2Skin Sens. 1Aquatic Chronic 2	H350H341H361f ***H301H312H373 **H319H317H411	GHS06GHS08GHS09Dgr	H350H341H361f ***H301H312H373 **H319H317H411				CLP00/ATP01
612-152-00-0	"N,N-diethyl-N',N'-dimethylpropan-1,3-diyl-diamine"	406-610-7	62478-82-4	Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Skin Corr. 1AAquatic Chronic 3	H226H332H302H373 **H314H412	GHS02GHS08GHS05GHS07Dgr	H226H332H302H373 **H314H412				CLP00
612-153-00-6	"4-[N-ethyl-N-(2-hydroxyethyl)amino]-1-(2-hydroxyethyl)amino-2-nitrobenzene, monohydrochloride"	407-020-2	132885-85-9	Acute Tox. 4 *Skin Sens. 1Aquatic Chronic 3	H302H317H412	GHS07Wng	H302H317H412				CLP00
612-154-00-1	"6'-(isobutylethylamino)-3'-methyl-2'-phenylamino-spiro[isobenzo-2-oxofuran-7,9'-[9H]-xanthene]"	410-890-6	95235-29-3	Aquatic Chronic 4	H413		H413				CLP00
612-155-00-7	2'-anilino-6'-((3-ethoxypropyl)ethylamino)-3'-methylspiro(isobenzo-3-oxofuran)-1-(1H)-9'-xanthene	411-730-8	93071-94-4	Aquatic Chronic 4	H413		H413				CLP00
612-156-00-2	reaction mass of: trihexadecylmethylammonium chloride; dihexadecyldimethylammonium chloride	405-620-9		Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H318H400H410	GHS05GHS09Dgr	H318H410				CLP00
612-157-00-8	(Z)-1-benzo[b]thien-2-ylethanone oxime hydrochloride	410-780-8		Acute Tox. 4 *STOT RE 2 *Eye Dam. 1Skin Sens. 1Aquatic Chronic 2	H302H373 **H318H317H411	GHS08GHS05GHS07GHS09Dgr	H302H373 **H318H317H411				CLP00
612-158-00-3	reaction mass of: bis(5-dodecyl-2-hydroxybenzald-oximate) copper (II) C12-alkyl group is branched; 4-dodecylsalicylaldoxime	410-820-4		Aquatic Chronic 4	H413		H413				CLP00
612-159-00-9	"Reaction products of: trimethylhexamethylene diamine (a mixture of 2,2,4-trimethyl-1,6-hexanediamine and 2,4,4-trimethyl-1,6-hexanediamine, EINECS listed), Epoxide 8 (mono[(C10-C16-alkyloxy)methyl]oxirane derivatives) and p-toluene-sulfonic acid"	410-880-1		Acute Tox. 4 *Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1	H302H314H400H410	GHS05GHS07GHS09Dgr	H302H314H410				CLP00
612-160-00-4	p-toluidine; 4-aminotoluene [1]toluidinium chloride [2]toluidine sulphate (1:1)  [3]	203-403-1 [1]208-740-8 [2]208-741-3 [3]	106-49-0 [1]540-23-8 [2]540-25-0 [3]	Carc. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Eye Irrit. 2Skin Sens. 1Aquatic Acute 1	H351H331H311H301H319H317H400	GHS06GHS08GHS09Dgr	H351H331H311H301H319H317H400				CLP00
612-161-00-X	"2,6-xylidine; 2,6-dimethylaniline"	201-758-7	87-62-7	Carc. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *STOT SE 3Skin Irrit. 2Aquatic Chronic 2	H351H332H312H302H335H315H411	GHS08GHS07GHS09Wng	H351H332H312H302H335H315H411				CLP00
612-162-00-5	dimethyldioctadecylammonium chloride; DODMAC	203-508-2	107-64-2	Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H318H400H410	GHS05GHS09Dgr	H318H410				CLP00
612-163-00-0	"metalaxyl-M (ISO); mefenoxam; (R)-2-[(2,6-dimethylphenyl)-methoxyacetylamino]propionic acid methyl ester"		70630-17-0	Acute Tox. 4 *Eye Dam. 1	H302H318	GHS05GHS07Dgr	H302H318				CLP00
612-164-00-6	"2-butyl-2-ethyl-1,5-diaminopentane"	412-700-7	137605-95-9	Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Skin Corr. 1BSkin Sens. 1Aquatic Chronic 3	H312H302H373 **H314H317H412	GHS08GHS05GHS07Dgr	H312H302H373 **H314H317H412				CLP00
612-165-00-1	"N,N'-diphenyl-N,N'-bis(3-methylphenyl)-(1,1'-diphenyl)-4,4'-diamine"	413-810-8	65181-78-4	Aquatic Chronic 2	H411	GHS09	H411				CLP00
612-166-00-7	"reaction mass of: cis-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1); trans-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1)"	411-830-1	114765-88-7	Eye Dam. 1Skin Sens. 1Aquatic Chronic 3	H318H317H412	GHS05GHS07Dgr	H318H317H412				CLP00
612-167-00-2	"5-acetyl-3-amino-10,11-dihydro-5H-dibenz[b,f]azepine-hydrochloride"	410-490-1		Acute Tox. 4 *STOT RE 2 *Eye Dam. 1Skin Sens. 1Aquatic Chronic 2	H302H373 **H318H317H411	GHS08GHS05GHS07GHS09Dgr	H302H373 **H318H317H411				CLP00
612-168-00-8	"3,5-dichloro-2,6-difluoropyrdine-4-amine"	220-630-1	2840-00-8	Acute Tox. 4 *Acute Tox. 4 *Aquatic Chronic 2	H312H302H411	GHS07GHS09Wng	H312H302H411				CLP00
612-169-00-3	bis(N-methyl-N-phenylhydrazine)sulfate	423-170-1	618-26-8	Flam. Liq. 2Acute Tox. 4 *STOT RE 1Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H225H302H372 **H318H317H400H410	GHS02GHS05GHS08GHS07GHS09Dgr	H225H372 **H302H318H317H410				ATP01
612-170-00-9	4-chlorophenyl cyclopropyl ketone O-(4-aminobenzyl)oxime	405-260-2		Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H317H400H410	GHS07GHS09Wng	H302H317H410				CLP00
612-171-00-4	"N,N,N',N'-tetraglycidyl-4,4'-diamino-3,3'-diethyldiphenylmethane"	410-060-3	130728-76-6	Muta. 2Skin Sens. 1Aquatic Chronic 2	H341H317H411	GHS08GHS09Wng	H341H317H411				CLP00
612-172-00-X	"4,4'-methylenebis(N,N'-dimethylcyclohexanamine"	412-840-9	13474-64-1	Acute Tox. 4 *STOT RE 2 *Skin Corr. 1AAquatic Chronic 3	H302H373 **H314H412	GHS08GHS05GHS07Dgr	H302H373 **H314H412				CLP00
612-173-00-5	lithium 1-amino-4-(4-tert-butylanilino)anthraquinone-2-sulfonate	411-140-0	125328-86-1	Eye Dam. 1Skin Sens. 1Aquatic Chronic 2	H318H317H411	GHS05GHS07GHS09Dgr	H318H317H411				CLP00
612-174-00-0	"4,4-dimethoxybutylamine"	407-690-6	19060-15-2	Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Chronic 3	H302H314H317H412	GHS05GHS07Dgr	H302H314H317H412				CLP00
612-175-00-6	2-(O-aminooxy)ethylamine dihydrochloride	412-310-7	37866-45-8	Skin Sens. 1Aquatic Chronic 3	H317H412	GHS07Wng	H317H412				CLP00
612-176-00-1	"Polymer of 1,3-dibromopropane and N,N-diethyl-N',N'-dimethyl-1,3-propanediamine"	410-570-6	143747-73-3	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
612-177-00-7	2-naphthylamino-6-sulfomethylamide	412-120-4	104295-55-8	STOT RE 2 *Skin Sens. 1Aquatic Chronic 2	H373 **H317H411	GHS08GHS09Wng	H373 **H317H411				CLP00
612-178-00-2	"1,4,7,10-tetraazacyclododecane disulfate"	412-080-8	112193-77-8	Acute Tox. 4 *STOT SE 3Eye Dam. 1Aquatic Chronic 3	H302H335H318H412	GHS05GHS07Dgr	H302H335H318H412				CLP00
612-179-00-8	1-(2-propenyl)pyridinium chloride	412-740-5	25965-81-5	Acute Tox. 4 *Skin Sens. 1	H302H317	GHS07Wng	H302H317				CLP00
612-180-00-3	3-aminobenzylamine	412-230-2	4403-70-7	Acute Tox. 4 *Skin Corr. 1BAquatic Chronic 2	H302H314H411	GHS05GHS07GHS09Dgr	H302H314H411				CLP00
612-181-00-9	2-phenylthioaniline	413-030-8	1134-94-7	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				CLP00
612-182-00-4	1-ethyl-1-methylmorpholinium bromide	418-210-1	65756-41-4	Muta. 2	H341	GHS08Wng	H341				CLP00
612-183-00-X	1-ethyl-1-methylpyrrolidinium bromide	418-200-5	69227-51-6	Muta. 2	H341	GHS08Wng	H341				CLP00
612-184-00-5	"6'-(dibutylamino)-3'-methyl-2'-(phenylamino)spiro[isobenzofuran-1(3H),9-(9H)-xanthen]-3-one"	403-830-5	89331-94-2	Aquatic Chronic 3	H412		H412				CLP00
612-185-00-0	"1-[3-[4-((heptadecafluorononyl)oxy)-benzamido]propyl]-N,N,N-trimethylammonium iodide"	407-400-8	59493-72-0	Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H318H400H410	GHS05GHS09Dgr	H318H410				CLP00
612-186-00-6	bis(N-(7-hydroxy-8-methyl-5-phenylphenazin-3-ylidene)dimethylammonium) sulfate	406-770-8	149057-64-7	STOT RE 2 *Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H373 **H318H317H400H410	GHS08GHS05GHS07GHS09Dgr	H373 **H318H317H410				CLP00
612-187-00-1	"2,3,4-trifluoroaniline"	407-170-9	3862-73-5	Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Skin Irrit. 2Eye Dam. 1Aquatic Chronic 2	H312H302H373 **H315H318H411	GHS08GHS05GHS07GHS09Dgr	H312H302H373 **H315H318H411				CLP00
612-188-00-7	"4,4'-(9H-fluoren-9-ylidene)bis(2-chloroaniline)"	407-560-9	107934-68-9	Aquatic Chronic 2	H411	GHS09	H411				CLP00
612-189-00-2	4-amino-2-(aminomethyl)phenol dihydrochloride	412-510-4	135043-64-0	Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H317H400H410	GHS07GHS09Wng	H302H317H410				CLP00
612-190-00-8	"4,4'-methylenebis(2-isopropyl-6-methylaniline)"	415-150-6	16298-38-7	STOT RE 2 *Aquatic Chronic 2	H373 **H411	GHS08GHS09Wng	H373 **H411				CLP00
612-191-00-3	Polymer of allylamine hydrochloride	415-050-2	71550-12-4	Acute Tox. 4 *Skin Sens. 1	H302H317	GHS07Wng	H302H317				CLP00
612-192-00-9	2-isopropyl-4-(N-methyl)aminomethylthiazole	414-800-6	154212-60-9	Acute Tox. 4 *Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1Aquatic Chronic 2	H312H302H315H318H411	GHS05GHS07GHS09Dgr	H312H302H315H318H411				CLP00
612-193-00-4	3-methylaminomethylphenylamine	414-570-7	18759-96-1	Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H312H302H314H317H400H410	GHS05GHS07GHS09Dgr	H312H302H314H317H410				CLP00
612-194-00-X	"2-hydroxy-3-[(2-hydroxyethyl)-[2-(1-oxotetradecyl)amino]ethyl]amino]-N,N,N-trimethyl-1-propanammonium chloride"	414-670-0	141890-30-4	Acute Tox. 4 *Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H302H318H400H410	GHS05GHS07GHS09Dgr	H302H318H410				CLP00
612-195-00-5	"bis[tributyl 4-(methylbenzyl)ammonium] 1,5-naphthalenedisulfonate"	415-210-1	160236-81-7	Acute Tox. 4 *Acute Tox. 4 *Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H332H302H318H400H410	GHS05GHS07GHS09Dgr	H332H302H318H410				CLP00
612-196-00-0	4-chloro-o-toluidine [1]4-chloro-o-toluidine hydrochloride  [2]	202-441-6 [1]221-627-8 [2]	95-69-2 [1]3165-93-3 [2]	Carc. 1BMuta. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H350H341H331H311H301H400H410	GHS06GHS08GHS09Dgr	H350H341H331H311H301H410				CLP00
612-197-00-6	"2,4,5-trimethylaniline [1]2,4,5-trimethylaniline hydrochloride  [2]"	205-282-0 [1]	137-17-7 [1]21436-97-5 [2]	Carc. 1BAcute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Aquatic Chronic 2	H350H331H311H301H411	GHS06GHS08GHS09Dgr	H350H331H311H301H411				CLP00
612-198-00-1	"4,4'-thiodianiline and its salts"	205-370-9	139-65-1	Carc. 1BAcute Tox. 4 *Aquatic Chronic 2	H350H302H411	GHS08GHS07GHS09Dgr	H350H302H411				CLP00
612-199-00-7	"4,4'-oxydianiline and its salts; p-aminophenyl ether"	202-977-0	101-80-4	Carc. 1BMuta. 1BRepr. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Aquatic Chronic 2	H350H340H361f ***H331H311H301H411	GHS06GHS08GHS09Dgr	H350H340H361f ***H331H311H301H411				CLP00
612-200-00-0	"2,4-diaminoanisole; 4-methoxy-m-phenylenediamine [1]2,4-diaminoanisole sulphate  [2]"	210-406-1 [1]254-323-9 [2]	615-05-4 [1]39156-41-7 [2]	Carc. 1BMuta. 2Acute Tox. 4 *Aquatic Chronic 2	H350H341H302H411	GHS08GHS07GHS09Dgr	H350H341H302H411				CLP00
612-201-00-6	"N,N,N',N'-tetramethyl-4,4'-methylendianiline"	202-959-2	101-61-1	Carc. 1BAquatic Acute 1Aquatic Chronic 1	H350H400H410	GHS08GHS09Dgr	H350H410				CLP00
612-202-00-1	"3,4-dichloroaniline"	202-448-4	95-76-1	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H331H311H301H318H317H400H410	GHS06GHS05GHS09Dgr	H331H311H301H318H317H410				CLP00
612-203-00-7	"C8-10 alkyl dimethyl hydroxyethyl ammoniumchloride (chain < C8: <3%, chain = C8: 15%-70%, chain = C10: 30%-85%, chain > C10: <3%)"	417-360-3	-	Acute Tox. 4 *Acute Tox. 4 *Skin Irrit. 2	H312H302H315	GHS07Wng	H312H302H315				ATP01
612-204-00-2	"C.I. Basic Violet 3; 4-[4,4'-bis(dimethylamino) benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride"	208-953-6	548-62-9	Carc. 2Acute Tox. 4 *Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H351H302H318H400H410	GHS08GHS05GHS07GHS09Dgr	H351H302H318H410				CLP00
612-205-00-8	C.I. Basic Violet 3 with ? 0.1 % of Michler's ketone (EC no. 202-027-5)	208-953-6	548-62-9	Carc. 1BAcute Tox. 4 *Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H350H302H318H400H410	GHS08GHS05GHS07GHS09Dgr	H350H302H318H410				CLP00
612-206-00-3	"famoxadone (ISO); 3-anilino-5-methyl-5-(4-phenoxyphenyl)-1,3-oxazolidine-2,4-dione"		131807-57-3	STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H373 **H400H410	GHS08GHS09Wng	H373 **H410				CLP00
612-207-00-9	4-ethoxyaniline; p-phenetidine	205-855-5	156-43-4	Muta. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2Skin Sens. 1	H341H332H312H302H319H317	GHS08GHS07Wng	H341H332H312H302H319H317				CLP00
612-208-00-4	"N-methylbenzene-1,2-diammonium hydrogen phosphate"	424-460-0	-	Acute Tox. 4 *Skin Sens. 1Aquatic Chronic 2	H302H317H411	GHS07GHS09Wng	H302H317H411				ATP01
612-209-00-X	6-methoxy-m-toluidine; p-cresidine	204-419-1	120-71-8	Carc. 1BAcute Tox. 4 *	H350H302	GHS08GHS07Dgr	H350H302				CLP00
612-210-00-5	5-nitro-o-toluidine [1]5-nitro-o-toluidine hydrochloride  [2]	202-765-8 [1]256-960-8 [2]	99-55-8 [1]51085-52-0 [2]	Carc. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Aquatic Chronic 3	H351H331H311H301H412	GHS06GHS08Dgr	H351H331H311H301H412				CLP00
612-211-00-0	N-[(benzotriazole-1-yl)methyl)]-4-carboxybenzenesulfonamide	416-470-9	170292-97-4	Eye Irrit. 2Aquatic Chronic 2	H319H411	GHS07GHS09Wng	H319H411				CLP00
612-212-00-6	"2,6-dichloro-4-trifluoromethylaniline"	416-430-0	24279-39-8	Acute Tox. 4 *Acute Tox. 4 *Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H332H302H315H317H400H410	GHS07GHS09Wng	H332H302H315H317H410				CLP00
612-213-00-1	"isobutylidene-(2-(2-isopropyl-4,4-dimethyloxazolidine-3-yl)-1,1-dimethylethyl)amine"	419-850-2	148348-13-4	Skin Corr. 1BAquatic Chronic 3	H314H412	GHS05Dgr	H314H412				CLP00
612-214-00-7	"4-(2,2-diphenylethenyl)-N,N-di-phenylbenzenamine"	421-390-2	89114-90-9	Aquatic Chronic 4	H413		H413				CLP00
612-215-00-2	3-chloro-2-(isopropylthio)aniline	421-700-6	179104-32-6	Skin Irrit. 2Aquatic Chronic 2	H315H411	GHS07GHS09Wng	H315H411				CLP00
612-216-00-8	"1-amino-1-cyanamino-2,2-dicyanoethylene, sodium salt"	425-870-2	19450-38-5	Skin Sens. 1Aquatic Chronic 3	H317H412	GHS07Wng	H317H412				ATP01
612-217-00-3	1-methoxy-2-propylamine	422-550-4	37143-54-7	Flam. Liq. 2Acute Tox. 4 *Skin Corr. 1BAquatic Chronic 3	H225H302H314H412	GHS02GHS05GHS07Dgr	H225H314H302H412				CLP00
612-219-00-4	"(2-hydroxy-3-(3,4-dimethyl-9-oxo-10-thiaanthracen-2-yloxy)propyl)trimethylammonium chloride"	402-200-7	-	Aquatic Chronic 3	H412	-	H412				ATP01
612-220-00-X	"N-nitro-N-(3-methyl-3,6-dihydro-2H-1,3,5-oxadiazin-4-yl)amine"	431-060-1	153719-38-1	Acute Tox. 4 *Skin Sens. 1Aquatic Chronic 3	H302H317H412	GHS07Wng	H302H317H412				ATP01
612-221-00-5	2-amino-4-(trifluoromethyl)benzenethiol hydrochloride	429-560-8	4274-38-8	Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1	H332H312H302H373 **H314H317H400	GHS05GHS08GHS07GHS09Dgr	H314H332H312H302H373 **H317H400				ATP01
612-222-00-0	cis-1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinamine	425-080-8	104860-26-6	Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H312H302H373 **H318H400H410	GHS05GHS08GHS07GHS09Dgr	H312H302H373 **H318H410				ATP01
612-223-00-6	N-benzyl-N-ethyl-(4-(5-nitro-benzo[c]isothiazol-3-ylazo)phenyl)amine	425-300-2	186450-73-7	Skin Sens. 1Aquatic Chronic 4	H317H413	GHS07Wng	H317H413				ATP01
612-224-00-1	"N2,N4,N6-tris{4-[(1,4-dimethylpentyl)amino]phenyl}-1,3,5-triazine-2,4,6-triamine"	426-150-0	121246-28-4	Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410				ATP01
612-225-00-7	"1,4,7,10-tetraazacyclododecane"	425-450-9	294-90-6	Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1	H312H302H314H400H410	GHS05GHS07GHS09Dgr	H314H312H302H410				ATP01
612-226-00-2	3-(2'-phenoxyethoxy)propylamine	427-870-8	6903-18-0	Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1Aquatic Chronic 3	H302H315H318H412	GHS05GHS07Dgr	H302H315H318H412				ATP01
612-227-00-8	benzyl-N-(2-(2-methoxyphenoxy)ethyl)amine hydrochloride	428-290-8	120606-08-8	Acute Tox. 4 *Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H302H318H400H410	GHS05GHS07GHS09Dgr	H302H318H410				ATP01
612-228-00-3	"reaction mass of: N-(3-(trimethoxysilyl)propyl)ethylenediamine; N-benzyl-N-(3-(trimethoxysilyl)propyl)ethylenediamine; N-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine; N,N'-bis-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine; N,N,N'-tris-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine; N,N-bis-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine"	414-340-6	-	Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *STOT SE 2Eye Dam. 1Skin Sens. 1Aquatic Chronic 3	H226H332H312H302H371H318H317H412	GHS02GHS05GHS08GHS07Dgr	H226H332H312H302H371H318H317H412				ATP01
612-229-00-9	mepanipyrim; 4-methyl-N-phenyl-6-(1-propynyl)-2-pyrimidinamine	-	110235-47-7	Carc. 2Aquatic Acute 1Aquatic Chronic 1	H351H400H410	GHS08GHS09Wng	H351H410				ATP01
612-230-00-4	"N,N-bis(cocoyl-2-oxypropyl)-N,N-dibutylammonium bromide"	431-530-4	-	Skin Corr. 1ASkin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H314H317H400H410	GHS05GHS07GHS09Dgr	H314H317H410				ATP01
612-231-00-X	"3-((C12-18)-acylamino)-N-(2-((2-hydroxyethyl)amino)-2-oxoethyl)-N,N-dimethyl-1-propanaminium chloride"	427-370-1	164288-56-6	Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H318H400H410	GHS05GHS09Dgr	H318H410				ATP01
612-232-00-5	"reaction mass of: triisopropanolamine salt of 1-amino-4-(3-propionamidoanilino)anthraquinone-2-sulfonic acid; triisopropanolamine salt of 1-amino-4-[3,4-dimethyl-5-(2-hydroxyethylaminosulfonyl)anilino]anthraquinone-2-sulfonic acid"	430-410-9	186148-38-9	Aquatic Chronic 3	H412	-	H412				ATP01
612-237-00-2	hydroxylammonium hydrogensulfate; hydroxylamine sulfate(1:1) [1]hydroxylamine phosphate [2]hydroxylamine dihydrogenphosphate [3]hydroxylamine 4-methylbenzenesulfonate [4]	233-154-4 [1]244-077-0 [2]242-818-2 [3]258-872-5 [4]	10046-00-1 [1]20845-01-6 [2]19098-16-9 [3]53933-48-5 [4]	Expl. 1.1Carc. 2Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Skin Irrit. 2Eye Irrit. 2Skin Sens. 1Aquatic Acute 1	H201H351H312H302H373 **H315H319H317H400	GHS01GHS08GHS07GHS09Dgr	H201H302H312H315H319H317H351H373 **H400			T	ATP01/ATP01corr
612-238-00-8	(3-chloro-2-hydroxypropyl) trimethylammonium chloride ...%	222-048-3	3327-22-8	Carc. 2Aquatic Chronic 3	H351H412	GHS08Wng	H351H412			B	ATP01
612-239-00-3	"biphenyl-3,3',4,4'-tetrayltetraamine; diaminobenzidine"	202-110-6	91-95-2	Carc. 1BMuta. 2	H350H341	GHS08Dgr	H350H341				ATP01
612-240-00-9	"pyrimethanil (ISO); N-(4,6-dimethylpyrimidin-2-yl)aniline"	-	53112-28-0	Aquatic Chronic 2	H411	GHS09	H411				ATP01
612-241-00-4	piperazine hydrochloride [1]piperazine dihydrochloride [2]piperazine phosphate  [3]	228-042-7 [1]205-551-2 [2]217-775-8 [3]	6094-40-2 [1]142-64-3 [2]1951-97-9 [3]	Repr. 2Skin Irrit. 2Eye Irrit. 2Resp. Sens. 1Skin Sens. 1Aquatic Chronic 3	H361fdH315H319H334H317H412	GHS08Dgr	H361fdH319H315H334H317H412				ATP01
612-242-00-X	cyprodinil (ISO); 4-cyclopropyl-6-methyl-N-phenylpyrimidin-2-amine	-	121552-61-2	Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410		M=10		ATP01
612-243-00-5	"(1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine 2-hydroxy-2-phenylacetate"	420-560-3	79617-97-3	Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H318H400H410	GHS05GHS09Dgr	H318H410		M=10		ATP01
612-244-00-0	3-(piperazin-1-yl)-benzo[d]isothiazole hydrochloride	421-310-6	87691-88-1	Repr. 2Acute Tox. 4 *Eye Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H361f ***H302H319H317H400H410	GHS08GHS07GHS09Wng	H361f ***H302H319H317H410				ATP01
612-245-00-6	2-ethylphenylhydrazine hydrochloride	421-460-2	19398-06-2	Carc. 2Acute Tox. 4 *STOT RE 1Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H351H302H372 **H318H317H400H410	GHS05GHS08GHS07GHS09Dgr	H351H372 **H302H318H317H410		M=10		ATP01
612-246-00-1	(2-chloroethyl)(3-hydroxypropyl)ammonium chloride	429-740-6	40722-80-3	Carc. 1BMuta. 1BSTOT RE 2 *Skin Sens. 1Aquatic Chronic 3	H350H340H373 **H317H412	GHS08GHS07Dgr	H350H340H373 **H317H412				ATP01
612-247-00-7	"N-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N'-hydroxy-4-nitrobenzenecarboximidamide"	423-530-8	152828-23-4	Acute Tox. 4 *STOT RE 1Aquatic Chronic 3	H302H372 **H412	GHS08GHS07Dgr	H372 **H302H412				ATP01
612-248-00-2	"reaction product of diphenylamine, phenothiazine, and alkenes, branched (C8-10, C9-rich)"	439-540-0	-	Skin Irrit. 2Skin Sens. 1Aquatic Chronic 4	H315H317H413	GHS07Wng	H315H317H413				ATP01
612-249-00-8	"4-[(3-chlorophenyl)(1H-imidazol-1-yl)methyl]-1,2-benzenediamine dihydrochloride"	425-030-5	159939-85-2	Repr. 2Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Chronic 2	H361f ***H302H314H317H411	GHS05GHS08GHS07GHS09Dgr	H361f ***H302H314H317H411				ATP01
612-250-00-3	"chloro-N,N-dimethylformiminium chloride"	425-970-6	3724-43-4	Repr. 1BAcute Tox. 4 *Skin Corr. 1A	H360D ***H302H314	GHS05GHS08GHS07Dgr	H360D ***H302H314	EUH014			ATP01
612-251-00-9	"cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride"	426-020-3	51229-78-8	Flam. Sol. 2Repr. 2Acute Tox. 4 *Skin Irrit. 2Skin Sens. 1Aquatic Chronic 2	H228H361d ***H302H315H317H411	GHS02GHS08GHS07GHS09Wng	H228H361d ***H302H315H317H411				ATP01
612-252-00-4	imidacloprid (ISO); 1-(6-chloropyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamine	428-040-8	138261-41-3	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410				ATP01
612-253-00-X	7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one; [containing < 0.5 % formamide (EC No 200-842-0)]	429-400-7	199327-61-2	Aquatic Chronic 3	H412	-	H412				ATP01
612-253-01-7	7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one; [containing ? 0.5 % formamide (EC No 200-842-0) ]	429-400-7	199327-61-2	Repr. 1BAquatic Chronic 3	H360D ***H412	GHS08Dgr	H360D ***H412				ATP01
612-254-00-5	reaction products of diisopropanolamine with formaldehyde (1:4)	432-440-8	220444-73-5	Carc. 2Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Chronic 2	H351H302H314H317H411	GHS05GHS08GHS07GHS09Dgr	H351H302H314H317H411				ATP01
612-255-00-0	1-(3-methoxypropyl)-4-piperidinamine	431-950-8	179474-79-4	Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1BAquatic Chronic 3	H312H302H314H412	GHS05GHS07Dgr	H312H302H314H412				ATP01
612-256-00-6	benzyl(S)-2-[(2'-cyanobiphenyl-4-ylmethyl)pentanoylamino]-3-methylbutyrate	427-470-3	137864-22-3	Acute Tox. 4 *Skin Sens. 1	H302H317	GHS07Wng	H302H317				ATP01
612-257-00-1	tripropylammonium dihydrogenphosphate	433-700-3	35687-90-2	Acute Tox. 4 *	H302	GHS07Wng	H302				ATP01
612-259-00-2	N-ethyl-3-trimethoxysilyl-2-methyl-propanamine	437-720-3	227085-51-0	Eye Dam. 1	H318	GHS05Dgr	H318				ATP01
612-261-00-3	"3,5-dichloro-2-fluoro-4-(1,1,2,3,3,3-hexafluoropropoxy)aniline"	441-190-9	121451-05-6	Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H317H400H410	GHS07GHS09Wng	H302H317H410		M=10		ATP01
612-265-00-5	bis(2-hydroxyethyl)-(2-hydroxypropyl)ammonium acetate	444-360-0	191617-13-7	Aquatic Chronic 3	H412	-	H412				ATP01
612-266-00-0	3-chloro-4-(3-fluorobenzyloxy)aniline	445-590-4	202197-26-0	Muta. 2Acute Tox. 4 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H341H302H373 **H400H410	GHS08GHS07GHS09Wng	H341H302H373 **H410				ATP01
612-267-00-6	bis(hydrogenated tallow C16-18-alkyl)hydroxylamine	418-370-0	-	Skin Sens. 1Aquatic Chronic 4	H317H413	GHS07Wng	H317H413				ATP01
612-269-00-7	reaction mass of: 1-[di(4-octylphenyl)aminomethyl]-5-methyl-1H-benzotriazole; 1-[di(4-octylphenyl)aminomethyl]-4-methyl-1H-benzotriazole; reaction mass of: N-[(5-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline; N-[(4-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline	420-720-2	-	Aquatic Chronic 4	H413	-	H413				ATP01
612-270-00-2	(S)-azetidine-2-carboxylic acid 4-cyanobenzylamide hydrochloride	433-010-2	-	Acute Tox. 4 *Skin Sens. 1Aquatic Chronic 3	H302H317H412	GHS07Wng	H302H317H412				ATP01
612-271-00-8	"reaction mass of: ethyl 2-((4-(5,6-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate; ethyl 2-((4-(6,7-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate"	434-970-5	160987-57-5	Aquatic Chronic 4	H413	-	H413				ATP01
612-272-00-3	"ammonium (?-6-2-(2-(1,2-dicarboxylatoethylamino)ethylamino)butane-1,4-dioato(4-))iron(3+) monohydrate"	435-210-5	-	Aquatic Chronic 2	H411	GHS09	H411				ATP01
612-273-00-9	"alkyl(rapeseed oil), bis(2-hydroxyethyl)ammonium fluoride"	435-650-8	-	Acute Tox. 4 *Skin Corr. 1AAquatic Acute 1Aquatic Chronic 1	H302H314H400H410	GHS05GHS07GHS09Dgr	H302H314H410				ATP01
612-274-00-4	"(R,S)-1-[2-amino-1(4-methoxyphenyl)ethyl]cyclohexanol acetate"	445-750-3	-	Acute Tox. 4 *Eye Dam. 1Skin Sens. 1Aquatic Chronic 3	H302H318H317H412	GHS05GHS07Dgr	H302H318H317H412				ATP01
612-275-00-X	"fatty acids, C18-unsatd.,  dimers, reaction products with 1-piperazineethanamine and tall oil"	447-880-6	206565-89-1	Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H315H318H317H400H410	GHS05GHS07GHS09Dgr	H315H318H317H410		M=10		ATP01
612-276-00-5	"1-amino-4-[(4-amino-2-sulfofenyl)amino]-9,10-dihydro-9,10-dioxo-2-anthracenesulfonic acid, disodium salt, reaction products with 2-[[3-[(4,6-dichloro-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethyl hydrogen sulfate, sodium salts"	451-430-4	500717-36-2	Eye Dam. 1Skin Sens. 1Aquatic Chronic 3	H318H317H412	GHS05GHS07Dgr	H318H317H412				ATP01
612-277-00-0	"reaction mass of: 4-amino-3-(4-ethenesulfonyl-2-sulfonatophenylazo)-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)naphthalene-2,7-disulfonate potassium/sodium; 4-amino-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-3-(2-sulfonato-4-(2-sulfonatooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate potassium/sodium"	451-440-9	586372-44-3	Eye Dam. 1	H318	GHS05Dgr	H318				ATP01
612-278-00-6	"ethidium bromide; 3,8-diamino-1-ethyl-6-phenylphenantridinium bromide"	214-984-6	1239-45-8	Muta. 2Acute Tox. 2 *Acute Tox. 4 *	H341H330H302	GHS06GHS08Dgr	H341H330H302				ATP01
612-279-00-1	"(R,S)-2-amino-3,3-dimethylbutane amide"	447-860-7	144177-62-8	Repr. 2STOT RE 2 *Skin Irrit. 2Eye Irrit. 2Skin Sens. 1	H361f ***H373 **H315H319H317	GHS08GHS07Wng	H361f ***H373 **H319H315H317				ATP01
612-280-00-7	3-amino-9-ethyl carbazole; 9-ethylcarbazol-3-ylamine	205-057-7	132-32-1	Carc. 1B	H350	GHS08Dgr	H350				ATP01
612-281-00-2	"leucomalachite green; N,N,N',N'-tetramethyl-4,4'-benzylidenedianiline"	204-961-9	129-73-7	Carc. 2Muta. 2	H351H341	GHS08Wng	H351H341				ATP03
612-282-00-8	octadecylamine	204-695-3	124-30-1	Asp. Tox. 1STOT RE 2Skin Irrit. 2Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	"H304H373 (gastro-intestinal tract, liver, immune system)H315H318H400H410"	GHS05GHS08GHS09Dgr	"H315H318H373 (gastro-intestinal tract, liver, immune system)H304H410"		M=10M=10		ATP05
612-283-00-3	(Z)-octadec-9-enylamine	204-015-5	112-90-3	Acute Tox. 4Asp. Tox. 1STOT SE 3STOT RE 2Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1	"H302H304H335H373 (gastro-intestinal tract, liver, immune system)H314H400H410"	GHS05GHS07GHS08GHS09Dgr	"H302H314H335H373 (gastro-intestinal tract, liver, immune system)H304H410"		M=10M=10		ATP05
612-284-00-9	"amines, hydrogenated tallow alkyl"	262-976-6	61788-45-2	Asp. Tox. 1STOT RE 2Skin Irrit. 2Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	"H304H373 (gastro-intestinal tract, liver, immune system)H315H318H400H410"	GHS08GHS05GHS09Dgr	"H315H318H373 (gastro-intestinal tract, liver, immune system)H304H410"		M=10M=10		ATP05
612-285-00-4	"amines, coco alkyl"	262-977-1	61788-46-3	Acute Tox. 4Asp. Tox. 1STOT SE 3STOT RE 2Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1	H302H304H335H373H314H400H410	GHS05GHS07GHS08GHS09Dgr	"H302H314H335H373 (gastro-intestinal tract, liver, immune system)H304H410"		M=10M=10		ATP05
612-286-00-X	"amines, tallow alkyl"	263-125-1	61790-33-8	Acute Tox. 4Asp. Tox. 1STOT RE 2Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1	"H302H304H373 (gastro-intestinal tract, liver, immune system)H314H400H410"	GHS05GHS07GHS08GHS09Dgr	"H302H314H373 (gastro-intestinal tract, liver, immune system)H304H410"		M=10M=10		ATP05
612-287-00-5	"fluazinam (ISO); 3-chloro-N-[3-chloro-2,6-dinitro-4-(trifluoromethyl)phenyl]-5-(trifluoromethyl)pyridin-2-amine"		79622-59-6	Repr. 2Acute Tox. 4Eye Dam. 1Skin Sens. 1AAquatic Acute 1Aquatic Chronic 1	H361dH332H318H317H400H410	GHS08GHS07GHS05GHS09Dgr	H332H318H317H361dH410		M=10M=10		ATP06
613-001-00-1	ethyleneimine; aziridine	205-793-9	151-56-4	Flam. Liq. 2Carc. 1BMuta. 1BAcute Tox. 1Acute Tox. 2 *Acute Tox. 2 *Skin Corr. 1BAquatic Chronic 2	H225H350H340H310H330H300H314H411	GHS02GHS06GHS08GHS05GHS09Dgr	H225H350H340H330H310H300H314H411			D	CLP00
613-002-00-7	pyridine	203-809-9	110-86-1	Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *	H225H332H312H302	GHS02GHS07Dgr	H225H332H312H302		*		CLP00
613-003-00-2	"1,2,3,4-tetranitrocarbazole"	-	6202-15-9	Expl. 1.1Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *	H201H332H312H302	GHS01GHS07Dgr	H201H332H312H302				CLP00/ATP01
613-004-00-8	crimidine (ISO); 2-chloro-6-methylpyrimidin-4-yldimethylamine	208-622-6	535-89-7	Acute Tox. 2 *	H300	GHS06Dgr	H300				CLP00
613-007-00-4	"desmetryne (ISO); 6-isopropylamino-2-methylamino-4-methylthio-1,3,5-triazine"	213-800-1	1014-69-3	Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H312H302H400H410	GHS07GHS09Wng	H312H302H410				CLP00
613-008-00-X	"dazomet (ISO); tetrahydro-3,5-dimethyl-1,3,5-thiadiazine-2-thione"	208-576-7	533-74-4	Acute Tox. 4 *Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H302H319H400H410	GHS07GHS09Wng	H302H319H410				CLP00
613-009-00-5	"2,4,6-trichloro-1,3,5-triazine; cyanuric chloride"	203-614-9	108-77-0	Acute Tox. 2 *Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1	H330H302H314H317	GHS06GHS05Dgr	H330H302H314H317	EUH014	STOT SE 3; H335: C ? 5 %		CLP00
613-010-00-0	"ametryn (ISO); N-ethyl-N'-isopropyl-6-(methylthio)-1,3,5-triazine-2,4-diamine"	212-634-7	834-12-8	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410		M=100		CLP00/ATP01corr
613-011-00-6	"amitrole (ISO); 1,2,4-triazol-3-ylamine"	200-521-5	61-82-5	Repr. 2STOT RE 2 *Aquatic Chronic 2	H361d ***H373 **H411	GHS08GHS09Wng	H361d ***H373 **H411				CLP00
613-012-00-1	"bentazone (ISO); 3-isopropyl-2,1,3-benzothiadiazine-4-one-2,2-dioxide"	246-585-8	25057-89-0	Acute Tox. 4 *Eye Irrit. 2Skin Sens. 1Aquatic Chronic 3	H302H319H317H412	GHS07Wng	H302H319H317H412				CLP00
613-013-00-7	"cyanazine (ISO); 2-(4-chloro-6-ethylamino-1,3,5-triazine-2-ylamino)-2-methylpropionitrile"	244-544-9	21725-46-2	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410				CLP00
613-014-00-2	"ethoxyquin (ISO); 6-ethoxy-1,2-dihydro-2,2,4-trimethylquinoline"	202-075-7	91-53-2	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
613-015-00-8	"fenazaflor (ISO); phenyl 5,6-dichloro-2-trifluoromethylbenzimidazole-1-carboxylate"	238-134-9	14255-88-0	Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H312H302H400H410	GHS07GHS09Wng	H312H302H410				CLP00
613-016-00-3	fuberidazole (ISO); 2-(2-furyl)-1H-benzimidazole	223-404-0	3878-19-1	Carc. 2Acute Tox. 4STOT RE 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H351H302H373 (heart)H317H400H410	GHS07GHS08GHS09Wng	H351H302H373 (heart)H317H410		M=1		CLP00/ATP03
613-017-00-9	bis (8-hydroxyquinolinium) sulphate	205-137-1	134-31-6	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
613-018-00-4	"morfamquat (ISO); 1,1'-bis(3,5-dimethylmorpholinocarbonylmethyl)-4,4'-bipyridilium ion"		7411-47-4	Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Irrit. 2Aquatic Chronic 3	H302H335H315H319H412	GHS07Wng	H302H319H335H315H412				CLP00
613-019-00-X	"thioquinox (ISO); 2-thio-1,3-dithiolo(4,5,b)quinoxaline"	202-272-8	93-75-4	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
613-020-00-5	"tridemorph (ISO); 2,6-dimethyl-4-tridecylmorpholine"	246-347-3	24602-86-6	Repr. 1BAcute Tox. 4 *Acute Tox. 4 *Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H360D ***H332H302H315H400H410	GHS08GHS07GHS09Dgr	H360D ***H332H302H315H410				CLP00
613-021-00-0	"dithianon (ISO); 5,10-dihydro-5,10-dioxonaphtho(2,3-b)(1,4)dithiazine-2,3-dicarbonitrile"	222-098-6	3347-22-6	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410				CLP00
613-022-00-6	"pyrethrins including cinerins, with the exception of those specified elsewhere in this Annex"			Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H332H312H302H400H410	GHS07GHS09Wng	H332H312H302H410			A	CLP00
613-023-00-1	"2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl [1R-[1?[S*(Z)],3?]]-chrysanthemate; pyrethrin I"	204-455-8	121-21-1	Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H332H312H302H400H410	GHS07GHS09Wng	H332H312H302H410				CLP00
613-024-00-7	"2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl[1R-[1?[S*(Z)](3?)]]-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate; pyrethrin II"	204-462-6	121-29-9	Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H332H312H302H400H410	GHS07GHS09Wng	H332H312H302H410				CLP00
613-025-00-2	"cinerin I; 3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate"	246-948-0	25402-06-6	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410				CLP00
613-026-00-8	"cinerin II; 3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)cyclopropanecarboxylate"	204-454-2	121-20-0	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410				CLP00
613-027-00-3	piperidine	203-813-0	110-89-4	Flam. Liq. 2Acute Tox. 3 *Acute Tox. 3 *Skin Corr. 1B	H225H331H311H314	GHS02GHS06GHS05Dgr	H225H331H311H314		*		CLP00
613-028-00-9	morpholine	203-815-1	110-91-8	Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1B	H226H332H312H302H314	GHS02GHS05GHS07Dgr	H226H332H312H302H314				CLP00
613-029-00-4	"dichloro-1,3,5-triazinetrione; dichloroisocyanuric acid"	220-487-5	2782-57-2	Ox. Sol. 2Acute Tox. 4 *STOT SE 3Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H272H302H335H319H400H410	GHS03GHS07GHS09Dgr	H272H302H319H335H410	EUH031		T	CLP00
613-030-00-X	troclosene potassium [1]troclosene sodium  [2]	218-828-8 [1]220-767-7 [2]	2244-21-5 [1]2893-78-9 [2]	Ox. Sol. 2Acute Tox. 4 *STOT SE 3Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H272H302H335H319H400H410	GHS03GHS07GHS09Dgr	H272H302H319H335H410	EUH031	*STOT SE 3; H335: C ? 10 %EUH031: C ? 10 %	G	CLP00/ATP01
613-030-01-7	"troclosene sodium, dihydrate"	220-767-7	51580-86-0	Acute Tox. 4 *STOT SE 3Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H302H335H319H400H410	GHS07GHS09Wng	H302H319H335H410	EUH031			CLP00
613-031-00-5	"symclosene; trichloroisocyanuric acid; trichloro-1,3,5-triazinetrion"	201-782-8	87-90-1	Ox. Sol. 2Acute Tox. 4 *STOT SE 3Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H272H302H335H319H400H410	GHS03GHS07GHS09Dgr	H272H302H319H335H410	EUH031			CLP00
613-032-00-0	"methyl-2,3,5,6-tetrachloro-4-pyridylsulphone; 2,3,5,6-tetrachloro-4-(methylsulphonyl)pyridine"	236-035-5	13108-52-6	Acute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2Skin Sens. 1	H312H302H319H317	GHS07Wng	H312H302H319H317				CLP00
613-033-00-6	2-methylaziridine; propyleneimine	200-878-7	75-55-8	Flam. Liq. 2Carc. 1BAcute Tox. 1Acute Tox. 2 *Acute Tox. 2 *Eye Dam. 1Aquatic Chronic 2	H225H350H310H330H300H318H411	GHS02GHS06GHS08GHS05GHS09Dgr	H225H350H330H310H300H318H411		"Carc. 1B; H350: C ? 0,01 %"		CLP00
613-034-00-1	"1,2-dimethylimidazole"	217-101-2	1739-84-0	Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1	H302H315H318	GHS05GHS07Dgr	H302H315H318				CLP00
613-035-00-7	1-methylimidazole	210-484-7	616-47-7	Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1B	H312H302H314	GHS05GHS07Dgr	H312H302H314				CLP00
613-036-00-2	2-methylpyridine; 2-picoline	203-643-7	109-06-8	Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *STOT SE 3Eye Irrit. 2	H226H332H312H302H335H319	GHS02GHS07Wng	H226H332H312H302H319H335				CLP00
613-037-00-8	4-methylpyridine; 4-picoline	203-626-4	108-89-4	Flam. Liq. 3Acute Tox. 3 *Acute Tox. 4 *Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Irrit. 2	H226H311H332H302H335H315H319	GHS02GHS06Dgr	H226H311H332H302H319H335H315				CLP00
613-038-00-3	"6-phenyl-1,3,5-triazine-2,4-diyldiamine; 6-phenyl-1,3,5-triazine-2,4-diamine; benzoguanamine"	202-095-6	91-76-9	Acute Tox. 4 *Aquatic Chronic 3	H302H412	GHS07Wng	H302H412				CLP00
613-039-00-9	ethylene thiourea; imidazolidine-2-thione; 2-imidazoline-2-thiol	202-506-9	96-45-7	Repr. 1BAcute Tox. 4 *	H360D ***H302	GHS08GHS07Dgr	H360D ***H302				CLP00
613-040-00-4	"azaconazole (ISO); 1-{}{[2-(2,4-dichlorophenyl)-1,3-dioxolan-2-yl]methyl}}-1H-1,2.4-triazole"	262-102-3	60207-31-0	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
613-041-00-X	morpholine-4-carbonyl chloride	239-213-0	15159-40-7	Carc. 2Skin Irrit. 2Eye Irrit. 2	H351H315H319	GHS08Wng	H351H319H315	EUH014			CLP00
613-042-00-5	"imazalil (ISO); 1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole"	252-615-0	35554-44-0	Carc. 2Acute Tox. 3Acute Tox. 4Eye Dam. 1Aquatic Chronic 1	H351H301H332H318H410	GHS08GHS06GHS05GHS09Dgr	H301H332H318H351H410		M=10		CLP00/ATP07
613-043-00-0	"imazalil sulphate (ISO) powder; 1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate [1](±)-1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate  [2]"	261-351-5 [1]281-291-3 [2]	58594-72-2 [1]83918-57-4 [2]	Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H317H400H410	GHS07GHS09Wng	H302H317H410				CLP00
613-043-01-8	"imazalil sulphate (ISO), aqueous solution; 1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate [1](±)-1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate  [2]"	261-351-5 [1]281-291-3 [2]	58594-72-2 [1]83918-57-4 [2]	Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H314H317H400H410	GHS05GHS07GHS09Wng	H302H314H317H410		Skin Corr. 1B; H314: C ? 50 %Skin Irrit. 2; H315: 30 % ? C < 50 %Eye Dam. 1; H318: 15 % ? C < 50 %Eye Irrit. 2; H319: 5 % ? C < 15 %		CLP00
613-044-00-6	"captan (ISO); 1,2,3,6-tetrahydro-N-(trichloromethylthio)phthalimide"	205-087-0	133-06-2	Carc. 2Acute Tox. 3 *Eye Dam. 1Skin Sens. 1Aquatic Acute 1	H351H331H318H317H400	GHS06GHS05GHS08GHS09Dgr	H351H331H318H317H400		M=10		CLP00/ATP01
613-045-00-1	folpet (ISO); N-(trichloromethylthio)phthalimide	205-088-6	133-07-3	Carc. 2Acute Tox. 4 *Eye Irrit. 2Skin Sens. 1Aquatic Acute 1	H351H332H319H317H400	GHS08GHS07GHS09Wng	H351H332H319H317H400		M=10		CLP00/ATP01
613-046-00-7	"captafol (ISO); 1,2,3,6-tetrahydro-N-(1,1,2,2-tetrachloroethylthio)phthalimide"	219-363-3	2425-06-1	Carc. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H350H317H400H410	GHS08GHS09Dgr	H350H317H410				CLP00
613-047-00-2	1-dimethylcarbamoyl-5-methylpyrazol-3-yl dimethylcarbamate; dimetilan (ISO)	211-420-0	644-64-4	Acute Tox. 3 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H301H312H400H410	GHS06GHS09Dgr	H301H312H410				CLP00
613-048-00-8	carbendazim (ISO); methyl benzimidazol-2-ylcarbamate	234-232-0	10605-21-7	Muta. 1BRepr. 1BAquatic Acute 1Aquatic Chronic 1	H340H360FDH400H410	GHS08GHS09Dgr	H340H360FDH410				CLP00
613-049-00-3	benomyl (ISO); methyl 1-(butylcarbamoyl)benzimidazol-2-ylcarbamate	241-775-7	17804-35-2	Muta. 1BRepr. 1BSTOT SE 3Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H340H360FDH335H315H317H400H410	GHS08GHS07GHS09Dgr	H340H360FDH335H315H317H410		M=10		CLP00
613-050-00-9	"carbadox (INN); methyl 3-(quinoxalin-2-ylmethylene)carbazate 1,4-dioxide; 2-(methoxycarbonylhydrazonomethyl)quinoxaline 1,4-dioxide"	229-879-0	6804-07-5	Flam. Sol. 1Carc. 1BAcute Tox. 4 *	H228H350H302	GHS02GHS08GHS07Dgr	H228H350H302			T	CLP00
613-051-00-4	molinate (ISO); S-ethyl 1-perhydroazepinecarbothioate; S-ethyl perhydroazepine-1-carbothioate	218-661-0	2212-67-1	Carc. 2Repr. 2Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H351H361f ***H332H302H373 **H317H400H410	GHS08GHS07GHS09Wng	H351H361f ***H332H302H373 **H317H410		M=100		CLP00
613-052-00-X	trifenmorph (ISO); 4-tritylmorpholine	215-812-2	1420-06-0	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410				CLP00
613-053-00-5	"anilazine (ISO); 2-chloro-N-(4,6-dichloro-1,3,5-triazin-2-yl)aniline"	202-910-5	101-05-3	Skin Irrit. 2Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H315H319H400H410	GHS07GHS09Wng	H319H315H410				CLP00
613-054-00-0	thiabendazol (ISO); 2-(thiazole-4-yl)benzimidazole	205-725-8	148-79-8	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
613-056-00-1	"1,2-dimethyl-3,5-diphenylpyrazolium methylsulphate; difenzoquat methyl sulfate"	256-152-5	43222-48-6	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS09Wng	H302H410				CLP00
613-057-00-7	"dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholine"	216-474-9	1593-77-7	Repr. 2STOT RE 2Skin Corr. 1CSkin Sens. 1AAquatic Acute 1Aquatic Chronic 1	H361dH373 (liver)H314H317H400H410	GHS08GHS05GHS07GHS09Dgr	H314H317H361dH373 (liver)H410	EUH071	M=1M=1		CLP00/ATP07
613-058-00-2	"permethrin (ISO); m-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate"	258-067-9	52645-53-1	Acute Tox. 4 *Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H332H302H317H400H410	GHS07GHS09Wng	H332H302H317H410		M=1000		CLP00
613-059-00-8	"profluralin (ISO); N-(cyclopropylmethyl)-?,?,?-trifluoro-2,6-dinitro-N-propyl-p-toluidine"	247-656-6	26399-36-0	Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H319H400H410	GHS07GHS09Wng	H319H410				CLP00
613-060-00-3	resmethrin (ISO); 5-benzyl-3-furylmethyl (±)-cis-trans-chrysanthemate	233-940-7	10453-86-8	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410		M=1000		CLP00/ATP01
613-061-00-9	"6-(1?,5a?,8a?,9-pentahydroxy-7?-isopropyl-2?,5?,8?-trimethylperhydro-8b?,9-epoxy-5,8-ethanocyclopenta[1,2-b]indenyl) pyrrole-2-carboxylate; ryania"	239-732-2	15662-33-6	Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H312H302H400H410	GHS07GHS09Wng	H312H302H410				CLP00
613-062-00-4	sabadilla (ISO); veratrine		8051-02-3	STOT SE 3Skin Irrit. 2Eye Irrit. 2	H335H315H319	GHS07Wng	H319H335H315				CLP00
613-063-00-X	"secbumeton (ISO); 2-sec-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine"	247-554-1	26259-45-0	Acute Tox. 4 *Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H302H319H400H410	GHS07GHS09Wng	H302H319H410				CLP00
613-064-00-5	"5-(3,6,9-trioxa-2-undecyloxy)benzo(d)-1,3-dioxolane; sesamex"		51-14-9	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
613-065-00-0	"simetryn (ISO); 2,4-bis(ethylamino)-6-methylthio-1,3,5-triazine"	213-801-7	1014-70-6	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410				CLP00
613-066-00-6	"terbumeton (ISO); 2-tert-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine"	251-637-8	33693-04-8	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410				CLP00
613-067-00-1	"propazine (ISO); 2-chloro-4,6-bis(isopropylamino)-1,3,5-triazine"	205-359-9	139-40-2	Carc. 2Aquatic Acute 1Aquatic Chronic 1	H351H400H410	GHS08GHS09Wng	H351H410				CLP00
613-068-00-7	"atrazine (ISO); 2-chloro-4-ethylamine-6-isopropylamine-1,3,5-triazine"	217-617-8	1912-24-9	STOT RE 2 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H373 **H317H400H410	GHS08GHS09Wng	H373 **H317H410				CLP00
613-069-00-2	?-caprolactam	203-313-2	105-60-2	Acute Tox. 4 *Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Irrit. 2	H332H302H335H315H319	GHS07Wng	H332H302H319H335H315				CLP00
613-070-00-8	propylenethiourea		2122-19-2	Repr. 2Acute Tox. 4 *Aquatic Chronic 3	H361d ***H302H412	GHS08GHS07Wng	H361d ***H302H412				CLP00
613-071-00-3	2-fluoro-5-trifluoromethylpyridine	400-290-2	69045-82-5	Flam. Liq. 3Skin Sens. 1Aquatic Chronic 3	H226H317H412	GHS02GHS07Wng	H226H317H412				CLP00
613-072-00-9	"N,N-bis(2-ethylhexyl)-((1,2,4-triazol-1-yl)methyl)amine"	401-280-0	91273-04-0	Skin Corr. 1BSkin Sens. 1Aquatic Chronic 2	H314H317H411	GHS05GHS07GHS09Dgr	H314H317H411				CLP00
613-073-00-4	"N,N-dimethyl-2-(3-(4-chlorophenyl)-4,5-dihydropyrazol-1-ylphenylsulphonyl)ethylamine"	401-410-6	10357-99-0	STOT RE 2 *Skin Sens. 1Aquatic Chronic 2	H373 **H317H411	GHS08GHS09Wng	H373 **H317H411				CLP00
613-074-00-X	3-(3-methylpent-3-yl)isoxazol-5-ylamine	401-460-9	82560-06-3	Acute Tox. 3 *Acute Tox. 3 *Eye Dam. 1Aquatic Chronic 3	H331H301H318H412	GHS06GHS05Dgr	H331H301H318H412				CLP00
613-075-00-5	"1,3-dichloro-5-ethyl-5-methylimidazolidine-2,4-dione"	401-570-7	89415-87-2	Ox. Sol. 1 ****Acute Tox. 3 *Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1	H271H331H302H314H317H400	GHS03GHS06GHS05GHS09Dgr	H271H331H314H302H317H400				CLP00
613-076-00-0	3-chloro-5-trifluoromethyl-2-pyridylamine	401-670-0	79456-26-1	Acute Tox. 4 *Aquatic Chronic 3	H302H412	GHS07Wng	H302H412				CLP00
613-077-00-6	"reaction mass of 5-heptyl-1,2,4-triazol-3-ylamine and 5-nonyl-1,2,4-triazol-3-ylamine"	401-940-8		Acute Tox. 4 *Eye Irrit. 2Aquatic Chronic 2	H302H319H411	GHS07GHS09Wng	H302H319H411				CLP00
613-078-00-1	"N,N,N,N-tetrakis(4,6-bis(butyl-(N-methyl-2,2,6,6-tetramethylpiperidin-4-yl)amino)triazin-2-yl)-4,7-diazadecane-1,10-diamine"	401-990-0	106990-43-6	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				CLP00
613-079-00-7	"4-(1(or 4 or 5 or 6)-methyl-8,9,10-trinorborn-5-en-2-yl)pyridine, reaction mass of isomers"	402-520-7		Acute Tox. 4 *Acute Tox. 4 *Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H312H302H315H317H400H410	GHS07GHS09Wng	H312H302H315H317H410				CLP00
613-080-00-2	3-(bis(2-ethylhexyl)aminomethyl)benzothiazole-2(3H)-thione	402-540-6	105254-85-1	Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H314H317H400H410	GHS05GHS07GHS09Dgr	H314H317H410				CLP00
613-081-00-8	1-butyl-2-methylpyridinium bromide	402-680-8	26576-84-1	Acute Tox. 4 *Aquatic Chronic 3	H302H412	GHS07Wng	H302H412				CLP00
613-082-00-3	2-methyl-1-pentylpyridinium bromide	402-690-2		Acute Tox. 4 *Acute Tox. 4 *Aquatic Chronic 3	H312H302H412	GHS07Wng	H312H302H412				CLP00
613-083-00-9	2-(4-(3-(4-chlorophenyl)-2-pyrazolin-1-yl)phenylsulfonyl)ethyldimethylammonium formate	402-120-2		STOT RE 2 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H373 **H314H317H400H410	GHS08GHS05GHS07GHS09Dgr	H314H373 **H317H410				CLP00
613-084-00-4	"2-(4-(3-(4-chlorophenyl)-4,5-dihydropyrazolyl)phenylsulphonyl)ethyldimethylammonium hydrogen phosphonate"	402-490-5	106359-93-7	Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H319H400H410	GHS07GHS09Wng	H319H410				CLP00
613-085-00-X	"reaction mass of 1,1'-(methylenebis(4,1-phenylene))dipyrrole-2,5-dione and N-(4-(4-(2,5-dioxopyrrol-1-yl)benzyl)phenyl)acetamide and 1-(4-(4-(5-oxo-2H-2-furylidenamino)benzyl)phenyl)pyrrole-2,5-dione"	401-970-1		Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410				CLP00
613-086-00-5	caffeine	200-362-1	58-08-2	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
613-087-00-0	tetrahydrothiophene	203-728-9	110-01-0	Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Skin Irrit. 2Eye Irrit. 2Aquatic Chronic 3	H225H332H312H302H315H319H412	GHS02GHS07Dgr	H225H332H312H302H319H315H412				CLP00
613-088-00-6	"1,2-benzisothiazol-3(2H)-one; 1,2-benzisothiazolin-3-one"	220-120-9	2634-33-5	Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Acute 1	H302H315H318H317H400	GHS05GHS07GHS09Dgr	H302H315H318H317H400		"Skin Sens. 1; H317: C ? 0,05 %"		CLP00
613-089-00-1	"diquat dibromide [1]diquat dichloride [2]6,7-dihydrodipyrido[1,2-?:2',1'-c]pyrazinediylium dihydroxide  [3]"	201-579-4 [1]223-714-6 [2]301-467-6 [3]	85-00-7 [1]4032-26-2 [2]94021-76-8 [3]	Acute Tox. 2 *Acute Tox. 4 *STOT SE 3STOT RE 1Skin Irrit. 2Eye Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H330H302H335H372 **H315H319H317H400H410	GHS06GHS08GHS09Dgr	H330H372 **H302H319H335H315H317H410				CLP00
613-090-00-7	"paraquat dichloride; 1,1-dimethyl-4,4'-bipyridinium dichloride [1]paraquat dimethylsulfate; 1,1-dimethyl-4,4'-bipyridinium dimethyl sulphate  [2]"	217-615-7 [1]218-196-3 [2]	1910-42-5 [1]2074-50-2 [2]	Acute Tox. 2 *Acute Tox. 3 *Acute Tox. 3 *STOT SE 3STOT RE 1Skin Irrit. 2Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H330H311H301H335H372 **H315H319H400H410	GHS06GHS08GHS09Dgr	H330H311H301H372 **H319H335H315H410				CLP00
613-091-00-2	morfamquat dichloride [1]morfamquat sulfate  [2]	225-062-8 [1]	4636-83-3 [1]29873-36-7 [2]	Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Irrit. 2Aquatic Chronic 3	H302H335H315H319H412	GHS07Wng	H302H319H335H315H412				CLP00
613-092-00-8	"1,10-phenanthroline"	200-629-2	66-71-7	Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H301H400H410	GHS06GHS09Dgr	H301H410				CLP00
613-093-00-3	"hexasodium 6,13-dichloro-3,10-bis((4-(2,5-disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate"	400-050-7	85153-92-0	Resp. Sens. 1Skin Sens. 1	H334H317	GHS08Dgr	H334H317				CLP00
613-094-00-9	"4-methoxy-N,6-dimethyl-1,3,5-triazin-2-ylamine"	401-360-5	5248-39-5	Acute Tox. 4 *STOT RE 2 *	H302H373 **	GHS08GHS07Wng	H302H373 **				CLP00
613-095-00-4	sodium 3-(2H-benzotriazol-2-yl)-5-sec-butyl-4-hydroxybenzenesulfonate	403-080-9	92484-48-5	Eye Dam. 1	H318	GHS05Dgr	H318				CLP00
613-096-00-X	"2-amino-6-ethoxy-4-methylamino-1,3,5-triazine"	403-580-7	62096-63-3	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
613-097-00-5	"7-amino-3-((5-carboxymethyl-4-methyl-1,3-thiazol-2-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid"	403-690-5	111298-82-9	Resp. Sens. 1Skin Sens. 1Aquatic Chronic 3	H334H317H412	GHS08Dgr	H334H317H412				CLP00
613-098-00-0	N-(n-octyl)-2-pyrrolidone	403-700-8	2687-94-7	Skin Corr. 1BAquatic Chronic 2	H314H411	GHS05GHS09Dgr	H314H411				CLP00
613-099-00-6	1-dodecyl-2-pyrrolidone	403-730-1	2687-96-9	Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H314H317H400H410	GHS05GHS07GHS09Dgr	H314H317H410				CLP00
613-100-00-X	"2,9-bis(3-(diethylamino)propylsulfamoyl)quino(2,3-b)acridine-7,14-dione"	404-230-6		Skin Sens. 1Aquatic Chronic 4	H317H413	GHS07Wng	H317H413				CLP00
613-101-00-5	N-tert-pentyl-2-benzothiazolesulfenamide	404-380-2	110799-28-5	Skin Sens. 1Aquatic Chronic 3	H317H412	GHS07Wng	H317H412				CLP00
613-102-00-0	"dimethomorph (ISO); 4-(3-(4-chlorophenyl)-3-(3,4-dimethoxyphenyl)acryloyl)morpholine"	404-200-2	110488-70-5	Aquatic Chronic 2	H411	GHS09	H411				CLP00
613-103-00-6	sodium 5-n-butylbenzotriazole	404-450-2	118685-34-0	Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Chronic 2	H302H314H317H411	GHS05GHS07GHS09Dgr	H302H314H317H411				CLP00
613-104-00-1	5-tert-butyl-3-isoxazolylamine hydrochloride	404-840-2		Acute Tox. 4 *STOT RE 2 *Eye Dam. 1Aquatic Chronic 3	H302H373 **H318H412	GHS08GHS05GHS07Dgr	H302H373 **H318H412				CLP00
613-105-00-7	"hexakis(tetramethylammonium) 4,4'-vinylenebis((3-sulfonato-4,1-phenylene)imino(6-morpholino-1,3,5-triazine-4,2-diyl)imino)bis(5-hydroxy-6-phenylazonaphthalene-2,7-disulfonate)"	405-160-9	124537-30-0	Acute Tox. 3 *Skin Sens. 1Aquatic Chronic 3	H301H317H412	GHS06Dgr	H301H317H412				CLP00
613-106-00-2	"tetrapotassium 2-(4-(5-(1-(2,5-disulfonatophenyl)-3-ethoxycarbonyl-5-hydroxypyrazol-4-yl)penta-2,4-dienylidene)-3-ethoxycarbonyl-5-oxo-2-pyrazolin-1-yl)benzene-1,4-disulfonate"	405-240-3		Skin Sens. 1	H317	GHS07Wng	H317				CLP00
613-107-00-8	"hexasodium 2,2'-vinylenebis((3-sulfonato-4,1-phenylene)imino(6-(N-cyanoethyl-N-(2-hydroxypropyl)amino)-1,3,5-triazine-4,2-diyl)imino)dibenzene-1,4-disulfonate"	405-280-1	76508-02-6	Eye Irrit. 2	H319	GHS07Wng	H319				CLP00
613-108-00-3	benzothiazole-2-thiol	205-736-8	149-30-4	Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410				CLP00
613-109-00-9	bis(piperidinothiocarbonyl) disulphide	202-328-1	94-37-1	STOT SE 3Skin Irrit. 2Eye Irrit. 2Skin Sens. 1	H335H315H319H317	GHS07Wng	H319H335H315H317				CLP00
613-110-00-4	dimepiperate (ISO); S-(1-methyl-1-phenylethyl) piperidine-1-carbothioate	262-784-2	61432-55-1	Acute Tox. 4 *Aquatic Chronic 2	H302H411	GHS07GHS09Wng	H302H411				CLP00
613-111-00-X	"1,2,4-triazole"	206-022-9	288-88-0	Repr. 2Acute Tox. 4 *Eye Irrit. 2	H361d ***H302H319	GHS08GHS07Wng	H361d ***H302H319				CLP00
613-112-00-5	octhilinone (ISO); 2-octyl-2H-isothiazol-3-one	247-761-7	26530-20-1	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H331H311H302H314H317H400H410	GHS06GHS05GHS09Dgr	H331H311H302H314H317H410		"Skin Sens. 1; H317: C ? 0,05 %"		CLP00
613-113-00-0	2-(morpholinothio)benzothiazole	203-052-4	102-77-2	Skin Irrit. 2Eye Irrit. 2Skin Sens. 1Aquatic Chronic 2	H315H319H317H411	GHS07GHS09Wng	H319H315H317H411				CLP00
613-114-00-6	"2,2',2""-(hexahydro-1,3,5-triazine-1,3,5-triyl)triethanol; 1,3,5-tris(2-hydroxyethyl)hexahydro-1,3,5-triazine"	225-208-0	4719-04-4	Acute Tox. 4 *Skin Sens. 1	H302H317	GHS07Wng	H302H317		"Skin Sens. 1; H317: C ? 0,1 %"		CLP00
613-115-00-1	hymexazol (ISO); 3-hydroxy-5-methylisoxazole	233-000-6	10004-44-1	Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 3	H302H318H412	GHS05GHS07Dgr	H302H318H412				CLP00
613-116-00-7	tolylfluanid (ISO); dichloro-N- [(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide; [containing = 0.1 % (w/w) of particles with an aerodynamic diameter of below 50 µm]	211-986-9	731-27-1	Acute Tox. 2 *STOT SE 3STOT RE 1Skin Irrit. 2Eye Irrit. 2Skin Sens. 1Aquatic Acute 1	H330H335H372 **H315H319H317H400	GHS06GHS08GHS09Dgr	H330H315H319H317H335H372 **H400		M=10		CLP00/ATP01
613-116-01-4	tolylfluanid (ISO); dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide; [containing < 0.1% (w/w) of particles with an aerodynamic diameter of below 50 ?m]	211-986-9	731-27-1	STOT SE 3Skin Irrit. 2Eye Irrit. 2Skin Sens. 1Aquatic Acute 1	H335H315H319H317H400	GHS07GHS09Wng	H319H335H315H317H400		M=10		ATP01
613-117-00-2	"diniconazole (ISO); (E)-?-[(2,4-dichlorophenyl)methylene]-?-(1,1-dimethylethyl)-1H-1,2,4-triazol-1-ethanol; (E)-(RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pent-1-en-3-ol"		76714-88-0	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410				CLP00
613-118-00-8	"flubenzimine (ISO); N-[3-phenyl-4,5-bis[(trifluoromethyl)imino]thiazolidin-2-ylidene]aniline"	253-703-1	37893-02-0	Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H319H400H410	GHS07GHS09Wng	H319H410				CLP00
613-119-00-3	(benzothiazol-2-ylthio)methyl thiocyanate; TCMTB	244-445-0	21564-17-0	Acute Tox. 2 *Acute Tox. 4 *Skin Irrit. 2Eye Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H330H302H315H319H317H400H410	GHS06GHS09Dgr	H330H302H319H315H317H410				CLP00
613-120-00-9	"bioresmethrin (ISO); (5-benzyl-3-furyl)methyl (1R)-2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropanecarboxylate"	249-014-0	28434-01-7	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410		M=1000		CLP00/ATP01corr
613-121-00-4	"chlorsulfuron (ISO); 2-chloro-N-[[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)amino]carbonyl]benzenesulphonamide"	265-268-5	64902-72-3	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
613-122-00-X	"diclobutrazole (ISO); (R*, R*)-(±)-?-[(2,4-dichlorophenyl)methyl]-?-(1,1-dimethylethyl)-1H-1,2,4-triazole-1-ethanol; (2RS, 3RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1yl)pentan-3-ol"		75736-33-3	Eye Irrit. 2Aquatic Chronic 2	H319H411	GHS07GHS09Wng	H319H411				CLP00
613-123-00-5	"5,6-dihydro-3H-imidazo[2,1-c]-1,2,4-dithiazole-3-thione; etem"	251-684-4	33813-20-6	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410				CLP00
613-124-00-0	"fenpropimorph (ISO); cis-4-[3-(p-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine"	266-719-9	67564-91-4	Repr. 2Acute Tox. 4 *Skin Irrit. 2Aquatic Chronic 2	H361d ***H302H315H411	GHS08GHS07GHS09Wng	H361d ***H302H315H411				CLP00
613-125-00-6	hexythiazox (ISO); trans-5-(4-chlorophenyl)-N-cyclohexyl-4-methyl-2-oxo-3-thiazolidine-carboxamide		78587-05-0	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
613-126-00-1	"imazapyr (ISO); 2-[4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazol-2-yl]-3-pyridine carboxylate"		81334-34-1	Eye Irrit. 2Aquatic Chronic 3	H319H412	GHS07Wng	H319H412				CLP00
613-127-00-7	"1,1-dimethylpiperidinium chloride; mepiquat chloride"	246-147-6	24307-26-4	Acute Tox. 4 *Aquatic Chronic 3	H302H412	GHS07Wng	H302H412				CLP00
613-128-00-2	"prochloraz (ISO); N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]-1H-imidazole-1-carboxamide"	266-994-5	67747-09-5	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410				CLP00
613-129-00-8	"metamitron (ISO); 4-amino-3-methyl-6-phenyl-1,2,4-triazin-5-one"	255-349-3	41394-05-2	Acute Tox. 4 *Aquatic Acute 1	H302H400	GHS07GHS09Wng	H302H400				CLP00
613-131-00-9	"pyroquilon (ISO); 1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-one"		57369-32-1	Acute Tox. 4 *Aquatic Chronic 3	H302H412	GHS07Wng	H302H412				CLP00
613-132-00-4	"hexazinone (ISO); 3-cyclohexyl-6-dimethylamino-1-methyl-1,2,3,4-tetrahydro-1,3,5-triazine-2,4-dione"	257-074-4	51235-04-2	Acute Tox. 4 *Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H302H319H400H410	GHS07GHS09Wng	H302H319H410				CLP00
613-133-00-X	"etridiazole (ISO); 5-ethoxy-3-trichloromethyl-1,2,4-thiadiazole"	219-991-8	2593-15-9	Carc. 2Acute Tox. 4Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H351H302H317H400H410	GHS08GHS07GHS09Wng	H302H317H351H410		M=1M=1		CLP00/ATP07
613-134-00-5	"myclobutanil (ISO); 2-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)hexanenitrile"		88671-89-0	Repr. 2Acute Tox. 4 *Eye Irrit. 2Aquatic Chronic 2	H361d ***H302H319H411	GHS08GHS07GHS09Wng	H361d ***H302H319H411				CLP00
613-135-00-0	di(benzothiazol-2-yl) disulphide	204-424-9	120-78-5	Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410	EUH031			CLP00
613-136-00-6	N-cyclohexylbenzothiazole-2-sulphenamide	202-411-2	95-33-0	Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410				CLP00
613-137-00-1	"methabenzthiazuron (ISO); 1-(1,3-benzothiazol-2-yl)1,3-dimethylurea"	242-505-0	18691-97-9	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
613-138-00-7	"quinoxyfen (ISO); 5,7-dichloro-4-(4-fluorophenoxy)quinoline"		124495-18-7	Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410				CLP00
613-139-00-2	"metsulfuron-methyl (ISO); methyl 2-{[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoyl]sulfamoyl}benzoate"		74223-64-6	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410		M=1000		CLP00/ATP01corr
613-140-00-8	"cycloheximide (ISO); 4-{}{(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl}}piperidine-2,6-dione"	200-636-0	66-81-9	Muta. 2Repr. 1BAcute Tox. 2 *Aquatic Chronic 2	H341H360D ***H300H411	GHS06GHS08GHS09Dgr	H341H360D ***H300H411				CLP00
613-141-00-3	"1,4-diamino-2-(2-butyltetrazol-5-yl)-3-cyanoanthraquinone"	401-470-3	93686-63-6	Aquatic Chronic 4	H413		H413				CLP00
613-142-00-9	trans-N-methyl-2-styryl-[4'-aminomethine-(1-acetyl-1-(2-methoxyphenyl)acetamido)]pyridinium acetate	405-860-4		Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				CLP00
613-143-00-4	1-(3-phenylpropyl)-2-methylpyridinium bromide	405-930-4	10551-42-5	Acute Tox. 4 *Eye Irrit. 2Aquatic Chronic 3	H302H319H412	GHS07Wng	H302H319H412				CLP00
613-144-00-X	"Reaction products of: poly(vinyl acetate), partially hydrolyzed, with (E)-2-(4-formylstyryl)-3,4-dimethylthiazoliummethyl sulfate"	406-460-2	125139-08-4	Aquatic Chronic 3	H412		H412				CLP00
613-145-00-5	"(S)-3-benzyloxycarbonyl-1,2,3,4-tetrahydro-isoquinolinium 4-methylbenzenesulfonate"	406-960-0	77497-97-3	Aquatic Chronic 2	H411	GHS09	H411				CLP00
613-146-00-0	N-ethyl-N-methylpiperidinium iodide	407-780-5	4186-71-4	Acute Tox. 4 *Aquatic Chronic 2	H302H411	GHS07GHS09Wng	H302H411				CLP00
613-147-00-6	4-[2-(1-methyl-2-(4-morpholinyl)ethoxy)ethyl]morpholine	407-940-4	111681-72-2	Eye Dam. 1	H318	GHS05Dgr	H318				CLP00
613-148-00-1	"tetrasodium 1,2-bis(4-fluoro-6-[5-(1-amino-2-sulfonatoanthrachinon-4-ylamino)-2,4,6-trimethyl-3-sulfonatophenylamino]-1,3,5-triazin-2-ylamino)ethane"	411-240-4	143683-23-2	Skin Sens. 1Aquatic Chronic 3	H317H412	GHS07Wng	H317H412				CLP00
613-149-00-7	pyridaben (ISO); 2-tert-butyl-5-(4-tert-butylbenzylthio)-4-chloropyridazin-3(2H)-one	405-700-3	96489-71-3	Acute Tox. 3Acute Tox. 3Aquatic Acute 1Aquatic Chronic 1	H331H301H400H410	GHS06GHS09Dgr	H331H301H410		M=1000M=1000		CLP00/ATP07
613-150-00-2	"2,2'-[3,3'-(piperazine-1,4-diyl)dipropyl]bis(1H-benzimidazo[2,1-b]benzo[l,m,n][3,8]phenanthroline-1,3,6-trione"	406-295-6		Aquatic Chronic 4	H413		H413				CLP00
613-151-00-8	1-(3-mesyloxy-5-trityloxymethyl-2-D-threofuryl)thymine	406-360-9	104218-44-2	Aquatic Chronic 4	H413		H413				CLP00
613-152-00-3	"phenyl N-(4,6-dimethoxypyrimidin-2-yl)carbamate"	406-600-2	89392-03-0	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				CLP00
613-153-00-9	"2,3,5-trichloropyridine"	407-270-2	16063-70-0	Aquatic Chronic 3	H412		H412				CLP00
613-154-00-4	2-amino-4-chloro-6-methoxypyrimidine	410-050-9	5734-64-5	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
613-155-00-X	"5-chloro-2,3-difluoropyridine"	410-090-7	89402-43-7	Flam. Liq. 3Acute Tox. 4 *Aquatic Chronic 3	H226H302H412	GHS02GHS07Wng	H226H302H412				CLP00
613-156-00-5	2-butyl-4-chloro-5-formylimidazole	410-260-0	83857-96-9	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				CLP00
613-157-00-0	"2,4-diamino-5-methoxymethylpyrimidine"	410-330-0	54236-98-5	Acute Tox. 4 *STOT RE 2 *Eye Irrit. 2	H302H373 **H319	GHS08GHS07Wng	H302H373 **H319				CLP00
613-158-00-6	"2,3-dichloro-5-trifluoromethyl-pyridine"	410-340-5	69045-84-7	Acute Tox. 4 *Acute Tox. 4 *Eye Dam. 1Skin Sens. 1Aquatic Chronic 2	H332H302H318H317H411	GHS05GHS07GHS09Dgr	H332H302H318H317H411				CLP00
613-159-00-1	"fenazaquin (ISO); 4-[2-[4-(1,1-dimethylethyl)phenyl]-ethoxy]quinazoline"	410-580-0	120928-09-8	Acute Tox. 3 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H301H332H400H410	GHS06GHS09Dgr	H301H332H410				CLP00
613-160-00-7	"(1S)-2-methyl-2,5-diazobicyclo[2.2.1]heptane dihydrobromide"	411-000-9	125224-62-6	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
613-161-00-2	"(2,4-diaminopteridin-6-yl)methanol hydrobromide"	430-620-0	76145-91-0	STOT RE 2 *Skin Sens. 1Aquatic Chronic 3	H373 **H317H412	GHS08GHS07Wng	H317H373 **H412				ATP01/ATP01corr
613-162-00-8	(6R-trans)-1-((7-ammonio-2-carboxylato-8-oxo-5-thia-1-azabicyclo-[4.2.0]oct-2-en-3-yl)methyl)pyridinium iodide	423-260-0	100988-63-4	Muta. 2Skin Sens. 1Aquatic Chronic 2	H341H317H411	GHS08GHS07GHS09Wng	H341H317H411				ATP01
613-163-00-3	"azimsulfuron (ISO); 1-(4,6-dimethoxypyrimidin-2-yl)-3-[1-methyl-4-(2-methyl-2H-tetrazol-5-yl)pyrazol-5-ylsulfonyl]urea"	-	120162-55-2	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410		M=1000		CLP00/ATP01
613-164-00-9	"flufenacet (ISO); N-(4-fluorophenyl)-N-isopropyl-2-(5-trifluoromethyl-[1,3,4]thiadiazol-2-yloxy)acetamide"	-	142459-58-3	Acute Tox. 4 *STOT RE 2 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H373 **H317H400H410	GHS08GHS07GHS09Wng	H302H373 **H317H410		M=100		CLP00/ATP01
613-165-00-4	"flupyrsulfuron-methyl-sodium (ISO); methyl 2-[[(4,6-dimethoxypyrimidin-2-ylcarbamoyl)sulfamoyl]-6-trifluoromethyl]nicotinate, monosodium salt"	-	144740-54-5	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410		M=100		CLP00/ATP01
613-166-00-X	"flumioxazin (ISO); N-(7-fluoro-3,4-dihydro-3-oxo-4-prop-2-ynyl-2H-1,4-benzoxazin-6-yl)cyclohex-1-ene-1,2-dicarboxamide"	-	103361-09-7	Repr. 1BAquatic Acute 1Aquatic Chronic 1	H360D ***H400H410	GHS08GHS09Dgr	H360D ***H410		M=1000		CLP00/ATP01
613-167-00-5	reaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7]; and 2-methyl-2H -isothiazol-3-one [EC no. 220-239-6] (3:1); reaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7]; and 2-methyl-4-isothiazolin-3-one [EC no. 220-239-6] (3:1)		55965-84-9	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H331H311H301H314H317H400H410	GHS06GHS05GHS09Dgr	H331H311H301H314H317H410		"Skin Corr. 1B; H314: C ? 0,6 %Skin Irrit. 2; H315: 0,06 % ? C < 0,6 %Eye Irrit. 2; H319: 0,06 % ? C < 0,6 %Skin Sens. 1; H317: C ? 0,0015 %"		CLP00
613-168-00-0	1-vinyl-2-pyrrolidone	201-800-4	88-12-0	Carc. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *STOT SE 3STOT RE 2 *Eye Dam. 1	H351H332H312H302H335H373 **H318	GHS06GHS05GHS09Dgr	H351H332H312H302H373 **H335H318			D	CLP00
613-169-00-6	9-vinylcarbazole	216-055-0	1484-13-5	Muta. 2Acute Tox. 4 *Acute Tox. 4 *Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H341H312H302H315H317H400H410	GHS08GHS07GHS09Wng	H341H312H302H315H317H410		M=100		CLP00/ATP01
613-170-00-1	"2,2-ethylmethylthiazolidine"	404-500-3	694-64-4	Acute Tox. 4 *Eye Dam. 1Skin Sens. 1Aquatic Chronic 2	H302H318H317H411	GHS05GHS07GHS09Dgr	H302H318H317H411				CLP00
613-171-00-7	"hexaconazole (ISO); (RS)-2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)hexan-2-ol"	413-050-7	79983-71-4	Acute Tox. 4 *Skin Sens. 1Aquatic Chronic 2	H302H317H411	GHS07GHS09Wng	H302H317H411				CLP00
613-172-00-2	"5-chloro-1,3-dihydro-2H-indol-2-one"	412-200-9	17630-75-0	Repr. 2Acute Tox. 4 *Skin Sens. 1Aquatic Chronic 3	H361f ***H302H317H412	GHS08GHS07Wng	H361f ***H302H317H412				CLP00
613-173-00-8	"fluquinconazole (ISO); 3-(2,4-dichlorophenyl)-6-fluoro-2-(1H-1,2,4-triazol-1-yl)quinazolin-4-(3H)-one"	411-960-9	136426-54-5	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 4 *STOT RE 1Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H331H301H312H372 **H315H400H410	GHS06GHS08GHS09Dgr	H331H301H372 **H312H315H410				CLP00
613-174-00-3	"tetraconazole (ISO); (±) 2-(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propyl-1,1,2,2-tetrafluoroethylether"	407-760-6	112281-77-3	Acute Tox. 4 *Acute Tox. 4 *Aquatic Chronic 2	H332H302H411	GHS07GHS09Wng	H332H302H411				CLP00/ATP01
613-175-00-9	"epoxiconazole (ISO); (2RS,3SR)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[( 1H-1,2,4-triazol-1-yl)methyl]oxirane"	406-850-2	133855-98-8	Carc. 2Repr. 1BAquatic Chronic 2	H351H360DfH411	GHS08GHS09Dgr	H351H360DfH411				CLP00/ATP05
613-176-00-4	2-methyl-2-azabicyclo[2.2.1]heptane	404-810-9	4524-95-2	Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Skin Corr. 1B	H226H312H302H373 **H314	GHS02GHS08GHS05GHS07Dgr	H226H312H302H373 **H314				CLP00
613-177-00-X	8-amino-7-methylquinoline	412-760-4	5470-82-6	Acute Tox. 4 *Acute Tox. 4 *Skin Sens. 1Aquatic Chronic 2	H312H302H317H411	GHS07GHS09Wng	H312H302H317H411				CLP00
613-178-00-5	"4-ethyl-2-methyl-2-isopentyl-1,3-oxazolidine"	410-470-2	137796-06-6	Skin Corr. 1BSkin Sens. 1	H314H317	GHS05GHS07Dgr	H314H317		STOT SE 3; H335: C ? 5 %		CLP00
613-179-00-0	"lithium 3-oxo-1,2(2H)-benzisothiazol-2-ide"	411-690-1	111337-53-2	Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Chronic 2	H302H314H317H411	GHS05GHS07Dgr	H302H314H317H411				CLP00
613-180-00-6	"N-(1,1-dimethylethyl)bis(2-benzothiazolesulfen)amide"	407-430-1	3741-80-8	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
613-181-00-1	"5,5-dimethyl-perhydro-pyrimidin-2-one ?-(4-trifluoromethylstyryl)-?-(4-trifluoromethyl)cinnamylidenehydrazone"	405-090-9	67485-29-4	Acute Tox. 4 *STOT RE 1Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H302H372 **H319H400H410	GHS08GHS07GHS09Dgr	H372 **H302H319H410				CLP00
613-182-00-7	1-(1-naphthylmethyl)quinolinium chloride	406-220-7	65322-65-8	Carc. 2Muta. 2Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1Aquatic Chronic 3	H351H341H302H315H318H412	GHS08GHS05GHS07Dgr	H351H341H302H315H318H412				CLP00
613-183-00-2	"reaction mass of: 5-(N-methylperfluorooctylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one; 5-(N-methylperfluoroheptylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one"	413-640-4		STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H373 **H400H410	GHS08GHS09Wng	H373 **H410				CLP00
613-184-00-8	nitrilotriethyleneammoniopropane-2-ol 2-ethylhexanoate	413-670-8		Eye Irrit. 2Skin Sens. 1	H319H317	GHS07Wng	H319H317				CLP00
613-185-00-3	"2,3,5,6-tetrahydro-2-methyl-2H-cyclopenta[d]-1,2-thiazol-3-one"	407-630-9	82633-79-2	Acute Tox. 3 *Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H301H318H317H400H410	GHS06GHS05GHS09Dgr	H301H318H317H410				CLP00
613-186-00-9	"(2R,3R)-3-((R)-1-(tert-butyldimethylsiloxy)ethyl)-4-oxoazetidin-2-yl acetate"	408-050-9	76855-69-1	Eye Irrit. 2Skin Sens. 1Aquatic Chronic 2	H319H317H411	GHS07GHS09Wng	H319H317H411				CLP00
613-187-00-4	"5-(2-amino-5-cyano-6-[2-(2-hydroxyethoxy)ethylamino]-4-methylpyridin-3-ylazo)-3-methyl-2,4-dicarbonitrilethiophene"	410-530-8	-	Skin Sens. 1	H317	GHS07Wng	H317				ATP01
613-188-00-X	1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinone	411-500-7	116256-11-2	Acute Tox. 4 *Eye Dam. 1Skin Sens. 1Aquatic Chronic 2	H302H318H317H411	GHS05GHS07GHS09Dgr	H302H318H317H411				CLP00
613-189-00-5	"1,4,7,10-tetrakis(p-toluensulfonyl)-1,4,7,10-tetraazacyclododecane"	414-030-0	52667-88-6	Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410				CLP00
613-190-00-0	"disodium 1-amino-4-(2-(5-chloro-6-fluoro-pyrimidin-4-ylamino-methyl)-4-methyl-6-sulfo-phenylamino)-9,10-dioxo-9,10-dihydro-anthracene-2-sulfonate"	414-040-5	149530-93-8	Acute Tox. 4 *Skin Sens. 1	H302H317	GHS07Wng	H302H317				CLP00
613-191-00-6	"3-ethyl-2-methyl-2-(3-methylbutyl)-1,3-oxazolidine"	421-150-7	143860-04-2	Repr. 1BSkin Corr. 1BAquatic Acute 1Aquatic Chronic 1	H360F ***H314H400H410	GHS08GHS05GHS09Dgr	H360F ***H314H410				CLP00
613-192-00-1	"3-benzyl-exo-6-nitro-2,4-dioxo-3-aza-cis-bicyclo[3.1.0]hexane"	426-750-2	151860-15-0	Skin Sens. 1Aquatic Chronic 3	H317H412	GHS07Wng	H317H412				ATP01
613-193-00-7	"pentakis[3-(dimethylammonio)propylsulfamoyl]-[(6-hydroxy-4,4,8,8-tetramethyl-4,8-diazoniaundecane-1,11-diyldisulfamoyl)di[phthalocyaninecopper(II)]] heptalactate"	414-930-3		Aquatic Chronic 2	H411	GHS09	H411				CLP00
613-194-00-2	"6,13-dichloro-3,10-bis{}{2-[4-fluoro-6-(2-sulfophenylamino)-1,3,5-triazin-2-ylamino]propylamino}}benzo[5,6][1,4]oxazino[2,3-.b.]phenoxazine-4,11-disulphonic acid, lithium-, sodium salt"	418-000-8	163062-28-0	Eye Dam. 1	H318	GHS05Dgr	H318				CLP00
613-195-00-8	"2,2-(1,4-phenylene)bis((4H-3,1-benzoxazine-4-one)"	418-280-1	18600-59-4	Skin Sens. 1Aquatic Chronic 4	H317H413	GHS07Wng	H317H413				CLP00
613-196-00-3	"5-[[4-chloro-6-[[2-[[4-fluoro-6-[[5-hydroxy-6-[(4-methoxy-2-sulfophenyl)azo]-7-sulfo-2-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-1-methylethyl]amino]-1,3,5-triazin-2-yl]amino]-3-[[4-(ethenylsulfonyl)phenyl]azo]-4-hydroxy-naphtalene-2,7-disulfonic acid, sodium salt"	418-380-5	168113-78-8	Eye Dam. 1	H318	GHS05Dgr	H318				CLP00
613-197-00-9	"reaction mass of: 2,4,6-tri(butylcarbamoyl)-1,3,5-triazine; 2,4,6-tri(methylcarbamoyl)-1,3,5-triazine; [(2-butyl-4,6-dimethyl)tricarbamoyl]-1,3,5-triazine; [(2,4-dibutyl-6-methyl)tricarbamoyl]-1,3,5-triazine"	420-390-1	187547-46-2	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				CLP00
613-198-00-4	"2-amino-4-dimethylamino-6-trifluoroethoxy-1,3,5-triazine"	415-500-8	145963-84-4	Acute Tox. 4 *STOT RE 2 *Aquatic Chronic 3	H302H373 **H412	GHS08GHS07Wng	H302H373 **H412				ATP01
613-199-00-X	"reaction mass of: 1,3,5-tris(3-aminomethylphenyl)-1,3,5-(1H,3H,5H)-triazine-2,4,6-trione; reaction mass of oligomers of 3,5-bis(3-aminomethylphenyl)-1-poly[3,5-bis(3-aminomethylphenyl)-2,4,6-trioxo-1,3,5-(1H,3H,5H)-triazin-1-yl]-1,3,5-(1H,3H,5H)-triazine-2,4,6-trione"	421-550-1		Carc. 1BRepr. 1BSkin Sens. 1Aquatic Chronic 3	H350H360D ***H317H412	GHS08Dgr	H350H360D ***H317H412				CLP00
613-200-00-3	"Reaction product of: copper, (29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32)-, chlorosulfuric acid and 3-(2-sulfooxyethylsulfonyl)aniline, sodium salts"	420-980-7		Eye Dam. 1	H318	GHS05Dgr	H318				CLP00
613-201-00-9	(R)-5-bromo-3-(1-methyl-2-pyrrolidinyl methyl)-1H-indole	422-390-5	143322-57-0	Repr. 2Acute Tox. 4 *Acute Tox. 4 *STOT RE 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H361f ***H332H302H372 **H317H400H410	GHS08GHS07GHS09Dgr	H361f ***H372 **H332H302H317H410	EUH070			CLP00
613-202-00-4	"pymetrozine (ISO); (E)-4,5-dihydro-6-methyl-4-(3-pyridylmethyleneamino)-1,2,4-triazin-3(2H)-one"		123312-89-0	Carc. 2Aquatic Chronic 3	H351H412	GHS08Wng	H351H412				CLP00
613-203-00-X	pyraflufen-ethyl (ISO); 2-chloro-5-(4-chloro-5-difluoromethoxy-1-methylpyrazol-3-yl)-4-fluorophenoxyacetic acid ethyl ester [1]pyraflufen (ISO); 2-chloro-5-(4-chloro-5-difluoromethoxy-1-methylpyrazol-3-yl)-4-fluorophenoxyacetic acid  [2]		129630-19-9 [1]129630-17-7 [2]	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410		M=1000		CLP00/ATP01
613-204-00-5	"oxadiargyl (ISO); 3-[2,4-dichloro-5-(2-propynyloxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one"	254-637-6	39807-15-3	Repr. 2STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H361d ***H373 **H400H410	GHS08GHS09Wng	H361d ***H373 **H410		M=1000		CLP00/ATP01corr
613-205-00-0	"propiconazole (ISO); (±)-1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazole"	262-104-4	60207-90-1	Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H317H400H410	GHS07GHS09Wng	H302H317H410				CLP00
613-206-00-6	"fenamidone (ISO); (S)-5-methyl-2-methylthio-5-phenyl-3-phenylamino-3,5-dihydroimidazol-4-one"		161326-34-7	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
613-208-00-7	imazamox (ISO); (RS)-2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)-5-methoxymethylnicotinic acid		114311-32-9	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
613-209-00-2	"cis-1-(3-chloropropyl)-2,6-dimethyl-piperidin hydrochloride"	417-430-3	63645-17-0	Acute Tox. 3 *STOT RE 2 *Skin Sens. 1Aquatic Chronic 2	H301H373 **H317H411	GHS06GHS08GHS09Dgr	H301H373 **H317H411				CLP00
613-210-00-8	"2-(3-chloropropyl)-2,5,5-trimethyl-1,3-dioxane"	417-650-1	88128-57-8	STOT RE 2 *Aquatic Chronic 3	H373 **H412	GHS08Wng	H373 **H412				CLP00
613-211-00-3	N-methyl-4-(p-formylstyryl)pyridinium methylsulfate	418-240-3	74401-04-0	Skin Sens. 1Aquatic Chronic 3	H317H412	GHS07Wng	H317H412				CLP00
613-212-00-9	"4-[4-(2-ethylhexyloxy)phenyl](1,4-thiazinane-1,1-dioxide)"	418-320-8	133467-41-1	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410				CLP00
613-213-00-4	cis-1-benzoyl-4-[(4-methylsulfonyl)oxy]-L-proline	416-040-0	120807-02-5	Aquatic Chronic 3	H412		H412				CLP00
613-214-00-X	"N,N-di-n-butyl-2-(1,2-dihydro-3-hydroxy-6-isopropyl-2-quinolylidene)-1,3-dioxoindan-5-carboxamide"	416-260-7	147613-95-4	Aquatic Chronic 4	H413		H413				CLP00
613-215-00-5	"2-chloromethyl-3,4-dimethoxypyridinium chloride"	416-440-5	72830-09-2	Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Chronic 2	H312H302H373 **H315H318H317H411	GHS08GHS05GHS07GHS09Dgr	H312H302H373 **H315H318H317H411				CLP00
613-216-00-0	"6-tert-butyl-7-(6-diethylamino-2-methyl-3-pyridylimino)-3-(3-methylphenyl)pyrazolo[3,2-c][1,2,4]triazole"	416-490-8	162208-01-7	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
613-217-00-6	"4-[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionyloxy]-1-[2-[3-(3,5-di-tert-butyl-4-hydrophenyl)propionyloxy]ethyl]-2,2,6,6-tetramethylpiperidine"	416-770-1	73754-27-5	Aquatic Chronic 4	H413		H413				CLP00
613-218-00-1	6-hydroxyindole	417-020-4	2380-86-1	Acute Tox. 4 *Eye Dam. 1Skin Sens. 1Aquatic Chronic 2	H302H318H317H411	GHS05GHS07GHS09Dgr	H302H318H317H411				CLP00
613-219-00-7	"7a-ethyl-3,5-bis(1-methylethyl)-2,3,4,5-tetrahydrooxazolo[3,4-c]-2,3,4,5-tetrahydrooxazole"	417-140-7	79185-77-6	Skin Irrit. 2Aquatic Chronic 2	H315H411	GHS07GHS09Wng	H315H411				CLP00
613-220-00-2	"trans-(4S,6S)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-ol, 7,7-dioxide"	417-290-3	147086-81-5	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
613-221-00-8	2-chloro-5-methyl-pyridine	418-050-0	18368-64-4	Acute Tox. 4 *Acute Tox. 4 *Skin Irrit. 2Aquatic Chronic 3	H312H302H315H412	GHS07Wng	H312H302H315H412				CLP00
613-222-00-3	4-(1-oxo-2-propenyl)-morpholine	418-140-1	5117-12-4	Acute Tox. 4 *STOT RE 2 *Eye Dam. 1Skin Sens. 1	H302H373 **H318H317	GHS08GHS05GHS07Dgr	H302H373 **H318H317				CLP00
613-223-00-9	N-isopropyl-3-(4-fluorophenyl)-1H-indole	418-790-4	93957-49-4	Aquatic Chronic 4	H413		H413				CLP00
613-224-00-4	"2,5-dimercaptomethyl-1,4-dithiane"	419-770-8	136122-15-1	Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H314H317H400H410	GHS05GHS07GHS09Dgr	H302H314H317H410				CLP00
613-225-00-X	"reaction mass of:[2-(anthraquinon-1-ylamino)-6-[(5-benzoylamino)-anthraquinone-1-ylamino]-4-phenyl]-1,3,5-triazine; 2,6-bis-[(5-benzoylamino)-anthraquinon-1-ylamino]-4-phenyl-1,3,5-triazine."	421-290-9		STOT RE 2 *Aquatic Chronic 4	H373 **H413	GHS08Wng	H373 **H413				CLP00
613-226-00-5	1-(2-(ethyl(4-(4-(4-(4-(ethyl(2-pyridinoethyl)amino)-2-methylphenylazo)benzoylamino)-phenylazo)-3-methylphenyl)amino)ethyl)-pyridinium dichloride	420-950-3	163831-67-2	Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H318H400H410	GHS05GHS09Dgr	H318H410				CLP00
613-227-00-0	"(±)-[(R*,R*) and (R*,S*)]-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran"	419-600-2	99199-90-3	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				CLP00
613-228-00-6	"(±)-(R*,S*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran"	419-630-6	793669-26-8	Aquatic Chronic 2	H411	GHS09	H411				CLP00
613-229-00-1	"1-acetyl-4-(3-dodecyl-2,5-dioxo-1-pyrrolidinyl)-2,2,6,6-tetramethylpiperidine"	411-930-5	106917-31-1	Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H315H317H400H410	GHS07GHS09Wng	H315H317H410				ATP01
613-230-00-7	"florasulam (ISO); 2',6',8-trifluoro-5-methoxy-5-triazolo[1,5-c]; pyrimidine-2-sulfonanilide"		145701-23-1	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
613-231-00-2	"2,6-diamino-3-((pyridine-3-yl)azo)pyridine"	421-430-9	28365-08-4	Acute Tox. 4 *STOT RE 2 *Aquatic Chronic 2	H302H373 **H411	GHS08GHS07GHS09Wng	H302H373 **H411				ATP01
613-232-00-8	"3-(benzo[b]thien-2-yl)-5,6-dihydro-1,4,2-oxathiazine-4-oxide"	431-030-6	163269-30-5	Acute Tox. 3 *STOT RE 2 *Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H331H373 **H318H400H410	GHS06GHS05GHS08GHS09Dgr	H331H373 **H318H410				ATP01
613-233-00-3	"4,4'-(oxy-(bismethylene))-bis-1,3-dioxolane"	423-230-7	56552-15-9	Eye Dam. 1	H318	GHS05Dgr	H318				CLP00
613-234-00-9	"imidazo[1,2-b]pyridazin hydrochloride"	431-510-5	18087-70-2	Acute Tox. 4 *Eye Irrit. 2	H302H319	GHS07Wng	H302H319				ATP01
613-235-00-4	"2,3-dihydro-2,2-dimethyl-1H-perimidine"	424-060-6	6364-17-6	Acute Tox. 4 *STOT RE 2 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H373 **H317H400H410	GHS08GHS07GHS09Wng	H302H373 **H317H410				ATP01
613-236-00-X	2-chloro-3-trifluoromethylpyridine	424-520-6	65753-47-1	Acute Tox. 3 *Acute Tox. 3 *STOT RE 1Skin Corr. 1BAquatic Chronic 3	H311H301H372 **H314H412	GHS06GHS05GHS08Dgr	H311H301H372 **H314H412				ATP01
613-237-00-5	"6-tert-butyl-3-(3-dodecylsulfonyl)propyl-7H-1,2,4-triazolo[3.4b][1,3,4]thiadiazine"	424-950-4	133949-92-5	Aquatic Chronic 4	H413	-	H413				ATP01
613-238-00-0	"sodium 2-[[4-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]phenyl]sulfonyl]ethyl sulfate"	430-890-1	81992-66-7	Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410				ATP01
613-239-00-6	2-[3-(methylamino)propyl]-1H-benzimidazole	425-760-4	64137-52-6	Eye Dam. 1Aquatic Chronic 3	H318H412	GHS05Dgr	H318H412				ATP01
613-241-00-7	3-(2H-tetrazol-5-yl)pyridine	426-810-8	3250-74-6	Eye Dam. 1	H318	GHS05Dgr	H318				ATP01
613-242-00-2	"reaction products of 3,10-bis((2-aminopropyl)amino)-6,13-dichloro-4,11-triphenodioxazinedisulfonic acid with 2-amino-1,4-benzenedisulfonic acid, 2-((4-aminophenyl)sulfonyl)ethyl hydrogen sulfate and 2,4,6-trifluoro-1,3,5-triazine, sodium salts"	426-860-0	191877-09-5	Eye Dam. 1	H318	GHS05Dgr	H318				ATP01
613-243-00-8	"4,4'-(1,6-hexamethylenebis(formylimino))bis(2,2,6,6-tetramethyl-1-oxylpiperidine)"	427-350-0	182235-14-9	Aquatic Chronic 2	H411	GHS09	H411				ATP01
613-244-00-3	"5,7-dichloro-4-hydroxyquinoline"	427-420-0	21873-52-9	Aquatic Chronic 2	H411	GHS09	H411				ATP01
613-245-00-9	2-fluoro-6-trifluoromethylpyridine	428-100-3	94239-04-0	Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *Aquatic Chronic 3	H226H332H302H412	GHS02GHS07Wng	H226H332H302H412				ATP01
613-246-00-4	"2-hydroxymethyl-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine"	428-200-7	103577-66-8	Aquatic Chronic 3	H412	-	H412				ATP01
613-247-00-X	3-(2-methoxy-4-methoxycarboxybenzyl)-5-nitroindole	428-910-7	107786-36-7	Aquatic Chronic 4	H413	-	H413				ATP01
613-248-00-5	"3,4-dimethyl-1H-pyrazole"	429-130-1	2820-37-3	Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 3	H302H318H412	GHS05GHS07Dgr	H302H318H412				ATP01
613-249-00-0	"1-(2-hydroxyethyl)-1H-pyrazol-4,5-diyldiammoniumsulfate"	429-300-3	155601-30-2	Eye Dam. 1Skin Sens. 1Aquatic Chronic 2	H318H317H411	GHS05GHS07GHS09Dgr	H318H317H411				ATP01
613-250-00-6	"reaction mass of: carbonato-bis-N-ethyl-2-isopropyl-1,3-oxazolidine; methyl carbonato-N-ethyl-2-isopropyl-1,3-oxazolidine; 2-isopropyl-N-hydroxyethyl 1,3-oxazolidine"	429-990-6	-	Eye Dam. 1Skin Sens. 1Aquatic Chronic 3	H318H317H412	GHS05GHS07Dgr	H318H317H412				ATP01
613-251-00-1	(R)-3-[(1-methylpyrrolidin-2-yl)methyl]-5-[2-(phenylsulfonyl)ethenyl]-1H-indole	430-560-5	180637-89-2	Acute Tox. 4 *STOT RE 2 *Eye Dam. 1Skin Sens. 1	H302H373 **H318H317	GHS05GHS08GHS07Dgr	H302H373 **H318H317				ATP01
613-253-00-2	"2,2-dialkyl-4-hydroxymethyl-1,3-dioxolane; reaction products with ethylene oxide (alkyl is C1-12 and the sum to C13, average degree of ethoxylation is 3.5)"	430-580-4	-	Skin Irrit. 2Aquatic Chronic 2	H315H411	GHS07GHS09Wng	H315H411	EUH019			ATP01
613-254-00-8	forchlorfenuron (ISO); 1-(2-chloro-4-pyridyl)-3-phenylurea	-	68157-60-8	Carc. 2Aquatic Chronic 2	H351H411	GHS08GHS09Wng	H351H411				ATP01
613-255-00-3	reaction mass of isomers of: sodium [(2-hydroxyethylsulfamoyl){[2-(2-piperazin-1-ylethylamino)ethylsulfamoyl][2-(4-aminoethylpiperazine-1-yl)ethylsulfamoyl](sulfamoyl)}(sulfonatophthalocyaninato)]copper(II)	424-270-8	-	Eye Dam. 1	H318	GHS05Dgr	H318				ATP01
613-256-00-9	3'5'-anhydro thymidine	425-810-5	38313-48-3	Aquatic Chronic 3	H412	-	H412				ATP01
613-257-00-4	2-phthalimidoethyl N-[4-(2-cyano-4-nitrophenylazo)phenyl]-N-methyl-?-alaninate	426-400-9	170222-39-6	Skin Sens. 1Aquatic Chronic 4	H317H413	GHS07Wng	H317H413				ATP01
613-258-00-X	reaction mass of: 4-chloro-7-methylbenzotriazole sodium salt; 4-chloro-5-methylbenzotriazole sodium salt; 5-chloro-4-methylbenzotriazole sodium salt	427-730-6	202420-04-0	Skin Corr. 1BAquatic Chronic 3	H314H412	GHS05Dgr	H314H412				ATP01
613-259-00-5	"reaction mass of: [2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-cis-chrysanthemate; [2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-trans-chrysanthemate"	428-790-6	72963-72-5	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410				ATP01
613-260-00-0	(±)-4-(3-chlorophenyl)-6-[(4-chlorophenyl)hydroxy(1-methyl-1H-imidazol-5-yl)methyl]-1-methyl-2(1H)-quinolin	430-730-9	-	Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H318H400H410	GHS05GHS09Dgr	H318H410				ATP01
613-261-00-6	pyrazole-1-carboxamidine monohydrochloride	429-520-1	4023-02-3	Acute Tox. 4 *STOT RE 2 *Eye Dam. 1Skin Sens. 1Aquatic Chronic 3	H302H373 **H318H317H412	GHS05GHS08GHS07Dgr	H302H373 **H318H317H412				ATP01
613-262-00-1	"disodium (E)-1,2-bis-(4-(4-methylamino-6-(4-methylcarbamoylphenylamino)-1,3,5-triazin-2-ylamino)phenyl-2-sulfonato)ethene"	427-310-2	180850-95-7	Eye Dam. 1	H318	GHS05Dgr	H318				ATP01
613-263-00-7	monosodium 3-cyano-5-fluoro-6-hydroxypyridine-2-olate	429-570-2	-	Skin Sens. 1	H317	GHS07Wng	H317				ATP01
613-266-00-3	2-chloro-5-chloromethylthiazole	429-830-5	105827-91-6	Acute Tox. 3 *Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Chronic 2	H311H302H314H317H411	GHS06GHS05GHS09Dgr	H311H314H302H317H411				ATP01
613-267-00-9	"thiamethoxam (ISO); 3-(2-chloro-thiazol-5-ylmethyl)-5-methyl[1,3,5]oxadiazinan-4-ylidene-N-nitroamine"	428-650-4	153719-23-4	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410		M=10		ATP01
613-268-00-4	(4aS-cis-)-6-benzyl-octahydropyrrolo[3.4-b]pyridine	425-930-8	151213-39-7	Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Skin Corr. 1BAquatic Chronic 2	H332H302H373 **H314H411	GHS05GHS08GHS07GHS09Dgr	H314H332H302H373 **H411				ATP01
613-269-00-X	2-thiazolidinylidenecyanamide	427-720-1	26364-65-8	Acute Tox. 4 *STOT RE 2 *Aquatic Chronic 3	H302H373 **H412	GHS08GHS07Wng	H302H373 **H412				ATP01
613-270-00-5	"5-amino-N-(2,6-dichloro-3-methylphenyl)-1H-1,2,4-triazole-3-sulfonamide"	428-150-6	113171-13-4	Aquatic Chronic 3	H412	-	H412				ATP01
613-271-00-0	"tritosulfuron (ISO) (containing ? 0,02% AMTT); 1-[4-methoxy-6-(trifluoromethyl)-1,3,5-triazin-2-yl]-3-[2-(trifluoromethyl)benzenesulfonyl]urea (containing ? 0,02% AMTT)"	-	142469-14-5	Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410		M=10		ATP01
613-272-00-6	pyraclostrobin (ISO); methyl N-{2-[1-(4-chlorophenyl)-1H-pyrazol-3-yloxymethyl]phenyl}(N-methoxy)carbamate	-	-	Acute Tox. 3 *Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H331H315H400H410	GHS06GHS09Dgr	H331H315H410		M=100		ATP01
613-273-00-1	"tetrahydro-3-methyl-5-((2-phenylthio)thiazol-5-ylmethyl)-[4H]-1,3,5-oxadiazinan-4-ylidene-N-nitroamine"	427-600-9	192439-46-6	Aquatic Chronic 2	H411	GHS09	H411				ATP01
613-274-00-7	"2,6-dichloro-1-fluoropyridiniumtetrafluoroborate"	427-400-1	140623-89-8	Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H314H317H400H410	GHS05GHS07GHS09Dgr	H314H302H317H410				ATP01
613-275-00-2	"3-(2-chloroethyl)-6,7,8,9-tetra-hydro-2-methyl-4H-pyrido[1,2-a] pyrimidin-4-one monohydrochloride"	424-530-0	93076-03-0	Acute Tox. 3 *STOT SE 2STOT RE 2 *Eye Dam. 1Skin Sens. 1Aquatic Chronic 2	H301H371 **H373 **H318H317H411	GHS06GHS05GHS08GHS09Dgr	H301H318H317H371 **H373 **H411				ATP01/ATP01corr
613-276-00-8	"1-(2-chlorophenyl)-1,2-dihydro-5H-tetrazol-5-one"	426-110-2	98377-35-6	Skin Sens. 1Aquatic Chronic 3	H317H412	GHS07Wng	H317H412				ATP01
613-277-00-3	"(4-(6-diethylamino-2-methylpyridin-3-yl)imino-4,5-dihydro-3-methyl-1-(4-methylphenyl)-1H-pyrazol-5-one"	427-070-9	-	Aquatic Chronic 4	H413	-	H413				ATP01
613-278-00-9	(3-aminophenyl)pyridin-3-ylmethanone	428-230-0	79568-06-2	STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H373 **H400H410	GHS08GHS09Wng	H373 **H410				ATP01
613-279-00-4	"2-ethyl-2,3-dihydro-2-methyl-1H-perimidine"	424-380-6	43057-68-7	Acute Tox. 4 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H302H373 **H400H410	GHS08GHS07GHS09Wng	H302H373 **H410				ATP01
613-280-00-X	"tetrahydro-1,3-dimethyl-1H-pyrimidin-2-one; dimethyl propyleneurea"	230-625-6	7226-23-5	Repr. 2Acute Tox. 4 *Eye Dam. 1	H361f ***H302H318	GHS05GHS08GHS07Dgr	H361f ***H302H318				ATP01
613-281-00-5	quinoline	202-051-6	91-22-5	Carc. 1BMuta. 2Acute Tox. 4 *Acute Tox. 4 *Skin Irrit. 2Eye Irrit. 2Aquatic Chronic 2	H350H341H312H302H315H319H411	GHS08GHS07GHS09Dgr	H350H341H312H302H319H315H411				ATP01
613-282-00-0	"triticonazole (ISO); (RS)-(E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanol"	-	131983-72-7	Aquatic Chronic 2	H411	GHS09	H411				ATP01
613-283-00-6	"ketoconazole; 1-[4-[4-[[(2SR,4RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone"	265-667-4	65277-42-1	Repr. 1BAcute Tox. 3 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H360F ***H301H373 **H400H410	GHS06GHS08GHS09Dgr	H360F ***H301H373 **H410				ATP01
613-284-00-1	"metconazole (ISO); (1RS,5RS;1RS,5SR)-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol"	-	125116-23-6	Repr. 2Acute Tox. 4 *Aquatic Chronic 2	H361d ***H302H411	GHS08GHS07GHS09Wng	H361d ***H302H411				ATP01
613-285-00-7	"1-hydroxybenzotriazole, anhydrous [1]1-hydroxybenzotriazole, monohydrated  [2]"	219-989-7 [1]219-989-7 [2]	2592-95-2 [1]123333-53-9 [2]	Expl. 1.3	H203	GHS01Dgr	H203				ATP01
613-286-00-2	"potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate; [containing < 0.5 % N,N-dimethylformamide (EC no 200-679-5)]"	418-260-2	183196-57-8	Skin Sens. 1	H317	GHS07Wng	H317				ATP01
613-286-01-X	"potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate; [containing ? 0.5 % N,N-dimethylformamide (EC No 200-679-5)]"	418-260-2	183196-57-8	Repr. 1BSkin Sens. 1	H360D ***H317	GHS08GHS07Dgr	H360D ***H317				ATP01
613-287-00-8	"1-(3-iodo-4-aminobenzyl)-1H-1,2,4-triazole"	419-540-7	160194-26-3	Acute Tox. 4 *Skin Sens. 1Aquatic Chronic 2	H302H317H411	GHS07GHS09Wng	H302H317H411				ATP01
613-288-00-3	"1,3-bis(dimethylcarbamoyl)-imidazolium chloride"	420-930-4	135756-61-5	Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 3	H302H318H412	GHS05GHS07Dgr	H302H318H412				ATP01
613-289-00-9	3-(4-chloro-2-fluoro-5-methylphenyl)-1-methyl-5-(trifluoromethyl)-1H-pyrazole	432-020-4	142623-48-1	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				ATP01
613-290-00-4	"4-hydroxy-7-(2-aminoethyl)-1,3-benzothiazol-2(3H)-one hydrochloride"	432-470-1	189012-93-9	Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H318H317H400H410	GHS05GHS07GHS09Dgr	H318H317H410				ATP01
613-291-00-X	"2,4-dihydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one"	434-820-9	106461-41-0	STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H373 **H400H410	GHS08GHS09Wng	H373 **H410				ATP01
613-292-00-5	"N,N',N''-tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazine"	435-010-8	26157-73-3	Muta. 2Aquatic Chronic 3	H341H412	GHS08Wng	H341H412				ATP01
613-293-00-0	"2-(4-tert-butylphenyl)-6-cyano-5-[bis(ethoxycarbonylmethyl)carbamoyloxy]-1H-pyrrolo[1,2-b][1,2,4] triazole-7-carboxylic acid 2,6-di-tert-butyl-4-methylcyclohexylester"	448-050-6	444065-11-6	Aquatic Chronic 4	H413	-	H413				ATP01
613-294-00-6	"2-hexyldecanoic acid [4-(6-tert-butyl-7-chloro-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenylcarbamoyl]methylester"	448-260-8	379268-96-9	Aquatic Chronic 4	H413	-	H413				ATP01
613-295-00-1	"11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]thiazepine hydrochloride"	448-720-8	363138-44-7	Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 3	H302H318H412	GHS05GHS07Dgr	H302H318H412				ATP01
613-296-00-7	"pentapotassium 2-(4-(5-[1-(2,5-disulfonatophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-methyl-1,3-pentadienyl)-3-methylcarbamoyl-5-oxidopyrazol-1-yl)benzene-1,4-disulfonate"	418-270-7	-	Skin Sens. 1Aquatic Chronic 3	H317H412	GHS07Wng	H317H412				ATP01
613-297-00-2	5-(2-bromophenyl)-2-tert-butyl-2H-tetrazole	420-820-6	-	Flam. Liq. 3Acute Tox. 4 *Aquatic Chronic 2	H226H302H411	GHS02GHS07GHS09Wng	H226H302H411				ATP01
613-298-00-8	bis-(6-hydroxy-4-methyl-5-(3-methylimidazolium-1-yl)-3-(4-phenylazo)-1H-pyridin-2-one)ethylene dilactate	421-560-6	-	STOT RE 2 *Eye Dam. 1Aquatic Chronic 2	H373 **H318H411	GHS05GHS08GHS09Dgr	H373 **H318H411				ATP01
613-299-00-3	"main component 1 (isomer 1): 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonapht-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt; main component 1 (isomer 2): 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt; main component 2: 2,3-bis-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt; main component 3: 2,3-bis-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt"	422-610-1	-	Eye Dam. 1	H318	GHS05Dgr	H318				ATP01
613-300-00-7	1-imidazol-1-yl-octadecan-2-ol	434-120-3	-	Skin Sens. 1Aquatic Chronic 4	H317H413	GHS07Wng	H317H413				ATP01
613-301-00-2	"dimethyl-1-{[2-methoxy-5-(2-methyl-butoxycarbonyl)phenylcarbamoyl]-[2-octadecyl-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]methyl} imidazole-4,5-dicarboxylate"	443-910-7	-	Aquatic Chronic 4	H413	-	H413				ATP01
613-302-00-8	"disodium 2-(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6-oxo-1,6-dihydro-pyridine-3-ylazo)-4-(4-fluoro-6-(4-(2-sulfonyloxy-ethylsulfonyl)-phenylamino)-1,3,5-triazine-2-ylamino)benzene sulfonate"	432-980-4	243858-60-8	Eye Dam. 1	H318	GHS05Dgr	H318				ATP01
613-303-00-3	2-(1-methyl-2-(4-phenoxyphenoxy)ethoxy)pyridine	429-800-1	95737-68-1	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				ATP01
613-304-00-9	"5,6-dihydroxy-2,3-dihydro-1H-indolium bromide"	421-170-6	138937-28-7	Acute Tox. 4 *Eye Dam. 1	H302H318	GHS05GHS07Dgr	H302H318				ATP01
613-305-00-4	2-(2-hydroxy-4-octyloxyphenyl)-2H-benzotriazole	448-630-9	3147-77-1	Aquatic Chronic 4	H413	-	H413				ATP01
613-306-00-X	"(2,5-dioxopyrrolidin-1-yl)-9H-fluoren-9-ylmethyl carbonate"	433-520-5	82911-69-1	Acute Tox. 4 *Skin Sens. 1Aquatic Chronic 2	H302H317H411	GHS07GHS09Wng	H302H317H411				ATP01
613-307-00-5	"clothianidin (ISO); 3-[(2-chloro-1,3-thiazol-5-yl)methyl]-2-methyl-1-nitroguanidine"	-	210880-92-5	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410		M=10		ATP01
613-308-00-0	2-amino-5-methylthiazole	423-800-5	7305-71-7	Acute Tox. 4 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H302H373 **H400H410	GHS08GHS07GHS09Wng	H302H373 **H410				ATP01
613-309-00-6	1-methyl-3-phenyl-1-piperazine	431-180-2	5271-27-2	Acute Tox. 4 *Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1Aquatic Chronic 3	H312H302H315H318H412	GHS05GHS07Dgr	H312H302H315H318H412				ATP01
613-310-00-1	"(-)(3S,4R)-4-(4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)-N-benzylpiperidine hydrochloride"	432-360-3	105813-13-6	Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H317H400H410	GHS07GHS09Wng	H302H317H410				ATP01
613-311-00-7	methyl-5-nitrophenyl-guanidine	435-500-1	152460-07-6	Acute Tox. 4 *Eye Irrit. 2Skin Sens. 1Aquatic Chronic 3	H302H319H317H412	GHS07Wng	H302H319H317H412				ATP01
613-312-00-2	2-(4-methyl-2-phenyl-1-piperazinyl)benzenemethanol monohydrochloride	420-200-5	-	Acute Tox. 4 *Eye Dam. 1Skin Sens. 1Aquatic Chronic 3	H302H318H317H412	GHS05GHS07Dgr	H302H318H317H412				ATP01
613-313-00-8	"2-(4-(4-(3-pyridinyl)-1H-imidazol-1-yl)butyl)-1H-isoindole-1,3(2H)-dione"	442-780-9	173838-67-0	Aquatic Chronic 3	H412	-	H412				ATP01
613-314-00-3	"4-decyloxazolidin-2-one; 4-decyl-1,3-oxazolidin-2-one"	443-770-7	7693-82-5	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				ATP01
613-315-00-9	"tetrapotassium 4-[5-[3-carboxylato-4,5-dihydro-5-oxo-1-(4-sulfonatophenyl)pyrazol-4-ylidene]-3-(piperidinocarbonyl)penta-1,3-dienylidene]-5-hydroxy-1-(4-sulfonatophenyl)pyrazole-3-carboxylate"	430-390-1	-	Acute Tox. 4 *Aquatic Chronic 3	H332H412	GHS07Wng	H332H412				ATP01
613-316-00-4	trimethylopropane tri(3-aziridinylpropanoate); (TAZ)	257-765-0	52234-82-9	Muta. 2Eye Dam. 1Skin Sens. 1	H341H318H317	GHS05GHS08GHS07Dgr	H341H318H317				ATP01
613-317-00-X	"penconazole (ISO); 1-[2-(2,4-dichlorophenyl)pentyl]-1H-1,2,4-triazole"		66246-88-6	Repr. 2Acute Tox. 4Aquatic Acute 1Aquatic Chronic 1	H361dH302H400H410	GHS08GHS07GHS09Wng	H302H361dH410		M=1M=1		ATP06
613-318-00-5	"fenpyrazamine (ISO); S-allyl 5-amino-2-isopropyl-4-(2-methylphenyl)-3-oxo-2,3-dihydro-1H-pyrazole-1-carbothioate"		473798-59-3	Aquatic Chronic 2	H411	GHS09	H411				ATP06
613-319-00-0	imidazole	206-019-2	288-32-4	Repr. 1BAcute Tox. 4Skin Corr. 1C	H360DH302H314	GHS08GHS07GHS05Dgr	H302H314H360D				ATP07
613-320-00-6	"lenacil (ISO); 3-cyclohexyl-6,7-dihydro-1H-cyclopenta[d]pyrimidine-2,4(3H,5H)-dione"	218-499-0	2164-08-1	Carc. 2Aquatic Acute 1Aquatic Chronic 1	H351H400H410	GHS08GHS09Wng	H351H410		M=10M=10		ATP07
614-001-00-4	nicotine (ISO); 3-(N-methyl-2-pyrrolidinyl)pyridine	200-193-3	54-11-5	Acute Tox. 1Acute Tox. 3 *Aquatic Chronic 2	H310H301H411	GHS06GHS09Dgr	H310H301H411				CLP00
614-002-00-X	salts of nicotine			Acute Tox. 1Acute Tox. 2 *Acute Tox. 2 *Aquatic Chronic 2	H310H330H300H411	GHS06GHS09Dgr	H330H310H300H411			A	CLP00
614-003-00-5	strychnine	200-319-7	57-24-9	Acute Tox. 1Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1	H310H300H400H410	GHS06GHS09Dgr	H310H300H410				CLP00
614-004-00-0	salts of strychnine			Acute Tox. 2 *Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1	H330H300H400H410	GHS06GHS09Dgr	H330H300H410			A	CLP00
614-005-00-6	colchicine	200-598-5	64-86-8	Muta. 1BAcute Tox. 2 *	H340H300	GHS06GHS08Dgr	H340H300				CLP00/ATP01
614-006-00-1	"brucine; 2,3-dimethoxystrychnine"	206-614-7	357-57-3	Acute Tox. 2 *Acute Tox. 2 *Aquatic Chronic 3	H330H300H412	GHS06Dgr	H330H300H412				CLP00
614-007-00-7	"brucine sulphate [1]brucine nitrate [2]Strychnidin-10-one, 2,3-dimethoxy-, mono[(R)-1-methylheptyl 1,2-benzenedicarboxylate] [3]Strychnidin-10-one, 2,3-dimethoxy-, compd. with (S)mono(1-methylheptyl)-1,2-benzenedicarboxylate (1:1)  [4]"	225-432-9 [1]227-317-9 [2]269-439-5 [3]269-710-8 [4]	4845-99-2 [1]5786-97-0 [2]68239-26-9 [3]68310-42-9 [4]	Acute Tox. 2 *Acute Tox. 2 *Aquatic Chronic 3	H330H300H412	GHS06Dgr	H330H300H412			A	CLP00
614-008-00-2	aconitine	206-121-7	302-27-2	Acute Tox. 2 *Acute Tox. 2 *	H330H300	GHS06Dgr	H330H300				CLP00
614-009-00-8	salts of aconitine			Acute Tox. 2 *Acute Tox. 2 *	H330H300	GHS06Dgr	H330H300			A	CLP00
614-010-00-3	atropine	200-104-8	51-55-8	Acute Tox. 2 *Acute Tox. 2 *	H330H300	GHS06Dgr	H330H300				CLP00
614-011-00-9	salts of atropine			Acute Tox. 2 *Acute Tox. 2 *	H330H300	GHS06Dgr	H330H300			A	CLP00
614-012-00-4	hyoscyamine	202-933-0	101-31-5	Acute Tox. 2 *Acute Tox. 2 *	H330H300	GHS06Dgr	H330H300				CLP00
614-013-00-X	salts of hyoscyamine			Acute Tox. 2 *Acute Tox. 2 *	H330H300	GHS06Dgr	H330H300			A	CLP00
614-014-00-5	hyoscine	200-090-3	51-34-3	Acute Tox. 1Acute Tox. 2 *Acute Tox. 2 *	H310H330H300	GHS06Dgr	H330H310H300				CLP00
614-015-00-0	salts of hyoscine			Acute Tox. 1Acute Tox. 2 *Acute Tox. 2 *	H310H330H300	GHS06Dgr	H330H310H300			A	CLP00
614-016-00-6	pilocarpine	202-128-4	92-13-7	Acute Tox. 2 *Acute Tox. 2 *	H330H300	GHS06Dgr	H330H300				CLP00
614-017-00-1	salts of pilocarpine			Acute Tox. 2 *Acute Tox. 2 *	H330H300	GHS06Dgr	H330H300			A	CLP00
614-018-00-7	papaverine	200-397-2	58-74-2	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
614-019-00-2	salts of papaverine			Acute Tox. 4 *	H302	GHS07Wng	H302			A	CLP00
614-020-00-8	physostigmine	200-332-8	57-47-6	Acute Tox. 2 *Acute Tox. 2 *	H330H300	GHS06Dgr	H330H300				CLP00
614-021-00-3	salts of physostigmine			Acute Tox. 2 *Acute Tox. 2 *	H330H300	GHS06Dgr	H330H300			A	CLP00
614-022-00-9	digitoxin	200-760-5	71-63-6	Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *	H331H301H373 **	GHS06GHS08Dgr	H331H301H373 **				CLP00
614-023-00-4	ephedrine	206-080-5	299-42-3	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
614-024-00-X	salts of ephedrine			Acute Tox. 4 *	H302	GHS07Wng	H302			A	CLP00
614-025-00-5	ouabain	211-139-3	630-60-4	Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *	H331H301H373 **	GHS06GHS08Dgr	H331H301H373 **				CLP00
614-026-00-0	strophantin-K	234-239-9	11005-63-3	Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *	H331H301H373 **	GHS06GHS08Dgr	H331H301H373 **				CLP00
614-027-00-6	"bufa-4,20,22-trienolide, 6-(acetyloxy)-3-(?-D-glucopyranosyloxy)-8,14-dihydroxy-, (3?, 6?)-; red squill; scilliroside"	208-077-4	507-60-8	Acute Tox. 2 *	H300	GHS06Dgr	H300				CLP00
614-028-00-1	reaction mass of: 2-ethylhexyl mono-D-glucopyranoside; 2-ethylhexyl di-D-glucopyranoside	414-420-0		Eye Dam. 1	H318	GHS05Dgr	H318				CLP00
614-029-00-7	constitutional isomers of penta-O-allyl-?-D-fructofuranosyl-?-D-glucopyranoside; constitutional isomers of hexa-O-allyl-?-D-fructofuranosyl-?-D-glucopyranoside; constitutional isomers of hepta-O-allyl-?-D-fructofuransoyl-?-D-glucopyranoside	419-640-0	68784-14-5	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
615-001-00-7	methyl isocyanate	210-866-3	624-83-9	Flam. Liq. 2Repr. 2Acute Tox. 2 *Acute Tox. 3 *Acute Tox. 3 *STOT SE 3Skin Irrit. 2Eye Dam. 1Resp. Sens. 1Skin Sens. 1	H225H361d ***H330H311H301H335H315H318H334H317	GHS02GHS06GHS05GHS08Dgr	H225H361d ***H330H311H301H334H317H335H315H318				CLP00/ATP01
615-002-00-2	methyl isothiocyanate	209-132-5	556-61-6	Acute Tox. 3 *Acute Tox. 3 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H331H301H314H317H400H410	GHS06GHS05GHS09Dgr	H331H301H314H317H410				CLP00
615-003-00-8	thiocyanic acid	207-337-4	463-56-9	Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Chronic 3	H332H312H302H412	GHS07Wng	H332H312H302H412	EUH032			CLP00
615-004-00-3	"salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex"	-	-	Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Chronic 3	H332H312H302H412	GHS07Wng	H332H312H302H412	EUH032		A	CLP00/ATP01
615-005-00-9	"4,4'-methylenediphenyl diisocyanate; diphenylmethane-4,4'-diisocyanate [1]2,2'-methylenediphenyl diisocyanate; diphenylmethane-2,2'-diisocyanate [2]o-(p-isocyanatobenzyl)phenyl isocyanate; diphenylmethane-2,4'-diisocyanate [3]methylenediphenyl diisocyanate  [4]"	202-966-0 [1]219-799-4 [2]227-534-9 [3]247-714-0 [4]	101-68-8 [1]2536-05-2 [2]5873-54-1 [3]26447-40-5 [4]	Carc. 2Acute Tox. 4 *STOT SE 3STOT RE 2 *Skin Irrit. 2Eye Irrit. 2Resp. Sens. 1Skin Sens. 1	H351H332H335H373 **H315H319H334H317	GHS08GHS07Dgr	H351H332H373 **H319H335H315H334H317		"Eye Irrit. 2; H319: C ? 5 %Skin Irrit. 2; H315: C ? 5 %Resp. Sens. 1; H334: C ? 0,1 %STOT SE 3; H335: C ? 5 %"	2 C	CLP00/ATP01
615-006-00-4	"2-methyl-m-phenylene diisocyanate; toluene-2,4-di-isocyanate [1]4-methyl-m-phenylene diisocyanate; toluene-2,6-di-isocyanate [2]m-tolylidene diisocyanate; toluene-diisocyanate  [3]"	202-039-0 [1]209-544-5 [2]247-722-4 [3]	91-08-7 [1]584-84-9 [2]26471-62-5 [3]	Carc. 2Acute Tox. 2 *STOT SE 3Skin Irrit. 2Eye Irrit. 2Resp. Sens. 1Skin Sens. 1Aquatic Chronic 3	H351H330H335H315H319H334H317H412	GHS06GHS08Dgr	H351H330H319H335H315H334H317H412		"Resp. Sens. 1; H334: C ? 0,1 %"	C	CLP00
615-007-00-X	"1,5-naphthylene diisocyanate"	221-641-4	3173-72-6	Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Irrit. 2Resp. Sens. 1Aquatic Chronic 3	H332H335H315H319H334H412	GHS08GHS07Dgr	H332H319H335H315H334H412				CLP00
615-008-00-5	"3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate; isophorone di-isocyanate"	223-861-6	4098-71-9	Acute Tox. 3 *STOT SE 3Skin Irrit. 2Eye Irrit. 2Resp. Sens. 1Skin Sens. 1Aquatic Chronic 2	H331H335H315H319H334H317H411	GHS06GHS08GHS09Dgr	H331H319H335H315H334H317H411		"*Resp. Sens. 1; H334: C ? 0,5 %Skin Sens.1; H317: C ? 0,5 %"	2 	CLP00
615-009-00-0	"4,4'-methylenedi(cyclohexyl isocyanate); dicyclohexylmethane-4,4'-di-isocyanate"	225-863-2	5124-30-1	Acute Tox. 3 *STOT SE 3Skin Irrit. 2Eye Irrit. 2Resp. Sens. 1Skin Sens. 1	H331H335H315H319H334H317	GHS06GHS08Dgr	H331H319H335H315H334H317		"*Resp. Sens. 1; H334: C ? 0,5 %Skin Sens. 1; H317: C ? 0,5 %"	2 	CLP00
615-010-00-6	"2,2,4-trimethylhexamethylene-1,6-di-isocyanate [1]2,4,4-trimethylhexamethylene-1,6-di-isocyanate  [2]"	241-001-8 [1]239-714-4 [2]	16938-22-0 [1]15646-96-5 [2]	Acute Tox. 3 *STOT SE 3Skin Irrit. 2Eye Irrit. 2Resp. Sens. 1	H331H335H315H319H334	GHS06GHS08Dgr	H331H319H335H315H334		"*Resp. Sens. 1; H334: C ? 0,5 %Skin Sens. 1; H317: C ? 0,5 %"	2 C	CLP00
615-011-00-1	hexamethylene-di-isocyanate	212-485-8	822-06-0	Acute Tox. 3 *STOT SE 3Skin Irrit. 2Eye Irrit. 2Resp. Sens. 1Skin Sens. 1	H331H335H315H319H334H317	GHS06GHS08Dgr	H331H319H335H315H334H317		"*Resp. Sens. 1; H334: C ? 0,5 %Skin Sens. 1; H317: C ? 0,5 %"	2 	CLP00
615-012-00-7	4-isocyanatosulphonyltoluene; tosyl isocyanate	223-810-8	4083-64-1	STOT SE 3Skin Irrit. 2Eye Irrit. 2Resp. Sens. 1	H335H315H319H334	GHS08GHS07Dgr	H319H335H315H334	EUH014	Eye Irrit.; H319: C ? 5 %STOT SE 3; H335: C ? 5 %Skin Irrit. 2; H315: C ? 5 %		CLP00
615-013-00-2	cyanamide; carbanonitril	206-992-3	420-04-2	Acute Tox. 3 *Acute Tox. 4 *Skin Irrit. 2Eye Irrit. 2Skin Sens. 1	H301H312H315H319H317	GHS06Dgr	H301H312H319H315H317				CLP00
615-014-00-8	tris(1-dodecyl-3-methyl-2-phenylbenzimidazolium)hexacyanoferrate		7276-58-6	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
615-015-00-3	"1,7,7-trimethylbicyclo(2,2,1)hept-2-yl thiocyanatoacetate; isobornyl thiocyanoacetate"	204-081-5	115-31-1	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410				CLP00
615-016-00-9	potassium cyanate	209-676-3	590-28-3	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
615-017-00-4	calcium cyanamide	205-861-8	156-62-7	Acute Tox. 4 *STOT SE 3Eye Dam. 1	H302H335H318	GHS05GHS07Dgr	H302H335H318				CLP00
615-018-00-X	2-(2-butoxyethoxy)ethyl thiocyanate	203-985-7	112-56-1	Flam. Liq. 3Acute Tox. 3 *Acute Tox. 3 *	H226H311H301	GHS02GHS06Dgr	H226H311H301				CLP00
615-019-00-5	dicyclohexylcarbodiimide	208-704-1	538-75-0	Acute Tox. 3 *Acute Tox. 4 *Eye Dam. 1Skin Sens. 1	H311H302H318H317	GHS06GHS05Dgr	H311H302H318H317				CLP00
615-020-00-0	methylene dithiocyanate	228-652-3	6317-18-6	Acute Tox. 2 *Acute Tox. 3 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1	H330H301H314H317H400	GHS06GHS05GHS09Dgr	H330H301H314H317H400				CLP00
615-021-00-6	"1,3,5-tris(oxiranylmethyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione; TGIC"	219-514-3	2451-62-9	Muta. 1BAcute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Eye Dam. 1Skin Sens. 1Aquatic Chronic 3	H340H331H301H373 **H318H317H412	GHS06GHS08GHS05Dgr	H340H331H301H373 **H318H317H412				CLP00
615-022-00-1	methyl 3-isocyanatosulfonyl-2-thiophene-carboxylate	410-550-7	79277-18-2	STOT RE 2 *Resp. Sens. 1Skin Sens. 1	H373 **H334H317	GHS08Dgr	H373 **H334H317	EUH014			CLP00/ATP01
615-023-00-7	2-(isocyanatosulfonylmethyl)benzoic acid methyl ester; (alt.):methyl 2-(isocyanatosulfonylmethyl)benzoate	410-900-9	83056-32-0	Flam. Liq. 3Muta. 2Acute Tox. 4 *STOT RE 2 *Eye Dam. 1Resp. Sens. 1	H226H341H332H373 **H318H334	GHS02GHS08GHS05GHS07Dgr	H226H341H332H373 **H318H334	EUH014			CLP00
615-024-00-2	2-phenylethylisocyanate	413-080-0	1943-82-4	Acute Tox. 3 *Acute Tox. 4 *Skin Corr. 1AResp. Sens. 1Skin Sens. 1Aquatic Chronic 2	H331H302H314H334H317H411	GHS06GHS08GHS05GHS09Dgr	H331H302H314H334H317H411				CLP00
615-025-00-8	"4,4'-ethylidenediphenyl dicyanate"	405-740-1	47073-92-7	Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H332H302H373 **H318H400H410	GHS08GHS05GHS07GHS09Dgr	H332H302H373 **H318H410				CLP00
615-026-00-3	"4,4'-methylenebis(2,6-dimethylphenyl cyanate)"	405-790-4	101657-77-6	Skin Sens. 1Aquatic Chronic 3	H317H412	GHS07Wng	H317H412				CLP00
615-028-00-4	ethyl 2-(isocyanatosulfonyl)benzoate	410-220-2	77375-79-2	Acute Tox. 4 *STOT RE 2 *Eye Dam. 1Resp. Sens. 1Skin Sens. 1	H302H373 **H318H334H317	GHS05GHS08GHS07Dgr	H302H373 **H318H334H317	EUH014			CLP00/ATP01
615-029-00-X	"2,5-bis-isocyanatomethyl-bicyclo[2.2.1]heptane"	411-280-2		Acute Tox. 2 *Acute Tox. 4 *Skin Corr. 1BResp. Sens. 1Skin Sens. 1Aquatic Chronic 3	H330H302H314H334H317H412	GHS06GHS08GHS05Dgr	H330H302H314H334H317H412				CLP00
615-030-00-5	"alkali salts and alkali earth salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex"	-	-	Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Chronic 3	H332H312H302H412	GHS07Wng	H332H312H302H412			A	CLP00/ATP01
615-031-00-0	thallium thiocyanate	222-571-7	3535-84-0	Acute Tox. 2 *Acute Tox. 2 *Acute Tox. 4 *STOT RE 2Aquatic Chronic 2	H330H300H312H373 **H411	GHS06GHS08GHS09Dgr	H330H300H312H373 **H411				CLP00/ATP01
615-032-00-6	"metal salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex"	-	-	Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H332H312H302H400H410	GHS07GHS09Wng	H332H312H302H410			A	CLP00/ATP01
615-033-00-1	"reaction product of diphenylmethanediisocyanate, octylamine, oleylamine and cyclohexylamine (1:1.58:0.32:0.097)"	430-980-9	-	Aquatic Chronic 4	H413	-	H413				ATP01
615-034-00-7	"reaction product of diphenylmethanediisocyanate, octylamine, 4-ethoxyaniline and ethylenediamine (1:0,37:1,53:0,05)"	430-750-8	-	Aquatic Chronic 4	H413	-	H413				ATP01
615-035-00-2	"reaction product of diphenylmethanediisocyanate, octylamine and oleylamine (molar ratio 1:1.86:0.14)"	430-930-6	122886-55-9	Aquatic Chronic 4	H413	-	H413				ATP01
615-036-00-8	"reaction product of diphenylmethanediisocyanate, toluenediisocyanate ( reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine, oleylamine and 4-ethoxyaniline (molar ratio 4:1:7:1:2)"	430-940-0	-	Aquatic Chronic 4	H413	-	H413				ATP01
615-037-00-3	"reaction product of diphenylmethanediisocyanate, toluenediisocyanate ( reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine and oleylamine (molar ratio 4:1:9:1)"	430-950-5	-	Aquatic Chronic 4	H413	-	H413				ATP01
615-038-00-9	"reaction product of toluenediisocyanate ( reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate) and aniline (molarratio 1:2)"	430-960-1	-	Aquatic Chronic 4	H413	-	H413				ATP01
615-039-00-4	"reaction product of diphenylmethanediisocyanate, toluenediisocyanate ( reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine, oleylamine and 4-ethoxyaniline (molar ratio 3.88:1:6.38:0.47:2.91)"	430-970-4	-	Aquatic Chronic 4	H413	-	H413				ATP01
615-044-00-1	4-chlorophenylisocyanate	203-176-9	104-12-1	Acute Tox. 2 *Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Dam. 1Resp. Sens. 1Aquatic Acute 1Aquatic Chronic 1	H330H302H335H315H318H334H400H410	GHS06GHS05GHS08GHS09Dgr	H330H302H335H315H318H334H410				ATP01
615-045-00-7	"4,4'-methylene bis(3-chloro-2,6-di-ethylphenylisocyanate)"	420-530-1	-	Resp. Sens. 1Skin Sens. 1Aquatic Chronic 4	H334H317H413	GHS08Dgr	H334H317H413				ATP01
616-001-00-X	"N,N-dimethylformamide; dimethyl formamide"	200-679-5	68-12-2	Repr. 1BAcute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2	H360D ***H332H312H319	GHS08GHS07Dgr	H360D ***H332H312H319				CLP00
616-002-00-5	2-fluoroacetamide	211-363-1	640-19-7	Acute Tox. 2 *Acute Tox. 3 *	H300H311	GHS06Dgr	H300H311				CLP00
616-003-00-0	acrylamide; prop-2-enamide	201-173-7	79-06-1	Carc. 1BMuta. 1BRepr. 2Acute Tox. 3 *Acute Tox. 4 *Acute Tox. 4 *STOT RE 1Skin Irrit. 2Eye Irrit. 2Skin Sens. 1	H350H340H361f ***H301H332H312H372 **H315H319H317	GHS06GHS08Dgr	H350H340H361f ***H301H372 **H332H312H319H315H317			D	CLP00
616-004-00-6	"allidochlor (ISO); N,N-diallylchloroacetamide"	202-270-7	93-71-0	Acute Tox. 4 *Acute Tox. 4 *Skin Irrit. 2Eye Irrit. 2Aquatic Chronic 2	H312H302H315H319H411	GHS07GHS09Wng	H312H302H319H315H411				CLP00
616-005-00-1	"chlorthiamid (ISO); 2,6-dichloro (thiobenzamide)"	217-637-7	1918-13-4	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
616-006-00-7	"dichlofluanid (ISO); N-dichlorofluoromethylthio-N',N'-dimethyl-N-phenylsulfamide"	214-118-7	1085-98-9	Acute Tox. 4 *Eye Irrit. 2Skin Sens. 1Aquatic Acute 1	H332H319H317H400	GHS07GHS09Wng	H332H319H317H400		M=10		CLP00/ATP01
616-007-00-2	"diphenamid (ISO); N,N-dimethyl-2,2-diphenylacetamide"	213-482-4	957-51-7	Acute Tox. 4 *Aquatic Chronic 3	H302H412	GHS07Wng	H302H412				CLP00
616-008-00-8	propachlor (ISO); 2-chloro-N-isopropylacetanilide; ?-chloro-N-isopropylacetanilide	217-638-2	1918-16-7	Acute Tox. 4 *Eye Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H319H317H400H410	GHS07GHS09Wng	H302H319H317H410				CLP00
616-009-00-3	"propanil (ISO); 3',4'-dichloropropionanilide"	211-914-6	709-98-8	Acute Tox. 4 *Aquatic Acute 1	H302H400	GHS07GHS09Wng	H302H400		M=10		CLP00/ATP01
616-010-00-9	tosylchloramide sodium	204-854-7	127-65-1	Acute Tox. 4 *Skin Corr. 1BResp. Sens. 1	H302H314H334	GHS08GHS05GHS07Dgr	H302H314H334	EUH031			CLP00
616-011-00-4	"N,N-dimethylacetamide"	204-826-4	127-19-5	Repr. 1BAcute Tox. 4 *Acute Tox. 4 *	H360D ***H332H312	GHS08GHS07Dgr	H360D ***H332H312		Repr. 1B; H360D: C ? 5 %		CLP00
616-012-00-X	N-(dichlorofluoromethylthio)phthalimide; N-(fluorodichloromethylthio)phthalimide	211-952-3	719-96-0	Skin Irrit. 2	H315	GHS07Wng	H315				CLP00
616-013-00-5	butyraldehyde oxime	203-792-8	110-69-0	Acute Tox. 3 *Acute Tox. 4 *Eye Irrit. 2	H311H302H319	GHS06Dgr	H311H302H319				CLP00
616-014-00-0	2-butanone oxime; ethyl methyl ketoxime; ethyl methyl ketone oxime	202-496-6	96-29-7	Carc. 2Acute Tox. 4 *Eye Dam. 1Skin Sens. 1	H351H312H318H317	GHS08GHS05GHS07Dgr	H351H312H318H317				CLP00
616-015-00-6	"alachlor (ISO); 2-chloro-2',6'-diethyl-N-(methoxymethyl)acetanilide"	240-110-8	15972-60-8	Carc. 2Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H351H302H317H400H410	GHS08GHS07GHS09Wng	H351H302H317H410		M=10		CLP00
616-016-00-1	"1-(3,4-dichlorophenylimino) thiosemicarbazide"		5836-73-7	Acute Tox. 2 *	H300	GHS06Dgr	H300				CLP00
616-017-00-7	cartap hydrochloride	239-309-2	15263-52-2	Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H312H302H400H410	GHS07GHS09Wng	H312H302H410				CLP00
616-018-00-2	"N,N-diethyl-m-toluamide; deet"	205-149-7	134-62-3	Acute Tox. 4 *Skin Irrit. 2Eye Irrit. 2Aquatic Chronic 3	H302H315H319H412	GHS07Wng	H302H319H315H412				CLP00
616-019-00-8	"perfluidone (ISO); 1,1,1-trifluoro-N-(4-phenylsulphonyl-o-tolyl)methanesulphonamide"	253-718-3	37924-13-3	Acute Tox. 4 *Eye Irrit. 2	H302H319	GHS07Wng	H302H319				CLP00
616-020-00-3	"tebuthiuron (ISO); 1-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea"	251-793-7	34014-18-1	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410				CLP00
616-021-00-9	"thiazafluron (ISO); 1,3-dimethyl-1-(5-trifluoromethyl-1,3,4-thiadiazol-2-yl)urea"	246-901-4	25366-23-8	Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410				CLP00
616-022-00-4	acetamide	200-473-5	60-35-5	Carc. 2	H351	GHS08Wng	H351				CLP00
616-023-00-X	N-hexadecyl(or octadecyl)-N-hexadecyl(or octadecyl)benzamide	401-980-6		Skin Irrit. 2Skin Sens. 1	H315H317	GHS07Wng	H315H317				CLP00
616-024-00-5	"2-(4,4-dimethyl-2,5-dioxooxazolidin-1-yl)-2-chloro-5-(2-(2,4-di-tert-pentylphenoxy)butyramido)-4,4-dimethyl-3-oxovaleranilide"	402-260-4	54942-74-4	Aquatic Chronic 4	H413		H413				CLP00
616-025-00-0	valinamide	402-840-7	20108-78-5	Repr. 2Eye Irrit. 2Skin Sens. 1	H361f ***H319H317	GHS08Wng	H361f ***H319H317				CLP00
616-026-00-6	thioacetamide	200-541-4	62-55-5	Carc. 1BAcute Tox. 4 *Skin Irrit. 2Eye Irrit. 2Aquatic Chronic 3	H350H302H315H319H412	GHS08GHS07Dgr	H350H302H319H315H412				CLP00
616-027-00-1	tris(2-(2-hydroxyethoxy)ethyl)ammonium 3-acetoacetamido-4-methoxybenzenesulfonate	403-760-5		Skin Sens. 1	H317	GHS07Wng	H317				CLP00
616-028-00-7	"N-(4-(3-(4-cyanophenyl)ureido)-3-hydroxyphenyl)-2-(2,4-di-tert-pentylphenoxy)octanamide"	403-790-9	108673-51-4	Skin Sens. 1Aquatic Chronic 4	H317H413	GHS07Wng	H317H413				CLP00
616-029-00-2	"N,N'-ethylenebis(vinylsulfonylacetamide)"	404-790-1	66710-66-5	Eye Dam. 1Skin Sens. 1	H318H317	GHS05GHS07Dgr	H318H317				CLP00
616-030-00-8	"ethidimuron (ISO); 1-(5-ethylsulphonyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea"	250-010-6	30043-49-3	Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410				CLP00
616-031-00-3	"dimethachlor (ISO); 2-chloro-N-(2,6-dimethylphenyl)-N-(2-methoxyethyl)acetamide"	256-625-6	50563-36-5	Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H317H400H410	GHS07GHS09Wng	H302H317H410				CLP00
616-032-00-9	"diflufenican (ISO); N-(2,4-difluorophenyl)-2-[3-(trifluoromethyl)phenoxy]-3-pyridinecarboxamide"		83164-33-4	Aquatic Chronic 3	H412		H412				CLP00
616-033-00-4	cyprofuram (ISO); N-(3-chlorophenyl)-N-(tetrahydro-2-oxo-3-furyl)cyclopropanecarboxamide	274-050-9	69581-33-5	Acute Tox. 3 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H301H312H400H410	GHS06GHS09Dgr	H301H312H410				CLP00
616-034-00-X	"pyracarbolid (ISO); 3,4-dihydro-6-methyl-2H-pyran-5-carboxanilide"	246-419-4	24691-76-7	Aquatic Chronic 3	H412		H412				CLP00
616-035-00-5	cymoxanil (ISO); 2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide	261-043-0	57966-95-7	Repr. 2Acute Tox. 4STOT RE 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	"H361fdH302H373 (blood, thymus)H317H400H410"	GHS08GHS07GHS09Wng	"H302H317H361fdH373 (blood, thymus)H410"		M=1M=1		CLP00/ATP06
616-036-00-0	2-chloracetamide	201-174-2	79-07-2	Repr. 2Acute Tox. 3 *Skin Sens. 1	H361f ***H301H317	GHS06GHS08Dgr	H361f ***H301H317		"Skin Sens. 1; H317: C ? 0,1 %"		CLP00
616-037-00-6	acetochlor (ISO); 2-chloro-N-(ethoxymethyl)-N-(2-ethyl-6-methylphenyl)acetamide	251-899-3	34256-82-1	Acute Tox. 4 *STOT SE 3Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H332H335H315H317H400H410	GHS07GHS09Wng	H332H335H315H317H410				CLP00
616-038-00-1	(4-aminophenyl)-N-methylmethylensulfonamide hydrochloride	406-010-5	88918-84-7	Eye Dam. 1Skin Sens. 1Aquatic Chronic 2	H318H317H411	GHS05GHS07GHS09Dgr	H318H317H411				CLP00
616-039-00-7	"3',5'-dichloro-4'-ethyl-2'-hydroxypalmitanilide"	406-200-8	117827-06-2	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
616-040-00-2	potassium N-(4-toluenesulfonyl)-4-toluenesulfonamide	406-650-5	97888-41-0	Eye Dam. 1	H318	GHS05Dgr	H318				CLP00
616-041-00-8	"3',5'-dichloro-2-(2,4-di-tert-pentylphenoxy)-4'-ethyl-2'-hydroxyhexananilide"	406-840-8	101664-25-9	Aquatic Chronic 4	H413		H413				CLP00
616-042-00-3	"N-(2-(6-ethyl-7-(4-methylphenoxy)-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)propyl)-2-octadecyloxybenzamide"	407-070-5	142859-67-4	Skin Sens. 1Aquatic Chronic 4	H317H413	GHS07Wng	H317H413				CLP00
616-043-00-9	"isoxaben (ISO); N-[3-(1-ethyl-1-methylpropyl)-1,2-oxazol-5-yl]-2,6-dimethoxybenzamide"	407-190-8	82558-50-7	Aquatic Chronic 4	H413		H413				CLP00
616-044-00-4	"N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-2-(3-pentadecylphenoxy)-butanamide"	402-510-2		Aquatic Chronic 2	H411	GHS09	H411				CLP00
616-045-00-X	2'-(4-chloro-3-cyano-5-formyl-2-thienylazo)-5'-diethylamino-2-methoxyacetanilide	405-190-2	122371-93-1	Skin Sens. 1Aquatic Chronic 4	H317H413	GHS07Wng	H317H413				CLP00
616-046-00-5	"N-(2-(6-chloro-7-methylpyrazolo(1,5-b)-1,2,4-triazol-4-yl)propyl)-2-(2,4-di-tert-pentylphenoxy)octanamide"	406-390-2		Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
616-047-00-0	"reaction mass of: 2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C16)alkylacetamide; 2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C18)alkylacetamide"	406-640-0		Skin Sens. 1	H317	GHS07Wng	H317				CLP00
616-048-00-6	3'-trifluoromethylisobutyranilide	406-740-4	1939-27-1	STOT RE 2 *Aquatic Chronic 2	H373 **H411	GHS08GHS09Wng	H373 **H411				CLP00
616-049-00-1	"2-(2,4-bis(1,1-dimethylethyl)phenoxy)-N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-hexanamide"	408-150-2	99141-89-6	Aquatic Chronic 4	H413		H413				CLP00
616-050-00-7	"lufenuron (ISO); N-[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)-phenyl-aminocarbonyl]-2,6-difluorobenzamide"	410-690-9	103055-07-8	Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410				CLP00
616-051-00-2	"reaction mass of: 2,4 -bis(N'-(4-methylphenyl)-ureido)-toluene; 2,6 -bis(N'-(4-methylphenyl)-ureido)-toluene"	411-070-0		Aquatic Chronic 4	H413		H413				CLP00
616-052-00-8	formamide	200-842-0	75-12-7	Repr. 1B	H360D ***	GHS08Dgr	H360D ***				CLP00
616-053-00-3	N-methylacetamide	201-182-6	79-16-3	Repr. 1B	H360D ***	GHS08Dgr	H360D ***				CLP00
616-054-00-9	"iprodione (ISO); 3-(3,5-dichlorophenyl)-2,4-dioxo-N-isopropylimidazolidine-1-carboxamide"	253-178-9	36734-19-7	Carc. 2Aquatic Acute 1Aquatic Chronic 1	H351H400H410	GHS08GHS09Wng	H351H410				CLP00
616-055-00-4	"propyzamide (ISO); 3,5-dichloro-N-(1,1-dimethylprop-2-ynyl)benzamide"	245-951-4	23950-58-5	Carc. 2Aquatic Acute 1Aquatic Chronic 1	H351H400H410	GHS08GHS09Wng	H351H410				CLP00
616-056-00-X	N-methylformamide	204-624-6	123-39-7	Repr. 1BAcute Tox. 4 *	H360D ***H312	GHS08GHS07Dgr	H360D ***H312				CLP00
616-057-00-5	"reaction mass of: N-[3-hydroxy-2-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide; N-[2,3-bis-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide; methacrylamide; 2-methyl-N-(2-methylacryloylaminomethoxymethyl)-acrylamide; N-(2,3-dihydroxypropoxymethyl)-2-methylacrylamide"	412-790-8		Carc. 1BMuta. 2STOT RE 2 *	H350H341H373 **	GHS08Dgr	H350H341H373 **				CLP00
616-058-00-0	"1,3-bis(3-methyl-2,5-dioxo-1H-pyrrolinylmethyl)benzene"	412-570-1	119462-56-5	STOT RE 2 *Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H373 **H318H317H400H410	GHS08GHS05GHS07GHS09Dgr	H373 **H318H317H410				CLP00
616-059-00-6	"4-((4-(diethylamino)-2-ethoxyphenyl)imino)-1,4-dihydro-1-oxo-N-propyl-2-naphthalenecarboxamide"	412-650-6	121487-83-0	Aquatic Chronic 4	H413		H413				CLP00
616-060-00-1	"Condensation product of: 3-(7-carboxyhept-1-yl)-6-hexyl-4-cyclohexene-1,2-dicarboxylic acid with polyamines (primarily amino-ethyl-piperazine and triethylenetetramine)"	413-770-1		Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H314H317H400H410	GHS05GHS07GHS09Dgr	H302H314H317H410				CLP00
616-061-00-7	"N,N'-1,6-hexanediylbis(N-(2,2,6,6-tetramethyl-piperidin-4-yl)-formamide"	413-610-0	124172-53-8	Eye Irrit. 2Aquatic Chronic 3	H319H412	GHS07Wng	H319H412				CLP00
616-062-00-2	N-[3-[(2-acetyloxy)ethyl](phenyl-methyl)amino]-4-methoxyphenylacetamide	411-590-8	70693-57-1	Skin Corr. 1BAquatic Chronic 3	H314H412	GHS05Dgr	H314H412				CLP00
616-063-00-8	"3-dodecyl-(1-(1,2,2,6,6-pentamethyl-4-piperidin)-yl)-2,5-pyrrolidindione"	411-920-0	106917-30-0	Acute Tox. 3 *Acute Tox. 4 *STOT RE 2 *Skin Corr. 1AAquatic Acute 1Aquatic Chronic 1	H331H302H373 **H314H400H410	GHS06GHS08GHS05GHS09Dgr	H331H302H373 **H314H410				CLP00
616-064-00-3	N-tert-butyl-3-methylpicolinamide	406-720-5	32998-95-1	Aquatic Chronic 3	H412		H412				CLP00
616-065-00-9	"3'-(3-acetyl-4-hydroxyphenyl)-1,1-diethylurea"	411-970-3	79881-89-3	Acute Tox. 4 *STOT RE 2 *	H302H373 **	GHS08GHS07Wng	H302H373 **				CLP00
616-066-00-4	"5,6,12,13-tetrachloroanthra(2,1,9-def:6,5,10-d'e'f')diisoquinoline-1,3,8,10(2H,9H)-tetrone"	405-100-1	115662-06-1	Repr. 2	H361f ***	GHS08Wng	H361f ***				CLP00
616-067-00-X	"dodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-4,4-dimethyl-3-oxovaleramido)-4-chlorobenzoate"	407-300-4	92683-20-0	Aquatic Chronic 4	H413		H413				CLP00
616-068-00-5	potassium 4-(11-methacrylamidoundecanamido)benzenesulfonate	406-500-9	174393-75-0	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
616-069-00-0	1-hydroxy-5-(2-methylpropyloxycarbonylamino)-N-(3-dodecyloxypropyl)-2-naphthoamide	406-210-2	110560-22-0	Aquatic Chronic 4	H413		H413				CLP00
616-070-00-6	"reaction mass of: 3,3'-dicyclohexyl-1,1'-methylenebis(4,1-phenylene)diurea; 3-cyclohexyl-1-(4-(4-(3-octadecylureido)benzyl)phenyl)urea; 3,3'-dioctadecyl-1,1'-methylenebis(4,1-phenylene)diurea"	406-530-2		Aquatic Chronic 4	H413		H413				CLP00
616-071-00-1	reaction mass of: bis(N-cyclohexyl-N'-phenyleneureido)methylene; bis(N-octadecyl-N'-phenyleneureido)methylene; bis(N-dicyclohexyl-N'-phenyleneureido)methylene (1:2:1)	406-550-1		Skin Sens. 1Aquatic Chronic 4	H317H413	GHS07Wng	H317H413				CLP00
616-072-00-7	1-(2-deoxy-5-O-trityl-?-D-threopentofuranosyl)thymine	407-120-6	55612-11-8	Aquatic Chronic 4	H413		H413				CLP00
616-073-00-2	4'-ethoxy-2-benzimidazoleanilide	407-600-5	120187-29-3	Muta. 2Aquatic Chronic 4	H341H413	GHS08Wng	H341H413				CLP00
616-074-00-8	N-butyl-2-(4-morpholinylcarbonyl)benzamide	407-730-2	104958-67-0	Eye Irrit. 2Skin Sens. 1Aquatic Chronic 3	H319H317H412	GHS07Wng	H319H317H412				CLP00
616-075-00-3	"D,L-(N,N-diethyl-2-hydroxy-2-phenylacetamide)"	408-120-9	65197-96-8	Acute Tox. 4 *Eye Dam. 1	H302H318	GHS05GHS07Dgr	H302H318				CLP00
616-076-00-9	"tebufenozide (ISO); N-tert-butyl-N'-(4-ethylbenzoyl)-3,5-dimethylbenzohydrazide"	412-850-3	112410-23-8	Aquatic Chronic 2	H411	GHS09	H411				CLP00
616-077-00-4	"reaction mass of: 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfonic acid; potassium 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfate"	411-310-4		Eye Dam. 1	H318	GHS05Dgr	H318				CLP00
616-078-00-X	"2-[2,4-bis(1,1-dimethyl-ethyl)phenoxy]-N-(2-hydroxy-5-methyl-phenyl)hexanamide"	411-330-3	104541-33-5	Aquatic Chronic 4	H413		H413				CLP00
616-079-00-5	"1,6-hexanediyl-bis(2-(2-(1-ethylpentyl)-3-oxazolidinyl)ethyl)carbamate"	411-700-4	140921-24-0	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
616-080-00-0	4-(2-((3-ethyl-4-methyl-2-oxo-pyrrolin-1-yl)carboxamido)ethyl)benzenesulfonamide)	411-850-0	119018-29-0	Aquatic Chronic 3	H412		H412				CLP00
616-081-00-6	5-bromo-8-naphtholactam	413-480-5	24856-00-6	Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H317H400H410	GHS07GHS09Wng	H302H317H410				CLP00
616-082-00-1	"N-(5-chloro-3-((4-(diethylamino)-2-methylphenyl)imino-4-methyl-6-oxo-1,4-cyclohexadien-1-yl)benzamide"	413-200-1	129604-78-0	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
616-083-00-7	[2-[(4-nitrophenyl)amino]ethyl]urea	410-700-1	27080-42-8	Skin Sens. 1Aquatic Chronic 3	H317H412	GHS07Wng	H317H412				CLP00
616-084-00-2	"2,4-bis[N'-(4-methylphenyl)ureido]toluene"	411-790-5		Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
616-085-00-8	"3-(2,4-dichlorophenyl)-6-fluoro-quinazoline-2,4(1H,3H)-dione"	412-190-6	168900-02-5	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
616-086-00-3	"2-acetylamino-6-chloro-4-[(4-diethylamino)2-methylphenyl-imino]-5-methyl-1-oxo-2,5-cyclohexadiene"	412-250-1	102387-48-4	Aquatic Chronic 4	H413		H413				CLP00
616-087-00-9	"reaction mass of: 7,9,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecane-1,16-diyl-prop-2-enoate; 7,7,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecan-1,16-diyl-prop-2-enoate"	412-260-6	52658-19-2	Eye Irrit. 2Skin Sens. 1Aquatic Chronic 2	H319H317H411	GHS07GHS09Wng	H319H317H411				CLP00
616-088-00-4	"2-aminosulfonyl-N,N-dimethylnicotinamide"	413-440-7	112006-75-4	Skin Sens. 1Aquatic Chronic 3	H317H412	GHS07Wng	H317H412				CLP00
616-089-00-X	"5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidine)-3-fluoro-2-hydroxymethyltetrahydrofuran"	415-360-8	41107-56-6	Muta. 2	H341	GHS08Wng	H341				CLP00
616-090-00-5	"1-(1,4-benzodioxan-2-ylcarbonyl)piperazine hydrochloride"	415-660-9	70918-74-0	Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Chronic 2	H331H311H301H373 **H411	GHS06GHS08GHS09Dgr	H331H311H301H373 **H411				CLP00
616-091-00-0	"1,3,5-tris-[(2S and 2R)-2,3-epoxypropyl]-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione"	423-400-0	59653-74-6	Muta. 1BAcute Tox. 3 *Acute Tox. 4 *STOT RE 2 *Eye Dam. 1Skin Sens. 1	H340H331H302H373 **H318H317	GHS06GHS08GHS05Dgr	H340H331H302H373 **H318H317				CLP00
616-092-00-6	"Polymeric reaction product of bicyclo[2.2.1]hepta-2,5-diene, ethene, 1,4-hexadiene, 1-propene with N,N-di-2-propenylformamide"	404-035-6		Skin Sens. 1Aquatic Chronic 4	H317H413	GHS07Wng	H317H413				CLP00
616-093-00-1	Reaction products of: aniline-terephthalaldehyde-o-toluidine condensate with maleic anhydride	406-620-1	129217-90-9	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				CLP00
616-094-00-7	"3,3'-dicyclohexyl-1,1'-methylenebis(4,1-phenylene)diurea"	406-370-3	58890-25-8	Skin Sens. 1Aquatic Chronic 4	H317H413	GHS07Wng	H317H413				CLP00
616-095-00-2	"3,3'-dioctadecyl-1,1'-methylenebis(4,1-phenylene)diurea"	406-690-3	43136-14-7	Aquatic Chronic 4	H413		H413				CLP00
616-096-00-8	N-(3-hexadecyloxy-2-hydroxyprop-1-yl)-N-(2-hydroxyethyl)palmitamide	408-110-4	110483-07-3	Aquatic Chronic 4	H413		H413				CLP00
616-097-00-3	"N,N'-1,4-phenylenebis(2-((2-methoxy-4-nitrophenyl)azo)-3-oxobutanamide"	411-840-6	83372-55-8	Aquatic Chronic 4	H413		H413				CLP00
616-098-00-9	"1-[4-chloro-3-((2,2,3,3,3-pentafluoropropoxy)methyl)phenyl]-5-phenyl-1H-1,2,4-triazole-3-carboxamide"	411-750-7	119126-15-7	Aquatic Chronic 2	H411	GHS09	H411				CLP00
616-099-00-4	"2-[4-[(4-hydroxyphenyl)sulfonyl]phenoxy]-4,4-dimethyl-N-[5-[(methylsulfonyl)amino]-2-[4-(1,1,3,3-tetramethylbutyl)phenoxy]phenyl]-3-oxopentanamide"	414-170-2	135937-20-1	Aquatic Chronic 4	H413		H413				CLP00
616-100-00-8	"1,3-dimethyl-1,3-bis(trimethylsilyl)urea"	414-180-7	10218-17-4	Acute Tox. 4 *Skin Irrit. 2	H302H315	GHS07Wng	H302H315				CLP00
616-101-00-3	"(S)-N-tert-butyl-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide"	414-600-9	149182-72-9	Acute Tox. 4 *Aquatic Chronic 3	H302H412	GHS07Wng	H302H412				CLP00
616-102-00-9	"reaction mass of: ?-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl]-?-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyloxy]-poly-(oxyethylene-co-oxypropylene); 1,2-(or 1,3-)bis[?-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl)-?-oxy-poly(oxyethylene-co-oxypropylene)]-3-(or 2-)propanol; 1,2,3-tris[?-(3-mercaptopropanoxycarbonyl-amino)methylphenylaminocarbonyl)-?-oxy-poly-(oxyethylene-co-oxypropylene)]propane]"	415-870-0		Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				CLP00
616-103-00-4	"(S,S)-trans-4-(acetylamino)-5,6-dihydro-6-methyl-7,7-dioxo-4H-thieno[2,3-b]thiopyran-2-sulfonamide"	415-030-3	120298-38-6	Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410				CLP00
616-104-00-X	"benalaxyl (ISO); methyl N-(2,6-dimethylphenyl)-N-(phenylacetyl)-DL-alaninate"	275-728-7	71626-11-4	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
616-105-00-5	"chlorotoluron (ISO); 3-(3-chloro-p-tolyl)-1,1-dimethylurea"	239-592-2	15545-48-9	Carc. 2Repr. 2Aquatic Acute 1Aquatic Chronic 1	H351H361d ***H400H410	GHS08GHS09Wng	H351H361d ***H410				CLP00
616-106-00-0	phenmedipham (ISO); methyl 3-(3-methylcarbaniloyloxy)carbanilate	237-199-0	13684-63-4	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
616-107-00-6	"cinidon ethyl (ISO); ethyl (Z)-2-chloro-3-[2-chloro-5-(cyclohex-1-ene-1,2-dicarboximido)phenyl]acrylate"	-	142891-20-1	Carc. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H351H317H400H410	GHS08GHS07GHS09Wng	H351H317H410				ATP01
616-108-00-1	"iodosulfuron-methyl-sodium; sodium ({}{[5-iodo-2-(methoxycarbonyl)phenyl]sulfonyl}}carbamoyl)(4-methoxy-6-methyl-1,3,5-triazin-2-yl)azanide"		144550-36-7	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
616-109-00-7	"sulfosulfuron (ISO); 1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethylsulfonylimidazo[1,2-a]pyridin-3-yl)sulfonylurea"		141776-32-1	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
616-110-00-2	"cyclanilide (ISO); 1-(2,4-dichloroanilinocarbonyl)cyclopropanecarboxylic acid"	419-150-7	113136-77-9	Acute Tox. 4 *Aquatic Chronic 2	H302H411	GHS07GHS09Wng	H302H411				CLP00
616-111-00-8	"fenhexamid (ISO); N-(2,3-dichlor-4-hydroxyphenyl)-1-methylcyclohexancarboxamid"	422-530-5	126833-17-8	Aquatic Chronic 2	H411	GHS09	H411				CLP00
616-112-00-3	"oxasulfuron (ISO); oxetan-3-yl 2-[(4,6-dimethylpyrimidin-2-yl)-carbamoylsulfamoyl]benzoate"		144651-06-9	STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1	H373 **H400H410	GHS08GHS09Wng	H373 **H410				CLP00
616-113-00-9	desmedipham (ISO); ethyl 3-phenylcarbamoyloxyphenylcarbamate	237-198-5	13684-56-5	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410		M=10		CLP00
616-114-00-4	"dodecanamide, N,N'-(9,9',10,10'-tetrahydro-9,9',10,10'-tetraoxo(1,1'-bianthracene)-4,4'-diyl)bis-"	418-010-2	136897-58-0	Aquatic Chronic 4	H413		H413				CLP00
616-115-00-X	N-(3-acetyl-2-hydroxyphenyl)-4-(4-phenylbutoxy)benzamide	416-150-9	136450-06-1	Aquatic Chronic 4	H413		H413				CLP00
616-116-00-5	N-(4-dimethylaminopyridinium)-3-methoxy-4-(1-methyl-5-nitroindol-3-ylmethyl)-N-(o-tolylsulfonyl)benzamidate	416-790-9	143052-96-4	Aquatic Chronic 4	H413		H413				CLP00
616-117-00-0	N-[2-(3-acetyl-5-nitrothiophen-2-ylazo)-5-diethylaminophenyl]acetamide	416-860-9	777891-21-1	Repr. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H361f ***H317H400H410	GHS08GHS09Wng	H361f ***H317H410				CLP00
616-118-00-6	"N-(2',6'-dimethylphenyl)-2-piperidinecarboxamide hydrochloride"	417-950-0	65797-42-4	Acute Tox. 4 *Aquatic Chronic 3	H302H412	GHS07Wng	H302H412				CLP00
616-119-00-1	"2-(1-butyl-3,5-dioxo-2-phenyl-(1,2,4)-triazolidin-4-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-(2-(dodecyl-1-sulfonyl))propionylamino)-phenyl)-pentanamide"	418-060-5	118020-93-2	Aquatic Chronic 4	H413		H413				CLP00
616-120-00-7	reaction mass of: N-(3-dimethylamino-4-methyl-phenyl)-benzamide; N-(3-dimethylamino-2-methyl-phenyl)-benzamide; N-(3-dimethylamino-3-methyl-phenyl)-benzamide	420-600-1		STOT RE 2 *Aquatic Chronic 2	H373 **H411	GHS08GHS09Wng	H373 **H411				CLP00
616-121-00-2	"2,4-dihydroxy-N-(2-methoxyphenyl)benzamide"	419-090-1	129205-19-2	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				CLP00
616-122-00-8	methyl neodecanamide	414-460-9	105726-67-8	Acute Tox. 4 *	H302	GHS07Wng	H302				ATP01
616-123-00-3	"N-[3-[[4-(diethylamino)-2-methylphenyl]imino]-6-oxo-1,4-cyclohexadienyl]acetamide"	414-740-0	96141-86-5	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
616-124-00-9	lithium bis(trifluoromethylsulfonyl)imide	415-300-0	90076-65-6	Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Skin Corr. 1BAquatic Chronic 3	H311H301H373 **H314H412	GHS06GHS05GHS08Dgr	H311H301H373 **H314H412				CLP00/ATP01
616-125-00-4	"3-cyano-N-(1,1-dimethylethyl)androsta-3,5-diene-17-?-carboxamide"	415-730-9	151338-11-3	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
616-126-00-X	1-methyl-4-nitro-3-propyl-1H-pyrazole-5-carboxamide	423-960-6	139756-01-7	Acute Tox. 4 *STOT RE 2 *Aquatic Chronic 3	H302H373 **H412	GHS08GHS07Wng	H302H373 **H412				ATP01
616-127-00-5	"reaction mass of: N,N'-Ethane-1,2-diylbis(decanamide); 12-Hydroxy-N-[2-[1-oxydecyl)amino]ethyl]octadecanamide; N,N'-Ethane-1,2-diylbis(12-hydroxyoctadecanamide)"	430-050-2		Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				CLP00
616-128-00-0	"N-(2-(1-allyl-4,5-dicyanoimidazol-2-ylazo)-5-(dipropylamino)phenyl)-acetamide"	417-530-7	123590-00-1	Aquatic Chronic 4	H413		H413				CLP00
616-129-00-6	"N,N'-bis(2,2,6,6-tetramethyl-4-piperidyl)isophthalamide"	419-710-0	42774-15-2	Acute Tox. 4 *Eye Irrit. 2	H302H319	GHS07Wng	H302H319				CLP00
616-130-00-1	"N-(3-(2-(4,4-dimethyl-2,5-dioxo-imidazolin-1-yl)-4,4-dimethyl-3-oxo-pentanoylamino)-4-methoxy-phenyl)-octadecanamide"	421-780-2	150919-56-5	Aquatic Chronic 4	H413		H413				CLP00
616-131-00-7	1-aminocyclopentanecarboxamide	422-950-9	17193-28-1	Acute Tox. 4 *STOT RE 1Eye Dam. 1	H302H372 **H318	GHS05GHS08GHS07Dgr	H372 **H302H318				ATP01
616-132-00-2	"N-[4-(4-cyano-2-furfurylidene-2,5-dihydro-5-oxo-3-furyl)phenyl]butane-1-sulfonamide"	423-250-6	130016-98-7	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
616-133-00-8	"N-cyclohexyl-S,S-dioxobenzo[b]tiophene-2-carboxamide"	423-990-1	149118-66-1	Acute Tox. 4 *Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H302H318H400H410	GHS05GHS07GHS09Dgr	H302H318H410				CLP00
616-134-00-3	"3,3'-bis(dioctyloxyphosphinothioylthio)-N,N'-oxybis(methylene)dipropionamide"	401-820-5	793710-14-2	Aquatic Chronic 3	H412		H412				CLP00
616-135-00-9	"(3S,4aS,8aS)-2-[(2R,3S)-3-amino-2-hydroxy-4-phenylbutyl]-N-tert-butyldecahydroisoquinoline-3-carboxamide"	430-230-0	136522-17-3	Acute Tox. 4 *Aquatic Chronic 3	H302H412	GHS07Wng	H302H412				CLP00
616-136-00-4	reaction product of cocoalkyldiethanolamides and cocoalkylmonoglycerides and molybdenumtrioxide (1.75-2.2: 0.75-1.0:0.1-1.1)	430-380-7	-	Aquatic Chronic 2	H411	GHS09	H411				ATP01
616-137-00-X	4-dichloroacetyl-1-oxa-4-azaspiro[4.5]decane	401-130-4	71526-07-3	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				ATP01
616-138-00-5	"benzoic acid, N-tert-butyl-N'-(4-chlorobenzoyl)hydrazide"	431-600-4	112226-61-6	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				ATP01
616-139-00-0	"(3S,4aS,8aS)-N-tert-butyldecahydro-3-isoquinolinecarboxamide"	420-380-5	136465-81-1	Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 3	H302H318H412	GHS05GHS07Dgr	H302H318H412				ATP01
616-140-00-6	"N,N''-(methylenedi-4,1-phenylene)bis[N'-(4-methylphenyl)urea]"	429-380-1	133336-92-2	Skin Sens. 1Aquatic Chronic 4	H317H413	GHS07Wng	H317H413				ATP01
616-141-00-1	"zoxamide (ISO); (RS)-3,5-dichloro-N-(3-chloro-1-ethyl-1-methyl-2-oxopropyl)-p-toluamide"	-	156052-68-5	Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H317H400H410	GHS07GHS09Wng	H317H410		M=10		ATP01
616-142-00-7	"1,3-Bis(vinylsulfonylacetamido)propane"	428-350-3	93629-90-4	Muta. 2Eye Dam. 1Skin Sens. 1Aquatic Chronic 3	H341H318H317H412	GHS08GHS05GHS07Dgr	H341H318H317H412				CLP00
616-143-00-2	"N,N'-dihexadecyl-N,N'-bis(2-hydroxyethyl)propanediamide"	422-560-9	149591-38-8	Repr. 2Eye Irrit. 2Aquatic Chronic 4	H361f ***H319H413	GHS08Wng	H361f ***H319H413				CLP00
616-144-00-8	"3,4-dichloro-N-[5-chloro-4-[2-[4-dodecyloxyphenylsulfonyl]butyramido]-2-hydroxyphenyl]benzamide"	431-130-1	-	Aquatic Chronic 4	H413	-	H413				ATP01
616-145-00-3	pethoxamide (ISO); 2-chloro-N-(2-ethoxyethyl)-N-(2-methyl-1-phenylprop-1-enyl)acetamide	-	106700-29-2	Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H317H400H410	GHS07GHS09Wng	H302H317H410		M=100		ATP01
616-146-00-9	"N-(2-methoxy-5-octadecanoylaminophenyl)-2-(3-benzyl-2,5-dioxoimidazolidin-1-yl)-4,4-dimethyl-3-oxopentanoic acidamide"	431-330-7	142776-95-2	Aquatic Chronic 4	H413	-	H413				ATP01
616-147-00-4	1-methyl-4-(2-methyl-2H-tetrazol-5-yl)-1H-pyrazole-5-sulfonamide	424-160-1	139481-22-4	Acute Tox. 4 *Aquatic Chronic 3	H302H412	GHS07Wng	H302H412				ATP01
616-148-00-X	"N-[6,9-dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6-oxo-1H-purin-2-yl]acetamide"	424-550-1	84245-12-5	Carc. 1BMuta. 1BRepr. 1B	H350H340H360FD	GHS08Dgr	H350H340H360FD				ATP01
616-150-00-0	"(2R,3S)-N-(3-amino-2-hydroxy-4-phenylbutyl)-N-isobutyl-4-nitrobenzenesulfonamide hydrochloride"	425-260-6	-	STOT RE 2 *Eye Dam. 1Skin Sens. 1Aquatic Chronic 2	H373 **H318H317H411	GHS05GHS08GHS07GHS09Dgr	H373 **H318H317H411				ATP01
616-151-00-6	"N-(2-amino-4,6-dichloropyrimidin-5-yl)formamide"	425-650-6	171887-03-9	Acute Tox. 4 *Eye Dam. 1Skin Sens. 1Aquatic Chronic 3	H302H318H317H412	GHS05GHS07Dgr	H302H318H317H412				ATP01
616-152-00-1	"4-(4-fluorophenyl)-2-(2-methyl-1-oxopropyl)-4-oxo-3,N-diphenylbutanamide"	425-850-3	125971-96-2	Aquatic Chronic 4	H413	-	H413				ATP01
616-153-00-7	4-methyl-3-oxo-N-phenyl-2-(phenylmethylene)pentanamide	425-860-8	125971-57-5	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				ATP01
616-154-00-2	"3,4-dichloro-N-[5-chloro-4-[2-[4-(hexadecyloxy)phenylsulfonyl]butyramido]-2-hydroxyphenyl]benzamide"	431-110-0	-	Aquatic Chronic 4	H413	-	H413				ATP01
616-155-00-8	"N,N,N',N'-tetracyclohexyl-1,3-benzenedicarboxamide"	431-040-0	104560-40-9	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				ATP01
616-156-00-3	6-(2-chloro-6-cyano-4-nitrophenylazo)-4-methoxy-3-[N-(methoxycarbonylmethyl)-N-(1-methoxycarbonylethyl)amino]acetanilide	430-500-8	204277-61-2	Aquatic Chronic 4	H413	-	H413				ATP01
616-157-00-9	3-amino-4-hydroxy-N-(3-isopropoxypropyl)benzenesulfonamide hydrochloride	427-780-9	114565-70-7	Acute Tox. 4 *Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1	H302H318H400H410	GHS05GHS07GHS09Dgr	H302H318H410				ATP01/ATP01corr
616-158-00-4	N-[4-cyano-3-trifluoromethylphenyl]methacrylamide	427-880-2	90357-53-2	STOT RE 2 *Aquatic Chronic 2	H373 **H411	GHS08GHS09Wng	H373 **H411				ATP01
616-160-00-5	"2,2'-azobis[N-(2-hydroxyethyl)-2-methylpropionamide]"	429-090-3	61551-69-7	Skin Sens. 1Aquatic Chronic 3	H317H412	GHS07Wng	H317H412				ATP01
616-161-00-0	"2,4-dichloro-5-hydroxyacetanilide"	429-110-0	67669-19-6	Aquatic Chronic 3	H412	-	H412				ATP01
616-162-00-6	isostearic acid monoisopropanolamide	431-540-9	-	Skin Irrit. 2Aquatic Chronic 2	H315H411	GHS07GHS09Wng	H315H411				ATP01
616-163-00-1	"4,4'-methylenebis[N-(4-chlorophenyl)-3-hydroxynaphthalene-2-carboxamide]"	430-350-3	192463-88-0	Aquatic Chronic 4	H413	-	H413				ATP01
616-164-00-7	"dimoxystrobin (ISO); (E)-2-(methoxyimino)-N-methyl-2-[?-(2,5-xylyloxy)-o-tolyl]acetamide"	-	149961-52-4	Carc. 2Repr. 2Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H351H361d ***H332H400H410	GHS08GHS07GHS09Wng	H351H361d ***H332H410		M=10		ATP01
616-165-00-2	"beflubutamid (ISO); (RS)-N-benzyl-2-(?,?,?,4-tetrafluoro-m-tolyoxy)butyramide"	-	113614-08-7	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410		M=100		ATP01
616-166-00-8	"cyazofamid (ISO); 4-chloro-2-cyano-N,N-dimethyl-5-p-tolylimidazole-1-sulfonamide"	-	120116-88-3	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410		M=10		ATP01
616-167-00-3	"N,N-dibutyl-(2,5-dihydro-5-thioxo-1H-tetrazol-1-yl)acetamide"	418-290-6	168612-06-4	Eye Irrit. 2Skin Sens. 1	H319H317	GHS07Wng	H319H317				ATP01
616-168-00-9	1-dimethylcarbamoyl-4-(2-sulfonatoethyl)pyridinium	418-440-0	136997-71-2	Skin Sens. 1	H317	GHS07Wng	H317				ATP01
616-169-00-4	"4-[4-(2,2-dimethyl-propanamido)]phenylazo-3-(2-chloro-5-(2-(3-pentadecylphenoxy)butylamido)anilino)-1-(2,4,6-trichlorophenyl)-2-pyrazoline-5-one"	420-220-4	92771-56-7	Skin Sens. 1Aquatic Chronic 4	H317H413	GHS07Wng	H317H413				ATP01
616-170-00-X	(2R)-2-amino-2-phenylacetamide	420-370-0	6485-67-2	Eye Irrit. 2Skin Sens. 1	H319H317	GHS07Wng	H319H317				ATP01
616-171-00-5	2-(para-chlorophenyl)glycineamide	420-830-0	102333-75-5	Eye Dam. 1Skin Sens. 1	H318H317	GHS05GHS07Dgr	H318H317				ATP01
616-172-00-0	"N-(2,2,6,6-tetramethyl-1-oxylpiperidin-4-yl)acetamide; (4-acetamido-2,2,6,6-tetramethyl-1-piperidinyl)oxidanyl"	423-840-3	14691-89-5	Acute Tox. 4 *	H302	GHS07Wng	H302				ATP01
616-174-00-1	"2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride"	424-560-4	151257-01-1	Acute Tox. 4 *Eye Irrit. 2	H302H319	GHS07Wng	H302H319				ATP01
616-175-00-7	2-(2-hexyldecyloxy)benzamide	431-230-3	202483-62-3	Aquatic Chronic 4	H413	-	H413				ATP01
616-176-00-2	"3-N,N-bis(methoxyethyl)aminoacetanilide"	432-530-7	24294-01-7	Acute Tox. 4 *Aquatic Chronic 3	H302H412	GHS07Wng	H302H412				ATP01
616-177-00-8	"(3-(4-(2-(butyl-(4-methylphenylsulfonyl)amino)phenylthio)-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazole-3-ylamino)-4-chlorophenyl)tetradecanamide; N-[3-({4-[(2-{butyl[(4-methylphenyl)sulfonyl]amino}phenyl)thio]-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl}amino)-4-chlorophenyl]tetradecanamide"	432-970-1	217324-98-6	Aquatic Chronic 4	H413	-	H413				ATP01
616-178-00-3	"N-(5-(bis(2-methoxyethyl)amino)-2-((2-cyano-4,6-dinitrophenyl)-azo)phenyl)acetamide"	434-500-9	52583-35-4	Aquatic Chronic 4	H413	-	H413				ATP01
616-179-00-9	2-chloro-N-(4-methylphenyl)acetamide	435-170-9	16634-82-5	Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H318H317H400H410	GHS05GHS07GHS09Dgr	H318H317H410				ATP01
616-180-00-4	"N,N-(dimethylamino)thioacetamide hydrochloride"	435-470-1	27366-72-9	Repr. 1BAquatic Acute 1Aquatic Chronic 1	H360D ***H400H410	GHS08GHS09Dgr	H360D ***H410				ATP01
616-181-00-X	4'-methyldodecane-1-sulfonanilide	435-490-9	17417-32-2	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				ATP01
616-182-00-5	"N'-(1,3-dimethylbutylidene)-3-hydroxy-2-naphthohydrazide"	435-860-1	214417-91-1	Skin Sens. 1Aquatic Chronic 2	H317H411	GHS07GHS09Wng	H317H411				ATP01
616-183-00-0	N-dodecyl-4-methoxybenzamide	442-340-6	1854-15-5	Aquatic Chronic 4	H413	-	H413				ATP01
616-184-00-6	"3-methyl-N-(5,8,13,14-tetrahydro-5,8,14-trioxonaphth[2,3-c]acridin-6-yl)benzamide"	442-560-2	105043-55-8	Aquatic Chronic 4	H413	-	H413				ATP01
616-186-00-7	"N,N'-(2-chloro-1,4-phenylene)bis(3-oxobutaneamide)"	443-010-4	53641-10-4	Aquatic Chronic 3	H412	-	H412				ATP01
616-188-00-8	"2-(5,5-dimethyl-2,4-dioxooxazolidin-3-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-octadecanoylaminophenyl)pentanoic acid amide"	443-980-9	221215-20-9	Skin Sens. 1Aquatic Chronic 4	H317H413	GHS07Wng	H317H413				ATP01
616-189-00-3	"N-[5-(bis-(2-methoxy-ethyl)-amino]-2-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-phenyl]acetamide"	444-780-4	452962-97-9	Aquatic Chronic 4	H413	-	H413				ATP01
616-190-00-9	N-decyl-4-nitrobenzamide	445-880-0	64026-19-3	Aquatic Chronic 4	H413	-	H413				ATP01
616-191-00-4	2-ethyl-N-methyl-N-(3-methylphenyl)butanamide	446-190-2	406488-30-0	Acute Tox. 4 *Skin Irrit. 2Eye Irrit. 2Skin Sens. 1Aquatic Chronic 2	H302H315H319H317H411	GHS07GHS09Wng	H302H319H315H317H411				ATP01
616-192-00-X	"2-[2-(3-butoxypropyl)-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]-5'-tert-butyl-2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-2'-[(2-ethylhexyl)thio]acetanilide"	448-060-0	727678-39-9	Aquatic Chronic 4	H413	-	H413				ATP01
616-193-00-5	"N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-5-diethylamino-phenyl]acetamide"	449-940-7	368450-39-9	Aquatic Chronic 4	H413	-	H413				ATP01
616-194-00-0	"2,2-diethoxy-N,N-dimethylacetamide"	449-950-1	34640-92-1	Eye Irrit. 2	H319	GHS07Wng	H319				ATP01
616-196-00-1	"disodium salt of 1-hydroxy-4-(?-(4-(1-hydroxy-3,6-disulfo-8-acetylamino-2-naphthylazo)phenoxy)ethoxy)-N-dodecyl-2-naphthamide"	419-990-4	-	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				ATP01
616-197-00-7	"reaction mass of: potassium N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamidate; N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamide"	422-500-1	-	STOT RE 2 *	H373 **	GHS08Wng	H373 **				ATP01
616-198-00-2	"1,3-bis[12-hydroxy-octadecamide-N-methylene]-benzene"	423-300-7	-	Skin Sens. 1Aquatic Chronic 4	H317H413	GHS07Wng	H317H413				ATP01
616-200-00-1	"reaction mass of N,N'-ethane-1,2-diylbis(hexanamide) and 12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide and N,N'-ethane-1,2-diylbis(12-hydroxyoctadecan amide)"	432-430-3		Aquatic Chronic 4	H413	GHS07	H413				ATP01/ATP05
616-201-00-7	"12-hydroxyoctadecanoic acid, reaction products with 1,3-benzenedimethanamine and hexamethylenediamine"	432-840-2	220926-97-6	Acute Tox. 4 *Aquatic Chronic 4	H332H413	GHS07Wng	H332H413				ATP01
616-202-00-2	"reaction mass of: 2,2'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)]-3-oxo-butanamide; 2-[[3,3'-dichloro-4'-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-biphenyl]-4-yl]azo]-N-(2-methylphenyl)-3-oxo-butanamide; 2-[[3,3'-dichloro-4'-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-biphenyl]-4-yl]azo]-N-(2-carboxylphenyl)-3-oxo-butanamide"	434-330-5	-	Carc. 2Skin Sens. 1Aquatic Chronic 4	H351H317H413	GHS08GHS07Wng	H351H317H413				ATP01
616-203-00-8	"reaction mass of: N-[5-[bis-(2-methoxyethyl)amino]-2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl-azo)phenyl]acetamide; N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)5-diethylaminophenyl]acetamide"	442-280-0	-	Aquatic Chronic 4	H413	-	H413				ATP01
616-204-00-3	"N,N''-(methylenedi-4,1-phenylene)bis[N'-octylurea]"	451-060-3	122886-55-9	Aquatic Chronic 4	H413	-	H413				ATP01
616-205-00-9	"Metazachlor (ISO); 2-chloro-N-(2,6-dimethylphenyl)-N-(1H-pyrazol-1-ylmethyl)acetamide"	266-583-0	67129-08-2	Carc. 2Skin Sens. 1BAquatic Acute 1Aquatic Chronic 1	H351H317H400H410	GHS07GHS08GHS09Wng	H317H351H410		M=100M=100		ATP03
616-206-00-4	"flufenoxuron (ISO); 1-(4-(2-cloro-?,?,?-p-trifluorotolyloxy)-2-fluorophenyl)-3-(2,6-difluorobenzolyl)urea"	417-680-3	101463-69-8	Lact.Aquatic Acute 1Aquatic Chronic 1	H362H400H410	GHS09Wng	H362H410		M=10000M=10000		ATP05
616-207-00-X	polyhexamethylene biguanide hydrochloride [1]polyhexamethylene biguanide hydrochloride [2]		27083-27-8 [1]32289-58-0 [2]	Carc. 2Acute Tox. 4STOT RE 1Eye Dam. 1Skin Sens. 1BAquatic Acute 1Aquatic Chronic 1	H351H302H372 (respiratory tract) (inhalation)H318H317H400H410	GHS05GHS07GHS08GHS09Dgr	H302H318H317H351H372 (respiratory tract) (inhalation)H410		M=10M=10		ATP05
616-208-00-5	N-ethyl-2-pyrrolidone; 1-ethylpyrrolidin-2-one	220-250-6	2687-91-4	Repr. 1B	H360D	GHS08Dgr	H360D				ATP05
616-209-00-0	"amidosulfuron (ISO); 3-(4,6-dimethoxypyrimidin-2-yl)-1-((N-methyl-N-methylsulfonylamino)sulfonyl)urea"	407-380-0	120923-37-7	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410		M=100M=100		ATP05
616-210-00-6	tebufenpyrad (ISO); N-(4-tertbutylbenzyl)-4-chloro-3-ethyl-1-methyl-1Hpyrazole-5- carboxamide		119168-77-3	Acute Tox. 3Acute Tox. 4STOT RE 2Skin Sens. 1BAquatic Acute 1Aquatic Chronic 1	H301H332H373 (gastro-intestinal tract) (oral)H317H400H410	GHS06GHS08GHS09Dgr	H301H332H317H373 (gastro-intestinal tract) (oral)H410		M=10M=10		ATP05
616-211-00-1	proquinazid (ISO); 6-iodo-2-propoxy-3-propylquinazolin-4(3H)-one		189278-12-4	Carc. 2Aquatic Acute 1Aquatic Chronic 1	H351H400H410	GHS08GHS09Wng	H351H410		M=1M=10		ATP05
616-212-00-7	3-iodo-2-propynyl butylcarbamate; 3-iodoprop-2-yn-1-yl butylcarbamate	259-627-5	55406-53-6	Acute Tox. 3Acute Tox. 4STOT RE 1Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H331H302H372 (larynx)H318H317H400H410	GHS06GHS08GHS05GHS09Dgr	H302H331H318H317H372 (larynx)H410		M=10M=1		ATP06
616-213-00-2	mandipropamid (ISO); 2-(4-chlorophenyl)-N-{2-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]ethyl}-2-(prop-2-yn-1-yloxy)acetamide		374726-62-2	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410		M=1M=1		ATP07
616-214-00-8	"metosulam (ISO); N-(2,6-dichloro-3-methylphenyl)-5,7-dimethoxy[1,2,4]triazolo[1,5-a]pyrimidine-2-sulfonamide"		139528-85-1	Carc. 2STOT RE 2Aquatic Acute 1Aquatic Chronic 1	"H351H373 (eyes, kidneys)H400H410"	GHS08GHS09Wng	"H351H373 (eyes, kidneys)H410"		M=1000M=100		ATP07
616-215-00-3	"dimethenamid-P (ISO); 2-chloro-N-(2,4-dimethyl-3-thienyl)-N-[(2S)-1-methoxypropan-2-yl]acetamide"		163515-14-8	Acute Tox. 4Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H317H400H410	GHS07GHS09Wng	H302H317H410		M=10M=10		ATP07
616-216-00-9	flonicamid (ISO); N-(cyanomethyl)-4-(trifluoromethyl)pyridine-3-carboxamide		158062-67-0	Acute Tox. 4	H302	GHS07Wng	H302				ATP07
616-217-00-4	sulfoxaflor (ISO); [methyl(oxo){1-[6-(trifluoromethyl)-3-pyridyl]ethyl}-?6-sulfanylidene]cyanamide		946578-00-3	Acute Tox. 4Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410		M=1M=1		ATP07
617-001-00-2	di-tert-butyl peroxide	203-733-6	110-05-4	Flam. Liq. 2Org. Perox. EMuta. 2	H225H242H341	GHS02GHS08Dgr	H242H225H341				CLP00/ATP03
617-002-00-8	"?,?-dimethylbenzyl hydroperoxide; cumene hydroperoxide"	201-254-7	80-15-9	Org. Perox. EAcute Tox. 3 *Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Skin Corr. 1BAquatic Chronic 2	H242H331H312H302H373 **H314H411	GHS02GHS06GHS08GHS05GHS09Dgr	H242H331H312H302H373 **H314H411		Skin Corr. 1B; H314: C ? 10 %Skin Irrit. 2; H315: 3 % ? C < 10 %Eye Dam. 1; H318: 3 % ? C < 10 %Eye Irrit. 2; H319: 1 % ? C < 3 %STOT SE 3; H335: C < 10 %		CLP00
617-003-00-3	dilauroyl peroxide	203-326-3	105-74-8	Org. Perox. D	H242	GHS02Dgr	H242				CLP00
617-004-00-9	"1,2,3,4-tetrahydro-1-naphthyl hydroperoxide"	212-230-0	771-29-9	Org. Perox. DAcute Tox. 4 *Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1	H242H302H314H400H410	GHS02GHS05GHS07GHS09Dgr	H242H302H314H410		STOT SE 3; H335: C ? 5 %		CLP00
617-006-00-X	"bis(?,?-dimethylbenzyl) peroxide"	201-279-3	80-43-3	Org. Perox. FSkin Irrit. 2Eye Irrit. 2Aquatic Chronic 2	H242H315H319H411	GHS02GHS07GHS09Wng	H242H319H315H411				CLP00
617-007-00-5	"tert-butyl ?,?-dimethylbenzyl peroxide"	222-389-8	3457-61-2	Org. Perox. ESkin Irrit. 2Aquatic Chronic 2	H242H315H411	GHS02GHS07GHS09Wng	H242H315H411				CLP00
617-008-00-0	dibenzoyl peroxide; benzoyl peroxide	202-327-6	94-36-0	Org. Perox. BEye Irrit. 2Skin Sens. 1	H241H319H317	GHS01GHS02GHS07Dgr	H241H319H317				CLP00/ATP01corr
617-010-00-1	"1-hydroperoxycyclohexyl 1-hydroxycyclohexyl peroxide [1]1,1’-dioxybiscyclohexan-1-ol [2]cyclohexylidene hydroperoxide [3]cyclohexanone, peroxide [4]"	201-091-1 [1]219-306-2 [2]220-279-4 [3]235-527-7 [4]	78-18-2 [1]2407-94-5 [2]2699-11-8 [3]12262-58-7 [4]	Org. Perox. AAcute Tox. 4 *Skin Corr. 1B	H240H302H314	GHS01GHS05GHS07Dgr	H240H302H314		STOT SE 3; H335: C = 5 %	C	CLP00/ATP01corr
617-010-01-9	"1-hydroperoxycyclohexyl 1-hydroxycyclohexyl peroxide [1]1,1'-dioxybiscyclohexan-1-ol [2]cyclohexylidene hydroperoxide [3]cyclohexanone, peroxide  [4]"	201-091-1 [1]219-306-2 [2]220-279-4 [3]235-527-7 [4]	78-18-2 [1]2407-94-5 [2]2699-11-8 [3]12262-58-7 [4]	Org. Perox. CAcute Tox. 4 *Skin Corr. 1B	H242H302H314	GHS02GHS05GHS07Dgr	H242H302H314		STOT SE 3; H335: C ? 5 %	C T	CLP00
617-012-00-2	8-p-menthyl hydroperoxide; p-menthane hydroperoxide	201-281-4	80-47-7	Org. Perox. DAcute Tox. 4 *Skin Corr. 1B	H242H332H314	GHS02GHS05GHS07Dgr	H242H314H332		STOT SE 3; H335: C ? 5 %		CLP00
617-013-00-8	"O,O-tert-butyl O-docosyl monoperoxyoxalate"	404-300-6	116753-76-5	Org. Perox. C ****Aquatic Acute 1Aquatic Chronic 1	H242H400H410	GHS02GHS09Dgr	H242H410				CLP00
617-014-00-3	6-(nonylamino)-6-oxo-peroxyhexanoic acid	406-680-9	104788-63-8	Org. Perox. C ****Eye Dam. 1Skin Sens. 1Aquatic Acute 1	H242H318H317H400	GHS02GHS05GHS07GHS09Dgr	H242H318H317H400				CLP00
617-015-00-9	bis(4-methylbenzoyl)peroxide	407-950-9	895-85-2	Org. Perox. B ****Aquatic Acute 1Aquatic Chronic 1	H241H400H410	GHS01GHS02GHS09Dgr	H241H410				CLP00
617-016-00-4	"3-hydroxy-1,1-dimethylbutyl 2-ethyl-2-methylheptaneperoxoate"	413-910-1		Flam. Liq. 3Org. Perox. C ****Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H226H242H315H400H410	GHS02GHS07GHS09Dgr	H242H226H315H410				CLP00
617-017-00-X	"reaction mass of: 2,2'-bis(tert-pentylperoxy)-p-diisopropylbenzene; 2,2'-bis(tert-pentylperoxy)-m-diisopropylbenzene"	412-140-3	32144-25-5	Org. Perox. DAquatic Chronic 4	H242H413	GHS02Dgr	H242H413			T	CLP00/ATP01
617-018-00-5	"reaction mass of: 1-methyl-1-(3-(1-methylethyl)phenyl)ethyl-1-methyl-1-phenylethylperoxide, 63 % by weight; 1-methyl-1-(4-(1-methylethyl)phenyl)ethyl-1-methyl-1-phenylethylperoxide, 31 % by weight"	410-840-3	71566-50-2	Org. Perox. C ****Aquatic Chronic 2	H242H411	GHS02GHS09Dgr	H242H411			T	CLP00
617-019-00-0	6-(phthalimido)peroxyhexanoic acid	410-850-8	128275-31-0	Org. Perox. DEye Dam. 1Aquatic Acute 1	H242H318H400	GHS02GHS05GHS09Dgr	H242H318H400			T	CLP00
617-020-00-6	"1,3-di(prop-2,2-diyl)benzene bis(neodecanoylperoxide)"	420-060-5	117663-11-3	Flam. Liq. 3Org. Perox. D ****Aquatic Chronic 2	H226H242H411	GHS02GHS09Dgr	H226H242H411				CLP00
617-021-00-1	methylethylketone peroxide trimer	429-320-2	-	Org. Perox. B ****Asp. Tox. 1Skin Irrit. 2Skin Sens. 1	H241H304H315H317	GHS01GHS02GHS08GHS07Dgr	H241H304H315H317				ATP01
617-022-00-7	"reaction mass of: 1,2-dimethylpropylidene dihydroperoxide; dimethyl 1,2-benzenedicarboxylate"	442-480-8	-	Org. Perox. CAcute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Chronic 2	H242H302H314H317H411	GHS02GHS05GHS07GHS09Dgr	H242H302H314H317H411				ATP01
647-001-00-8	"glucosidase, ?-"	232-589-7	9001-22-3	Resp. Sens. 1	H334	GHS08Dgr	H334				CLP00
647-002-00-3	cellulase	232-734-4	9012-54-8	Resp. Sens. 1	H334	GHS08Dgr	H334				CLP00
647-003-00-9	"cellobiohydrolase, exo-"	253-465-9	37329-65-0	Resp. Sens. 1	H334	GHS08Dgr	H334				CLP00
647-004-00-4	cellulases with the exception of those specified elsewhere in this Annex			Resp. Sens. 1	H334	GHS08Dgr	H334			A	CLP00
647-005-00-X	"bromelain, juice"	232-572-4	9001-00-7	STOT SE 3Skin Irrit. 2Eye Irrit. 2Resp. Sens. 1	H335H315H319H334	GHS08GHS07Dgr	H319H335H315H334				CLP00
647-006-00-5	ficin	232-599-1	9001-33-6	STOT SE 3Skin Irrit. 2Eye Irrit. 2Resp. Sens. 1	H335H315H319H334	GHS08GHS07Dgr	H319H335H315H334				CLP00
647-007-00-0	papain	232-627-2	9001-73-4	STOT SE 3Skin Irrit. 2Eye Irrit. 2Resp. Sens. 1	H335H315H319H334	GHS08GHS07Dgr	H319H335H315H334				CLP00
647-008-00-6	pepsin A	232-629-3	9001-75-6	STOT SE 3Skin Irrit. 2Eye Irrit. 2Resp. Sens. 1	H335H315H319H334	GHS08GHS07Dgr	H319H335H315H334				CLP00
647-009-00-1	rennin	232-645-0	9001-98-3	STOT SE 3Skin Irrit. 2Eye Irrit. 2Resp. Sens. 1	H335H315H319H334	GHS08GHS07Dgr	H319H335H315H334				CLP00
647-010-00-7	trypsin	232-650-8	9002-07-7	STOT SE 3Skin Irrit. 2Eye Irrit. 2Resp. Sens. 1	H335H315H319H334	GHS08GHS07Dgr	H319H335H315H334				CLP00
647-011-00-2	chymotrypsin	232-671-2	9004-07-3	STOT SE 3Skin Irrit. 2Eye Irrit. 2Resp. Sens. 1	H335H315H319H334	GHS08GHS07Dgr	H319H335H315H334				CLP00
647-012-00-8	subtilisin	232-752-2	9014-01-1	STOT SE 3Skin Irrit. 2Eye Dam. 1Resp. Sens. 1	H335H315H318H334	GHS08GHS05GHS07Dgr	H335H315H318H334				CLP00
647-013-00-3	"proteinase, microbial neutral"	232-966-6	9068-59-1	STOT SE 3Skin Irrit. 2Eye Irrit. 2Resp. Sens. 1	H335H315H319H334	GHS08GHS07Dgr	H319H335H315H334				CLP00
647-014-00-9	proteases with the exception of those specified elsewhere in this Annex			STOT SE 3Skin Irrit. 2Eye Irrit. 2Resp. Sens. 1	H335H315H319H334	GHS08GHS07Dgr	H319H335H315H334				CLP00
647-015-00-4	"amylase, ?-"	232-565-6	9000-90-2	Resp. Sens. 1	H334	GHS08Dgr	H334				CLP00
647-016-00-X	amylases with the exception of those specified elsewhere in this Annex			Resp. Sens. 1	H334	GHS08Dgr	H334				CLP00
647-017-00-5	laccase	420-150-4	80498-15-3	Resp. Sens. 1	H334	GHS08Dgr	H334				ATP01
648-001-00-0	"Distillates (coal tar), benzole fraction; Light Oil; [A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists of hydrocarbons having carbon numbers primarily in the range of C4 to C10 and distilling in the approximate range of 80 °C to 160 °C (175 °F to 320 °F).]"	283-482-7	84650-02-2	Carc. 1B	H350	GHS08Dgr	H350				CLP00
648-002-00-6	"Tar oils, brown-coal; Light Oil; [The distillate from lignite tar boiling in the range of approximately 80°C to 250°C (176°F to 482°F).  Composed primarily of aliphatic and aromatic hydrocarbons and monobasic phenols.]"	302-674-4	94114-40-6	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-003-00-1	"Benzol forerunnings (coal); Light Oil Redistillate, low boiling; [The distillate from coke oven light oil having an approximate distillation range below 100°C (212°F).  Composed primarily of C4 to C6 aliphatic hydrocarbons.]"	266-023-5	65996-88-5	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-004-00-7	"Distillates (coal tar), benzole fraction, BTX-rich; Light Oil Redistillate, low boiling; [A residue from the distillation of crude benzole to remove benzole fronts.  Composed primarily of benzene, toluene and xylenes boiling in the range of approximately 75°C to 200°C (167°F to 392°F).]"	309-984-9	101896-26-8	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-005-00-2	"Aromatic hydrocarbons, C6-10, C8-rich; Light Oil Redistillate, low boiling"	292-697-5	90989-41-6	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-006-00-8	"Solvent naphtha (coal), light; Light Oil Redistillate, low boiling"	287-498-5	85536-17-0	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-007-00-3	"Solvent naphtha (coal), xylene-styrene cut; Light Oil Redistillate, intermediate boiling"	287-502-5	85536-20-5	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-008-00-9	"Solvent naphtha (coal), coumarone-styrene contg.; Light Oil Redistillate, intermediate boiling"	287-500-4	85536-19-2	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-009-00-4	"Naphtha (coal), distn. residues; Light Oil Redistillate, high boiling; [The residue remaining from the distillation of recovered naphtha.  Composed primarily of naphthalene and condensation products of indene and styrene.]"	292-636-2	90641-12-6	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-010-00-X	"Aromatic hydrocarbons, C8; Light Oil Redistillate, high boiling"	292-694-9	90989-38-1	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-012-00-0	"Aromatic hydrocarbons, C8-9, hydrocarbon resin polymn. by-product; Light Oil Redistillate, high boiling; [A complex combination of hydrocarbons obtained from the evaporation of solvent under vacuum from polymerized hydrocarbon resin.  It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C9 and boiling in the range of approximately 120°C to 215°C (248°F to 419°F).]"	295-281-1	91995-20-9	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-013-00-6	"Aromatic hydrocarbons, C9-12, benzene distn.; Light Oil Redistillate, high boiling"	295-551-9	92062-36-7	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-014-00-1	"Extract residues (coal), benzole fraction alk., acid ext.; Light Oil Extract Residues, low boiling; [The redistillate from the distillate, freed of tar acids and tar bases, from bituminous coal high temperature tar boiling in the approximate range of 90°C to 160°C (194°F to 320°F).  It consists predominantly of benzene, toluene and xylenes.]"	295-323-9	91995-61-8	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-015-00-7	"Extract residues (coal tar), benzole fraction alk., acid ext.; Light Oil Extract Residues, low boiling; [A complex combination of hydrocarbons obtained by the redistillation of the distillate of high temperature coal tar (tar acid and tar base free).  It consists predominantly of unsubstituted and substituted mononuclear aromatic hydrocarbons boiling in the range of 85°C to 195°C (185°F to 383°F).]"	309-868-8	101316-63-6	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-016-00-2	"Extract residues (coal), benzole fraction acid; Light Oil Extract Residues, low boiling; [An acid sludge by-product of the sulfuric acid refining of crude high temperature coal.  Composed primarily of sulfuric acid and organic compounds.]"	298-725-2	93821-38-6	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-017-00-8	"Extract residues (coal), light oil alk., distn. overheads; Light Oil Extract Residues, low boiling; [The first fraction from the distillation of aromatic hydrocarbons, coumarone, naphthalene and indene rich prefractionator bottoms or washed carbolic oil boiling substantially below 145°C (293°F).  Composed primarily of C7 and C8 aliphatic and aromatic hydrocarbons.]"	292-625-2	90641-02-4	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-018-00-3	"Extract residues (coal), light oil alk., acid ext., indene fraction; Light Oil Extract Residues, intermediate boiling"	309-867-2	101316-62-5	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-019-00-9	"Extract residues (coal), light oil alk., indene naphtha fraction; Light Oil Extract Residues, high boiling; [The distillate from aromatic hydrocarbons, coumarone, naphthalene and indene rich prefractionator bottoms or washed carbolic oils, having an approximate boiling range of 155°C to 180°C (311°F to 356°F).  Composed primarily of indene, indan and trimethylbenzenes.]"	292-626-8	90641-03-5	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-020-00-4	"Solvent naphtha (coal); Light Oil Extract Residues, high boiling; [The distillate from either high temperature coal tar, coke oven light oil, or coal tar oil alkaline extract residue having an approximate distillation range of 130°C to 210°C (266°F to 410°F). Composed primarily of indene and other polycyclic ring systems containing a single aromatic ring. May contain phenolic compounds and aromatic nitrogen bases.]"	266-013-0	65996-79-4	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-021-00-X	"Distillates (coal tar), light oils, neutral fraction; Light Oil Extract Residues, high boiling; [A distillate from the fractional distillation of high temperature coal tar. Composed primarily of alkyl-substituted one ring aromatic hydrocarbons boiling in the range of approximately 135°C to 210°C (275°F to 410°F). May also include unsaturated hydrocarbons such as indene and coumarone.]"	309-971-8	101794-90-5	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-022-00-5	"Distillates (coal tar), light oils, acid exts.; Light Oil Extract Residues, high boiling; [This oil is a complex reaction mass of aromatic hydrocarbons, primarily indene, naphthalene, coumarone, phenol, and o-, m- and p-cresol and boiling in the range of 140°C to 215°C (284°F to 419°F).]"	292-609-5	90640-87-2	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-023-00-0	"Distillates (coal tar), light oils; Carbolic Oil; [A complex combination of hydrocarbons obtained by distillation of coal tar. It consists of aromatic and other hydrocarbons, phenolic compounds and aromatic nitrogen compounds and distills at the approximate range of 150°C to 210°C (302°F to 410°F).]"	283-483-2	84650-03-3	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-024-00-6	"Tar oils, coal; Carbolic Oil; [The distillate from high temperature coal tar having an approximate distillation range of 130°C to 250°C (266°F to 410°F). Composed primarily of naphthalene, alkylnaphthalenes, phenolic compounds, and aromatic nitrogen bases.]"	266-016-7	65996-82-9	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-026-00-7	"Extract residues (coal), light oil alk., acid ext.; Carbolic Oil Extract Residue; [The oil resulting from the acid washing of alkali-washed carbolic oil to remove the minor amounts of basic compounds (tar bases). Composed primarily of indene, indan and alkylbenzenes.]"	292-624-7	90641-01-3	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-027-00-2	"Extract residues (coal), tar oil alk.; Carbolic Oil Extract Residue; [The residue obtained from coal tar oil by an alkaline wash such as aqueous sodium hydroxide after the removal of crude coal tar acids. Composed primarily of naphthalenes and aromatic nitrogen bases.]"	266-021-4	65996-87-4	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-028-00-8	"Extract oils (coal), light oil; Acid Extract; [The aqueous extract produced by an acidic wash of alkali-washed carbolic oil. Composed primarily of acid salts of various aromatic nitrogen bases including pyridine, quinoline and their alkyl derivatives.]"	292-622-6	90640-99-6	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-029-00-3	"Pyridine, alkyl derivs.; Crude Tar Bases; [The complex combination of polyalkylated pyridines derived from coal tar distillation or as high-boiling distillates approximately above 150°C (302°F) from the reaction of ammonia with acetaldehyde, formaldehyde or paraformaldehyde.]"	269-929-9	68391-11-7	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-030-00-9	"Tar bases, coal, picoline fraction; Distillate Bases; [Pyridine bases boiling in the range of approximately 125°C to 160°C (257°F 320°F) obtained by distillation of neutralized acid extract of the base-containing tar fraction obtained by the distillation of bituminous coal tars. Composed chiefly of lutidines and picolines.]"	295-548-2	92062-33-4	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-031-00-4	"Tar bases, coal, lutidine fraction; Distillate Bases"	293-766-2	91082-52-9	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-032-00-X	"Extract oils (coal), tar base, collidine fraction; Distillate Bases; [The extract produced by the acidic extraction of bases from crude coal tar aromatic oils, neutralization, and distillation of the bases. Composed primarily of collidines, aniline, toluidines, lutidines, xylidines.]"	273-077-3	68937-63-3	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-033-00-5	"Tar bases, coal, collidine fraction; Distillate Bases; [The distillation fraction boiling in the range of approximately 181 °C to 186 °C (356 °F to 367 °F) from the crude bases obtained from the neutralized, acid-extracted base-containing tar fractions obtained by the distillation of bituminous coal tar. It contains chiefly aniline and collidines.]"	295-543-5	92062-28-7	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-034-00-0	"Tar bases, coal, aniline fraction; Distillate Bases; [The distillation fraction boiling in the range of approximately 180 °C to 200 °C (356 °F to 392 °F) from the crude bases obtained by dephenolating and debasing the carbolated oil from the distillation of coal tar. It contains chiefly aniline, collidines, lutidines and toluidines.]"	295-541-4	92062-27-6	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-035-00-6	"Tar bases, coal, toluidine fraction; Distillate Bases"	293-767-8	91082-53-0	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-036-00-1	"Distillates (petroleum), alkene-alkyne manuf. pyrolysis oil, mixed with high-temp. coal tar, indene fraction; Redistillates; [A complex combination of hydrocarbons obtained as a redistillate from the fractional distillation of bituminous coal high temperature tar and residual oils that are obtained by the pyrolytic production of alkenes and alkynes from petroleum products or natural gas. It consists predominantly of indene and boils in a range of approximately 160°C to 190°C (320°F to 374°F).]"	295-292-1	91995-31-2	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-037-00-7	"Distillates (coal), coal tar-residual pyrolysis oils, naphthalene oils; Redistillates; [The redistillate obtained from the fractional distillation of bituminous coal high temperature tar and pyrolysis residual oils and boiling in the range of approximately 190°C to 270°C (374°F to 518°F). Composed primarily of substituted dinuclear aromatics.]"	295-295-8	91995-35-6	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-038-00-2	"Extract oils (coal), coal tar-residual pyrolysis oils, naphthalene oil, redistillate; Redistillates; [The redistillate from the fractional distillation of dephenolated and debased methylnaphthalene oil obtained from bituminous coal high temperature tar and pyrolysis residual oils boiling in the approximate range of 220°C to 230°C (428°F to 446°F). It consists predominantly of unsubstituted and substituted dinuclear aromatic hydrocarbons.]"	295-329-1	91995-66-3	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-039-00-8	"Extract oils (coal), coal tar-residual pyrolysis oils, naphthalene oils; Redistillates; [A neutral oil obtained by debasing and dephenolating the oil obtained from the distillation of high temperature tar and pyrolysis residual oils which has a boiliing range of 225°C to 255°C (437°F to 491°F). Composed primarily of substituted dinuclear aromatic hydrocarbons.]"	310-170-0	122070-79-5	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-040-00-3	"Extract oils (coal), coal tar residual pyrolysis oils, naphthalene oil, distn. residues; Redistillates; [Residue from the distillation of dephenolated and debased methylnaphthalene oil (from bituminous coal tar and pyrolysis residual oils) with a boiling range of 240°C to 260°C (464°F to 500°F). Composed primarily of substituted dinuclear aromatic and heterocyclic hydrocarbons.]"	310-171-6	122070-80-8	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-041-00-9	"Absorption oils, bicyclo arom. and heterocyclic hydrocarbon fraction; Wash Oil Redistillate; [A complex combination of hydrocarbons obtained as a redistillate from the distillation of wash oil. It consists predominantly of 2-ringed aromatic and heterocyclic hydrocarbons boiling in the range of approximately 260 °C to 290 °C (500 °F to 554 °F).]"	309-851-5	101316-45-4	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00
648-042-00-4	"Distillates (coal tar), upper, fluorene-rich; Wash Oil Redistillate; [A complex combination of hydrocarbons obtained by the crystallization of tar oil. It consists af aromatic and polycyclic hydrocarbons primarily fluorene and some acenaphthene.]"	284-900-0	84989-11-7	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00
648-043-00-X	"Creosote oil, acenaphthene fraction, acenaphthene-free; Wash Oil Redistillate; [The oil remaining after removal by a crystallization process of acenaphthene from acenaphthene oil from coal tar. Composed primarily of naphthalene and alkylnaphthalenes.]"	292-606-9	90640-85-0	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00/ATP01
648-044-00-5	"Distillates (coal tar), heavy oils; Heavy Anthracene Oil; [Distillate from the fractional distillation of coal tar of bituminous coal, with boiling range of 240 °C to 400 °C (464 °F to 752 °F). Composed primarily of tri- and polynuclear hydrocarbons and heterocyclic compounds.]"	292-607-4	90640-86-1	Carc. 1B	H350	GHS08Dgr	H350				CLP00
648-045-00-0	"Distillates (coal tar), upper; Heavy Anthracene Oil; [The distillate from coal tar having an approximate distillation range of 220 °C to 450 °C (428 °F to 842 °F). Composed primarily of three to four membered condensed ring aromatic hydrocarbons and other hydrocarbons.]"	266-026-1	65996-91-0	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00
648-046-00-6	"Anthracene oil, acid ext.; Anthracene Oil Extract Residue; [A complex combination of hydrocarbons from the base-freed fraction obtained from the distillation of coal tar and boiling in the range of approximately 325 °C to 365 °C (617 °F to 689 °F). It contains predominantly anthracene and phenanthrene and their alkyl derivatives.]"	295-274-3	91995-14-1	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00
648-047-00-1	"Distillates (coal tar); Heavy Anthracene Oil; [The distillate from coal tar having an approximate distillation range of 100 °C to 450 °C (212 °F to 842 °F). Composed primarily of two to four membered condensed ring aromatic hydrocarbons, phenolic compounds, and aromatic nitrogen bases.]"	266-027-7	65996-92-1	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00
648-048-00-7	"Distillates (coal tar), pitch, heavy oils; Heavy Anthracene Oil; [The distillate from the distillation of the pitch obtained from bituminous high temperature tar. Composed primarily of tri- and polynuclear aromatic hydrocarbons and boiling in the range of approximately 300 °C to 470 °C (572 °F to 878 °F). The product may also contain heteroatoms.]"	295-312-9	91995-51-6	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00
648-049-00-2	"Distillates (coal tar), pitch; Heavy Anthracene Oil; [The oil obtained from condensation of the vapors from the heat treatment of pitch. Composed primarily of two- to four-ring aromatic compounds boiling in the range of 200 °C to greater than 400 °C (392 °F to greater than 752 °F).]"	309-855-7	101316-49-8	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00
648-050-00-8	"Distillates (coal tar), heavy oils, pyrene fraction; Heavy Anthracene Oil Redistillate; [The redistillate obtained from the fractional distillation of pitch distillate boiling in the range of approximately 350 °C to 400 °C (662 °F to 752 °F). Consists predominantly of tri- and polynuclear aromatics and heterocyclic hydrocarbons.]"	295-304-5	91995-42-5	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00
648-051-00-3	"Distillates (coal tar), pitch, pyrene fraction; Heavy Anthracene Oil Redistillate; [The redistillate obtained from the fractional distillation of pitch distillate and boiling in the range of approximately 380 °C to 410 °C (7160 to 770 °F). Composed primarily of tri- and polynuclear aromatic hydrocarbons and heterocyclic compounds.]"	295-313-4	91995-52-7	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00
648-052-00-9	"Paraffin waxes (coal), brown-coal high-temp. tar, carbon-treated; Coal Tar Extract; [A complet combination of hydrocarbons obtained by the treatment of lignite carbonization tar with activated carbon for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]"	308-296-6	97926-76-6	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00
648-053-00-4	"Paraffin waxes (coal), brown-coal high-temp tar, clay-treated; Coal Tar Extract; [A complex combination of hydrocarbons obtained by the treatment of lignite carbonization tar with bentonite for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]"	308-297-1	97926-77-7	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00
648-054-00-X	Pitch; Pitch	263-072-4	61789-60-4	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00
648-055-00-5	"pitch, coal tar, high-temp.; [The residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 30 °C to 180 °C (86 °F to 356 °F). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.]"	266-028-2	65996-93-2	Carc. 1AMuta. 1BRepr. 1BAquatic Acute 1Aquatic Chronic 1	H350H340H360FDH400H410	GHS08GHS09Dgr	H340H350H360FDH410		M=1000M=1000		CLP00/ATP05
648-056-00-0	"Pitch, coal tar, high-temp., heat-treated; Pitch; [The heat treated residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 80 °C to 180 °C (176 °F to 356 °F). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.]"	310-162-7	121575-60-8	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00
648-057-00-6	"Pitch, coal tar, high-temp., secondary; Pitch Redistillate; [The residue obtained during the distillation of high boiling fractions from bituminous coal high temperature tar and/or pitch coke oil, with a softening point of 140 °C to 170 °C (284 °F to 392 °F) according to DIN 52025. Composed primarily of tri- and polynuclear aromatic compounds which also contain heteroatoms.]"	302-650-3	94114-13-3	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00
648-058-00-1	"Residues (coal tar), pitch distn.; Pitch Redistillate; [Residue from the fractional distillation of pitch distillate boiling in the range of approximately 400 °C to 470 °C (752 °F to 846 °F). Composed primarily of polynuclear aromatic hydrocarbons, and heterocyclic compounds.]"	295-507-9	92061-94-4	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00
648-059-00-7	"Tar, coal, high-temp., distn. and storage residues; Coal Tar Solids Residue; [Coke- and ash-containing solid residues that separate on distillation and thermal treatment of bituminous coal high temperature tar in distillation installations and storage vessels. Consists predominantly of carbon and contains a small quantity of hetero compounds as well as ash components.]"	295-535-1	92062-20-9	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00
648-060-00-2	"Tar, coal, storage residues; Coal Tar Solids Residue; [The deposit removed from crude coal tar storages. Composed primarily of coal tar and carbonaceous particulate matter.]"	293-764-1	91082-50-7	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00
648-061-00-8	"Tar, coal, high-temp., residues; Coal Tar Solids Residue; [Solids formed during the coking of bituminous coal to produce crude bituminous coal high temperature tar. Composed primarily of coke and coal particles, highly aromatized compounds and mineral substances.]"	309-726-5	100684-51-3	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00
648-062-00-3	"Tar, coal, high-temp., high-solids; Coal Tar Solids Residue; [The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in the high temperature (greater than 700 °C (1292 °F)) destructive distillation of coal. Composed primarily of a complex mixture of condensed ring aromatic hydrocarbons with a high solid content of coal-type materials.]"	273-615-7	68990-61-4	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00
648-063-00-9	"Waste solids, coal-tar pitch coking; Coal Tar Solids Residue; [The combination of wastes formed by the coking of bituminous coal tar pitch. It consists predominantly of carbon.]"	295-549-8	92062-34-5	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00
648-064-00-4	"Extract residues (coal), brown; Coal Tar Extract; [The residue from extraction of dried coal.]"	294-285-0	91697-23-3	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00
648-065-00-X	"Paraffin waxes (coal), brown-coal-high-temp. tar; Coal Tar Extract; [A complex combination of hydrocarbons obtained from lignite carbonization tar by solvent crystallisation (solvent deoiling), by sweating or an adducting process. It consists predominantly of straight and branched chain saturated hydrocarbons having carbon numbers predominantly greater than C12.]"	295-454-1	92045-71-1	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00
648-066-00-5	"Paraffin waxes (coal), brown-coal-high-temp. tar, hydrotreated; Coal Tar Extract; [A complex combination of hydrocarbons obtained from lignite carbonization tar by solvent crystallisation (solvent deoiling), by sweating or an adducting process treated with hydrogen in the presence of a catalyst. It consists predominantly of straight and branched chain saturated hydrocarbons having carbon numbers predominantly greater than C12.]"	295-455-7	92045-72-2	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00
648-067-00-0	"Paraffin waxes (coal), brown-coal high-temp tar, silicic acid-treated; Coal Tar Extract; [A complex combination of hydrocarbons obtained by the treatment of lignite carbonization tar with silicic acid for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]"	308-298-7	97926-78-8	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00
648-068-00-6	"Tar, coal, low-temp., distn. residues; Tar Oil, intermediate boiling; [Residues from fractional distillation of low temperature coal tar to remove oils that boil in a range up to approximately 300 °C (572 °F). Composed primarily of aromatic compounds.]"	309-887-1	101316-85-2	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00
648-069-00-1	"Pitch, coal tar, low-temp; Pitch Residue; [A complex black solid or semi-solid obtained from the distillation of a low temperature coal tar. It has a softening point within the approximate range of 40 °C to 180 °C (104 °F to 356 °F). Composed primarily of a complex mixture of hydrocarbons.]"	292-651-4	90669-57-1	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00
648-070-00-7	"Pitch, coal tar, low-temp., oxidized; Pitch Residue, oxidised; [The product obtained by air-blowing, at elevated temperature, low-temperature coal tar pitch. It has a softening-point within the approximate range of 70 °C to 180 °C (158 °F to 356 °F). Composed primarily of a complex mixture of hydrocarbons.]"	292-654-0	90669-59-3	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00
648-071-00-2	"Pitch, coal tar, low-temp., heat-treated; Pitch Residue, oxidised; Pitch Residue, heat-treated; [A complex black solid obtained by the heat treatment of low temperature coal tar pitch. It has a softening point within the approximate range of 50 °C to 140 °C (122 °F to 284 °F). Composed primarily of a complex mixture of aromatic compounds.]"	292-653-5	90669-58-2	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00
648-072-00-8	"Distillates (coal-petroleum), condensed-ring arom; Distillates; [The distillate from a mixture of coal and tar and aromatic petroleum streams having an approximate distillation range of 220 °C to 450 °C (428 °F to 842 °F). Composed primarily of 3- to 4-membered condensed ring aromatic hydrocarbons.]"	269-159-3	68188-48-7	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00
648-073-00-3	"Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polyethylene-polypropylene pyrolysis-derived; Pyrolysis Products; [A complex combination hydrocarbons obtained from mixed coal tar pitch-polyethylene-polypropylene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 °C to 220 °C (212 °F to 428 °F) according to DIN 52025.]"	309-956-6	101794-74-5	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00
648-074-00-9	"Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polyethylene pyrolysis-derived; Pyrolysis Products; [A complex combination of hydrocarbons obtained from mixed coal tar pitch-polyethylene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 °C to 220 °C (212 °F to 428 °F) according to DIN 52025.]"	309-957-1	101794-75-6	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00
648-075-00-4	"Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polystyrene pyrolysis-derived; Pyrolysis Products; [A complex combination of hydrocarbons obtained from mixed coal tar pitch-polystyrene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 °C to 220 °C (212 °F to 428 °F) according to DIN 52025.]"	309-958-7	101794-76-7	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00
648-076-00-X	"Pitch, coal tar-petroleum; Pitch Residues; [The residue from the distillation of a mixture of coal tar and aromatic petroleum streams. A solid with a softening point from 40 °C to 180 °C (140 °F to 356 °F). Composed primarily of a complex combination of three or more membered condensed ring aromatic hydrocarbons.]"	269-109-0	68187-57-5	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00
648-077-00-5	"Phenanthrene, distn. residues; Heavy Anthracene Oil Redistillate; [Residue from the distillation of crude phenanthrene boiling in the approximate range of 340 °C to 420 °C (644 °F to 788 °F). It consists predominantly of phenanthrene, anthracene and carbazole.]"	310-169-5	122070-78-4	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00
648-078-00-0	"Distillates (coal tar), upper, fluorene-free; Wash Oil Redistillate; [A complex combination of hydrocarbons obtained by the crystallization of tar oil. It consists of aromatic polycyclic hydrocarbons, primarily diphenyl, dibenzofuran and acenaphthene.]"	284-899-7	84989-10-6	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00
648-079-00-6	"Anthracene oil; Anthracene oil; [A complex combination of polycyclic aromatic hydrocarbons obtained from coal tar having an approximate distillation range of 300 °C ot 400 °C (572 °F to 752 °F). Composed primarily of phenanthrene, anthracene and carbazole.]"	292-602-7	90640-80-5	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00
648-080-00-1	"Residues (coal tar), creosote oil distn.; Wash Oil Redistillate; [The residue from the fractional distillation of wash oil boiling in the approximate range of 270°C to 330°C (518°F to 626°F). It consists predominantly of dinuclear aromatic and heterocyclic hydrocarbons.]"	295-506-3	92061-93-3	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00/ATP01
648-081-00-7	"Tar, coal; Coal tar; [The by-product from the destructive distillation of coal. Almost black semisolid. A complex combination of aromatic hydro-carbons, phenolic compounds, nitrogen bases and thiophene.]"	232-361-7	8007-45-2	Carc. 1A	H350	GHS08Dgr	H350				CLP00
648-082-00-2	"Tar, coal, high-temp.; Coal tar; [The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in the high temperature (greater than 700 °C (1292 °F)) destructive distillation of coal. A black viscous liquid denser than water. Composed primarily of a complex mixture of condensed ring aromatic hydrocarbons. May contain minor amounts of phenolic compounds and aromatic nitrogen bases.]"	266-024-0	65996-89-6	Carc. 1A	H350	GHS08Dgr	H350				CLP00
648-083-00-8	"Tar, coal, low-temp.; Coal oil; [The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in low temperature (less than 700 °C (1292 °F)) destructive distillation of coal. A black viscous liquid denser than water. Composed primarily of condensed ring aromatic hydrocarbons, phenolic compounds, aromatic nitrogen bases, and their alkyl derivatives.]"	266-025-6	65996-90-9	Carc. 1A	H350	GHS08Dgr	H350				CLP00
648-084-00-3	"Distillates (coal), coke-oven light oil, naphthalene cut; Naphthalene Oil; [The complex combination of hydrocarbons obtained from prefractionation (continuous distillation) of coke oven light oil.  It consists predominantly of naphthalene, coumarone and indene and boils above 148°C (298°F).]"	285-076-5	85029-51-2	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-085-00-9	"Distillates (coal tar), naphthalene oils; Naphthalene Oil; [A complex combination of hydrocarbons obtained by the distillation of coal tar.  It consists primarily of aromatic and other hydrocarbons, phenolic compounds and aromatic nitrogen compounds and distills in the approximate range of 200°C to 250°C (392°F to 482°F).]"	283-484-8	84650-04-4	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-086-00-4	"Distillates (coal tar), naphthalene oils, naphthalene-low; Naphthalene Oil Redistillate; [A complex combination of hydrocarbons obtained by crystallization of naphthalene oil.  Composed primarily of naphthalene, alkyl naphthalenes and phenolic compounds.]"	284-898-1	84989-09-3	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-087-00-X	"Distillates (coal tar), naphthalene oil crystn. mother liquor; Naphthalene Oil Redistillate; [A complex combination of organic compounds obtained as a filtrate from the crystallization of the naphthalene fraction from coal tar and boiling in the range of approximately 200°C to 230°C (392°F to 446°F).  Contains chiefly naphthalene, thionaphthene and alkylnaphthalenes.]"	295-310-8	91995-49-2	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-088-00-5	"Extract residues (coal), naphthalene oil, alk.; Naphthalene Oil Extract Residue; [A complex combination of hydrocarbons obtained from the alkali washing of naphthalene oil to remove phenolic compounds (tar acids).  It is composed of naphthalene and alkyl naphthalenes.]"	310-166-9	121620-47-1	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-089-00-0	"Extract residues (coal), naphthalene oil, alk., naphthalene-low; Naphthalene Oil Extract Residue; [A complex combination of hydrocarbons remaining after the removal of naphthalene from alkali-washed naphthalene oil by a crystallization process.  It is composed primarily of naphthalene and alkyl naphthalenes.]"	310-167-4	121620-48-2	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-090-00-6	"Distillates (coal tar), naphthalene oils, naphthalene-free, alk. exts.; Naphthalene Oil Extract Residue; [The oil remaining after the removal of phenolic compounds (tar acids) from drained naphthalene oil by an alkali wash.  Composed primarily of naphthalene and alkyl naphthalenes.]"	292-612-1	90640-90-7	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-091-00-1	"Extract residues (coal), naphthalene oil alk., distn. overheads; Naphthalene Oil Extract Residue; [The distillate from alkali-washed naphthalene oil having an approximate distillation range of 180°C to 220°C (356°F to 428°F).  Composed primarily of naphthalene, alkylbenzenes, indene and indan.]"	292-627-3	90641-04-6	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-092-00-7	"Distillates (coal tar), naphthalene oils, methylnaphthalene fraction; Methylnaphthalene Oil; [A distillate from the fractional distillation of high temperature coal tar.  Composed primarily of substituted two ring aromatic hydrocarbons and aromatic nitrogen bases boiling in the range of approximately 225°C to 255°C (437°F to 491°F).]"	309-985-4	101896-27-9	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-093-00-2	"Distillates (coal tar), naphthalene oils, indole-methylnaphthalene fraction; Methylnaphthalene Oil; [A distillate from the fractional distillation of high temperature coal tar.  Composed primarily of indole and methylnaphthalene boiling in the range of approximately 235°C to 255°C (455°F to 491°F).]"	309-972-3	101794-91-6	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-094-00-8	"Distillates (coal tar), naphthalene oils, acid exts.; Methylnaphthalene Oil Extract Residue; [A complex combination of hydrocarbons obtained by debasing the methylnaphthalene fraction obtained by the distillation of coal tar and boiling in the range of approximately 230°C to 255°C (446°F to 491°F).  Contains chiefly 1(2)-methylnaphthalene, naphthalene, dimethylnaphthalene and biphenyl.]"	295-309-2	91995-48-1	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-095-00-3	"Extract residues (coal), naphthalene oil alk., distn. residues; Methylnaphthalene Oil Extract Residue; [The residue from the distillation of alkali-washed naphthalene oil having an approximate distillation range of 220°C to 300°C (428°F to 572°F).  Composed primarily of naphthalene, alkylnaphthalenes and aromatic nitrogen bases.]"	292-628-9	90641-05-7	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-096-00-9	"Extract oils (coal), acidic, tar-base free; Methylnaphthalene Oil Extract Residue; [The extract oil boiling in the range of approximately 220°C to 265°C (428°F to 509°F) from coal tar alkaline extract residue produced by an acidic wash such as aqueous sulfuric acid after distillation to remove tar bases.  Composed primarily of alkylnaphthalenes.]"	284-901-6	84989-12-8	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-097-00-4	"Distillates (coal tar), benzole fraction, distn. residues; Wash Oil; [A complex combination of hydrocarbons obtained from the distillation of crude benzole (high temperature coal tar).  It may be a liquid with the approximate distillation range of 150°C to 300°C (302°F to 572°F) or a semi-solid or solid with a melting point up to 70°C (158°F).  It is composed primarily of naphthalene and alkyl naphthalenes.]"	310-165-3	121620-46-0	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-098-00-X	"Creosote oil, acenaphthene fraction; Wash Oil; [A complex combination of hydrocarbons produced by the distillation of coal tar and boiling in the range of approximately 240°C to 280°C (464°F to 536°F). Composed primarily of acenaphthene, naphthalene and alkyl naphthalene.]"	292-605-3	90640-84-9	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00/ATP01
648-099-00-5	Creosote oil; [A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic hydrocarbons and may contain appreciable quantities of tar acids and tar bases. It distills at the approximate range of 200°C to 325°C (392°F to 617°F).]	263-047-8	61789-28-4	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00/ATP01
648-100-00-9	"Creosote oil, high-boiling distillate; Wash Oil; [The high-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillates, removed. It is crystal free at approximately 5°C (41°F).]"	274-565-9	70321-79-8	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00/ATP01
648-101-00-4	"Creosote; [The distillate of coal tar produced by the high temperature carbonization of bituminous coal. It consists primarily of aromatic hydrocarbons, tar acids and tar bases.]"	232-287-5	8001-58-9	Carc. 1B	H350	GHS08Dgr	H350				CLP00
648-102-00-X	"Extract residues (coal), creosote oil acid; Wash Oil Extract Residue; [A complex combination of hydrocarbons from the base-freed fraction from the distillation of coal tar, boiling in the range of approximately 250°C to 280°C (482°F to 536°F). It consists predominantly of biphenyl and isomeric diphenylnaphthalenes.]"	310-189-4	122384-77-4	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00/ATP01
648-103-00-5	"Anthracene oil, anthracene paste; Anthracene Oil Fraction; [The anthracene-rich solid obtained by the crystallization and centrifuging of anthracene oil.  It is composed primarily of anthracene, carbazole and phenanthrene.]"	292-603-2	90640-81-6	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-104-00-0	"Anthracene oil, anthracene-low; Anthracene Oil Fraction; [The oil remaining after the removal, by a crystallization process, of an anthracene-rich solid (anthracene paste) from anthracene oil.  It is composed primarily of two, three and four membered aromatic compounds.]"	292-604-8	90640-82-7	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-105-00-6	"Residues (coal tar), anthracene oil distn.; Anthracene Oil Fraction; [The residue from the fraction distillation of crude anthracene boiling in the approximate range of 340°C to 400°C (644°F to 752°F).  It consists predominantly of tri- and polynuclear aromatic and heterocyclic hydrocarbons.]"	295-505-8	92061-92-2	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-106-00-1	"Anthracene oil, anthracene paste, anthracene fraction; Anthracene Oil Fraction; [A complex combination of hydrocarbons from the distillation of anthracene obtained by the crystallization of anthracene oil from bituminous high temperature tar and boiling in the range of 330°C to 350°C (626°F to 662°F).  It contains chiefly anthracene, carbazole and phenanthrene.]"	295-275-9	91995-15-2	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-107-00-7	"Anthracene oil, anthracene paste, carbazole fraction; Anthracene Oil Fraction; [A complex combination of hydrocarbons from the distillation of anthracene obtained by crystallization of anthracene oil from bituminous coal high temperature tar and boiling in the approximate range of 350°C to 360°C (662°F to 680°F).  It contains chiefly anthracene, carbazole and phenanthrene.]"	295-276-4	91995-16-3	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-108-00-2	"Anthracene oil, anthracene paste, distn. lights; Anthracene Oil Fraction; [A complex combination of hydrocarbons from the distillation of anthracene obtained by crystallization of anthracene oil from bituminous high temperature tar and boiling in the range of approximately 290°C to 340°C (554°F to 644°F). It contains chiefly trinuclear aromatics and their dihydro derivatives.]"	295-278-5	91995-17-4	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-109-00-8	"Tar oils, coal, low-temp.; Tar Oil, high boiling; [A distillate from low-temperature coal tar.  Composed primarily of hydrocarbons, phenolic compounds and aromatic nitrogen bases boiling in the range of approximately 160°C to 340°C (320°F to 644°F).]"	309-889-2	101316-87-4	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-110-00-3	"Extract residues (coal), low temp. coal atar alk.; [The residue from low temperature coal tar oils after an alkaline wash, such as aqueous sodium hydroxide, to remove crude coal tar acids.  Composed primarily of hydrocarbons and aromatic nitrogen bases.]"	310-191-5	122384-78-5	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-111-00-9	"Phenols, ammonia liquor ext.; Alkaline Extract; [The combination of phenols extracted, using isobutyl acetate, from the ammonia liquor condensed from the gas evolved in low-temperature (less than 700°C (1292°F)) destructive distillation of coal.  It consists predominantly of a reaction mass of monohydric and dihydric phenols.]"	284-881-9	84988-93-2	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-112-00-4	"Distillates (coal tar), light oils, alk. exts.; Alkaline Extract; [The aqueous extract from carbolic oil produced by an alkaline wash such as aqueous sodium hydroxide.  Composed primarily of the alkali salts of various phenolic compounds.]"	292-610-0	90640-88-3	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-113-00-X	"Extracts, coal tar oil alk.; Alkaline Extract; [The extract from coal tar oil produced by an alkaline wash such as aqueous sodium hydroxide.  Composed primarily of the alkali salts of various phenolic compounds.]"	266-017-2	65996-83-0	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-114-00-5	"Distillates (coal tar), naphthalene oils, alk. exts.; Alkaline Extract; [The aqueous extract from naphthalene oil produced by an alkaline wash such as aqueous sodium hydroxide.  Composed primarily of the alkali salts of various phenolic compounds.]"	292-611-6	90640-89-4	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-115-00-0	"Extract residues (coal), tar oil alk., carbonated, limed; Crude Phenols; [The product obtained by treatment of coal tar oil alkaline extract with CO2 and CaO.  Composed primarily of CaCO3, Ca(OH)2, Na2CO3 and other organic and inorganic impurities.]"	292-629-4	90641-06-8	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-116-00-6	"Tar acids, coal, crude; Crude Phenols; [The reaction product obtained by neutralizing coal tar oil alkaline extract with an acidic solution, such as aqueous sulfuric acid, or gaseous carbon dioxide, to obtain the free acids.  Composed primarily of tar acids such as phenol, cresols, and xylenols.]"	266-019-3	65996-85-2	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-117-00-1	"Tar acids, brown-coal, crude; Crude Phenols; [An acidified alkaline extract of brown coal tar distillate.  Composed primarily of phenol and phenol homologs.]"	309-888-7	101316-86-3	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-118-00-7	"Tar acids, brown-coal gasification; Crude Phenols; [A complex combination of organic compounds obtained from brown coal gasification.  Composed primarily of C6-10 hydroxy aromatic phenols and their homologs.]"	295-536-7	92062-22-1	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-119-00-2	"Tar acids, distn. residues; Distillate Phenols; [A residue from the distillation of crude phenol from coal.  It consists predominantly of phenols having carbon numbers in the range of C8 through C10 with a softening point of 60°C to 80°C (140°F to 176°F).]"	306-251-5	96690-55-0	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-120-00-8	"Tar acids, methylphenol fraction; Distillate Phenols; [The fraction of tar acid rich in 3- and 4-methylphenol, recovered by distillation of low-temperature coal tar crude tar acids.]"	284-892-9	84989-04-8	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-121-00-3	"Tar acids, polyalkylphenol fraction; Distillate Phenols; [The fraction of tar acids, recovered by distillation of low-temperature coal tar crude tar acids, having an approximate boiling range of 225°C to 320°C (437°F to 608°F).  Composed primarily of polyalkylphenols.]"	284-893-4	84989-05-9	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-122-00-9	"Tar acids, xylenol fraction; Distillate Phenols; [The fraction of tar acids, rich in 2,4- and 2,5-dimethylphenol, recovered by distillation of low-temperature coal tar crude tar acids.]"	284-895-5	84989-06-0	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-123-00-4	"Tar acids, ethylphenol fraction; Distillate Phenols; [The fraction of tar acids, rich in 3- and 4-ethylphenol, recovered by distillation of low-temperature coal tar crude tar acids.]"	284-891-3	84989-03-7	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-124-00-X	"Tar acids, 3,5-xylenol fraction; Distillate Phenols; [The fraction of tar acids, rich in 3,5-dimethylphenol, recovered by distillation of low-temperature coal tar acids.]"	284-896-0	84989-07-1	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-125-00-5	"Tar acids, residues, distillates, first-cut; Distillate Phenols; [The residue from the distillation in the range of 235°C to 355°C (481°F to 697°F) of light carbolic oil.]"	270-713-1	68477-23-6	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-126-00-0	"Tar acids, cresylic, residues; Distillate Phenols; [The residue from crude coal tar acids after removal of phenol, cresols, xylenols and any higher boiling phenols.  A black solid with a melting point approximately 80°C (176°F). Composed primarily of polyalkylphenols, resin gums, and inorganic salts.]"	271-418-0	68555-24-8	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-127-00-6	"Phenols, C9-11; Distillate Phenols"	293-435-2	91079-47-9	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-128-00-1	"Tar acids, cresylic; Distillate Phenols; [A complex combination of organic compounds obtained from brown coal and boiling in the range of approximately 200°C to 230°C (392°F to 446°F).  It contains chiefly phenols and pyridine bases.]"	295-540-9	92062-26-5	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-129-00-7	"Tar acids, brown-coal, C2-alkylphenol fraction; Distillate Phenols; [The distillate from the acidification of alkaline washed lignite tar distillate boiling in the range of approximately 200°C to 230°C (392°F to 446°F).  Composed primarily of m- and p-ethylphenol as well as cresols and xylenols.]"	302-662-9	94114-29-1	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-130-00-2	"Extract oils (coal), naphthalene oils; Acid Extract; [The aqueous extract produced by an acidic wash of alkali-washed naphthalene oil.  Composed primarily of acid salts of various aromatic nitrogen bases including pyridine, quinoline and their alkyl derivatives.]"	292-623-1	90641-00-2	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-131-00-8	"Tar bases, quinoline derivs.; Distillate Bases"	271-020-7	68513-87-1	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-132-00-3	"Tar bases, coal, quinoline derivs. fraction; Distillate Bases"	274-560-1	70321-67-4	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-133-00-9	"Tar bases, coal, distn. residues; Distillate Bases; [The distillation residue remaining after the distillation of the neutralized, acid-extracted base-containing tar fractions obtained by the distillation of coal tars.  It contains chiefly aniline, collidines, quinoline and quinoline derivatives and toluidines.]"	295-544-0	92062-29-8	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-134-00-4	"Hydrocarbon oils, arom., mixed with polyethylene and polypropylene, pyrolyzed, light oil fraction; Heat Treatment Products; [The oil obtained from the heat treatment of a polyethylene/polypropylene reaction mass with coal tar pitch or aromatic oils.  It consists predominantly of benzene and its homologs boiling in a range of approximately 70°C to 120°C (158°F to 248°F).]"	309-745-9	100801-63-6	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-135-00-X	"Hydrocarbon oils, arom., mixed with polyethylene, pyrolyzed, light oil fraction; Heat Treatment Products; [The oil obtained from the heat treatment of polyethylene with coal tar pitch or aromatic oils.  It consists predominantly of benzene and its homologs boiling in a range of 70°C to 120°C (158°F to 248°F).]"	309-748-5	100801-65-8	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-136-00-5	"Hydrocarbon oils, arom., mixed with polystyrene, pyrolyzed, light oil fraction; Heat Treatment Products; [The oil obtained from the heat treatment of polystyrene with coal tar pitch or aromatic oils.  It consists predominantly of benzene and its homologs boiling in a range of approximately 70°C to 210°C (158°F to 410°F).]"	309-749-0	100801-66-9	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-137-00-0	"Extract residues (coal), tar oil alk., naphthalene distn. residues; Naphthalene Oil Extract Residue; [The residue obtained from chemical oil extracted after the removal of naphthalene by distillation composed primarily of two to four membered condensed ring aromatic hydrocarbons and aromatic nitrogen bases.]"	277-567-8	73665-18-6	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-138-00-6	"Creosote oil, low-boiling distillate; Wash Oil; [The low-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal, which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillate, removed. It is crystal free at approximately 38°C (100°F).]"	274-566-4	70321-80-1	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00/ATP01
648-139-00-1	"Tar acids, cresylic, sodium salts, caustic solns.; Alkaline Extract"	272-361-4	68815-21-4	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-140-00-7	"Extract oils (coal), tar base; Acid Extract; [The extract from coal tar oil alkaline extract residue produced by an acidic wash such as aqueous sulfuric acid after distillation to remove naphthalene.  Composed primarily of the acid salts of various aromatic nitrogen bases including pyridine, quinoline, and their alkyl derivatives.]"	266-020-9	65996-86-3	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-141-00-2	"Tar bases, coal, crude; Crude Tar Bases; [The reaction product obtained by neutralizing coal tar base extract oil with an alkaline solution, such as aqueous sodium hydroxide, to obtain the free bases. Composed primarily of such organic bases as acridine, phenanthridine, pyridine, quinoline and their alkyl derivatives.]"	266-018-8	65996-84-1	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J M	CLP00/ATP01
648-142-00-8	"Residues (coal), liq. solvent extn.; [A cohesive powder composed of coal mineral matter and undissolved coal remaining after extraction of coal by a liquid solvent.]"	302-681-2	94114-46-2	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00
648-143-00-3	"Coal liquids, liq. solvent extn. soln.; [The product obtained by filtration of coal mineral matter and undissolved coal from coal extract solution produced by digesting coal in a liquid solvent. A black, viscous, highly complex liquid combination composed primarily of aromatic and partly hydro-genated aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic and other aromatic oxygen compounds and their alkyl derivatives.]"	302-682-8	94114-47-3	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00
648-144-00-9	"Coal liquids, liq. solvent extn.; [The substantially solvent-free product obtained by the distillation of the solvent from filtered coal extract solution produced by digesting coal in a liquid solvent. A black semi-solid, composed primarily of a complex combination of condensed-ring aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic compounds and other aromatic oxygen compounds, and their alkyl derivatives.]"	302-683-3	94114-48-4	Carc. 1B	H350	GHS08Dgr	H350			M	CLP00
648-145-00-4	"Tar brown-coal; [An oil distilled from brown-coal tar. Composed primarily of aliphatic, naphthenic and one- to three-ring aromatic hydrocarbons, their alkyl derivates, heteroaromatics and one- and two-ring phenols boiling in the range of approximately 150 °C to 360 °C (302 °F to 680 °F).]"	309-885-0	101316-83-0	Carc. 1A	H350	GHS08Dgr	H350				CLP00
648-146-00-X	"Tar, brown-coal, low-temp.; [A tar obtained from low temperature carbonization and low temperature gasification of brown coal. Composed primarily of aliphatic, naphthenic and cyclic aromatic hydrocarbons, heteroaromatic hydrocarbons and cyclic phenols.]"	309-886-6	101316-84-1	Carc. 1A	H350	GHS08Dgr	H350				CLP00
648-147-00-5	"Light oil (coal), coke-oven; Crude benzole; [The volatile organic liquid extracted from the gas evolved in the high temperature (greater than 700°C (1292°F)) destructive distillation of coal.  Composed primarily of benzene, toluene, and xylenes.  May contain other minor hydrocarbon constituents.]"	266-012-5	65996-78-3	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-148-00-0	"Distillates (coal), liq. solvent extn., primary; [The liquid product of condensation of vapors emitted during the digestion of coal in a liquid solvent and boiling in the range of approximately 30°C to 300°C (86°F to 572°F).  Composed primarily of partly hydrogenated condensed-ring aromatic hydrocarbons, aromatic compounds containing nitrogen, oxygen and sulfur, and their alkyl derivatives having carbon numbers predominantly in the range of C4 through C14.]"	302-688-0	94114-52-0	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-149-00-6	"Distillates (coal), solvent extn., hydrocracked; [Distillate obtained by hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30°C to 300°C (86°F to 572°F).  Composed primarily of aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes with carbon numbers predominantly in the range of C4 through C14.  Nitrogen, sulfur and oxygen-containing aromatic and hydrogenated aromatic compounds are also present.]"	302-689-6	94114-53-1	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-150-00-1	"Naphtha (coal), solvent extn., hydrocracked; [Fraction of the distillate obtained by hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30°C to 180°C (86°F to 356°F).  Composed primarily of aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes with carbon numbers predominantly in the range of C4 to C9.  Nitrogen, sulfur and oxygen-containing aromatic and hydrogenated aromatic compounds are also present.]"	302-690-1	94114-54-2	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-151-00-7	"Gasoline, coal solvent extn., hydrocracked naphtha; [Motor fuel produced by the reforming of the refined naphtha fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 °C to 180 °C (86 °F to 356 °F). Composed primarily of aromatic and naphthenic hydrocarbons, their alkyl derivatives and alkyl hydrocarbons having carbon numbers in the range of C4 through C9.]"	302-691-7	94114-55-3	Carc. 1B	H350	GHS08Dgr	H350				CLP00
648-152-00-2	"Distillates (coal), solvent extn., hydrocracked middle; [Distillate obtained from the hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180°C to 300°C (356°F to 572°F.  Composed primarily of two-ring aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes having carbon numbers predominantly in the range of C9 through C14.  Nitrogen, sulfur and oxygen-containing compounds are also present.]"	302-692-2	94114-56-4	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-153-00-8	"Distillates (coal), solvent extn., hydrocracked hydrogenated middle; [Distillate from the hydrogenation of hydrocracked middle distillate from coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180°C to 280°C (356°F to 536°F).  Composed primarily of hydrogenated two- ring carbon compounds and their alkyl derivatives having carbon numbers predominantly in the range of C9 through C14.]"	302-693-8	94114-57-5	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
648-154-00-3	"Fuels, jet aircraft, coal solvent extn., hydrocracked hydrogenated; [Jet engine fuel produced by hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 °C to 225 °C (356 °F to 473 °F). Composed primarily of hydrogenated two-ring hydrocarbons and their alkyl derivatives having carbon numbers predominantly in the range of C10 through C12.]"	302-694-3	94114-58-6	Carc. 2	H351	GHS08Wng	H350				CLP00
648-155-00-9	"Fuels, diesel, coal solvent extn., hydrocracked hydrogenated; [Diesel engine fuel produced by the hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 200 °C to 280 °C (392 °F to 536 °F). Composed primarily of hydrogenated two-ring hydrocarbons and their alkyl derivatives having carbon numbers predominantly in the range of C11 through C14.]"	302-695-9	94114-59-7	Carc. 2	H351	GHS08Wng	H350				CLP00
648-156-00-4	"Light oil (coal), semi-coking process; Fresh oil; [The volatile organic liquid condensed from the gas evolved in the low-temperature (less than 700°C (1292°F)) destructive distillation of coal.  Composed primarily of C6-10 hydrocarbons.]"	292-635-7	90641-11-5	Carc. 1BMuta. 1B	H350H340	GHS08Dgr	H350H340			J	CLP00/ATP01
649-001-00-3	"Extracts (petroleum), light naphthenic distillate solvent"	265-102-1	64742-03-6	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-002-00-9	"Extracts (petroleum), heavy paraffinic distillate solvent"	265-103-7	64742-04-7	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-003-00-4	"Extracts (petroleum), light paraffinic distillate solvent"	265-104-2	64742-05-8	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-004-00-X	"Extracts (petroleum), heavy naphthenic distillate solvent"	265-111-0	64742-11-6	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-005-00-5	"Extracts (petroleum), light vacuum gas oil solvent"	295-341-7	91995-78-7	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-006-00-0	"hydrocarbons C26-55, arom-rich"	307-753-7	97722-04-8	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-007-00-6	"fatty acids, tall-oil, reaction products with iminodiethanol and boric acid"	400-160-5		Skin Irrit. 2Aquatic Chronic 2	H315H411	GHS07GHS09Wng	H315H411				CLP00
649-008-00-1	"Residues (petroleum), atm. tower; Heavy Fuel oil; [A complex residuum from the atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 °C (662 °F). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]"	265-045-2	64741-45-3	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-009-00-7	"Gas oils (petroleum), heavy vacuum; Heavy Fuel oil; [A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and boiling in the range of approximately 350 °C to 600 °C (662 °F to 1112 °F). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]"	265-058-3	64741-57-7	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-010-00-2	"Distillates (petroleum), heavy catalytic cracked; Heavy Fuel oil; [A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C35 and boiling in the range of approximately 260 °C to 500 °C (500 °F to 932 °F). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]"	265-063-0	64741-61-3	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-011-00-8	"Clarified oils (petroleum), catalytic cracked; Heavy Fuel oil; [A complex combination of hydrocarbons produced as the residual fraction from distillation of the products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 °C (662 °F). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]"	265-064-6	64741-62-4	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-012-00-3	"Residues (petroleum), hydrocracked; Heavy Fuel oil; [A complex combination of hydrocarbons produced as the residual fraction from distillation of the products of a hydrocracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 °C (662 °F).]"	265-076-1	64741-75-9	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-013-00-9	"Residues (petroleum), thermal cracked; Heavy Fuel oil; [A complex combination of hydrocarbons produced as the residual fraction from distillation of the product from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 °C (662 °F). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]"	265-081-9	64741-80-6	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-014-00-4	"Distillates (petroleum), heavy thermal cracked; Heavy Fuel oil; [A complex combination of hydrocarbons from the distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C15 through C36 and boiling in the range of approximately 260 °C to 480 °C (500 °F to 896 °F). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]"	265-082-4	64741-81-7	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-015-00-X	"Gas oils (petroleum), hydrotreated vacuum; Heavy Fuel oil; [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C50 and boiling in the range of approximately 230 °C to 600 °C (446 °F to 1112 °F). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]"	265-162-9	64742-59-2	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-016-00-5	"Residues (petroleum), hydrodesulfurized atmospheric tower; Heavy Fuel oil; [A complex combination of hydrocarbons obtained by treating an atmospheric tower residuum with hydrogen in the presence of a catalyst under conditions primarily to remove organic sulfur compounds. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 °C (662 °F). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]"	265-181-2	64742-78-5	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-017-00-0	"Gas oils (petroleum), hydrodesulfurized heavy vacuum; Heavy Fuel oil; [A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and boiling in the range of approximately 350 °C to 600 °C (662 °F to 1112 °C). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]"	265-189-6	64742-86-5	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-018-00-6	"Residues (petroleum), steam-cracked; Heavy Fuel oil; [A complex combination of hydrocarbons obtained as the residual fraction from the distillation of the products of a steam cracking process (including steam cracking to produce ethylene). It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly greater than C14 and boiling above approximately 260 °C (500 °F). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]"	265-193-8	64742-90-1	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-019-00-1	"Residues (petroleum), atmospheric; Heavy Fuel oil; [A complex residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C11 and boiling above approximately 200 °C (392 °F). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]"	269-777-3	68333-22-2	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-020-00-7	"Clarified oils (petroleum), hydrodesulfurized catalytic cracked; Heavy Fuel oil; [A complex combination of hydrocarbons obtained by treating catalytic cracked clarified oil with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 °C (662 °F). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]"	269-782-0	68333-26-6	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-021-00-2	"Distillates (petroleum), hydrodesulfurized intermediate catalytic cracked; Heavy Fuel oil; [A complex combination of hydrocarbons obtained by treating intermediate catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C30 and boiling in the range of approximately 205 °C to 450 °C (401 °F to 842 °F). It contains a relatively large proportion of tricyclic aromatic hydrocarbons.]"	269-783-6	68333-27-7	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-022-00-8	"Distillates (petroleum), hydrodesulfurized heavy catalytic cracked; Heavy Fuel oil; [A complex combination of hydrocarbons obtained by treatment of heavy catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C35 and boiling in the range of approximately 260 °C to 500 °C (500 °F to 932 °F). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]"	269-784-1	68333-28-8	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-023-00-3	"Fuel oil, residues-straight-run gas oils, high-sulfur; Heavy Fuel oil"	270-674-0	68476-32-4	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-024-00-9	"Fuel oil, residual; Heavy Fuel oil; [The liquid product from various refinery streams, usually residues. The composition is complex and varies with the source of the crude oil.]"	270-675-6	68476-33-5	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-025-00-4	"Residues (petroleum), catalytic reformer fractionator residue distn.; Heavy Fuel oil; [A complex residuum from the distillation of catalytic reformer fractionator residue. It boils approximately above 399 °C (750 °F).]"	270-792-2	68478-13-7	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-026-00-X	"Residues (petroleum), heavy coker gas oil and vacuum gas oil; Heavy Fuel oil; [A complex combination of hydrocarbons produced as the residual fraction from the distillation of heavy coker gas oil and vacuum gas oil. It predominantly consists of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 °C (446 °F).]"	270-796-4	68478-17-1	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-027-00-5	"Residues (petroleum), heavy coker and light vacuum; Heavy Fuel oil; [A complex combination of hydrocarbons produced as the residual fraction from the distillation of heavy coker gas oil and light vacuum gas oil. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 °C (446 °F).]"	270-983-0	68512-61-8	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-028-00-0	"Residues (petroleum), light vacuum; Heavy Fuel oil; [A complex residuum from the vacuum distillation of the residuum from the atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 °C (446 °F).]"	270-984-6	68512-62-9	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-029-00-6	"Residues (petroleum), steam-cracked light; Heavy Fuel oil; [A complex residuum from the distillation of the products from a steam-cracking process. It consists predominantly of aromatic and unsaturated hydrocarbons having carbon numbers greater than C7 and boiling in the range of approximately 101 °C to 555 °C (214 °F to 1030 °F).]"	271-013-9	68513-69-9	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-030-00-1	"Fuel oil, No 6; Heavy Fuel oil; [A distillate oil having a minimum viscosity of 900 SUS at 37.7 °C (100 °F) to a maximum of 9000 SUS at 37.7 °C (100 °F).]"	271-384-7	68553-00-4	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-031-00-7	"Residues (petroleum), topping plant, low-sulfur; Heavy Fuel oil; [A low-sulfur complex combination of hydrocarbons produced as the residual fraction from the topping plant distillation of crude oil. It is the residuum after the straight-run gasoline cut, kerosene cut and gas oil cut have been removed.]"	271-763-7	68607-30-7	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-032-00-2	"Gas oils (petroleum), heavy atmospheric; Heavy Fuel oil; [A complex combination of hydrocarbons obtained by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C35 and boiling in the range of approximately 121 °C to 510 °C (250 °F to 950 °F).]"	272-184-2	68783-08-4	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-033-00-8	"Residues (petroleum), coker scrubber, Condensed-ring-arom.-contg.; Heavy Fuel oil; [A very complex combination of hydrocarbons produced as the residual fraction from the distillation of vaccum residuum and the products from a thermal cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 °C (662 °F). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed rind aromatic hydrocarbons.]"	272-187-9	68783-13-1	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-034-00-3	"Distillates (petroleum), petroleum residues vacuum; Heavy Fuel oil; [A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from the atmospheric distillation of crude oil.]"	273-263-4	68955-27-1	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-035-00-9	"Residues (petroleum), steam-cracked, resinous; Heavy Fuel oil; [A complex residuum from the distillation of steam-cracked petroleum residues.]"	273-272-3	68955-36-2	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-036-00-4	"Distillates (petroleum), intermediate vacuum; Heavy Fuel oil; [A complex combination of hydrocarbons produced by the vacuum, distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C14 through C42 and boiling in the range of approximately 250 °C to 545 °C (482 °F to 1013 °F). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]"	274-683-0	70592-76-6	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-037-00-X	"Distillates (petroleum), light vacuum; Heavy Fuel oil; [A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C35 and boiling in the range of approximately 250 °C to 545 °C (482 °F to 1013 °F).]"	274-684-6	70592-77-7	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-038-00-5	"Distillates (petroleum), vacuum; Heavy Fuel oil; [A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having numbers predominantly in the range of C15 through C50 and boiling in the range of approximately 270 °C to 600 °C (518 °F to 1112 °F). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]"	274-685-1	70592-78-8	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-039-00-0	"Gas oils (petroleum), hydrodesulfurized coker heavy vacuum; Heavy Fuel oil; [A complex combination of hydrocarbons obtained by hydrodesulfurization of heavy coker distillate stocks, It consists predominantly of hydrocarbons having carbon numbers predominantly in the range C18 to C44 and boiling in the range of approximately 304 °C to 548 °C (579 °F to 1018 °F). Likely to contain 5 % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]"	285-555-9	85117-03-9	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-040-00-6	"Residues (petroleum), steam-cracked, distillates; Heavy Fuel oil; [A complex combination of hydrocarbons obtained during the production of refined petroleum tar by the distillation of steam cracked tar. It consists predominantly of aromatic and other hydrocarbons and organic sulfur compounds.]"	292-657-7	90669-75-3	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-041-00-1	"Residues (petroleum), vacuum, light; Heavy Fuel oil; [A complex residuum from the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C24 and boiling above approximately 390 °C (734 °F).]"	292-658-2	90669-76-4	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-042-00-7	"Fuel oil, heavy, high-sulfur; Heavy Fuel oil; [A complex combination of hydrocarbons obtained by the distillation of crude petroleum. It consists predominantly of aliphatic, aromatic and cycloaliphatic hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 °C (752 °F).]"	295-396-7	92045-14-2	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-043-00-2	"Residues (petroleum), catalytic cracking; Heavy Fuel oil; [A complex combination of hydrocarbons produced as the residual fraction from the distillation of the products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C11 and boiling above approximately 200 °C (392 °F).]"	295-511-0	92061-97-7	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-044-00-8	"Distillates (petroleum), intermediate catalytic cracked, thermally degraded; Heavy Fuel oil; [A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process which has been used as a heat transfer fluid. It consists predominantly of hydrocarbons boiling in the range of approximately 220 °C to 450 °C (428 °F to 842 °F). This stream is likely to contain organic sulfur compounds.]"	295-990-6	92201-59-7	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-045-00-3	"Residual oils (petroleum); Heavy Fuel oil; [A complex combination of hydrocarbons, sulfur compounds and metal-containing organic compounds obtained as the residue from refinery fractionation cracking processes. It produces a finished oil with a viscosity above 2cSt. at 100 °C.]"	298-754-0	93821-66-0	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-046-00-9	"Residues, steam cracked, thermally treated; Heavy Fuel oil; [A complex combination of hydrocarbons obtained by the treatment and distillation of raw steam-cracked naphtha. It consists predominantly of unsaturated hydrocarbons boiling in the range above approximately 180 °C (356 °F).]"	308-733-0	98219-64-8	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-047-00-4	"Distillates (petroleum), hydrodesulfurized full-range middle; Heavy Fuel oil; [A complex combination of hydrocarbons obtained by treating a petroleum stock with hydrogen. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 °C to 400 °C (302 °F to 752 °F).]"	309-863-0	101316-57-8	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-048-00-X	"Residues (petroleum), catalytic reformer fractionator; Heavy Fuel oil; [A complex combination of hydrocarbons produced as the residual fraction from distillation of the product from a catalytic reforming process. It consists of predominantly aromatic hydrocarbons having carbon numbers predominantly in the range of C10 through C25 and boiling in the range of approximately 160 °C to 400 °C (320 °F to 725 °F). This stream is likely to contain 5 wt. % or more of 4- or 6-membered condensed ring aromatic hydrocarbons.]"	265-069-3	64741-67-9	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-049-00-5	"Petroleum; Crude oil; [A complex combination of hydrocarbons, It consists predominantly of aliphatic, alicyclic and aromatic hydrocarbons. It may also contain small amounts of nitrogen, oxygen and sulfur compounds. This category encompasses light, medium, and heavy petroleums, as well as the oils extended from tar sands. Hydrocarbonaceous materials requiring major chemical changes for their recovery or conversion to petroleum refinery feedstocks such as crude shale oils; upgraded shale oils and liquid coal fuels are not included in this definition.]"	232-298-5	8002-05-9	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-050-00-0	"Distillates (petroleum), light paraffinic; Unrefined or mildly refined baseoil; [A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 °F (19cSt at 40 °C). It contains a relatively large proportion of saturated aliphatic hydrocarbons normally present in this distillation range of crude oil.]"	265-051-5	64741-50-0	Carc. 1A	H350	GHS08Dgr	H350				CLP00
649-051-00-6	"Distillates (petroleum), heavy paraffinic; Unrefined or mildly refined baseoil; [A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 °F (19cSt at 40 °C). It contains a relatively large proportion of saturated aliphatic hydrocarbons.]"	265-052-0	64741-51-1	Carc. 1A	H350	GHS08Dgr	H350				CLP00
649-052-00-1	"Distillates (petroleum), light naphthenic; Unrefined or mildly refined baseoil; [A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 °F (19cSt at 40 °C). It contains relatively few normal paraffins.]"	265-053-6	64741-52-2	Carc. 1A	H350	GHS08Dgr	H350				CLP00
649-053-00-7	"Distillates (petroleum), heavy naphthenic; Unrefined or mildly refined baseoil; [A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 °F (19cSt at 40 °C). It contains relatively few normal paraffins.]"	265-054-1	64741-53-3	Carc. 1A	H350	GHS08Dgr	H350				CLP00
649-054-00-2	"Distillates (petroleum), acid-treated heavy naphthenic; Unrefined or mildly refined baseoil; [A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 °F (19cSt at 40 °C). It contains relatively few normal paraffins.]"	265-117-3	64742-18-3	Carc. 1A	H350	GHS08Dgr	H350				CLP00
649-055-00-8	"Distillates (petroleum), acid-treated light naphthenic; Unrefined or mildly refined baseoil; [A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 °F (19cSt at 40 °C). It contains relatively few normal paraffins.]"	265-118-9	64742-19-4	Carc. 1A	H350	GHS08Dgr	H350				CLP00
649-056-00-3	"Distillates (petroleum), acid-treated heavy paraffinic; Unrefined or mildly refined baseoil; [A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of a least 100 SUS at 100 °F (19cSt at 40 °C).]"	265-119-4	64742-20-7	Carc. 1A	H350	GHS08Dgr	H350				CLP00
649-057-00-9	"Distillates (petroleum), acid-treated light paraffinic; Unrefined or mildly refined baseoil; [A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity of less than 100 SUS at 100 °F (19cSt at 40 °C).]"	265-121-5	64742-21-8	Carc. 1A	H350	GHS08Dgr	H350				CLP00
649-058-00-4	"Distillates (petroleum), chemically neutralized heavy paraffinic; Unrefined or mildly refined baseoil; [A complex combination of hydrocarbons obtained from a treating process to remove acidic materials. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 °F (19cSt at 40 °C). It contains a relatively large proportion of aliphatic hydrocarbons.]"	265-127-8	64742-27-4	Carc. 1A	H350	GHS08Dgr	H350				CLP00
649-059-00-X	"Distillates (petroleum), chemically neutralized light paraffinic; Unrefined or mildly refined baseoil; [A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity less than 100 SUS at 100 °F (19cSt at 40 °C).]"	265-128-3	64742-28-5	Carc. 1A	H350	GHS08Dgr	H350				CLP00
649-060-00-5	"Distillates (petroleum), chemically neutralized heavy naphthenic; Unrefined or mildly refined baseoil; [A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 °F (19cSt at 40 °C). It contains relatively few normal paraffins.]"	265-135-1	64742-34-3	Carc. 1A	H350	GHS08Dgr	H350				CLP00
649-061-00-0	"Distillates (petroleum), chemically neutralized light naphthenic; Unrefined or mildly refined baseoil; [A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS a 100 °F (19cSt at 40 °C). It contains relatively few normal paraffins.]"	265-136-7	64742-35-4	Carc. 1A	H350	GHS08Dgr	H350				CLP00
649-062-00-6	"Gases (petroleum), catalytic cracked naphtha depropanizer overhead, C3-rich acid-free; Petroleum gas; [A complex combination of hydrocarbons obtained from fractionation of catalytic cracked hydrocarbons and treated to remove acidic impurities. It consists of hydrocarbons having carbon numbers in the range of C2 through C4, predominantly C3.]"	270-755-0	68477-73-6	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-063-00-1	"Gases (petroleum), catalytic cracker; Petroleum gas; [A complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]"	270-756-6	68477-74-7	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-064-00-7	"Gases (petroleum), catalytic cracker, C1-5-rich; Petroleum gas; [A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of aliphatic hydrocarbons having carbon numbers in the range of C1 through C6, predominantly C1 through C5.]"	270-757-1	68477-75-8	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-065-00-2	"Gases (petroleum), catalytic polymd. naphtha stabilizer overhead, C2-4-rich; Petroleum gas; [A complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic polymerized naphtha. It consists of aliphatic hydrocarbons having carbon numbers in the range of C2 through C6, predominantly C2 through C4.]"	270-758-7	68477-76-9	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-066-00-8	"Gases (petroleum), catalytic reformer, C1-4-rich; Petroleum gas; [A complex combination of hydrocarbons produced by distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers in the range of C1 through C6, predominantly C1 through C4.]"	270-760-8	68477-79-2	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-067-00-3	"Gases (petroleum), C3-5 olefinic-paraffinic alkylation feed; Petroleum gas; [A complex combination of olefinic and paraffinic hydrocarbons having carbon numbers in the range of C3 through C5 which are used as alkylation feed. Ambient temperatures normally exceed the critical temperature of these combinations.]"	270-765-5	68477-83-8	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-068-00-9	"Gases (petroleum), C4-rich; Petroleum gas; [A complex combination of hydrocarbons produced by distillation of products from a catalytic fractionation process. It consists of aliphatic hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C4.]"	270-767-6	68477-85-0	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-069-00-4	"Gases (petroleum), deethanizer overheads; Petroleum gas; [A complex combination of hydrocarbons produced from distillation of the gas and gasoline fractions from the catalytic cracking process. It contains predominantly ethane and ethylene.]"	270-768-1	68477-86-1	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-070-00-X	"Gases (petroleum), deisobutanizer tower overheads; Petroleum gas; [A complex combination of hydrocarbons produced by the atmospheric distillation of a butane-butylene stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C4.]"	270-769-7	68477-87-2	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-071-00-5	"Gases (petroleum), depropanizer dry, propene-rich; Petroleum gas; [A complex combination of hydrocarbons produced by the distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists predominantly of propylene with some ethane and propane.]"	270-772-3	68477-90-7	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-072-00-0	"Gases (petroleum), depropanizer overheads; Petroleum gas; [A complex combination of hydrocarbons produced by distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]"	270-773-9	68477-91-8	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-073-00-6	"Gases (petroleum), gas recovery plant depropanizer overheads; Petroleum gas; [A complex combination of hydrocarbons obtained by fractionation of miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4, predominantly propane.]"	270-777-0	68477-94-1	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-074-00-1	"Gases (petroleum), Girbotol unit feed; Petroleum gas; [A complex combination of hydrocarbons that is used as the feed into the Girbatol unit to remove hydrogen sulfide. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]"	270-778-6	68477-95-2	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-075-00-7	"Gases (petroleum), isomerized naphtha fractionator, C4-rich, hydrogen sulfide-free; Petroleum gas"	270-782-8	68477-99-6	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-076-00-2	"Tail gas (petroleum), catalytic cracked clarified oil and thermal cracked vacuum residue fractionation reflux drum; Petroleum gas; [A complex combination of hydrocarbons obtained from fractionation of catalytic cracked clarified oil and thermal cracked vacuum residue. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]"	270-802-5	68478-21-7	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-077-00-8	"Tail gas (petroleum), catalytic cracked naphtha stabilization absorber; Petroleum gas; [A complex combination of hydrocarbons obtained from the stabilization of catalytic cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]"	270-803-0	68478-22-8	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-078-00-3	"Tail gas (petroleum), catalytic cracker, catalytic reformer and hydrodesulfurizer combined fractionater; Petroleum gas; [A complex combination of hydrocarbons obtained from the fractionation of products from catalytic cracking, catalytic reforming and hydrodesulfurizing processes treated to remove acidic impurities. It consists predominantly of hydrocarbons having cabon numbers predominantly in the range of C1 through C5.]"	270-804-6	68478-24-0	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-079-00-9	"Tail gas (petroleum), catalytic reformed naphtha fractionation stabilizer; Petroleum gas; [A complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic reformed naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]"	270-806-7	68478-26-2	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-080-00-4	"Tail gas (petroleum), saturate gas plant mixed stream, C4-rich; Petroleum gas; [A complex combination of hydrocarbons obtained from the fractionation stabilization of straight-run naphtha, distillation tail gas and catalytic reformed naphtha stabilizer tail gas. It consists of hydrocarbons having carbon numbers in the range of C3 through C6, predominantly butane and isobutane.]"	270-813-5	68478-32-0	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-081-00-X	"Tail gas (petroleum), saturate gas recovery plant, C1-2-rich; Petroleum gas; [A complex combination of hydrocarbons obtained from fractionation of distillate tail gas, straight-run naphtha, catalytic reformed naphtha stabilizer tail gas. It consists predominantly of hydrocarbons having carbon numbers in the range of C1through C5, predominantly methane and ethane.]"	270-814-0	68478-33-1	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-082-00-5	"Tail gas (petroleum), vacuum residues thermal cracker; Petroleum gas; [A complex combination of hydrocarbons obtained from the thermal cracking of vacuum residues. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]"	270-815-6	68478-34-2	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-083-00-0	"Hydrocarbons, C3-4-rich, petroleum distillate; Petroleum gas; [A complex combination of hydrocarbons produced by distillation and condensation of crude oil. It consists of hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C3 through C4.]"	270-990-9	68512-91-4	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-084-00-6	"Gases (petroleum), full-range straight-run naphtha dehexanizer off; petroleum gas; [A complex combination of hydrocarbons obtained by the fractionation of the full-range straight-run naphtha. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]"	271-000-8	68513-15-5	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-085-00-1	"Gases (petroleum), hydrocracking depropanizer off, hydrocarbon-rich; Petroleum gas; [A complex combination of hydrocarbon produced by the distillation of products from a hydrocracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4. It may also contain small amounts of hydrogen and hydrogen sulfide.]"	271-001-3	68513-16-6	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-086-00-7	"Gases (petroleum), light straight-run naphtha stabilizer off; Petroleum gas; [A complex combination of hydrocarbons obtained by the stabilization of light straight-run naphtha. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]"	271-002-9	68513-17-7	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-087-00-2	"Residues (petroleum), alkylation splitter, C4-rich; Petroleum gas; [A complex residuum from the distillation of streams various refinery operations. It consists of hydrocarbons having carbon numbers in the range of C4 through C5, predominantly butane and boiling in the range of approximately – 11.7 °C to 27.8 °C (11 °F to 82 °F).]"	271-010-2	68513-66-6	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-088-00-8	"Hydrocarbons, C1-4; Petroleum gas; [A complex combination of hydrocarbons provided by thermal cracking and absorber operations and by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately minus 164 °C to minus 0.5 °C (– 263 °F to 31 °F).]"	271-032-2	68514-31-8	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-089-00-3	"Hydrocarbons, C1-4, sweetened; Petroleum gas; [A complex combination of hydrocarbons obtained by subjecting hydrocarbon gases to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately – 164 °C to – 0.5 °C (– 263 °F to 31 °F).]"	271-038-5	68514-36-3	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-090-00-9	"Hydrocarbons, C1-3; Petroleum gas; [A complex combination of hydrocarbons having carbon numbers predominantly in the range of C1 through C3 and boiling in the range of approximately minus 164 °C to minus 42 °C (– 263 °F to – 44 °F).]"	271-259-7	68527-16-2	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-091-00-4	"Hydrocarbons, C1-4, debutanizer fraction; Petroleum gas"	271-261-8	68527-19-5	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-092-00-X	"Gases (petroleum), C1-5, wet; Petroleum gas; [A complex combination of hydrocarbons produced by the distillation of crude oil and/or the cracking of tower gas oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]"	271-624-0	68602-83-5	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-093-00-5	"Hydrocarbons, C2-4; Petroleum gas"	271-734-9	68606-25-7	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-094-00-0	"Hydrocarbons, C3; Petroleum gas"	271-735-4	68606-26-8	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-095-00-6	"Gases (petroleum), alkylation feed; Petroleum gas; [A complex combination of hydrocarbons produced by the catalytic cracking of gas oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C4.]"	271-737-5	68606-27-9	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-096-00-1	"Gases (petroleum), depropanizer bottoms fractionation off; Petroleum gas; [A complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms. It consists predominantly of butane, isobutane and butadiene.]"	271-742-2	68606-34-8	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-097-00-7	"Gases (petroleum), refinery blend; Petroleum gas; [A complex combination obtained from various processes. It consists of hydrogen, hydrogen sulfide and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]"	272-183-7	68783-07-3	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-098-00-2	"Gases (petroleum), catalytic cracking; Petroleum gas; [A complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C3 through C5.]"	272-203-4	68783-64-2	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-099-00-8	"Gases (petroleum), C2-4, sweetened; Petroleum gas; [A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers predominantly in the range of C2 through C4 and boiling in the range of approximately – 51 °C to – 34 °C (– 60 °F to – 30 °F).]"	272-205-5	68783-65-3	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-100-00-1	"Gases (petroleum), crude oil fractionation off; Petroleum gas; [A complex combination of hydrocarbons produced by the fractionation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]"	272-871-7	68918-99-0	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-101-00-7	"Gases (petroleum), dehexanizer off; Petroleum gas; [A complex combination of hydrocarbons obtained by the fractionation of combined naphtha streams. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]"	272-872-2	68919-00-6	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-102-00-2	"Gases (petroleum), light straight run gasoline fractionation stabilizer off; Petroleum gas; [A complex combination of hydrocarbons obtained by the fractionation of light straight-run gasoline. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]"	272-878-5	68919-05-1	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-103-00-8	"Gases (petroleum), naphtha unifiner desulfurization stripper off; Petroleum gas; [A complex combination of hydrocarbons produced by a naphtha unifiner desulfurization process and stripped from the naphtha product. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]"	272-879-0	68919-06-2	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-104-00-3	"Gases (petroleum), straight-run naphtha catalytic reforming off; Petroleum gas; [A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha and fractionation of the total effluent. It consists of methane, ethane, and propane.]"	272-882-7	68919-09-5	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-105-00-9	"Gases (petroleum), fluidized catalytic cracker splitter overheads; Petroleum gas; [A complex combination of hydrocarbons produced by the fractionation of the charge to the C3-C4 splitter. It consists predominantly of C3 hydrocarbons.]"	272-893-7	68919-20-0	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08	H220H350H340			K U	CLP00/ATP01corr
649-106-00-4	"Gases (petroleum), straight-run stabilizer off; Petroleum gas; [A complex combination of hydrocarbons obtained from the fractionation of the liquid from the first tower used in the distillation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]"	272-883-2	68919-10-8	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-107-00-X	"Gases (petroleum), catalytic cracked naphtha debutanizer; Petroleum gas; [A complex combination of hydrocarbons obtained from fractionation of catalytic cracked naphtha. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]"	273-169-3	68952-76-1	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-108-00-5	"Tail gas (petroleum), catalytic cracked distillate and naphtha stabilizer; Petroleum gas; [A complex combination of hydrocarbons obtained by the fractionation of catalytic cracked naphtha and distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]"	273-170-9	68952-77-2	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08	H220H350H340			K U	CLP00/ATP01corr
649-109-00-0	"Tail gas (petroleum), thermal-cracked distillate, gas oil and naphtha absorber; petroleum gas; [A complex combination of hydrocarbons obtained from the separation of thermal-cracked distillates, naphtha and gas oil. It consists pedrominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]"	273-175-6	68952-81-8	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-110-00-6	"Tail gas (petroleum), thermal cracked hydrocarbon fractionation stabilizer, petroleum coking; Petroleum gas; [A complex combination of hydrocarbons obtained from the fractionation stabilization of thermal cracked hydrocarbons from petroleum coking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]"	273-176-1	68952-82-9	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-111-00-1	"Gases (petroleum, light steam-cracked, butadiene conc.; Petroleum gas; [A complex combination of hydrocarbons produced by the distillation of products from a thermal cracking process. It consists of hydrocarbons having a carbon number predominantly of C4.]"	273-265-5	68955-28-2	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-112-00-7	"Gases (petroleum), straight-run naphtha catalytic reformer stabilizer overhead; Petroleum gas; [A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha and the fractionation of the total effluent. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]"	273-270-2	68955-34-0	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-113-00-2	"Hydrocarbons, C4; Petroleum gas"	289-339-5	87741-01-3	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-114-00-8	"Alkanes, C1-4, C3-rich; Petroleum gas"	292-456-4	90622-55-2	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-115-00-3	"Gases (petroleum), steam-cracker C3-rich; Petroleum gas; [A complex combination of hydrocarbons produced by the distillation of products from a steam cracking process. It consists predominantly of propylene with some propane and boils in the range of approximately – 70 °C to 0 °C (– 94 °F to 32 °F).]"	295-404-9	92045-22-2	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-116-00-9	"Hydrocarbons, C4, steam-cracker distillate; Petroleum gas; [A complex combination of hydrocarbons produced by the distillation of the products of a steam cracking process. It consists predominantly of hydrocarbons having a carbon number of C4, predominantly 1-butene and 2-butene, containing also butane and isobutene and boiling in the range of approximately minus 12 °C to 5 °C (10.4 °F to 41 °F).]"	295-405-4	92045-23-3	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-117-00-4	"Petroleum gases, liquefied, sweetened, C4 fraction; Petroleum gas; [A complex combination of hydrocarbons obtained by subjecting a liquified petroleum gas mix to a sweetening process to oxidize mercaptans or to remove acidic impurities. It consists predominantly of C4 saturated and unsaturated hydrocarbons.]"	295-463-0	92045-80-2	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K S U	CLP00/ATP01corr
649-118-00-X	"Hydrocarbons, C4, 1,3-butadiene- and isobutene-free; Petroleum gas"	306-004-1	95465-89-7	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-119-00-5	"Raffinates (petroleum), steam-cracked C4 fraction cuprous ammonium acetate extn., C3-5 and C3-5 unsatd., butadiene-free; Petroleum gas"	307-769-4	97722-19-5	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-120-00-0	"Gases (petroleum), amine system feed; Refinery gas; [The feed gas to the amine system for removal of hydrogen sulfide. It consists of hydrogen. Carbon monoxide, carbon dioxide, hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5 may also be present.]"	270-746-1	68477-65-6	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-121-00-6	"Gases (petroleum), benzene unit hydrodesulfurizer off; Refinery gas; [Off gases produced by the benzene unit. It consists primarily of hydrogen. Carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6, including benzene, may also be present.]"	270-747-7	68477-66-7	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-122-00-1	"Gases (petroleum), benzene unit recycle, hydrogen-rich; Refinery gas; [A complex combination of hydrocarbons obtained by recycling the gases of the benzene unit. It consists primarily of hydrogen with various small amounts of carbon monoxide and hydrocarbons having carbon numbers in the range of C1 through C6.]"	270-748-2	68477-67-8	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-123-00-7	"Gases (petroleum), blend oil, hydrogen-nitrogen-rich; Refinery gas; [A complex combination of hydrocarbons obtained by distillation of a blend oil. It consists primarily of hydrogen and nitrogen with various small amounts of carbon monoxide, carbon dioxide, and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]"	270-749-8	68477-68-9	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-124-00-2	"Gases (petroleum), catalytic reformed naphtha stripper overheads; Refinery gas; [A complex combination of hydrocarbons obtained from stabilization of catalytic reformed naphtha. Its consists of hydrogen and saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]"	270-759-2	68477-77-0	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-125-00-8	"Gases (petroleum), C6-8 catalytic reformer recycle; Refinery gas; [A complex combination of hydrocarbons produced by distillation of products from catalytic reforming of C6-C8 feed and recycled to conserve hydrogen. It consists primarily of hydrogen. It may also contain various small amounts of carbon monoxide, carbon dioxide, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]"	270-761-3	68477-80-5	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-126-00-3	"Gases (petroleum), C6-8 catalytic reformer; Refinery gas; [A complex combination of hydrocarbons produced by distillation of products from catalytic reforming of C6-C8feed. It consists of hydrocarbons having carbon numbers in the range of C1 through C5 and hydrogen.]"	270-762-9	68477-81-6	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-127-00-9	"Gases (petroleum), C6-8 catalytic reformer recycle, hydrogen-rich; Refinery gas"	270-763-4	68477-82-7	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-128-00-4	"Gases (petroleum), C2-return stream; Refinery gas; [A complex combination of hydrocarbons obtained by the extraction of hydrogen from a gas stream which consists primarily of hydrogen with small amounts of nitrogen, carbon monoxide, methane, ethane, and ethylene. It contains predominantly hydrocarbons such as methane, ethane, and ethylene with small amounts of hydrogen, nitrogen and carbon monoxide.]"	270-766-0	68477-84-9	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08	H220H350H340			K U	CLP00/ATP01corr
649-129-00-X	"Gases (petroleum), dry sour, gas-concn.-unit-off; Refinery gas; [The complex combination of dry gases from a gas concentration unit. It consists of hydrogen, hydrogen sulfide and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]"	270-774-4	68477-92-9	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-130-00-5	"Gases (petroleum), gas concn. reabsorber distn.; Refinery gas; [A complex combination of hydrocarbons produced by distillation of products from combined gas streams in a gas concentration reabsorber. It consists predominantly of hydrogen, carbon monoxide, carbon dioxide, nitrogen, hydrogen sulfide and hydrocarbons having carbon numbers in the range of C1 through C3.]"	270-776-5	68477-93-0	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-131-00-0	"Gases (petroleum), hydrogen absorber off; Refinery gas; [A complex combination obtained by absorbing hydrogen from a hydrogen rich stream. It consists of hydrogen, carbon monoxide, nitrogen, and methane with small amounts of C2 hydrocarbons.]"	270-779-1	68477-96-3	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-132-00-6	"Gases (petroleum), hydrogen-rich; Refinery gas; [A complex combination separated as a gas from hydrocarbon gases by chilling. It consists primarily of hydrogen with various small amounts of carbon monoxide, nitrogen, methane, and C2 hydrocarbons.]"	270-780-7	68477-97-4	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-133-00-1	"Gases (petroleum), hydrotreater blend oil recycle, hydrogen-nitrogen-rich; Refinery gas; [A complex combination obtained from recycled hydrotreated blend oil. It consists primarily of hydrogen and nitrogen with various small amounts of carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]"	270-781-2	68477-98-5	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-134-00-7	"Gases (petroleum), recycle, hydrogen-rich; Refinery gas; [A complex combination obtained from recycled reactor gases. It consists primarily of hydrogen with various small amounts of carbon monoxide, carbon dioxide, nitrogen, hydrogen sulfide, and saturated aliphatic hydrocarbons having carbon numbers in the range of C1 through C5.]"	270-783-3	68478-00-2	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-135-00-2	"Gases (petroleum), reformer make-up, hydrogen-rich; Refinery gas; [A complex combination obtained from the reformers. It consists primarily of hydrogen with various small amounts of carbon monoxide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]"	270-784-9	68478-01-3	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-136-00-8	"Gases (petroleum), reforming hydrotreater; Refinery gas; [A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen, methane, and ethane with various small amounts of hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C5.]"	270-785-4	68478-02-4	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-137-00-3	"Gases (petroleum), reforming hydrotreater, hydrogen-methane-rich; Refinery gas; [A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen and methane with various small amounts of carbon monoxide, carbon dioxide, nitrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C5.]"	270-787-5	68478-03-5	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-138-00-9	"Gases (petroleum), reforming hydrotreater make-up, hydrogen-rich; Refinery gas; [A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen with various small amounts of carbon monoxide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]"	270-788-0	68478-04-6	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-139-00-4	"Gases (petroleum), thermal cracking distn.; Refinery gas; [A complex combination produced by distillation of products from a thermal cracking process. It consists of hydrogen, hydrogen sulfide, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]"	270-789-6	68478-05-7	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-140-00-X	"Tail gas (petroleum), catalytic cracker refractionation absorber; Refinery gas; [A complex combination of hydrocarbons obtained from refractionation of products from a catalytic cracking process. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]"	270-805-1	68478-25-1	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-141-00-5	"Tail gas (petroleum), catalytic reformed naphtha separator; Refinery gas; [A complex combination of hydrocarbons obtained from the catalytic reforming of straight run naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]"	270-807-2	68478-27-3	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-142-00-0	"Tail gas (petroleum), catalytic reformed naphtha stabilizer; Refinery gas; [A complex combination of hydrocarbons obtained from the stabilization of catalytic reformed naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]"	270-808-8	68478-28-4	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-143-00-6	"Tail gas (petroleum), cracked distillate hydrotreater separator; Refinery gas; [A complex combination of hydrocarbons obtained by treating cracked distillates with hydrogen in the presence of a catalyst. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]"	270-809-3	68478-29-5	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-144-00-1	"Tail gas (petroleum), hydrodesulfurized straight-run naphtha separator; Refinery gas; [A complex combination of hydrocarbons obtained from hydrodesulfurization of straight-run naphtha. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]"	270-810-9	68478-30-8	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-145-00-7	"Gases (petroleum), catalytic reformed straight-run naphtha stabilizer overheads; Refinery gas; [A complex combination of hydrocarbons obtained from the catalytic reforming of straight-run naphtha followed by fractionation of the total effluent. It consists of hydrogen, methane, ethane and propane.]"	270-999-8	68513-14-4	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-146-00-2	"Gases (petroleum), reformer effluent high-pressure flash drum off; Refinery gas; [A complex combination produced by the high-pressure flashing of the effluent from the reforming reactor. It consists primarily of hydrogen with various small amounts of methane, ethane, and propane.]"	271-003-4	68513-18-8	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-147-00-8	"Gases (petroleum), reformer effluent low-pressure flash drum off; Refinery gas; [A complex combination produced by low-pressure flashing of the effluent from the reforming reactor. It consists primarily of hydrogen with various small amounts of methane, ethane, and propane.]"	271-005-5	68513-19-9	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-148-00-3	"Gases (petroleum), oil refinery gas distn. off; Refinery gas; [A complex combination separated by distillation of a gas stream containing hydrogen, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers in the range of C1 through C6 or obtained by cracking ethane and propane. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C2, hydrogen, nitrogen, and carbon monoxide.]"	271-258-1	68527-15-1	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-149-00-9	"Gases (petroleum), benzene unit hydrotreater depentanizer overheads; Refinery gas; [A complex combination produced by treating the feed from the benzene unit with hydrogen in the presence of a catalyst followed by depentanizing. It consists primarily of hydrogen, ethane and propane with various small amounts of nitrogen, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6. It may contain trace amounts of benzene.]"	271-623-5	68602-82-4	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-150-00-4	"Gases (petroleum), secondary absorber off, fluidized catalytic cracker overheads fractionator; Refinery gas; [A complex combination produced by the fractionation of the overhead products from the catalytic cracking process in the fluidized catalytic cracker. It consists of hydrogen, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]"	271-625-6	68602-84-6	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-151-00-X	"Petroleum products, refinery gases; Refinery gas; [A complex combination which consists primarily of hydrogen with various small amounts of methane, ethane, and propane.]"	271-750-6	68607-11-4	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-152-00-5	"Gases (petroleum), hydrocracking low-pressure separator; Refinery gas; [A complex combination obtained by the liquid-vapor separation of the hydrocracking process reactor effluent. It consists predominantly of hydrogen and saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]"	272-182-1	68783-06-2	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-153-00-0	"Gases (petroleum), refinery; Refinery gas; [A complex combination obtained from various petroleum refining operations. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]"	272-338-9	68814-67-5	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-154-00-6	"Gases (petroleum), platformer products separator off; Refinery gas; [A complex combination obtained from the chemical reforming of naphthenes to aromatics. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]"	272-343-6	68814-90-4	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-155-00-1	"Gases (petroleum), hydrotreated sour kerosine depentanizer stabilizer off; Refinery gas; [The complex combination obtained from the depentanizer stabilization of hydrotreated kerosine. It consists primarily of hydrogen, methane, ethane, and propane with various small amounts of nitrogen, hydrogen sulfide, carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C4 through C5.]"	272-775-5	68911-58-0	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-156-00-7	"Gases (petroleum), hydrotreated sour kerosine flash drum; Refinery gas; [A complex combination obtained from the flash drum of the unit treating sour kerosine with hydrogen in the presence of a catalyst. It consists primarily of hydrogen and methane with various small amounts of nitrogen, carbon monoxide, and hydrocarbons having carbon numbers predominantly in the range of C2 through C5.]"	272-776-0	68911-59-1	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-157-00-2	"Gases (petroleum), distillate unifiner desulfurization stripper off; Refinery gas; [A complex combination stripped from the liquid product of the unifiner desulfurization process. It consists of hydrogen sulfide, methane, ethane, and propane.]"	272-873-8	68919-01-7	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-158-00-8	"Gases (petroleum), fluidized catalytic cracker fractionation off; Refinery gas; [A complex combination produced by the fractionation of the overhead product of the fluidized catalytic cracking process. It consists of hydrogen, hydrogen sulfide, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]"	272-874-3	68919-02-8	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-159-00-3	"Gases (petroleum), fluidized catalytic cracker scrubbing secondary absorber off; Refinery gas; [A complex combination produced by scrubbing the overhead gas from the fluidized catalytic cracker. It consists of hydrogen, nitrogen, methane, ethane and propane.]"	272-875-9	68919-03-9	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-160-00-9	"Gases (petroleum), heavy distillate hydrotreater desulfurization stripper off; Refinery gas; [A complex combination stripped from the liquid product of the heavy distillate hydrotreater desulfurization process. It consists of hydrogen, hydrogen sulfide, and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]"	272-876-4	68919-04-0	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-161-00-4	"Gases (petroleum), platformer stabilizer off, light ends fractionation; Refinery gas; [A complex combination obtained by the fractionation of the light ends of the platinum reactors of the platformer unit. It consists of hydrogen, methane, ethane and propane.]"	272-880-6	68919-07-3	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-162-00-X	"Gases (petroleum), preflash tower off, crude distn.; Refinery gas; [A complex combination produced from the first tower used in the distillation of crude oil. It consists of nitrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]"	272-881-1	68919-08-4	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-163-00-5	"Gases (petroleum), tar stripper off; Refinery gas; [A complex combination obtained by the fractionation of reduced crude oil. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]"	272-884-8	68919-11-9	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-164-00-0	"Gases (petroleum), unifiner stripper off; Refinery gas; [A combination of hydrogen and methane obtained by fractionation of the products from the unifiner unit.]"	272-885-3	68919-12-0	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-165-00-6	"Tail gas (petroleum), catalytic hydrodesulfurized naphtha separator; Refinery gas; [A complex combination of hydrocarbons obtained from the hydrodesulfurization of naphtha. It consists of hydrogen, methane, ethane, and propane.]"	273-173-5	68952-79-4	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-166-00-1	"Tail gas (petroleum), straight-run naphtha hydrodesulfurizer; Refinery gas; [A complex combination obtained from the hydrodesulfurization of straight-run naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]"	273-174-0	68952-80-7	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-167-00-7	"Gases (petroleum), sponge absorber off, fluidized catalytic cracker and gas oil desulfurizer overhead fractionation; Refinery gas; [A complex combination obtained by the fractionation of products from the fluidized catalytic cracker and gas oil desulfurizer. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]"	273-269-7	68955-33-9	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-168-00-2	"Gases (petroleum), crude distn. and catalytic cracking; Refinery gas; [A complex combination produced by crude distillation and catalytic cracking processes. It consists of hydrogen, hydrogen sulfide, nitrogen, carbon monoxide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]"	273-563-5	68989-88-8	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-169-00-8	"Gases (petroleum), gas oil diethanolamine scrubber off; Refinery gas; [A complex combination produced by desulfurization of gas oils with diethanolamine. It consists predominantly of hydrogen sulfide, hydrogen and aliphatic hydrocarbons having carbon numbers in the range of C1 through C5.]"	295-397-2	92045-15-3	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-170-00-3	"Gases (petroleum), gas oil hydrodesulfurization effluent; Refinery gas; [A complex combination obtained by separation of the liquid phase from the effluent from the hydrogenation reaction. It consists predominantly of hydrogen, hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]"	295-398-8	92045-16-4	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-171-00-9	"Gases (petroleum), gas oil hydrodesulfurization purge; Refinery gas; [A complex combination of gases obtained from the reformer and from the purges from the hydrogenation reactor. It consists predominantly of hydrogen and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]"	295-399-3	92045-17-5	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-172-00-4	"Gases (petroleum), hydrogenator effluent flash drum off; Refinery gas; [A complex combination of gases obtained from flash of the effluents after the hydrogenation reaction. It consists predominantly of hydrogen and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]"	295-400-7	92045-18-6	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-173-00-X	"Gases (petroleum), naphtha steam cracking high-pressure residual; Refinery gas; [A complex combination obtained as a reaction mass of the non-condensable portions from the product of a naphtha steam cracking process as well as residual gases obtained during the preparation of subsequent products. It consists predominantly of hydrogen and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C5 with which natural gas may also be mixed.]"	295-401-2	92045-19-7	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-174-00-5	"Gases (petroleum), residue visbaking off; Refinery gas; [A complex combination obtained from viscosity reduction of residues in a furnace. It consists predominantly of hydrogen sulfide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]"	295-402-8	92045-20-0	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-175-00-0	"Foots oil (petroleum), acid-treated; Foots oil; [A complex combination of hydrocarbons obtained by treatment of Foot's oil with sulfuric acid. It consists predominantly of branched-chain hydrocarbons with carbon numbers predominantly in the range of C20 through C50.]"	300-225-7	93924-31-3	Flam. Gas 1Press. GasCarc. 1B	H220H350	GHS02GHS04GHS08Dgr	H220H340H350			H K U	CLP00
649-176-00-6	"Foots oil (petroleum), clay-treated; Foots oil; [A complex combination of hydrocarbons obtained by treatment of Foot's oil with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists predominantly of branched chain hydrocarbons with carbon numbers predominantly in the range of C20 through C50.]"	300-226-2	93924-32-4	Flam. Gas 1Press. GasCarc. 1B	H220H350	GHS02GHS04GHS08Dgr	H220H340H350			H K U	CLP00
649-177-00-1	"Gases (petroleum), C3-4; Petroleum gas; [A complex combination of hydrocarbons produced by distillation of products from the cracking of crude oil. It consists of hydrocarbons having carbon numbers in the range of C3 through C4, predominantly of propane and propylene, and boiling in the range of approximately – 51 °C to – 1 °C (– 60 °F to 30 °F.)]"	268-629-5	68131-75-9	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-178-00-7	"Tail gas (petroleum), catalytic cracked distillate and catalytic cracked naphtha fractionation absorber; Petroleum gas; [The complex combination of hydrocarbons from the distillation of the products from catalytic cracked distillates and catalytic cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4.]"	269-617-2	68307-98-2	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-179-00-2	"Tail gas (petroleum), catalytic polymn. naphtha fractionation stabilizer; Petroleum gas; [A complex combination of hydrocarbons from the fractionation stabilization products from polymerization of naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4.]"	269-618-8	68307-99-3	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-180-00-8	"Tail gas (petroleum), catalytic reformed naphtha fractionation stabilizer, hydrogen sulfide-free; Petroleum gas; [A complex combination of hydrocarbons obtained from fractionation stabilization of catalytic reformed naphtha and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]"	269-619-3	68308-00-9	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-181-00-3	"Tail gas (petroleum), cracked distillate hydrotreater stripper; Petroleum gas; [A complex combination of hydrocarbons obtained by treating thermal cracked distillates with hydrogen in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]"	269-620-9	68308-01-0	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-182-00-9	"Tail gas (petroleum), straight-run distillate hydrodesulfurizer, hydrogen sulfide-free; Petroleum gas; [A complex combination of hydrocarbons obtained from catalytic hydrodesulfurization of straight run distillates and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]"	269-630-3	68308-10-1	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-183-00-4	"Tail gas (petroleum), gas oil catalytic cracking absorber; Petroleum gas; [A complex combination of hydrocarbons obtained from the distillation of products from the catalytic cracking of gas oil. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]"	269-623-5	68308-03-2	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-184-00-X	"Tail gas (petroleum), gas recovery plant; Petroleum gas; [A complex combination of hydrocarbons from the distillation of products from miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]"	269-624-0	68308-04-3	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-185-00-5	"Tail gas (petroleum), gas recovery plant deethanizer; Petroleum gas; [A complex combination of hydrocarbons from the distillation of products from miscellaneous hydrocarbon streams. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]"	269-625-6	68308-05-4	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-186-00-0	"Tail gas (petroleum), hydrodesulfurized distillate and hydrodesulfurized naphtha fractionator, acid-free; Petroleum gas; [A complex combination of hydrocarbons obtained from fractionation of hydrodesulfurized naphtha and distillate hydrocarbon streams and treated to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]"	269-626-1	68308-06-5	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-187-00-6	"Tail gas (petroleum), hydrodesulfurized vacuum gas oil stripper, hydrogen sulfide-free; Petroleum gas; [A complex combination of hydrocarbons obtained from stripping stabilization of catalytic hydrodesulfurized vacuum gas oil and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]"	269-627-7	68308-07-6	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-188-00-1	"Tail gas (petroleum), light straight-run naphtha stabilizer, hydrogen sulfide-free; Petroleum gas; [A complex combination of hydrocarbons obtained from fractionation stabilization of light straight run naphtha and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]"	269-629-8	68308-09-8	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-189-00-7	"Tail gas (petroleum), propane-propylene alkylation feed prep deethanizer; Petroleum gas; [A complex combination of hydrocarbons obtained from the distillation of the reaction products of propane with propylene. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]"	269-631-9	68308-11-2	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-190-00-2	"Tail gas (petroleum), vacuum gas oil hydrodesulfurizer, hydrogen sulfide-free; Petroleum gas; [A complex combination of hydrocarbons obtained from catalytic hydrodesulfurization of vacuum gas oil and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]"	269-632-4	68308-12-3	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-191-00-8	"Gases (petroleum), catalytic cracked overheads; Petroleum gas; [A complex combination of hydrocarbons produced by the distillation of products from the catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C5 and boiling in the range of approximately – 48 °C to 32 °C (– 54 °F to 90 °F).]"	270-071-2	68409-99-4	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-193-00-9	"Alkanes, C1-2; Petroleum gas"	270-651-5	68475-57-0	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-194-00-4	"Alkanes, C2-3; Petroleum gas"	270-652-0	68475-58-1	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-195-00-X	"Alkanes, C3-4; petroleum gas"	270-653-6	68475-59-2	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08	H220H350H340			K U	CLP00/ATP01corr
649-196-00-5	"Alkanes, C4-5; Petroleum gas"	270-654-1	68475-60-5	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-197-00-0	Fuel gases; Petroleum gas; [A combination of light gases. It consists predominantly of hydrogen and/or low molecular weight hydrocarbons.]	270-667-2	68476-26-6	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-198-00-6	"Fuel gases, crude oil of distillates; Petroleum gas; [A complex combination of light gases produced by distillation of crude oil and by catalytic reforming of naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately – 217 °C to – 12 °C (– 423 °F to 10 °F).]"	270-670-9	68476-29-9	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-199-00-1	"Hydrocarbons, C3-4; Petroleum gas"	270-681-9	68476-40-4	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-200-00-5	"Hydrocarbons, C4-5; Petroleum gas"	270-682-4	68476-42-6	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-201-00-0	"Hydrocarbons, C2-4, C3-rich; Petroleum gas"	270-689-2	68476-49-3	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-202-00-6	"Petroleum gases, liquefied; Petroleum gas; [A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C7 and boiling in the range of approximately – 40 °C to 80 °C (– 40 °F to 176 °F).]"	270-704-2	68476-85-7	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K S U	CLP00/ATP01corr
649-203-00-1	"Petroleum gases, liquefied, sweetened; Petroleum gas; [A complex combination of hydrocarbons obtained by subjecting liquefied petroleum gas mix to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C7 and boiling in the range of approximately – 40 °C to 80 °C (– 40 °F to 176 °F).]"	270-705-8	68476-86-8	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K S U	CLP00/ATP01corr
649-204-00-7	"gases (petroleum), C3-4, isobutane-rich; Petroleum gas; [A complex combination of hydrocarbons from the distillation of saturated and unsaturated hydrocarbons usually ranging in carbon numbers from C3 through C6, predominantly butane and isobutane. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C4, predominantly isobutane.]"	270-724-1	68477-33-8	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-205-00-2	"Distillates (petroleum), C3-6, piperylene-rich; Petroleum gas; [A complex combination of hydrocarbons from the distillation of saturated and unsaturated aliphatic hydrocarbons usually ranging in the carbon numbers C3 through C6. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C6, predominantly piperylenes.]"	270-726-2	68477-35-0	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-206-00-8	"Gases (petroleum), butane splitter overheads; Petroleum gas; [A complex combination of hydrocarbons obtained from the distillation of the butane stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C4.]"	270-750-3	68477-69-0	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-207-00-3	"Gases (petroleum), C2-3-; Petroleum gas; [A complex combination of hydrocarbons produced by the distillation of products from a catalytic fractionation process. It contains predominantly ethane, ethylene, propane, and propylene.]"	270-751-9	68477-70-3	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-208-00-9	"Gases (petroleum), catalytic-cracked gas oil depropanizer bottoms, C4-rich acid-free; Petroleum gas; [A complex combination of hydrocarbons obtained from fractionation of catalytic cracked gas oil hydrocarbon stream and treated to remove hydrogen sulfide and other acidic components. It consists of hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C4.]"	270-752-4	68477-71-4	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-209-00-4	"Gases (petroleum), catalytic-cracked naphtha debutanizer bottoms, C3-5-rich; Petroleum gas; [A complex combination of hydrocarbons obtained from the stabilization of catalytic cracked naphtha. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C5.]"	270-754-5	68477-72-5	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-210-00-X	"Tail gas (petroleum), isomerized naphtha fractionation stabilizer; Petroleum gas; [A complex combination of hydrocarbons obtained from the fractionation stabilization products from isomerized naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]"	269-628-2	68308-08-7	Flam. Gas 1Press. GasCarc. 1AMuta. 1B	H220H350H340	GHS04GHS02GHS08Dgr	H220H340H350			K U	CLP00/ATP01corr
649-211-00-5	"Foots oil (petroleum), carbon-treated; Foots oil; [A complex combination of hydrocarbons obtained by the treatment of Foots oil with activated carbon for the removal of trace constituents and impurities. It consists predominantly of saturated straight chain hydrocarbons having carbon numbers predominantly greater than C12.]"	308-126-0	97862-76-5	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-212-00-0	"Distillates (petroleum), sweetened middle; Gasoil - unspecified; [A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150 °C to 345 °C (302 °F to 653 °F).]"	265-088-7	64741-86-2	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-213-00-6	"Gas oils (petroleum), solvent-refined; Gasoil - unspecified; [A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205 °C to 400 °C (401 °F to 752 °F).]"	265-092-9	64741-90-8	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-214-00-1	"Distillates (petroleum), solvent-refined middle; Gasoil - unspecified; [A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150 °C to 345 °C (302 °F to 653 °F).]"	265-093-4	64741-91-9	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-215-00-7	"Gas oils (petroleum), acid-treated; Gasoil - unspecified; [A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 °C to 400 °C (446 °F to 752 °F).]"	265-112-6	64742-12-7	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-216-00-2	"Distillates (petroleum), acid-treated middle; Gasoil - unspecified; [A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C20 and boiling in the range of approximately 205 °C to 345 °C (401 °F to 653 °F).]"	265-113-1	64742-13-8	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-217-00-8	"Distillates (petroleum), acid-treated light; Gasoil - unspecified; [A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 °C to 290 °C (302 °F to 554 °F).]"	265-114-7	64742-14-9	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-218-00-3	"Gas oils (petroleum), chemically neutralized; Gasoil - unspecified; [A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 °C to 400 °C (446 °F to 752 °F).]"	265-129-9	64742-29-6	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-219-00-9	"Distillates (petroleum), chemically neutralized middle; Gasoil - unspecified; [A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C20 and boiling in the range of approximately 205 °C to 345 °C (401 °F to 653 °F).]"	265-130-4	64742-30-9	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-220-00-4	"Distillates (petroleum), clay-treated middle; Gasoil - unspecified; [A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150 °C to 345 °C (302 °F to 653 °F).]"	265-139-3	64742-38-7	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-221-00-X	"Distillates (petroleum), hydrotreated middle; Gasoil - unspecified; [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205 °C to 400 °C (401 °F to 752 °F).]"	265-148-2	64742-46-7	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-222-00-5	"Gas oils (petroleum), hydrodesulfurized; Gasoil - unspecified; [A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 °C to 400 °C (446 °F to 752 °F).]"	265-182-8	64742-79-6	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-223-00-0	"Distillates (petroleum), hydrodesulfurized middle; Gasoil - unspecified; [A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205 °C to 400 °C (401 °F to 752 °F).]"	265-183-3	64742-80-9	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-224-00-6	"Fuels, diesel; Gasoil - unspecified; [A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 163 °C to 357 °C (325 °F to 675 °F).]"	269-822-7	68334-30-5	Carc. 2	H351	GHS08Wng	H351			N	CLP00
649-225-00-1	"Fuel oil, No 2; Gasoil - unspecified; [A distillate oil having a minimum viscosity of 32,6 SUS at 37,7 °C (100 °F) to a maximum of 37,9 SUS at 37,7 °C (100 °F).]"	270-671-4	68476-30-2	Carc. 2	H351	GHS08Wng	H351				CLP00
649-226-00-7	"Fuel oil, No 4; Gasoil - unspecified; [A distillate oil having a minimum viscosity of 45 SUS at 37,7 °C (100 °F) to a maximum of 125 SUS at 37,7 °C (100 °F).]"	270-673-5	68476-31-3	Carc. 2	H351	GHS08Wng	H351				CLP00
649-227-00-2	"Fuels, diesel, No 2; Gasoil - unspecified; [A distillate oil having a minimum viscosity of 32,6 SUS at 37,7 °C (100 °F).]"	270-676-1	68476-34-6	Carc. 2	H351	GHS08Wng	H351				CLP00
649-228-00-8	"Distillates (petroleum), catalytic reformer fractionator residue, high-boiling; Gasoil - unspecified; [A complex combination of hydrocarbons from the distillation of catalytic reformer fracftionator residue. It boils in the range of approximately 343 °C to 399 °C (650 °F to 750 °F).]"	270-719-4	68477-29-2	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-229-00-3	"Distillates (petroleum), catalytic reformer fractionator residue, intermediate-boiling; Gasoil - unspecified; [A complex combination of hydrocarbons from the distillation of catalytic reformer fractionator residue. It boils in the range of approximately 288 °C to 371 °C (550 °F to 700 °F).]"	270-721-5	68477-30-5	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-230-00-9	"Distillates (petroleum), catalytic reformer fractionator residue, low-boiling; Gasoil - unspecified; [The complex combination of hydrocarbons from the distillation of catalytic reformer fractionator residue. It boils approximately below 288 °C (550 °F).]"	270-722-0	68477-31-6	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-231-00-4	"Distillates (petroleum), highly refined middle; Gasoil - unspecified; [A complex combination of hydrocarbons obtained by the subjection of a petroleum fraction to several of the following steps: filtration, centrifugation, atmospheric distillation, vacuum distillation, acidification, neutralization and clay treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C20.]"	292-615-8	90640-93-0	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-232-00-X	"Distillates (petroleum) catalytic reformer, heavy arom. conc.; Gasoil - unspecified; [A complex combination of hydrocarbons obtained from the distillation of a catalytically reformed petroleum cut. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C10 through C16 and boiling in the range of approximately 200 °C to 300 °C (392 °F to 572 °F).]"	295-294-2	91995-34-5	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-233-00-5	"Gas oils, paraffinic; Gasoil - unspecified; [A distillate obtained from the redistillation of a complex combination of hydrocarbons obtained by the distillation of the effluents from a severe catalytic hydrotreatment of paraffins. It boils in the range of approximately 190 °C to 330 °C (374 °F to 594 °F).]"	300-227-8	93924-33-5	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-234-00-0	"Naphtha (petroleum), solvent-refined hydrodesulfurized heavy; Gasoil - unspecified"	307-035-3	97488-96-5	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-235-00-6	"Hydrocarbons, C16-20, hydrotreated middle distillate, distn. lights; Gasoil - unspecified; [A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of a middle distillate with hydrogen. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C20 and boiling in the range of approximately 290 °C to 350 °C (554 °F to 662 °F). It produces a finished oil having a viscosity of 2cSt at 100 °C (212 °F).]"	307-659-6	97675-85-9	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-236-00-1	"Hydrocarbons, C12-20, hydrotreated paraffinic, distn. lights; Gasoil - unspecified; [A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of heavy paraffins with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C20 and boiling in the range of approximately 230 °C to 350 °C (446 °F to 662 °F). It produces a finished oil having a viscosity of 2cSt at 100 °C (212 °F).]"	307-660-1	97675-86-0	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-237-00-7	"Hydrocarbons, C11-17, solvent-extd. light naphthenic; Gasoil - unspecified; [A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a visciosity of 2.2 cSt at 40 °C (104 °F). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C11 through C17 and boiling in the range of approximately 200 °C to 300 °C (392 °F to 572 °F).]"	307-757-9	97722-08-2	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-238-00-2	"Gas oils, hydrotreated; Gasoil - unspecified; [A complex combination of hydrocarbons obtained from the redistillation of the effluents from the treatment of paraffins with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C27 and boiling in the range of approximately 330 °C to 340 °C (626 °F to 644 °F).]"	308-128-1	97862-78-7	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-239-00-8	"Distillates (petroleum), carbon-treated light paraffinic; Gasoil - unspecified; [A complex combination of hydrocarbons obtained by the treatment of a petroleum oil fraction with activated charcoal for the removal of traces of polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C28.]"	309-667-5	100683-97-4	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-240-00-3	"Distillates (petroleum), intermediate paraffinic, carbon-treated; Gasoil - unspecified; [A complex combination of hydrocarbons obtained by the treatment of petroleum with activated charcoal for the removal of trace polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C36.]"	309-668-0	100683-98-5	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-241-00-9	"Distillates (petroleum), intermediate paraffinic, clay-treated; Gasoil - unspecified; [A complex combination of hydrocarbons obtained by the treatment of petroleum with bleaching earth for the removal of trace polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C36.]"	309-669-6	100683-99-6	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-242-00-4	"Alkanes, C12-26-branched and linear"	292-454-3	90622-53-0	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-243-00-X	"Lubricating greases; Grease; [A complex combination of hydrocarbons having carbon numbers predominantly in the range of C12 through C50. May contain organic salts of alkali metals, alkaline earth metals, and/or aluminium compounds.]"	278-011-7	74869-21-9	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-244-00-5	Slack wax (petroleum); Slack wax; [A complex combination of hydrocarbons obtained from a petroleum fraction by solvent crystallization (solvent dewaxing) or as a distillation fraction from a very waxy crude. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.]	265-165-5	64742-61-6	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-245-00-0	"Slack wax (petroleum), acid-treated; Slack wax; [A complex combination of hydrocarbons obtained as a raffinate by treatment of a petroleum slack wax fraction with sulfuric acid treating process. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.]"	292-659-8	90669-77-5	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-246-00-6	"Slack wax (petroleum), clay-treated; Slack wax; [A complex combination of hydrocarbons obtained by treatment of a petroleum slack wax fraction with natural or modified clay in either a contacting or percolation process. It consists predominantly of saturated straight and branched hydrocarbons having carbon numbers predominantly greater than C20.]"	292-660-3	90669-78-6	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-247-00-1	"Slack wax (petroleum), hydrotreated; Slack wax; [A complex combination of hydrocarbons obtained by treating slack wax with hydrogen in the presence of a catalyst. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.]"	295-523-6	92062-09-4	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-248-00-7	"Slack wax (petroleum), low-melting; Slack wax; [A complex combination of hydrocarbons obtained from a petroleum fraction by solvent deparaffination. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]"	295-524-1	92062-10-7	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-249-00-2	"Slack wax (petroleum), low-melting, hydrotreated; Slack wax; [A complex combination of hydrocarbons obtained by treatment of low-melting petroleum slack wax with hydrogen in the presence of a catalyst. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]"	295-525-7	92062-11-8	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-250-00-8	"Slack wax (petroleum), low-melting, carbon-treated; Slack wax; [A complex combination of hydrocarbons obtained by the treatment of low-melting slack wax with activated carbon for the removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]"	308-155-9	97863-04-2	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-251-00-3	"Slack wax (petroleum), low-melting, clay-treated; Slack wax; [A complex combination of hydrocarbons obtained by the treatment of low-melting petroleum slack wax with bentonite for removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]"	308-156-4	97863-05-3	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-252-00-9	"Slack wax (petroleum), low-melting, silicic acid-treated; Slack wax; [A complex combination of hydrocarbons obtained by the treatment of low-melting petroleum slack wax with silicic acid for the removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]"	308-158-5	97863-06-4	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-253-00-4	"Slack wax (petroleum), carbon-treated; Slack wax; [A complex combination of hydrocarbons obtained by treatment of petroleum slack wax with activated charcoal for the removal of trace polar constituents and impurities.]"	309-723-9	100684-49-9	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-254-00-X	Petrolatum; Petrolatum; [A complex combination of hydrocarbons obtained as a semi-solid from dewaxing paraffinic residual oil. It consists predominantly of saturated crystalline and liquid hydrocarbons having carbon numbers predominantly greater than C25.]	232-373-2	8009-03-8	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-255-00-5	"Petrolatum (petroleum), oxidized; Petrolatum; [A complex combination of organic compounds, predominantly high molecular weight carboxylic acids, obtained by the air oxidation of petrolatum.]"	265-206-7	64743-01-7	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-256-00-0	"Petrolatum (petroleum), alumina-treated; Petrolatum; [A complex combination of hydrocarbons obtained when petrolatum is treated with Al2O3 to remove polar components and impurities. It consists predominantly of saturated, crystalline, and liquid hydrocarbons having carbon numbers predominantly greater than C25.]"	285-098-5	85029-74-9	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-257-00-6	"Petrolatum (petroleum), hydrotreated; Petrolatum; [A complex combination of hydrocarbons obtained as a semi-solid from dewaxed paraffinic residual oil treated with hydrogen in the presence of a catalyst. It consists predominantly of saturated microcrystalline and liquid hydrocarbons having carbon numbers predominantly greater than C20.]"	295-459-9	92045-77-7	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-258-00-1	"Petrolatum (petroleum), carbon-treated; Petrolatum; [A complex combination of hydrocarbons obtained by the treatment of petroleum petrolatum with activated carbon for the removal of trace polar constituents and impurities. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly greater than C20.]"	308-149-6	97862-97-0	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-259-00-7	"Petrolatum (petroleum), silicic acid-treated; Petrolatum; [A complex combination of hydrocarbons obtained by the treatment of petroleum petrolatum with silicic acid for the removal of trace polar constituents and impurities. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly greater than C20.]"	308-150-1	97862-98-1	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-260-00-2	"Petrolatum (petroleum), clay-treated; Petrolatum; [A complex combination of hydrocarbons obtained by treatment of petrolatum with bleaching earth for the removal of traces of polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of greater than C25.]"	309-706-6	100684-33-1	Carc. 1B	H350	GHS08Dgr	H350			N	CLP00
649-261-00-8	"Gasoline, natural; Low boiling point naphtha; [A complex combination of hydrocarbons separated from natural gas by processes such as refrigeration or absorption.  It consists predominantly of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C8 and boiling in the range of approximately minus 20°C to 120°C (-4°F to 248°F).]"	232-349-1	8006-61-9	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-262-00-3	"Naphtha; Low boiling point naphtha; [Refined, partly refined, or unrefined petroleum products produced by the distillation of natural gas.  It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C6 and boiling in the range of approximately 100°C to 200°C (212°F to 392°F).]"	232-443-2	8030-30-6	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-263-00-9	Ligroine; Low boiling point naphtha; [A complex combination of hydrocarbons obtained by the fractional distillation of petroleum.  This fraction boils in a range of approximately 20°C to 135°C (58°F to 275°F).]	232-453-7	8032-32-4	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-264-00-4	"Naphtha (petroleum), heavy straight-run; Low boiling point naphtha; [A complex combination of hydrocarbons produced by distillation of crude oil.  It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65°C to 230°C (149°F to 446°F).]"	265-041-0	64741-41-9	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-265-00-X	"Naphtha (petroleum), full-range straight-run; Low boiling point naphtha; [A complex combination of hydrocarbons produced by distillation of crude oil.  It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately -20°C to 220°C (-4°F to 428°F).]"	265-042-6	64741-42-0	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-266-00-5	"Naphtha (petroleum), light straight-run; Low boiling point naphtha; [A complex combination of hydrocarbons produced by distillation of crude oil.  It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C10 and boiling in the range of approximately -20°C to 180°C (-4°F to 356°F).]"	265-046-8	64741-46-4	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-267-00-0	"Solvent naphtha (petroleum), light aliph.; Low boiling point naphtha; [A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline.  It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C5 through C10 and boiling in the range of approximately 35°C to 160°C (95°F to 320°F).]"	265-192-2	64742-89-8	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-268-00-6	"Distillates (petroleum), straight-run light; Low boiling point naphtha; [A complex combination of hydrocarbons produced by the distillation of crude oil.  It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C7 and boiling in the range of approximately -88°C to 99°C (-127°F to 210°F).]"	270-077-5	68410-05-9	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-269-00-1	"Gasoline, vapor-recovery; Low boiling point naphtha; [A complex combination of hydrocarbons separated from the gases from vapor recovery systems by cooling.  It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately -20°C to 196°C(-4°F to 384°F).]"	271-025-4	68514-15-8	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-270-00-7	"Gasoline, straight-run, topping-plant; Low boiling point naphtha; [A complex combination of hydrocarbons produced from the topping plant by the distillation of crude oil.  It boils in the range of approximately 36.1°C to 193.3°C (97°F to 380°F).]"	271-727-0	68606-11-1	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-271-00-2	"Naphtha (petroleum), unsweetened; Low boiling point naphtha; [A complex combination of hydrocarbons produced from the distillation of naphtha streams from various refinery processes.  It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 0°C to 230°C (25°F to 446°F).]"	272-186-3	68783-12-0	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-272-00-8	"Distillates (petroleum), light straight-run gasoline fractionation stabilizer overheads; Low boiling point naphtha; [A complex combination of hydrocarbons obtained by the fractionation of light straight-run gasoline.  It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C6.]"	272-931-2	68921-08-4	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-273-00-3	"Naphtha (petroleum), heavy straight run, arom.-contg.; Low boiling point naphtha; [A complex combination of hydrocarbons obtained from a distillation process of crude petroleum.  It consists predominantly of hydrocarbons having carbon numbers in the range of C8 through C12 and boiling in the range of approximately 130°C to 210°C (266°F to 410°F).]"	309-945-6	101631-20-3	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-274-00-9	"Naphtha (petroleum), full-range alkylate; Low boiling point modified naphtha; [A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5  It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90°C to 220°C (194°F to 428°F).]"	265-066-7	64741-64-6	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-275-00-4	"Naphtha (petroleum), heavy alkylate; Low boiling point modified naphtha; [A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 to C5.  It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 150°C to 220°C (302°F to 428°F).]"	265-067-2	64741-65-7	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-276-00-X	"Naphtha (petroleum), light alkylate; Low boiling point modified naphtha; [A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5.  It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C7 through C10 and boiling in the range of approximately 90°C to 160°C (194°F to 320°F).]"	265-068-8	64741-66-8	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-277-00-5	"Naphtha (petroleum), isomerization; Low boiling point modified naphtha; [A complex combination of hydrocarbons obtained from catalytic isomerization of straight chain paraffinic C4 through C6 hydrocarbons.  It consists predominantly of saturated hydrocarbons such as isobutane, isopentane, 2,2-dimethylbutane, 2-methylpentane, and 3-methylpentane.]"	265-073-5	64741-70-4	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-278-00-0	"Naphtha (petroleum), solvent-refined light; Low boiling point modified naphtha; [A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process.  It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35°C to 190°C (95°F to 374°F).]"	265-086-6	64741-84-0	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-279-00-6	"Naphtha (petroleum), solvent-refined heavy; Low boiling point modified naphtha; [A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process.  It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90°C to 230°C (194°F to 446°F).]"	265-095-5	64741-92-0	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-280-00-1	"Raffinates (petroleum), catalytic reformer ethylene glycol-water countercurrent exts.; Low boiling point modified naphtha; [A complex combination of hydrocarbons obtained as the raffinate from the UDEX extraction process on the catalytic reformer stream.  It consists of saturated hydrocarbons having carbon numbers predominantly in the range of C6 through C9.]"	270-088-5	68410-71-9	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-281-00-7	"Raffinates (petroleum), reformer, Lurgi unit-sepd.; Low boiling point modified naphtha; [The complex combination of hydrocarbons obtained as a raffinate from a Lurgi separation unit.  It consists predominantly of non-aromatic hydrocarbons with various small amounts of aromatic hydrocarbons having carbon numbers predominantly in the range of C6 through C8.]"	270-349-3	68425-35-4	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-282-00-2	"Naphtha (petroleum), full-range alkylate, butane-contg.; Low boiling point modified naphta; [A complex combination of hydrocarbons produced by the distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5.  It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C7 through C12 with some butanes and boiling in the range of approximately 35°C to 200°C (95°F to 428°F).]"	271-267-0	68527-27-5	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-283-00-8	"Distillates (petroleum), naphtha steam cracking-derived, solvent-refined light hydrotreated; Low boiling point modified naphtha; [A complex combination of hydrocarbons obtained as the raffinates from a solvent extraction process of hydrotreated light distillate from steam-cracked naphtha.]"	295-315-5	91995-53-8	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-284-00-3	"Naphtha (petroleum), C4-12, butane-alkylate, isooctane-rich; Low boiling point modified naphtha; [A complex combination of hydrocarbons obtained by alkylation of butanes.  It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C12, rich in isooctane, and boiling in the range of approximately 35°C to 210°C (95°F to 410°F).]"	295-430-0	92045-49-3	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-285-00-9	"Hydrocarbons, hydrotreated light naphtha distillates, solvent-refined; Low boiling point modified naphtha; [A combination of hydrocarbons obtained from the distillation of hydrotreated naphtha followed by a solvent extraction and distillation process.  It consists predominantly of saturated hydrocarbons boiling in the range of approximately 94°C to 99°C (201°F to 210°F).]"	295-436-3	92045-55-1	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-286-00-4	"Naphtha (petroleum), isomerization, C6-fraction; Low boiling point modified naphtha; [A complex combination of hydrocarbons obtained by distillation of a gasoline which has been catalytically isomerized.  It consists predominantly of hexane isomers boiling in the range of approximately 60°C to 66°C (140°F to 151°F).]"	295-440-5	92045-58-4	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-287-00-X	"Hydrocarbons, C6-7, naphtha-cracking, solvent-refined; Low boiling point modified naphtha; [A complex combination of hydrocarbons obtained by the sorption of benzene from a catalytically fully hydrogenated benzene-rich hydrocarbon cut that was distillatively obtained from prehydrogenated cracked naphtha.  It consists predominantly of paraffinic and naphthenic hydrocarbons having carbon numbers predominantly in the range of C6 through C7 and boiling in the range of approximately 70°C to 100°C (158°F to 212°F).]"	295-446-8	92045-64-2	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-288-00-5	"Hydrocarbons, C6-rich, hydrotreated light naphtha distillates, solvent-refined; Low boiling point modified naphtha; [A complex combination of hydrocarbons obtained by distillation of hydrotreated naphtha followed by solvent extraction.  It consists predominantly of saturated hydrocarbons and boiling in the range of approximately 65°C to 70°C (149°F to 158°F).]"	309-871-4	101316-67-0	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-289-00-0	"Naphtha (petroleum), heavy catalytic cracked; Low boiling point cat-cracked naphtha; [A complex combination of hydrocarbons produced by a distillation of products from a catalytic cracking process.  It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65°C to 230°C (148°F to 446°F).  It contains a relatively large proportion of unsaturated hydrocarbons.]"	265-055-7	64741-54-4	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-290-00-6	"Naphtha (petroleum), light catalytic cracked; Low boiling point cat-cracked naphtha; [A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process.  It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately -20°C to 190°C (-4°F to 374°F).  It contains a relatively large proportion of unsaturated hydrocarbons.]"	265-056-2	64741-55-5	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-291-00-1	"Hydrocarbons, C3-11, catalytic cracker distillates; Low boiling point cat-cracked naphtha; [A complex combination of hydrocarbons produced by the distillations of products from a catalytic cracking process.  It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C11 and boiling in a range approximately up to 204°C (400°F).]"	270-686-6	68476-46-0	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-292-00-7	"Naphtha (petroleum), catalytic cracked light distd.; Low boiling point cat-cracked naphtha; [A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process.  It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]"	272-185-8	68783-09-5	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-293-00-2	"Distillates (petroleum), naphtha steam cracking-derived, hydrotreated light arom.; Low boiling point cat-cracked naphtha.; [A complex combination of hydrocarbons obtained by treating a light distillate from steam-cracked naphtha.  It consists predominantly of aromatic hydrocarbons.]"	295-311-3	91995-50-5	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-294-00-8	"Naphtha (petroleum), heavy catalytic cracked, sweetened; Low boiling point cat-cracked naphtha; [A complex combination of hydrocarbons obtained by subjecting a catalytic cracked petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities.  It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 60°C to 200°C (140°F to 392°F).]"	295-431-6	92045-50-6	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-295-00-3	"Naphtha (petroleum), light catalytic cracked sweetened; Low boiling point cat-cracked naphtha; [A complex combination of hydrocarbons obtained by subjecting naphtha from a catalytic cracking process to a sweetening process to convert mercaptans or to remove acidic impurities.  It consists predominantly of hydrocarbons boiling in a range of approximately 35°C to 210°C (95°F to 410°F).]"	295-441-0	92045-59-5	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-296-00-9	"Hydrocarbons, C8-12, catalytic-cracking, chem. neutralized; Low boiling point cat-cracked naphtha; [A complex combination of hydrocarbons produced by the distillation of a cut from the catalytic cracking process, having undergone an alkaline washing.  It consists predominantly of hydrocarbons having carbon numbers in the range of C8 through C12 and boiling in the range of approximately 130°C to 210°C (266°F to 410°F).]"	295-794-0	92128-94-4	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-297-00-4	"Hydrocarbons, C8-12, catalytic cracker distillates; Low boiling point cat-cracked naphtha; [A complex combination of hydrocarbons obtained by distillation of products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C12 and boiling in the range of approximately 140°C to 210°C (284°F to 410°F).]"	309-974-4	101794-97-2	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-298-00-X	"Hydrocarbons, C8-12, catalytic cracking, chem. neutralized, sweetened; Low boiling point cat-cracked naphtha"	309-987-5	101896-28-0	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-299-00-5	"Naphtha (petroleum), light catalytic reformed; Low boiling point cat-reformed naphtha; [A complex combination of hydrocarbons produced from the distillation of products from a catalytic reforming process.  It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35°C to 190°C (95°F to 374°F).  It contains a relatively large proportion of aromatic and branched chain hydrocarbons.  This stream may contain 10 vol. % or more benzene.]"	265-065-1	64741-63-5	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-300-00-9	"Naphtha (petroleum), heavy catalytic reformed; Low boiling point cat-reformed naphtha; [A complex combination of hydrocarbons produced from the distillation of products from a catalytic reforming process.  It consists of predominantly aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90°C to 230°C (194°F to 446°F).]"	265-070-9	64741-68-0	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-301-00-4	"Distillates (petroleum), catalytic reformed depentanizer; Low boiling point cat-reformed naphtha; [A complex combination of hydrocarbons from the distillation of products from a catalytic reforming process.  It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately -49°C to 63°C (-57°F to 145°F).]"	270-660-4	68475-79-6	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-302-00-X	"Hydrocarbons, C2-6, C6-8 catalytic reformer; Low boiling point cat-reformed naphtha"	270-687-1	68476-47-1	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-303-00-5	"Residues (petroleum), C6-8 catalytic reformer; Low boiling point cat-reformed naphtha; [A complex residuum from the catalytic reforming of C6-8 feed.  It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]"	270-794-3	68478-15-9	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-304-00-0	"Naphtha (petroleum), light catalytic reformed, arom.-free; Low boiling point cat-reformed naphtha; [A complex combination of hydrocarbons obtained from distillation of products from a catalytic reforming process.  It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C8 and boiling in the range of approximately 35°C to 120°C (95°F to 248°F).  It contains a relatively large proportion of branched chain hydrocarbons with the aromatic components removed.]"	270-993-5	68513-03-1	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-305-00-6	"Distillates (petroleum), catalytic reformed straight-run naphtha overheads; Low boiling point cat-reformed naphtha; [A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha followed by the fractionation of the total effluent.  It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]"	271-008-1	68513-63-3	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-306-00-1	"Petroleum products, hydrofiner-powerformer reformates; Low boiling point cat-reformed naphtha; [The complex combination of hydrocarbons obtained in a hydrofiner-powerformer process and boiling in a range of approximately 27°C to 210°C (80°F to 410°F).]"	271-058-4	68514-79-4	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-307-00-7	"Naphtha (petroleum), full-range reformed; Low boiling point cat-reformed naphtha; [A complex combination of hydrocarbons produced by the distillation of the products from a catalytic reforming process.  It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 35°C to 230°C (95°F to 446°F).]"	272-895-8	68919-37-9	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-308-00-2	"Naphtha (petroleum), catalytic reformed; Low boiling point cat-reformed naphtha; [A complex combination of hydrocarbons produced by the distillation of products from a catalytic reforming process.  It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 30°C to 220°C (90°F to 430°F).  It contains a relatively large proportion of aromatic and branched chain hydrocarbons.  This stream may contain 10 vol. % or more benzene.]"	273-271-8	68955-35-1	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-309-00-8	"Distillates (petroleum), catalytic reformed hydrotreated light, C8-12 arom. fraction; Low boiling point cat-reformed naphtha; [A complex combination of alkylbenzenes obtained by the catalytic reforming of petroleum naphtha.  It consists predominantly of alkylbenzenes having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 160°C to 180°C (320°F to 356°F).]"	285-509-8	85116-58-1	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-310-00-3	"Aromatic hydrocarbons, C8, catalytic reforming-derived; Low boiling point cat-reformed naphtha"	295-279-0	91995-18-5	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-311-00-9	"Aromatic hydrocarbons, C7-12, C8-rich; Low boiling point cat-reformed naphtha; [A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction.  It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 (primarily C8) and can contain nonaromatic hydrocarbons, both boiling in the range of approximately 130°C to 200°C (266°F to 392°F).]"	297-401-8	93571-75-6	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-312-00-4	"Gasoline, C5-11, high-octane stabilised reformed; Low boiling point cat-reformed naphtha; [A complex high octane combination of hydrocarbons obtained by the catalytic dehydrogenation of a predominantly naphthenic naphtha.  It consists predominantly of aromatics and non-aromatics having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 45°C to 185°C (113°F to 365°F).]"	297-458-9	93572-29-3	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-313-00-X	"Hydrocarbons, C7-12, C?9-arom.-rich, reforming heavy fraction; Low boiling point cat-reformed naphtha; [A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction.  It consists predominantly of nonaromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 120°C to 210°C (248°F to 380°F) and C9 and higher aromatic hydrocarbons.]"	297-465-7	93572-35-1	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-314-00-5	"Hydrocarbons, C5-11, nonaroms.-rich, reforming light fraction; Low boiling point cat-reformed naphtha; [A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction.  It consists predominantly of nonaromatic hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35°C to 125°C (94°F to 257°F), benzene and toluene.]"	297-466-2	93572-36-2	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-315-00-0	"Foots oil (petroleum), silicic acid-treated; Foots oil; [A complex combination of hydrocarbons obtained by the treatment of Foots oil with silicic acid for removal of trace constituents and impurities. It consists predominantly of straight chain hydrocarbons having carbon numbers predominantly greater than C12.]"	308-127-6	97862-77-6	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-316-00-6	"Naphtha (petroleum), light thermal cracked; Low boiling point thermally cracked naphtha; [A complex combination of hydrocarbons from distillation of products from a thermal cracking process.  It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C8 and boiling in the range of approximately -10 °C to 130 °C (14 °F to 266 °F).]"	265-075-6	64741-74-8	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-317-00-1	"Naphtha (petroleum), heavy thermal cracked; Low boiling point thermally cracked naphtha; [A complex combination of hydrocarbons from distillation of the products from a thermal cracking process.  It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65°C to 220°C (148°F to 428°F).]"	265-085-0	64741-83-9	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-318-00-7	"Distillates (petroleum), heavy arom.; Low boiling point thermally cracked naphtha; [The complex combination of hydrocarbons from the distillation of the products from the thermal cracking of ethane and propane.  This higher boiling fraction consists predominantly of C5-7 aromatic hydrocarbons with some unsaturated aliphatic hydrocarbons having carbon number predominantly of C5.  This stream may contain benzene.]"	267-563-4	67891-79-6	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-319-00-2	"Distillates (petroleum), light arom.; Low boiling point thermally cracked naphtha; [The complex combination of hydrocarbons from the distillation of the products from the thermal cracking of ethane and propane.  This lower boiling fraction consists predominantly of C5-7 aromatic hydrocarbons with some unsaturated aliphatic hydrocarbons having a carbon number predominantly of C5.  This stream may contain benzene.]"	267-565-5	67891-80-9	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-320-00-8	"Distillates (petroleum), naphtha-raffinate pyrolyzate-derived, gasoline-blending; Low boiling point thermally cracked naphtha; [The complex combination of hydrocarbons obtained by the pyrolysis fractionation at 816°C (1500°F) of naphtha and raffinate.  It consists predominantly of hydrocarbons having a carbon number of C9 and boiling at approximately 204°C (400°F).]"	270-344-6	68425-29-6	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-321-00-3	"Aromatic hydrocarbons, C6-8, naphtha-raffinate pyrolyzate-derived; Low boiling point thermally cracked naphtha; [A complex combination of hydrocarbons obtained by the fractionation pyrolysis at 816°C (1500°F) of naphtha and raffinate.  It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C6 through C8, including benzene.]"	270-658-3	68475-70-7	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-322-00-9	"Distillates (petroleum), thermal cracked naphtha and gas oil; Low boiling point thermally cracked naphtha; [A complex combination of hydrocarbons produced by distillation of thermally cracked naphtha and/or gas oil.  It consists predominantly of olefinic hydrocarbons having a carbon number of C5 and boiling in the range of approximately 33°C to 60°C (91°F to 140°F).]"	271-631-9	68603-00-9	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-323-00-4	"Distillates (petroleum), thermal cracked naphtha and gas oil, C5-dimer-contg.; Low boiling point thermally cracked naphtha; [A complex combination of hydrocarbons produced by the extractive distillation of thermal cracked naphtha and/or gas oil.  It consists predominantly of hydrocarbons having a carbon number of C5 with some dimerized C5 olefins and boiling in the range of approximately 33°C to 184°C (91°F to 363°F).]"	271-632-4	68603-01-0	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-324-00-X	"Distillates (petroleum), thermal cracked naphtha and gas oil, extractive; Low boiling point thermally cracked naphtha; [A complex combination of hydrocarbons produced by the extractive distillation of thermal cracked naphtha and/or gas oil.  It consists of paraffinic and olefinic hydrocarbons, predominantly isoamylenes such as 2-methyl-1-butene and 2-methyl-2-butene and boiling in the range of approximately 31°C to 40°C (88°F to 104°F).]"	271-634-5	68603-03-2	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-325-00-5	"Distillates (petroleum), light thermal cracked, debutanized arom.; Low boiling point thermally cracked naphtha; [A complex combination of hydrocarbons produced by the distillation of products from a thermal cracking process.  It consists predominantly of aromatic hydrocarbons, primarily benzene.]"	273-266-0	68955-29-3	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-326-00-0	"Naphtha (petroleum), light thermal cracked, sweetened; Low boiling point thermally cracked naphtha; [A complex combination of hydrocarbons obtained by subjecting a petroleum distillate from the high temperature thermal cracking of heavy oil fractions to a sweetening process to convert mercaptans.  It consists predominantly of aromatics, olefins and saturated hydrocarbons boiling in the range of approximately 20°C to 100°C (68°F to 212°F).]"	295-447-3	92045-65-3	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-327-00-6	"Naphtha (petroleum), hydrotreated heavy; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst.  It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C13 and boiling in the range of approximately 65°C to 230°C (149°F to 446°F).]"	265-150-3	64742-48-9	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-328-00-1	"Naphtha (petroleum), hydrotreated light; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst.  It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20°C to 190°C (-4°F to 374°F).]"	265-151-9	64742-49-0	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-329-00-7	"Naphtha (petroleum), hydrodesulfurized light; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process.  It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately -20°C to 190°C (-4°F to 374°F).]"	265-178-6	64742-73-0	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-330-00-2	"naphtha (petroleum), hydrodesulphurized heavy; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).]"	265-185-4	64742-82-1	Carc. 1BMuta. 1BAsp. Tox. 1STOT RE 1	H350H340H304H372 (central nervous system)	GHS08Dgr	H340H350H372 (central nervous system)H304			P	CLP00/ATP05
649-331-00-8	"Distillates (petroleum), hydrotreated middle, intermediate boiling; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained by the distillation of products from a middle distillate hydrotreating process.  It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C10 and boiling in the range of approximately 127°C to 188°C (262°F to 370°F).]"	270-092-7	68410-96-8	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-332-00-3	"Distillates (petroleum), light distillate hydrotreating process, low-boiling; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained by the distillation of products from the light distillate hydrotreating process.  It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C9 and boiling in the range of approximately 3°C to 194°C (37°F to 382°F).]"	270-093-2	68410-97-9	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-333-00-9	"Distillates (petroleum), hydrotreated heavy naphtha, deisohexanizer overheads; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained by distillation of the products from a heavy naphtha hydrotreating process.  It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately -49°C to 68°C (-57°F to 155°F).]"	270-094-8	68410-98-0	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-334-00-4	"Solvent naphtha (petroleum), light arom., hydrotreated; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst.  It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 135°C to 210°C (275°F to 410°F).]"	270-988-8	68512-78-7	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-335-00-X	"Naphtha (petroleum), hydrodesulfurized thermal cracked light; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained by fractionation of hydrodesulfurized thermal cracker distillate.  It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 to C11 and boiling in the range of approximately 23°C to 195°C (73°F to 383°F).]"	285-511-9	85116-60-5	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-336-00-5	"Naphtha (petroleum), hydrotreated light, cycloalkane-contg.; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained from the distillation of a petroleum fraction.  It consists predominantly of alkanes and cycloalkanes boiling in the range of approximately -20°C to 190°C (-4°F to 374°F).]"	285-512-4	85116-61-6	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-337-00-0	"Naphtha (petroleum), heavy steam-cracked, hydrogenated; Low boiling point hydrogen treated naphtha"	295-432-1	92045-51-7	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-338-00-6	"Naphtha (petroleum), hydrodesulfurized full-range; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process.  It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately 30°C to 250°C (86°F to 482°F).]"	295-433-7	92045-52-8	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-339-00-1	"Naphtha (petroleum), hydrotreated light steam-cracked; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained by treating a petroleum fraction, derived from a pyrolysis process, with hydrogen in the presence of a catalyst.  It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35°C to 190°C (95°F to 374°F).]"	295-438-4	92045-57-3	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-340-00-7	"Hydrocarbons, C4-12, naphtha-cracking, hydrotreated; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained by distillation from the product of a naphtha steam cracking process and subsequent catalytic selective hydrogenation of gum formers.  It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 30°C to 230°C (86°F to 446°F).]"	295-443-1	92045-61-9	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-341-00-2	"Solvent naphtha (petroleum), hydrotreated light naphthenic; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst.  It consists predominantly of cycloparaffinic hydrocarbons having carbon numbers predominantly in the range of C6 through C7 and boiling in the range of approximately 73°C to 85°C (163°F to 185°F).]"	295-529-9	92062-15-2	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-342-00-8	"Naphtha (petroleum), light steam-cracked, hydrogenated; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons produced from the separation and subsequent hydrogenation of the products of a steam-cracking process to produce ethylene. It consists predominantly of saturated and unsaturated paraffins, cyclic paraffins and cyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C4 through C10 and boiling in the range of approximately 50°C to 200°C (122°F to 392°F).  The proportion of benzene hydrocarbons may vary up to 30 wt. % and the stream may also contain small amounts of sulfur and oxygenated compounds.]"	296-942-7	93165-55-0	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-343-00-3	"Hydrocarbons, C6-11, hydrotreated, dearomatized; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.]"	297-852-0	93763-33-8	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-344-00-9	"Hydrocarbons, C9-12, hydrotreated, dearomatized; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.]"	297-853-6	93763-34-9	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-345-00-4	"stoddard solvent; Low boiling point naphtha - unspecified; [A colourless, refined petroleum distillate that is free from rancid or objectionable odours and that boils in a range of approximately 148,8 °C to 204,4 °C (300 °F to 400 °F).]"	232-489-3	8052-41-3	Carc. 1BMuta. 1BAsp. Tox. 1STOT RE 1	H350H340H304H372 (central nervous system)	GHS08Dgr	H340H350H372 (central nervous system)H304			P	CLP00/ATP05
649-346-00-X	Natural gas condensates (petroleum); Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons separated as a liquid from natural gas in a surface separator by retrograde condensation.  It consists mainly of hydrocarbons having carbon numbers predominantly in the range of C2 to C20.  It is a liquid at atmospheric temperature and pressure.]	265-047-3	64741-47-5	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-347-00-5	"Natural gas (petroleum), raw liq. mix; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons separated as a liquid from natural gas in a gas recycling plant by processes such as refrigeration or absorption.  It consists mainly of saturated aliphatic hydrocarbons having carbon numbers in the range of C2 through C8.]"	265-048-9	64741-48-6	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-348-00-0	"Naphtha (petroleum), light hydrocracked; Low boiling naphtha - unspecified; [A complex combination of hydrocarbons from distillation of the products from a hydrocracking process.  It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C4 through C10, and boiling in the range of approximately -20°C to 180°C (-4°F to 356°F).]"	265-071-4	64741-69-1	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-349-00-6	"Naphtha (petroleum), heavy hydrocracked; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons from distillation of the products from a hydrocracking process.  It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C6 through C12, and boiling in the range of approximately 65°C to 230°C (148°F to 446°F).]"	265-079-8	64741-78-2	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-350-00-1	"Naphtha (petroleum), sweetened; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities.  It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately -10°C to 230°C (14°F to 446°F).]"	265-089-2	64741-87-3	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-351-00-7	"Naphtha (petroleum), acid-treated; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process.  It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90°C to 230°C (194°F to 446°F).]"	265-115-2	64742-15-0	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-352-00-2	"Naphtha (petroleum), chemically neutralized heavy; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons produced by a treating process to remove acidic materials.  It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65°C to 230°C (149°F to 446°F).]"	265-122-0	64742-22-9	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-353-00-8	"Naphtha (petroleum), chemically neutralized light; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons produced by a treating process to remove acidic materials.  It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately -20°C to 190°C (-4°F to 374°F).]"	265-123-6	64742-23-0	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-354-00-3	"Naphtha (petroleum), catalytic dewaxed; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained from the catalytic dewaxing of a petroleum fraction.  It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 35°C to 230°C (95°F to 446°F).]"	265-170-2	64742-66-1	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-355-00-9	"Naphtha (petroleum), light steam-cracked; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained by the distillation of the products from a steam cracking process.  It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20°C to 190°C (-4°F to 374°F).  This stream is likely to contain 10 vol. % or more benzene.]"	265-187-5	64742-83-2	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-356-00-4	"Solvent naphtha (petroleum), light arom.; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained from distillation of aromatic streams.  It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 135°C to 210°C (275°F to 410°F).]"	265-199-0	64742-95-6	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-357-00-X	"Aromatic hydrocarbons, C6-10, acid-treated, neutralized; Low boiling point naphtha - unspecified"	268-618-5	68131-49-7	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-358-00-5	"Distillates (petroleum), C3-5, 2-methyl-2-butene-rich; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons from the distillation of hydrocarbons usually ranging in carbon numbers from C3 through C5, predominantly isopentane and 3-methyl-1-butene.  It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C5, predominantly 2-methyl-2-butene.]"	270-725-7	68477-34-9	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-359-00-0	"Distillates (petroleum), polymd. steam-cracked petroleum distillates, C5-12 fraction; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained from the distillation of polymerized steam-cracked petroleum distillate.  It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C12.]"	270-735-1	68477-50-9	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-360-00-6	"Distillates (petroleum), steam-cracked, C5-12 fraction; Low boiling point naphtha - unspecified; [A complex combination of organic compounds obtained by the distillation of products from a steam cracking process.  It consists of unsaturated hydrocarbons having carbon numbers predominantly in the range of C5 through C12.]"	270-736-7	68477-53-2	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-361-00-1	"Distillates (petroleum), steam-cracked, C5-10 fraction, mixed with light steam-cracked petroleum naphtha C5 fraction; Low boiling point naphtha - unspecified"	270-738-8	68477-55-4	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-362-00-7	"Extracts (petroleum), cold-acid, C4-6; Low boiling point naphtha - unspecified; [A complex combination of organic compounds produced by cold acid unit extraction of saturated and unsaturated aliphatic hydrocarbons usually ranging in carbon numbers from C3 through C6, predominantly pentanes and amylenes.  It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers in the range of C4 through C6, predominantly C5.]"	270-741-4	68477-61-2	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-363-00-2	"Distillates (petroleum), depentanizer overheads; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained from a catalytic cracked gas stream.  It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.]"	270-771-8	68477-89-4	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-364-00-8	"Residues (petroleum), butane splitter bottoms; Low boiling point naphtha - unspecified; [A complex residuum from the distillation of butane stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.]"	270-791-7	68478-12-6	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H340H350H304			P	CLP00/ATP01corr
649-365-00-3	"Residual oils (petroleum), deisobutanizer tower; Low boiling point naphtha - unspecified; [A complex residuum from the atmospheric distillation of the butane-butylene stream.  It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.]"	270-795-9	68478-16-0	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-366-00-9	"Naphtha (petroleum), full-range coker; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons produced by the distillation of products from a fluid coker.  It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C15 and boiling in the range of approximately 43°C to 250°C (110°F-500°F).]"	270-991-4	68513-02-0	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-367-00-4	"Naphtha (petroleum), steam-cracked middle arom.; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons produced by the distillation of products from a steam-cracking process.  It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 130°C to 220°C (266°F to 428°F).]"	271-138-9	68516-20-1	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-368-00-X	"Naphtha (petroleum), clay-treated full-range straight-run; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons resulting from treatment of full-range straight-run naphtha with natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present.  It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately -20°C to 220°C (-4°F to 429°F).]"	271-262-3	68527-21-9	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-369-00-5	"Naphtha (petroleum), clay-treated light straight-run; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons resulting from treatment of light straight-run naphtha with a natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present.  It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C10 and boiling in the range of approximately 93°C to 180°C (200°F to 356°F).]"	271-263-9	68527-22-0	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-370-00-0	"Naphtha (petroleum), light steam-cracked arom.; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons produced by distillation of products from a steam-cracking process.  It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C9 and boiling in the range of approximately 110°C to 165°C (230°F to 329°F).]"	271-264-4	68527-23-1	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-371-00-6	"Naphtha (petroleum), light steam-cracked, debenzenized; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons produced by distillation of products from a steam-cracking process.  It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 80°C to 218°C (176°F to 424°F).]"	271-266-5	68527-26-4	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-372-00-1	"Naphtha (petroleum), arom.-contg.; Low boiling point naphtha - unspecified"	271-635-0	68603-08-7	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-373-00-7	"Gasoline, pyrolysis, debutanizer bottoms; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms.  It consists of hydrocarbons having carbon numbers predominantly greater than C5.]"	271-726-5	68606-10-0	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-374-00-2	"Naphtha (petroleum), light, sweetened; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities.  It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately -20°C to 100°C (-4°F to 212°F).]"	272-206-0	68783-66-4	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-375-00-8	"Natural gas condensates; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons separated and/or condensed from natural gas during transportation and collected at the wellhead and/or from the production, gathering, transmission, and distribution pipelines in deeps, scrubbers, etc.  It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C2 through C8.]"	272-896-3	68919-39-1	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-376-00-3	"Distillates (petroleum), naphtha unifiner stripper; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons produced by stripping the products from the naphtha unifiner.  It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]"	272-932-8	68921-09-5	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-377-00-9	"Naphtha (petroleum), catalytic reformed light, arom.-free fraction; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons remaining after removal of aromatic compounds from catalytic reformed light naphtha in a selective absorption process.  It consists predominantly of paraffinic and cyclic compounds having carbon numbers predominantly in the range of C5 to C8 and boiling in the range of approximately 66°C to 121°C (151°F to 250°F).]"	285-510-3	85116-59-2	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-378-00-4	"Gasoline; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons consisting primarily of paraffins, cycloparaffins, aromatic and olefinic hydrocarbons having carbon numbers predominantly greater than C3 and boiling in the range of 30°C to 260°C (86°F to 500°F).]"	289-220-8	86290-81-5	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-379-00-X	"Aromatic hydrocarbons, C7-8, dealkylation products, distn. residues; Low boiling point naphtha - unspecified"	292-698-0	90989-42-7	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-380-00-5	"Hydrocarbons, C4-6, depentanizer lights, arom. hydrotreater; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained as first runnings from the depentanizer column before hydrotreatment of the aromatic charges.  It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C6, predominantly pentanes and pentenes, and boiling in the range of approximately 25°C to 40°C (77°F to 104°F).]"	295-298-4	91995-38-9	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-381-00-0	"Distillates (petroleum), heat-soaked steam-cracked naphtha, C5-rich; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained by distillation of heat-soaked steam-cracked naphtha.  It consists predominantly of hydrocarbons having carbon numbers in the range of C4 through C6, predominantly C5.]"	295-302-4	91995-41-4	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-382-00-6	"Extracts (petroleum), catalytic reformed light naphtha solvent; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained as the extract from the solvent extraction of a catalytically reformed petroleum cut.  It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C8 and boiling in the range of approximately 100°C to 200°C (212°F to 392°F).]"	295-331-2	91995-68-5	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-383-00-1	"Naphtha (petroleum), hydrodesulfurized light, dearomatized; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained by distillation of hydrodesulfurized and dearomatized light petroleum fractions.  It consists predominantly of C7 paraffins and cycloparaffins boiling in a range of approximately 90°C to 100°C (194°F to 212°F).]"	295-434-2	92045-53-9	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-384-00-7	"Naphtha (petroleum), light, C5-rich, sweetened; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities.  It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C5, predominantly C5, and boiling in the range of approximately minus 10°C to 35°C (14°F to 95°F).]"	295-442-6	92045-60-8	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-385-00-2	"Hydrocarbons, C8-11, naphtha-cracking, toluene cut; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained by distillation from prehydrogenated cracked naphtha.  It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C11 and boiling in the range of approximately 130°C to 205°C (266°F to 401°F).]"	295-444-7	92045-62-0	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-386-00-8	"Hydrocarbons, C4-11, naphtha-cracking, arom.-free; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained from prehydrogenated cracked naphtha after distillative separation of benzene- and toluene-containing hydrocarbon cuts and a higher boiling fraction.  It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately 30°C to 205°C (86°F to 401°F).]"	295-445-2	92045-63-1	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-387-00-3	"Naphtha (petroleum), light heat-soaked, steam-cracked; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained by the fractionation of steam cracked naphtha after recovery from a heat soaking process.  It consists predominantly of hydrocarbons having a carbon number predominantly in the range of C4 through C6 and boiling in the range of approximately 0°C to 80°C (32°F to 176°F).]"	296-028-8	92201-97-3	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-388-00-9	"Distillates (petroleum), C6-rich; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained from the distillation of a petroleum feedstock.  It consists predominantly of hydrocarbons having carbon numbers of C5 through C7, rich in C6, and boiling in the range of approximately 60°C to 70°C (140°F to 158°F).]"	296-903-4	93165-19-6	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-389-00-4	"Gasoline, pyrolysis, hydrogenated; Low boiling point naphtha-unspecified; [A distillation fraction from the hydrogenation of pyrolysis gasoline boiling in the range of approximately 20°C to 200°C (68°F to 392°F).]"	302-639-3	94114-03-1	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-390-00-X	"Distillates (petroleum), steam-cracked, C8-12 fraction, polymd., distn. lights; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained by distillation of the polymerized C8 through C12 fraction from steam-cracked petroleum distillates.  It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C12.]"	305-750-5	95009-23-7	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-391-00-5	"Extracts (petroleum) heavy naphtha solvent, clay-treated; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained by the treatment of heavy naphthic solvent petroleum extract with bleaching earth.  It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C10 and boiling in the range of approximately 80°C to 180°C (175°F to 356°F).]"	308-261-5	97926-43-7	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-392-00-0	"Naphtha (petroleum), light steam-cracked, debenzenized, thermally treated; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained by the treatment and distillation of debenzenized light steam-cracked petroleum naphtha.  It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 95°C to 200°C (203°F to 392°F).]"	308-713-1	98219-46-6	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-393-00-6	"Naphtha (petroleum), light steam-cracked, thermally treated; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained by the treatment and distillation of light steam-cracked petroleum naphtha.  It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C6 and boiling in the range of approximately 35°C to 80°C (95°F to 176°F).]"	308-714-7	98219-47-7	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-394-00-1	"Distillates (petroleum), C7-9, C8-rich, hydrodesulfurized dearomatized; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained by the distillation of petroleum light fraction, hydrodesulfurized and dearomatized.  It consists predominantly of hydrocarbons having carbon numbers in the range of C7 through C9, predominantly C8 paraffins and cycloparaffins, boiling in the range of approximately 120°C to 130°C (248°F to 266°F).]"	309-862-5	101316-56-7	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-395-00-7	"Hydrocarbons, C6-8, hydrogenated sorption-dearomatized, toluene raffination; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained during the sorptions of toluene from a hydrocarbon fraction from cracked gasoline treated with hydrogen in the presence of a catalyst.  It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C8 and boiling in the range of approximately 80°C to 135°C (176°F to 275°F).]"	309-870-9	101316-66-9	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-396-00-2	"Naphtha (petroleum), hydrodesulfurised full-range coker; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurised coker distillate.  It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 to C11 and boiling in the range of approximately 23°C to 196°C (73°F to 385°F).]"	309-879-8	101316-76-1	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-397-00-8	"Naphtha (petroleum), sweetened light; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities.  It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C8 and boiling in the range of approximately 20°C to 130°C (68°F to 266°F).]"	309-976-5	101795-01-1	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-398-00-3	"Hydrocarbons, C3-6, C5-rich, steam-cracked naphtha; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained by distillation of steam-cracked naphtha.  It consists predominantly of hydrocarbons having carbon numbers in the range of C3 through C6, predominantly C5.]"	310-012-0	102110-14-5	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-399-00-9	"Hydrocarbons, C5-rich, dicyclopentadiene-contg.; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained by distillation of the products from a steam-cracking process.  It consists predominantly of hydrocarbons having carbon numbers of C5 and dicyclopentadiene and boiling in the range of approximately 30°C to 170°C (86°F to 338°F).]"	310-013-6	102110-15-6	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-400-00-2	"Residues (petroleum), steam-cracked light, arom.; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained by the distillation of the products of steam cracking or similar processes after taking off the very light products resulting in a residue starting with hydrocarbons having carbon numbers greater than C5.  It consists predominantly of aromatic hydrocarbons having carbon numbers greater than C5 and boiling above approximately 40°C (104°F).]"	310-057-6	102110-55-4	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-401-00-8	"Hydrocarbons, C?5, C5-6-rich; Low boiling point naphtha - unspecified"	270-690-8	68476-50-6	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-402-00-3	"Hydrocarbons, C5-rich; Low boiling point naphtha - unspecified"	270-695-5	68476-55-1	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-403-00-9	"Aromatic hydrocarbons, C8-10; Low boiling point naphtha - unspecified"	292-695-4	90989-39-2	Carc. 1BMuta. 1BAsp. Tox. 1	H350H340H304	GHS08Dgr	H350H340H304			P	CLP00/ATP01
649-404-00-4	Kerosine (petroleum); Straight run kerosine; [A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 °C to 290 °C (320 °F to 554 °F).]	232-366-4	8008-20-6	Asp. Tox. 1	H304	GHS08Dgr	H304				CLP00
649-405-00-X	"solvent naphtha (petroleum), medium aliph.; Straight run kerosine; [A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 140 °C to 220 °C (284 °F to 428 °F).]"	265-191-7	64742-88-7	Asp. Tox. 1STOT RE 1	H304H372 (central nervous system)	GHS08Dgr	H372 (central nervous system)H304				CLP00/ATP05
649-406-00-5	Solvent naphtha (petroleum) heavy aliph.; Straight run kerosine; [A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C11 through C16 and boiling in the range of approximately 190 °C to 290 °C (374 °F to 554 °F).]	265-200-4	64742-96-7	Asp. Tox. 1	H304	GHS08Dgr	H304				CLP00
649-407-00-0	"Kerosine (petroleum), straight-run wide-cut; Straight run kerosine; [A complex combination of hydrocarbons obtained as a wide cut hydrocarbon fuel cut from atmospheric distillation and boiling in the range of approximately 70 °C to 220 °C (158 °F to 428 °F).]"	295-418-5	92045-37-9	Asp. Tox. 1	H304	GHS08Dgr	H304				CLP00
649-408-00-6	"Distillates (petroleum), steam-cracked; Cracked kerosine; [A complex combination of hydrocarbons obtained by the distillation of the products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C7 through C16 and boiling in the range of approximately 90 °C to 290 °C (190 °F to 554 °F).]"	265-194-3	64742-91-2	Asp. Tox. 1	H304	GHS08Dgr	H304				CLP00
649-409-00-1	"Distillates (petroleum), cracked stripped steam-cracked petroleum distillates, C8-10 fraction; Cracked kerosine; [A complex combination of hydrocarbons obtained by distilling cracked stripped steam-cracked distillates. It consists of hydro-carbons having carbon numbers in the range of C8 through C10 and boiling in the range of approximately 129 °C to 194 °C (264 °F to 382 °F).]"	270-728-3	68477-39-4	Asp. Tox. 1	H304	GHS08Dgr	H304				CLP00
649-410-00-7	"Distillates (petroleum), cracked stripped steam-cracked petroleum distillates, C10-12 fraction; Cracked kerosine; [A complex combination of hydrocarbons obtained by distilling cracked stripped steam-cracked distillates. It consists predominantly of aromatic hydrocarbons having carbon numbers in the range of C10 through C12.]"	270-729-9	68477-40-7	Asp. Tox. 1	H304	GHS08Dgr	H304				CLP00
649-411-00-2	"Distillates (petroleum), steam-cracked, C8-12 fraction; Cracked kerosine; [A complex combination of organic compounds obtained by the distillation of products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C8 through C12.]"	270-737-2	68477-54-3	Asp. Tox. 1	H304	GHS08Dgr	H304				CLP00
649-412-00-8	"Kerosine (petroleum), hydrodesulfurized thermal cracked; Cracked kerosine; [A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized thermal cracker distillate. It consists predominantly of hydrocarbons predominantly in the range of C8 to C16 and boiling in the range of approximately 120 °C to 283 °C (284 °F to 541 °F).]"	285-507-7	85116-55-8	Asp. Tox. 1	H304	GHS08Dgr	H304				CLP00
649-413-00-3	"Aromtic hydrocarbons, C?10, steam-cracking, hydrotreated; Cracked kerosine; [A complex combination of hydrocarbons produced by the distillation of the products from a steam cracking process treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly greater than C10 and boiling in the range of approximately 150 °C to 320 °C (302 °F to 608 °F).]"	292-621-0	90640-98-5	Asp. Tox. 1	H304	GHS08Dgr	H304				CLP00
649-414-00-9	"Naphtha (petroleum), steam-cracked, hydrotreated, C9-10-arom.-rich; Cracked kerosine; [A complex combination of hydrocarbons produced by the distillation of the products from a steam cracking process thereafter treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers in the range of C9 through C10 and boiling in the range of approximately 140 °C to 200 °C (284 °F to 392 °F).]"	292-637-8	90641-13-7	Asp. Tox. 1	H304	GHS08Dgr	H304				CLP00
649-415-00-4	"Distillates (petroleum), thermal-cracked, alkylarom. hydrocarbon-rich; Cracked kerosine; [A complex combination of hydrocarbons obtained by distillation of thermal-cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 °C to 250 °C (212 °F to 482 °F.]"	309-866-7	101316-61-4	Asp. Tox. 1	H304	GHS08Dgr	H304				CLP00
649-416-00-X	"Distillates (petroleum), catalytic cracked heavy tar light; Cracked kerosine; [A complex combination of hydrocarbons obtained by distillation of catalytic cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 °C to 250 °C (212 °F to 482 °F).]"	309-938-8	101631-13-4	Asp. Tox. 1	H304	GHS08Dgr	H304				CLP00
649-417-00-5	"Solvent naphtha (petroleum), hydrocracked heavy arom.; Cracked kerosine; [A complex combination of hydrocarbons obtained by the distillation of hydrocracked petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 235 °C to 290 °C (455 °F to 554 °F).]"	309-881-9	101316-80-7	Asp. Tox. 1	H304	GHS08Dgr	H304				CLP00
649-418-00-0	"Distillates (petroleum), steam-cracked heavy tar light; Cracked kerosine; [A complex combination of hydrocarbons obtained by distillation of steam cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 °C to 250 °C (212 °F to 482 °F).]"	309-940-9	101631-15-6	Asp. Tox. 1	H304	GHS08Dgr	H304				CLP00
649-419-00-6	"Distillates (petroleum), alkylate; Kerosine - unspecified; [A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydro-carbons having carbon numbers predominantly in the range of C11 through C17 and boiling in the range of approximately 205 °C to 320 °C (401 °F to 608 °F).]"	265-074-0	64741-73-7	Asp. Tox. 1	H304	GHS08Dgr	H304				CLP00
649-420-00-1	"Extracts (petroleum), heavy naphtha solvent; Kerosine - unspecified; [A complex combination of hydrocarbons obtained as the extract from a solvent extraction process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 220 °C (194 °F to 428 °F).]"	265-099-7	64741-98-6	Asp. Tox. 1	H304	GHS08Dgr	H304				CLP00
649-421-00-7	"Distillates (petroleum), chemically neutralized light; Kerosine - unspecified; [A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 °C to 290 °C (302 °F to 554 °F).]"	265-132-5	64742-31-0	Asp. Tox. 1	H304	GHS08Dgr	H304				CLP00
649-422-00-2	"Distillates (petroleum), hydrotreated light; Kerosine - unspecified; [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 °C to 290 °C (302 °F to 554 °F).]"	265-149-8	64742-47-8	Asp. Tox. 1	H304	GHS08Dgr	H304				CLP00
649-423-00-8	"Kerosine (petroleum), hydrodesulfurized; Kerosine - unspecified; [A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 °C to 290 °C (302 °F to 554 °F).]"	265-184-9	64742-81-0	Asp. Tox. 1	H304	GHS08Dgr	H304				CLP00
649-424-00-3	"Solvent naphtha (petroleum), heavy arom.; Kerosine - unspecified; [A complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 165 °C to 290 °C (330 °F to 554 °F).]"	265-198-5	64742-94-5	Asp. Tox. 1	H304	GHS08Dgr	H304				CLP00
649-425-00-9	"Naphtha (petroleum), heavy coker; Kerosine - unspecified; [A complex combination of hydrocarbons from the distillation of products from a fluid coker. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C6 through C15 and boiling in the range of approximately 157 °C to 288 °C (315 °F to 550 °F).]"	269-778-9	68333-23-3	Asp. Tox. 1	H304	GHS08Dgr	H304				CLP00
649-426-00-4	"Naphtha (petroleum), catalytic reformed hydrodesulfurized heavy, arom. fraction; Kerosine - unspecified; [A complex combination of hydrocarbons produced by fractionation from catalytically reformed hydrodesulfurized naphtha. It consists predominantly of aromatic hydrocarbons having carbon numbers predominently in the range of C7 to C 13 and boiling in the range of approximately 98 °C to 218 °C (208 °F to 424 °F).]"	285-508-2	85116-57-0	Asp. Tox. 1	H304	GHS08Dgr	H304				CLP00
649-427-00-X	"Kerosine (petroleum), sweetened; Kerosine - unspecified; [A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of 130 °C to 290 °C (266 °F to 554 °F).]"	294-799-5	91770-15-9	Asp. Tox. 1	H304	GHS08Dgr	H304				CLP00
649-428-00-5	"Kerosine (petroleum), solvent-refined sweetened; Kerosine - unspecified; [A complex combination of hydrocarbons obtained from a petroleum stock by solvent refining and sweetening and boiling in the range of approximately 150 °C to 260 °C (302 °F to 500 °F).]"	295-416-4	92045-36-8	Asp. Tox. 1	H304	GHS08Dgr	H304				CLP00
649-429-00-0	"Hydrocarbons, C9-16, hydrotreated, dearomatized; Kerosine - unspecified; [A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.]"	297-854-1	93763-35-0	Asp. Tox. 1	H304	GHS08Dgr	H304				CLP00
649-430-00-6	"Kerosine (petroleum), solvent-refined hydrodesulfurized; Kerosine - unspecified"	307-033-2	97488-94-3	Asp. Tox. 1	H304	GHS08Dgr	H304				CLP00
649-431-00-1	"Distillates (petroleum), hydrodesulfurized full-range middle coker; Kerosine - unspecified; [A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized coker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C16 and boiling in the range of approximately 120 °C to 283 °C (248 °F to 541 °F).]"	309-864-6	101316-58-9	Asp. Tox. 1	H304	GHS08Dgr	H304				CLP00
649-432-00-7	"Solvent naphtha (petroleum), hydrodesulfurized heavy arom.; Kerosine - unspecified; [A complex combination of hydrocarbons obtained by the catalytic hydrodesulfurization of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C13 and boiling in the range of approximately 180 °C to 240 °C (356 °F to 464 °F).]"	309-882-4	101316-81-8	Asp. Tox. 1	H304	GHS08Dgr	H304				CLP00
649-433-00-2	"Solvent naphtha (petroleum), hydrodesulfurized medium; Kerosine - unspecified; [A complex combination of hydrocarbons obtained by the catalytic hydrodesulfurization of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C13 and boiling in the range of approximately 175 °C to 220 °C (347 °F to 428 °F).]"	309-884-5	101316-82-9	Asp. Tox. 1	H304	GHS08Dgr	H304				CLP00
649-434-00-8	"Kerosine (petroleum), hydrotreated; Kerosine - unspecified; [A complex combination of hydrocarbons obtained from the distillation of petroleum and subsequent hydrotreatment. It consists predominantly of alkanes, cycloalkanes and alkylbenzenes having carbon numbers predominantly in the range of C12 through C16 and boiling in the range of approximately 230 °C to 270 °C (446 °F to 518 °F).]"	309-944-0	101631-19-0	Asp. Tox. 1	H304	GHS08Dgr	H304				CLP00
649-435-00-3	"Distillates (petroleum), light catalytic cracked; Cracked gasoil; [A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 °C to 400 °C (302 °F to 752 °F). It contains a relatively large proportion of bicyclic aromatic hydrocarbons.]"	265-060-4	64741-59-9	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-436-00-9	"Distillates (petroleum), intermediate catalytic cracked; Cracked gasoil; [A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C30 and boiling in the range of approximately 205 °C to 450 °C (401 °F to 842 °F). It contains a relatively large proportion of tricyclic aromatic hydrocarbons.]"	265-062-5	64741-60-2	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-437-00-4	"Distillates (petroleum), light hydrocracked; Cracked gasoil; [A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C10 through C18 and boiling in the range of approximately 160 °C to 320 °C (320 °F to 608 °F).]"	265-078-2	64741-77-1	Carc. 2	H351	GHS08Wng	H351				CLP00
649-438-00-X	"Distillates (petroleum), light thermal cracked; Cracked gasoil; [A complex combination of hydrocarbons from the distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C10 through C22 and boiling in the range of approximately 160 °C to 370 °C (320 °F to 698 °F).]"	265-084-5	64741-82-8	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-439-00-5	"Distillates (petroleum), hydrodesulfurized light catalytic cracked; Cracked gasoil; [A complex combination of hydrocarbons obtained by treating light catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 °C to 400 °C (302 °F to 752 °F). It contains a relatively large proportion of bicyclic aromatic hydrocarbons.]"	269-781-5	68333-25-5	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-440-00-0	"Distillates (petroleum), light steam-cracked naphtha; Cracked gasoil; [A complex combination of hydrocarbons from the multiple distillation of products from a steam cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C10 through C18.]"	270-662-5	68475-80-9	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-441-00-6	"Distillates (petroleum), cracked steam-cracked petroleum distillates; Cracked gasoil; [A complex combination of hydrocarbons produced by distilling cracked steam cracked distillate and/or its fractionation products. It consists of hydrocarbons having carbon numbers predominently in the range of C10 to low molecular weight polymers.]"	270-727-8	68477-38-3	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-442-00-1	"Gas oils (petroleum), steam-cracked; Cracked gasoil; [A complex combination of hydrocarbons produced by distillation of the products from a steam cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C9 and boiling in the range of from approximately 205 °C to 400 °C (400 °F to 752 °F).]"	271-260-2	68527-18-4	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-443-00-7	"Distillates (petroleum), hydrodesulfurized thermal cracked middle; Cracked gasoil; [A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized themal cracker distillate stocks. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C11 to C25 and boiling in the range of approximately 205 °C to 400 °C (401 °F to 752 °F).]"	285-505-6	85116-53-6	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-444-00-2	"Gas oils (petroleum), thermal-cracked, hydrodesulfurized; Cracked gasoil"	295-411-7	92045-29-9	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-445-00-8	"Residues (petroleum), hydrogenated steam-cracked naphtha; Cracked gasoil; [A complex combination of hydrocarbons obtained as a residual fraction from the distillation of hydrotreated steam-cracked naphtha. It consists predominantly of hydrocarbons boiling in the range of approximately 200 °C to 350 °C (32 °F to 662 °F).]"	295-514-7	92062-00-5	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-446-00-3	"Residues (petroleum), steam-cracked naphtha distn.; Cracked gasoil; [A complex combination of hydrocarbons obtained as a column bottom from the separation of effluents from steam cracking naphtha at a high temperature. It boils in the range of approximately 147 °C to 300 °C (297 °F to 572 °F) and produces a finished oil having a viscosity of 18cSt at 50 °C.]"	295-517-3	92062-04-9	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-447-00-9	"Distillates (petroleum), light catalytic cracked, thermally degraded; Cracked gasoil; [A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process which has been used as a heat transfer fluid. It consists predominantly of hydrocarbons boiling in the range of approximately 190 °C to 340 °C (374 °F to 644 °F). This stream is likely to contain organic sulfur compounds.]"	295-991-1	92201-60-0	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-448-00-4	"Residues (petroleum), steam-cracked heat-soaked naphtha; Cracked gasoil; [A complex combination of hydrocarbons obtained as residue from the distillation of steam cracked heat soaked naphtha and boiling in the range of approximately 150 °C to 350 °C (302 °F to 662 °F).]"	297-905-8	93763-85-0	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-449-00-X	"Hydrocarbons, C16-20, solvent-dewaxed hydrocracked paraffinic distn. residue; Cracked gasoil; [A complex combination of hydrocarbons obtained by solvent dewaxing of a distillation residue from a hydrocracked paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C20 and boiling in the range of approximately 360 °C to 500 °C (680 °F to 932 °F). It produces a finished oil having a viscosity of 4,5 cSt at approximately 100 °C (212 °F).]"	307-662-2	97675-88-2	Carc. 2	H351	GHS08Wng	H351				CLP00
649-450-00-5	"Gas oils (petroleum), light vacuum, thermal-cracked hydrodesulfurized; Cracked gasoil; [A complex combination of hydrocarbons obtained by catalytic dehydrosulfurization of thermal-cracked light vacuum petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C14 through C20 and boiling in the range of approximately 270 °C to 370 °C (518 °F to 698 °F).]"	308-278-8	97926-59-5	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-451-00-0	"Distillates (petroleum), hydrodesulfurized middle coker; Cracked gasoil; [A complex combination of hydrocarbons by fractionation from hydrodesulfurised coker distillate stocks. Is consists of hydro-carbons having carbon numbers predominantly in the range of C12 through C21 and boiling in the range of approximately 200 °C to 360 °C (392 °F to 680 °F).]"	309-865-1	101316-59-0	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-452-00-6	"Distillates (petroleum), heavy steam-cracked; Cracked gasoil; [A complex combination of hydrocarbons obtained by distillation of steam cracking heavy residues. It consists predominantly of highly alkylated heavy aromatic hydrocarbons boiling in the range of approximately 250 °C to 400 °C (482 °F to 752 °F).]"	309-939-3	101631-14-5	Carc. 1B	H350	GHS08Dgr	H350				CLP00
649-453-00-1	"Distillates (petroleum), heavy hydrocracked; Baseoil - unspecified; [A complex combination of hydrocarbons from the distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers in the range of C15-C39 and boiling in the range of approximately 260 °C to 600 °C (500 °F to 1112 °F).]"	265-077-7	64741-76-0	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-454-00-7	"Distillates (petroleum), solvent-refined heavy paraffinic; Baseoil - unspecified; [A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 °F (19cSt at 40 °C).]"	265-090-8	64741-88-4	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-455-00-2	"Distillates (petroleum), solvent-refined light paraffinic; Baseoil - unspecified; [A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 °F (19cSt at 40 °C).]"	265-091-3	64741-89-5	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-456-00-8	"Residual oils (petroleum), solvent deasphalted; Baseoil - unspecified; [A complex combination of hydrocarbons obtained as the solvent soluble fraction from C3-C4 solvent deasphalting of a residuum. It consists of hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 °C (752 °F).]"	265-096-0	64741-95-3	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-457-00-3	"Distillates (petroleum), solvent-refined heavy naphthenic; Baseoil - unspecified; [A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 °F (19cSt a 40 °C). It contains relatively few normal paraffins.]"	265-097-6	64741-96-4	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-458-00-9	"Distillates (petroleum), solvent-refined light naphthenic; Baseoil - unspecified; [A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 °F (19cSt at 40 °C). It contains relatively few normal paraffins.]"	265-098-1	64741-97-5	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-459-00-4	"Residual oils (petroleum,) solvent-refined; Baseoil - unspecified; [A complex combination by hydrocarbons obtained as the solvent insoluble fraction from solvent refining of a residuum using a polar organic solvent such as phenol or furfural. It consists of hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 °C (752 °F).]"	265-101-6	64742-01-4	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-460-00-X	"Distillates (petroleum), clay-treated paraffinic; Baseoil - unspecified; [A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 °F (19cSt at 40 °C). It contains a relatively large proportion of saturated hydrocarbons.]"	265-137-2	64742-36-5	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-461-00-5	"Distillates (petroleum), clay-treated light paraffinic; Baseoil - unspecified; [A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 °F (19cSt at 40 °C). It contains a relatively large proportion of saturated hydrocarbons.]"	265-138-8	64742-37-6	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-462-00-0	"Residual oils (petroleum), clay-treated; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by treatment of a residual oil with a natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydro-carbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 °C (752 °F).]"	265-143-5	64742-41-2	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-463-00-6	"Distillates (petroleum), clay-treated heavy naphthenic; Baseoil - unspecified; [A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 °F (19cSt at 40 °C). It contains relatively few normal paraffins.]"	265-146-1	64742-44-5	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-464-00-1	"Distillates (petroleum), clay-treated light naphthenic; Baseoil - unspecified; [A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 °F (19cSt at 40 °C). It contains relatively few normal paraffins.]"	265-147-7	64742-45-6	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-465-00-7	"Distillates (petroleum), hydrotreated heavy naphthenic; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 100 SUS at 100 °F (19cSt at 40 °C). It contains relatively few normal paraffins.]"	265-155-0	64742-52-5	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-466-00-2	"Distillates (petroleum), hydrotreated light naphthenic; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 °F (19cSt at 40 °C). It contains relatively few normal paraffins.]"	265-156-6	64742-53-6	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-467-00-8	"Distillates (petroleum), hydrotreated heavy paraffinic; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 100 SUS at 100 °F (19cSt at 40 °C). It contains a relatively large proportion of saturated hydrocarbons.]"	265-157-1	64742-54-7	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-468-00-3	"Distillates (petroleum), hydrotreated light paraffinic; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 °F (19cSt at 40 °C). It contains a relatively large proportion of saturated hydrocarbons.]"	265-158-7	64742-55-8	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-469-00-9	"Distillates (petroleum), solvent-dewaxed light paraffinic; Baseoil - unspecified; [A complex comination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 °F (19cSt at 40 °C).]"	265-159-2	64742-56-9	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-470-00-4	"Residual oils (petroleum), hydrotreated; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly greater than C25 and boiling above approximately 400 °C (752 °F).]"	265-160-8	64742-57-0	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-471-00-X	"Residual oils (petroleum), solvent-dewaxed; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by removal of long, branched chain hydrocarbons from a residual oil by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly greater than C25 and boiling above approximately 400 °C (752 °F).]"	265-166-0	64742-62-7	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-472-00-5	"Distillates (petroleum), solvent-dewaxed heavy naphthenic; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 . through C50 and produces a finished oil of not less than 100 SUS at 100 °F (19cSt at 40 °C). It contains relatively few normal paraffins.]"	265-167-6	64742-63-8	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-473-00-0	"Distillates (petroleum), solvent-dewaxed light naphthenic; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly in the range C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 °F (19cSt at 40 °C). It contains relatively few normal paraffins.]"	265-168-1	64742-64-9	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-474-00-6	"Distillates (petroleum), solvent-dewaxed heavy paraffinic; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity not less than 100 SUS at 100 °F (19cSt at 40 °C).]"	265-169-7	64742-65-0	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-475-00-1	"Naphthenic oils (petroleum), catalytic dewaxed heavy; Baseoil - unspecified; [A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 °F (19cSt at 40 °C). It contains relatively few normal paraffins.]"	265-172-3	64742-68-3	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-476-00-7	"Naphthenic oils (petroleum), catalytic dewaxed light; Baseoil - unspecified; [A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity less than 100 SUS at 100 °F (19cSt at 40 °C). It contains relatively few normal paraffins.]"	265-173-9	64742-69-4	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-477-00-2	"Paraffin oils (petroleum), catalytic dewaxed heavy; Baseoil - unspecified; [A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 °F (19cSt at 40 °C).]"	265-174-4	64742-70-7	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-478-00-8	"Paraffin oils (petroleum), catalytic dewaxed light; Baseoil - unspecified; [A complex combination of hydrocarbons obtained from a catalytic dewxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 °F (19cSt at 40 °C).]"	265-176-5	64742-71-8	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-479-00-3	"Naphthenic oils (petroleum), complex dewaxed heavy; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by removing straight chain paraffin hydrocarbons as a solid by treatment with an agent such as urea. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of at least 100 SUS at 100 °F (19cSt at 40 °C). It contains relatively few normal paraffins.]"	265-179-1	64742-75-2	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-480-00-9	"Naphthenic oils (petroleum), complex dewaxed light; Baseoil - unspecified; [A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity less than 100 SUS at 100 °F (19cSt at 40 °C). It contains relatively few normal paraffins.]"	265-180-7	64742-76-3	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-481-00-4	"Lubricating oils (petroleum), C20-50, hydrotreated neutral oil-based, high-viscosity; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil, and solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of approximately 112cSt at 40 °C. It contains a relatively large proportion of saturated hydrocarbons.]"	276-736-3	72623-85-9	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-482-00-X	"Lubricating oils (petroleum), C15-30, hydrotreated neutral oil-based; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by treating light vacuum gas oil and heavy vacuum gas oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity of approximately 15cSt at 40 °C. It contains a relatively large proportion of saturated hydrocabons.]"	276-737-9	72623-86-0	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-483-00-5	"Lubricating oils (petroleum), C20-50, hydrotreated neutral oil-based; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil and solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of approximately 32cSt at 40 °C. It contains a relatively large proportion of saturated hydrocarbons.]"	276-738-4	72623-87-1	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-484-00-0	Lubricating oils; Baseoil - unspecified; [A complex combination of hydrocarbons obtained from solvent extraction and dewaxing processes. It consists predominantly of saturated hydrocarbons having carbon numbers in the range C15 through C50.]	278-012-2	74869-22-0	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-485-00-6	"Distillates (petroleum), complex dewaxed heavy paraffinci; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by dewaxing heavy paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of equal to or greater than 100 SUS at 100 °F (19cSt at 40 °C). It contains relatively few normal paraffins.]"	292-613-7	90640-91-8	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-486-00-1	"Distillates (petroleum), complex dewaxed light paraffinic; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by dewaxing light paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 °F (19cSt at 40 °C). It contains relatively few normal paraffins.]"	292-614-2	90640-92-9	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-487-00-7	"Distillates (petroleum), solvent dewaxed heavy paraffinic, clay-treated; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by treating dewaxed heavy paraffinic distillate with neutral or modified clay in either a contacting or percolation process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50.]"	292-616-3	90640-94-1	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-488-00-2	"Hydrocarbons, C20-50, solvent dewaxed heavy paraffinic, hydrotreated; Baseoil - unspecified; [A complex combination of hydrocarbons produced by treating dewaxed heavy paraffinic distillate with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50.]"	292-617-9	90640-95-2	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-489-00-8	"Distillates (petroleum), solvent dewaxed light paraffinic, clay-treated; Baseoil - unspecified; [A complex combination of hydrocarbons resulting from treatment of dewaxed light paraffinic distillate with natural or modified clay in either a contacting or percolation process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30.]"	292-618-4	90640-96-3	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-490-00-3	"Distillates (petroleum), solvent dewaxed light paraffinic, hydrotreated; Baseoil - unspecified; [A complex combination of hydrocarbons produced by treating a dewaxed light paraffinic distillate with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30.]"	292-620-5	90640-97-4	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-491-00-9	"Residual oils (petroleum), hydrotreated solvent dewaxed; Baseoil - unspecified"	292-656-1	90669-74-2	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-492-00-4	"Residual oils (petroleum), catalytic dewaxed; Baseoil - unspecified"	294-843-3	91770-57-9	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-493-00-X	"Distillates (petroleum), dewaxed heavy paraffinic, hydrotreated; Baseoil - unspecified; [A complex combination of hydrocarbons obtained from an intensive treatment of dewaxed distillate by hydrogenation in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C25 through C39 and produces a finished oil with a viscosity of approximately 44 cSt at 50 °C.]"	295-300-3	91995-39-0	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-494-00-5	"Distillates (petroleum), dewaxed light paraffinic, hydrotreated; Baseoil - unspecified; [A complex combination of hydrocarbons obtained from an intensive treatment of dewaxed distillate by hydrogenation in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C21 through C29 and produces a finished oil with a viscosity of approximately 13 cSt at 50 °C.]"	295-301-9	91995-40-3	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-495-00-0	"Distillates (petroleum), hydrocracked solvent-refined, dewaxed; Baseoil - unspecified; [A complex combination of liquid hydrocarbons obtained by recrystallization of dewaxed hydrocracked solvent-refined petroleum distillates.]"	295-306-6	91995-45-8	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-496-00-6	"Distillates (petroleum), solvent-refined light naphthenic, hydrotreated; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst and removing the aromatic hydrocarbons by solvent extraction. It consists predominantly of naphthenic hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of between 13-15cSt at 40 °C.]"	295-316-0	91995-54-9	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-497-00-1	"Lubricating oils (petroleum), C17-35, solvent-extd., dewaxed, hydrotreated; Baseoil - unspecified"	295-423-2	92045-42-6	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-498-00-7	"Lubricating oils (petroleum), hydrocracked nonarom. solvent-deparaffined; Baseoil - unspecified"	295-424-8	92045-43-7	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-499-00-2	"Residual oils (petroleum), hydrocracked acid-treated solvent-dewaxed; Baseoil - unspecified; [A complex combination of hydrocarbons produced by solvent removal of paraffins from the residue of the distillation of acid-treated, hydrocracked heavy paraffins and boiling approximately above 380 °C (716 °F).]"	295-499-7	92061-86-4	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-500-00-6	"Paraffin oils (petroleum), solvent-refined dewaxed heavy; Baseoil - unspecified; [A complex combination of hydrocarbons obtained from sulfur-containing paraffinic crude oil. It consists predominantly of a solvent refined deparaffinated lubricating oil with a viscosity of 65cSt at 50 °C.]"	295-810-6	92129-09-4	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-501-00-1	"Lubricating oils (petroleum), base oils, paraffinic; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by refining of crude oil. It consists predominantly of aromatics, naphthenics and paraffinics and produces a finished oil with a viscosity of 120 SUS at 100 °F (23cSt at 40 °C).]"	297-474-6	93572-43-1	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-502-00-7	"Hydrocarbons, hydrocracked paraffinic distn. residues, solvent-dewaxed; Baseoil - unspecified"	297-857-8	93763-38-3	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-503-00-2	"Hydrocarbons, C20-50, residual oil hydrogenation vacuum distillate; Baseoil - unspecified"	300-257-1	93924-61-9	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-504-00-8	"Distillates (petroleum), solvent-refined hydrotreated heavy, hydrogenated; Baseoil - unspecified"	305-588-5	94733-08-1	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-505-00-3	"Distillates (petroleum), solvent-refined hydrocracked light; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by solvent dearomatization of the residue of hydrocracked petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C27 and boiling in the range of approximately 370 °C to 450 °C (698 °F to 842 °F).]"	305-589-0	94733-09-2	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-506-00-9	"Lubricating oils (petroleum), C18-40, solvent-dewaxed hydrocracked distillate-based; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by solvent deparaffination of the distillation residue from hydrocracked petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C40 and boiling in the range of approximately 370 °C to 550 °C (698 °F to 1022 °F).]"	305-594-8	94733-15-0	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-507-00-4	"Lubricating oils (petroleum), C18-40, solvent-dewaxed hydrogenated raffinate-based; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by solvent deparaffination of the hydrogenated raffinate obtained by solvent extraction of a hydrotreated petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C40 and boiling in the range of approximately 370 °C to 550 °C (698 °F to 1022 °F).]"	305-595-3	94733-16-1	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-508-00-X	"Hydrocarbons, C13-30, arom.-rich, solvent-extd. naphthenic distillate; Baseoil - unspecified"	305-971-7	95371-04-3	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-509-00-5	"Hydrocarbons, C16-32, arom. rich, solvent-extd. naphthenic distillate; Baseoil - unspecified"	305-972-2	95371-05-4	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-510-00-0	"Hydrocarbons, C37-68, dewaxed deasphalted hydrotreated vacuum distn. residues; Baseoil - unspecified"	305-974-3	95371-07-6	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-511-00-6	"Hydrocarbons, C37-65, hydrotreated deasphalted vacuum distn. residues; Baseoil - unspecified"	305-975-9	95371-08-7	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-512-00-1	"Distillates (petroleum), hydrocracked solvent-refined light; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by the solvent treatment of a distillate from hydrocracked petroleum distillates. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C27 and boiling in the range of approximately 370 °C to 450 °C (698 °F to 842 °F.]"	307-010-7	97488-73-8	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-513-00-7	"Distillates (petroleum), solvent-refined hydrogenated heavy; Baseoil - unspecified; [A complex combination of hydrocarbons, obtained by the treatment of a hydrogenated petroleum distillate with a solvent. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C19 through C40 and boiling in the range of approximately 390 °C to 550 °C (734 °F to 1022 °F).]"	307-011-2	97488-74-9	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-514-00-2	"Lubricating oils (petroleum), C18-27, hydrocracked solvent-dewaxed; Baseoil - unspecified"	307-034-8	97488-95-4	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-515-00-8	"Hydrocarbons, C17-30, hydrotreated solvent-deasphalted atm. distn. residue, distn. lights; Baseoil - unspecified; [A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of a solvent deasphalted short residue with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C30 and boiling in the range of approximately 300 °C to 400 °C (572 °F to 752 °F). It produces a finished oil having a viscosity of 4cSt at approximately 100 °C (212 °F).]"	307-661-7	97675-87-1	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-516-00-3	"Hydrocarbons, C17-40, hydrotreated solvent-deasphalted distn. residue, vacuum distn. lights; Baseoil - unspecified; [A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the catalytic hydrotreatment of a solvent deasphalted short residue having a viscosity of 8cSt at approximately 100 °C (212 °F). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C40 and boiling in the range of approximately 300 °C to 500 °C (592 °F to 932 °F).]"	307-755-8	97722-06-0	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-517-00-9	"Hydrocarbons, C13-27, solvent-extd. light naphthenic; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 9.5cSt at 40 °C (104 °F). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C13 through C27 and boiling in the range of approximately 240 °C to 400 °C (464 °F to 752 °F.]"	307-758-4	97722-09-3	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-518-00-4	"Hydrocarbons, C14-29, solvent-extd. light naphthenic; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 16cSt at 40 °C (104 °F). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C14 through C29 and boiling in the range of approximately 250 °C to 425 °C (482 °F to 797 °F).]"	307-760-5	97722-10-6	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-519-00-X	"Hydrocarbons, C27-42, dearomatized; Baseoil - unspecified"	308-131-8	97862-81-2	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-520-00-5	"Hydrocarbons, C17-30, hydrotreated distillates, distn. lights; Baseoil - unspecified"	308-132-3	97862-82-3	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-521-00-0	"Hydrocarbons, C27-45, naphthenic vacuum distn.; Baseoil - unspecified"	308-133-9	97862-83-4	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-522-00-6	"Hydrocarbons, C27-45, dearomatized; Baseoil - unspecified"	308-287-7	97926-68-6	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-523-00-1	"Hydrocarbons, C20-58, hydrotreated; Baseoil - unspecified"	308-289-8	97926-70-0	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-524-00-7	"Hydrocarbons, C27-42, naphthenic; Baseoil - unspecified"	308-290-3	97926-71-1	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-525-00-2	"Residual oils (petroleum), carbon-treated solvent-dewaxed; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by the treatment of solvent-dewaxed petroleum residual oils with activated charcoal for the removal of trace polar constituents and impurities.]"	309-710-8	100684-37-5	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-526-00-8	"Residual oils (petroleum), clay-treated solvent-dewaxed; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by treatment of solvent-dewaxed petroleum residual oils with bleaching earth for the removal of trace polar constituents and impurities.]"	309-711-3	100684-38-6	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-527-00-3	"Lubricating oils (petroleum), C >25, solvent-extd., deasphalted, dewaxed, hydrogenated; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of vacuum distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C25 and produces a finished oil with a viscosity in the order of 32cSt to 37cSt at 100 °C (212 °F).]"	309-874-0	101316-69-2	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-528-00-9	"Lubricating oils (petroleum), C17-32, solvent-extd., dewaxed, hydrogenated; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C32 and produced a finished oil with a viscosity in the order of 17cSt to 23cSt at 40 °C (104 °F.]"	309-875-6	101316-70-5	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-529-00-4	"Lubricating oils (petroleum), C20-35, solvent-extd., dewaxed, hydrogenated; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C35 and produces a finished oil with a viscosity in the order of 37cSt to 44cSt at 40 °C (104 °F).]"	309-876-1	101316-71-6	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-530-00-X	"Lubricating oils (petroleum), C24-50, solvent-extd., dewaxed, hydrogenated; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C24 through C50 and produces a finished oil with a viscosity in the order of 16cSt to 75cSt at 40 °C (104 °F).]"	309-877-7	101316-72-7	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-531-00-5	"Extracts (petroleum), heavy naphthenic distillate solvent, arom. conc.; Distillate aromatic extract (treated); [An aromatic concentrate produced by adding water to heavy naphthenic distillate solvent extract and extraction solvent.]"	272-175-3	68783-00-6	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-532-00-0	"Extracts (petroleum), solvent-refined heavy paraffinic distillate solvent; Distillate aromatic extract (treated); [A complex combination of hydrocarbons obtained as the extract from the re-extraction of solvent-refined heavy paraffinic distillate. It consists of saturated and aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50.]"	272-180-0	68783-04-0	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-533-00-6	"Extracts (petroleum), heavy paraffinic distillates, solvent-deasphalted; Distillate aromatic extract (treated); [A complex combination of hydrocarbons obtained as the extract from a solvent extraction of heavy paraffinic distillate.]"	272-342-0	68814-89-1	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-534-00-1	"Extracts (petroleum), heavy naphthenic distillate solvent, hydrotreated; Distillate aromatic extract (treated); [A complex combination of hydrocarbons obtained by treating a heavy naphthenic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 19cSt at 40 °C (100 SUS at 100 °F).]"	292-631-5	90641-07-9	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-535-00-7	"Extracts (petroleum), heavy paraffinic distillate solvent, hydrotreated; Distillate aromatic extract (treated); [A complex combination of hydrocarbons produced by treating a heavy paraffinic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C21 through C33 and boiling in the range of approximately 350 °C to 480 °C (662 °F to 896 °F)."	292-632-0	90641-08-0	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-536-00-2	"Extracts (petroleum), light paraffinic distillate solvent, hydrotreated; Distillate aromatic extract (treated); [A complex combination of hydrocarbons produced by treating a light paraffinic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C26 and boiling in the range of approximately 280 °C to 400 °C (536 °F to 752 °F).]"	292-633-6	90641-09-1	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-537-00-8	"Extracts (petroleum), hydrotreated light paraffinic distillate solvent; Distillate aromatic extract (treated); [A complex combination of hydrocarbons obtained as the extract from solvent extraction of intermediate paraffinic top solvent distillate that is treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C36.]"	295-335-4	91995-73-2	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-538-00-3	"Extracts (petroleum), light naphthenic distillate solvent, hydrodesulfurized; Distillate aromatic extract (treated); [A complex combination of hydrocarbons obtained by treating the extract, obtained from a solvent extraction process, with hydrogen in the presence of a catalyst under conditions primarily to remove sulfur compounds. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C15 through C30. This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]"	295-338-0	91995-75-4	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-539-00-9	"Extracts (petroleum), light paraffinic distillate solvent, acid-treated; Distillate aromatic extract (treated); [A complex combination of hydrocarbons obtained as a fraction of the distillation of an extract from the solvent extraction of light paraffinic top petroleum distillates that is subjected to a sulfuric acid refining. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.]"	295-339-6	91995-76-5	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-540-00-4	"Extracts (petroleum), light paraffinic distillate solvent, hydrodesulfurized; Distillate aromatic extract (treated); [A complex combination of hydrocarbons obtained by solvent extraction of a light paraffin distillate and treated with hydrogen to convert the organic sulfur to hydrogen sulfide which is eliminated. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C40 and produces a finished oil with a viscosity of greater than 10cSt at 40 °C.]"	295-340-1	91995-77-6	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-541-00-X	"Extracts (petroleum), light vacuum gas oil solvent, hydrotreated; Distillate aromatic extract (treated); [A complex combination of hydrocarbons, obtained by solvent extraction from light vacuum petroleum gas oils and treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.]"	295-342-2	91995-79-8	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-542-00-5	"Extracts (petroleum), heavy paraffinic distillate solvent, clay-treated; Distillate aromatic extract (treated); [A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contact or percolation process to remove the trace amounts of polar compounds and impurities present. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50. This stream is likely to contain 5 wt.% or more 4-6 membered ring aromatic hydrocarbons.]"	296-437-1	92704-08-0	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-543-00-0	"Extracts (petroleum), heavy naphthenic distillate solvent, hydrodesulfurized; Distillate aromatic extract (treated); [A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C50 and produces a finished oil with a viscosity of greater than 19cSt at 40 °C.]"	297-827-4	93763-10-1	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-544-00-6	"Extracts (petroleum), solvent-dewaxed heavy paraffinic distillate solvent, hydrodesulfurized; Distillate aromatic extract (treated); [A complex combination of hydrocarbons obtained from a solvent dewaxed petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C50 and produces a finished oil with a viscosity of greater than 19cSt at 40 °C.]"	297-829-5	93763-11-2	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-545-00-1	"Extracts (petroleum), light paraffinic distillate solvent, carbon-treated; Distillate aromatic extract (treated); [A complex combination of hydrocarbons obtained as a fraction from distillation of an extract recovered by solvent extraction of light paraffinic top petroleum distillate treated with activated charcoal to remove traces of polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.]"	309-672-2	100684-02-4	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-546-00-7	"Extracts (petroleum), light paraffinic distillate solvent, clay-treated; Distillate aromatic extract (treated); [A complex combination of hydrocarbons obtained as a fraction from distillation of an extract recovered by solvent extraction of light paraffinic top petroleum distillates treated with bleaching earth to remove traces of polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.]"	309-673-8	100684-03-5	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-547-00-2	"Extracts (petroleum), light vacuum, gas oil solvent, carbon-treated; Distillate aromatic extract (treated); [A complex combination of hydrocarbons obtained by solvent extraction of light vacuum petroleum gas oil treated with activated charcoal for the removal of trace polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.]"	309-674-3	100684-04-6	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-548-00-8	"Extracts (petroleum), light vacuum gas oil solvent, clay-treated; Distillate aromatic extract (treated); [A complex combination of hydrocarbons obtained by solvent extraction of light vacuum petroleum gas oils treated with bleaching earth for removal of trace polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.]"	309-675-9	100684-05-7	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-549-00-3	Foots oil (petroleum); Foots oil; [A complex combination of hydrocarbons obtained as the oil fraction from a solvent deoiling or a wax sweating process. It consists predominantly of branched chain hydrocarbons having carbon numbers predominantly in the range of C20 through C50.]	265-171-8	64742-67-2	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
649-550-00-9	"Foots oil (petroleum), hydrotreated; Foots oil"	295-394-6	92045-12-0	Carc. 1B	H350	GHS08Dgr	H350			L	CLP00
650-002-00-6	"turpentine, oil"	232-350-7	8006-64-2	Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Asp. Tox. 1Skin Irrit. 2Eye Irrit. 2Skin Sens. 1Aquatic Chronic 2	H226H332H312H302H304H315H319H317H411	GHS02GHS08GHS07GHS09Dgr	H226H332H312H302H304H319H315H317H411				CLP00
650-003-00-1	fenson (ISO); 4-chlorophenyl benzenesulphonate	201-274-6	80-38-6	Acute Tox. 4 *Eye Irrit. 2Aquatic Chronic 2	H302H319H411	GHS07GHS09Wng	H302H319H411				CLP00
650-004-00-7	"norbormide (ISO); 5-(?-hydroxy-?-2-pyridylbenzyl)-7-(?-2-pyridylbenzylidene)bicyclo [2.2.1] hept-5-ene-2,3-dicarboximide"	213-589-6	991-42-4	Acute Tox. 4 *	H302	GHS07Wng	H302				CLP00
650-005-00-2	"(2R,6aS,12aS)-1,2,6,6a,12,12a-hexahydro-2-isopropenyl-8,9-dimethoxychromeno[3,4-b]furo[2,3-h]chromen-6-one, rotenone"	201-501-9	83-79-4	Acute Tox. 3 *STOT SE 3Skin Irrit. 2Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1	H301H335H315H319H400H410	GHS06GHS09Dgr	H301H319H335H315H410				CLP00
650-006-00-8	benquinox (ISO); p-benzoquinone 1-benzoylhydrazone 4-oxime	207-807-9	495-73-8	Acute Tox. 3 *Acute Tox. 4 *	H301H312	GHS06Dgr	H301H312				CLP00
650-007-00-3	"chlordimeform (ISO); N2-(4-chloro-o-tolyl)-N1,N1-dimethylformamidine"	228-200-5	6164-98-3	Carc. 2Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H351H312H302H400H410	GHS08GHS07GHS09Wng	H351H312H302H410				CLP00
650-008-00-9	drazoxolon (ISO); 4-(2-chlorophenylhydrazone)-3-methyl-5-isoxazolone	227-197-8	5707-69-7	Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1	H301H400H410	GHS06GHS09Dgr	H301H410				CLP00
650-009-00-4	"chlordimeform hydrochloride; N'-(4-chloro-o-tolyl)-N,N-dimethylformamidine monohydrochloride; N2-(4-chloro-o-tolyl)-N1,N1-dimethylformamidine hydorchloride"	243-269-1	19750-95-9	Carc. 2Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H351H302H400H410	GHS08GHS07GHS09Wng	H351H302H410				CLP00
650-010-00-X	"benzyl violet 4B; ?-[4-(4-dimethylamino-?-{}{4-[ethyl(3-sodiosulphonatobenzyl)amino] phenyl}}benzylidene)cyclohexa-2,5-dienylidene(ethyl)ammonio]toluene-3-sulphonate"	216-901-9	1694-09-3	Carc. 2	H351	GHS08Wng	H351				CLP00
650-012-00-0	erionite		12510-42-8	Carc. 1A	H350	GHS08Dgr	H350				CLP00
650-013-00-6	asbestos [1]asbestos [2]asbestos [3]asbestos [4]asbestos [5]asbestos [6]asbestos [7]		12001-28-4 [1]132207-32-0 [2]12172-73-5 [3]77536-66-4 [4]77536-68-6 [5]77536-67-5 [6]12001-29-5 [7]	Carc. 1ASTOT RE 1	H350H372 **	GHS08Dgr	H350H372 **				CLP00
650-014-00-1	"diethyl 2,4-dihydroxycyclodisiloxane-2,4-diylbis(trimethylene)diphosphonate, tetrasodium salt, reaction products with disodium metasilicate"	401-770-4		Acute Tox. 4 *Skin Corr. 1B	H302H314	GHS05GHS07Dgr	H314H302				CLP00
650-015-00-7	rosin; colophony [1]rosin; colophony [2]rosin; colophony [3]	232-475-7 [1]232-484-6 [2]277-299-1 [3]	8050-09-7 [1]8052-10-6 [2]73138-82-6 [3]	Skin Sens. 1	H317	GHS07Wng	H317				CLP00
650-016-00-2	"Mineral wool, with the exception of those specified elsewhere in this Annex; [Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content greater than 18 % by weight]"	-	-	Carc. 2	H351	GHS08Wng	H351			A Q R	CLP00/ATP01
650-017-00-8	"Refractory Ceramic Fibres, Special Purpose Fibres, with the exception of those specified elsewhere in this Annex; [Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+ MgO+BaO) content less or equal to 18 % by weight]"	-	-	Carc. 1B	H350i	GHS08Dgr	H350i			A R	CLP00/ATP01
650-018-00-3	"reaction product of: acetophenone, formaldehyde, cyclohexylamine, methanol and acetic acid"	406-230-1		Flam. Liq. 3Carc. 2Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H226H351H332H314H317H400H410	GHS02GHS08GHS05GHS07GHS09Dgr	H226H351H314H332H317H410				CLP00
650-031-00-4	bis(4-hydroxy-N-methylanilinium) sulphate	200-237-1	55-55-0	Acute Tox. 4 *STOT RE 2 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H302H373 **H317H400H410	GHS08GHS07GHS09Wng	H302H373 **H317H410				CLP00
650-032-00-X	"cyproconazole (ISO); (2RS,3RS;2RS,3SR)-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol"		94361-06-5	Repr. 2Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H361d ***H302H400H410	GHS08GHS07GHS09Wng	H361d ***H302H410				CLP00
650-041-00-9	"triasulfuron (ISO); 1-[2-(2-chloroethoxy)phenylsulfonyl]-3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)urea"		82097-50-5	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
650-042-00-4	reaction product of: polyethylene-polyamine-(C16-C18)-alkylamides with monothio-(C2)-alkyl phosphonates	417-450-2		Skin Irrit. 2Eye Irrit. 2Skin Sens. 1Aquatic Chronic 3	H315H319H317H412	GHS07Wng	H319H315H317H412				CLP00
650-043-00-X	"reaction product of: 3,5-bis-tert-butylsalicylic acid and aluminiumsulfate"	420-310-3		Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1	H302H400H410	GHS07GHS09Wng	H302H410				CLP00
650-044-00-5	"mixed linear and branched C14-15 alcohols ethoxylated, reaction product with epichlorohydrin"	420-480-9	158570-99-1	Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H315H317H400H410	GHS07GHS09Wng	H315H317H410				CLP00
650-045-00-0	"reaction product of: 1,2,3-propanetricarboxylic acid, 2-hydroxy, diethyl ester, 1-propanol and zirconium tetra-n-propanolate"	417-110-3		Flam. Liq. 2Skin Irrit. 2Eye Dam. 1Aquatic Chronic 2	H225H315H318H411	GHS02GHS05GHS09Dgr	H225H315H318H411				CLP00
650-046-00-6	"di(tetramethylammonium)(29H,31H-phthalocyanin-N29,N30,N31,N32)disulfonamide disulfonate, cuprate(2-)complex, derivates"	416-180-2	12222-04-7	Acute Tox. 4 *STOT RE 2 *Aquatic Chronic 2	H302H373 **H411	GHS08GHS07GHS09Wng	H302H373 **H411				CLP00
650-047-00-1	dibenzylphenylsulfonium hexafluoroantimonate	417-760-8	134164-24-2	Acute Tox. 4 *STOT RE 1Eye Dam. 1Skin Sens. 1Aquatic Chronic 2	H302H372 **H318H317H411	GHS08GHS05GHS07GHS09Dgr	H372 **H302H318H317H411				CLP00
650-048-00-7	"reaction product of: borax, hydrogen peroxide, acetic acid anhydride and acetic acid"	420-070-1		Org. Perox. D ****Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1AAquatic Acute 1	H242H332H312H302H314H400	GHS02GHS05GHS07GHS09Dgr	H242H332H312H302H314H400				CLP00
650-049-00-2	"2-alkoyloxyethyl hydrogen maleate, where alkoyl represents (by weight) 70 to 85 % unsaturated octadecoyl, 0.5 to 10 % saturated octadecoyl, and 2 to 18 % saturated hexadecoyl"	417-960-5		Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1	H315H318H317H400H410	GHS05GHS07GHS09Dgr	H315H318H317H410				CLP00
650-050-00-8	"reaction mass of: 1-methyl-3-hydroxypropyl 3,5-[1,1-dimethylethyl]-4-hydroxydihydro-cinnamate and/or 3-hydroxybutyl 3,5-[1,1-dimethylethyl]-4-hydroxydihydrocinnamate; 1,3-butanediol bis[3-(3'-(1,1-dimethylethyl)4'-hydroxy-phenyl)propionate] isomers; 1,3-butanediol bis[3-(3',5'-(1,1-dimethylethyl)-4'-hydroxyphenyl)propionate] isomers"	423-600-8		Aquatic Chronic 2	H411	GHS09	H411				CLP00
650-055-00-5	silver sodium zirconium hydrogenphosphate	422-570-3	155925-27-2	Aquatic Acute 1Aquatic Chronic 1	H400H410	GHS09Wng	H410				CLP00
